{"head": {"vars": ["disease", "gene", "span_text", "doc"]}, "results": {"bindings": [{"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOA1"}, "span_text": {"type": "literal", "value": "A significant relationship between the apolipoprotein A1 concentration and endothelial behavior supports the suggestion that aberrant lipid metabolism may be involved in the endothelial dysfunction characteristic of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9988805"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CP"}, "span_text": {"type": "literal", "value": "Copper and ceruloplasmin were assayed in maternal and cord blood sera and in the placenta of 10 women with normal pregnancies, in 10 patients mild and 10 with severe pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/998171"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CP"}, "span_text": {"type": "literal", "value": "Copper and ceruloplasmin levels were significantly elevated in the maternal blood of pre-eclamptic patients as compared with normal pregnant women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/998171"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CP"}, "span_text": {"type": "literal", "value": "Ceruloplasmin and copper level in maternal and cord blood and in the placenta in normal pregnancy and in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/998171"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EPO"}, "span_text": {"type": "literal", "value": "This paper is a summary of results obtained in our studies on leptinemia in patients with chronic renal failure treated with recombinant human erythropoietin (rHuEPO), in kidney transplant patients, in patients with essential hypertension, and in pregnant women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9950182"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "From these studies, it follows that the elucidation of abnormal leptin secretion in the pathogenesis of preeclampsia needs further study."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9950182"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Pathophysiological role of leptin in patients with chronic renal failure, in kidney transplant patients, in patients with essential hypertension, and in pregnant women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9950182"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "The mean plasma concentration of C-type natriuretic peptide in the women with normal pregnancy was 7.1 +/-2.5 pg/mL, in those with gestational hypertension 9.6+/-4.2 pg/mL, and in those with preeclampsia 8.1+/-2.4 pg/mL."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9932555"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "C-type natriuretic peptide levels in women with gestational hypertension and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9932555"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "Our results suggest that C-type natriuretic peptide plasma levels are not significantly different in normal pregnancies and those complicated by gestational hypertension or preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9932555"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "To measure plasma levels of C-type natriuretic peptide in women with normal pregnancies and those complicated by gestational hypertension and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9932555"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EPO"}, "span_text": {"type": "literal", "value": "Are maternal diabetes and preeclampsia independent simulators of fetal erythropoietin production?"}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9926879"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EPO"}, "span_text": {"type": "literal", "value": "To determine if diabetes and preeclampsia are independent stimulators of erythropoietin, distinct from hypoxia, we measured umbilical cord plasma erythropoietin in 239 deliveries from 24 to 40 weeks of gestation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9926879"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VCAM1"}, "span_text": {"type": "literal", "value": "Although vascular cell adhesion molecule 1 and E-selectin were elevated in maternal serum samples from women with preeclampsia and on the endothelial surface after stimulation with such sera, there were no detectable increases in the levels of both of these adhesion molecules in the supernatant of cultured endothelial cells."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9914581"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VCAM1"}, "span_text": {"type": "literal", "value": "In contrast, with immunofluorescence microscopy we could detect higher amounts of vascular cell adhesion molecule 1, intercellular cell adhesion molecule 1, and E-selectin on the endothelial surface after stimulation with sera from women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9914581"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VCAM1"}, "span_text": {"type": "literal", "value": "We stimulated these cells for 24 hours with sera from patients with preeclampsia and then determined the levels of vascular cell adhesion molecule 1, intercellular cell adhesion molecule 1, E-selectin, and P-selectin in the supernatant and in the maternal serum by means of enzyme-linked immunosorbent assay."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9914581"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VCAM1"}, "span_text": {"type": "literal", "value": "Adhesion molecules, such as vascular cell adhesion molecule 1, are known to be increased in the serum of patients with preeclampsia, indicating that these molecules are possible markers of endothelial cell activation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9914581"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SHBG"}, "span_text": {"type": "literal", "value": "Serum testosterone, dehydroepiandrosterone sulfate, sex hormone binding globulin, and estradiol levels were measured in 16 subjects in the third trimester of pregnancy with documented preeclampsia and 26 healthy, normotensive women with similar maternal and gestational ages."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9914579"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "A complete understanding of the role of insulin resistance in the generation of preeclampsia will aid significantly in the discovery of the genetic polymorphisms and intracellular pathways by which insulin resistance is translated into cardiovascular disease, stroke, and nephropathy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9891620"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Insulin resistance and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9891620"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Evidence is beginning to accumulate that preeclampsia is at least partially mediated by insulin resistance as well, and that individuals with preeclampsia may have clinically silent but persistent alterations in insulin resistance."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9891620"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VCAM1"}, "span_text": {"type": "literal", "value": "Vascular cell adhesion molecule-1 (VCAM-1) and leukocyte activation in pre-eclampsia and eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9856316"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ELN"}, "span_text": {"type": "literal", "value": "Elastin of the umbilical cord arteries and its alterations in EPH gestosis (preeclampsia)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9852359"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "Peripartal temporal course of endothelin 1, angiotensin II, and atrial natriuretic peptide in pre-eclampsia and normotensive pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9813426"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "To investigate the temporal peripartal course of plasma endothelin 1 (ET-1), angiotensin II (ANG II), and atrial natriuretic peptide (ANP) in patients with pre-eclampsia as compared to women with normotensive pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9813426"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "To investigate the temporal peripartal course of plasma endothelin 1 (ET-1), angiotensin II (ANG II), and atrial natriuretic peptide (ANP) in patients with pre-eclampsia as compared to women with normotensive pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9813426"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Peripartal temporal course of endothelin 1, angiotensin II, and atrial natriuretic peptide in pre-eclampsia and normotensive pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9813426"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Antibodies against copper-oxidised and malondialdehyde-modified low density lipoproteins in pre-eclampsia pregnancies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9800936"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "There are increased titers of serum autoantibodies against copper-oxidised LDL in pre-eclampsia, which may reflect enhanced lipid peroxidation involving circulating lipoproteins."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9800936"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "In pre-eclampsia there is an increase in the maternal circulation of two strong vasoconstrictor factors (endothelin-1 and noradrenalin) and a sharp increase both in the density and the affinity of calcium-channel binding sites in placental bed central area."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9800935"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Higher plasma levels of endothelin-1 and noradrenalin were found in women with pre-eclampsia compared with normotensive women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9800935"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "To investigate whether pre-eclampsia is associated with an exaggeration of the insulin resistance seen in normotensive pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9800933"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Insulin sensitivity in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9800933"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Insulin sensitivity (S(I)) was increased in the group with pre-eclampsia compared with the normotensive women (mean [+/-SEM]:"}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9800933"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "As with other forms of secondary hypertension, and unlike essential hypertension, the pathophysiology of pre-eclampsia is not associated with insulin resistance."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9800933"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CSF1"}, "span_text": {"type": "literal", "value": "To evaluate the serum levels of interleukin-4, interleukin-10, and granulocyte-macrophage colony-stimulating factor at the moment of diagnosis and in early second-trimester serum from women with preeclampsia and from gestational age-matched controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9794681"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CSF1"}, "span_text": {"type": "literal", "value": "Interleukin-4, interleukin-10, and granulocyte-macrophage colony stimulating factor in second-trimester serum from women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9794681"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CSF2"}, "span_text": {"type": "literal", "value": "In second-trimester serum, granulocyte-macrophage colony-stimulating factor detection rates (20 and 70% respectively, P = .06) and concentrations (0 pg/mL [range 0-32] and 2.5 pg/mL [range 0-37], respectively, P = .08) were lower in the group of preeclampsia, but the differences do not reach statistical significance."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9794681"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CSF1"}, "span_text": {"type": "literal", "value": "Serum levels of granulocyte-macrophage colony-stimulating factor at the moment of diagnosis were detected less frequently (21 compared with 71%, P < .01) and in lower concentrations (0 pg/mL [range 0-56] compared with 55.5 pg/mL [range 0-105], P = .01) in women with preeclampsia as compared with controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9794681"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CSF2"}, "span_text": {"type": "literal", "value": "Serum levels of granulocyte-macrophage colony-stimulating factor at the moment of diagnosis were detected less frequently (21 compared with 71%, P < .01) and in lower concentrations (0 pg/mL [range 0-56] compared with 55.5 pg/mL [range 0-105], P = .01) in women with preeclampsia as compared with controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9794681"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CSF2"}, "span_text": {"type": "literal", "value": "Differences in granulocyte-macrophage colony-stimulating factor support the concept of the existence of an immunologic imbalance as part of the etiologic mechanisms leading to preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9794681"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL4"}, "span_text": {"type": "literal", "value": "Interleukin-4, interleukin-10, and granulocyte-macrophage colony stimulating factor in second-trimester serum from women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9794681"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CSF1"}, "span_text": {"type": "literal", "value": "Differences in granulocyte-macrophage colony-stimulating factor support the concept of the existence of an immunologic imbalance as part of the etiologic mechanisms leading to preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9794681"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CSF2"}, "span_text": {"type": "literal", "value": "To evaluate the serum levels of interleukin-4, interleukin-10, and granulocyte-macrophage colony-stimulating factor at the moment of diagnosis and in early second-trimester serum from women with preeclampsia and from gestational age-matched controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9794681"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL4"}, "span_text": {"type": "literal", "value": "To evaluate the serum levels of interleukin-4, interleukin-10, and granulocyte-macrophage colony-stimulating factor at the moment of diagnosis and in early second-trimester serum from women with preeclampsia and from gestational age-matched controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9794681"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CSF1"}, "span_text": {"type": "literal", "value": "In second-trimester serum, granulocyte-macrophage colony-stimulating factor detection rates (20 and 70% respectively, P = .06) and concentrations (0 pg/mL [range 0-32] and 2.5 pg/mL [range 0-37], respectively, P = .08) were lower in the group of preeclampsia, but the differences do not reach statistical significance."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9794681"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CSF2"}, "span_text": {"type": "literal", "value": "Interleukin-4, interleukin-10, and granulocyte-macrophage colony stimulating factor in second-trimester serum from women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9794681"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL10"}, "span_text": {"type": "literal", "value": "Interleukin-4, interleukin-10, and granulocyte-macrophage colony stimulating factor in second-trimester serum from women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9794681"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL10"}, "span_text": {"type": "literal", "value": "To evaluate the serum levels of interleukin-4, interleukin-10, and granulocyte-macrophage colony-stimulating factor at the moment of diagnosis and in early second-trimester serum from women with preeclampsia and from gestational age-matched controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9794681"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Elevated levels of lipoprotein(a) in women with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9790410"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "These findings suggest that insulin resistance may play a role in the pathogenesis of the hypertensive disorders of pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9790393"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VCAM1"}, "span_text": {"type": "literal", "value": "Small low-density lipoproteins and vascular cell adhesion molecule-1 are increased in association with hyperlipidemia in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9781635"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VCAM1"}, "span_text": {"type": "literal", "value": "In the same individuals, we measured serum concentrations of a marker of vascular dysfunction previously reported to be increased in preeclampsia, soluble vascular cell adhesion molecule-1 (VCAM-1), and examined the association of VCAM-1 with LDL diameter and serum lipids."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9781635"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADM2"}, "span_text": {"type": "literal", "value": "To investigate the possibility that adrenomedullin is involved in the pathophysiology of preeclampsia, we measured its concentration in maternal and fetoplacental compartments."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9774376"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADM"}, "span_text": {"type": "literal", "value": "Adrenomedullin, a new vasoactive peptide, is increased in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9774376"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADM2"}, "span_text": {"type": "literal", "value": "Adrenomedullin, a new vasoactive peptide, is increased in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9774376"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADM2"}, "span_text": {"type": "literal", "value": "Increased local production of adrenomedullin is associated with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9774376"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADM"}, "span_text": {"type": "literal", "value": "Increased local production of adrenomedullin is associated with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9774376"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADM"}, "span_text": {"type": "literal", "value": "To investigate the possibility that adrenomedullin is involved in the pathophysiology of preeclampsia, we measured its concentration in maternal and fetoplacental compartments."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9774376"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADM"}, "span_text": {"type": "literal", "value": "Preeclamptic patients showed higher concentrations (P<0.01) than normotensive pregnant women of adrenomedullin in amniotic fluid (252+/-29 versus 112+/-10 fmol/ micromol creatinine) and umbilical vein plasma (18.1+/-2.1 versus 8."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9774376"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADM2"}, "span_text": {"type": "literal", "value": "Preeclamptic patients showed higher concentrations (P<0.01) than normotensive pregnant women of adrenomedullin in amniotic fluid (252+/-29 versus 112+/-10 fmol/ micromol creatinine) and umbilical vein plasma (18.1+/-2.1 versus 8."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9774376"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ICAM1"}, "span_text": {"type": "literal", "value": "To determine whether in preeclampsia endothelial cellular-surface adhesion molecules are responsible for increased neutrophil-endothelial adhesion, cellular adhesion molecule expression of P-selectin, intercellular adhesion molecule-1 (ICAM-1), vascular cellular adhesion molecule-1 (VCAM-1), and E-selectin were examined by an enzyme-linked binding assay."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9773398"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CGB2"}, "span_text": {"type": "literal", "value": "Midtrimester urine human chorionic gonadotropin beta-subunit core fragment levels and the subsequent development of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9757981"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CGB5"}, "span_text": {"type": "literal", "value": "Midtrimester urine human chorionic gonadotropin beta-subunit core fragment levels and the subsequent development of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9757981"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CGB7"}, "span_text": {"type": "literal", "value": "Our purpose was to determine whether midtrimester maternal urine human chorionic gonadotropin beta-subunit core fragment predicts later pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9757981"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CGB1"}, "span_text": {"type": "literal", "value": "Midtrimester urine human chorionic gonadotropin beta-subunit core fragment levels and the subsequent development of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9757981"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CGB5"}, "span_text": {"type": "literal", "value": "Our purpose was to determine whether midtrimester maternal urine human chorionic gonadotropin beta-subunit core fragment predicts later pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9757981"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CGB2"}, "span_text": {"type": "literal", "value": "Our purpose was to determine whether midtrimester maternal urine human chorionic gonadotropin beta-subunit core fragment predicts later pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9757981"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CGB7"}, "span_text": {"type": "literal", "value": "Midtrimester urine human chorionic gonadotropin beta-subunit core fragment levels and the subsequent development of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9757981"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CGB8"}, "span_text": {"type": "literal", "value": "Our purpose was to determine whether midtrimester maternal urine human chorionic gonadotropin beta-subunit core fragment predicts later pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9757981"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CGB1"}, "span_text": {"type": "literal", "value": "Our purpose was to determine whether midtrimester maternal urine human chorionic gonadotropin beta-subunit core fragment predicts later pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9757981"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CGB8"}, "span_text": {"type": "literal", "value": "Midtrimester urine human chorionic gonadotropin beta-subunit core fragment levels and the subsequent development of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9757981"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VCAM1"}, "span_text": {"type": "literal", "value": "Addition of free fatty acids to normal pregnancy serum to mimic the effect of preeclampsia resulted in increased expression of vascular cell adhesion molecule-1 on the cells."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9757968"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VCAM1"}, "span_text": {"type": "literal", "value": "The elevated level of free fatty acids in women with preeclampsia may contribute to increased vascular cell adhesion molecule expression in vivo."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9757968"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Augmented placental production of leptin in preeclampsia: possible involvement of placental hypoxia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9745432"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL4"}, "span_text": {"type": "literal", "value": "The aim of this study was to characterise the localisation and staining intensity of immunoreactive (ir) interleukin-4 (IL-4) and IL-4 receptor (IL-4R) in human placenta and fetal membranes in association with pre-term and term labour, and pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9736798"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL4"}, "span_text": {"type": "literal", "value": "Immunolocalisation of interleukin-4 and interleukin-4 receptor in placenta and fetal membranes in association with pre-term labour and pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9736798"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL4R"}, "span_text": {"type": "literal", "value": "Immunolocalisation of interleukin-4 and interleukin-4 receptor in placenta and fetal membranes in association with pre-term labour and pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9736798"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Endothelin-1 (ET-1) is a vasoconstrictor peptide of the endotheliocyte and is increased in the sera of preeclamptic patients."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9736792"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VCAM1"}, "span_text": {"type": "literal", "value": "Women with established pre-eclampsia had increased vascular cell adhesion molecule-1 levels compared with the normotensive pregnancy group (P = .01)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9731854"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VCAM1"}, "span_text": {"type": "literal", "value": "Vascular cell adhesion molecule-1 levels were not elevated in women with established gestational hypertension."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9731854"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VCAM1"}, "span_text": {"type": "literal", "value": "Established pre-eclampsia is characterized by selective dysregulation of vascular cell adhesion molecule-1 homeostasis."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9731854"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VCAM1"}, "span_text": {"type": "literal", "value": "Induction of vascular cell adhesion molecule-1 expression in pre-eclampsia may contribute to leukocyte-mediated tissue injury in this condition or may reflect perturbation of other, previously unrecognized, functions of this molecule in pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9731854"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VCAM1"}, "span_text": {"type": "literal", "value": "Circulating vascular cell adhesion molecule-1 in pre-eclampsia, gestational hypertension, and normal pregnancy: evidence of selective dysregulation of vascular cell adhesion molecule-1 homeostasis in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9731854"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PDGFD"}, "span_text": {"type": "literal", "value": "Expression of platelet-derived growth factor-A mRNA in human placenta: effect of magnesium infusion in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9699964"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PDGFD"}, "span_text": {"type": "literal", "value": "The expression of platelet-derived growth factor-A (PDGF-A) mRNA was examined in the cotyledons of normal human placentae and those from patients with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9699964"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL2"}, "span_text": {"type": "literal", "value": "Increased serum concentrations of interleukin-2 receptor in the first trimester in women who later developed severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9688233"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOE"}, "span_text": {"type": "literal", "value": "Apolipoprotein E alleles in women with severe pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9659248"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOE"}, "span_text": {"type": "literal", "value": "This study investigated the frequency of apolipoprotein E (apoE) alleles among women with severe pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9659248"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Because changes in lipids, lipoprotein, and other metabolic processes, such as hyperinsulinemia and hyperuricemia, found in preeclampsia resemble the main features of the insulin resistance syndrome, it has been proposed that insulin resistance may be the common denominator for such metabolic changes."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9654606"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Women with preeclampsia had higher fasting insulin levels, but also exaggerated hyperinsulinemia, in response to an oral glucose tolerance test, which is consistent with increased insulin resistance in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9654606"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Because changes in lipids, lipoprotein, and other metabolic processes, such as hyperinsulinemia and hyperuricemia, found in preeclampsia resemble the main features of the insulin resistance syndrome, it has been proposed that insulin resistance may be the common denominator for such metabolic changes."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9654606"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Insulin resistance may not be the cause of preeclampsia, but is one of the pathogenic factors, especially in genetically predisposed women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9654606"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Insulin resistance syndrome in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9654606"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "No direct measurement of insulin sensitivity (clamp or minimal model) has as yet been performed during preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9654606"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "Placental expression of endothelial constitutive nitric oxide synthase mRNA in pregnancy complicated by preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9654168"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "Midtrimester N-terminal proatrial natriuretic peptide, free beta hCG, and alpha-fetoprotein in predicting preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9611000"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AFP"}, "span_text": {"type": "literal", "value": "To determine whether maternal midtrimester serum N-terminal peptide of proatrial natriuretic peptide, free beta subunit of human chorionic gonadotropin (hCGbeta), or alpha-fetoprotein (AFP) levels can predict preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9611000"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "To determine whether maternal midtrimester serum N-terminal peptide of proatrial natriuretic peptide, free beta subunit of human chorionic gonadotropin (hCGbeta), or alpha-fetoprotein (AFP) levels can predict preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9611000"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "No difference was found in the concentrations of the N-terminal peptide of proatrial natriuretic peptide among the 30 women in whom preeclampsia developed later (median 270 [range 142-604] pmol/L) compared with 536 women who remained normotensive (274 [51-2626] pmol/L)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9611000"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AFP"}, "span_text": {"type": "literal", "value": "Midtrimester N-terminal proatrial natriuretic peptide, free beta hCG, and alpha-fetoprotein in predicting preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9611000"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "Determinations of the proposed new marker N-terminal peptide of proatrial natriuretic peptide, as well as serum hCGbeta or AFP, are not helpful in predicting preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9611000"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ESAM"}, "span_text": {"type": "literal", "value": "Circulating levels of endothelial cell adhesion molecules are elevated in women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9605448"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "No differences were found at the 30th week of pregnancy in total body water, serum sodium, potassium, chloride and osmolality, plasma volume, total protein concentration, intravascular protein mass, serum albumin concentration, intravascular albumin mass, and urinary estriol and pregnanediol in 94 primigravidae who remained normotensive, 35 who developed mild preeclampsia, and 23 who developed severe preeclampsia (i.e. hypertension and significant proteinuria in the third trimester)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/955865"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "Plasma concentrations of asymmetric dimethylarginine, a natural inhibitor of nitric oxide synthase, in normal pregnancy and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9539525"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Leptin concentrations were significantly higher in the normal pregnant women (37.1 microg/L, [15.4-117.0], geometric mean, [range]; p=0.049), and women with pre-eclampsia (45.3 microg/L, [21.3-98.4]; p=0.001), than in non-pregnant controls (17.85 microg/L, [1.3-36.5]), however, there was no significant difference between uncomplicated and pre-eclamptic pregnancies (p=0.22)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9539272"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "We measured third trimester plasma leptin concentrations in 12 uncomplicated pregnant women, nine women with pre-eclampsia matched for age and booking BMI, and 18 non-pregnant women similarly matched."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9539272"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Insulin resistance increases during late pregnancy and is believed to be further enhanced in pregnancies complicated by pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9539272"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Endothelin-1 levels in mothers with eclampsia--pre-eclampsia and their newborns."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9538607"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CSF1"}, "span_text": {"type": "literal", "value": "Blood macrophage colony-stimulating factor and thrombin-antithrombin III complex concentrations in pregnancy and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9537640"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CSF1"}, "span_text": {"type": "literal", "value": "Macrophage colony-stimulating factor (M-CSF) is a characteristic cytokine that plays an essential role in placenta maintenance, and thrombin-antithrombin III complex (TAT) is a hemostatic marker that is remarkably altered both in normal pregnancy and in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9537640"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CSF2"}, "span_text": {"type": "literal", "value": "Macrophage colony-stimulating factor (M-CSF) is a characteristic cytokine that plays an essential role in placenta maintenance, and thrombin-antithrombin III complex (TAT) is a hemostatic marker that is remarkably altered both in normal pregnancy and in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9537640"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CSF2"}, "span_text": {"type": "literal", "value": "Blood macrophage colony-stimulating factor and thrombin-antithrombin III complex concentrations in pregnancy and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9537640"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:F12"}, "span_text": {"type": "literal", "value": "A serial study of coagulation factors XII, XI and X in plasma has been carried out on 60 primigravidae, prospectively comparing those who remained normal with those who developed pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/952795"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:F12"}, "span_text": {"type": "literal", "value": "A serial study of coagulation factors XII, XI and X in plasma in normal pregnancy and in pregnancy complicated by pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/952795"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Plasma levels of Lp(a) lipoprotein were lower in the total preeclampsia group as well as in all preeclampsia subgroups (5.45+/-7.41, 5.58+/-8.02, 5.08+/-5.38, and 4.32+/-5.28 mg/dl in the total preeclampsia group, and in subgroups with mild preeclampsia, severe preeclampsia, and preeclampsia with fetal growth retardation, respectively) than in the control group (7.84+/-9.26 mg/dl) as determined by quantitative electroimmunoassay."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9520129"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "This study was performed to investigate the possible association between preeclampsia and the plasma concentrations of Lp(a) lipoprotein and TGF-beta1 in a large series of patients."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9520129"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Plasma concentrations of Lp(a) lipoprotein and the active form of TGF-beta1 did not differ significantly between the preeclampsia subgroups."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9520129"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Plasma concentrations of Lp(a) lipoprotein and TGF-beta1 are altered in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9520129"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CSF1"}, "span_text": {"type": "literal", "value": "An elevation of erythropoietin and interleukin (IL)-3 levels was seen in babies born under the conditions of preeclampsia, whereas the concentrations of granulocyte/macrophage-colony-stimulating factor (CSF), granulocyte-CSF, and IL-1 beta were reduced, and the levels of IL-6 and IL-8 remained constant."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9505273"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EPO"}, "span_text": {"type": "literal", "value": "An elevation of erythropoietin and interleukin (IL)-3 levels was seen in babies born under the conditions of preeclampsia, whereas the concentrations of granulocyte/macrophage-colony-stimulating factor (CSF), granulocyte-CSF, and IL-1 beta were reduced, and the levels of IL-6 and IL-8 remained constant."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9505273"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CSF2"}, "span_text": {"type": "literal", "value": "An elevation of erythropoietin and interleukin (IL)-3 levels was seen in babies born under the conditions of preeclampsia, whereas the concentrations of granulocyte/macrophage-colony-stimulating factor (CSF), granulocyte-CSF, and IL-1 beta were reduced, and the levels of IL-6 and IL-8 remained constant."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9505273"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADM2"}, "span_text": {"type": "literal", "value": "Adrenomedullin in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9500359"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADM"}, "span_text": {"type": "literal", "value": "Adrenomedullin in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9500359"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Preeclampsia has, therefore, several features in common with the insulin resistance syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9492712"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "These results support the concept that preeclampsia is associated with metabolic aberrations found in insulin resistance syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9492712"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "The objective of the present study was to investigate the glucose tolerance and insulin response of women with preeclampsia compared to women with normal pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9492712"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "The incremental area under the curve for the glucose (p = 0.001) and insulin (p = 0.02) responses to oral glucose tolerance test showed higher values for preeclampsia as compared to women with normal pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9492712"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "In contrast, the increased concentrations of NO metabolites in amniotic fluid and the positive immunostaining of endothelial nitric oxide synthase in the placental villi suggest that the placental L-arginine-NO system is up-regulated in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9481550"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EGFR"}, "span_text": {"type": "literal", "value": "Placental pathology in preeclampsia (PE) and intrauterine growth retardation (IUGR) is associated with alterations of the placental epidermal growth factor receptor (EGFR)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9475680"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EGFR"}, "span_text": {"type": "literal", "value": "Altered mRNA expression pattern of placental epidermal growth factor receptor (EGFR) in pregnancies complicated by preeclampsia and/or intrauterine growth retardation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9475680"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GSTA1"}, "span_text": {"type": "literal", "value": "Plasma glutathione S-transferase Alpha 1-1 measurements may provide a more sensitive indicator of acute hepatic damage in preeclampsia and the syndrome of hemolysis, elevated liver enzymes, and low platelets compared with the assessment of aminotransferase activity and therefore may allow earlier recognition of these syndromes."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9465822"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GSTA1"}, "span_text": {"type": "literal", "value": "Almost half the patients with preeclampsia showed elevated levels of alanine aminotransferase and/or glutathione S-transferase Alpha 1-1."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9465822"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GSTA1"}, "span_text": {"type": "literal", "value": "Our purpose was to investigate the value of plasma glutathione S-transferase Alpha 1-1 measurements in the assessment of hepatocellular damage in hypertensive disorders of pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9465822"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GSTA1"}, "span_text": {"type": "literal", "value": "Plasma glutathione S-transferase alpha 1-1: a more sensitive marker for hepatocellular damage than serum alanine aminotransferase in hypertensive disorders of pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9465822"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GSTA1"}, "span_text": {"type": "literal", "value": "When both levels were elevated, the relative magnitude of the increase of glutathione S-transferase Alpha 1-1 levels was significantly higher than that of alanine aminotransferase activity in preeclampsia (p < 0.01) and the syndrome of hemolysis, elevated liver enzymes, and low platelets (p < 0.0001)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9465822"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "The lipoprotein(a) level was significantly higher in severe than in mild preeclampsia (p < 0.001)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9465819"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "This study has demonstrated that lipoprotein(a) levels are elevated in preeclampsia and associated with severity of the disease."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9465819"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "The plasma lipoprotein(a) levels were increased in pregnant women with both severe preeclampsia (median 826.9 mg/L [interquartile range 590.7, 986.9 mg/L], n = 8, p < 0.0001) and mild preeclampsia (median 357.7 mg/L [interquartile range 208.0, 477.1 mg/L], n = 18, p < 0.0001) compared with normal pregnancy (median 78.5 mg/L [interquartile range 45.2, 127.9 mg/L], n = 24)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9465819"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "We examined the hypothesis that lipoprotein(a) levels are elevated in preeclampsia and associated with severity of the disease."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9465819"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Elevated levels of lipoprotein(a) in women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9465819"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "We suggest 15-hydroxyeicosatetraenoic acid plays a role in the oxidation of lipoproteins and the endothelial damage characteristic of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9465803"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "Expanding the severly pre-eclamptic patient's blood volume with intravenous albumin appears to be an effective and appropriate therapy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/945695"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AVP"}, "span_text": {"type": "literal", "value": "We evaluated contraction (KCl and arginine vasopressin [AVP]) and dilation (acetylcholine and bradykinin) in small resistance-size omental arteries obtained during surgery from women with preeclampsia, postulating that these vessels would exhibit augmented contraction and diminished endothelium-dependent relaxation, most likely due to decreased NO synthesis."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9435319"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "The differences between normal and preeclamptic cytotrophoblasts in prostacyclin, PGE2, and endothelin-1 secretion and in response to preeclamptic serum suggest altered arachidonic acid metabolism in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9423756"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Serum from women with preeclampsia partially corrects the abnormal in vitro prostacyclin secretion of preeclamptic villous cytotrophoblasts but not that of prostaglandin E2 or endothelin-1."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9423756"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL6"}, "span_text": {"type": "literal", "value": "Preeclampsia is associated with decreased placental interleukin-6 production."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9420866"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "These results provide evidence to suggest that elevation of circulating endothelin-1 in pregnant sheep can produce cardiovascular and hemodynamic changes that in many ways resemble the human disease preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9403587"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "This supports the hypothesis that endothelial cell damage and/or dysfunction that is associated with increased production of endothelin-1 could directly contribute to the progression of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9403587"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Plasma concentration of endothelin-1, a potent vasoconstrictor produced by the vascular endothelium, has been observed to be significantly increased in a number of pathophysiological states, including preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9403587"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADM2"}, "span_text": {"type": "literal", "value": "Decreased circulating adrenomedullin in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9393346"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADM"}, "span_text": {"type": "literal", "value": "Decreased circulating adrenomedullin in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9393346"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL1B"}, "span_text": {"type": "literal", "value": "Cytokines have been implicated in the pathogenesis of pre-eclampsia, so we determined the effects of interleukin-1beta (IL-1beta) and tumor necrosis factor-alpha (TNF-alpha) on the in vitro aggregation of human platelets."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9364994"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL1B"}, "span_text": {"type": "literal", "value": "The regulation of platelet aggregation in vitro by interleukin-1beta and tumor necrosis factor-alpha: changes in pregnancy and in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9364994"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "We previously hypothesized that the endothelial cell dysfunction observed in women with preeclampsia might be caused by an imbalance between circulating very low density lipoproteins and a cytoprotective pI 5.6 isoform of albumin, referred to as toxicity preventing albumin (TxPA)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9360542"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "However, the quantity of NEFA bound to albumin was greater in preeclampsia plasma (2.5 mol NEFA/mol albumin) compared to that in normal pregnancy plasma (0.8 mol NEFA/mol albumin), accounting for the acidic pI shift observed in albumin from the former patients."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9360542"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "Elevated nonesterified fatty acid concentrations in severe preeclampsia shift the isoelectric characteristics of plasma albumin."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9360542"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "We previously hypothesized that the endothelial cell dysfunction observed in women with preeclampsia might be caused by an imbalance between circulating very low density lipoproteins and a cytoprotective pI 5.6 isoform of albumin, referred to as toxicity preventing albumin (TxPA)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9360542"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "This study was conducted to determine whether altered levels of vascular endothelial growth factor (VEGF) may play a role in the pathogenesis of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9352019"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "This study was conducted to determine whether altered levels of vascular endothelial growth factor (VEGF) may play a role in the pathogenesis of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9352019"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Vascular endothelial growth factor is increased in patients with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9352019"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Vascular endothelial growth factor is increased in patients with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9352019"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "This study was conducted to determine whether altered levels of vascular endothelial growth factor (VEGF) may play a role in the pathogenesis of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9352019"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Vascular endothelial growth factor is increased in patients with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9352019"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "Atrial natriuretic peptide in preeclampsia: metabolic clearance, sodium excretion and renal hemodynamics."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9321923"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "To further elucidate the role of atrial natriuretic peptide (ANP) in preeclampsia, its metabolic clearance (MCRANP) was determined concomitantly with its effects on sodium excretion (UNa), glomerular filtration rate (GFR), and effective renal plasma flow (ERPF)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9321923"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Effects of anti-endothelial cell antibody in pre-eclampsia on endothelin-1 release from cultured endothelial cells."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9315474"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "In order to investigate the pathophysiological significance of anti-endothelial cell antibody (AECA) in pre-eclampsia, the effects of AECA on endothelin-1 (ET-1) and prostaglandin I2 (PGI2) release from cultured human umbilical vein endothelial cells (HUVEC) was evaluated."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9315474"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGT"}, "span_text": {"type": "literal", "value": "Preeclampsia is associated with a common molecular variant of angiotensinogen (Met235Thr)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9294106"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGT"}, "span_text": {"type": "literal", "value": "Since angiotensin II levels could play a role in atherotic changes of the uterine spiral arteries associated with preeclampsia, we investigated angiotensinogen expression in the first trimester uterus."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9294106"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOO"}, "span_text": {"type": "literal", "value": "Lipoprotein(a) and apolipoprotein(a) phenotype do not contribute significantly to the pathogenesis of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9292635"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOM"}, "span_text": {"type": "literal", "value": "Lipoprotein(a) and apolipoprotein(a) phenotype do not contribute significantly to the pathogenesis of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9292635"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGFB2"}, "span_text": {"type": "literal", "value": "Pre-eclampsia might result from a less effective invasion of trophoblast cells in the myometrium, caused by attenuated immunosuppression in the spiral arteries, resulting from inhibition of plasmin-mediated activation of transforming growth factor-beta-like substances."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9292635"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOE"}, "span_text": {"type": "literal", "value": "Elevated levels of serum lipoprotein(a) and apolipoprotein(a) phenotype are not related to pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9292635"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Elevated levels of serum lipoprotein(a) and apolipoprotein(a) phenotype are not related to pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9292635"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Lipoprotein(a) and apolipoprotein(a) phenotype do not contribute significantly to the pathogenesis of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9292635"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOM"}, "span_text": {"type": "literal", "value": "Elevated levels of serum lipoprotein(a) and apolipoprotein(a) phenotype are not related to pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9292635"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Thus, high plasma levels of lipoprotein(a) might result in increased incidence of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9292635"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGFB1"}, "span_text": {"type": "literal", "value": "Pre-eclampsia might result from a less effective invasion of trophoblast cells in the myometrium, caused by attenuated immunosuppression in the spiral arteries, resulting from inhibition of plasmin-mediated activation of transforming growth factor-beta-like substances."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9292635"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOF"}, "span_text": {"type": "literal", "value": "Elevated levels of serum lipoprotein(a) and apolipoprotein(a) phenotype are not related to pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9292635"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOE"}, "span_text": {"type": "literal", "value": "Lipoprotein(a) and apolipoprotein(a) phenotype do not contribute significantly to the pathogenesis of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9292635"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGFB3"}, "span_text": {"type": "literal", "value": "Pre-eclampsia might result from a less effective invasion of trophoblast cells in the myometrium, caused by attenuated immunosuppression in the spiral arteries, resulting from inhibition of plasmin-mediated activation of transforming growth factor-beta-like substances."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9292635"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOF"}, "span_text": {"type": "literal", "value": "Lipoprotein(a) and apolipoprotein(a) phenotype do not contribute significantly to the pathogenesis of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9292635"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOO"}, "span_text": {"type": "literal", "value": "Elevated levels of serum lipoprotein(a) and apolipoprotein(a) phenotype are not related to pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9292635"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VCAM1"}, "span_text": {"type": "literal", "value": "Longitudinal analysis of soluble plasma intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 levels during pregnancy revealed that these molecules (1) show little variation in healthy pregnant women, (2) do not vary during normal pregnancy, and (3) are significantly elevated in women with preeclampsia and the syndrome of hemolysis, elevated liver enzymes, and low platelets compared with control pregnant women and those with uncomplicated pregnancy-induced hypertension."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9290466"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ICAM1"}, "span_text": {"type": "literal", "value": "Plasma levels of intercellular adhesion molecule-1, vascular cell adhesion molecule-1, E-selectin, and platelet endothelial cell adhesion molecule-1 were significantly elevated in women with preeclampsia compared with healthy control pregnant women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9290466"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ESAM"}, "span_text": {"type": "literal", "value": "The aim of the current study was to determine levels of circulating endothelial cell adhesion molecules during preeclampsia and to assess their predictive value as diagnostic markers for the early identification of pregnant women at risk of developing preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9290466"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VCAM1"}, "span_text": {"type": "literal", "value": "Plasma levels of intercellular adhesion molecule-1, vascular cell adhesion molecule-1, E-selectin, and platelet endothelial cell adhesion molecule-1 were significantly elevated in women with preeclampsia compared with healthy control pregnant women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9290466"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PECAM1"}, "span_text": {"type": "literal", "value": "Plasma levels of intercellular adhesion molecule-1, vascular cell adhesion molecule-1, E-selectin, and platelet endothelial cell adhesion molecule-1 were significantly elevated in women with preeclampsia compared with healthy control pregnant women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9290466"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VCAM1"}, "span_text": {"type": "literal", "value": "Although currently based on a limited database, significantly elevated levels of soluble intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in the plasma of otherwise healthy pregnant women suggest a very high predictive value of these molecules for the earliest identification of women at risk of developing preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9290466"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ICAM1"}, "span_text": {"type": "literal", "value": "Although currently based on a limited database, significantly elevated levels of soluble intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in the plasma of otherwise healthy pregnant women suggest a very high predictive value of these molecules for the earliest identification of women at risk of developing preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9290466"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Differences in mRNA expression of endothelin-1, c-fos and c-jun in placentas from normal pregnancies and pregnancies complicated with preeclampsia and/or intrauterine growth retardation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9286720"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "In the postglucose ingestion state, the gestational hypertension trend was toward insulin resistance even though normal insulin activity occurs in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9284010"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "In the postglucose ingestion state, insulin activity and glucose tolerance was lower in gestational hypertension than in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9284010"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Gestational diabetes associated with gestational hypertension was characterized by high insulin resistance."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9284010"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Fasting corrected insulin response and glucose tolerance were higher in gestational hypertension and preeclampsia than in the control group."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9284010"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "We have tested the hypothesis that placental activity of the enzyme which synthesizes nitric oxide (nitric oxide synthase) is reduced in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9279203"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "These results provide evidence that human placental nitric oxide synthase activity is significantly reduced in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9279203"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "Reduced placental nitric oxide synthase activity may have an adverse effect on placental haemodynamic function in pre-eclampsia, and could be involved in the pathogenesis of this important and common obstetric complication."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9279203"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "Reduction of placental nitric oxide synthase activity in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9279203"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL2"}, "span_text": {"type": "literal", "value": "Evidence for an elevation in serum interleukin-2 and tumor necrosis factor-alpha levels before the clinical manifestations of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9272206"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL2"}, "span_text": {"type": "literal", "value": "The serum concentrations of interleukin-2 (IL-2) and tumor necrosis factor-alpha (TNF-alpha) were determined by using enzyme-linked immunoadsorbent assay (ELISA) in the first trimester of pregnancy in women who had preeclampsia develop after 28 weeks of pregnancy (preeclamptic group) and in women who completed pregnancy uneventfully (control group)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9272206"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL2"}, "span_text": {"type": "literal", "value": "Interleukin-2 (IL-2) expressed in preeclamptic decidua might reduce the angiogenic substances arising from trophoblasts by inducing LAK-cells from decidual lymphocytes, which might be relevant to deranged vasculature of the placenta, a characteristic histology in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9272205"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL2"}, "span_text": {"type": "literal", "value": "Pathogenetic implication of interleukin-2 expressed in preeclamptic decidual tissues: a possible mechanism of deranged vasculature of the placenta associated with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9272205"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "Small subcutaneous arteries from normotensive pregnant women showed substantial flow-induced relaxation, which was attenuated by the nitric oxide synthase inhibitor N(omega)-nitro-L-arginine methyl ester (L-NAME) (mean relaxation, 48.3+/-8.0% [absence of L-NAME] versus 19.2+/-10.6% [presence of L-NAME]), whereas those from nonpregnant women and women with preeclampsia demonstrated modest constriction (mean constriction, 10.1+/-7.3% and 1.2+/-7.2%, respectively)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9260988"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HGF"}, "span_text": {"type": "literal", "value": "Levels of hepatocyte growth factor and its messenger ribonucleic acid in uncomplicated pregnancies and those complicated by preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9253361"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HGF"}, "span_text": {"type": "literal", "value": "The purpose of this study was to elucidate the possible relationship between hepatocyte growth factor (HGF) expression and the pathogenesis of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9253361"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "This does not appear to be due to changes in potassium, atrial natriuretic peptide, dopamine or ACTH, and may be another manifestation of increased (adrenal) sensitivity to AII in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9247750"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGT"}, "span_text": {"type": "literal", "value": "Total renin concentration is normal and plasma concentrations of high molecular weight angiotensinogen are increased in pre-eclampsia though total angiotensinogen is normal."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9247750"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:DPP3"}, "span_text": {"type": "literal", "value": "Histochemical evaluation of placental dipeptidyl peptidase IV (CD26) in pre-eclampsia: enzyme activity in villous trophoblast indicates an enhanced likelihood of gestational hypertensive disorders."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9228301"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:DPP4"}, "span_text": {"type": "literal", "value": "Histochemical evaluation of placental dipeptidyl peptidase IV (CD26) in pre-eclampsia: enzyme activity in villous trophoblast indicates an enhanced likelihood of gestational hypertensive disorders."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9228301"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:DPP8"}, "span_text": {"type": "literal", "value": "Histochemical evaluation of placental dipeptidyl peptidase IV (CD26) in pre-eclampsia: enzyme activity in villous trophoblast indicates an enhanced likelihood of gestational hypertensive disorders."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9228301"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:DPP9"}, "span_text": {"type": "literal", "value": "Histochemical evaluation of placental dipeptidyl peptidase IV (CD26) in pre-eclampsia: enzyme activity in villous trophoblast indicates an enhanced likelihood of gestational hypertensive disorders."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9228301"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:DPP7"}, "span_text": {"type": "literal", "value": "Histochemical evaluation of placental dipeptidyl peptidase IV (CD26) in pre-eclampsia: enzyme activity in villous trophoblast indicates an enhanced likelihood of gestational hypertensive disorders."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9228301"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MTHFR"}, "span_text": {"type": "literal", "value": "Methylenetetrahydrofolate reductase polymorphism and pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9192280"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Placental expression of vascular endothelial growth factor in placentae from pregnancies complicated by pre-eclampsia and intrauterine growth restriction does not support placental hypoxia at delivery."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9179920"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Placental expression of vascular endothelial growth factor in placentae from pregnancies complicated by pre-eclampsia and intrauterine growth restriction does not support placental hypoxia at delivery."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9179920"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "In view of the pathological placental features of pre-eclampsia and intrauterine growth restriction (IUGR), and the angiogenic effects of vascular endothelial growth factor (VEGF), the aim of this study was to determine the expression of VEGF in placentae from normal pregnancies and to compare the results with placentae from pregnancies complicated by pre-eclampsia and intrauterine growth restriction (IUGR)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9179920"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Placental expression of vascular endothelial growth factor in placentae from pregnancies complicated by pre-eclampsia and intrauterine growth restriction does not support placental hypoxia at delivery."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9179920"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "In view of the pathological placental features of pre-eclampsia and intrauterine growth restriction (IUGR), and the angiogenic effects of vascular endothelial growth factor (VEGF), the aim of this study was to determine the expression of VEGF in placentae from normal pregnancies and to compare the results with placentae from pregnancies complicated by pre-eclampsia and intrauterine growth restriction (IUGR)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9179920"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "In view of the pathological placental features of pre-eclampsia and intrauterine growth restriction (IUGR), and the angiogenic effects of vascular endothelial growth factor (VEGF), the aim of this study was to determine the expression of VEGF in placentae from normal pregnancies and to compare the results with placentae from pregnancies complicated by pre-eclampsia and intrauterine growth restriction (IUGR)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9179920"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "We have utilized two distinct monospecific antibodies against the type II (macrophage or inducible) nitric oxide synthase (NOS) isoform to localize the distribution of the enzyme within the human placenta in tissues from normotensive pregnancies and those complicated by pre-eclampsia and/or intrauterine growth restriction."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9179919"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL1RN"}, "span_text": {"type": "literal", "value": "Plasma interleukin-1alpha, interleukin-1beta and interleukin-1 receptor antagonist levels in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9175684"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL1B"}, "span_text": {"type": "literal", "value": "The values of plasma interleukin-1alpha (IL-1alpha), interleukin-1beta (IL-1beta) and interleukin-1 receptor antagonist (IL-1ra) levels were evaluated as the markers of pre-eclampsia in 35 serial plasma samples from ten pregnant women who subsequently developed pre-eclampsia and in 74 plasma samples from 20 uncomplicated pregnancies, retrospectively."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9175684"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL1A"}, "span_text": {"type": "literal", "value": "Plasma interleukin-1alpha, interleukin-1beta and interleukin-1 receptor antagonist levels in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9175684"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL1RN"}, "span_text": {"type": "literal", "value": "The values of plasma interleukin-1alpha (IL-1alpha), interleukin-1beta (IL-1beta) and interleukin-1 receptor antagonist (IL-1ra) levels were evaluated as the markers of pre-eclampsia in 35 serial plasma samples from ten pregnant women who subsequently developed pre-eclampsia and in 74 plasma samples from 20 uncomplicated pregnancies, retrospectively."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9175684"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL1A"}, "span_text": {"type": "literal", "value": "The values of plasma interleukin-1alpha (IL-1alpha), interleukin-1beta (IL-1beta) and interleukin-1 receptor antagonist (IL-1ra) levels were evaluated as the markers of pre-eclampsia in 35 serial plasma samples from ten pregnant women who subsequently developed pre-eclampsia and in 74 plasma samples from 20 uncomplicated pregnancies, retrospectively."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9175684"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL1B"}, "span_text": {"type": "literal", "value": "Plasma interleukin-1alpha, interleukin-1beta and interleukin-1 receptor antagonist levels in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9175684"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Twelve patients with severe preeclampsia undergoing an indicated abdominal delivery had endothelin-1 levels measured from plasma specimens drawn from right and left uterine and antecubital veins before delivery and after placenta removal with uterine curettage."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9166315"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "To determine the site of origin of increased concentrations of plasma endothelin-1 in patients with severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9166315"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "The origin of endothelin-1 in patients with severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9166315"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Overall, patients with preeclampsia had higher plasma concentrations of endothelin-1 (mean 11.0 +/- 6.6 pg/mL) compared with normotensive patients (mean 8.4 +/- 6.7 pg/mL, P < .005)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9166315"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "An increase of the plasma N-terminal peptide of proatrial natriuretic peptide in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9166314"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "A marked elevation in N-terminal peptide of proatrial natriuretic peptide may predict development of severe preeclampsia and/or an SGA infant."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9166314"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "The levels of N-terminal peptide of proatrial natriuretic peptide were higher in women with preeclampsia than in those with gestational hypertension and higher in women with gestational hypertension than in those with normal pregnancies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9166314"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "At entry into the study the values for the N-terminal peptide of proatrial natriuretic peptide were higher in the subgroup of women who developed severe preeclampsia and/or gave birth to a small for gestational age (SGA) infant compared to the values in the subgroup of women in whom the hypertensive condition remained stable (710 [271-1475] versus 407 pmol/L [189-1067], P = .006)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9166314"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "To determine whether increased concentrations of the N-terminal peptide of proatrial natriuretic peptide and of atrial natriuretic peptide are related to the severity of preeclampsia and gestational hypertension."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9166314"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "The N-terminal peptide of proatrial natriuretic peptide levels were significantly higher in preeclamptic women than in healthy pregnant controls (median 571 [range 189-2000] versus 266 pmol/L [80-634], P < .001) and also significantly higher in women with severe preeclampsia than in women with mild preeclampsia (766 [431-2000] versus 492 pmol/L [189-1283], P = .01)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9166314"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AFP"}, "span_text": {"type": "literal", "value": "The association between hypertensive disorders of pregnancy and abnormal second-trimester maternal serum levels of hCG and alpha-fetoprotein."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9166297"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AFP"}, "span_text": {"type": "literal", "value": "To examine the association between hypertensive disorders of pregnancy and second-trimester maternal serum alpha-fetoprotein (MSAFP) and hCG levels."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9166297"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AFP"}, "span_text": {"type": "literal", "value": "The association of early-onset fetal growth restriction, elevated maternal serum alpha-fetoprotein, and the development of severe pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9160381"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ICAM1"}, "span_text": {"type": "literal", "value": "To investigate the correlation between soluble forms of the intercellular adhesion molecule (sICAM-1) and vascular cell adhesion molecule (sVCAM-1) and the severity of pre-eclampsia or its possible consequences for fetal growth."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9141584"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VCAM1"}, "span_text": {"type": "literal", "value": "To investigate the correlation between soluble forms of the intercellular adhesion molecule (sICAM-1) and vascular cell adhesion molecule (sVCAM-1) and the severity of pre-eclampsia or its possible consequences for fetal growth."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9141584"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ICAM1"}, "span_text": {"type": "literal", "value": "Increased levels of intercellular adhesion molecules and vascular cell adhesion molecules in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9141584"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ICAM2"}, "span_text": {"type": "literal", "value": "Increased levels of intercellular adhesion molecules and vascular cell adhesion molecules in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9141584"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ICAM5"}, "span_text": {"type": "literal", "value": "To investigate the correlation between soluble forms of the intercellular adhesion molecule (sICAM-1) and vascular cell adhesion molecule (sVCAM-1) and the severity of pre-eclampsia or its possible consequences for fetal growth."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9141584"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VCAM1"}, "span_text": {"type": "literal", "value": "Increased levels of intercellular adhesion molecules and vascular cell adhesion molecules in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9141584"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ICAM5"}, "span_text": {"type": "literal", "value": "Increased levels of intercellular adhesion molecules and vascular cell adhesion molecules in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9141584"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ICAM2"}, "span_text": {"type": "literal", "value": "To investigate the correlation between soluble forms of the intercellular adhesion molecule (sICAM-1) and vascular cell adhesion molecule (sVCAM-1) and the severity of pre-eclampsia or its possible consequences for fetal growth."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9141584"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP5"}, "span_text": {"type": "literal", "value": "Circulating insulin-like growth factor binding protein-1 levels in subjects with severe preeclampsia were 428.3 +/- 85.9 ng/ml compared with 76.6 +/- 11.8 in controls (p = 0.0007)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9125598"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP4"}, "span_text": {"type": "literal", "value": "Circulating insulin-like growth factor binding protein-1 levels in subjects with severe preeclampsia were 428.3 +/- 85.9 ng/ml compared with 76.6 +/- 11.8 in controls (p = 0.0007)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9125598"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP7"}, "span_text": {"type": "literal", "value": "Circulating insulin-like growth factor binding protein-1 levels in subjects with severe preeclampsia were 428.3 +/- 85.9 ng/ml compared with 76.6 +/- 11.8 in controls (p = 0.0007)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9125598"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP2"}, "span_text": {"type": "literal", "value": "Insulin-like growth factor binding protein-1 at the maternal-fetal interface and insulin-like growth factor-I, insulin-like growth factor-II, and insulin-like growth factor binding protein-1 in the circulation of women with severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9125598"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP2"}, "span_text": {"type": "literal", "value": "Circulating levels of insulin-like growth factor binding protein-1, insulin-like growth factor-I, and insulin-like growth factor-II in 16 patients with severe preeclampsia and 29 controls at the same gestational age were determined by an immunoradiometric assay and correlated with clinical parameters."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9125598"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP7"}, "span_text": {"type": "literal", "value": "Insulin-like growth factor binding protein-1 was investigated by immunohistochemistry at the maternal-fetal interface of eight pregnancies complicated by severe preeclampsia and six controls between 21 and 34 weeks of gestation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9125598"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP5"}, "span_text": {"type": "literal", "value": "Circulating levels of insulin-like growth factor binding protein-1, insulin-like growth factor-I, and insulin-like growth factor-II in 16 patients with severe preeclampsia and 29 controls at the same gestational age were determined by an immunoradiometric assay and correlated with clinical parameters."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9125598"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP4"}, "span_text": {"type": "literal", "value": "Insulin-like growth factor binding protein-1 was investigated by immunohistochemistry at the maternal-fetal interface of eight pregnancies complicated by severe preeclampsia and six controls between 21 and 34 weeks of gestation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9125598"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF1"}, "span_text": {"type": "literal", "value": "Circulating levels of insulin-like growth factor binding protein-1, insulin-like growth factor-I, and insulin-like growth factor-II in 16 patients with severe preeclampsia and 29 controls at the same gestational age were determined by an immunoradiometric assay and correlated with clinical parameters."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9125598"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP4"}, "span_text": {"type": "literal", "value": "In subjects with severe preeclampsia insulin-like growth factor binding protein-1 levels correlated with diastolic blood pressure (r = 0.498, p 0.049) and aspartate transcarbamylase (0.621, p = 0.010)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9125598"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF2"}, "span_text": {"type": "literal", "value": "We also investigated circulating levels of insulin-like growth factor-I and insulin-like growth factor-II in subjects with severe preeclampsia compared with controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9125598"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP7"}, "span_text": {"type": "literal", "value": "In subjects with severe preeclampsia insulin-like growth factor binding protein-1 levels correlated with diastolic blood pressure (r = 0.498, p 0.049) and aspartate transcarbamylase (0.621, p = 0.010)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9125598"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF1"}, "span_text": {"type": "literal", "value": "We also investigated circulating levels of insulin-like growth factor-I and insulin-like growth factor-II in subjects with severe preeclampsia compared with controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9125598"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP7"}, "span_text": {"type": "literal", "value": "Circulating levels of insulin-like growth factor binding protein-1, insulin-like growth factor-I, and insulin-like growth factor-II in 16 patients with severe preeclampsia and 29 controls at the same gestational age were determined by an immunoradiometric assay and correlated with clinical parameters."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9125598"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP5"}, "span_text": {"type": "literal", "value": "Insulin-like growth factor binding protein-1 was investigated by immunohistochemistry at the maternal-fetal interface of eight pregnancies complicated by severe preeclampsia and six controls between 21 and 34 weeks of gestation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9125598"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP3"}, "span_text": {"type": "literal", "value": "Insulin-like growth factor binding protein-1 was investigated by immunohistochemistry at the maternal-fetal interface of eight pregnancies complicated by severe preeclampsia and six controls between 21 and 34 weeks of gestation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9125598"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP3"}, "span_text": {"type": "literal", "value": "In subjects with severe preeclampsia insulin-like growth factor binding protein-1 levels correlated with diastolic blood pressure (r = 0.498, p 0.049) and aspartate transcarbamylase (0.621, p = 0.010)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9125598"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP3"}, "span_text": {"type": "literal", "value": "Circulating insulin-like growth factor binding protein-1 levels in subjects with severe preeclampsia were 428.3 +/- 85.9 ng/ml compared with 76.6 +/- 11.8 in controls (p = 0.0007)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9125598"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP2"}, "span_text": {"type": "literal", "value": "Circulating insulin-like growth factor binding protein-1 levels in subjects with severe preeclampsia were 428.3 +/- 85.9 ng/ml compared with 76.6 +/- 11.8 in controls (p = 0.0007)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9125598"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP4"}, "span_text": {"type": "literal", "value": "Insulin-like growth factor binding protein-1 at the maternal-fetal interface and insulin-like growth factor-I, insulin-like growth factor-II, and insulin-like growth factor binding protein-1 in the circulation of women with severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9125598"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP4"}, "span_text": {"type": "literal", "value": "Circulating levels of insulin-like growth factor binding protein-1, insulin-like growth factor-I, and insulin-like growth factor-II in 16 patients with severe preeclampsia and 29 controls at the same gestational age were determined by an immunoradiometric assay and correlated with clinical parameters."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9125598"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF2"}, "span_text": {"type": "literal", "value": "Circulating levels of insulin-like growth factor binding protein-1, insulin-like growth factor-I, and insulin-like growth factor-II in 16 patients with severe preeclampsia and 29 controls at the same gestational age were determined by an immunoradiometric assay and correlated with clinical parameters."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9125598"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP2"}, "span_text": {"type": "literal", "value": "Insulin-like growth factor binding protein-1 was investigated by immunohistochemistry at the maternal-fetal interface of eight pregnancies complicated by severe preeclampsia and six controls between 21 and 34 weeks of gestation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9125598"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP2"}, "span_text": {"type": "literal", "value": "In subjects with severe preeclampsia insulin-like growth factor binding protein-1 levels correlated with diastolic blood pressure (r = 0.498, p 0.049) and aspartate transcarbamylase (0.621, p = 0.010)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9125598"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP5"}, "span_text": {"type": "literal", "value": "Insulin-like growth factor binding protein-1 at the maternal-fetal interface and insulin-like growth factor-I, insulin-like growth factor-II, and insulin-like growth factor binding protein-1 in the circulation of women with severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9125598"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP7"}, "span_text": {"type": "literal", "value": "Insulin-like growth factor binding protein-1 at the maternal-fetal interface and insulin-like growth factor-I, insulin-like growth factor-II, and insulin-like growth factor binding protein-1 in the circulation of women with severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9125598"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP5"}, "span_text": {"type": "literal", "value": "In subjects with severe preeclampsia insulin-like growth factor binding protein-1 levels correlated with diastolic blood pressure (r = 0.498, p 0.049) and aspartate transcarbamylase (0.621, p = 0.010)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9125598"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF1"}, "span_text": {"type": "literal", "value": "Insulin-like growth factor binding protein-1 at the maternal-fetal interface and insulin-like growth factor-I, insulin-like growth factor-II, and insulin-like growth factor binding protein-1 in the circulation of women with severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9125598"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF2"}, "span_text": {"type": "literal", "value": "Insulin-like growth factor binding protein-1 at the maternal-fetal interface and insulin-like growth factor-I, insulin-like growth factor-II, and insulin-like growth factor binding protein-1 in the circulation of women with severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9125598"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP3"}, "span_text": {"type": "literal", "value": "Circulating levels of insulin-like growth factor binding protein-1, insulin-like growth factor-I, and insulin-like growth factor-II in 16 patients with severe preeclampsia and 29 controls at the same gestational age were determined by an immunoradiometric assay and correlated with clinical parameters."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9125598"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP3"}, "span_text": {"type": "literal", "value": "Insulin-like growth factor binding protein-1 at the maternal-fetal interface and insulin-like growth factor-I, insulin-like growth factor-II, and insulin-like growth factor binding protein-1 in the circulation of women with severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9125598"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Suppression of serum vascular endothelial growth factor immunoreactivity in normal pregnancy and in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9070144"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "To determine whether vascular endothelial growth factor (VEGF) concentrations are altered in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9070144"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Suppression of serum vascular endothelial growth factor immunoreactivity in normal pregnancy and in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9070144"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "To determine whether vascular endothelial growth factor (VEGF) concentrations are altered in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9070144"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Suppression of serum vascular endothelial growth factor immunoreactivity in normal pregnancy and in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9070144"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "To determine whether vascular endothelial growth factor (VEGF) concentrations are altered in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9070144"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PECAM1"}, "span_text": {"type": "literal", "value": "The increased platelet endothelial cell adhesion molecule-1 expression in preeclamptic patients demonstrates that, besides alpha-granular and lysosomal release, other hitherto unknown mechanisms are involved."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9065199"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SELP"}, "span_text": {"type": "literal", "value": "With this analysis an enhanced platelet activation status was present in 4 of 10 normotensive patients and a more extensive platelet activation status in all 10 preeclamptic patients, as indicated by P-selectin (p = 0.008) and CD63 (p = 0.03) expression."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9065199"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CADM1"}, "span_text": {"type": "literal", "value": "Extensive platelet activation in preeclampsia compared with normal pregnancy: enhanced expression of cell adhesion molecules."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9065199"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PECAM1"}, "span_text": {"type": "literal", "value": "Increased platelet endothelial cell adhesion molecule-1 (p = 0.005) expression was also observed in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9065199"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CADM3"}, "span_text": {"type": "literal", "value": "Extensive platelet activation in preeclampsia compared with normal pregnancy: enhanced expression of cell adhesion molecules."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9065199"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PECAM1"}, "span_text": {"type": "literal", "value": "Platelet endothelial cell adhesion molecule-1 appears to be the best marker to distinguish preeclamptic patients from normotensive pregnant women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9065199"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "To determine whether large triglyceride-rich lipoproteins, very-low-density lipoprotein1 (VLDL1), and small, dense low-density lipoprotein (LDL-III), are significantly increased in women with preeclampsia compared with concentrations seen in normal pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9052594"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Women with preeclampsia exhibit markedly elevated concentrations of triglyceride-rich lipoproteins in the circulation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9052594"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Plasma concentrations of very-low-density and low-density lipoprotein subfractions and pre-heparin hepatic lipase activity were measured in eight women with preeclampsia and in eight healthy pregnant controls matched for age, gestational age, and weight."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9052594"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Lipoprotein subfraction concentrations in preeclampsia: pathogenic parallels to atherosclerosis."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9052594"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "As increased resistance to blood flow is seen in the fetal-placental vasculature in pregnancies complicated by pre-eclampsia and/or intrauterine growth restriction (IUGR), we examined expression of endothelial nitric oxide synthase (eNOS) in these placentas."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9043923"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ICAM1"}, "span_text": {"type": "literal", "value": "29 normotensive pregnancies, and 18 nonpregnant women to test the hypothesis that serum from preeclamptic patients induces expression of intercellular adhesion molecule-1 (ICAM-1) and vascular adhesion molecule-1 (VCAM-1) and stimulates intracellular free calcium concentrations [Ca2+]i in cultured endothelial cells."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9039117"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Drug actions in preeclampsia: aspirin, but not magnesium chloride or dihydralazine, differentially inhibits cultured human trophoblast release of thromboxane and prostacyclin without affecting angiotensin II, endothelin-1, or leukotriene B4 secretion."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9024091"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ESR2"}, "span_text": {"type": "literal", "value": "Quantitative immunological detection of total estrogen receptor (cytosolic and nuclear) in term decidua of preeclampsia: a preliminary study."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9023149"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "We have measured the level of vascular endothelial growth factor (VEGF) in maternal plasma during normotensive pregnancy and in pregnancies complicated by pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9013097"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "We have measured the level of vascular endothelial growth factor (VEGF) in maternal plasma during normotensive pregnancy and in pregnancies complicated by pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9013097"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Maternal plasma levels of vascular endothelial growth factor in normotensive pregnancies and in pregnancies complicated by pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9013097"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Maternal plasma levels of vascular endothelial growth factor in normotensive pregnancies and in pregnancies complicated by pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9013097"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Maternal plasma levels of vascular endothelial growth factor in normotensive pregnancies and in pregnancies complicated by pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9013097"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "We have measured the level of vascular endothelial growth factor (VEGF) in maternal plasma during normotensive pregnancy and in pregnancies complicated by pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/9013097"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Endothelin-1 and big endothelin-1 levels in normal term pregnancy and in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8988523"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "Pre-eclampsia: the effect of intravenous fluid preload on atrial natriuretic peptide secretion during caesarean section under spinal anaesthesia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8986183"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL4"}, "span_text": {"type": "literal", "value": "Effect of antihypertensive therapy in preeclampsia on levels of serum interleukin-4."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8979093"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CSF1"}, "span_text": {"type": "literal", "value": "High blood levels of macrophage colony-stimulating factor in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8977233"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CSF2"}, "span_text": {"type": "literal", "value": "High blood levels of macrophage colony-stimulating factor in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8977233"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "To measure the mRNA levels of vascular endothelial growth factor and its receptor in the placenta following delivery after uncomplicated pregnancy and after pregnancies complicated by pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8968234"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "To measure the mRNA levels of vascular endothelial growth factor and its receptor in the placenta following delivery after uncomplicated pregnancy and after pregnancies complicated by pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8968234"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "To measure the mRNA levels of vascular endothelial growth factor and its receptor in the placenta following delivery after uncomplicated pregnancy and after pregnancies complicated by pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8968234"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD1"}, "span_text": {"type": "literal", "value": "Superoxide dismutase (SOD) activity of erythrocytes from normal pregnant women (controls) and from pre-eclamptic toxaemia (PET) cases was determined by the method of Winterbourn et al. (J Lab Clin Med 1975;85:337-341) with slight modifications."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8920222"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD3"}, "span_text": {"type": "literal", "value": "Superoxide dismutase (SOD) activity of erythrocytes from normal pregnant women (controls) and from pre-eclamptic toxaemia (PET) cases was determined by the method of Winterbourn et al. (J Lab Clin Med 1975;85:337-341) with slight modifications."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8920222"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:G6PD"}, "span_text": {"type": "literal", "value": "The activity of placental superoxide dismutase (P = 0.003) and glucose 6-phosphate-dehydrogenase (P = 0.019) was significantly lower in pre-eclampsia than in normal pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8899868"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD1"}, "span_text": {"type": "literal", "value": "The activity of placental superoxide dismutase (P = 0.003) and glucose 6-phosphate-dehydrogenase (P = 0.019) was significantly lower in pre-eclampsia than in normal pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8899868"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD3"}, "span_text": {"type": "literal", "value": "The activity of placental superoxide dismutase (P = 0.003) and glucose 6-phosphate-dehydrogenase (P = 0.019) was significantly lower in pre-eclampsia than in normal pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8899868"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "High levels of Lp(a) lipoprotein in a family with cases of severe pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8891386"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "A previous report suggested that a high maternal serum Lp(a) lipoprotein level can cause fetal growth retardation, and it is proposed that very high levels might lead to increased deposition of fibrin in the uterine spiral arteries in pregnancy, which is central in the pathogenesis of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8891386"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "If confirmed, a very high Lp(a) lipoprotein level could be one risk factor for pre-eclampsia that is genetically determined."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8891386"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AFP"}, "span_text": {"type": "literal", "value": "To determine whether high levels of serum alpha-fetoprotein (AFP) predict increased risk of adverse pregnancy outcomes, including preterm birth (before 37 weeks), preterm birth occurring at or before 28 weeks, small for gestational age (SGA) infant, preeclampsia, and placental abnormalities, and to determine whether low levels of serum AFP predict increased or decreased risk of these outcomes."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8885920"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AFP"}, "span_text": {"type": "literal", "value": "The association between maternal serum alpha-fetoprotein and preterm birth, small for gestational age infants, preeclampsia, and placental complications."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8885920"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "To measure plasma atrial natriuretic peptide (ANP) in relation to maternal haemodynamics and body fluid balance in the early puerperium following uncomplicated pregnancy and pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8863696"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:F5"}, "span_text": {"type": "literal", "value": "Women with earlier severe preeclampsia displayed increased levels of coagulation factors and the main fibrinolytic inhibitor, high levels of which are known to predict cardiovascular events."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8821879"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP7"}, "span_text": {"type": "literal", "value": "Developmental regulation of circulating insulin-like growth factor-binding proteins in normal pregnancies and in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8817692"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP3"}, "span_text": {"type": "literal", "value": "Developmental regulation of circulating insulin-like growth factor-binding proteins in normal pregnancies and in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8817692"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP5"}, "span_text": {"type": "literal", "value": "Developmental regulation of circulating insulin-like growth factor-binding proteins in normal pregnancies and in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8817692"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP2"}, "span_text": {"type": "literal", "value": "Developmental regulation of circulating insulin-like growth factor-binding proteins in normal pregnancies and in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8817692"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP4"}, "span_text": {"type": "literal", "value": "Developmental regulation of circulating insulin-like growth factor-binding proteins in normal pregnancies and in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8817692"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "Brain natriuretic peptide and cyclic guanosine-3',5' monophosphate in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8796782"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "We compared the presence and localization of nitrotyrosine and of the endothelial isoform of nitric oxide synthase in placental villous tissue from normotensive pregnancies (n = 5) with pregnancies complicated by preeclampsia (n = 5), intrauterine growth restriction (n = 5), and preeclampsia plus intrauterine growth restriction (n = 4), conditions characterized by increases in fetoplacental vascular resistance, fetal platelet consumption, and fetal morbidity and mortality."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8794838"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "To assess whether hyperinsulinemia is also present in hypertensive disease induced by pregnancy, we studied the plasma glucose and insulin responses to 50 g of oral glucose in 10 women with definite, severe preeclampsia but normal glucose tolerance, and compared them with the responses observed in a well-matched control group of healthy pregnant women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8783787"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "We conclude that preeclampsia is associated with marked hyperinsulinemia both in the fasting state and after oral glucose ingestion, suggesting that insulin resistance may play a role in pregnancy-induced hypertension."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8783787"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Changes of endothelin-1 level in normotensive pregnancy and in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8783588"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Because preeclampsia, representing a pregnancy-specific occlusive vascular disorder, is known to be accompanied by metabolic changes similar to those in insulin resistance syndrome, we compared carbohydrate and lipid metabolism in 22 women who had a preeclamptic first pregnancy and in 22 control women who had normotensive first pregnancy, both, on the average, 17.0 +/- 0.7 yr earlier."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8768850"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL6"}, "span_text": {"type": "literal", "value": "Interleukin-6 was detected more frequently and in higher concentrations in the plasma collected before labor for preeclamptic patients compared with controls, but no difference was noted in interleukin-6 detection rates or plasma concentrations at delivery."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8752252"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL6"}, "span_text": {"type": "literal", "value": "Soluble tumor necrosis factor receptors and interleukin-6 levels in patients with severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8752252"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL6"}, "span_text": {"type": "literal", "value": "To investigate whether serum and amniotic fluid (AF) levels of soluble tumor necrosis factor receptors and interleukin-6, markers of immune activation and endothelial dysfunction, are altered in patients with severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8752252"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL6"}, "span_text": {"type": "literal", "value": "Conversely, AF concentrations of interleukin-6 were significantly reduced in patients with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8752252"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL4"}, "span_text": {"type": "literal", "value": "However, excessive interleukin-4 production may contribute to the pathophysiology of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8748253"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL4"}, "span_text": {"type": "literal", "value": "The comparative value of interleukin-4 in sera of women with preeclampsia and cord sera."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8748253"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "An endogenous inhibitor of nitric oxide synthase (NOS), NG,NG dimethylarginine (asymmetric dimethylarginine, ADMA), which is present in human plasma and urine, has been reported to be elevated in the plasma of women with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8743168"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "Nitric oxide synthase activity in placentae from women with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8710800"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG6"}, "span_text": {"type": "literal", "value": "Maternal plasma levels of the trophoblast product, pregnancy-specific beta 1-glycoprotein (PS beta G), have been measured both in normal pregnancies and in pregnancies complicated by pre-eclampsia and/or fetal growth retardation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/870010"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG3"}, "span_text": {"type": "literal", "value": "Maternal plasma levels of the trophoblast product, pregnancy-specific beta 1-glycoprotein (PS beta G), have been measured both in normal pregnancies and in pregnancies complicated by pre-eclampsia and/or fetal growth retardation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/870010"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG2"}, "span_text": {"type": "literal", "value": "Maternal plasma levels of the trophoblast product, pregnancy-specific beta 1-glycoprotein (PS beta G), have been measured both in normal pregnancies and in pregnancies complicated by pre-eclampsia and/or fetal growth retardation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/870010"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG11"}, "span_text": {"type": "literal", "value": "Maternal plasma levels of the trophoblast product, pregnancy-specific beta 1-glycoprotein (PS beta G), have been measured both in normal pregnancies and in pregnancies complicated by pre-eclampsia and/or fetal growth retardation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/870010"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG9"}, "span_text": {"type": "literal", "value": "Maternal plasma levels of the trophoblast product, pregnancy-specific beta 1-glycoprotein (PS beta G), have been measured both in normal pregnancies and in pregnancies complicated by pre-eclampsia and/or fetal growth retardation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/870010"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG4"}, "span_text": {"type": "literal", "value": "Maternal plasma levels of the trophoblast product, pregnancy-specific beta 1-glycoprotein (PS beta G), have been measured both in normal pregnancies and in pregnancies complicated by pre-eclampsia and/or fetal growth retardation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/870010"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG5"}, "span_text": {"type": "literal", "value": "Maternal plasma levels of the trophoblast product, pregnancy-specific beta 1-glycoprotein (PS beta G), have been measured both in normal pregnancies and in pregnancies complicated by pre-eclampsia and/or fetal growth retardation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/870010"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG1"}, "span_text": {"type": "literal", "value": "Maternal plasma levels of the trophoblast product, pregnancy-specific beta 1-glycoprotein (PS beta G), have been measured both in normal pregnancies and in pregnancies complicated by pre-eclampsia and/or fetal growth retardation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/870010"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG8"}, "span_text": {"type": "literal", "value": "Maternal plasma levels of the trophoblast product, pregnancy-specific beta 1-glycoprotein (PS beta G), have been measured both in normal pregnancies and in pregnancies complicated by pre-eclampsia and/or fetal growth retardation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/870010"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VTN"}, "span_text": {"type": "literal", "value": "Trophoblast was isolated from placentas of normotensive (n = 5) and preeclamptic patients (n = 5) and cultured up to 7 days on LabTek slides precoated with fibronectin, laminin, or vitronectin."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8694071"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VTN"}, "span_text": {"type": "literal", "value": "Trophoblast from placentas of preeclamptic patients showed a significantly lower attachment on fibronectin and vitronectin compared with controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8694071"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP7"}, "span_text": {"type": "literal", "value": "Lower circulating concentrations of insulin-like growth factor binding protein-1 in women destined to have preeclampsia were observed 12 to 26 weeks before the onset of clinical signs of this syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8694068"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP4"}, "span_text": {"type": "literal", "value": "Lower circulating concentrations of insulin-like growth factor binding protein-1 in women destined to have preeclampsia were observed 12 to 26 weeks before the onset of clinical signs of this syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8694068"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP7"}, "span_text": {"type": "literal", "value": "Midtrimester plasma insulin-like growth factor binding protein-1 concentrations were significantly lower in women who later had preeclampsia compared with normal pregnant controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8694068"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP2"}, "span_text": {"type": "literal", "value": "Lower circulating concentrations of insulin-like growth factor binding protein-1 in women destined to have preeclampsia were observed 12 to 26 weeks before the onset of clinical signs of this syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8694068"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP3"}, "span_text": {"type": "literal", "value": "Midtrimester plasma insulin-like growth factor binding protein-1 concentrations were significantly lower in women who later had preeclampsia compared with normal pregnant controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8694068"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP5"}, "span_text": {"type": "literal", "value": "Midtrimester plasma insulin-like growth factor binding protein-1 concentrations were significantly lower in women who later had preeclampsia compared with normal pregnant controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8694068"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP2"}, "span_text": {"type": "literal", "value": "Midtrimester plasma insulin-like growth factor binding protein-1 concentrations were significantly lower in women who later had preeclampsia compared with normal pregnant controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8694068"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP3"}, "span_text": {"type": "literal", "value": "Lower circulating concentrations of insulin-like growth factor binding protein-1 in women destined to have preeclampsia were observed 12 to 26 weeks before the onset of clinical signs of this syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8694068"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP4"}, "span_text": {"type": "literal", "value": "Midtrimester plasma insulin-like growth factor binding protein-1 concentrations were significantly lower in women who later had preeclampsia compared with normal pregnant controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8694068"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP5"}, "span_text": {"type": "literal", "value": "Lower circulating concentrations of insulin-like growth factor binding protein-1 in women destined to have preeclampsia were observed 12 to 26 weeks before the onset of clinical signs of this syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8694068"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP2"}, "span_text": {"type": "literal", "value": "Insulin-like growth factor-binding protein 1 and insulin-like growth factor-binding protein 3 in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8688391"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP3"}, "span_text": {"type": "literal", "value": "Insulin-like growth factor-binding protein 1 and insulin-like growth factor-binding protein 3 in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8688391"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP2"}, "span_text": {"type": "literal", "value": "To investigate circulating levels of insulin-like growth factor-binding protein 1 (IGFBP-1) and IGFBP-3 in the mother and the fetus in pregnancies complicated by pre-eclampsia, and the relationship between serum levels of IGFBPs and fetal birthweight."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8688391"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP5"}, "span_text": {"type": "literal", "value": "Insulin-like growth factor-binding protein 1 and insulin-like growth factor-binding protein 3 in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8688391"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP4"}, "span_text": {"type": "literal", "value": "Insulin-like growth factor-binding protein 1 and insulin-like growth factor-binding protein 3 in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8688391"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP7"}, "span_text": {"type": "literal", "value": "Insulin-like growth factor-binding protein 1 and insulin-like growth factor-binding protein 3 in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8688391"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP3"}, "span_text": {"type": "literal", "value": "To investigate circulating levels of insulin-like growth factor-binding protein 1 (IGFBP-1) and IGFBP-3 in the mother and the fetus in pregnancies complicated by pre-eclampsia, and the relationship between serum levels of IGFBPs and fetal birthweight."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8688391"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP4"}, "span_text": {"type": "literal", "value": "To investigate circulating levels of insulin-like growth factor-binding protein 1 (IGFBP-1) and IGFBP-3 in the mother and the fetus in pregnancies complicated by pre-eclampsia, and the relationship between serum levels of IGFBPs and fetal birthweight."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8688391"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP5"}, "span_text": {"type": "literal", "value": "To investigate circulating levels of insulin-like growth factor-binding protein 1 (IGFBP-1) and IGFBP-3 in the mother and the fetus in pregnancies complicated by pre-eclampsia, and the relationship between serum levels of IGFBPs and fetal birthweight."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8688391"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP7"}, "span_text": {"type": "literal", "value": "To investigate circulating levels of insulin-like growth factor-binding protein 1 (IGFBP-1) and IGFBP-3 in the mother and the fetus in pregnancies complicated by pre-eclampsia, and the relationship between serum levels of IGFBPs and fetal birthweight."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8688391"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Potential pathogenic roles of aberrant lipoprotein and fatty acid metabolism in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8688385"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "In women with preeclampsia the contractile response induced by endothelin-1 was significantly higher in omental as compared to myometrial vessels."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8677766"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Endothelin-1 is a potent constrictor of resistance arteries from different vascular beds in normal pregnancy and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8677766"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Endothelin-1 (ET-1), known to be present in high concentrations in serum from pre-eclamptic compared with normotensive pregnant women, may contribute to the increased vascular reactivity seen in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8587373"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Pre-eclampsia does not alter the response to endothelin-1 in human omental artery."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8587373"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CADM3"}, "span_text": {"type": "literal", "value": "The purpose of this study was to determine the expression of cell adhesion molecules in placentae from normal pregnancies and pregnancies complicated by pre-eclampsia and intrauterine growth retardation (IUGR)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8577657"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CADM3"}, "span_text": {"type": "literal", "value": "There were no differences in cell adhesion molecule immunostaining or mRNA expression in placentae from pregnancies complicated by pre-eclampsia and IUGR inconclusion, expression of cell adhesion molecules in placentae from pre-eclampsia and IUGR are consistent with a normal physiological role in vascular function."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8577657"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CADM1"}, "span_text": {"type": "literal", "value": "The purpose of this study was to determine the expression of cell adhesion molecules in placentae from normal pregnancies and pregnancies complicated by pre-eclampsia and intrauterine growth retardation (IUGR)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8577657"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CADM1"}, "span_text": {"type": "literal", "value": "There were no differences in cell adhesion molecule immunostaining or mRNA expression in placentae from pregnancies complicated by pre-eclampsia and IUGR inconclusion, expression of cell adhesion molecules in placentae from pre-eclampsia and IUGR are consistent with a normal physiological role in vascular function."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8577657"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CADM3"}, "span_text": {"type": "literal", "value": "Expression of cell adhesion molecules in placentae from pregnancies complicated by pre-eclampsia and intrauterine growth retardation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8577657"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CADM1"}, "span_text": {"type": "literal", "value": "Expression of cell adhesion molecules in placentae from pregnancies complicated by pre-eclampsia and intrauterine growth retardation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8577657"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LDHA"}, "span_text": {"type": "literal", "value": "Severe preeclampsia with fulminant and extreme elevation of aspartate aminotransferase and lactate dehydrogenase levels: high risk for maternal death."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8540929"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LDHA"}, "span_text": {"type": "literal", "value": "We report a subgroup of patients with fulminant hemolysis, elevated liver enzymes, low platelet count (HELLP) syndrome, manifesting extreme elevation of aspartate aminotransferase (AST; SGOT) and lactate dehydrogenase (LDH) levels and abnormal mental status."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8540929"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LDHB"}, "span_text": {"type": "literal", "value": "We report a subgroup of patients with fulminant hemolysis, elevated liver enzymes, low platelet count (HELLP) syndrome, manifesting extreme elevation of aspartate aminotransferase (AST; SGOT) and lactate dehydrogenase (LDH) levels and abnormal mental status."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8540929"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LDHD"}, "span_text": {"type": "literal", "value": "Severe preeclampsia with fulminant and extreme elevation of aspartate aminotransferase and lactate dehydrogenase levels: high risk for maternal death."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8540929"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LDHB"}, "span_text": {"type": "literal", "value": "Severe preeclampsia with fulminant and extreme elevation of aspartate aminotransferase and lactate dehydrogenase levels: high risk for maternal death."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8540929"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LDHD"}, "span_text": {"type": "literal", "value": "We report a subgroup of patients with fulminant hemolysis, elevated liver enzymes, low platelet count (HELLP) syndrome, manifesting extreme elevation of aspartate aminotransferase (AST; SGOT) and lactate dehydrogenase (LDH) levels and abnormal mental status."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8540929"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "Women with a history of pregnancy induced hypertension or pre-eclampsia had an increased risk, relative to controls, for hypertension at follow up (37% and 20% vs 2%; P < 0.001), microalbuminuria (14% and 20% vs 2%; P < 0.05) and demonstrated increased plasma levels of albumin corrected calcium (2.41 [SE 0.02] and 2.40 [0.01] vs 2.32 [0.01] mmol/l; P < 0.001)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8534622"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF2"}, "span_text": {"type": "literal", "value": "Lower circulating insulin-like growth factor I and 1,25-dihydroxyvitamin D levels in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8525127"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF1"}, "span_text": {"type": "literal", "value": "Lower circulating insulin-like growth factor I and 1,25-dihydroxyvitamin D levels in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8525127"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGT"}, "span_text": {"type": "literal", "value": "In a series of Caucasian women with pregnancy-induced hypertension, we have observed a significant association of preeclampsia with a molecular variant of angiotensinogen, T235, found previously to be associated with essential hypertension."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8513325"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGT"}, "span_text": {"type": "literal", "value": "A molecular variant of angiotensinogen associated with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8513325"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Our results suggest that an increase in the maximal density of receptor sites to endothelin-1 in the placenta may play a role in the pathophysiology of pre-eclampsia by contributing to the placental insufficiency that characterizes this disorder."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8506766"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX1"}, "span_text": {"type": "literal", "value": "The activities of erythrocyte and plasma glutathione peroxidase were increased in severe pre-eclampsia, and high levels of plasma or platelet glutathione peroxidase were found to have some association with fetal growth retardation or asphyxia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8476834"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX3"}, "span_text": {"type": "literal", "value": "The activities of erythrocyte and plasma glutathione peroxidase were increased in severe pre-eclampsia, and high levels of plasma or platelet glutathione peroxidase were found to have some association with fetal growth retardation or asphyxia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8476834"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX2"}, "span_text": {"type": "literal", "value": "The activities of erythrocyte and plasma glutathione peroxidase were increased in severe pre-eclampsia, and high levels of plasma or platelet glutathione peroxidase were found to have some association with fetal growth retardation or asphyxia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8476834"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CRH"}, "span_text": {"type": "literal", "value": "Concentration of corticotropin-releasing hormone (CRH) has earlier been found to increase greatly in maternal plasma during the last trimester of normal pregnancy and even more in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8476473"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GP2"}, "span_text": {"type": "literal", "value": "The relationship between urinary Tamm-Horsfall glycoprotein excretion and urinary activity of glycosidases in normal pregnancy and pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8449258"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GP2"}, "span_text": {"type": "literal", "value": "Electrophoretic analyses of the urinary proteins of pre-eclamptic patients revealed a decrease in the staining intensity of the protein band representing the Tamm-Horsfall glycoprotein (THP)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8449258"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Urinary endothelin-1 levels were assayed from 50 gravidas with preeclampsia and 11 with normotension in the third trimester of pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8438935"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Urinary endothelin-1 excretion is not significantly increased in patients with preeclampsia and therefore not a good marker for preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8438935"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Urinary endothelin-1: not a useful marker for preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8438935"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Urinary endothelin-1 levels (mean +/- SEM) were similar between gravidas with normotension and preeclampsia (62.7 +/- 7.5 vs 79.8 +/- 9.3 fmol/mg urinary creatinine, respectively)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8438935"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Endothelin-1 levels in women abusing cocaine are comparable to those in women with preeclampsia and are significantly higher than those in gravid women with chronic hypertension and women with uncomplicated pregnancies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8438922"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Plasma endothelin-1 levels were measured in 30 women with acute cocaine intoxication, 32 women with preeclampsia, 14 pregnant women with chronic hypertension, 26 women with uncomplicated pregnancies, and 16 nonpregnant individuals."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8438922"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "The purpose of this study was to determine if the plasma concentration of endothelin-1 is elevated in pregnant women abusing cocaine and to determine how these levels differ from those in patients with preeclampsia and in women with uncomplicated pregnancies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8438922"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PRL"}, "span_text": {"type": "literal", "value": "It is suggested that prolactin acts by reducing the sensitivity of the blood vessels to circulating pressor substances and further that a reduced prolactin response may be the cause of heightened sensitivity to pressor substances observed in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/842588"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Plasma endothelin-1 and big endothelin-1 levels in women with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8372594"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "To examine a possible role for endothelin-1 (ET-1) and conversion of big ET-1 to ET-1 in the pathophysiology of pre-eclampsia, we measured plasma levels of ET-1 and big ET-1 in 16 women with pre-eclampsia in the third trimester and compared them with those in 11 age-matched normotensive pregnant women and in 10 age-matched pregnant women with chronic hypertension in the third trimester."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8372594"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "Recent studies have defined an abnormal aldosterone:renin ratio, dopaminergic inhibition of aldosterone, elevations of plasma atrial natriuretic peptide and reduced urinary prostacyclin:thromboxane ratios in women with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8361130"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGT"}, "span_text": {"type": "literal", "value": "Angiotensinogen: a candidate gene involved in preeclampsia?"}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8348146"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG11"}, "span_text": {"type": "literal", "value": "Pregnancy specific beta 1 glycoprotein (SP-1) in maternal serum and amniotic fluid; pre-eclampsia, small for gestational age fetus and fetal distress."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8290497"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG1"}, "span_text": {"type": "literal", "value": "Pregnancy specific beta 1 glycoprotein (SP-1) in maternal serum and amniotic fluid; pre-eclampsia, small for gestational age fetus and fetal distress."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8290497"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG2"}, "span_text": {"type": "literal", "value": "Pregnancy specific beta 1 glycoprotein (SP-1) in maternal serum and amniotic fluid; pre-eclampsia, small for gestational age fetus and fetal distress."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8290497"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG3"}, "span_text": {"type": "literal", "value": "Pregnancy specific beta 1 glycoprotein (SP-1) in maternal serum and amniotic fluid; pre-eclampsia, small for gestational age fetus and fetal distress."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8290497"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG5"}, "span_text": {"type": "literal", "value": "Pregnancy specific beta 1 glycoprotein (SP-1) in maternal serum and amniotic fluid; pre-eclampsia, small for gestational age fetus and fetal distress."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8290497"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG8"}, "span_text": {"type": "literal", "value": "Pregnancy specific beta 1 glycoprotein (SP-1) in maternal serum and amniotic fluid; pre-eclampsia, small for gestational age fetus and fetal distress."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8290497"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG6"}, "span_text": {"type": "literal", "value": "Pregnancy specific beta 1 glycoprotein (SP-1) in maternal serum and amniotic fluid; pre-eclampsia, small for gestational age fetus and fetal distress."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8290497"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG9"}, "span_text": {"type": "literal", "value": "Pregnancy specific beta 1 glycoprotein (SP-1) in maternal serum and amniotic fluid; pre-eclampsia, small for gestational age fetus and fetal distress."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8290497"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG4"}, "span_text": {"type": "literal", "value": "Pregnancy specific beta 1 glycoprotein (SP-1) in maternal serum and amniotic fluid; pre-eclampsia, small for gestational age fetus and fetal distress."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8290497"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX3"}, "span_text": {"type": "literal", "value": "In preeclampsia deficient glutathione peroxidase activity results in in increased peroxide levels leading to increased stimulation of prostaglandin H synthase, which results in increased production of lipid peroxides and thromboxane."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8267046"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX2"}, "span_text": {"type": "literal", "value": "Deficient glutathione peroxidase activity in preeclampsia is associated with increased placental production of thromboxane and lipid peroxides."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8267046"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX1"}, "span_text": {"type": "literal", "value": "Deficient glutathione peroxidase activity in preeclampsia is associated with increased placental production of thromboxane and lipid peroxides."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8267046"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX1"}, "span_text": {"type": "literal", "value": "In preeclampsia deficient glutathione peroxidase activity results in in increased peroxide levels leading to increased stimulation of prostaglandin H synthase, which results in increased production of lipid peroxides and thromboxane."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8267046"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX3"}, "span_text": {"type": "literal", "value": "Deficient glutathione peroxidase activity in preeclampsia is associated with increased placental production of thromboxane and lipid peroxides."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8267046"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX2"}, "span_text": {"type": "literal", "value": "In preeclampsia deficient glutathione peroxidase activity results in in increased peroxide levels leading to increased stimulation of prostaglandin H synthase, which results in increased production of lipid peroxides and thromboxane."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8267046"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL6"}, "span_text": {"type": "literal", "value": "Amniotic fluid interleukin-6 levels in women with preeclampsia and small-for-gestational-age perinates were less than in controls (p < 0.01)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8238167"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL6"}, "span_text": {"type": "literal", "value": "A case control study design was used to compare third-trimester amniotic fluid interleukin-6 levels from women with normal pregnancies (n = 25) and pregnancies complicated by preeclampsia (n = 15), small-for-gestational-age perinates (n = 8), and premature labor (n = 29)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8238167"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL6"}, "span_text": {"type": "literal", "value": "Our purpose was to determine if abnormal amniotic fluid interleukin-6 levels correlate with pregnancies complicated by preeclampsia, small-for-gestational-age fetus, and premature labor."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8238167"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL6"}, "span_text": {"type": "literal", "value": "Interleukin-6 levels in amniotic fluid in normal and abnormal pregnancies: preeclampsia, small-for-gestational-age fetus, and premature labor."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8238167"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LAP3"}, "span_text": {"type": "literal", "value": "Placental leucine aminopeptidase (P-LAP) activities of puerperal hypertensive patients with severe preeclampsia during prior pregnancy were equal to or somewhat lower levels than those in normal puerperal women after a normal pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8235062"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LAP3"}, "span_text": {"type": "literal", "value": "To elucidate the involvement of angiotensin in puerperal hypertension with and without preeclampsia in the course of prior pregnancy, we measured plasma angiotensin I levels and serum placental leucine aminopeptidase (P-LAP) activities in several puerperal hypertensive patients."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8235062"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL1B"}, "span_text": {"type": "literal", "value": "Our purpose was to investigate whether markers for activation of the immune system are present in patients with preeclampsia by assessing maternal plasma and amniotic fluid for tumor necrosis factor-alpha and interleukin-1 beta."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8203436"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Plasma and urinary endothelin 1, prostacyclin metabolites and platelet consumption in pre-eclampsia and essential hypertensive pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8199718"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "This study examined plasma and urinary endothelin 1 and urinary metabolites of prostacyclin and thromboxane, in women with pre-eclampsia and age and gestation matched controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8199718"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "To determine if changes in endothelin 1 and urinary prostanoids in pre-eclampsia were due to hypertension per se, a comparison was made to a group of age and gestation matched pregnant uncomplicated essential hypertensive women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8199718"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "Women with essential hypertension [6(4-16) mg/day] and mild pre-eclampsia [7(4-10) mg/day] had a urinary albumin excretion rate similar to that of normal pregnant women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8156734"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "Twenty-four hour urinary creatinine and albumin excretions were determined prospectively in 26 non-pregnant and 115 pregnant women in their third trimester (40 in normal pregnancy, 38 with mild pre-eclampsia, 20 with severe pre-eclampsia, 17 with essential hypertension) in whom urinary total protein excretion was normal."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8156734"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "Women with severe pre-eclampsia had an urinary albumin excretion rate increased [13(7-32) mg/day] compared with other groups (P < 0.05)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8156734"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "The clearance of albumin relative to that of creatinine was elevated significantly only in women with severe pre-eclampsia compared with normal pregnant women (0.00054 versus 0.00012; P < 0.05)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8156734"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "To study the effects of low doses of the hormone atrial natriuretic peptide (ANP) on uteroplacental blood flow in patients with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8041537"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "Possible improvement in uteroplacental blood flow during atrial natriuretic peptide infusion in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/8041537"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VWF"}, "span_text": {"type": "literal", "value": "To evaluate the levels of von Willebrand factor and fibronectin as markers for the severity of endothelial cell injury in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7970473"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VWF"}, "span_text": {"type": "literal", "value": "The increased maternal plasma levels of von Willebrand factor and fibronectin indicate that endothelial stimulation is present during preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7970473"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VWF"}, "span_text": {"type": "literal", "value": "Plasma levels of von Willebrand factor and fibronectin as markers of persisting endothelial damage in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7970473"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VWF"}, "span_text": {"type": "literal", "value": "In preeclampsia, the levels of von Willebrand factor and fibronectin were higher than in normal pregnancy samples drawn in the second and third trimesters."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7970473"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VWF"}, "span_text": {"type": "literal", "value": "In 63 pregnant women with preeclampsia, the plasma levels of von Willebrand factor and fibronectin were measured as soon as symptoms were detected, at 5 weeks postpartum, and after lactation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7970473"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VWF"}, "span_text": {"type": "literal", "value": "Four patients with severe preeclampsia who were studied frequently had high levels of von Willebrand factor 5 weeks postpartum."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7970473"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "Brain natriuretic peptide and atrial natriuretic peptide levels in normal pregnancy and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7959344"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "In this study, we have evaluated maternal, umbilical plasma and amniotic fluid BNP and atrial natriuretic peptide (ANP) in 19 normotensive pregnant women and in 35 preeclamptic patients."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7959344"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Serum antibodies to oxidised low-density lipoprotein in pre-eclampsia and coronary heart disease."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7911891"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GGT2"}, "span_text": {"type": "literal", "value": "Gamma-glutamyl transferase activity in gestational hypertension."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7910757"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GGT7"}, "span_text": {"type": "literal", "value": "Gamma-glutamyl transferase activity in gestational hypertension."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7910757"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GGT1"}, "span_text": {"type": "literal", "value": "Gamma-glutamyl transferase activity in gestational hypertension."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7910757"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPR3"}, "span_text": {"type": "literal", "value": "Fetal vascular atrial natriuretic peptide receptors in human placenta: alteration in intrauterine growth retardation and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7905249"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPR2"}, "span_text": {"type": "literal", "value": "Fetal vascular atrial natriuretic peptide receptors in human placenta: alteration in intrauterine growth retardation and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7905249"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "Because fetal plasma atrial natriuretic peptide concentration is normal or elevated in intrauterine growth retardation and preeclampsia, these data suggest that atrial natriuretic peptide-mediated fetoplacental vasodilation is augmented in these disorders even in the presence of increased vascular resistance within the fetoplacental unit."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7905249"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPR2"}, "span_text": {"type": "literal", "value": "Our purpose was to quantify fetoplacental vascular atrial natriuretic peptide receptor subtypes in human pregnancies complicated by intrauterine growth retardation or preeclampsia and to relate these parameters to the fetoplacental vascular impedance as assessed by Doppler velocimetry."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7905249"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPR3"}, "span_text": {"type": "literal", "value": "Our purpose was to quantify fetoplacental vascular atrial natriuretic peptide receptor subtypes in human pregnancies complicated by intrauterine growth retardation or preeclampsia and to relate these parameters to the fetoplacental vascular impedance as assessed by Doppler velocimetry."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7905249"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Possible mechanisms are increased phospholipase A2, lipoprotein, or lipid peroxide activities in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7892893"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "The diseases of pre-eclampsia and fetal growth retardation are associated with reduced output of nitric oxide and prostacyclin and with increased production of thromboxane A2 and endothelin-1."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7867224"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "Possible improvement in uteroplacental blood flow during atrial natriuretic peptide infusion in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7865013"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EPO"}, "span_text": {"type": "literal", "value": "In this study we determine the erythropoietin levels and hematocrit in 22 women with preterm labor, 21 with insulin-dependent diabetes, 22 with preeclampsia, and 20 with normal gestation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7857436"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EPO"}, "span_text": {"type": "literal", "value": "Erythropoietin umbilical serum levels during labor in women with preeclampsia, diabetes, and preterm labor."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7857436"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AVP"}, "span_text": {"type": "literal", "value": "Platelet intracellular free calcium response to arginine vasopressin is similar in preeclampsia and normal pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7856701"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AVP"}, "span_text": {"type": "literal", "value": "Our purpose was to compare the effect of arginine vasopressin stimulation on platelet free intracellular calcium levels in normal pregnancy, incipient preeclampsia, and established preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7856701"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AVP"}, "span_text": {"type": "literal", "value": "The platelet intracellular free calcium response to arginine vasopressin is not a feature of incipient or established preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7856701"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VWF"}, "span_text": {"type": "literal", "value": "In addition to higher maternal plasma concentrations of cellular fibronectin, we found higher levels of von Willebrand factor, tissue plasminogen activator, and plasminogen activator inhibitor-1 in maternal plasma, providing biochemical corroboration of endothelial dysfunction in severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7847535"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL6"}, "span_text": {"type": "literal", "value": "Interleukin-6, tumour necrosis factor and soluble tumour necrosis factor receptors in women with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7833306"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Recently, insulin resistance has been related to the development of hypertension in young African-Americans and hyperinsulinemia and elevated insulin-to-glucose ratios, suggesting insulin resistance, have been demonstrated in women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7826558"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Postpartum blood pressure and insulin sensitivity in African-American women with recent preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7826558"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "To investigate whether insulin resistance existed postpartum and, therefore, independently of the pregnant state, the hyperinsulinemic, euglycemic technique was used 3 to 6 months postpartum to assess insulin sensitivity in 10 young, black, primiparous, inner-city women with recent preeclampsia and seven age-, weight- and body-mass-index-matched black women with healthy pregnancies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7826558"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "The marked increase in plasma atrial natriuretic peptide levels observed in preeclampsia is not likely to result from elevated arterial pressures alone but may reflect underlying factors unique to this disease process."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7802082"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "Compared with levels in pregnant control subjects, plasma atrial natriuretic peptide levels increased 52% to 52.1 pg/ml (95% confidence interval 32.9 to 82.5) in women with gestational hypertension (p < 0.005) and 130% to 78.8 pg/ml (95% confidence interval 52.3 to 118.8) in women with preeclampsia (p < 0.0001)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7802082"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GSTA4"}, "span_text": {"type": "literal", "value": "Glutathione S-transferase alpha as marker for hepatocellular damage in pre-eclampsia and HELLP syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7791457"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GSTA2"}, "span_text": {"type": "literal", "value": "Glutathione S-transferase alpha as marker for hepatocellular damage in pre-eclampsia and HELLP syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7791457"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GSTA3"}, "span_text": {"type": "literal", "value": "Glutathione S-transferase alpha as marker for hepatocellular damage in pre-eclampsia and HELLP syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7791457"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GSTA1"}, "span_text": {"type": "literal", "value": "Glutathione S-transferase alpha as marker for hepatocellular damage in pre-eclampsia and HELLP syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7791457"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GSTA5"}, "span_text": {"type": "literal", "value": "Glutathione S-transferase alpha as marker for hepatocellular damage in pre-eclampsia and HELLP syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7791457"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGT"}, "span_text": {"type": "literal", "value": "In a preeclamptic patient, we have identified a mutation leading to the replacement of leucine by phenylalanine at position 10 of mature angiotensinogen (L10F), the site of renin cleavage."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7744780"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGT"}, "span_text": {"type": "literal", "value": "A mutation of angiotensinogen in a patient with preeclampsia leads to altered kinetics of the renin-angiotensin system."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7744780"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGT"}, "span_text": {"type": "literal", "value": "Angiotensinogen exhibits genetic linkage to and association with essential hypertension and preeclampsia, a common hypertensive disorder of pregnancy; however, the polymorphisms detected thus far provide no functional clues."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7744780"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Hyperinsulinemia and insulin resistance are associated with preeclampsia in African-Americans."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7734090"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "The finding that elevated second-trimester insulin levels characterize the subsequent development of preeclampsia with control for increased MAP supports the hypothesis that hyperinsulinemia and associated insulin resistance may contribute to the pathogenesis of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7734090"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "To test the hypothesis that hyperinsulinemia may be related to the development of preeclampsia, discriminant analysis of mean arterial pressure (MAP), fasting plasma insulin levels, insulin to glucose ratios, and left lateral forearm vascular resistance were examined as predictors of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7734090"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Only MAP [F(4,135) = 8.8, P < .01] and insulin [F(1,135) = 6.5, P < .05] were related to the development of preeclampsia [F(4,135) = 4.39, R2 = 11.5%]."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7734090"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Women who subsequently developed preeclampsia had mean (+/- SE) fasting plasma insulin levels of 51.0 +/- 12.0 microU/mL at 20 weeks and controls had values of 29.0 +/- 2.8."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7734090"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP3"}, "span_text": {"type": "literal", "value": "The findings indicate that insulin-like growth factor-binding protein-3 concentrations do not account for the elevated mitogenic activity observed in plasma from women with preeclampsia and are not a useful screening test for preeclampsia risk."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7694465"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP3"}, "span_text": {"type": "literal", "value": "We hypothesized that increased endothelial cell release or decreased proteolytic degradation of insulin-like growth factor-binding protein-3 in preeclampsia would result in higher circulating levels of insulin-like growth factors and hence in increased mitogenic activity."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7694465"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF2"}, "span_text": {"type": "literal", "value": "We hypothesized that increased endothelial cell release or decreased proteolytic degradation of insulin-like growth factor-binding protein-3 in preeclampsia would result in higher circulating levels of insulin-like growth factors and hence in increased mitogenic activity."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7694465"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF1"}, "span_text": {"type": "literal", "value": "We hypothesized that increased endothelial cell release or decreased proteolytic degradation of insulin-like growth factor-binding protein-3 in preeclampsia would result in higher circulating levels of insulin-like growth factors and hence in increased mitogenic activity."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7694465"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF1"}, "span_text": {"type": "literal", "value": "Plasma insulin-like growth factor-binding protein-3 concentrations were determined by iodine-125 insulin-like growth factor-II radioligand blots of nonreducing gels in 16 normal and 16 preeclamptic patients collected from a prospective, case-control study."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7694465"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF2"}, "span_text": {"type": "literal", "value": "Plasma insulin-like growth factor-binding protein-3 concentrations were determined by iodine-125 insulin-like growth factor-II radioligand blots of nonreducing gels in 16 normal and 16 preeclamptic patients collected from a prospective, case-control study."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7694465"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP3"}, "span_text": {"type": "literal", "value": "Plasma insulin-like growth factor-binding protein-3 concentrations were determined by iodine-125 insulin-like growth factor-II radioligand blots of nonreducing gels in 16 normal and 16 preeclamptic patients collected from a prospective, case-control study."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7694465"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP3"}, "span_text": {"type": "literal", "value": "Evaluation of plasma insulin-like growth factor-binding protein-3 as a potential predictor of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7694465"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AFP"}, "span_text": {"type": "literal", "value": "Plasma levels of tumor markers (CEA, TPA, CA 15.3, CA 125, alpha-fetoprotein) for 50 patients with hypertensive disorders of pregnancy were compared with those of 50 healthy women with singleton pregnancies and 50 healthy non-pregnant controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7687229"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Pre-eclampsia and gestational age differently alter binding of endothelin-1 to placental and trophoblast membrane preparations."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7672454"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:B2M"}, "span_text": {"type": "literal", "value": "beta2-microglobulin and other proteins in serum and urine during preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/76695"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "Atrial natriuretic peptide plasma level remains unchanged in various hypertensive disorders of pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7657015"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "Our objectives were to determine whether there was a difference in plasma levels of atrial natriuretic peptide in the various hypertensive disorders of pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7657015"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "Atrial natriuretic peptide plasma levels remained stable in the various hypertensive disorders of pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7657015"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GP2"}, "span_text": {"type": "literal", "value": "The purpose of this study was to determine if plasma thrombomodulin levels, a glycoprotein found on the surface of the endothelial cell, are elevated in pregnant women with mild preeclampsia and if these levels correlated with other features of disease severity."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7641965"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LDHD"}, "span_text": {"type": "literal", "value": "Increased concentrations of lactate dehydrogenase in pregnancy with preeclampsia: a predictor for the birth of small-for-gestational-age infants."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7635366"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LDHB"}, "span_text": {"type": "literal", "value": "Increased concentrations of lactate dehydrogenase in pregnancy with preeclampsia: a predictor for the birth of small-for-gestational-age infants."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7635366"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LDHA"}, "span_text": {"type": "literal", "value": "Increased concentrations of lactate dehydrogenase in pregnancy with preeclampsia: a predictor for the birth of small-for-gestational-age infants."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7635366"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "Change in atrial natriuretic peptide concentration after acute plasma volume expansion in normal pregnancy and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7635365"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "Atrial natriuretic peptide (ANP) is found to be elevated in preeclamptic patients despite the presence of hemodynamic characteristics such as vasoconstriction and hypovolemia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7635365"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGT"}, "span_text": {"type": "literal", "value": "Pre-eclampsia and the angiotensinogen gene."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7632643"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL2"}, "span_text": {"type": "literal", "value": "The presence of interleukin-2 (IL-2) protein in the decidua was examined in five preeclamptic patients and seven normal pregnant women employing the immunohistochemistry."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7576130"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL2"}, "span_text": {"type": "literal", "value": "Histochemical demonstration of interleukin-2 in decidua cells of patients with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7576130"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "Differences in endothelial nitric oxide synthase expression in terminal villous vessels and in syncytiotrophoblast may be a result of vascular alterations or damage that take place in the placenta in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7573227"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "Immunohistochemical characterization of placental nitric oxide synthase expression in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7573227"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "To determine whether altered levels of vascular endothelial growth factor (VEGF) may be implicated in the pathogenesis of preeclampsia, and whether VEGF mediates the endothelial cell activation that is involved in the pathogenesis of the clinical syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7566855"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Elevated serum levels of vascular endothelial growth factor in patients with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7566855"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Elevated serum levels of vascular endothelial growth factor in patients with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7566855"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Elevated serum levels of vascular endothelial growth factor in patients with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7566855"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "To determine whether altered levels of vascular endothelial growth factor (VEGF) may be implicated in the pathogenesis of preeclampsia, and whether VEGF mediates the endothelial cell activation that is involved in the pathogenesis of the clinical syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7566855"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "To determine whether altered levels of vascular endothelial growth factor (VEGF) may be implicated in the pathogenesis of preeclampsia, and whether VEGF mediates the endothelial cell activation that is involved in the pathogenesis of the clinical syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7566855"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "Placental villous homogenates from pregnancies complicated by pre-eclampsia and fetal growth retardation had significantly lower activities of nitric oxide synthase than those from normotensive women with appropriately grown babies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7547761"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL6"}, "span_text": {"type": "literal", "value": "Interleukin-6, tumour necrosis factor and soluble tumour necrosis factor receptors in women with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7547749"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SST"}, "span_text": {"type": "literal", "value": "Plasma glucose and insulin responses to a 75-g oral glucose load, and the steady-state plasma insulin (SSPI) and glucose (SSPG) concentrations after an infusion of somatostatin, insulin, and glucose, were determined 2 months after delivery in 26 women; 13 who had a normal pregnancy and 13 who developed preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7546505"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Plasma glucose and insulin responses to a 75-g oral glucose load, and the steady-state plasma insulin (SSPI) and glucose (SSPG) concentrations after an infusion of somatostatin, insulin, and glucose, were determined 2 months after delivery in 26 women; 13 who had a normal pregnancy and 13 who developed preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7546505"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Thus, when studied 2 months after delivery, women who developed preeclampsia were relatively insulin resistant and hyperinsulinemic when compared to those who had an uncomplicated pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7546505"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "The vascular reactivity to endothelin-1, noradrenalin, serotonin, the thromboxane A2 analogue U46619, substance P and prostacyclin was determined in umbilical artery segments from 13 normal pregnancies and 29 pregnancies complicated with preeclampsia and/or intrauterine growth retardation with normal or abnormal umbilical flow velocity waveforms."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7545576"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADCY7"}, "span_text": {"type": "literal", "value": "Compared with healthy women, platelets from women with a previous history of pre-eclampsia tended to accumulate less cyclic AMP in response to adenylate cyclase stimulators."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7545563"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADCY6"}, "span_text": {"type": "literal", "value": "Further investigation of adenylate cyclase activity in platelets in relation to pre-eclampsia is required."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7545563"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADCY5"}, "span_text": {"type": "literal", "value": "Further investigation of adenylate cyclase activity in platelets in relation to pre-eclampsia is required."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7545563"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADCY5"}, "span_text": {"type": "literal", "value": "Compared with healthy women, platelets from women with a previous history of pre-eclampsia tended to accumulate less cyclic AMP in response to adenylate cyclase stimulators."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7545563"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADCY9"}, "span_text": {"type": "literal", "value": "Further investigation of adenylate cyclase activity in platelets in relation to pre-eclampsia is required."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7545563"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADCY3"}, "span_text": {"type": "literal", "value": "Further investigation of adenylate cyclase activity in platelets in relation to pre-eclampsia is required."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7545563"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADCY7"}, "span_text": {"type": "literal", "value": "Further investigation of adenylate cyclase activity in platelets in relation to pre-eclampsia is required."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7545563"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADCY9"}, "span_text": {"type": "literal", "value": "Compared with healthy women, platelets from women with a previous history of pre-eclampsia tended to accumulate less cyclic AMP in response to adenylate cyclase stimulators."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7545563"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADCY8"}, "span_text": {"type": "literal", "value": "Compared with healthy women, platelets from women with a previous history of pre-eclampsia tended to accumulate less cyclic AMP in response to adenylate cyclase stimulators."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7545563"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADCY3"}, "span_text": {"type": "literal", "value": "Compared with healthy women, platelets from women with a previous history of pre-eclampsia tended to accumulate less cyclic AMP in response to adenylate cyclase stimulators."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7545563"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADCY6"}, "span_text": {"type": "literal", "value": "Compared with healthy women, platelets from women with a previous history of pre-eclampsia tended to accumulate less cyclic AMP in response to adenylate cyclase stimulators."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7545563"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADCY8"}, "span_text": {"type": "literal", "value": "Further investigation of adenylate cyclase activity in platelets in relation to pre-eclampsia is required."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7545563"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "We measured the in vitro effects of 2% plasma from women with preeclampsia, compared with 2% plasma from normotensive pregnant women, on cultured endothelial cell nitrite production and nitric oxide synthase activity."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7543451"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "The nitric oxide synthase activity was significantly higher in normotensive pregnant women [36.8 +/- 2.7 pmol h-1 mg-1 of protein (mean +/- SEM), P < 0.001] than in non-pregnant control subjects (16.8 +/- 1.4 pmol h-1 mg-1 of protein) and in women with pre-eclampsia (24.5 +/- 2.1 pmol h-1 mg-1 of protein, P < 0.01)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7543394"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "Differential nitric oxide synthase activity in human platelets during normal pregnancy and pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7543394"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "Nitric oxide synthase activity was measured in the platelets of 21 normotensive pregnant women, 16 non-pregnant women and seven pregnant women who had developed pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7543394"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CADM1"}, "span_text": {"type": "literal", "value": "The cell adhesion molecule, VCAM-1, is selectively elevated in serum in pre-eclampsia: does this indicate the mechanism of leucocyte activation?"}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7538783"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CADM3"}, "span_text": {"type": "literal", "value": "The cell adhesion molecule, VCAM-1, is selectively elevated in serum in pre-eclampsia: does this indicate the mechanism of leucocyte activation?"}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7538783"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CSF2"}, "span_text": {"type": "literal", "value": "Nine low birth weight infants with neutropenia born to mothers with preeclampsia were treated with granulocyte-colony stimulating factor, 10 micrograms/kg intravenously, within 24 hours of birth and at 24-hour intervals for a maximum of three doses if neutropenia persisted."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7532708"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CSF1"}, "span_text": {"type": "literal", "value": "Administration of granulocyte colony-stimulating factor to neutropenic low birth weight infants of mothers with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7532708"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CSF2"}, "span_text": {"type": "literal", "value": "Administration of granulocyte colony-stimulating factor to neutropenic low birth weight infants of mothers with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7532708"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CSF1"}, "span_text": {"type": "literal", "value": "Nine low birth weight infants with neutropenia born to mothers with preeclampsia were treated with granulocyte-colony stimulating factor, 10 micrograms/kg intravenously, within 24 hours of birth and at 24-hour intervals for a maximum of three doses if neutropenia persisted."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7532708"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF2"}, "span_text": {"type": "literal", "value": "There is now a well recognized series of findings which suggests that the insulin-like growth factors (IGFs) and their binding proteins (IGFBPs) may play an important role in both normal and abnormal human fetal growth: (1) IGFs are detectable in many fetal tissues from the first trimester onwards; (2) the levels of the IGFs in the fetal circulation increase during pregnancy, and at term the levels of IGF-I are directly related to birthweight; (3) in mice, disruption of the IGF gene leads to severe growth retardation; (4) in the first trimester the levels of IGFBP-1 are higher in the coelomic fluid than in amniotic fluid or maternal serum; (5) at 9-12 weeks there is a striking increase in IGFBP-1 and IGFBP-2 levels in amniotic fluid; (6) the major binding proteins in the human fetus are IGFBP-1 and IGFBP-2; (7) from as early as 16 weeks there is an inverse correlation between fetal levels of IGFBP-1 and birthweight; (8) in the mother, circulating levels of IGF-I and IGFBP-1 increase during pregnancy; (10) maternal levels of IGFBP-1 are elevated in severe pre-eclampsia and intrauterine growth retardation; (11) fetal levels of IGFBP-1 are elevated in cases of intrauterine growth retardation, especially those associated with specific evidence of reduced uteroplacental bloodflow; and (12) fetal levels of IGFBP-1 are elevated in labour, especially if there is evidence of fetal hypoxia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7532055"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF1"}, "span_text": {"type": "literal", "value": "There is now a well recognized series of findings which suggests that the insulin-like growth factors (IGFs) and their binding proteins (IGFBPs) may play an important role in both normal and abnormal human fetal growth: (1) IGFs are detectable in many fetal tissues from the first trimester onwards; (2) the levels of the IGFs in the fetal circulation increase during pregnancy, and at term the levels of IGF-I are directly related to birthweight; (3) in mice, disruption of the IGF gene leads to severe growth retardation; (4) in the first trimester the levels of IGFBP-1 are higher in the coelomic fluid than in amniotic fluid or maternal serum; (5) at 9-12 weeks there is a striking increase in IGFBP-1 and IGFBP-2 levels in amniotic fluid; (6) the major binding proteins in the human fetus are IGFBP-1 and IGFBP-2; (7) from as early as 16 weeks there is an inverse correlation between fetal levels of IGFBP-1 and birthweight; (8) in the mother, circulating levels of IGF-I and IGFBP-1 increase during pregnancy; (10) maternal levels of IGFBP-1 are elevated in severe pre-eclampsia and intrauterine growth retardation; (11) fetal levels of IGFBP-1 are elevated in cases of intrauterine growth retardation, especially those associated with specific evidence of reduced uteroplacental bloodflow; and (12) fetal levels of IGFBP-1 are elevated in labour, especially if there is evidence of fetal hypoxia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7532055"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL1RN"}, "span_text": {"type": "literal", "value": "Increased concentrations of cytokines interleukin-6 and interleukin-1 receptor antagonist in plasma of women with preeclampsia: a mechanism for endothelial dysfunction?"}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7526306"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL6"}, "span_text": {"type": "literal", "value": "Increased concentrations of cytokines interleukin-6 and interleukin-1 receptor antagonist in plasma of women with preeclampsia: a mechanism for endothelial dysfunction?"}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7526306"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VCAM1"}, "span_text": {"type": "literal", "value": "To determine if plasma concentrations of defined cytokines are increased in women with preeclampsia, and to correlate any increases with the elevated concentrations of the vascular cell adhesion molecule (VCAM)-1."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7526306"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AFP"}, "span_text": {"type": "literal", "value": "Elevated maternal serum alpha-fetoprotein was significantly associated with early postamniocentesis complications and fetal growth restriction, whereas elevated human chorionic gonadotropin was associated with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7524322"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CADM3"}, "span_text": {"type": "literal", "value": "This study shows that concentrations of cell adhesion molecules, which indicate leucocyte-endothelial attachment and activation, are elevated in the serum of patients with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7517182"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CADM1"}, "span_text": {"type": "literal", "value": "To determine whether circulating levels of cell adhesion molecules, markers of endothelial damage and leucocyte activation, were increased in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7517182"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CADM3"}, "span_text": {"type": "literal", "value": "Such increases in soluble circulating cell adhesion molecules may reflect increased expression of these molecules on the endothelium and thereby explain the mechanism for leucocyte activation in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7517182"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CADM3"}, "span_text": {"type": "literal", "value": "The cell adhesion molecule, VCAM-1, is selectively elevated in serum in pre-eclampsia: does this indicate the mechanism of leucocyte activation?"}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7517182"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CADM1"}, "span_text": {"type": "literal", "value": "Such increases in soluble circulating cell adhesion molecules may reflect increased expression of these molecules on the endothelium and thereby explain the mechanism for leucocyte activation in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7517182"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CADM1"}, "span_text": {"type": "literal", "value": "The cell adhesion molecule, VCAM-1, is selectively elevated in serum in pre-eclampsia: does this indicate the mechanism of leucocyte activation?"}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7517182"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CADM1"}, "span_text": {"type": "literal", "value": "This study shows that concentrations of cell adhesion molecules, which indicate leucocyte-endothelial attachment and activation, are elevated in the serum of patients with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7517182"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CADM3"}, "span_text": {"type": "literal", "value": "To determine whether circulating levels of cell adhesion molecules, markers of endothelial damage and leucocyte activation, were increased in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7517182"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MAOA"}, "span_text": {"type": "literal", "value": "These findings suggest that the higher levels of plasma free 5-HT in umbilical cord plasma in preeclampsia are attributable to excess release of 5-HT from platelets as well as lower monoamine oxidase activity."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7513511"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Pre-eclampsia and serum antibodies to oxidised low-density lipoprotein."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7509433"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "We assessed whether the titre of IgG autoantibody to an epitope of Ox-LDL, malondialdehyde-conjugated low-density lipoprotein (MDA-LDL), was increased in the sera of pre-eclamptic patients."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7509433"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "The hypothesis is supported by observations of (1) hemolytic effect of FFA, and protection by albumin in vitro, (2) inhibition of white blood cells by FFA, (3) increased FFA/albumin ratio and erythrocyte susceptibility to hemolysis in pre-eclampsia, (4) increased incidence of eclampsia in undernutrition, (5) the paradox at famine suppresses and refeeding activates malaria, and (6) an inverse relationship between serum albumin level and mortality."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7476603"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "No significant effect was noted in patients with normal pregnancies or in those complicated by insulin dependent diabetes or mild pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7437376"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PRL"}, "span_text": {"type": "literal", "value": "Infants of mothers with gestational hypertension also tended to have elevated serum prolactin concentrations."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7386551"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PRL"}, "span_text": {"type": "literal", "value": "The results of the present study show that the estimation of plasma prolactin level is of no clinical significance in patients with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7366897"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PRL"}, "span_text": {"type": "literal", "value": "At 37 to 38 weeks' gestation the maternal plasma free estriol levels correlated positively with the prolactin levels in preeclampsia (r = .313; P less than .05; N = 64)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7366897"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PRL"}, "span_text": {"type": "literal", "value": "Maternal plasma prolactin, estradiol-17 beta, and free estriol levels were estimated in 118 normal pregnancies and in 90 patients with preeclampsia at 35 to 40 weeks' gestation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7366897"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PRL"}, "span_text": {"type": "literal", "value": "In the preeclamptic patients, the prolactin values were similar to those of normal pregnancy; the levels were not affected by the severity of disease."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7366897"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PRL"}, "span_text": {"type": "literal", "value": "Maternal plasma prolactin levels in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7366897"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Lipid peroxide levels and lipids content of serum lipoprotein fractions of pregnant subjects with or without pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7285362"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:DCTD"}, "span_text": {"type": "literal", "value": "The results confirm that elevated dCMP deaminase activity (greater than 4.8 units) is associated with the development of pre-eclampsia but not with essential hypertension in pregnancy; a high rising level can precede eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/7073998"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GP2"}, "span_text": {"type": "literal", "value": "Laminin, a large basement membrane glycoprotein, type IV collagen, fibronectin, and a basement membrane proteoglycan were found in moderate amounts in the mesangium and prominently in the thickened glomerular capillary walls of patients with preeclampsia or other hypertensive syndromes of pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/6887782"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:DBH"}, "span_text": {"type": "literal", "value": "Maternal and fetal plasma renin and dopamine-beta-hydroxylase activities in toxemic pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/683663"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:F5"}, "span_text": {"type": "literal", "value": "In severe toxemia of pregnancy, decreases in extrinsic coagulation factors, platelet, antithrombin III, plasminogen, alpha 2-plasmin inhibitor, and increases in soluble fibrin-monomer complex, fibrin degradation products, beta-thromboglobulin were observed."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/6652168"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "The results suggest that the use of albumin infusion is of no specific value in the treatment of severe pre-eclampsia in terms of evaluation at the level of placental circulation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/6637407"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "Intervillous blood flow (IVBF) was measured by the 133Xe intravenous method before and after a 100 ml infusion of 20% human albumin in 13 cases of severe pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/6637407"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "Albumin infusion does not alter the intervillous blood flow in severe pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/6637407"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:F5"}, "span_text": {"type": "literal", "value": "The effect of pre-eclampsia on selected maternal and neonatal coagulation factors was studied by comparing plasma concentrations in 5 severely pre-eclamptic and 5 normal pregnancies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/6625637"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CP"}, "span_text": {"type": "literal", "value": "It is suggested that reduced plasma alpha 2-PAG may be of prognostic value and have a role in the aetiology of preeclampsia whereas increased ceruloplasmin levels may be no more than an acute phase reactant resulting from pathological changes due to hypertension."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/6575751"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CP"}, "span_text": {"type": "literal", "value": "Ceruloplasmin levels were significantly elevated in preeclampsia patients and in patients with essential hypertension."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/6575751"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AFP"}, "span_text": {"type": "literal", "value": "A history of infertility, headaches (particularly migraine), pre-eclampsia in a previous pregnancy, or a raised serum alpha-fetoprotein concentration at the time of screening for neural tube defect in the index pregnancy were all identified as significant risk factors in the pre-eclamptic women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/6411232"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PRL"}, "span_text": {"type": "literal", "value": "In the present studies, the content and the in vitro production of prolactin by decidua as well as the concentrations of prolactin in amniotic fluid, maternal and fetal serum in normal term pregnancies, induced abortions at various gestational ages, and in pregnancies complicated by diabetes mellitus, preeclampsia, chronic hypertension, and polyhydramnios were measured."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/6366659"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AFP"}, "span_text": {"type": "literal", "value": "Toxemia of pregnancy: assessment of fetal distress by urinary estriol and circulating human placental lactogen and alpha-fetoprotein levels."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/63245"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LDHB"}, "span_text": {"type": "literal", "value": "Serum lactate dehydrogenase in detecting liver damage associated with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/623724"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LDHD"}, "span_text": {"type": "literal", "value": "Assessment of liver damage by estimation of serum enzymes including lactate dehydrogenase (LDH) and its hepatic fraction, LDH5, was made in 60 normal pregnant women, 20 patients with pre-eclampsia and 10 with eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/623724"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LDHA"}, "span_text": {"type": "literal", "value": "Serum lactate dehydrogenase in detecting liver damage associated with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/623724"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LDHD"}, "span_text": {"type": "literal", "value": "Serum lactate dehydrogenase in detecting liver damage associated with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/623724"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LDHA"}, "span_text": {"type": "literal", "value": "Assessment of liver damage by estimation of serum enzymes including lactate dehydrogenase (LDH) and its hepatic fraction, LDH5, was made in 60 normal pregnant women, 20 patients with pre-eclampsia and 10 with eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/623724"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LDHB"}, "span_text": {"type": "literal", "value": "Assessment of liver damage by estimation of serum enzymes including lactate dehydrogenase (LDH) and its hepatic fraction, LDH5, was made in 60 normal pregnant women, 20 patients with pre-eclampsia and 10 with eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/623724"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:A2M"}, "span_text": {"type": "literal", "value": "The blood levels of alpha 2-macroglobulin, alpha 1-antitrypsin, CT inactivator, antithrombin III and alpha 2-antiplasmin were measured in 18 primigravidae with moderate or severe pre-eclampsia and in 18 gestation-matched primigravidae with uncomplicated pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/6194812"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:B2M"}, "span_text": {"type": "literal", "value": "In patients with preeclampsia the renal excretion of beta 2-microglobulin allows to differentiate between a primary preeclampsia and a preeclampsia superimposed upon chronic pyelonephritis."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/6164517"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "Intravascular mass of albumin in pre-eclampsia and normal pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/6048635"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "Albumin metabolism in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/5958378"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:DCTD"}, "span_text": {"type": "literal", "value": "Serial antenatal observations for a mean period of 104 days (36-179 days) on 33 of the patients demonstrated that plasma urate and serum dCMP deaminase increased together as early changes in the development of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/588501"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:DCTD"}, "span_text": {"type": "literal", "value": "Elevations of plasma urate and serum dCMP deaminase are therefore both early features of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/588501"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:DCTD"}, "span_text": {"type": "literal", "value": "The value of measuring plasma urate and serum deoxycytidylate deaminase (dCMP deaminase) for the early diagnosis of pre-eclampsia has been investigated in 45 patients."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/588501"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "Albumin metabolism in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/5710444"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PRL"}, "span_text": {"type": "literal", "value": "Prolactin levels in the plasma and amniotic fluid of 121 normal pregnant women, 78 women with pre-eclampsia and 30 women with essential hypertension complicating pregnancy were determined by radioimmunoassay."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/565211"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PRL"}, "span_text": {"type": "literal", "value": "Mean prolactin levels in plasma, but not in amniotic fluid, were significantly lower than controls in the group with pre-eclampsia (P less than 0.01) and in the group with essential hypertension (P less than 0.05)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/565211"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "Serum-alpha2-macroglobulin, transferrin, albumin, and IgG levels in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/4991000"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:A2M"}, "span_text": {"type": "literal", "value": "Since alpha(2)-macroglobulin has antiplasmin activity it is possible that increased levels of this protein in preeclampsia accompanied by proteinuria contribute to the intravascular coagulation which has been described in this disorder."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/4991000"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:A2M"}, "span_text": {"type": "literal", "value": "When preeclampsia is accompanied by proteinuria there is a marked fall in albumin and an increase in alpha(2)-macroglobulin."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/4991000"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:A2M"}, "span_text": {"type": "literal", "value": "In preeclampsia unaccompanied by proteinuria, albumin and transferrin levels are similar to those found in the normal pregnant controls, but there are significant falls in alpha(2)-macroglobulin and IgG."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/4991000"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "In preeclampsia unaccompanied by proteinuria, albumin and transferrin levels are similar to those found in the normal pregnant controls, but there are significant falls in alpha(2)-macroglobulin and IgG."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/4991000"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "When preeclampsia is accompanied by proteinuria there is a marked fall in albumin and an increase in alpha(2)-macroglobulin."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/4991000"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Insulin response to oral glucose in patients with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/4694989"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:A2M"}, "span_text": {"type": "literal", "value": "Compared with normal pregnancy, alpha(2)-macroglobulin is significantly raised in preeclampsia with proteinuria but normal in preeclampsia without proteinuria."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/4627103"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:A2M"}, "span_text": {"type": "literal", "value": "The serum levels of alpha(2)-macroglobulin and pregnancy-associated globulin (another alpha-macroglobulin) have been measured by means of a radial immunodiffusion technique in (1) renal disease with and without proteinuria, (2) in age- and sex-matched controls, (3) in preeclampsia with and without proteinuria, and (4) in normal pregnant controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/4627103"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GP2"}, "span_text": {"type": "literal", "value": "Collagen, glycoprotein and inorganic constituents of amniotic fluid from normal and toxaemic pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/4461681"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Serum lipids and lipoproteins in hepatosis of pregnancy and pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/4364930"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LDHD"}, "span_text": {"type": "literal", "value": "Investigation of urinary protein and lactate dehydrogenase in normal pregnancy and in pre-eclampsia by means of disc electrophoresis."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/4103938"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LDHA"}, "span_text": {"type": "literal", "value": "Investigation of urinary protein and lactate dehydrogenase in normal pregnancy and in pre-eclampsia by means of disc electrophoresis."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/4103938"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LDHB"}, "span_text": {"type": "literal", "value": "Investigation of urinary protein and lactate dehydrogenase in normal pregnancy and in pre-eclampsia by means of disc electrophoresis."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/4103938"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AVP"}, "span_text": {"type": "literal", "value": "Plasma concentrations of arginine vasopressin (AVP), angiotensin II (A II), aldosterone (Aldo), serum osmolality (Sosm), urine volume (V), and free water clearance (CH2O) were determined in the third trimester of pregnancy, and 5 days and 3 months after delivery in pre-eclampsia (group I), in normotensive pregnancy (group II), and in non-pregnant control subjects (group III)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/4070961"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CDA"}, "span_text": {"type": "literal", "value": "These results show a poor correlation of elevated cytidine deaminase activity with pre-eclampsia and a significant false positive elevation of the enzyme activity in normal pregnancies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/4037669"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CDA"}, "span_text": {"type": "literal", "value": "Increased activity of cytidine deaminase was found in 42.9% of patients with severe pre-eclampsia, 9.1% of patients with mild pre-eclampsia and in 8.6% of normal pregnancies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/4037669"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CDA"}, "span_text": {"type": "literal", "value": "Cytidine deaminase--a marker for pre-eclampsia?"}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/4037669"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GOT1"}, "span_text": {"type": "literal", "value": "A case of gravida presenting with upper abdominal pain, an elevated serum glutamic oxaloacetic transaminase level, and thrombocytopenia, all of which resolved promptly after delivery, and with none of the standard signs and symptoms needed for the diagnosis of preeclampsia is presented."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/4022510"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LAP3"}, "span_text": {"type": "literal", "value": "Plasma angiotensin I and serum placental leucine aminopeptidase (P-LAP) in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/4015192"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPL"}, "span_text": {"type": "literal", "value": "Intracellular lipolytic activity and lipoprotein lipase activity were determined in healthy human placental tissue, in placentas obtained from patients with severe pre-eclampsia, and from cases of intra-uterine growth retardation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/3984686"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PRL"}, "span_text": {"type": "literal", "value": "In vitro prolactin (hPrl) secretion by explants of decidual tissue was studied in pre-eclampsia and normal controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/3969805"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PRL"}, "span_text": {"type": "literal", "value": "Decreased prolactin secretion by decidual tissue of pre-eclampsia in vitro."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/3969805"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "Preeclamptic patients with bacteriuria had significantly lower total serum protein and albumin than preeclamptic patients without bacteriuria (P less than .001)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/3960425"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "These data suggest that proteinuric pre-eclampsia, as defined by relatively insensitive routine laboratory measurement, is not preceded by a phase of increasing albumin loss which can be detected by more sensitive assays."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/3947591"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Serum lipid and lipoprotein metabolism in toxemia of pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/3938726"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PTGS1"}, "span_text": {"type": "literal", "value": "Uterine prostacyclin synthase (PGI synthase) and prostaglandin endoperoxide synthase (PGH synthase) concentrations, measured by specific immunoradiometric assays, did not differ between patients with severe pregnancy-induced hypertension (syn. pre-eclampsia; n = 5) and normotensive gravidae (n = 6) with comparable gestational ages (34 - 38 weeks)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/3923569"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:C3"}, "span_text": {"type": "literal", "value": "We determined in normal nonpregnant (group I) and normal pregnant (group II) women and in patients with preeclampsia (group III): (1) immunoglobulins and complement C3b associated with polymorphonuclear leukocytes and platelet surfaces in an attempt to evaluate the interaction in vivo of immune complexes with the membranes of these cells; (2) the occurrence of circulating immune complexes; (3) the serum levels of immunoglobulins, C3, and C4; and (4) the plasma levels of complement C3d."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/3893134"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:C3"}, "span_text": {"type": "literal", "value": "The plasma levels of complement C3d were markedly increased in the most severe cases of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/3893134"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "In a study of 72 normotensive and preeclamptic patients, peripartum colloid osmotic pressure, serum albumin, and total serum protein were compared."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/3785794"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PRL"}, "span_text": {"type": "literal", "value": "Prolactin in severe toxemia of pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/3781070"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "Microalbuminuria, (relative albumin clearance) detected by means of a sensitive, specific immunochemical method was a more discriminatory diagnostic test in pre-eclampsia than the customary test strip reaction for clinical proteinuria."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/3731490"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "Furthermore, relative albumin clearance may serve as a valuable quantitative and objective measurement for monitoring therapy or control of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/3731490"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LCAT"}, "span_text": {"type": "literal", "value": "Lecithin cholesterol acyl transferase activity in pregnancy & toxaemia of pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/3692558"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:B2M"}, "span_text": {"type": "literal", "value": "Tubular function is reduced in normal pregnancy, whereas increased 'net tubular reabsorption' of uric acid and beta 2-microglobulin occurs in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/3524096"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:B2M"}, "span_text": {"type": "literal", "value": "Serum uric acid correlates with beta 2-microglobulin in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/3524096"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:B2M"}, "span_text": {"type": "literal", "value": "In order to evaluate renal tubular function, beta 2-microglobulin was measured in serum and urine from 15 patients with severe pre-eclampsia and 13 normal pregnant women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/3524096"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:B2M"}, "span_text": {"type": "literal", "value": "Serum and urinary beta 2-microglobulin levels in gravida with chronic glomerulonephritis and pure toxemia of pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/3320425"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PRL"}, "span_text": {"type": "literal", "value": "It is suggested that either elevated prolactin levels or an increased responsiveness to normal prolactin levels may play a key role in the pathogenesis of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/329615"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PRL"}, "span_text": {"type": "literal", "value": "The possible role of prolactin in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/329615"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "The increase in triglycerides in toxemia of pregnancy was estimated in VLDL and low density lipoprotein (LDL), mainly in VLDL."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/3209913"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "In order to clarify the mechanism of hypertriglyceridemia caused by toxemia of pregnancy, apoprotein B, CII, CIII, and E in serum were determined by single radial immunodiffusion, and apoprotein CIII0, CII, CIII1 and CIII2 in very low density lipoprotein (VLDL) fractionated by ultracentrifugation were quantified by analytical isoelectric focusing."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/3209913"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPL"}, "span_text": {"type": "literal", "value": "In toxemia of pregnancy, the relative amounts of apoprotein CII, an activator of lipoprotein lipase, and CIII, an inhibitor of lipoprotein lipase, in serum were similar to those in normal pregnancy, but those in VLDL decreased significantly."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/3209913"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EPO"}, "span_text": {"type": "literal", "value": "We conclude that a high erythropoietin level after normal pregnancy, but not after preeclampsia, indicates an increased risk for cerebral palsy or death."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/3183848"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EPO"}, "span_text": {"type": "literal", "value": "A high erythropoietin level was found in infants born after preeclampsia regardless of outcome: normal outcome (geometric mean (GM), 102; 95% confidence interval [CI], 69 to 153 mU/ml), slightly abnormal outcome (GM, 100; 95% CI, 37 to 270 mU/ml) or clearly abnormal outcome (GM, 84; 95% CI, 19 to 378 mU/ml)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/3183848"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AVP"}, "span_text": {"type": "literal", "value": "For an assessment of whether cord plasma arginine vasopressin, erythropoietin, and hypoxanthine concentrations are predictors of perinatal brain damage, these concentrations were measured in 62 infants born after preeclampsia of pregnancy, 31 acutely asphyxiated infants, and 38 control infants."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/3183848"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EPO"}, "span_text": {"type": "literal", "value": "For an assessment of whether cord plasma arginine vasopressin, erythropoietin, and hypoxanthine concentrations are predictors of perinatal brain damage, these concentrations were measured in 62 infants born after preeclampsia of pregnancy, 31 acutely asphyxiated infants, and 38 control infants."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/3183848"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EPO"}, "span_text": {"type": "literal", "value": "To assess the value of cord plasma arginine vasopressin (AVP), erythropoietin (EP), and hypoxanthine (HX) as indices of asphyxia, we studied 62 infants of mothers with preeclampsia, 34 acutely asphyxiated infants, with 5-min Apgar score less than or equal to 6 and/or umbilical arterial pH less than or equal to 7.05, and 38 control infants."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/3174294"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AVP"}, "span_text": {"type": "literal", "value": "To assess the value of cord plasma arginine vasopressin (AVP), erythropoietin (EP), and hypoxanthine (HX) as indices of asphyxia, we studied 62 infants of mothers with preeclampsia, 34 acutely asphyxiated infants, with 5-min Apgar score less than or equal to 6 and/or umbilical arterial pH less than or equal to 7.05, and 38 control infants."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/3174294"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG9"}, "span_text": {"type": "literal", "value": "Pregnancy-specific beta-1-glycoprotein levels in normal and toxemic pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/315526"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG6"}, "span_text": {"type": "literal", "value": "Maternal plasma levels of pregnancy-specific beta-1-glycoprotein (PSBG) in 166 normal and 169 toxemic pregnancies were measured by radioimmunoassay in the third trimester."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/315526"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG3"}, "span_text": {"type": "literal", "value": "Pregnancy-specific beta-1-glycoprotein levels in normal and toxemic pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/315526"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG9"}, "span_text": {"type": "literal", "value": "Maternal plasma levels of pregnancy-specific beta-1-glycoprotein (PSBG) in 166 normal and 169 toxemic pregnancies were measured by radioimmunoassay in the third trimester."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/315526"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG2"}, "span_text": {"type": "literal", "value": "Maternal plasma levels of pregnancy-specific beta-1-glycoprotein (PSBG) in 166 normal and 169 toxemic pregnancies were measured by radioimmunoassay in the third trimester."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/315526"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG6"}, "span_text": {"type": "literal", "value": "Pregnancy-specific beta-1-glycoprotein levels in normal and toxemic pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/315526"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG8"}, "span_text": {"type": "literal", "value": "Pregnancy-specific beta-1-glycoprotein levels in normal and toxemic pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/315526"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG1"}, "span_text": {"type": "literal", "value": "Pregnancy-specific beta-1-glycoprotein levels in normal and toxemic pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/315526"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG11"}, "span_text": {"type": "literal", "value": "Maternal plasma levels of pregnancy-specific beta-1-glycoprotein (PSBG) in 166 normal and 169 toxemic pregnancies were measured by radioimmunoassay in the third trimester."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/315526"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG5"}, "span_text": {"type": "literal", "value": "Maternal plasma levels of pregnancy-specific beta-1-glycoprotein (PSBG) in 166 normal and 169 toxemic pregnancies were measured by radioimmunoassay in the third trimester."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/315526"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG8"}, "span_text": {"type": "literal", "value": "Maternal plasma levels of pregnancy-specific beta-1-glycoprotein (PSBG) in 166 normal and 169 toxemic pregnancies were measured by radioimmunoassay in the third trimester."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/315526"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG3"}, "span_text": {"type": "literal", "value": "Maternal plasma levels of pregnancy-specific beta-1-glycoprotein (PSBG) in 166 normal and 169 toxemic pregnancies were measured by radioimmunoassay in the third trimester."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/315526"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG4"}, "span_text": {"type": "literal", "value": "Pregnancy-specific beta-1-glycoprotein levels in normal and toxemic pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/315526"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG4"}, "span_text": {"type": "literal", "value": "Maternal plasma levels of pregnancy-specific beta-1-glycoprotein (PSBG) in 166 normal and 169 toxemic pregnancies were measured by radioimmunoassay in the third trimester."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/315526"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG2"}, "span_text": {"type": "literal", "value": "Pregnancy-specific beta-1-glycoprotein levels in normal and toxemic pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/315526"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG5"}, "span_text": {"type": "literal", "value": "Pregnancy-specific beta-1-glycoprotein levels in normal and toxemic pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/315526"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG1"}, "span_text": {"type": "literal", "value": "Maternal plasma levels of pregnancy-specific beta-1-glycoprotein (PSBG) in 166 normal and 169 toxemic pregnancies were measured by radioimmunoassay in the third trimester."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/315526"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG11"}, "span_text": {"type": "literal", "value": "Pregnancy-specific beta-1-glycoprotein levels in normal and toxemic pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/315526"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VWF"}, "span_text": {"type": "literal", "value": "Factor VIII: von Willebrand factor patterns in the plasma of patients with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/3122779"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "In cases of severe preeclampsia, levels of atrial natriuretic peptide were significantly higher than in the other subjects, but aldosterone levels decreased to nearly those seen in the nonpregnant subjects."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/2963545"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "In severe cases of preeclampsia, atrial natriuretic peptide established a circadian rhythm similar to that of blood pressure, and the circadian rhythm of aldosterone disappeared."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/2963545"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "Changes in concentration of human atrial natriuretic peptide (hANP) in normal and toxaemic pregnancy were examined."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/2958577"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "Atrial natriuretic peptide concentrations in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/2958106"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "These findings are clear evidence that atrial pressure may not be the principal determinant of the release of the natriuretic peptide in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/2955845"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "A study was therefore undertaken to test the hypothesis that plasma atrial natriuretic peptide concentrations are low in pre-eclampsia owing to deficient secretion."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/2955845"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "Despite failure of plasma volume expansion and low central venous and pulmonary capillary wedge pressures in pre-eclampsia this condition is associated with greatly increased plasma concentrations of plasma immunoreactive atrial natriuretic peptide, which increase still further with the severity of the disease."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/2955845"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "Atrial natriuretic peptide concentrations in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/2955845"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "In a study of eight patients with severe preeclampsia, cumulative rapid infusions of 500 mL (set of eight patients) and 1000 mL (subset of five patients) of 5% albumin in normal saline were followed with invasive hemodynamic measurements at 5 and 30 minutes."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/2927849"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VWF"}, "span_text": {"type": "literal", "value": "The findings support the potential role of the ADAMTS13-von Willebrand factor pathway in normal pregnancy and pathogenesis of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/28751574"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Patients with preeclampsia display elevated placenta-derived sFlt-1 (soluble Fms-like tyrosine kinase-1) and endoglin levels and decreased placental growth factor levels."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/28716993"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Low Soluble Fms-Like Tyrosine Kinase-1, Endoglin, and Endothelin-1 Levels in Women With Confirmed or Suspected Preeclampsia Using Proton Pump Inhibitors."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/28716993"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Patients with preeclampsia display elevated placenta-derived sFlt-1 (soluble Fms-like tyrosine kinase-1) and endoglin levels and decreased placental growth factor levels."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/28716993"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "In conclusion, PPI use associates with low sFlt-1, endoglin, and endothelin-1 levels, warranting prospective trials to investigate the therapeutic potential of PPIs in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/28716993"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "In conclusion, PPI use associates with low sFlt-1, endoglin, and endothelin-1 levels, warranting prospective trials to investigate the therapeutic potential of PPIs in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/28716993"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Low Soluble Fms-Like Tyrosine Kinase-1, Endoglin, and Endothelin-1 Levels in Women With Confirmed or Suspected Preeclampsia Using Proton Pump Inhibitors."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/28716993"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Patients with preeclampsia display elevated placenta-derived sFlt-1 (soluble Fms-like tyrosine kinase-1) and endoglin levels and decreased placental growth factor levels."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/28716993"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FLT1"}, "span_text": {"type": "literal", "value": "Protective Low-Frequency Variants for Preeclampsia in the Fms Related Tyrosine Kinase 1 Gene in the Finnish Population."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/28652462"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD1"}, "span_text": {"type": "literal", "value": "Alterations in Lipid Profile, Zinc and Copper Levels and Superoxide Dismutase Activities in Normal Pregnancy and Preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/28641718"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD3"}, "span_text": {"type": "literal", "value": "Alterations in Lipid Profile, Zinc and Copper Levels and Superoxide Dismutase Activities in Normal Pregnancy and Preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/28641718"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:COMT"}, "span_text": {"type": "literal", "value": "Catechol-O-methyltransferase Gene Polymorphism (Val158Met) and Development of Pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/28625321"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "Placentae from patients with preeclampsia have reduced levels of endothelial nitric oxide synthase (eNOS) and, thus, less nitric oxide (NO)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/28607124"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:COMT"}, "span_text": {"type": "literal", "value": "Catechol-O-methyltransferase (COMT) metabolizes 2-hydroxyestradiol into 2-methoxyestradiol (2-ME); COMT deficiency has shown to be associated with hypertension in men and preeclampsia, the disease associated with hypersensitivity of pressor response against angiotensin II (Ang II)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/28461606"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "The aim of this study is to determine preeclampsia risk with soluble fms-like tyrosin kinase 1/placental growth factor ratio, serum NT-proBNP (N-terminal pro B-type natriuretic peptide), and biophysical markers of cardiovascular function in a prospective case-control study."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/28461601"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "The aim of this study is to determine preeclampsia risk with soluble fms-like tyrosin kinase 1/placental growth factor ratio, serum NT-proBNP (N-terminal pro B-type natriuretic peptide), and biophysical markers of cardiovascular function in a prospective case-control study."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/28461601"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TCF4"}, "span_text": {"type": "literal", "value": "Hypoxia-inducible factor 1-alpha (HIF-1\u03b1) is the oxygen-sensitive subunit of the transcription factor HIF-1, and its expression is increased in placentas from pregnancies complicated by pre-eclampsia (PE)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/28423052"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL4"}, "span_text": {"type": "literal", "value": "Association between interleukin-4 polymorphisms and risk of pre-eclampsia in a population of Chinese pregnant women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/28387873"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MAPK8"}, "span_text": {"type": "literal", "value": "This present study was designed to investigate the effects of alpha-1-antitrypsin (AAT) on oxidative stress in preeclampsia (PE) by regulating p38 mitogen-activated protein kinase (p38MAPK) signaling pathway."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/28358847"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MAPK6"}, "span_text": {"type": "literal", "value": "This present study was designed to investigate the effects of alpha-1-antitrypsin (AAT) on oxidative stress in preeclampsia (PE) by regulating p38 mitogen-activated protein kinase (p38MAPK) signaling pathway."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/28358847"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MAPK11"}, "span_text": {"type": "literal", "value": "This present study was designed to investigate the effects of alpha-1-antitrypsin (AAT) on oxidative stress in preeclampsia (PE) by regulating p38 mitogen-activated protein kinase (p38MAPK) signaling pathway."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/28358847"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MAPK9"}, "span_text": {"type": "literal", "value": "This present study was designed to investigate the effects of alpha-1-antitrypsin (AAT) on oxidative stress in preeclampsia (PE) by regulating p38 mitogen-activated protein kinase (p38MAPK) signaling pathway."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/28358847"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MAPK10"}, "span_text": {"type": "literal", "value": "This present study was designed to investigate the effects of alpha-1-antitrypsin (AAT) on oxidative stress in preeclampsia (PE) by regulating p38 mitogen-activated protein kinase (p38MAPK) signaling pathway."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/28358847"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MAPK15"}, "span_text": {"type": "literal", "value": "This present study was designed to investigate the effects of alpha-1-antitrypsin (AAT) on oxidative stress in preeclampsia (PE) by regulating p38 mitogen-activated protein kinase (p38MAPK) signaling pathway."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/28358847"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MAPK14"}, "span_text": {"type": "literal", "value": "This present study was designed to investigate the effects of alpha-1-antitrypsin (AAT) on oxidative stress in preeclampsia (PE) by regulating p38 mitogen-activated protein kinase (p38MAPK) signaling pathway."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/28358847"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MAPK1"}, "span_text": {"type": "literal", "value": "This present study was designed to investigate the effects of alpha-1-antitrypsin (AAT) on oxidative stress in preeclampsia (PE) by regulating p38 mitogen-activated protein kinase (p38MAPK) signaling pathway."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/28358847"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MAPK13"}, "span_text": {"type": "literal", "value": "This present study was designed to investigate the effects of alpha-1-antitrypsin (AAT) on oxidative stress in preeclampsia (PE) by regulating p38 mitogen-activated protein kinase (p38MAPK) signaling pathway."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/28358847"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MAPK12"}, "span_text": {"type": "literal", "value": "This present study was designed to investigate the effects of alpha-1-antitrypsin (AAT) on oxidative stress in preeclampsia (PE) by regulating p38 mitogen-activated protein kinase (p38MAPK) signaling pathway."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/28358847"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Alteration in the production of vascular endothelial growth factor (VEGF), a biomarker of endothelial dysfunction, is associated with pre-eclampsia although conflicting reports have been reported."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/28356151"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Alteration in the production of vascular endothelial growth factor (VEGF), a biomarker of endothelial dysfunction, is associated with pre-eclampsia although conflicting reports have been reported."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/28356151"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Alteration in the production of vascular endothelial growth factor (VEGF), a biomarker of endothelial dysfunction, is associated with pre-eclampsia although conflicting reports have been reported."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/28356151"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL6"}, "span_text": {"type": "literal", "value": "Polymorphisms in interleukin-6 and interleukin-10 may be associated with risk of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/28252161"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL10"}, "span_text": {"type": "literal", "value": "Polymorphisms in interleukin-6 and interleukin-10 may be associated with risk of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/28252161"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Women with a history of early-onset preeclampsia (n\u00a0= 131) had significantly greater systolic and diastolic blood pressure, greater body mass index, more often had an abnormal lipid profile (lower high-density lipoprotein levels, higher triglycerides), greater glycated hemoglobin, and greater levels of albuminuria compared to controls (n\u00a0= 56)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/28209494"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TFPI2"}, "span_text": {"type": "literal", "value": "Hypomethylation of tissue factor pathway inhibitor 2 in human placenta of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/28208084"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TFPI2"}, "span_text": {"type": "literal", "value": "To investigate the expression, DNA methylation status and its regulatory mechanism of tissue factor pathway inhibitor 2 (TFPI-2) in human placenta tissues of preeclampsia (PE)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/28208084"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "We sought to assess the ratio of sFlt-1 (soluble fms-like tyrosine kinase 1) to PlGF (placental growth factor) in maternal serum as a screening test for preeclampsia in unselected nulliparous women with a singleton pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/28167687"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Prediction of Preeclampsia Using the Soluble fms-Like Tyrosine Kinase 1 to Placental Growth Factor Ratio:"}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/28167687"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "We sought to assess the ratio of sFlt-1 (soluble fms-like tyrosine kinase 1) to PlGF (placental growth factor) in maternal serum as a screening test for preeclampsia in unselected nulliparous women with a singleton pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/28167687"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GP2"}, "span_text": {"type": "literal", "value": "In women with only 1 positive test result, women with anti-\u03b22 glycoprotein-I positivity present alone had a significantly lower live birth rate (47.7% vs 56.3% vs 79.6%; P<.01) and a significantly higher incidence of preeclampsia without (47.7% vs 34.1% vs 11.1%; P<.01) and with severe features (17.2% vs 14.4% vs 0%; P=.02), intrauterine growth restriction (48.4% vs 40.1% vs 25.9%; P<.01), and stillbirth (29.7% vs 21.2% vs 7.4%; P<.01) compared with women with anticardiolipin antibodies and with women with lupus anticoagulant present alone, respectively."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/28153662"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Levels of soluble fms-like tyrosine kinase-1 and soluble endoglin increased among those who developed preeclampsia, but there was no difference in levels of these antiangiogenic factors (nor any of the other serum analytes measured) among those treated with enoxaparin compared to those receiving standard high-risk care only."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/28153659"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Levels of soluble fms-like tyrosine kinase-1 and soluble endoglin increased among those who developed preeclampsia, but there was no difference in levels of these antiangiogenic factors (nor any of the other serum analytes measured) among those treated with enoxaparin compared to those receiving standard high-risk care only."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/28153659"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "In well-resourced settings, reduced circulating maternal-free placental growth factor (PlGF) aids in either predicting or confirming the diagnosis of preeclampsia, fetal growth restriction, stillbirth, preterm birth, and delivery within 14 days of testing when preeclampsia is suspected."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/28137987"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Diagnostic Performance of Placental Growth Factor in Women With Suspected Preeclampsia Attending Antenatal Facilities in Maputo, Mozambique."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/28137987"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SFTPB"}, "span_text": {"type": "literal", "value": "The major surfactant protein with a molecular weight of 35 kd and also saturated phosphatidylcholine and phosphatidylglycerol were analyzed in specimens of amniotic fluid; 68 were from cases of maternal diabetes, 41 from preeclampsia or maternal hypertension, 26 from premature rupture of the fetal membranes, and 45 from normal pregnancies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/2801845"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SFTPD"}, "span_text": {"type": "literal", "value": "In severe early-onset preeclampsia, the 35 kd surfactant protein/saturated phosphatidylcholine ratio was significantly higher than in the other pregnancies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/2801845"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SFTPC"}, "span_text": {"type": "literal", "value": "In severe early-onset preeclampsia, the 35 kd surfactant protein/saturated phosphatidylcholine ratio was significantly higher than in the other pregnancies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/2801845"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SFTPB"}, "span_text": {"type": "literal", "value": "In severe early-onset preeclampsia, the 35 kd surfactant protein/saturated phosphatidylcholine ratio was significantly higher than in the other pregnancies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/2801845"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SFTPD"}, "span_text": {"type": "literal", "value": "The major surfactant protein with a molecular weight of 35 kd and also saturated phosphatidylcholine and phosphatidylglycerol were analyzed in specimens of amniotic fluid; 68 were from cases of maternal diabetes, 41 from preeclampsia or maternal hypertension, 26 from premature rupture of the fetal membranes, and 45 from normal pregnancies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/2801845"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SFTPC"}, "span_text": {"type": "literal", "value": "The major surfactant protein with a molecular weight of 35 kd and also saturated phosphatidylcholine and phosphatidylglycerol were analyzed in specimens of amniotic fluid; 68 were from cases of maternal diabetes, 41 from preeclampsia or maternal hypertension, 26 from premature rupture of the fetal membranes, and 45 from normal pregnancies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/2801845"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "In women with a normal BMI, a family history of preeclampsia or gestational hypertension, mean arterial blood pressure, plasma endoglin and cystatin C, and uterine artery resistance index were associated with preeclampsia, while high fruit intake was protective."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/28008746"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL1B"}, "span_text": {"type": "literal", "value": "Plasma concentrations of tumor necrosis factor-alpha (TNF-\u03b1) and interleukin-1-beta (IL-1\u03b2) increase in pregnant women with pre-eclampsia, compared to normal pregnant women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27999242"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Recombinant vascular endothelial growth factor 121 injection for the prevention of fetal growth restriction in a preeclampsia mouse model."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27996960"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Recombinant vascular endothelial growth factor 121 injection for the prevention of fetal growth restriction in a preeclampsia mouse model."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27996960"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Recombinant vascular endothelial growth factor 121 injection for the prevention of fetal growth restriction in a preeclampsia mouse model."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27996960"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "N-terminal pro B-type natriuretic peptide and angiogenic biomarkers in the prognosis of adverse outcomes in women with suspected preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27983995"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Preeclampsia, a pregnancy-specific inflammatory disorder, is characterized by high levels of anti-angiogenic protein, soluble fms-like tyrosine kinase 1 (sFlt1), in the maternal circulation. sFlt1 producing molecular machinery is present in syncytiotrophoblast extracellular vesicles that are released by the placenta into maternal plasma during normal pregnancy, a process greatly accelerated in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27939478"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GSN"}, "span_text": {"type": "literal", "value": "To test whether pGSN levels would be lower in preeclampsia and to assess whether recombinant human plasma gelsolin (rhpGSN) may promote placental health by decreasing shedding of syncytiotrophoblast extracellular vesicles."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27939478"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Extensive human epidemiological and experimental studies suggest that excess placental soluble fms-like tyrosine kinase 1, a potent anti-angiogenic factor leads to the maternal hypertension, proteinuria and other systemic complications of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27939475"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Trophoblast mitochondrial function is impaired in preeclampsia and correlates negatively with the expression of soluble fms-like tyrosine kinase 1."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27939475"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SGPL1"}, "span_text": {"type": "literal", "value": "miR-125b Enhances IL-8 Production in Early-Onset Severe Preeclampsia by Targeting Sphingosine-1-Phosphate Lyase 1."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27935985"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "Hematocrit and plasma albumin levels difference may be a potential biomarker to discriminate preeclampsia and eclampsia in patients with hypertensive disorders of pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27919602"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "We evaluated whether alterations of hemoglobin (HB), hematocrit (HCT), serum albumin level (ALB), and the difference of HCT and ALB can be used in the diagnosis of preeclampsia and eclampsia in patients with hypertensive disorders of pregnancy (HDP)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27919602"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:BDNF"}, "span_text": {"type": "literal", "value": "Decreased plasma concentrations of brain-derived neurotrophic factor in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27887959"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL2"}, "span_text": {"type": "literal", "value": "Increased serum activity of interleukin-2 in patients with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/2788426"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "LMWH improves maternal endothelial function in pregnant women at high risk of developing preeclampsia, possibly mediated through increased placental growth factor bioavailability."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27840330"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "This study aimed to analyze the ultrastructure and histomorphometric changes of the human umbilical cord vessels of preeclampsia compared to healthy pregnancies and the possible role of vascular endothelial growth factor (VEGF) and its receptors."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27833959"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "This study aimed to analyze the ultrastructure and histomorphometric changes of the human umbilical cord vessels of preeclampsia compared to healthy pregnancies and the possible role of vascular endothelial growth factor (VEGF) and its receptors."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27833959"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "This study aimed to analyze the ultrastructure and histomorphometric changes of the human umbilical cord vessels of preeclampsia compared to healthy pregnancies and the possible role of vascular endothelial growth factor (VEGF) and its receptors."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27833959"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Therefore, these bioinformatics results led us to assume that the preeclampsia proteins are highly associated with the lipoproteins group, and that some preeclampsia-related proteins contain significant amounts of functional disorders."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27824362"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Our results showed a high graphical correlation between preeclampsia proteins, lipoproteins, and the angiogenesis proteins."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27824362"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "To measure placental growth factor (PlGF), free beta human chorionic gonadotropin (\u03b2-hCG), and pregnancy-associated plasma protein-A (PAPP-A) levels in the fetal circulation of near-term pregnancies complicated with severe preeclampsia (n\u2009=\u200920), and their controls matched for parity, and maternal and gestational age."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27809614"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Lower placental growth factor and higher free \u03b2-hCG and PAPP-A levels in the fetal circulation of near-term pregnancies complicated with severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27809614"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOE"}, "span_text": {"type": "literal", "value": "The protective effect of apolipoprotein in models of trophoblast invasion and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27806983"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOM"}, "span_text": {"type": "literal", "value": "The protective effect of apolipoprotein in models of trophoblast invasion and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27806983"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOO"}, "span_text": {"type": "literal", "value": "The protective effect of apolipoprotein in models of trophoblast invasion and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27806983"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "A dyslipidemia characterized by low plasma levels of high-density lipoproteins (HDL) and elevated triglycerides has been described in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27806983"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOF"}, "span_text": {"type": "literal", "value": "The protective effect of apolipoprotein in models of trophoblast invasion and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27806983"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Placental Growth Factor, Soluble fms-Like Tyrosine Kinase 1, Soluble Endoglin, IL-6, and IL-16 as Biomarkers in Preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27799724"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Placental Growth Factor, Soluble fms-Like Tyrosine Kinase 1, Soluble Endoglin, IL-6, and IL-16 as Biomarkers in Preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27799724"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Other angiogenic markers (placental growth factor, soluble fms-like tyrosine kinase-1, and soluble endoglin) have been shown to alter before clinically evident preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27793555"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "The preeclampsia group had higher soluble fms-like tyrosine kinase-1 from \u226528 weeks (P\u00a0= .003) and lower placental growth factor from 18 weeks (P\u00a0= .004)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27793555"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Angiogenic markers vary longitudinally during pregnancy and placental growth factor and soluble fms-like tyrosine kinase-1 have a role for predicting and diagnosing preeclampsia later in disease."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27793555"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "The preeclampsia group had higher soluble fms-like tyrosine kinase-1 from \u226528 weeks (P\u00a0= .003) and lower placental growth factor from 18 weeks (P\u00a0= .004)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27793555"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Angiogenic markers vary longitudinally during pregnancy and placental growth factor and soluble fms-like tyrosine kinase-1 have a role for predicting and diagnosing preeclampsia later in disease."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27793555"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Other angiogenic markers (placental growth factor, soluble fms-like tyrosine kinase-1, and soluble endoglin) have been shown to alter before clinically evident preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27793555"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Other angiogenic markers (placental growth factor, soluble fms-like tyrosine kinase-1, and soluble endoglin) have been shown to alter before clinically evident preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27793555"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PDCD5"}, "span_text": {"type": "literal", "value": "Autophagy, identified as type II programmed cell death, has already been known to be involved in the pathophysiology of preeclampsia (PE), which is a gestational disease with high morbidity."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27770612"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PDCD2"}, "span_text": {"type": "literal", "value": "Autophagy, identified as type II programmed cell death, has already been known to be involved in the pathophysiology of preeclampsia (PE), which is a gestational disease with high morbidity."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27770612"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PDCD6"}, "span_text": {"type": "literal", "value": "Autophagy, identified as type II programmed cell death, has already been known to be involved in the pathophysiology of preeclampsia (PE), which is a gestational disease with high morbidity."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27770612"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PDCD4"}, "span_text": {"type": "literal", "value": "Autophagy, identified as type II programmed cell death, has already been known to be involved in the pathophysiology of preeclampsia (PE), which is a gestational disease with high morbidity."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27770612"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PDCD7"}, "span_text": {"type": "literal", "value": "Autophagy, identified as type II programmed cell death, has already been known to be involved in the pathophysiology of preeclampsia (PE), which is a gestational disease with high morbidity."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27770612"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NFE2"}, "span_text": {"type": "literal", "value": "Increased Heme Oxygenase-1 and Nuclear Factor Erythroid 2-Related Factor-2 in the Placenta Have a Cooperative Action on Preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27764834"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HMOX1"}, "span_text": {"type": "literal", "value": "Increased Heme Oxygenase-1 and Nuclear Factor Erythroid 2-Related Factor-2 in the Placenta Have a Cooperative Action on Preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27764834"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PTPN22"}, "span_text": {"type": "literal", "value": "Evaluation of MicroRNA-210 and Protein tyrosine phosphatase, non-receptor type 2 in Pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27746364"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PTPN2"}, "span_text": {"type": "literal", "value": "Evaluation of MicroRNA-210 and Protein tyrosine phosphatase, non-receptor type 2 in Pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27746364"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PTPN21"}, "span_text": {"type": "literal", "value": "Evaluation of MicroRNA-210 and Protein tyrosine phosphatase, non-receptor type 2 in Pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27746364"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PTPN23"}, "span_text": {"type": "literal", "value": "Evaluation of MicroRNA-210 and Protein tyrosine phosphatase, non-receptor type 2 in Pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27746364"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Placental Growth Factor (PlGF) in Women with Suspected Pre-Eclampsia Prior to 35 Weeks' Gestation:"}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27741259"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "To model the resource implications of placental growth factor (PlGF) testing in women with suspected pre-eclampsia prior to 35 weeks' gestation as part of a management algorithm, compared with current practice."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27741259"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Increased serum leptin levels may merely reflect an elevated maternal body mass index, which is a well-known risk factor for pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27737735"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "This study aims to examine the association between serum inhibin and leptin levels and pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27737735"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "On the other hand, leptin was not independently associated with the occurrence of pre-eclampsia (multivariate OR=1.02, 95%CI:"}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27737735"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Serum and placental LXR\u03b1 and endoglin levels were significantly higher in patients with preeclampsia than those in control group (P<0.05, each)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27736929"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Elevated LXR\u03b1 and endoglin levels may be associated with preeclampsia pathogenesis and development and could be used as potential predictors for this disorder."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27736929"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Relationship of Liver X Receptors \u03b1 and Endoglin Levels in Serum and Placenta with Preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27736929"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "The objective of this study was to identify correlations between LXR\u03b1, endoglin and preeclampsia and provide new feasible methods of clinical prediction and treatment for preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27736929"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "LXR\u03b1 and endoglin levels in serum and placenta from patients with preeclampsia were positively correlated (serum: r = 0.486, P<0.01; placenta: r = 0.569, P<0.01)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27736929"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "However, the relationship between LXR\u03b1 and endoglin levels in serum and placenta of patients with preeclampsia remains poorly understood."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27736929"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Moreover, patients with severe preeclampsia displayed significantly higher LXR\u03b1 and endoglin levels than those with moderate preeclampsia (P<0.05, each)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27736929"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "The aim of the present study was to determine a predictive model for early-onset preeclampsia with fetal growth restriction (FGR) to be used at 11(+0) to 13(+6) gestational weeks, by combining the maternal serum level of pregnancy-associated plasma protein-A (PAPP-A), placental growth factor (PLGF), placental protein 13 (PP13), soluble endoglin (sEng), mean arterial pressure (MAP), and uterine artery Doppler."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27678097"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "The aim of the present study was to determine a predictive model for early-onset preeclampsia with fetal growth restriction (FGR) to be used at 11(+0) to 13(+6) gestational weeks, by combining the maternal serum level of pregnancy-associated plasma protein-A (PAPP-A), placental growth factor (PLGF), placental protein 13 (PP13), soluble endoglin (sEng), mean arterial pressure (MAP), and uterine artery Doppler."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27678097"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "The vascular endothelial growth factor (VEGF) family is important for establishing normal pregnancy, and related single nucleotide polymorphisms (SNPs) are implicated in abnormal placentation and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27668980"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "The vascular endothelial growth factor (VEGF) family is important for establishing normal pregnancy, and related single nucleotide polymorphisms (SNPs) are implicated in abnormal placentation and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27668980"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "The vascular endothelial growth factor (VEGF) family is important for establishing normal pregnancy, and related single nucleotide polymorphisms (SNPs) are implicated in abnormal placentation and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27668980"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CAT"}, "span_text": {"type": "literal", "value": "TBARS was significantly higher in women with preeclampsia, while the presence of thiol groups, levels of vitamin C, catalase and \u03b4-ALA-D activity were significantly lower in groups of pregnant women with preeclampsia compared with healthy women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27657831"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CAT"}, "span_text": {"type": "literal", "value": "The analysis and quantification of the following oxidative stress markers were performed: thiobarbituric acid-reactive species (TBARS); presence of protein and non-protein thiol group; quantification of vitamin C; Catalase and \u03b4-ALA--D activities in samples of blood of pregnant women with mild preeclampsia (n=25), with severe preeclampsia (n=30) and in a control group of healthy pregnant women (n=30)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27657831"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALAD"}, "span_text": {"type": "literal", "value": "Delta-aminolevulinate dehydratase activity and oxidative stress markers in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27657831"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Pre-eclampsia is a pregnancy-specific multisystem disorder and a state of physiological insulin resistance."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27646865"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Therefore, the goal of this study was to test the hypothesis that recombinant human relaxin-2 (Serelaxin, Novartis; RLX) could reduce mean arterial pressure (MAP) and improve uterine artery resistance index (UARI) and nitric oxide bioavailability, and/or decrease prepro-endothelin-1 (PPET-1), soluble fms-like tyrosine kinase-1 (sFlt-1), and TNF-\u03b1) in the reduced uterine perfusion pressure (RUPP) model of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27629886"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:RLN2"}, "span_text": {"type": "literal", "value": "Therefore, the goal of this study was to test the hypothesis that recombinant human relaxin-2 (Serelaxin, Novartis; RLX) could reduce mean arterial pressure (MAP) and improve uterine artery resistance index (UARI) and nitric oxide bioavailability, and/or decrease prepro-endothelin-1 (PPET-1), soluble fms-like tyrosine kinase-1 (sFlt-1), and TNF-\u03b1) in the reduced uterine perfusion pressure (RUPP) model of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27629886"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Endocrine gland-derived vascular endothelial growth factor (EG-VEGF) is an important regulator for embryo implantation and placental development, and is clinically associated with several obstetric disorders related to insufficient or inappropriate trophoblast invasion, such as recurrent abortion, preeclampsia, and intrauterine fetal growth restriction."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27619846"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Endocrine gland-derived vascular endothelial growth factor (EG-VEGF) is an important regulator for embryo implantation and placental development, and is clinically associated with several obstetric disorders related to insufficient or inappropriate trophoblast invasion, such as recurrent abortion, preeclampsia, and intrauterine fetal growth restriction."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27619846"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Endocrine gland-derived vascular endothelial growth factor (EG-VEGF) is an important regulator for embryo implantation and placental development, and is clinically associated with several obstetric disorders related to insufficient or inappropriate trophoblast invasion, such as recurrent abortion, preeclampsia, and intrauterine fetal growth restriction."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27619846"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADM"}, "span_text": {"type": "literal", "value": "It is not known whether decreases in trophoblast invasion promoting the peptide, adrenomedullin2 (ADM2) system is associated with preeclampsia (PreE)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27583470"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADM2"}, "span_text": {"type": "literal", "value": "It is not known whether decreases in trophoblast invasion promoting the peptide, adrenomedullin2 (ADM2) system is associated with preeclampsia (PreE)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27583470"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "The purpose of this prospective study was to investigate the predictive value of single prepartum findings combined with serum biomarkers sFlt-1 (soluble fms-like tyrosine kinase-1) and PlGF (placental growth factor) indicating severity of preeclampsia (PE) for occurrence and extent of impaired postpartum kidney function."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27563165"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "The purpose of this prospective study was to investigate the predictive value of single prepartum findings combined with serum biomarkers sFlt-1 (soluble fms-like tyrosine kinase-1) and PlGF (placental growth factor) indicating severity of preeclampsia (PE) for occurrence and extent of impaired postpartum kidney function."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27563165"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MST1"}, "span_text": {"type": "literal", "value": "This study aimed to investigate the diagnostic value of placenta-derived macrophage-stimulating protein \u03b1-chain (MSP-\u03b1) before the 20th week of gestation for the early diagnosis of preeclampsia (PE)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27559727"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LDHD"}, "span_text": {"type": "literal", "value": "RESULTS: HELLP syndrome characteristics of increased lactate dehydrogenase enzymes levels, low platelet counts, cell morphological abnormalities (red cell fragmentation) and anaemia were observed in 40% of the HIV infected pre-eclamptic group."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27521598"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LDHB"}, "span_text": {"type": "literal", "value": "RESULTS: HELLP syndrome characteristics of increased lactate dehydrogenase enzymes levels, low platelet counts, cell morphological abnormalities (red cell fragmentation) and anaemia were observed in 40% of the HIV infected pre-eclamptic group."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27521598"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LDHA"}, "span_text": {"type": "literal", "value": "RESULTS: HELLP syndrome characteristics of increased lactate dehydrogenase enzymes levels, low platelet counts, cell morphological abnormalities (red cell fragmentation) and anaemia were observed in 40% of the HIV infected pre-eclamptic group."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27521598"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Women with preeclampsia had lower plasma concentrations of placental growth factor and higher concentrations of soluble Fms-like tyrosine kinase 1 compared with control subjects (P<.001)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27503620"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Further, we investigated whether this release was altered in early-onset preeclampsia compared with control subjects and whether there was a release of placental growth factor and soluble Fms-like tyrosine kinase 1 from maternal systemic endothelium."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27503620"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "An imbalance in circulating angiogenic factors is a prominent feature of preeclampsia; placental growth factor and soluble Fms-like tyrosine kinase 1 have been implemented as biomarkers of placental function and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27503620"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Further, we investigated whether this release was altered in early-onset preeclampsia compared with control subjects and whether there was a release of placental growth factor and soluble Fms-like tyrosine kinase 1 from maternal systemic endothelium."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27503620"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Despite lower concentrations of plasma placental growth factor in women with preeclampsia, the arteriovenous differences were not significantly different from normal pregnancies (P=.53), even when we corrected for placental weight (P=.79)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27503620"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Women with preeclampsia had lower plasma concentrations of placental growth factor and higher concentrations of soluble Fms-like tyrosine kinase 1 compared with control subjects (P<.001)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27503620"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "There were significant uteroplacental arteriovenous differences of soluble Fms-like tyrosine kinase 1 in preeclampsia (P<.001), but not in the control subjects."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27503620"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "An imbalance in circulating angiogenic factors is a prominent feature of preeclampsia; placental growth factor and soluble Fms-like tyrosine kinase 1 have been implemented as biomarkers of placental function and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27503620"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Our findings are consistent with a net release of soluble Fms-like tyrosine kinase 1 from the placenta in early-onset preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27503620"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ESR2"}, "span_text": {"type": "literal", "value": "The proliferation and apoptosis of cells in the placenta play a critical role in preeclampsia (PE) in which estrogen has been implicated via estrogen receptors (ERs)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27481507"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "This study supports the growing body of evidence that a single angiogenesis-related biomarker (PlGF, sFlt-1, or endoglin) alone represents a useful diagnostic test for women presenting with suspected preterm preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27400001"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "In women presenting at less than 35 weeks of gestation (n=286), the best performing combination of PlGF, podocalyxin, endoglin, procalcitonin (receiver operating curve [ROC] area 0.90, 95% confidence interval [CI] 0.86-0.93) was not statistically better than PlGF alone (ROC 0.87, 95% CI 0.83-0.92; P=.43) for preeclampsia requiring delivery within 14 days."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27400001"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "To evaluate 47 biomarkers (selected from the current medical literature), in isolation or in combination with placental growth factor (PlGF), to determine the need for delivery within 14 days, in women presenting with suspected preterm preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27400001"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Soluble fms-Like Tyrosine Kinase-1-to-Placental Growth Factor Ratio and Time to Delivery in Women With Suspected Preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27399996"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PPARG"}, "span_text": {"type": "literal", "value": "By exploiting its pleiotropic molecular attributes in preeclampsia, relaxin supplementation is expected to (i) enhance endothelial nitric oxide synthesis and bioactivity, as well as directly reduce vascular smooth muscle cytosolic calcium, thus promoting vasodilation; (ii) improve the local angiogenic balance by augmenting arterial vascular endothelial and placental growth factor (VEGF and PLGF) activities; (iii) ameliorate vascular inflammation; (iv) enhance placental peroxisome proliferator-activated receptor gamma, coactivator 1 alpha (PCG1\u03b1) expression, and hence, peroxisome proliferator-activated receptor gamma\u00a0(PPAR-\u03b3) activity and (v) confer cytotrophoblast and endothelial cytoprotection."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27385360"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "By exploiting its pleiotropic molecular attributes in preeclampsia, relaxin supplementation is expected to (i) enhance endothelial nitric oxide synthesis and bioactivity, as well as directly reduce vascular smooth muscle cytosolic calcium, thus promoting vasodilation; (ii) improve the local angiogenic balance by augmenting arterial vascular endothelial and placental growth factor (VEGF and PLGF) activities; (iii) ameliorate vascular inflammation; (iv) enhance placental peroxisome proliferator-activated receptor gamma, coactivator 1 alpha (PCG1\u03b1) expression, and hence, peroxisome proliferator-activated receptor gamma\u00a0(PPAR-\u03b3) activity and (v) confer cytotrophoblast and endothelial cytoprotection."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27385360"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:RXFP1"}, "span_text": {"type": "literal", "value": "G-Protein-coupled receptors as potential drug candidates in preeclampsia: targeting the relaxin/insulin-like family peptide receptor 1 for treatment and prevention."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27385360"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGTR1"}, "span_text": {"type": "literal", "value": "Specifically, by exploiting its pleiotropic hemodynamic attributes in preeclampsia, relaxin administration is predicted to (i) reverse robust arterial myogenic constriction; (ii) blunt systemic and renal vasoconstriction in response to activation of the\u00a0angiotensin II receptor, type 1; (iii) mollify the action of endogenous vasoconstrictors on uterine spiral arteries with failed remodeling and retained smooth muscle; (iv) increase arterial compliance; (v) enhance insulin-mediated glucose disposal by promoting skeletal muscle vasodilation and (vi) mobilize and activate bone marrow-derived angiogenic progenitor cells, thereby repairing injured endothelium and improving maternal vascularity in organs such as breast, uterus, pancreas, skin and fat."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27385360"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Specifically, by exploiting its pleiotropic hemodynamic attributes in preeclampsia, relaxin administration is predicted to (i) reverse robust arterial myogenic constriction; (ii) blunt systemic and renal vasoconstriction in response to activation of the\u00a0angiotensin II receptor, type 1; (iii) mollify the action of endogenous vasoconstrictors on uterine spiral arteries with failed remodeling and retained smooth muscle; (iv) increase arterial compliance; (v) enhance insulin-mediated glucose disposal by promoting skeletal muscle vasodilation and (vi) mobilize and activate bone marrow-derived angiogenic progenitor cells, thereby repairing injured endothelium and improving maternal vascularity in organs such as breast, uterus, pancreas, skin and fat."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27385360"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TTR"}, "span_text": {"type": "literal", "value": "Preeclampsia is associated with low placental transthyretin levels."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27343320"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TTR"}, "span_text": {"type": "literal", "value": "To investigate the relationship between placental transthyretin (TTR) level and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27343320"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "Umbilical arterial N-terminal pro-B-type natriuretic peptide levels in preeclampsia, fetal growth restriction, preterm birth and fetal distress."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27328498"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "To evaluate fetal cardiopulmonary stress in pregnancies complicated by preeclampsia (PE), fetal growth restriction (FGR), preterm birth (PT), and fetal distress (FD) using umbilical arterial blood N-terminal pro-B-type natriuretic peptide (NT-proBNP)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27328498"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Soluble endoglin improved predictive values for preeclampsia in patients with abnormal uterine Doppler."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27317435"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Only soluble endoglin was predictive for the development of preeclampsia with an area under curve in the receiver operating curve analysis of 0.761 (P\u00a0=\u00a00.006)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27317435"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "To assess the economic impact of introducing into clinical practice in the UK the soluble fms-like tyrosine kinase (sFlt-1) to placental growth factor (PlGF) ratio test for guiding the management of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27300726"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "To assess the economic impact of introducing into clinical practice in the UK the soluble fms-like tyrosine kinase (sFlt-1) to placental growth factor (PlGF) ratio test for guiding the management of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27300726"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:S1PR1"}, "span_text": {"type": "literal", "value": "Impairment of Angiogenic Sphingosine Kinase-1/Sphingosine-1-Phosphate Receptors Pathway in Preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27284992"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:S1PR5"}, "span_text": {"type": "literal", "value": "Impairment of Angiogenic Sphingosine Kinase-1/Sphingosine-1-Phosphate Receptors Pathway in Preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27284992"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:S1PR2"}, "span_text": {"type": "literal", "value": "Impairment of Angiogenic Sphingosine Kinase-1/Sphingosine-1-Phosphate Receptors Pathway in Preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27284992"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CTSD"}, "span_text": {"type": "literal", "value": "The serum levels of cathepsin D were inversely correlated with uric acid in preeclamptic patients (r\u00a0=\u00a0-0.527; p\u00a0=\u00a00.03)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27264724"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CTSB"}, "span_text": {"type": "literal", "value": "Correlation with severity of preeclampsia needs further investigation to clarify the role of cathepsin B."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27264724"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CTSB"}, "span_text": {"type": "literal", "value": "However, cathepsin B and D levels were not correlated with severity of preeclampsia and small for gestational age."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27264724"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CTSB"}, "span_text": {"type": "literal", "value": "Elevated serum cathepsin B concentration in pregnant women is associated with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27264724"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "The use of the soluble fms-like tyrosine kinase 1/placental growth factor test influenced clinical decision making towards appropriate hospitalization in a considerable proportion of women with suspected preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27243815"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "To evaluate the influence of the soluble fms-like tyrosine kinase 1/placental growth factor ratio in physicians' decision making in pregnant women with signs and symptoms of preeclampsia in routine clinical practice."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27243815"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "To evaluate the influence of the soluble fms-like tyrosine kinase 1/placental growth factor ratio in physicians' decision making in pregnant women with signs and symptoms of preeclampsia in routine clinical practice."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27243815"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "The use of the soluble fms-like tyrosine kinase 1/placental growth factor test influenced clinical decision making towards appropriate hospitalization in a considerable proportion of women with suspected preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27243815"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "The atrial natriuretic peptide (ANP) knockout mouse does not exhibit the phenotypic features of pre-eclampsia or demonstrate fetal growth restriction."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27238710"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Placental growth factor (PlGF) and sFlt-1 during pregnancy: physiology, assay and interest in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27237799"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TLR4"}, "span_text": {"type": "literal", "value": "Abnormal inflammation mediated by Toll-like receptor 4 (TLR4) signaling pathway contributes to preeclampsia (PE)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27208407"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ACVR2B"}, "span_text": {"type": "literal", "value": "MiR-195 participates in the placental disorder of preeclampsia via targeting activin receptor type-2B in trophoblastic cells."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27176145"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "We aimed to investigate how maternal serum soluble Fms-like kinase 1 (sFlt-1), placental growth factor (PlGF), and sFlt-1/PlGF ratio prospectively associate to preeclampsia (PE) and clinical subtypes."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27159383"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Circulating markers for endothelial activation such as endothelin-1 (ET-1), ICAM-1 and VCAM-1 are elevated in women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27155341"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HPX"}, "span_text": {"type": "literal", "value": "The optimal prediction model was obtained by combining HbF, \u03b11-microglobulin and hemopexin in combination with the maternal characteristics parity, diabetes and pre-pregnancy hypertension."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27155336"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HPX"}, "span_text": {"type": "literal", "value": "There were significantly higher serum concentrations of HbF and \u03b11-microglobulin and significantly lower serum concentrations of hemopexin in patients who later developed preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27155336"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HPX"}, "span_text": {"type": "literal", "value": "Fetal hemoglobin, \u03b11-microglobulin and hemopexin are potential predictive first trimester biomarkers for preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27155336"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HPX"}, "span_text": {"type": "literal", "value": "The combination of HbF and \u03b11-microglobulin and/or hemopexin may serve as a prediction model for preeclampsia in combination with maternal risk factors and/or uterine artery Doppler ultrasound."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27155336"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "This study confirms that the PI3K/Akt cell protection pathway is down regulated in preeclampsia, but demonstrates that this dysregulation is unlikely to be responsible for the excessive placental soluble endoglin release characteristic of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27155335"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:RETN"}, "span_text": {"type": "literal", "value": "We investigated the roles of leptin, adiponectin and resistin and their relationships with clinical characteristics in normotensive and preeclamptic patients."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27154800"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Serum levels of leptin, adiponectin and resistin in relation to clinical characteristics in normal pregnancy and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27154800"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "We investigated the roles of leptin, adiponectin and resistin and their relationships with clinical characteristics in normotensive and preeclamptic patients."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27154800"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:RETN"}, "span_text": {"type": "literal", "value": "Serum levels of leptin, adiponectin and resistin in relation to clinical characteristics in normal pregnancy and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27154800"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EPHX4"}, "span_text": {"type": "literal", "value": "To evaluate EETs, formation as well as the expression of relevant CYP isoforms and the metabolizing enzyme, soluble epoxide hydrolase (sEH), biopsies of placenta were collected from 19 normal pregnancy and 10 preeclampsia at the time of cesarean section delivery."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27115337"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EPHX2"}, "span_text": {"type": "literal", "value": "To evaluate EETs, formation as well as the expression of relevant CYP isoforms and the metabolizing enzyme, soluble epoxide hydrolase (sEH), biopsies of placenta were collected from 19 normal pregnancy and 10 preeclampsia at the time of cesarean section delivery."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27115337"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EPHX3"}, "span_text": {"type": "literal", "value": "To evaluate EETs, formation as well as the expression of relevant CYP isoforms and the metabolizing enzyme, soluble epoxide hydrolase (sEH), biopsies of placenta were collected from 19 normal pregnancy and 10 preeclampsia at the time of cesarean section delivery."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27115337"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EPHX1"}, "span_text": {"type": "literal", "value": "To evaluate EETs, formation as well as the expression of relevant CYP isoforms and the metabolizing enzyme, soluble epoxide hydrolase (sEH), biopsies of placenta were collected from 19 normal pregnancy and 10 preeclampsia at the time of cesarean section delivery."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27115337"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Gestational hypertension and preeclampsia shared several baseline risk factors: family history of diabetes mellitus, pregravid diabetes mellitus, a high total cholesterol/high-density lipoprotein cholesterol ratio (>5), overweight and obesity, and elevated blood pressure status."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27113053"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Placental Growth Factor Reduces Blood Pressure in a Uteroplacental Ischemia Model of Preeclampsia in Nonhuman Primates."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27091894"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "We sought to investigate the distribution of midtrimester maternal serum levels of placental growth factor, soluble endoglin, and soluble vascular endothelial growth factor receptor 1 and their associations with early-onset preeclampsia in whites, Hispanics, and blacks."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27073062"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "The weakest association of early-onset preeclampsia with placental growth factor and soluble endoglin was observed in blacks."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27073062"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "The weakest association of early-onset preeclampsia with placental growth factor and soluble endoglin was observed in blacks."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27073062"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "We sought to investigate the distribution of midtrimester maternal serum levels of placental growth factor, soluble endoglin, and soluble vascular endothelial growth factor receptor 1 and their associations with early-onset preeclampsia in whites, Hispanics, and blacks."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27073062"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "We sought to investigate the distribution of midtrimester maternal serum levels of placental growth factor, soluble endoglin, and soluble vascular endothelial growth factor receptor 1 and their associations with early-onset preeclampsia in whites, Hispanics, and blacks."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27073062"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Racial-ethnic differences were observed in the distribution of midtrimester maternal levels of placental growth factor and soluble endoglin and in the associations with early-onset preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27073062"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "We sought to investigate the distribution of midtrimester maternal serum levels of placental growth factor, soluble endoglin, and soluble vascular endothelial growth factor receptor 1 and their associations with early-onset preeclampsia in whites, Hispanics, and blacks."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27073062"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Racial-ethnic differences were observed in the distribution of midtrimester maternal levels of placental growth factor and soluble endoglin and in the associations with early-onset preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27073062"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "We sought to investigate the distribution of midtrimester maternal serum levels of placental growth factor, soluble endoglin, and soluble vascular endothelial growth factor receptor 1 and their associations with early-onset preeclampsia in whites, Hispanics, and blacks."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27073062"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CADM3"}, "span_text": {"type": "literal", "value": "This review summarizes our current knowledge regarding known regulators of EMT in the human placenta, including the inducers of EMT, upstream transcription factors that control EMT and the downstream effectors, cell adhesion molecules and their differential expression and functions in pregnancy pathologies, preeclampsia (PE) and fetal growth restriction (FGR)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27070187"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CADM1"}, "span_text": {"type": "literal", "value": "This review summarizes our current knowledge regarding known regulators of EMT in the human placenta, including the inducers of EMT, upstream transcription factors that control EMT and the downstream effectors, cell adhesion molecules and their differential expression and functions in pregnancy pathologies, preeclampsia (PE) and fetal growth restriction (FGR)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27070187"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TCF4"}, "span_text": {"type": "literal", "value": "This review summarizes our current knowledge regarding known regulators of EMT in the human placenta, including the inducers of EMT, upstream transcription factors that control EMT and the downstream effectors, cell adhesion molecules and their differential expression and functions in pregnancy pathologies, preeclampsia (PE) and fetal growth restriction (FGR)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27070187"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Mean serum leptin levels did not differ statistically between patients with mild preeclampsia, severe preeclampsia, and the controls (10.77 ng/ml, 13.40 ng/ml, and 8.43 ng/ml, respectively)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27048026"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "The role of leptin in the pathophysiology of preeclampsia should be evaluated cautiously."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27048026"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "To investigate serum leptin levels in pregnancies complicated with preeclampsia and severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27048026"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Serum leptin levels are not associated with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27048026"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "The possible role of serum leptin in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27048026"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Maternal serum leptin levels were analyzed by solid phase enzyme amplified sensitivity immunoassay (EASIA) method in 23 patients with mild preeclampsia, 29 patients with severe preeclampsia, and 28 healthy pregnant controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27048026"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Pre-eclampsia and the vascular endothelial growth factor: a new aspect."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27048010"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Pre-eclampsia and the vascular endothelial growth factor: a new aspect."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27048010"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Pre-eclampsia and the vascular endothelial growth factor: a new aspect."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27048010"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "To evaluate KRYPTOR assays for circulating soluble fms-like tyrosine kinase-1 (sFlt1) and placental growth factor (PlGF) in risk assessment of adverse outcomes in women with suspected preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27028795"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "To evaluate KRYPTOR assays for circulating soluble fms-like tyrosine kinase-1 (sFlt1) and placental growth factor (PlGF) in risk assessment of adverse outcomes in women with suspected preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27028795"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Placental growth factor (PlGF) is an angiogenic molecule produced by the placenta and implicated in the pathogenesis of preeclampsia (PE) and intrauterine growth restriction (IUGR)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27028483"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TLR4"}, "span_text": {"type": "literal", "value": "We studied the expression of TLR4 (Toll-like receptor 4) in the syncytiotrophoblast and vascular endothelial cells of terminal and stem placental villi in severe preeclampsia and normal pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27021078"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:DCN"}, "span_text": {"type": "literal", "value": "A receiver operating characteristic curve analysis revealed strong diagnostic performance of plasma decorin in the prediction of preeclampsia status."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27001218"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:DCN"}, "span_text": {"type": "literal", "value": "Finally, retrospective measurement of plasma decorin levels during the second trimester in 28 body mass index-matched pairs of control subjects and subjects with preeclampsia revealed elevated plasma decorin levels in all subjects with preeclampsia in all body mass index groups."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27001218"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:DCN"}, "span_text": {"type": "literal", "value": "Furthermore, we conducted retrospective measurements of plasma decorin levels during the second trimester (15-18 weeks of gestation) in a cohort of 28 body mass index-matched pairs of control subjects and subjects with preeclampsia before the onset of clinical disease."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27001218"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:DCN"}, "span_text": {"type": "literal", "value": "We conclude that decorin over-expression by basal decidual cells is associated with hypoinvasive phenotype and poor endovascular differentiation of trophoblast cells in preeclampsia and that elevated plasma decorin concentration is a potential predictive biomarker for preeclampsia before the onset of clinical signs."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27001218"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:DCN"}, "span_text": {"type": "literal", "value": "Similarly decorin messenger RNA expression at the tissue level in chorionic villi (primarily resulting from fetally derived mesenchymal cells) did not differ significantly between control and preeclampsia placentas."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27001218"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:DCN"}, "span_text": {"type": "literal", "value": "Decorin messenger RNA expression was measured with quantitative polymerase chain reaction at the tissue level and with in situ hybridization at the cellular level using (35)S-labeled antisense complimentary RNA probe in placentas from healthy control subjects and subjects with preeclampsia (14 each, 23-40 weeks of gestation)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27001218"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:DCN"}, "span_text": {"type": "literal", "value": "Although there was no significant gestational age-related change in decorin levels during the second trimester in control or subjects with preeclampsia, we found that plasma decorin had a significant inverse relationship with body mass index or bodyweight."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27001218"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:DCN"}, "span_text": {"type": "literal", "value": "Because many studies have reported an association between poor trophoblast invasion and endovascular differentiation with preeclampsia, the studies reported here tested (1) whether decorin over-expression in the chorionic villi and/or basal decidua is associated with preeclampsia and, if so, (2) whether this association results in a hypoinvasive placenta, and (3) whether elevated plasma decorin concentration in the second trimester is a predictive biomarker for preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27001218"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:DCN"}, "span_text": {"type": "literal", "value": "Decorin over-expression by decidual cells in preeclampsia: a potential blood biomarker."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27001218"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "Associations between nitric oxide synthase 3 gene polymorphisms and preeclampsia risk: a meta-analysis."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26997284"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FABP4"}, "span_text": {"type": "literal", "value": "The aim of this investigation was to determine the expression of fatty acid binding protein 4 (FABP4) in the placenta from women with preeclampsia and normal pregnancy, and to delineate the regulatory effects on thophoblast cell by FABP4."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26992681"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FABP4"}, "span_text": {"type": "literal", "value": "Increased expression of fatty acid binding protein 4 in preeclamptic Placenta and its relevance to preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26992681"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:KL"}, "span_text": {"type": "literal", "value": "Potential Role of Placental Klotho in the Pathogenesis of Preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26972301"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:KL"}, "span_text": {"type": "literal", "value": "Klotho mRNA and protein levels were reduced in preeclamptic placentas compared with controls. -744delA single-nucleotide polymorphism was significantly associated with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26972301"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:KL"}, "span_text": {"type": "literal", "value": "Klotho mRNA and protein levels were determined using real-time PCR and Western blot, respectively, in placental tissue samples obtained from 34 patients affected with preeclampsia and 34 controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26972301"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:KL"}, "span_text": {"type": "literal", "value": "The aim of this study was to analyze the placental expression and allele status of promoter region of Klotho in association with preeclampsia, which represents the most common hypertensive disease of pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26972301"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:KL"}, "span_text": {"type": "literal", "value": "This study is the first to evaluate the placental expression level of Klotho in association with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26972301"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SPESP1"}, "span_text": {"type": "literal", "value": "Hypermethylation of WNT2, sperm equatorial segment protein (SPESP1), NADPH oxidase 5 (NOX5), and activated leukocyte cell adhesion molecule (ALCAM) in preeclampsia placentas was confirmed with pyrosequencing."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26968548"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALCAM"}, "span_text": {"type": "literal", "value": "Hypermethylation of WNT2, sperm equatorial segment protein (SPESP1), NADPH oxidase 5 (NOX5), and activated leukocyte cell adhesion molecule (ALCAM) in preeclampsia placentas was confirmed with pyrosequencing."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26968548"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:DCN"}, "span_text": {"type": "literal", "value": "Placental levels of total oxidative and anti-oxidative status, ADAMTS-12 and decorin in early- and late-onset severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26953866"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MFN2"}, "span_text": {"type": "literal", "value": "Downregulation of Mitofusin 2 in Placenta Is Related to Preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26942197"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MFN2"}, "span_text": {"type": "literal", "value": "Mitofusin 2 (Mfn2) is a novel mitochondrial protein that is implicated in cellular proliferation and metabolism; however, the role of Mfn2 in preeclampsia (PE) remains unknown."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26942197"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "We aimed to compare sFlt-1 and placental growth factor (PlGF) levels and the sFlt-1/PlGF ratio between women with preeclampsia and superimposed preeclampsia to, respectively, normotensive and chronic hypertensive ones."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26930132"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Although the role of soluble fms-like tyrosine kinase 1 (sFLT-1) in preeclampsia is well-established, the mechanism related to its synthesis remains poorly understood."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26910493"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "Western blotting showed significant elevated levels of prostasin in urine from preeclamptic patients that correlated with urine albumin."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26867056"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ESR2"}, "span_text": {"type": "literal", "value": "The effects of estrogen in preeclampsia are normally mediated by the classical estrogen receptors."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26848992"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Plasma protein endoglin in combination with circ_101222 strengthened the predictive power for pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26846540"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "The anti-angiogenic factor soluble fms-like tyrosine kinase-1 (sFlt-1), which antagonizes and reduces bioavailable vascular endothelial growth factor and placental growth factor (PlGF), is elevated in RUPP rats and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26831193"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "The anti-angiogenic factor soluble fms-like tyrosine kinase-1 (sFlt-1), which antagonizes and reduces bioavailable vascular endothelial growth factor and placental growth factor (PlGF), is elevated in RUPP rats and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26831193"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "The anti-angiogenic factor soluble fms-like tyrosine kinase-1 (sFlt-1), which antagonizes and reduces bioavailable vascular endothelial growth factor and placental growth factor (PlGF), is elevated in RUPP rats and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26831193"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "The anti-angiogenic factor soluble fms-like tyrosine kinase-1 (sFlt-1), which antagonizes and reduces bioavailable vascular endothelial growth factor and placental growth factor (PlGF), is elevated in RUPP rats and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26831193"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "The anti-angiogenic factor soluble fms-like tyrosine kinase-1 (sFlt-1), which antagonizes and reduces bioavailable vascular endothelial growth factor and placental growth factor (PlGF), is elevated in RUPP rats and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26831193"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SEMA3B"}, "span_text": {"type": "literal", "value": "Placental Semaphorin 3B (SEMA 3B) expression has been reported changed in preeclampsia and its possible involvement of in the disease proposed."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26828533"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SEMA3B"}, "span_text": {"type": "literal", "value": "Alteration of serum semaphorin 3B levels in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26828533"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Among women admitted for evaluation of preeclampsia, women at risk for adverse pregnancy outcomes have higher soluble fms-like tyrosine kinase/placental growth factor ratio on admission, which continued to rise until delivery."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26827880"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Among women admitted for evaluation of preeclampsia, women at risk for adverse pregnancy outcomes have higher soluble fms-like tyrosine kinase/placental growth factor ratio on admission, which continued to rise until delivery."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26827880"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:THBS3"}, "span_text": {"type": "literal", "value": "Hypoxia-inducible miR-210 contributes to preeclampsia via targeting thrombospondin type I domain containing 7A."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26796133"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:THBS1"}, "span_text": {"type": "literal", "value": "Hypoxia-inducible miR-210 contributes to preeclampsia via targeting thrombospondin type I domain containing 7A."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26796133"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:THBS4"}, "span_text": {"type": "literal", "value": "Hypoxia-inducible miR-210 contributes to preeclampsia via targeting thrombospondin type I domain containing 7A."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26796133"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Circulating Maternal Total Cell-Free DNA, Cell-Free Fetal DNA and Soluble Endoglin Levels in Preeclampsia:"}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26790664"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL10"}, "span_text": {"type": "literal", "value": "Investigations into the association between polymorphisms in the interleukin-10 gene and risk of early-onset preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26782585"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "The emerging role of endothelin-1 in the pathogenesis of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26755746"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP5"}, "span_text": {"type": "literal", "value": "Pregnancy Associated Plasma Protein A2 (PAPP-A2) is a pregnancy related insulin-like growth factor binding protein-5 (IGFBP-5) protease, known to be elevated in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26748159"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF1"}, "span_text": {"type": "literal", "value": "As the insulin-like growth factors are important in human implantation and placentation, we sought to determine the expression pattern of PAPP-A2 over human gestation in normal and preeclamptic pregnancies to evaluate its role in placental development and the pathogenesis of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26748159"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF2"}, "span_text": {"type": "literal", "value": "As the insulin-like growth factors are important in human implantation and placentation, we sought to determine the expression pattern of PAPP-A2 over human gestation in normal and preeclamptic pregnancies to evaluate its role in placental development and the pathogenesis of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26748159"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "The ratio of soluble fms-like tyrosine kinase 1 (sFlt-1) to placental growth factor (PlGF) is elevated in pregnant women before the clinical onset of preeclampsia, but its predictive value in women with suspected preeclampsia is unclear."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26735990"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "The ratio of soluble fms-like tyrosine kinase 1 (sFlt-1) to placental growth factor (PlGF) is elevated in pregnant women before the clinical onset of preeclampsia, but its predictive value in women with suspected preeclampsia is unclear."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26735990"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Furthermore, tumor necrosis factor-\u03b1, endothelin-1, and oxidative stress, which are characteristically increased in women with preeclampsia and in experimental models of the disease, were reduced in treated rats."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26729752"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PDE5A"}, "span_text": {"type": "literal", "value": "There is currently no effective treatment, but sildenafil, a phosphodiesterase-5 inhibitor, has been proposed as a potential therapy to reduce blood pressure and improve uteroplacental perfusion in preeclamptic patients."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26729752"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Maternal serum soluble fms-like tyrosine kinase-1 at 22 and 32 weeks in the prediction of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26726123"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "To investigate the potential value of repeat measurements of maternal serum concentration of soluble fms-like tyrosine kinase-1 (sFlt-1) at 22 and 32 weeks' gestation in the prediction of pre-eclampsia (PE) in women delivering after 32 weeks."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26726123"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VCAM1"}, "span_text": {"type": "literal", "value": "It reduced endothelial cell messenger RNA expression of vascular cell adhesion molecule 1 that was induced by tumor necrosis factor-\u03b1 (vascular cell adhesion molecule 1 is an inflammatory adhesion molecule up-regulated with endothelial dysfunction and is increased in preeclampsia)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26721779"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Metformin as a prevention and treatment for preeclampsia: effects\u00a0on\u00a0soluble fms-like tyrosine kinase 1 and soluble endoglin\u00a0secretion and endothelial dysfunction."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26721779"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Preeclampsia is associated with placental ischemia/hypoxia and secretion of soluble fms-like tyrosine kinase 1 and soluble endoglin into the maternal circulation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26721779"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Preeclampsia is associated with placental ischemia/hypoxia and secretion of soluble fms-like tyrosine kinase 1 and soluble endoglin into the maternal circulation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26721779"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Metformin as a prevention and treatment for preeclampsia: effects\u00a0on\u00a0soluble fms-like tyrosine kinase 1 and soluble endoglin\u00a0secretion and endothelial dysfunction."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26721779"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Preeclampsia is a systemic, pregnancy-related disorder featuring hypertension and proteinuria arising from placental overproduction of soluble FMS-like tyrosine kinase-1, resulting in an antiangiogenic state because of the inhibition of the vascular endothelial growth factor (VEGF) family."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26717314"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Preeclampsia is a systemic, pregnancy-related disorder featuring hypertension and proteinuria arising from placental overproduction of soluble FMS-like tyrosine kinase-1, resulting in an antiangiogenic state because of the inhibition of the vascular endothelial growth factor (VEGF) family."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26717314"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Preeclampsia is a systemic, pregnancy-related disorder featuring hypertension and proteinuria arising from placental overproduction of soluble FMS-like tyrosine kinase-1, resulting in an antiangiogenic state because of the inhibition of the vascular endothelial growth factor (VEGF) family."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26717314"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Preeclampsia is a systemic, pregnancy-related disorder featuring hypertension and proteinuria arising from placental overproduction of soluble FMS-like tyrosine kinase-1, resulting in an antiangiogenic state because of the inhibition of the vascular endothelial growth factor (VEGF) family."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26717314"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TLR4"}, "span_text": {"type": "literal", "value": "Hierarchical clustering revealed 2 distinct inflammatory clusters associated with previous preeclampsia: an adaptive response cluster associated with increased C-reactive protein and IL-6 before and after vaccination, increased weight, and low high-density lipoprotein cholesterol; and a toll-like receptor-4 mediated the cluster associated with increased IL-18 before and after vaccination but not associated with other cardiovascular markers."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26711734"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Hierarchical clustering revealed 2 distinct inflammatory clusters associated with previous preeclampsia: an adaptive response cluster associated with increased C-reactive protein and IL-6 before and after vaccination, increased weight, and low high-density lipoprotein cholesterol; and a toll-like receptor-4 mediated the cluster associated with increased IL-18 before and after vaccination but not associated with other cardiovascular markers."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26711734"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "To investigate the expression levels of neuropilin 1 (NRP1) and vascular endothelial growth factor (VEGF) in the placentas of women with pre-eclampsia (PE), determine whether homocysteine (Hcy) contributes to the development of PE in mice, and detect alterations in placental NRP1 and VEGF in Hcy-treated mice."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26708340"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "To investigate the expression levels of neuropilin 1 (NRP1) and vascular endothelial growth factor (VEGF) in the placentas of women with pre-eclampsia (PE), determine whether homocysteine (Hcy) contributes to the development of PE in mice, and detect alterations in placental NRP1 and VEGF in Hcy-treated mice."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26708340"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "To investigate the expression levels of neuropilin 1 (NRP1) and vascular endothelial growth factor (VEGF) in the placentas of women with pre-eclampsia (PE), determine whether homocysteine (Hcy) contributes to the development of PE in mice, and detect alterations in placental NRP1 and VEGF in Hcy-treated mice."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26708340"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NRP1"}, "span_text": {"type": "literal", "value": "To investigate the expression levels of neuropilin 1 (NRP1) and vascular endothelial growth factor (VEGF) in the placentas of women with pre-eclampsia (PE), determine whether homocysteine (Hcy) contributes to the development of PE in mice, and detect alterations in placental NRP1 and VEGF in Hcy-treated mice."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26708340"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Placental growth factor and vascular endothelial growth factor serum levels in Tunisian Arab women with suspected preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26702929"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Placental growth factor and vascular endothelial growth factor serum levels in Tunisian Arab women with suspected preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26702929"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Placental growth factor and vascular endothelial growth factor serum levels in Tunisian Arab women with suspected preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26702929"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Placental growth factor and vascular endothelial growth factor serum levels in Tunisian Arab women with suspected preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26702929"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "Analysis of the gene polymorphism of aldosterone synthase (CYP11B2) and atrial natriuretic peptide (ANP) in women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26686590"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGM2"}, "span_text": {"type": "literal", "value": "Elevated Transglutaminase Activity Triggers Angiotensin Receptor Activating Autoantibody Production and Pathophysiology of Preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26675250"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGM4"}, "span_text": {"type": "literal", "value": "Elevated Transglutaminase Activity Triggers Angiotensin Receptor Activating Autoantibody Production and Pathophysiology of Preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26675250"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGM3"}, "span_text": {"type": "literal", "value": "Elevated Transglutaminase Activity Triggers Angiotensin Receptor Activating Autoantibody Production and Pathophysiology of Preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26675250"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGM5"}, "span_text": {"type": "literal", "value": "Elevated Transglutaminase Activity Triggers Angiotensin Receptor Activating Autoantibody Production and Pathophysiology of Preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26675250"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGM1"}, "span_text": {"type": "literal", "value": "Elevated Transglutaminase Activity Triggers Angiotensin Receptor Activating Autoantibody Production and Pathophysiology of Preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26675250"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MMP1"}, "span_text": {"type": "literal", "value": "Increased urinary levels of podocyte glycoproteins, matrix metallopeptidases, inflammatory cytokines, and kidney injury biomarkers in women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26671966"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MMP7"}, "span_text": {"type": "literal", "value": "Increased urinary levels of podocyte glycoproteins, matrix metallopeptidases, inflammatory cytokines, and kidney injury biomarkers in women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26671966"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL11"}, "span_text": {"type": "literal", "value": "Interleukin-11 alters placentation and causes preeclampsia features in mice."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26655736"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF2"}, "span_text": {"type": "literal", "value": "Since preeclampsia is tightly connected to IUGR, glycosylation changes were investigated also on the functional membrane receptors responsible for growth: insulin receptor and the type 1 insulin-like growth factor receptor (IR and IGF1R)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26655437"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INSR"}, "span_text": {"type": "literal", "value": "Since preeclampsia is tightly connected to IUGR, glycosylation changes were investigated also on the functional membrane receptors responsible for growth: insulin receptor and the type 1 insulin-like growth factor receptor (IR and IGF1R)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26655437"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF1"}, "span_text": {"type": "literal", "value": "Since preeclampsia is tightly connected to IUGR, glycosylation changes were investigated also on the functional membrane receptors responsible for growth: insulin receptor and the type 1 insulin-like growth factor receptor (IR and IGF1R)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26655437"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GP2"}, "span_text": {"type": "literal", "value": "Thus, besides studying the glycosylation pattern of the entire placental membrane due to preeclampsia, it is inevitable to study directly glycoprotein of interest, as no general assumptions or extrapolations can be made."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26655437"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GP2"}, "span_text": {"type": "literal", "value": "Therefore, glycans on placental membranes alter due to preeclampsia, but changes seen at the level of the entire N-glycome may be different from the changes detected at the level of a specific glycoprotein."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26655437"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "These results suggest a critical role for endoglin in integrin-mediated adhesion of mural cells and provide a better understanding on the mechanisms of vessel maturation in normal physiology as well as in pathologies such as preeclampsia or hereditary hemorrhagic telangiectasia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26646071"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Effective screening for preeclampsia resulting in delivery at <37 weeks' gestation (preterm-PE) is provided by a combination of maternal factors, mean arterial pressure (MAP), uterine artery pulsatility index (UTPI) and serum placental growth factor (PLGF) at 11-13 or 19-24 weeks' gestation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26643929"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL10"}, "span_text": {"type": "literal", "value": "Association between Interleukin-10 gene polymorphisms and risk of early-onset preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26617906"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Placental growth factor (PlGF) levels early in pregnancy are lower in women who ultimately develop preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26597741"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Baseline placental growth factor levels for the prediction of benefit from early aspirin prophylaxis for preeclampsia prevention."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26597741"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGFB1"}, "span_text": {"type": "literal", "value": "Transforming growth factor beta-1 (TGF-\u03b21) gene single nucleotide polymorphisms (SNPs) and susceptibility to pre-eclampsia in Iranian women:"}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26597739"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "In 196 women with a history of pre-eclampsia we determined the presence or absence of metabolic syndrome using the World Health Organization criteria and measured plasma volume with the (125) I-human serum albumin indicator dilution technique."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26589850"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TLR3"}, "span_text": {"type": "literal", "value": "Role of Toll-Like Receptor 3 Gene Polymorphisms in Preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26584291"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AFP"}, "span_text": {"type": "literal", "value": "To examine the distribution of maternal serum alpha fetoprotein (AFP) at 12, 22 and 32 weeks' gestation in singleton pregnancies which develop preeclampsia (PE) and examine the performance of this biomarker in screening for PE."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26582719"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AFP"}, "span_text": {"type": "literal", "value": "Maternal serum alpha fetoprotein at 12, 22, 32 weeks' gestation in screening for preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26582719"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "To examine the distribution of maternal serum soluble fms-like tyrosine kinase-1 (sFLT-1) at 12, 22, 32 and 36 weeks' gestation in singleton pregnancies which develop preeclampsia (PE) and examine the performance of this biomarker in screening for PE."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26582564"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Serum soluble fms-like tyrosine kinase-1 at 12, 22, 32 and 36 weeks' gestation in screening for preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26582564"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Serum placental growth factor at 12, 22, 32 and 36 weeks' gestation in screening for preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26582455"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "To examine the distribution of serum placental growth factor (PLGF) at 12, 22, 32 and 36 weeks' gestation in singleton pregnancies which develop preeclampsia (PE) and examine the performance of this biomarker in screening for PE."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26582455"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL6"}, "span_text": {"type": "literal", "value": "Biochemical and immunochemical studies reveal a substantial increase in tumor necrosis factor alpha, interleukin-1 beta, and interleukin-6 concentrations in the blood of women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26571191"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL1B"}, "span_text": {"type": "literal", "value": "Biochemical and immunochemical studies reveal a substantial increase in tumor necrosis factor alpha, interleukin-1 beta, and interleukin-6 concentrations in the blood of women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26571191"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX2"}, "span_text": {"type": "literal", "value": "To evaluate diagnostic value of ceruloplasmin together with other enzymatic and nonenzymatic antioxidants (superoxide dismutase (SOD), glutathione peroxidase (GSH-Px) and uric acid) and to evaluate the level of oxidative stress in patients with pre-eclampsia (PE) and compare it with normal pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26571141"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CP"}, "span_text": {"type": "literal", "value": "Serum ceruloplasmin level may have significant role as the markers of oxidative stress in pre-eclampsia especially when used in combination with uric acid levels."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26571141"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX3"}, "span_text": {"type": "literal", "value": "To evaluate diagnostic value of ceruloplasmin together with other enzymatic and nonenzymatic antioxidants (superoxide dismutase (SOD), glutathione peroxidase (GSH-Px) and uric acid) and to evaluate the level of oxidative stress in patients with pre-eclampsia (PE) and compare it with normal pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26571141"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CP"}, "span_text": {"type": "literal", "value": "Ceruloplasmin and antioxidative enzymes in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26571141"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD3"}, "span_text": {"type": "literal", "value": "To evaluate diagnostic value of ceruloplasmin together with other enzymatic and nonenzymatic antioxidants (superoxide dismutase (SOD), glutathione peroxidase (GSH-Px) and uric acid) and to evaluate the level of oxidative stress in patients with pre-eclampsia (PE) and compare it with normal pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26571141"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX1"}, "span_text": {"type": "literal", "value": "To evaluate diagnostic value of ceruloplasmin together with other enzymatic and nonenzymatic antioxidants (superoxide dismutase (SOD), glutathione peroxidase (GSH-Px) and uric acid) and to evaluate the level of oxidative stress in patients with pre-eclampsia (PE) and compare it with normal pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26571141"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD1"}, "span_text": {"type": "literal", "value": "To evaluate diagnostic value of ceruloplasmin together with other enzymatic and nonenzymatic antioxidants (superoxide dismutase (SOD), glutathione peroxidase (GSH-Px) and uric acid) and to evaluate the level of oxidative stress in patients with pre-eclampsia (PE) and compare it with normal pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26571141"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CP"}, "span_text": {"type": "literal", "value": "To evaluate diagnostic value of ceruloplasmin together with other enzymatic and nonenzymatic antioxidants (superoxide dismutase (SOD), glutathione peroxidase (GSH-Px) and uric acid) and to evaluate the level of oxidative stress in patients with pre-eclampsia (PE) and compare it with normal pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26571141"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL1RN"}, "span_text": {"type": "literal", "value": "Association of interleukin-1 receptor antagonist VNTR polymorphism and risk of pre-eclampsia in southeast Iranian population."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26555681"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "The aim of the study was to evaluate the relationship between the concentrations of substances released by the placenta: placental growth factor (PIGF), pregnancy-associated plasma protein A (PAPP-A) and free beta-human chorionic gonadotropin (beta-hCG) and the risk of early and late preeclampsia (PE) and intrauterine fetal growth restriction (IUGR)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26492710"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Vascular endothelial growth factor (VEGF)-634G/C polymorphism was associated with severe pre-eclampsia and lower serum VEGF level."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26486233"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Vascular endothelial growth factor (VEGF) is an angiogenic factor whose production is increased in pre-eclampsia (PE)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26486233"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Vascular endothelial growth factor (VEGF)-634G/C polymorphism was associated with severe pre-eclampsia and lower serum VEGF level."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26486233"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Vascular endothelial growth factor (VEGF)-634G/C polymorphism was associated with severe pre-eclampsia and lower serum VEGF level."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26486233"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Vascular endothelial growth factor (VEGF) is an angiogenic factor whose production is increased in pre-eclampsia (PE)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26486233"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Vascular endothelial growth factor (VEGF) is an angiogenic factor whose production is increased in pre-eclampsia (PE)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26486233"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Association between preconception low high density lipoprotein cholesterol (HDLc level\u226450 mg/dL), high triglycerides (level\u2265150 mg/dL) and the primary outcome (composite of gestational diabetes mellitus/or preeclampsia) was assessed using Generalized Estimation Equations."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26452270"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:COMT"}, "span_text": {"type": "literal", "value": "To evaluate the association between fetal and maternal catechol-O-methyltransferase (COMT) Val158Met and methyl tetrahydrofolate reductase (MTHFR) C677T functional polymorphisms and preeclampsia, examining its influence on placental COMT and in maternal 2-methoxyestradiol (2-ME) plasma levels."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26450530"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:COMT"}, "span_text": {"type": "literal", "value": "Fetal Val108/158Met catechol-O-methyltransferase (COMT) polymorphism and placental COMT activity are associated with the development of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26450530"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Probability scores considering nulliparity, prior preeclampsia, body mass index, diastolic blood pressure and placental growth factor had an area under the receiver operating characteristic curve 0.784 (95% CI\u2009=\u20090.721-0.847)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26448637"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "Association of serum N-terminal pro-brain natriuretic peptide levels with the severity of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26444727"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "To investigate whether serum N-terminal pro-brain natriuretic peptide (NT-proBNP) levels could be used as a marker to determine the severity of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26444727"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Placental soluble fms-like tyrosine kinase-1 (sFlt-1) which is an antagonist of vascular endothelial growth factor and placental growth factor (PIGF), is considered as one of etiology factors cause endothelial damage in preeclampsia due to increase of sFlt-1 level that change vascular endothelial integrity."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26434493"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Placental soluble fms-like tyrosine kinase-1 (sFlt-1) which is an antagonist of vascular endothelial growth factor and placental growth factor (PIGF), is considered as one of etiology factors cause endothelial damage in preeclampsia due to increase of sFlt-1 level that change vascular endothelial integrity."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26434493"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Placental soluble fms-like tyrosine kinase-1 (sFlt-1) which is an antagonist of vascular endothelial growth factor and placental growth factor (PIGF), is considered as one of etiology factors cause endothelial damage in preeclampsia due to increase of sFlt-1 level that change vascular endothelial integrity."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26434493"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Placental soluble fms-like tyrosine kinase-1 (sFlt-1) which is an antagonist of vascular endothelial growth factor and placental growth factor (PIGF), is considered as one of etiology factors cause endothelial damage in preeclampsia due to increase of sFlt-1 level that change vascular endothelial integrity."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26434493"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Difference of concentration of placental soluble fms-like tyrosine kinase-1(sFlt-1), placental growth factor (PlGF), and sFlt-1/PlGF ratio in severe preeclampsia and normal pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26434493"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Difference of concentration of placental soluble fms-like tyrosine kinase-1(sFlt-1), placental growth factor (PlGF), and sFlt-1/PlGF ratio in severe preeclampsia and normal pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26434493"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Placental soluble fms-like tyrosine kinase-1 (sFlt-1) which is an antagonist of vascular endothelial growth factor and placental growth factor (PIGF), is considered as one of etiology factors cause endothelial damage in preeclampsia due to increase of sFlt-1 level that change vascular endothelial integrity."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26434493"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "To determine to what extent a history of preeclampsia affects traditional cardiometabolic (insulin resistance and dyslipidemia) and cardiovascular (hypertension and micro-albuminuria) risk factors of the metabolic syndrome irrespective of BMI."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26433185"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "We have demonstrated that sFLT-1 e15a is increased in preeclampsia, antagonizes vascular endothelial growth factor signaling, and has antiangiogenic activity."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26416849"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "We have demonstrated that sFLT-1 e15a is increased in preeclampsia, antagonizes vascular endothelial growth factor signaling, and has antiangiogenic activity."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26416849"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Placental-Specific sFLT-1 e15a Protein Is Increased in Preeclampsia, Antagonizes Vascular Endothelial Growth Factor Signaling, and Has Antiangiogenic Activity."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26416849"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "We have demonstrated that sFLT-1 e15a is increased in preeclampsia, antagonizes vascular endothelial growth factor signaling, and has antiangiogenic activity."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26416849"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Placental-Specific sFLT-1 e15a Protein Is Increased in Preeclampsia, Antagonizes Vascular Endothelial Growth Factor Signaling, and Has Antiangiogenic Activity."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26416849"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Placental-Specific sFLT-1 e15a Protein Is Increased in Preeclampsia, Antagonizes Vascular Endothelial Growth Factor Signaling, and Has Antiangiogenic Activity."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26416849"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "In preeclampsia, the antiangiogenic factor soluble fms-like tyrosine kinase-1 (sFLT-1) is released from placenta into the maternal circulation, causing endothelial dysfunction and organ injury."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26416849"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "The angiogenic factors soluble fms-like tyrosine kinase 1 and placental growth factor, both biomarkers associated with preeclampsia, were measured on antepartum blood samples."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26416810"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "The angiogenic factors soluble fms-like tyrosine kinase 1 and placental growth factor, both biomarkers associated with preeclampsia, were measured on antepartum blood samples."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26416810"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Soluble Fms-like tyrosine kinase-1 (sFlt-1) is an antiangiogenic protein believed to mediate the signs and symptoms of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26405111"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "We conducted an open pilot study to evaluate the safety and potential efficacy of therapeutic apheresis with a plasma-specific dextran sulfate column to remove circulating sFlt-1 in 11 pregnant women (20-38 years of age) with very preterm preeclampsia (23-32 weeks of gestation, systolic BP \u2265140 mmHg or diastolic BP \u226590 mmHg, new onset protein/creatinine ratio >0.30 g/g, and sFlt-1/placental growth factor ratio >85)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26405111"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FGF16"}, "span_text": {"type": "literal", "value": "Comparing the 2 hypertensive pregnancy disorders, women subsequently developing gestational hypertension had higher serum levels of IL-1\u03b2, IL-5, IL-7, IL-8, IL-13, basic fibroblast growth factor, and vascular endothelial growth factor than the women subsequently developing preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26404486"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Comparing the 2 hypertensive pregnancy disorders, women subsequently developing gestational hypertension had higher serum levels of IL-1\u03b2, IL-5, IL-7, IL-8, IL-13, basic fibroblast growth factor, and vascular endothelial growth factor than the women subsequently developing preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26404486"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FGF5"}, "span_text": {"type": "literal", "value": "Comparing the 2 hypertensive pregnancy disorders, women subsequently developing gestational hypertension had higher serum levels of IL-1\u03b2, IL-5, IL-7, IL-8, IL-13, basic fibroblast growth factor, and vascular endothelial growth factor than the women subsequently developing preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26404486"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FGF13"}, "span_text": {"type": "literal", "value": "Comparing the 2 hypertensive pregnancy disorders, women subsequently developing gestational hypertension had higher serum levels of IL-1\u03b2, IL-5, IL-7, IL-8, IL-13, basic fibroblast growth factor, and vascular endothelial growth factor than the women subsequently developing preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26404486"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Comparing the 2 hypertensive pregnancy disorders, women subsequently developing gestational hypertension had higher serum levels of IL-1\u03b2, IL-5, IL-7, IL-8, IL-13, basic fibroblast growth factor, and vascular endothelial growth factor than the women subsequently developing preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26404486"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FGF18"}, "span_text": {"type": "literal", "value": "Comparing the 2 hypertensive pregnancy disorders, women subsequently developing gestational hypertension had higher serum levels of IL-1\u03b2, IL-5, IL-7, IL-8, IL-13, basic fibroblast growth factor, and vascular endothelial growth factor than the women subsequently developing preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26404486"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FGF4"}, "span_text": {"type": "literal", "value": "Comparing the 2 hypertensive pregnancy disorders, women subsequently developing gestational hypertension had higher serum levels of IL-1\u03b2, IL-5, IL-7, IL-8, IL-13, basic fibroblast growth factor, and vascular endothelial growth factor than the women subsequently developing preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26404486"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FGF7"}, "span_text": {"type": "literal", "value": "Comparing the 2 hypertensive pregnancy disorders, women subsequently developing gestational hypertension had higher serum levels of IL-1\u03b2, IL-5, IL-7, IL-8, IL-13, basic fibroblast growth factor, and vascular endothelial growth factor than the women subsequently developing preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26404486"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Comparing the 2 hypertensive pregnancy disorders, women subsequently developing gestational hypertension had higher serum levels of IL-1\u03b2, IL-5, IL-7, IL-8, IL-13, basic fibroblast growth factor, and vascular endothelial growth factor than the women subsequently developing preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26404486"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FGF22"}, "span_text": {"type": "literal", "value": "Comparing the 2 hypertensive pregnancy disorders, women subsequently developing gestational hypertension had higher serum levels of IL-1\u03b2, IL-5, IL-7, IL-8, IL-13, basic fibroblast growth factor, and vascular endothelial growth factor than the women subsequently developing preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26404486"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FGF14"}, "span_text": {"type": "literal", "value": "Comparing the 2 hypertensive pregnancy disorders, women subsequently developing gestational hypertension had higher serum levels of IL-1\u03b2, IL-5, IL-7, IL-8, IL-13, basic fibroblast growth factor, and vascular endothelial growth factor than the women subsequently developing preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26404486"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGT"}, "span_text": {"type": "literal", "value": "The pregnant female human angiotensinogen (hAGN) transgenic rat mated with the male human renin (hREN) transgenic rat is a model of preeclampsia (TgA) with increased blood pressure, proteinuria, and placenta alterations of edema and necrosis at late gestation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26394667"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Longitudinal changes in maternal serum placental growth factor and soluble fms-like tyrosine kinase-1 in women at increased risk of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26387758"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "To investigate longitudinal changes in maternal serum placental growth factor (PlGF) and soluble fms-like tyrosine kinase-1 (sFlt-1) in pregnancies that develop preeclampsia (PE) and gestational hypertension (GH)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26387758"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "To investigate longitudinal changes in maternal serum placental growth factor (PlGF) and soluble fms-like tyrosine kinase-1 (sFlt-1) in pregnancies that develop preeclampsia (PE) and gestational hypertension (GH)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26387758"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Longitudinal changes in maternal serum placental growth factor and soluble fms-like tyrosine kinase-1 in women at increased risk of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26387758"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "The vascular endothelial growth factor receptors (VEGFR1, R2, R3) and STAT3 have critical functions in normal blood vessel development, but their potential roles in preeclampsia are currently unclear."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26386651"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "The vascular endothelial growth factor receptors (VEGFR1, R2, R3) and STAT3 have critical functions in normal blood vessel development, but their potential roles in preeclampsia are currently unclear."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26386651"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "The vascular endothelial growth factor receptors (VEGFR1, R2, R3) and STAT3 have critical functions in normal blood vessel development, but their potential roles in preeclampsia are currently unclear."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26386651"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "As a protein cosynthesized with vasopressin, copeptin is a potential marker of metabolic syndrome and insulin resistance, which shares similar risk factors with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26384049"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PRL"}, "span_text": {"type": "literal", "value": "Elevated vasoinhibin derived from prolactin and cathepsin D activities in sera of patients with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26376948"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CTSD"}, "span_text": {"type": "literal", "value": "Elevated vasoinhibin derived from prolactin and cathepsin D activities in sera of patients with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26376948"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF2"}, "span_text": {"type": "literal", "value": "Higher levels of apoptosis, reduced insulin-like growth factor-2 expression, and altered antioxidant defenses may contribute to abnormal placentation and the later development of pregnancy complications, such as preeclampsia, fetal growth restriction, and stillbirth."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26362067"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:DCN"}, "span_text": {"type": "literal", "value": "Thus, we suggested that the contribution of decorin to the modulation of trophoblast cells might have implications for the pathogenesis of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26357650"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NGF"}, "span_text": {"type": "literal", "value": "Maternal nerve growth factor levels during pregnancy in women with preeclampsia:"}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26342999"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "The aim of this study evaluate the value of vascular endothelial growth factor (VEGF) and placental growth factor (PGF) serum levels in prediction of preeclampsia, severity and onset time of the disease."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26333278"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "The aim of this study evaluate the value of vascular endothelial growth factor (VEGF) and placental growth factor (PGF) serum levels in prediction of preeclampsia, severity and onset time of the disease."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26333278"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "The aim of this study evaluate the value of vascular endothelial growth factor (VEGF) and placental growth factor (PGF) serum levels in prediction of preeclampsia, severity and onset time of the disease."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26333278"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "The aim of this study evaluate the value of vascular endothelial growth factor (VEGF) and placental growth factor (PGF) serum levels in prediction of preeclampsia, severity and onset time of the disease."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26333278"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "The lower level of serum albumin in third trimester of pregnancy is the major concern of development of physiological edema during pregnancy and may be associated with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26329940"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Elevated placental release of the antiangiogenic factors, soluble fms-like tyrosine kinase-1 (sFlt-1) and soluble endoglin (sENG), is central to the pathophysiology of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26324507"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Elevated placental release of the antiangiogenic factors, soluble fms-like tyrosine kinase-1 (sFlt-1) and soluble endoglin (sENG), is central to the pathophysiology of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26324507"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "Genetic studies have associated single nucleotide polymorphisms in genes encoding nitric oxide synthase and matrix metalloproteases with preeclampsia, but the results are largely inconclusive across different populations."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26317342"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGT"}, "span_text": {"type": "literal", "value": "The relative proportion of free thiol angiotensinogen, expressed as a percentage of that observed with an in-house standard, is significantly decreased in pre-eclamptic patients (70.85% \u00b1 29.49%) (mean \u00b1 SD) as compared to healthy pregnant controls (92.98 \u00b1 24.93%) (mean \u00b1 SD) p \u2264 0.0001."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26312482"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGT"}, "span_text": {"type": "literal", "value": "Hence, elevated levels of plasma oxidized angiotensinogen may be a contributing factor to hypertension in the setting of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26312482"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGT"}, "span_text": {"type": "literal", "value": "The predictive potential of the ratio of free-thiol to oxidized angiotensinogen in the plasma for pre-eclampsia was first suggested by the Read group in ref 10."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26312482"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGT"}, "span_text": {"type": "literal", "value": "Patients with pre-eclampsia had substantially lower levels of free thiol angiotensinogen compared to healthy pregnant controls, whilst maintaining similar total angiotensinogen levels in the plasma."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26312482"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGT"}, "span_text": {"type": "literal", "value": "Improved Assay for Quantifying a Redox Form of Angiotensinogen as a Biomarker for Pre-Eclampsia:"}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26312482"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Combined screening by maternal factors, uterine artery pulsatility index, mean arterial pressure, and placental growth factor predicted 75% (95%\u00a0confidence interval, 70-80%) of preterm-preeclampsia and 47% (95% confidence interval, 44-51%) of term-preeclampsia, at a false-positive rate of 10%; inclusion of pregnancy-associated plasma protein-A did not improve the performance of screening."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26297382"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "In pregnancies that experienced preeclampsia, the values of uterine artery pulsatility index and mean arterial pressure were increased, and the values of serum pregnancy-associated plasma protein-A and placental growth factor were decreased."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26297382"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL1A"}, "span_text": {"type": "literal", "value": "Interleukin-1 alpha variation is associated with the risk of developing preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26254854"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL1A"}, "span_text": {"type": "literal", "value": "The aim of this study is to investigate the relationships between the polymorphisms of interleukin-1 alpha-889 (IL-1A) gene and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26254854"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGTR1"}, "span_text": {"type": "literal", "value": "Additionally, autoantibodies (AT1-AAs) that bind and activate the angiotensin II receptor type 1 a (AT1 receptor) also have a role in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26233865"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Plasma levels of soluble receptor for vascular endothelial growth factor (VEGFR)-1, also known as sFlt1 (soluble fms-like tyrosine kinase 1), an antiangiogenic factor have been reported to be elevated in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26233865"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Plasma levels of soluble receptor for vascular endothelial growth factor (VEGFR)-1, also known as sFlt1 (soluble fms-like tyrosine kinase 1), an antiangiogenic factor have been reported to be elevated in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26233865"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Plasma levels of soluble receptor for vascular endothelial growth factor (VEGFR)-1, also known as sFlt1 (soluble fms-like tyrosine kinase 1), an antiangiogenic factor have been reported to be elevated in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26233865"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Plasma levels of soluble receptor for vascular endothelial growth factor (VEGFR)-1, also known as sFlt1 (soluble fms-like tyrosine kinase 1), an antiangiogenic factor have been reported to be elevated in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26233865"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Preeclampsia is a major pregnancy complication where excess placental release of soluble fms-like tyrosine kinase-1 (sFlt-1) and soluble endoglin causes maternal endothelial and multisystem organ injury."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26222708"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Preeclampsia is a major pregnancy complication where excess placental release of soluble fms-like tyrosine kinase-1 (sFlt-1) and soluble endoglin causes maternal endothelial and multisystem organ injury."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26222708"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PLEK"}, "span_text": {"type": "literal", "value": "The expression of the imprinted gene pleckstrin homology-like domain family A member 2 in placental tissues of preeclampsia and its effects on the proliferation, migration and invasion of trophoblast cells JEG-3."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26218012"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Although the pathophysiology of preeclampsia has not been established, placental growth factor (PlGF) is believed to be a key factor."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26214510"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MTHFR"}, "span_text": {"type": "literal", "value": "We investigated the correlation between 5,10-methylenetetrahydrofolate reductase (MTHFR) gene methylation and pre-eclampsia, and its clinical significance, by comparing methylation in the MTHFR gene promoter of the placenta and peripheral venous blood in pre-eclampsia and normal gravidas."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26214484"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EFNB2"}, "span_text": {"type": "literal", "value": "Ephrin-B2, a downstream of Dll4/Notch signaling pathway, might be act as an inhibitor of EPC-mediated vasculogenesis in\u00a0vitro, as well as a potential target in the effort to promote angiogenesis of patients with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26212082"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EFNB2"}, "span_text": {"type": "literal", "value": "Ephrin-B2 expression increased notably in preeclampsia EPCs and placenta, compared with controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26212082"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EFNB2"}, "span_text": {"type": "literal", "value": "We analyzed expression of ephrin-B2 in the EPCs and placenta from preeclampsia and normal pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26212082"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Endothelial dysfunction and insulin resistance (IR) are established features of pre-eclampsia, however the cause and effect relationship between them remain unexplained."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26172933"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Relationship between insulin resistance and circulating endothelial cells in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26172933"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "The influence of common disturbances seen in preeclampsia, such as changes in strong ions and weak acids (particularly albumin) on acid-base status, has not been fully elucidated."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26170350"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Strikingly, we discovered that all sera from the severe preeclamptic patients (16 cases) contained a novel agonist-like AAB directed against the endothelin-1 ETA receptor in addition to the AABs against the angiotensin II AT1 receptor."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26158852"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "PubMed, CENTRAL, and Embase databases were searched from inception until 8 May 2014 using combinations of the search terms: pre-eclampsia, ultrasonography, pregnancy, biomarker, mean arterial pressure, placental protein 13, pregnancy-associated plasma protein-A, placental growth factor, activin A, inhibin A, pulsatility index."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26153822"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Endoglin and its soluble component remains an area for dynamic placental exploration in preeclampsia development."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26153627"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ANGPT1"}, "span_text": {"type": "literal", "value": "Serum levels of ET-1, M30, and angiopoietins-1 and -2 in HELLP syndrome and preeclampsia compared to controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26138305"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "These target endothelial nitric oxide synthase (eNOS), which has been repeatedly reported to be involved in the development of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26133786"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "Upregulation of microRNA\u2011335 and microRNA\u2011584 contributes to the pathogenesis of severe preeclampsia through downregulation of endothelial nitric oxide synthase."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26133786"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "STUDY DESIGN: CECs, flow-mediated vasodilation, levels of adhesion molecules and soluble vascular endothelial growth factor receptor-1 (sVEGFR1), and urine albumin/creatinine ratio were determined in 21 healthy women with ongoing normal pregnancy, 24 healthy currently nonpregnant women with a history of normal pregnancy, a total of 17 women with currently active mild (n = 11) or severe (n = 6) PE without hemolysis, elevated liver enzymes, and low platelet count (HELLP) syndrome, and 16 currently nonpregnant women with a history of mild (n = 10) or severe (n = 6) PE."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26116870"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VCAM1"}, "span_text": {"type": "literal", "value": "Patients with active preeclampsia had significantly higher soluble vascular cell adhesion molecule-1, soluble E-selectin, sVEGFR1, and urinary albumin/creatinine ratio than healthy pregnant women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26116870"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "STUDY DESIGN: CECs, flow-mediated vasodilation, levels of adhesion molecules and soluble vascular endothelial growth factor receptor-1 (sVEGFR1), and urine albumin/creatinine ratio were determined in 21 healthy women with ongoing normal pregnancy, 24 healthy currently nonpregnant women with a history of normal pregnancy, a total of 17 women with currently active mild (n = 11) or severe (n = 6) PE without hemolysis, elevated liver enzymes, and low platelet count (HELLP) syndrome, and 16 currently nonpregnant women with a history of mild (n = 10) or severe (n = 6) PE."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26116870"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "STUDY DESIGN: CECs, flow-mediated vasodilation, levels of adhesion molecules and soluble vascular endothelial growth factor receptor-1 (sVEGFR1), and urine albumin/creatinine ratio were determined in 21 healthy women with ongoing normal pregnancy, 24 healthy currently nonpregnant women with a history of normal pregnancy, a total of 17 women with currently active mild (n = 11) or severe (n = 6) PE without hemolysis, elevated liver enzymes, and low platelet count (HELLP) syndrome, and 16 currently nonpregnant women with a history of mild (n = 10) or severe (n = 6) PE."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26116870"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "STUDY DESIGN: CECs, flow-mediated vasodilation, levels of adhesion molecules and soluble vascular endothelial growth factor receptor-1 (sVEGFR1), and urine albumin/creatinine ratio were determined in 21 healthy women with ongoing normal pregnancy, 24 healthy currently nonpregnant women with a history of normal pregnancy, a total of 17 women with currently active mild (n = 11) or severe (n = 6) PE without hemolysis, elevated liver enzymes, and low platelet count (HELLP) syndrome, and 16 currently nonpregnant women with a history of mild (n = 10) or severe (n = 6) PE."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26116870"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VCAM1"}, "span_text": {"type": "literal", "value": "However, soluble vascular cell adhesion molecule-1, soluble E-selectin, urinary albumin/creatinine ratio were similar in women with a history of preeclampsia and healthy nonpregnant women with a history of normal pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26116870"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Soluble fms-like tyrosine kinase-1 (sFlt1), a circulating vascular endothelial growth factor receptor 1 antagonist, is associated with the pathogenesis of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26094569"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Soluble fms-like tyrosine kinase-1 (sFlt1), a circulating vascular endothelial growth factor receptor 1 antagonist, is associated with the pathogenesis of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26094569"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Soluble fms-like tyrosine kinase-1 (sFlt1), a circulating vascular endothelial growth factor receptor 1 antagonist, is associated with the pathogenesis of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26094569"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Soluble fms-like tyrosine kinase-1 (sFlt1), a circulating vascular endothelial growth factor receptor 1 antagonist, is associated with the pathogenesis of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26094569"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Case of soluble fms-like tyrosine kinase 1 apheresis in severe pre-eclampsia developed at 15 weeks' gestation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26094569"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Some genes are related to immune response, oxidative stress, insulin resistance, and adipogenesis, which plays a central role in excessive systemic inflammatory response of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26089598"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "The aim of this article is to investigate the megakaryopoyesis and thrombopoiesis in preterm infants born to mothers with preeclampsia and the potential effects mediated by soluble fms-like tyrosine kinase 1 (sFlt1) and thrombopoietin (TPO)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26083681"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FKBP2"}, "span_text": {"type": "literal", "value": "Expression of 52-kDa FK506-binding protein (FKBP52) in human placenta complicated by preeclampsia and intrauterine growth restriction."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26065228"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FKBP9"}, "span_text": {"type": "literal", "value": "Expression of 52-kDa FK506-binding protein (FKBP52) in human placenta complicated by preeclampsia and intrauterine growth restriction."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26065228"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FKBP4"}, "span_text": {"type": "literal", "value": "Expression of 52-kDa FK506-binding protein (FKBP52) in human placenta complicated by preeclampsia and intrauterine growth restriction."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26065228"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FKBP3"}, "span_text": {"type": "literal", "value": "To investigate the expression of 52-kDa FK506-binding protein (FKBP52) in human placentas complicated by preeclampsia (PE) and intrauterine growth restriction (IUGR)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26065228"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FKBP6"}, "span_text": {"type": "literal", "value": "Expression of 52-kDa FK506-binding protein (FKBP52) in human placenta complicated by preeclampsia and intrauterine growth restriction."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26065228"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FKBP8"}, "span_text": {"type": "literal", "value": "Expression of 52-kDa FK506-binding protein (FKBP52) in human placenta complicated by preeclampsia and intrauterine growth restriction."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26065228"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FKBP2"}, "span_text": {"type": "literal", "value": "To investigate the expression of 52-kDa FK506-binding protein (FKBP52) in human placentas complicated by preeclampsia (PE) and intrauterine growth restriction (IUGR)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26065228"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FKBP6"}, "span_text": {"type": "literal", "value": "To investigate the expression of 52-kDa FK506-binding protein (FKBP52) in human placentas complicated by preeclampsia (PE) and intrauterine growth restriction (IUGR)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26065228"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FKBP5"}, "span_text": {"type": "literal", "value": "To investigate the expression of 52-kDa FK506-binding protein (FKBP52) in human placentas complicated by preeclampsia (PE) and intrauterine growth restriction (IUGR)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26065228"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FKBP4"}, "span_text": {"type": "literal", "value": "To investigate the expression of 52-kDa FK506-binding protein (FKBP52) in human placentas complicated by preeclampsia (PE) and intrauterine growth restriction (IUGR)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26065228"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FKBP5"}, "span_text": {"type": "literal", "value": "Expression of 52-kDa FK506-binding protein (FKBP52) in human placenta complicated by preeclampsia and intrauterine growth restriction."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26065228"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FKBP3"}, "span_text": {"type": "literal", "value": "Expression of 52-kDa FK506-binding protein (FKBP52) in human placenta complicated by preeclampsia and intrauterine growth restriction."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26065228"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FKBP7"}, "span_text": {"type": "literal", "value": "To investigate the expression of 52-kDa FK506-binding protein (FKBP52) in human placentas complicated by preeclampsia (PE) and intrauterine growth restriction (IUGR)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26065228"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FKBP7"}, "span_text": {"type": "literal", "value": "Expression of 52-kDa FK506-binding protein (FKBP52) in human placenta complicated by preeclampsia and intrauterine growth restriction."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26065228"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FKBP8"}, "span_text": {"type": "literal", "value": "To investigate the expression of 52-kDa FK506-binding protein (FKBP52) in human placentas complicated by preeclampsia (PE) and intrauterine growth restriction (IUGR)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26065228"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FKBP9"}, "span_text": {"type": "literal", "value": "To investigate the expression of 52-kDa FK506-binding protein (FKBP52) in human placentas complicated by preeclampsia (PE) and intrauterine growth restriction (IUGR)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26065228"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "We investigated the association of endothelial nitric oxide synthase (NOS3) polymorphisms -786T>C, 27-bp repeat 4b/4a, and Glu298Asp with preeclampsia (PE)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26049094"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Angiogenic biomarkers, including soluble fms-like tyrosine kinase 1 (sFlt1), are thought to be predictors of preeclampsia onset; however, improvement is needed before a widespread diagnostic test can be utilized."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26042465"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NUBP1"}, "span_text": {"type": "literal", "value": "We identified the role of regulator of G protein (heterotrimeric guanine nucleotide-binding protein) signaling 5 (RGS5) in blood pressure regulation during pregnancy and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26041705"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:RGS5"}, "span_text": {"type": "literal", "value": "Regulator of G protein signaling 5 is a determinant of gestational hypertension and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26041705"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MTHFR"}, "span_text": {"type": "literal", "value": "Preeclampsia has been related to single-nucleotide polymorphisms (SNPs) of the methylenetetrahydrofolate reductase (MTHFR) gene; however, data regarding the placenta are still lacking."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26036716"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MTHFR"}, "span_text": {"type": "literal", "value": "Polymorphisms of the methylenetetrahydrofolate reductase gene (C677T and A1298C) in the placenta of pregnancies complicated with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26036716"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Preeclampsia, a hypertensive disorder of pregnancy associated with endothelial dysfunction, is also linked with down regulation of Ca2+ driven vasodilator production and increased levels of vascular endothelial growth factor (VEGF)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26033246"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Preeclampsia, a hypertensive disorder of pregnancy associated with endothelial dysfunction, is also linked with down regulation of Ca2+ driven vasodilator production and increased levels of vascular endothelial growth factor (VEGF)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26033246"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Preeclampsia, a hypertensive disorder of pregnancy associated with endothelial dysfunction, is also linked with down regulation of Ca2+ driven vasodilator production and increased levels of vascular endothelial growth factor (VEGF)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26033246"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Placental soluble fms-like tyrosine kinase 1 (sFlt1) release is increased in preeclampsia, which might be associated with increased shedding of Flt-1 through a disintegrin and metalloproteinase 10 (ADAM10)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26021209"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOTCH1"}, "span_text": {"type": "literal", "value": "Alteration of Delta-like ligand 1 and Notch 1 receptor in various placental disorders with special reference to early onset preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26014475"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOTCH1"}, "span_text": {"type": "literal", "value": "We therefore executed methylation-specific polymerase chain reaction and immunostaining for Notch 1 receptor and the activating ligand, Delta-like (DLL) 1, with placental tissues from cases of preeclampsia (early onset, n = 18; late-onset, n = 19) and other placental disorders, including maternal complications such as diabetes mellitus and collagen disease (n = 10), fetal growth restriction (n = 17), fetal anomaly (n = 23), preterm birth (n = 15), miscarriage (n = 25), and hydatidiform moles (n = 9) as well as term births (n = 12)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26014475"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Low serum ABCA1 levels were associated with the increases in the concentrations of blood lipid (low density lipoprotein cholesterol, total cholesterol and triglycerides) and with the decrease in the concentration of high-density lipoprotein cholesterol (P < 0.01), all of which may contribute to the onset of hypertension and eventually preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26004638"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Women with prior preeclampsia have an atherogenic lipid profile and endothelial dysfunction compared to matched control subjects despite having similar adiposity and insulin sensitivity, suggesting that there are mechanisms separate from obesity and insulin resistance that lead to their cardiovascular risk factors."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26003058"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Despite this, women with preeclampsia had lower high-density lipoprotein (46.0 \u00b1 10.7 vs 51.3 \u00b1 9.3 mg/dL; P < .05), smaller/denser low-density lipoprotein relative flotation rate (0.276 \u00b1 0.022 vs 0.289 \u00b1 0.016; P = .02), higher systolic (114.6 \u00b1 10.9 vs 102.3 \u00b1 7.5 mm Hg) and diastolic (67.6 \u00b1 7.5 vs 60.9 \u00b1 3.6 mm Hg; P < .001) blood pressures, and impaired flow-mediated dilatation (4.5 [2-6.7] vs 8.8 [4.5-9.1] percent change, P < .05) compared to controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26003058"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "We compared intraabdominal fat (IAF) area, insulin sensitivity index (SI), fasting lipids, low-density lipoprotein relative flotation rate, and brachial artery flow-mediated dilatation in 49 women with prior preeclampsia and 22 controls who were at least 8 months postpartum and matched for age, parity, body mass index, and months postpartum."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26003058"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "We compared intraabdominal fat (IAF) area, insulin sensitivity index (SI), fasting lipids, low-density lipoprotein relative flotation rate, and brachial artery flow-mediated dilatation in 49 women with prior preeclampsia and 22 controls who were at least 8 months postpartum and matched for age, parity, body mass index, and months postpartum."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26003058"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Intraabdominal fat, insulin sensitivity, and cardiovascular risk factors in postpartum women with a history of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26003058"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Here, we tested the hypothesis that this DNA can activate IFI16 in the placentas of women with preeclampsia and is sufficient to induce soluble fms-like tyrosine kinase 1 (sFlt-1) and soluble endoglin (sEng) production."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26002845"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Here, we tested the hypothesis that this DNA can activate IFI16 in the placentas of women with preeclampsia and is sufficient to induce soluble fms-like tyrosine kinase 1 (sFlt-1) and soluble endoglin (sEng) production."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/26002845"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL10"}, "span_text": {"type": "literal", "value": "The reduced uterine perfusion pressure (RUPP) rat model of preeclampsia was used to determine the effects of added interleukin-10 (IL-10) on Tregs and hypertension in response to placental ischemia and how the decrease in these anti-inflammatory factors mediates the pathophysiology of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25996051"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Plasma nitric oxide, endothelin-1, arginase and superoxide dismutase in the plasma and placentae from preeclamptic patients."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25993363"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD3"}, "span_text": {"type": "literal", "value": "Plasma nitric oxide, endothelin-1, arginase and superoxide dismutase in the plasma and placentae from preeclamptic patients."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25993363"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD1"}, "span_text": {"type": "literal", "value": "Plasma nitric oxide, endothelin-1, arginase and superoxide dismutase in the plasma and placentae from preeclamptic patients."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25993363"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "We investigated the potential value of maternal serum copeptin, midregional proatrial natriuretic peptide (MR-proANP) and Procalcitonin (PCT) levels at 11-13 weeks' gestation in the prediction of preeclampsia (PE) in a case-control study."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25975456"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Our findings in human samples were validated using a soluble fms-like tyrosine kinase 1 mouse model of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25941343"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Placental growth factor (PlGF) has been suggested as a possible biomarker for major placenta-related disorders such as preeclampsia and intrauterine growth restriction."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25940355"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Totally, the administration of cholecalciferol supplements among pregnant women at risk for pre-eclampsia for 12 weeks had favorable effects on insulin metabolism parameters, serum HDL-cholesterol, and plasma TAC concentrations."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25938886"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EPO"}, "span_text": {"type": "literal", "value": "To investigate the possible effect of abnormal placentation disorders such as preeclampsia (PE), pregnancy induced hypertension (PIH) and intrauterine growth restriction (IUGR) on erythropoietin (EPO) serum concentration in women in the first trimester of pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25938218"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Reduction in serum placental growth factor (PLGF) frequently co-occurs with preeclampsia (PE) and gestational diabetes mellitus (GDM)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25924650"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "The major causes of a higher incidence of pre-eclampsia in case of assisted reproduction include: polycystic ovary syndrome, insulin resistance, subfertility, age and obesity of patients."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25924640"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Use of placental growth factor and uterine artery doppler pulsatility index in pregnancies involving intrauterine fetal growth restriction or preeclampsia to predict perinatal outcomes."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25924544"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "The potential of uterine artery (UA) Doppler pulsatility index (PI) and maternal serum placental growth factor (PlGF) level to predict perinatal outcome was explored in pregnancies complicated by intrauterine fetal growth restriction (IUGR) or preeclampsia (PE)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25924544"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GAS6"}, "span_text": {"type": "literal", "value": "Association between the growth arrest-specific 6 (Gas6) gene polymorphism c.834\u2009+\u20097G>A and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25915719"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Fasting insulin concentrations and Insulin Resistance Index were significantly higher in preeclampsia compared with normal pregnancy (P\u200a<\u200a0.001 for both variables)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25909702"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "These findings support our hypothesis and raise the possibility that reduced tissue blood flow may a play a role in the increased insulin resistance seen in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25909702"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Relationship between insulin resistance and tissue blood flow in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25909702"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "There were significant inverse correlations between resting calf blood flow and fasting insulin concentrations (r\u200a=\u200a-0.57, P\u200a=\u200a0.008) and FIRI (r\u200a=\u200a-0.59, P\u200a=\u200a0.006) in preeclampsia, but not in normal pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25909702"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Placental growth factor (PGF), soluble fms-like tyrosine kinase 1 (sFLT1) and asymmetric dimethylarginine (ADMA) are involved in the pathogenesis of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25906026"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Placental growth factor (PGF), soluble fms-like tyrosine kinase 1 (sFLT1) and asymmetric dimethylarginine (ADMA) are involved in the pathogenesis of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25906026"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FGF22"}, "span_text": {"type": "literal", "value": "Placental fibroblast growth factor 21 is not altered in late-onset preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25890271"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "To investigate whether renin-angiotensin-aldosterone system suppression in preeclampsia is because of this disturbed angiogenic balance, we measured mean arterial pressure, creatinine, endothelin-1 (ET-1), and renin-angiotensin-aldosterone system components in pregnant women with a high (\u226585; n=38) or low (<85; n=65) soluble Fms-like tyrosine kinase-1/placental growth factor ratio."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25870197"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "To investigate whether renin-angiotensin-aldosterone system suppression in preeclampsia is because of this disturbed angiogenic balance, we measured mean arterial pressure, creatinine, endothelin-1 (ET-1), and renin-angiotensin-aldosterone system components in pregnant women with a high (\u226585; n=38) or low (<85; n=65) soluble Fms-like tyrosine kinase-1/placental growth factor ratio."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25870197"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Association studies suggest a key role for endothelin-1 in the pathogenesis of preeclampsia and the accompanying renin-angiotensin-aldosterone system suppression."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25870197"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "To investigate whether renin-angiotensin-aldosterone system suppression in preeclampsia is because of this disturbed angiogenic balance, we measured mean arterial pressure, creatinine, endothelin-1 (ET-1), and renin-angiotensin-aldosterone system components in pregnant women with a high (\u226585; n=38) or low (<85; n=65) soluble Fms-like tyrosine kinase-1/placental growth factor ratio."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25870197"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Women with preeclampsia display low renin-angiotensin-aldosterone system activity and a high antiangiogenic state, the latter characterized by high levels of soluble Fms-like tyrosine kinase (sFlt)-1 and reduced placental growth factor levels."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25870197"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Most anti-angiogenic preeclampsia models in rodents utilized the overexpression of a truncated soluble fms-like tyrosine kinase-1 (sFlt-1) not expressed in any species."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25860260"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Knockdown of placental Hif-1\u03b1 mRNA by specific siRNA significantly attenuated hallmark features of preeclampsia induced by angiotensin II type I receptor agonistic autoantibody in pregnant mice, including hypertension, proteinuria, kidney damage, impaired placental vasculature, and elevated maternal circulating soluble fms-like tyrosine kinase-1 levels."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25847948"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "Effects of pre-eclampsia and fetal growth restriction on C-type natriuretic peptide."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25846957"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "To investigate the potential value of serum placental growth factor (PlGF), soluble fms-like tyrosine kinase-1 (sFlt-1), pregnancy-associated plasma protein-A (PAPP-A), free \u03b2-human chorionic gonadotropin (\u03b2-hCG) and \u03b1-fetoprotein (AFP) at 30-34 weeks' gestation in the prediction of delivery of small-for-gestational-age (SGA) neonates, in the absence of pre-eclampsia (PE)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25826797"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "To investigate the potential value of serum placental growth factor (PlGF), soluble fms-like tyrosine kinase-1 (sFlt-1), pregnancy-associated plasma protein-A (PAPP-A), free \u03b2-human chorionic gonadotropin (\u03b2-hCG) and \u03b1-fetoprotein (AFP) at 30-34 weeks' gestation in the prediction of delivery of small-for-gestational-age (SGA) neonates, in the absence of pre-eclampsia (PE)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25826797"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Preeclampsia was characterized by excessive thrombin generation in placentas and previous researches showed that thrombin could enhance soluble Fms-like tyrosine kinase 1 (sFlt-1) expression in first trimester trophoblasts."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25824463"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX1"}, "span_text": {"type": "literal", "value": "To examine placental malondialdehyde (MDA), catalase, and glutathione peroxidase (GPx) levels in four placental regions among women with and without pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25813884"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CAT"}, "span_text": {"type": "literal", "value": "Catalase activity was lower in the peripheral maternal (P=0.036) and fetal (P=0.050) regions in the preterm pre-eclampsia group versus the normotensive group."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25813884"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX2"}, "span_text": {"type": "literal", "value": "To examine placental malondialdehyde (MDA), catalase, and glutathione peroxidase (GPx) levels in four placental regions among women with and without pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25813884"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CAT"}, "span_text": {"type": "literal", "value": "To examine placental malondialdehyde (MDA), catalase, and glutathione peroxidase (GPx) levels in four placental regions among women with and without pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25813884"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX3"}, "span_text": {"type": "literal", "value": "To examine placental malondialdehyde (MDA), catalase, and glutathione peroxidase (GPx) levels in four placental regions among women with and without pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25813884"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Oxidation of placental insulin and insulin-like growth factor receptors in mothers with diabetes mellitus or preeclampsia complicated with intrauterine growth restriction."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25812587"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF2"}, "span_text": {"type": "literal", "value": "Oxidation of placental insulin and insulin-like growth factor receptors in mothers with diabetes mellitus or preeclampsia complicated with intrauterine growth restriction."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25812587"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF1"}, "span_text": {"type": "literal", "value": "Oxidation of placental insulin and insulin-like growth factor receptors in mothers with diabetes mellitus or preeclampsia complicated with intrauterine growth restriction."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25812587"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOE"}, "span_text": {"type": "literal", "value": "To establish the role of the interaction between maternal and newborn apolipoprotein E (APOE) genotypes on the risk, lipid profile and prognosis of preeclampsia (PE)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25806651"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AFP"}, "span_text": {"type": "literal", "value": "alpha-Fetoprotein elevation and proteinuric pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/2580550"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ANXA2"}, "span_text": {"type": "literal", "value": "The aims of present study were to investigate the expression of Annexin A2 in the placenta of patients with preeclampsia (PE) and correlate these data with acute worsening of clinical symptoms."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25803884"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ANXA2"}, "span_text": {"type": "literal", "value": "Increased annexin A2 expression in the placenta of women with acute worsening of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25803884"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "Pre-eclampsia is associated with ischemia and increased oxidative stress, which may lead to modification of plasma albumin to ischemia modified albumin (IMA)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25775261"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "Evaluation of cord blood ischemia modified albumin in normal pregnancies and pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25775261"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "We review diagnostic and predictive roles of the angiogenic proteins placental growth factor, soluble fms-like tyrosine kinase 1, and soluble endoglin in preeclampsia, and their association with future cardiovascular disease, diabetes, and breast cancer."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25753566"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "We review diagnostic and predictive roles of the angiogenic proteins placental growth factor, soluble fms-like tyrosine kinase 1, and soluble endoglin in preeclampsia, and their association with future cardiovascular disease, diabetes, and breast cancer."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25753566"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "We review diagnostic and predictive roles of the angiogenic proteins placental growth factor, soluble fms-like tyrosine kinase 1, and soluble endoglin in preeclampsia, and their association with future cardiovascular disease, diabetes, and breast cancer."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25753566"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "To investigate the accuracy of the soluble fms-like tyrosine kinase-1(sFlt-1)/placental growth factor (PlGF) ratio to predict preeclampsia (PE)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25716670"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "To investigate the accuracy of the soluble fms-like tyrosine kinase-1(sFlt-1)/placental growth factor (PlGF) ratio to predict preeclampsia (PE)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25716670"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Diagnostic accuracy of the soluble Fms-like tyrosine kinase-1/placental growth factor ratio for preeclampsia: a meta-analysis based on 20 studies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25716670"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Diagnostic accuracy of the soluble Fms-like tyrosine kinase-1/placental growth factor ratio for preeclampsia: a meta-analysis based on 20 studies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25716670"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "A preeclampsia-like state was induced in pregnant CD1 mice by overexpressing soluble fms-like tyrosine kinase-1, a circulating antiangiogenic protein that induces hypertension and glomerular disease resembling human preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25712723"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CAV1"}, "span_text": {"type": "literal", "value": "Additionally Caveolin-1 protein expression was also reduced in pre-eclampsia (P\u00a0=\u00a00.007); this could be an adaptive response in pre-eclampsia, possibly to attenuate the oxidative stress/inflammation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25707739"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CAV1"}, "span_text": {"type": "literal", "value": "Placental mRNA expression of caveolin-1, cavin 1-3, was lower and eNOS expression was increased in pre-eclampsia (P\u00a0<\u00a00.05 for all)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25707739"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Serum levels of leptin and IP-10 in preeclampsia compared to controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25693758"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NFE2"}, "span_text": {"type": "literal", "value": "Sofalcone upregulates the nuclear factor (erythroid-derived 2)-like 2/heme oxygenase-1 pathway, reduces soluble fms-like tyrosine kinase-1, and quenches endothelial dysfunction: potential therapeutic for preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25667213"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Sofalcone upregulates the nuclear factor (erythroid-derived 2)-like 2/heme oxygenase-1 pathway, reduces soluble fms-like tyrosine kinase-1, and quenches endothelial dysfunction: potential therapeutic for preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25667213"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Antiangiogenic factors, soluble fms-like tyrosine kinase-1 (sFlt-1) and soluble endoglin, play key pathophysiological roles in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25667213"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HMOX1"}, "span_text": {"type": "literal", "value": "Sofalcone upregulates the nuclear factor (erythroid-derived 2)-like 2/heme oxygenase-1 pathway, reduces soluble fms-like tyrosine kinase-1, and quenches endothelial dysfunction: potential therapeutic for preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25667213"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HMOX1"}, "span_text": {"type": "literal", "value": "Heme oxygenase-1 (HO-1) is a cytoprotective, antioxidant enzyme reported to be downregulated in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25667213"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LAP3"}, "span_text": {"type": "literal", "value": "Since these hormones are biologically active, the leakage of these hormones into the maternal circulation is regulated by degradation activity by placental aminopeptidases, in order to maintain the balance between carriage of pregnancy and onset of labor.Because the concentration of these hormones, being regulated by the amount of endogenous production and by physiological degradation by enzymes in the blood and tissue, the balance between production and degradation is a definitive element for maintaining normal gestation and term delivery.The changes of the balance between fetal angiotensin II (A-II) and vasopressin (AVP) andA-II and AVP degrading enzymes, between aminopeptidase A (APA) and placental leucine aminopeptidase( P-LAP) - in the placenta and maternal blood due to fetal stress such as hypoxia - are the provable causes of preeclampsia or preterm labor.Induction of APA and P-LAP by estradiol benzoate (E2) and progesterone (P) from placenta has been demonstrated."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25658663"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:OLR1"}, "span_text": {"type": "literal", "value": "Inhibition of lectin-like oxidized low-density lipoprotein receptor 1 protects against plasma/hypoxia-mediated trophoblast dysfunction associated with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25633310"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CFB"}, "span_text": {"type": "literal", "value": "Bb, the active fragment of complement factor B (fB), has been reported to be a predictor of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25604034"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CFB"}, "span_text": {"type": "literal", "value": "Complement factor B activation in patients with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25604034"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Diagnosis of preeclampsia with soluble Fms-like tyrosine kinase 1/placental growth factor ratio: an inter-assay comparison."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25600419"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "The angiogenic factor ratio soluble Fms-kinase 1 (sFlt-1)/placental growth factor (PlGF) is a novel diagnostic tool for preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25600419"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Diagnosis of preeclampsia with soluble Fms-like tyrosine kinase 1/placental growth factor ratio: an inter-assay comparison."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25600419"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Impaired proliferation of pancreatic beta cells, by reduced placental growth factor in pre-eclampsia, as a cause for gestational diabetes mellitus."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25594238"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Reduced increase in serum placental growth factor (PLGF) levels frequently occurs in patients with pre-eclampsia (PE) and thus has been used as a predictive factor for developing PE."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25594238"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HBEGF"}, "span_text": {"type": "literal", "value": "EGF, transforming growth factor-\u03b1 (TGFA), and heparin-binding EGF-like growth factor (HBEGF) were evaluated using ELISA in maternal plasma from another 20 pregnancies with or without preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25589361"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Adenosine and insulin stimulate vasodilation in endothelial cells, and this activity is mediated by adenosine receptor activation in uncomplicated pregnancies; however, this activity has yet to be examined in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25573092"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "Preeclampsia is associated with impaired placental vasodilation and reduced endothelial nitric oxide synthase (eNOS) activity in the foetoplacental circulation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25573092"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Insulin restores L-arginine transport requiring adenosine receptors activation in umbilical vein endothelium from late-onset preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25573092"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FST"}, "span_text": {"type": "literal", "value": "Longitudinal analysis of maternal serum Follistatin concentration in normal pregnancy and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25565002"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Women with previous early-onset preeclampsia were compared with women with late-onset preeclampsia and pregnancy-induced hypertension and had significantly higher fasting blood glucose (5.29 versus 4.80 and 4.83 mmol/L), insulin (9.12 versus 6.31 and 6.7 uIU/L), triglycerides (1.32 versus 1.02 and 0.97 mmol/L), and total cholesterol (5.14 versus 4.73 and 4.73 mmol/L)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25561694"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TFPI"}, "span_text": {"type": "literal", "value": "Potentiated hypercoagulability however, is associated with disorders of pregnancy such as pre-eclampsia but the results of TF and its inhibitor, tissue factor pathway inhibitor (TFPI), measurement, in pre eclampsic women are ambiguous and the data conflicting."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25559093"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TFPI2"}, "span_text": {"type": "literal", "value": "Potentiated hypercoagulability however, is associated with disorders of pregnancy such as pre-eclampsia but the results of TF and its inhibitor, tissue factor pathway inhibitor (TFPI), measurement, in pre eclampsic women are ambiguous and the data conflicting."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25559093"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "A proangiogenic protein, placental growth factor (PIGF), is reported to be dysregulated in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25545166"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "HIF-1 Alpha and Placental Growth Factor in Pregnancies Complicated With Preeclampsia:"}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25545166"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VTN"}, "span_text": {"type": "literal", "value": "Evaluation of Lp-PLA2 mass, vitronectin and PAI-1 activity levels in patients with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25527349"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VTN"}, "span_text": {"type": "literal", "value": "The aim of the current study is to determine, correlate and compare the plasma lipoprotein-associated phospholipase A2 (Lp-PLA2), vitronectin (Vn), Plasminogen activator inhibitor-1 (PAI-1) activity and tissue plasminogen activator (t-PA) levels in early-onset preeclampsia, late-onset preeclampsia and in control pregnant women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25527349"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PEG3"}, "span_text": {"type": "literal", "value": "The aim of this study was to investigate the expression and significance of the imprinted gene PEG10 (paternally expressed gene 10) in preeclampsia placental tissue."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25526181"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Studies examining leptin in preeclampsia are inconsistent, possibly because of small sample sizes and variability in sampling and outcome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25510827"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Leptin is a possible mediator of the association between body mass index and preeclampsia (P=0.0276)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25510827"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Serum leptin measured in early pregnancy is higher in women with preeclampsia compared with normotensive pregnant women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25510827"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Associations between leptin and preeclampsia (blood pressure \u2265140/90 mm Hg), term preeclampsia (preeclampsia and delivery \u226537 weeks gestation), or preterm preeclampsia (preeclampsia and delivery <37 weeks gestation) were examined using generalized linear models adjusting for body mass index, gestational age at blood draw, maternal age, smoking, and socio-occupational status."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25510827"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "As leptin is increased in obese women and the risk of preeclampsia increases with body mass index, we used the Sobel test to examine whether leptin is a mediator of this relationship."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25510827"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Leptin concentrations are higher in women with preeclampsia compared with normotensive controls and may mediate some of the relationship between body mass index and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25510827"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "After adjustments, leptin concentrations were significantly higher in women with preeclampsia (30.5 [24.6]; P=0.0117) and term preeclampsia (30.4 [24.9]; P=0.0228) compared with controls (20.9 [28.3])."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25510827"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "In singleton pregnancies, soluble fms-like tyrosine kinase-1 (sFlt-1), placental growth factor (PlGF) and the sFlt-1/PlGF ratio have shown utility as a diagnostic test for pre-eclampsia (PE)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25491901"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "In singleton pregnancies, soluble fms-like tyrosine kinase-1 (sFlt-1), placental growth factor (PlGF) and the sFlt-1/PlGF ratio have shown utility as a diagnostic test for pre-eclampsia (PE)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25491901"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Faulty placentation manifests in the mother as preeclampsia with vascular damage, enhanced systemic inflammation, and insulin resistance; in the placenta as oxygen and nutrient transfer restriction and oxidative stress; and in the fetus as growth restriction and progressive hypoxemia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25485869"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HMOX2"}, "span_text": {"type": "literal", "value": "Involvement of the heme oxygenase system in the development of preeclampsia and as a possible therapeutic target."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25482489"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HMOX1"}, "span_text": {"type": "literal", "value": "Involvement of the heme oxygenase system in the development of preeclampsia and as a possible therapeutic target."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25482489"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MTHFR"}, "span_text": {"type": "literal", "value": "The aim of this study was to examine the association of factor V Leiden, prothrombin and methylenetetrahydrofolate reductase (MTHFR) polymorphisms and preeclampsia (PE) in Southeast of Iran."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25480409"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "Corin, a serine protease which activates pro-atrial natriuretic peptide, has recently been shown to be involved in the pathophysiology of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25474356"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CP"}, "span_text": {"type": "literal", "value": "Plasma copper and ceruloplasmin concentrations were modestly but significantly elevated in women who subsequently developed preeclampsia (both P<0.001) compared to controls (median (IQR), copper, 1957.4 (1787, 2177.5) vs 1850.0 (1663.5, 2051.5) \u00b5g/L; ceruloplasmin, 2.5 (1.4, 3.2) vs 2.2 (1.2, 3.0) \u00b5g/ml)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25463281"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SEMA3B"}, "span_text": {"type": "literal", "value": "Recent evidence suggests that Semaphorin 3B (SEMA3B) is upregulated in severe preeclampsia, and a major driver of cytotrophoblast aberrations in this disease."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25454475"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Recent studies show that vascular endothelial growth factor (VEGF) downregulation is implicated in preeclampsia (PE) pathophysiology."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25450585"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Preeclampsia is associated with lower production of vascular endothelial growth factor by peripheral blood mononuclear cells."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25450585"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Preeclampsia is associated with lower production of vascular endothelial growth factor by peripheral blood mononuclear cells."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25450585"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Preeclampsia is associated with lower production of vascular endothelial growth factor by peripheral blood mononuclear cells."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25450585"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Recent studies show that vascular endothelial growth factor (VEGF) downregulation is implicated in preeclampsia (PE) pathophysiology."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25450585"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Recent studies show that vascular endothelial growth factor (VEGF) downregulation is implicated in preeclampsia (PE) pathophysiology."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25450585"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CNR1"}, "span_text": {"type": "literal", "value": "In the present study, we aimed to analyze cannabinoid receptor 1 (CB1), CB2 and fatty acid amid hydrolase (FAAH) expressions and localization in normal and preeclamptic placenta, in order to determine whether placental endocannabinoid expression pattern differs between normal pregnancy and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25444073"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CNR1"}, "span_text": {"type": "literal", "value": "Increased placental expression of cannabinoid receptor 1 in preeclampsia: an observational study."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25444073"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPR3"}, "span_text": {"type": "literal", "value": "Changes in placental atrial natriuretic peptide receptors associated with severe toxemia of pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/2543965"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPR2"}, "span_text": {"type": "literal", "value": "Changes in placental atrial natriuretic peptide receptors associated with severe toxemia of pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/2543965"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FABP3"}, "span_text": {"type": "literal", "value": "Is there an association between liver type fatty acid binding protein and severity of preeclampsia?"}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25399315"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FABP9"}, "span_text": {"type": "literal", "value": "Is there an association between liver type fatty acid binding protein and severity of preeclampsia?"}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25399315"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FABP5"}, "span_text": {"type": "literal", "value": "Is there an association between liver type fatty acid binding protein and severity of preeclampsia?"}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25399315"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FABP7"}, "span_text": {"type": "literal", "value": "Is there an association between liver type fatty acid binding protein and severity of preeclampsia?"}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25399315"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FABP4"}, "span_text": {"type": "literal", "value": "Is there an association between liver type fatty acid binding protein and severity of preeclampsia?"}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25399315"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CASC4"}, "span_text": {"type": "literal", "value": "Effect of preeclampsia on umbilical cord blood stem cells in relation to breast cancer susceptibility in the offspring."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25398884"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MPO"}, "span_text": {"type": "literal", "value": "Neutrophil release of myeloperoxidase in systemic vasculature of obese women may put them at risk for preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25394640"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Soluble fms-like tyrosine kinase (sFlt)-1-e15a, a primate-specific sFlt-1-isoform most abundant in the human placenta in preeclampsia, can induce preeclampsia in mice."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25393290"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "This study investigated whether angiotensin II type 1 receptor agonistic autoantibodies (AT1 -AAs) mediate the increased release of soluble endoglin (sEng) in women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25376533"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Autoantibodies isolated from patients with preeclampsia induce soluble endoglin production from trophoblast cells via interactions with angiotensin II type 1 receptor."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25376533"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "These results suggest that plasma human atrial natriuretic peptide may not strongly influence blood pressure, although it may induce the relaxation of vascular smooth muscles via the cyclic guanosine 3'5'-monophosphate system in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/2536220"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "To assess the effect of endogenous human atrial natriuretic peptide on the vascular system in preeclampsia, the circadian variations of plasma human atrial natriuretic peptide, cyclic guanosine 3'5'-monophosphate, cyclic adenosine 3'5'-monophosphate, and blood pressure were measured."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/2536220"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Decreased placental miR-126 expression and vascular endothelial growth factor levels in patients with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25341970"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "To detect microRNA (miR)-126 expression and its correlation with vascular endothelial growth factor (VEGF) levels in placentas from patients with pre-eclampsia compared with those from normotensive pregnancies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25341970"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Decreased placental miR-126 expression and vascular endothelial growth factor levels in patients with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25341970"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "To detect microRNA (miR)-126 expression and its correlation with vascular endothelial growth factor (VEGF) levels in placentas from patients with pre-eclampsia compared with those from normotensive pregnancies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25341970"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Decreased placental miR-126 expression and vascular endothelial growth factor levels in patients with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25341970"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "To detect microRNA (miR)-126 expression and its correlation with vascular endothelial growth factor (VEGF) levels in placentas from patients with pre-eclampsia compared with those from normotensive pregnancies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25341970"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "Natriuresis in response to acute volume expansion with albumin infusion occurred only in 50% of preeclamptic patients, and was associated with an ANP increase, an aldosterone decrease, and a further decrease in the ratio."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/2533297"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "The possibility of evaluating the ratio between aldosterone and atrial natriuretic peptide (ANP) instead of the two hormones by themselves in studying sodium handling in normal pregnancy and in preeclampsia in the steady state and following albumin infusion was examined in this study."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/2533297"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "The possibility of evaluating the ratio between aldosterone and atrial natriuretic peptide (ANP) instead of the two hormones by themselves in studying sodium handling in normal pregnancy and in preeclampsia in the steady state and following albumin infusion was examined in this study."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/2533297"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TG"}, "span_text": {"type": "literal", "value": "We evaluated the prevalence of preeclampsia, intra-uterine growth retardation (IUGR), preterm delivery and low Apgar score and their association with TSH, thyroid peroxidase (TPO), and thyroglobulin (Tg) antibodies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25330412"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TPO"}, "span_text": {"type": "literal", "value": "We evaluated the prevalence of preeclampsia, intra-uterine growth retardation (IUGR), preterm delivery and low Apgar score and their association with TSH, thyroid peroxidase (TPO), and thyroglobulin (Tg) antibodies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25330412"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "There is strong evidence that overproduction of soluble fms-like tyrosine kinase-1 (sFLT1) in the placenta is a major cause of vascular dysfunction in preeclampsia through sFLT1-dependent antagonism of VEGF."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25329693"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Among the genetic factors, there is an association between pre-eclampsia and polymorphisms in some genes of different population samples, as vascular endothelial growth factor and interleukin 1 alpha."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25322977"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "The aim of this study was to investigate the vascular endothelial growth factor (VEGF) G-634C and interleukin 1 alpha (IL1A) rs3783550 polymorphism in a specific Brazilian pre-eclampsia group."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25322977"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL1A"}, "span_text": {"type": "literal", "value": "The aim of this study was to investigate the vascular endothelial growth factor (VEGF) G-634C and interleukin 1 alpha (IL1A) rs3783550 polymorphism in a specific Brazilian pre-eclampsia group."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25322977"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "The aim of this study was to investigate the vascular endothelial growth factor (VEGF) G-634C and interleukin 1 alpha (IL1A) rs3783550 polymorphism in a specific Brazilian pre-eclampsia group."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25322977"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL1A"}, "span_text": {"type": "literal", "value": "On the other hand, the rs3783550 polymorphism in the interleukin 1 alpha gene is correlated to pre-eclampsia, indicating that women with the allele A have a higher probability of developing the disease."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25322977"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Among the genetic factors, there is an association between pre-eclampsia and polymorphisms in some genes of different population samples, as vascular endothelial growth factor and interleukin 1 alpha."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25322977"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL1A"}, "span_text": {"type": "literal", "value": "Among the genetic factors, there is an association between pre-eclampsia and polymorphisms in some genes of different population samples, as vascular endothelial growth factor and interleukin 1 alpha."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25322977"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "The aim of this study was to investigate the vascular endothelial growth factor (VEGF) G-634C and interleukin 1 alpha (IL1A) rs3783550 polymorphism in a specific Brazilian pre-eclampsia group."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25322977"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Among the genetic factors, there is an association between pre-eclampsia and polymorphisms in some genes of different population samples, as vascular endothelial growth factor and interleukin 1 alpha."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25322977"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Calculated odds ratios for metabolic syndrome, fasting insulin, HOMA, and microalbuminuria were all higher for women with a history of pre-eclampsia compared with women with SGA."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25318833"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:BECN1"}, "span_text": {"type": "literal", "value": "The expression of LC3, Beclin-1 and autophagosome was significantly increased in placentas from pregnancies complicated by early-onset preeclampsia and in HTR8/SVneo cells and HUVECs treated with glucose oxidase."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25318653"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL10"}, "span_text": {"type": "literal", "value": "Meta-analysis of associations between interleukin-10 polymorphisms and susceptibility to pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25305663"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL10"}, "span_text": {"type": "literal", "value": "To investigate whether interleukin-10 (IL-10) polymorphisms are associated with susceptibility to pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25305663"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "The odds of early onset preeclampsia were significantly increased when the biomarkers PlGF (OR 3.4, 95% CI 1.6, 7.2), PAPP-A (OR 4.8, 95% CI 2.5, 22.5), PP13 (OR 7.5, 95% CI 2.5, 22.5), soluble endoglin (OR 18.5, 95% CI 8.4, 41.0) and inhibin-A (OR 4.1, 95% CI 1.9, 8.8) were abnormal."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25305662"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Two biomarkers, soluble endoglin (OR 2.1, 95% CI 1.9, 2.4) and inhibin-A (OR 1.9, 95% CI 1.4, 2.8) were significantly associated with late onset preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25305662"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FABP4"}, "span_text": {"type": "literal", "value": "Regulation of fatty acid binding proteins by hypoxia inducible factors 1\u03b1 and 2\u03b1 in the placenta: relevance to pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25305177"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FABP7"}, "span_text": {"type": "literal", "value": "Regulation of fatty acid binding proteins by hypoxia inducible factors 1\u03b1 and 2\u03b1 in the placenta: relevance to pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25305177"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FABP9"}, "span_text": {"type": "literal", "value": "Regulation of fatty acid binding proteins by hypoxia inducible factors 1\u03b1 and 2\u03b1 in the placenta: relevance to pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25305177"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FABP5"}, "span_text": {"type": "literal", "value": "Regulation of fatty acid binding proteins by hypoxia inducible factors 1\u03b1 and 2\u03b1 in the placenta: relevance to pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25305177"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FABP3"}, "span_text": {"type": "literal", "value": "Regulation of fatty acid binding proteins by hypoxia inducible factors 1\u03b1 and 2\u03b1 in the placenta: relevance to pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25305177"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Very high maternal soluble fms-like tyrosine kinase-1 (sFlt-1 also known as sVEGFR) and very low placenta growth factor (PlGF) are unique to pre-eclampsia; however, abnormal spiral arteries and excessive inflammation are also prevalent in other placental disorders."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25303561"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HADH"}, "span_text": {"type": "literal", "value": "Long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) expression is decreased in placenta of some cases of preeclampsia (PE) which may result in free fatty acid (FFA) increased."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25302499"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "Longitudinal changes in maternal corin and mid-regional proatrial natriuretic peptide in women at risk of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25296530"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "The purpose of this study was to determine if both the placenta and umbilical vessels are possible sites of atrial natriuretic peptide metabolism and to evaluate the effects that labor, route of delivery, prolonged pregnancy, preeclampsia, and fetal distress have on umbilical arterial atrial natriuretic peptide levels."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/2528907"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "The increased umbilical arterial atrial natriuretic peptide levels present in preeclampsia and fetal distress may reflect an attempt by the fetus to regulate blood flow."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/2528907"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "Umbilical arterial atrial natriuretic peptide levels were elevated in pregnancies complicated by preeclampsia and fetal distress (p less than 0.01)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/2528907"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD3"}, "span_text": {"type": "literal", "value": "In patients under the age of 30 years, E-selectin was significantly higher in the pre-eclampsia group (p < 0.05), while P-selectin, catalase and superoxide dismutase were not significantly different between the two groups (p > 0.05)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25280210"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD1"}, "span_text": {"type": "literal", "value": "In patients under the age of 30 years, E-selectin was significantly higher in the pre-eclampsia group (p < 0.05), while P-selectin, catalase and superoxide dismutase were not significantly different between the two groups (p > 0.05)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25280210"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD3"}, "span_text": {"type": "literal", "value": "In patients over the age of 30 years, serum levels of L-selectin and E-selectin were lower in pre-eclamptic patients (p < 0.05); antioxidants, catalase and superoxide dismutase did not significantly differ between the two groups, while glutathione peroxidase was significantly higher in the normotensive group (p < 0.05)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25280210"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX1"}, "span_text": {"type": "literal", "value": "In patients over the age of 30 years, serum levels of L-selectin and E-selectin were lower in pre-eclamptic patients (p < 0.05); antioxidants, catalase and superoxide dismutase did not significantly differ between the two groups, while glutathione peroxidase was significantly higher in the normotensive group (p < 0.05)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25280210"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX3"}, "span_text": {"type": "literal", "value": "In patients over the age of 30 years, serum levels of L-selectin and E-selectin were lower in pre-eclamptic patients (p < 0.05); antioxidants, catalase and superoxide dismutase did not significantly differ between the two groups, while glutathione peroxidase was significantly higher in the normotensive group (p < 0.05)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25280210"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CAT"}, "span_text": {"type": "literal", "value": "In patients under the age of 30 years, E-selectin was significantly higher in the pre-eclampsia group (p < 0.05), while P-selectin, catalase and superoxide dismutase were not significantly different between the two groups (p > 0.05)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25280210"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CAT"}, "span_text": {"type": "literal", "value": "In patients over the age of 30 years, serum levels of L-selectin and E-selectin were lower in pre-eclamptic patients (p < 0.05); antioxidants, catalase and superoxide dismutase did not significantly differ between the two groups, while glutathione peroxidase was significantly higher in the normotensive group (p < 0.05)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25280210"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX2"}, "span_text": {"type": "literal", "value": "In patients over the age of 30 years, serum levels of L-selectin and E-selectin were lower in pre-eclamptic patients (p < 0.05); antioxidants, catalase and superoxide dismutase did not significantly differ between the two groups, while glutathione peroxidase was significantly higher in the normotensive group (p < 0.05)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25280210"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD1"}, "span_text": {"type": "literal", "value": "In patients over the age of 30 years, serum levels of L-selectin and E-selectin were lower in pre-eclamptic patients (p < 0.05); antioxidants, catalase and superoxide dismutase did not significantly differ between the two groups, while glutathione peroxidase was significantly higher in the normotensive group (p < 0.05)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25280210"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "Association of endothelial nitric oxide synthase gene G894T polymorphism and serum nitric oxide levels in patients with preeclampsia and gestational hypertension."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25275587"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Longitudinal changes in maternal soluble endoglin and angiopoietin-2 in women at risk for pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25274543"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "Patients with hypertensive diseases of pregnancy have been shown to experience elevation of circulating natriuretic peptide levels compared to normal pregnancies, especially in the setting of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25260544"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MPO"}, "span_text": {"type": "literal", "value": "Similar to preeclamptic patients, CD4(+) T cells from placental ischemic rats secreted significantly more myeloperoxidase (P=0.003) and induced oxidative stress in cultured vascular cells (P=0.003) than normal pregnant rat CD4(+)Tcells."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25259742"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MPO"}, "span_text": {"type": "literal", "value": "Women with preeclampsia had significantly increased circulating (P=0.02) and placental CD4(+) T cells (P=0.0001); lymphocyte secretion of myeloperoxidase (P=0.004); and placental reactive oxygen species (P=0.0004) when compared with normal pregnant women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25259742"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Independent of insulin resistance, every 1 nmol/l increase in Sex Hormone Binding Globulin, decreases the odds of preeclampsia by 1%, notifying Sex Hormone Binding Globulin as an important biomarker about its etiology and prediction."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25252481"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Is the sex hormone binding globulin related to preeclampsia independent of insulin resistance?"}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25252481"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SHBG"}, "span_text": {"type": "literal", "value": "To evaluate the association between Sex Hormone Binding Globulin and preeclampsia in Iranian women considering the probable confounding effect of insulin resistance."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25252481"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SHBG"}, "span_text": {"type": "literal", "value": "There was a significant reverse correlation between level of Sex Hormone Binding Globulin in blood and being a case of preeclampsia (adjusted odds ratio = 0.99; 95% Confidence Interval:"}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25252481"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SHBG"}, "span_text": {"type": "literal", "value": "Independent of insulin resistance, every 1 nmol/l increase in Sex Hormone Binding Globulin, decreases the odds of preeclampsia by 1%, notifying Sex Hormone Binding Globulin as an important biomarker about its etiology and prediction."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25252481"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SHBG"}, "span_text": {"type": "literal", "value": "Is the sex hormone binding globulin related to preeclampsia independent of insulin resistance?"}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25252481"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:S1PR1"}, "span_text": {"type": "literal", "value": "miR-125b-1-3p inhibits trophoblast cell invasion by targeting sphingosine-1-phosphate receptor 1 in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25251470"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "The optimization of a chronic nitric oxide synthase (NOS) inhibition model of pre-eclampsia by evaluating physiological changes."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25240245"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Vascular endothelial growth factor (VEGF) is relevant for healthy pregnancy, and abnormalities in VEGF functions have been associated with hypertensive disorders of pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25234518"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Vascular endothelial growth factor (VEGF) is relevant for healthy pregnancy, and abnormalities in VEGF functions have been associated with hypertensive disorders of pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25234518"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Vascular endothelial growth factor (VEGF) is relevant for healthy pregnancy, and abnormalities in VEGF functions have been associated with hypertensive disorders of pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25234518"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "An imbalance of circulating angiogenic and antiangiogenic factors, including raised soluble fms-like tyrosine kinase-1 (sFlt-1) and decreased placental growth factor (PlGF), has been found in women diagnosed with preeclampsia and before clinical onset of the disease."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25230734"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "An imbalance of circulating angiogenic and antiangiogenic factors, including raised soluble fms-like tyrosine kinase-1 (sFlt-1) and decreased placental growth factor (PlGF), has been found in women diagnosed with preeclampsia and before clinical onset of the disease."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25230734"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GP2"}, "span_text": {"type": "literal", "value": "Two meta-analyses and a number of case-control and cohort studies have found associations between pre-eclampsia and lupus anticoagulant, anticardiolipin, and/or anti-\u03b22 glycoprotein I."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25228712"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CRMP1"}, "span_text": {"type": "literal", "value": "Expression of collapsin response mediator protein 1 in placenta of normal gestation and link to early-onset preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25194153"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HPSE"}, "span_text": {"type": "literal", "value": "Heparanase is over expressed in preeclamptic placentas compared to normal healthy controls, suggesting its role in the development of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25189635"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HPSE"}, "span_text": {"type": "literal", "value": "We aimed to evaluate heparanase expression in placentas of preeclamptic patients."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25189635"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HPSE"}, "span_text": {"type": "literal", "value": "Placental tissue samples were collected immediately after delivery from 9 preeclamptic patients and 3 healthy controls at term, and were analyzed by immunohistochemistry, western blot analysis and real-time PCR, with regard to the presence of heparanase."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25189635"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "To investigate the prediction of preeclampsia and gestational hypertension using maternal characteristics, mean arterial pressure (MAP), uterine artery pulsatility index (UtAPI), pregnancy-associated plasma protein-A (PAPP-A) and placental growth factor (PlGF) at gestational weeks 11-13 in a Scandinavian population with a medium to high prior risk for developing hypertensive disorders of pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25146367"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PLAC1"}, "span_text": {"type": "literal", "value": "To develop a model for prediction of late preeclampsia (PE; which develops at or after 34 weeks' gestation) based on maternal history and characteristics, mean arterial pressure (MAP), and circulating levels of mRNA for the placenta-specific 1 (PLAC1) gene in maternal plasma at 14-18 weeks' gestation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25138310"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TCF12"}, "span_text": {"type": "literal", "value": "We studied the effect of pre-eclampsia sera on the expression of placenta growth factor (PlGF), soluble fms-like tyrosine kinase-1 (sFlt-1), metal-responsive transcription factor-1 (MTF-1), heme oxygenase 1 (HO-1) and hypoxia inducible factor-1\u03b1 (HIF-1\u03b1) mRNAs in JEG-3 cells (trophoblast-derived cells) and placenta from pre-eclampsia patients to investigate pre-eclampsia pathophysiology."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25132343"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TCF19"}, "span_text": {"type": "literal", "value": "Expression of placenta growth factor, soluble fms-like tyrosine kinase-1, metal-responsive transcription factor-1, heme oxygenase 1 and hypoxia inducible factor-1\u03b1 mRNAs in pre-eclampsia placenta and the effect of pre-eclampsia sera on their expression of choriocarcinoma cells."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25132343"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TCF19"}, "span_text": {"type": "literal", "value": "We studied the effect of pre-eclampsia sera on the expression of placenta growth factor (PlGF), soluble fms-like tyrosine kinase-1 (sFlt-1), metal-responsive transcription factor-1 (MTF-1), heme oxygenase 1 (HO-1) and hypoxia inducible factor-1\u03b1 (HIF-1\u03b1) mRNAs in JEG-3 cells (trophoblast-derived cells) and placenta from pre-eclampsia patients to investigate pre-eclampsia pathophysiology."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25132343"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TCF15"}, "span_text": {"type": "literal", "value": "We studied the effect of pre-eclampsia sera on the expression of placenta growth factor (PlGF), soluble fms-like tyrosine kinase-1 (sFlt-1), metal-responsive transcription factor-1 (MTF-1), heme oxygenase 1 (HO-1) and hypoxia inducible factor-1\u03b1 (HIF-1\u03b1) mRNAs in JEG-3 cells (trophoblast-derived cells) and placenta from pre-eclampsia patients to investigate pre-eclampsia pathophysiology."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25132343"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HMOX1"}, "span_text": {"type": "literal", "value": "Expression of placenta growth factor, soluble fms-like tyrosine kinase-1, metal-responsive transcription factor-1, heme oxygenase 1 and hypoxia inducible factor-1\u03b1 mRNAs in pre-eclampsia placenta and the effect of pre-eclampsia sera on their expression of choriocarcinoma cells."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25132343"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HMOX1"}, "span_text": {"type": "literal", "value": "We studied the effect of pre-eclampsia sera on the expression of placenta growth factor (PlGF), soluble fms-like tyrosine kinase-1 (sFlt-1), metal-responsive transcription factor-1 (MTF-1), heme oxygenase 1 (HO-1) and hypoxia inducible factor-1\u03b1 (HIF-1\u03b1) mRNAs in JEG-3 cells (trophoblast-derived cells) and placenta from pre-eclampsia patients to investigate pre-eclampsia pathophysiology."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25132343"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TCF12"}, "span_text": {"type": "literal", "value": "Expression of placenta growth factor, soluble fms-like tyrosine kinase-1, metal-responsive transcription factor-1, heme oxygenase 1 and hypoxia inducible factor-1\u03b1 mRNAs in pre-eclampsia placenta and the effect of pre-eclampsia sera on their expression of choriocarcinoma cells."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25132343"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "We studied the effect of pre-eclampsia sera on the expression of placenta growth factor (PlGF), soluble fms-like tyrosine kinase-1 (sFlt-1), metal-responsive transcription factor-1 (MTF-1), heme oxygenase 1 (HO-1) and hypoxia inducible factor-1\u03b1 (HIF-1\u03b1) mRNAs in JEG-3 cells (trophoblast-derived cells) and placenta from pre-eclampsia patients to investigate pre-eclampsia pathophysiology."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25132343"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TCF15"}, "span_text": {"type": "literal", "value": "Expression of placenta growth factor, soluble fms-like tyrosine kinase-1, metal-responsive transcription factor-1, heme oxygenase 1 and hypoxia inducible factor-1\u03b1 mRNAs in pre-eclampsia placenta and the effect of pre-eclampsia sera on their expression of choriocarcinoma cells."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25132343"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Expression of placenta growth factor, soluble fms-like tyrosine kinase-1, metal-responsive transcription factor-1, heme oxygenase 1 and hypoxia inducible factor-1\u03b1 mRNAs in pre-eclampsia placenta and the effect of pre-eclampsia sera on their expression of choriocarcinoma cells."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25132343"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD1"}, "span_text": {"type": "literal", "value": "There was an increased oxidative stress in pre-eclampsia as evidenced also by low serum level of superoxide dismutase in the third trimester.Diet rich in antioxidant enzyme might be beneficial."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25126869"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD3"}, "span_text": {"type": "literal", "value": "There was an increased oxidative stress in pre-eclampsia as evidenced also by low serum level of superoxide dismutase in the third trimester.Diet rich in antioxidant enzyme might be beneficial."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25126869"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ANG"}, "span_text": {"type": "literal", "value": "A predictive model of early-onset preeclampsia included angiogenin/placental growth factor as a ratio, mean arterial pressure, any pregnancy loss <10 weeks, and mean uterine artery resistance index (area under the receiver operator curve [95% confidence interval] in training and validation cohorts, 0.89 [0.78-1.0] and 0.78 [0.58-0.99], respectively)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25122928"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "The final model for the prediction of preeclampsia included placental growth factor, mean arterial pressure, and body mass index at 14 to 16 weeks' gestation, the consumption of \u22653 pieces of fruit per day, and mean uterine artery resistance index."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25122928"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "A predictive model of early-onset preeclampsia included angiogenin/placental growth factor as a ratio, mean arterial pressure, any pregnancy loss <10 weeks, and mean uterine artery resistance index (area under the receiver operator curve [95% confidence interval] in training and validation cohorts, 0.89 [0.78-1.0] and 0.78 [0.58-0.99], respectively)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25122928"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "The impact of obesity, maternal age 35 years or more, pre-eclampsia and insulin dependent diabetes on severe maternal morbidity (all severe complications, severe infections and severe) was studied in each mode of delivery and calculated as Odds ratios."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25115277"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "The impact of maternal obesity, age, pre-eclampsia and insulin dependent diabetes on severe maternal morbidity by mode of delivery-a register-based cohort study."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25115277"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HMOX1"}, "span_text": {"type": "literal", "value": "Increased serum heme oxygenase-1 levels as a diagnostic marker of oxidative stress in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25110805"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HPSE"}, "span_text": {"type": "literal", "value": "The results showed that dermatan sulfate (P=0.019), heparan sulfate levels (P=0.015) and heparanase activity (P=0.006) in preeclampsia were significantly higher than in the control group."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25083812"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HPSE"}, "span_text": {"type": "literal", "value": "Evaluation of glycosaminoglycans and heparanase in placentas of women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25083812"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HPSE"}, "span_text": {"type": "literal", "value": "We identified, quantified glycosaminoglycans and determined the enzymatic activity of heparanase in placentas of women with preeclampsia, in order to possibly explain if these compounds could be related to cellular processes involved with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25083812"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HPSE"}, "span_text": {"type": "literal", "value": "Alterations of extracellular matrix components in placentas with preeclampsia raise the possibility that heparan sulfate released by heparanase is involved in mechanisms of preeclampsia development."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25083812"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PLAC1"}, "span_text": {"type": "literal", "value": "Placental protein 13 (PP13), a placenta specific protein, is reduced in the first trimester of pregnancy in women who subsequently develop preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25079598"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PLAC4"}, "span_text": {"type": "literal", "value": "Placental protein 13 (PP13), a placenta specific protein, is reduced in the first trimester of pregnancy in women who subsequently develop preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25079598"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PLAC8"}, "span_text": {"type": "literal", "value": "Placental protein 13 (PP13), a placenta specific protein, is reduced in the first trimester of pregnancy in women who subsequently develop preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25079598"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PLAC9"}, "span_text": {"type": "literal", "value": "Placental protein 13 (PP13), a placenta specific protein, is reduced in the first trimester of pregnancy in women who subsequently develop preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25079598"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Falling insulin requirements were associated with an increased risk of preeclampsia (OR 3.5 [1.1-10.7], P < 0.05) and the composite of clinical markers of placental dysfunction (4.4 [1.73-11.26], P = 0.002)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25071078"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APLN"}, "span_text": {"type": "literal", "value": "On the other hand, maternal serum YKL-40 levels are not elavated significantly, indicating that adipose-derived apelin is primarily involved in the vascular pathogenesis of early-onset pre-eclampsia than macrophage-derived YKL-40."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25068525"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APLN"}, "span_text": {"type": "literal", "value": "Mean maternal serum apelin levels were both higher in women who subsequently developed early (8.6\u2009\u00b1\u20093.6 versus 5.7\u2009\u00b1\u20091.2) or late (9.6\u2009\u00b1\u20092.5 versus 8.1\u2009\u00b1\u20091.8) pre-eclampsia than those who remained normotensive."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25068525"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APLN"}, "span_text": {"type": "literal", "value": "The aim of the present study is to investigate whether alterations in the serum levels of apelin and YKL-40 differ between early and late onset pre-eclampsia and whether there is a correlation between apelin and YKL-40 in women who subsequently develop early and late pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25068525"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APLN"}, "span_text": {"type": "literal", "value": "Maternal serum apelin and YKL-40 levels in early and late-onset pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25068525"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APLN"}, "span_text": {"type": "literal", "value": "Circulating levels of apelin are significantly increased in early-onset pre-eclampsia, indicating the role of apelin in the discrimination of the early-onset of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25068525"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Adipokines and specifically leptin are known to be dysregulated in preeclampsia, but little is known regarding their regulation by miRNAs during pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25064070"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Placental miR-1301 is dysregulated in early-onset preeclampsia and inversely correlated with maternal circulating leptin."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25064070"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "CONCLUSIONS: miR-1301 is dysregulated in early-onset preeclampsia and could possibly play a role in the regulation of leptin during pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25064070"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOM"}, "span_text": {"type": "literal", "value": "Serum levels of apolipoprotein A-I, A-II and HDL-cholesterol in second half of normal pregnancy and in pregnancy complicated by pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/2506119"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOO"}, "span_text": {"type": "literal", "value": "Serum levels of apolipoprotein A-I, A-II and HDL-cholesterol in second half of normal pregnancy and in pregnancy complicated by pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/2506119"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Serum concentrations of Apolipoprotein A-I and A-II, (Apo A-1 and Apo A-II) HDL-cholesterol (HDL-C), Total Cholesterol (TC), triglycerides (TG) and lipoprotein electrophoresis were assayed serially in the second half of normal pregnancy (21 women), in pre-eclampsia (26 women) and in both groups one and six weeks after delivery."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/2506119"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOF"}, "span_text": {"type": "literal", "value": "Serum levels of apolipoprotein A-I, A-II and HDL-cholesterol in second half of normal pregnancy and in pregnancy complicated by pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/2506119"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOE"}, "span_text": {"type": "literal", "value": "Serum levels of apolipoprotein A-I, A-II and HDL-cholesterol in second half of normal pregnancy and in pregnancy complicated by pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/2506119"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL18"}, "span_text": {"type": "literal", "value": "Interleukin-18 and interferon gamma levels in preeclampsia: a systematic review and meta-analysis."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25060131"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL18"}, "span_text": {"type": "literal", "value": "This systematic review and meta-analysis aimed to investigate the relationship between preeclampsia (PE) and circulating interleukin-18 (IL-18) and interferon gamma (IFN-\u03b3)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25060131"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:OXSR1"}, "span_text": {"type": "literal", "value": "Abnormal oxidative stress responses in fibroblasts from preeclampsia infants."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25058409"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ANGPT1"}, "span_text": {"type": "literal", "value": "To investigate the placental expression of angiopoietin (Ang)-1, Ang-2 and their receptor, Tie-2, in preeclampsia (PE) with or without intrauterine growth restriction (IUGR)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25047691"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FST"}, "span_text": {"type": "literal", "value": "To assess the effects of activin on endothelial cell function, we cultured human umbilical vein endothelial cells in the presence of activin or serum from normal pregnant women or pregnant women with preeclampsia, with or without follistatin, a functional activin antagonist or apocynin, a NADPH oxidase (Nox2) inhibitor."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25046804"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "Last, we assessed endothelial cell Nox2 and nitric oxide synthase expression in normal pregnant women and pregnant women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25046804"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "We find that MR-proADM plasma concentrations are blunted in severe preeclampsia and that MR-proADM is similarly effective as established biomarkers endoglin and placental growth factor at discriminating patients with severe preeclampsia from controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25043691"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "We find that MR-proADM plasma concentrations are blunted in severe preeclampsia and that MR-proADM is similarly effective as established biomarkers endoglin and placental growth factor at discriminating patients with severe preeclampsia from controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25043691"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSEN1"}, "span_text": {"type": "literal", "value": "The human placenta abundantly expresses APP along with prototype APP-processing enzymes, of which the \u03b1-secretase ADAM10, the \u03b2-secretases BACE1 and BACE2, and the \u03b3-secretase presenilin-1 were all up-regulated in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25031267"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CP"}, "span_text": {"type": "literal", "value": "In the first attempt to characterize the preeclampsia misfoldome, we report that the urine congophilic material includes proteoforms of ceruloplasmin, immunoglobulin free light chains, SERPINA1, albumin, interferon-inducible protein 6-16, and Alzheimer's \u03b2-amyloid."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25031267"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "In the first attempt to characterize the preeclampsia misfoldome, we report that the urine congophilic material includes proteoforms of ceruloplasmin, immunoglobulin free light chains, SERPINA1, albumin, interferon-inducible protein 6-16, and Alzheimer's \u03b2-amyloid."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25031267"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:F5"}, "span_text": {"type": "literal", "value": "Meta-analysis showed a higher risk of severe preeclampsia with coagulation factor V gene (proaccelerin, labile factor) (F5) polymorphism rs6025 (odds ratio = 1.90, 95% confidence interval:"}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25028703"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "To evaluate the levels of salivary and serum IMA and IMA: albumin ratio (IMAR) in preeclampsia and with its severity and investigate their correlation with the fetal birth weight."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25019475"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL4"}, "span_text": {"type": "literal", "value": "An association study of interleukin-4 gene and preeclampsia in Taiwan."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25017270"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL4"}, "span_text": {"type": "literal", "value": "To test whether the interleukin-4 (IL-4) gene polymorphisms could be used as markers of susceptibility for preeclampsia in Taiwan."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25017270"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "As preeclampsia is associated with specific renal pathology including podocyte injury, early urinary podocyte (podocyturia), or the podocyte specific proteinuria nephrin in the urine (nephrinuria), as well as the more easily measured urinary albumin (albuminuria), have all been suggested as predictive markers."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25010746"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "To analyze the influence of maternal/newborn vascular endothelial growth factor (VEGF)-CT936 interaction as a modulating factor in preeclampsia as well as its influence on the maternal angiogenic balance."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25007988"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "To analyze the influence of maternal/newborn vascular endothelial growth factor (VEGF)-CT936 interaction as a modulating factor in preeclampsia as well as its influence on the maternal angiogenic balance."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25007988"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "To analyze the influence of maternal/newborn vascular endothelial growth factor (VEGF)-CT936 interaction as a modulating factor in preeclampsia as well as its influence on the maternal angiogenic balance."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25007988"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "To characterize the values of the soluble fms-like tyrosine kinase-1 (sFlt-1) to placental growth factor (PlGF) ratio in pregnancies with fetal growth restriction with or without concurrent preeclampsia or hemolysis, elevated liver enzymes and low platelets syndrome (HELLP) and in pregnancies with normally grown fetuses with or without concurrent preeclampsia or HELLP."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25004342"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AVP"}, "span_text": {"type": "literal", "value": "Because other nonpregnant low-renin hypertensive disorders often exhibit and are occasionally dependent on elevated arginine vasopressin (AVP) secretion, we hypothesized a possible use for plasma AVP measurements in the prediction of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/25001273"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TLR4"}, "span_text": {"type": "literal", "value": "The toll-like receptor-4 (TLR-4) and factor V Leiden mutation participate both in development of preeclampsia and the HELLP syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24991435"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TCF4"}, "span_text": {"type": "literal", "value": "Our objective was to examine whether abnormal expression of the cardiovascular developmental transcription factor, Nkx2-5, was associated with early onset and severe preeclampsia (EOSPE)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24987805"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SF1"}, "span_text": {"type": "literal", "value": "Nkx2-5 mRNA expression is highly correlated (Caucasians\u2009>\u2009African Americans) to mRNA expression of the preeclampsia marker sFlt-1, and of the Nkx2-5 target and RNA splicing factor, Sam68."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24987805"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:KCMF1"}, "span_text": {"type": "literal", "value": "MicroRNA-210 contributes to preeclampsia by downregulating potassium channel modulatory factor 1."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24980667"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:KCMF1"}, "span_text": {"type": "literal", "value": "In this study, miR-210 and potassium channel modulatory factor 1 (KCMF1) expressions were compared in placentas from healthy pregnant individuals and patients with preeclampsia, and the role of miR-210 in trophoblast cell invasion via the downregulation of KCMF1 was investigated in the immortal trophoblast cell line HTR8/SVneo."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24980667"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGTR1"}, "span_text": {"type": "literal", "value": "It is not known whether or not this risk is associated with angiotensin II receptor type 1 autoantibody (AT1-AA), an agonist acting via activation of AT1 receptor (AT1R), which is believed to be involved in the pathogenesis of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24979132"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL10"}, "span_text": {"type": "literal", "value": "Interleukin 10 gene promoter polymorphisms in women with early-onset pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24962617"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LVRN"}, "span_text": {"type": "literal", "value": "Placental expression of aminopeptidase-Q (laeverin) and its role in the pathophysiology of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24959655"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "Analysis of urinary markers revealed higher excretion of albumin and kidney injury molecule-1 and lower excretion of neutrophil gelatinase-associated lipocalin and epithelial growth factor in severe preeclampsia compared with chronic hypertension and healthy controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24958504"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:BDNF"}, "span_text": {"type": "literal", "value": "Levels of brain derived neurotrophic factors across gestation in women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24955870"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Among mothers with mild or moderate preeclampsia, levels of glucose, insulin, and homeostasis assessment model for insulin resistance were higher than in the nonpreeclampsia group and also higher compared with mothers with severe preeclampsia (all P < .05)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24949538"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL15"}, "span_text": {"type": "literal", "value": "Role of decidual natural killer cells, interleukin-15, and interferon-\u03b3 in placental development and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24920727"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "In this study, we evaluated serum levels of an angiogenic factor and an antiangiogenic factor - placental growth factor (PlGF) and soluble fms-like tyrosine kinase 1 (sFlt-1), respectively - in pregnant women with preeclampsia, as well as evaluating the impact of those factors on maternal and fetal outcomes."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24916790"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "In this study, we evaluated serum levels of an angiogenic factor and an antiangiogenic factor - placental growth factor (PlGF) and soluble fms-like tyrosine kinase 1 (sFlt-1), respectively - in pregnant women with preeclampsia, as well as evaluating the impact of those factors on maternal and fetal outcomes."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24916790"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:OLR1"}, "span_text": {"type": "literal", "value": "The main purpose of this study was to determine the maternal and umbilical cord blood oxidized LDL (oxLDL) and soluble lectin-like oxidized low-density lipoprotein receptor-1 (sLOX-1) levels in early- and late-onset preeclampsia (PE)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24916561"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:OLR1"}, "span_text": {"type": "literal", "value": "Comparison of maternal and umbilical cord blood soluble lectin-like oxidized low-density lipoprotein receptor 1 levels in early- and late-onset preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24916561"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF2"}, "span_text": {"type": "literal", "value": "Expression of insulin-like growth factors in the placenta in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24915949"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF1"}, "span_text": {"type": "literal", "value": "Expression of insulin-like growth factors in the placenta in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24915949"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Longitudinal changes in maternal soluble endoglin and angiopoietin-2 in women at risk for pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24913462"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "To investigate longitudinal changes in maternal plasma levels of soluble endoglin (sEng) and angiopoietin-2 (Ang-2) in pregnant women who develop pre-eclampsia (PE) and gestational hypertension (GH)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24913462"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Simple linear regression analysis showed that in patients with preeclampsia the serum concentrations of omentin-1 showed significant correlation with body mass index (P\u2009<\u20090.001), systolic blood pressure (P\u2009<\u20090.05) and homeostasis model assessment of insulin resistance (P\u2009<\u20090.001)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24912760"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "To assess the risk for preeclampsia (PE) by maternal characteristics, uterine artery pulsatility index (Ut-PI), mean arterial pressure (MAP), serum placental growth factor (PlGF) and soluble fms-like tyrosine kinase-1 (sFlt-1) at 30-33 weeks' gestation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24902880"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF2"}, "span_text": {"type": "literal", "value": "In contrast to placental growth factor, soluble endoglin, and insulin-like growth factor acid labile subunit, levels of metallopeptidase domain 12 (ADAM12) at 20 weeks were dependent on fetal gender in pregnancies complicated by preeclampsia, for male (n = 73) fetuses the multiples of the median (MoM; interquartile range [IQR] 1.1-1.5) was 1.3, whereas for female fetuses (n = 75) MoM was 1.1 (1.0-1.3); P < .01."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24899472"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "In contrast to placental growth factor, soluble endoglin, and insulin-like growth factor acid labile subunit, levels of metallopeptidase domain 12 (ADAM12) at 20 weeks were dependent on fetal gender in pregnancies complicated by preeclampsia, for male (n = 73) fetuses the multiples of the median (MoM; interquartile range [IQR] 1.1-1.5) was 1.3, whereas for female fetuses (n = 75) MoM was 1.1 (1.0-1.3); P < .01."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24899472"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF1"}, "span_text": {"type": "literal", "value": "In contrast to placental growth factor, soluble endoglin, and insulin-like growth factor acid labile subunit, levels of metallopeptidase domain 12 (ADAM12) at 20 weeks were dependent on fetal gender in pregnancies complicated by preeclampsia, for male (n = 73) fetuses the multiples of the median (MoM; interquartile range [IQR] 1.1-1.5) was 1.3, whereas for female fetuses (n = 75) MoM was 1.1 (1.0-1.3); P < .01."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24899472"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "In contrast to placental growth factor, soluble endoglin, and insulin-like growth factor acid labile subunit, levels of metallopeptidase domain 12 (ADAM12) at 20 weeks were dependent on fetal gender in pregnancies complicated by preeclampsia, for male (n = 73) fetuses the multiples of the median (MoM; interquartile range [IQR] 1.1-1.5) was 1.3, whereas for female fetuses (n = 75) MoM was 1.1 (1.0-1.3); P < .01."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24899472"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MTHFR"}, "span_text": {"type": "literal", "value": "To determine whether methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms are associated with pre-eclampsia susceptibility."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24898880"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MTHFR"}, "span_text": {"type": "literal", "value": "Methylenetetrahydrofolate reductase gene C677T, A1298C polymorphisms and pre-eclampsia risk: a meta-analysis."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24898880"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HMOX2"}, "span_text": {"type": "literal", "value": "Early preclinical and clinical studies have associated defects in the heme oxygenase with the obstetrical complication preeclampsia, as well as failure to establish adequate placental blood flow, an underlying mechanism of the disorder."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24898840"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HMOX2"}, "span_text": {"type": "literal", "value": "The heme oxygenases: important regulators of pregnancy and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24898840"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HMOX1"}, "span_text": {"type": "literal", "value": "This review will summarize the role of heme oxygenases in pregnancy and highlight their potential in advancing the management of patients with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24898840"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HMOX1"}, "span_text": {"type": "literal", "value": "The heme oxygenases: important regulators of pregnancy and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24898840"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HMOX2"}, "span_text": {"type": "literal", "value": "Several recent preclinical studies have suggested, however, that the heme oxygenase system could serve as a valuable therapeutic tool for the management of preeclampsia, which currently has few pharmacological options."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24898840"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HMOX1"}, "span_text": {"type": "literal", "value": "Early preclinical and clinical studies have associated defects in the heme oxygenase with the obstetrical complication preeclampsia, as well as failure to establish adequate placental blood flow, an underlying mechanism of the disorder."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24898840"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HMOX1"}, "span_text": {"type": "literal", "value": "Several recent preclinical studies have suggested, however, that the heme oxygenase system could serve as a valuable therapeutic tool for the management of preeclampsia, which currently has few pharmacological options."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24898840"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HMOX2"}, "span_text": {"type": "literal", "value": "This review will summarize the role of heme oxygenases in pregnancy and highlight their potential in advancing the management of patients with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24898840"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TFAP4"}, "span_text": {"type": "literal", "value": "Analysis of other relevant gene expression and gene regulatory network data also underscored the involvement of transcription pathways and identified JUNB and JUND (components of transcription factor AP-1) as transcription regulators of the network involving the TTD genes, GTF2E1, and selected gene regulators implicated in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24885447"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "To investigate the functionality of A2B adenosine receptor (A2BAR) and the nitric oxide (NO) and vascular endothelial growth factor (VEGF) signaling pathway in the endothelial cell proliferation/migration during preeclampsia, we used human umbilical vein endothelial cells (HUVECs) isolated from normal pregnancies (n = 15) or pregnancies with preeclampsia (n = 15)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24877077"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "To investigate the functionality of A2B adenosine receptor (A2BAR) and the nitric oxide (NO) and vascular endothelial growth factor (VEGF) signaling pathway in the endothelial cell proliferation/migration during preeclampsia, we used human umbilical vein endothelial cells (HUVECs) isolated from normal pregnancies (n = 15) or pregnancies with preeclampsia (n = 15)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24877077"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "To investigate the functionality of A2B adenosine receptor (A2BAR) and the nitric oxide (NO) and vascular endothelial growth factor (VEGF) signaling pathway in the endothelial cell proliferation/migration during preeclampsia, we used human umbilical vein endothelial cells (HUVECs) isolated from normal pregnancies (n = 15) or pregnancies with preeclampsia (n = 15)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24877077"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "On postpartum day one, 98 subjects (44 with preeclampsia, 54 controls) were recruited among women admitted to the postdelivery unit, and their serum 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, parathyroid hormone, serum calcium, and serum albumin levels were prospectively measured."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24853885"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "To assess the risk for preeclampsia (PE) by maternal characteristics, serum placental growth factor (PlGF) and soluble fms-like tyrosine kinase-1 (sFlt-1) at 30-33 weeks' gestation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24853452"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Competing risks model in screening for preeclampsia by serum placental growth factor and soluble fms-like tyrosine kinase-1 at 30-33 weeks' gestation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24853452"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Competing risks model in screening for preeclampsia by serum placental growth factor and soluble fms-like tyrosine kinase-1 at 30-33 weeks' gestation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24853452"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Soluble endoglin, transforming growth factor-Beta 1 and soluble tumor necrosis factor alpha receptors in different clinical manifestations of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24851923"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGFB1"}, "span_text": {"type": "literal", "value": "Soluble endoglin, transforming growth factor-Beta 1 and soluble tumor necrosis factor alpha receptors in different clinical manifestations of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24851923"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Edaravone inhibits hypoxia-induced trophoblast-soluble Fms-like tyrosine kinase 1 expression: a possible therapeutic approach to preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24840734"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VCAM1"}, "span_text": {"type": "literal", "value": "The aim of this study was to determine chemerin levels in preeclampsia and to assess the effects of this anti-inflammatory factor on endothelial nitric oxide synthase (eNOS), nuclear factor (NF)-\u03baB, and vascular cell adhesion molecule (VCAM) expression in human umbilical vein endothelial cells (HUVECs)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24840719"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "First, measurements of protein fractions were performed in sera from early-onset, severely preeclamptic women without HELLP syndrome, in which there was no significant difference in total proteins between the groups, but a reduced level of plasma albumin and an increase in \u03b11-globulin were observed in both groups of pregnant women compared with non-pregnant women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24837231"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGFB1"}, "span_text": {"type": "literal", "value": "Transforming growth factor-beta 1 (TGF-\u03b21) is thought to be involved in the pathogenesis of preeclampsia (PE), but the results are inconsistent among studies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24823830"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGFB1"}, "span_text": {"type": "literal", "value": "Polymorphisms and plasma level of transforming growth factor-Beta 1 and risk for preeclampsia: a systematic review."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24823830"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Their fasting blood glucose and insulin were also measured after diagnosis of preeclampsia by 20 weeks of pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24812607"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Estimating rate of insulin resistance in patients with preeclampsia using HOMA-IR index and comparison with nonpreeclampsia pregnant women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24812607"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TFPI2"}, "span_text": {"type": "literal", "value": "Tissue factor and tissue factor pathway inhibitor in women with a past history of preeclampsia: implication for a hypercoagulable state postpregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24806321"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TFPI"}, "span_text": {"type": "literal", "value": "Tissue factor and tissue factor pathway inhibitor in women with a past history of preeclampsia: implication for a hypercoagulable state postpregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24806321"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "MicroRNA-155 inhibits migration of trophoblast cells and contributes to the pathogenesis of severe preeclampsia by regulating endothelial nitric oxide synthase."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24806148"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ERP44"}, "span_text": {"type": "literal", "value": "To investigate a possible association between miR-101 and apoptosis of human trophoblast cells mediated by endoplasmic reticulum protein 44 (ERp44) in preeclampsia (PE), we explored the expression of miR-101 in PE placentas (n=30) compared with normotensive pregnant placentas (n=30) and the correlation between miR-101 and ERp44 was also analyzed."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24804790"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HMOX1"}, "span_text": {"type": "literal", "value": "Microsatellite polymorphism in the heme oxygenase-1 promoter is associated with nonsevere and late-onset preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24799610"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Differences between those who did and did not develop preeclampsia were noted in vascular cell adhesion molecule in the diabetes group; human chorionic gonadotropin, soluble tumor necrosis factor receptor-2, tumor necrosis factor-alpha, selectin and angiogenin in the chronic hypertension group; interleukin-6, placental growth factor, soluble fms-like tyrosine kinase plus endoglin to placental growth factor ratio in the multiple gestation group; and angiogenin in the previous preeclampsia group."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24769011"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL6"}, "span_text": {"type": "literal", "value": "Differences between those who did and did not develop preeclampsia were noted in vascular cell adhesion molecule in the diabetes group; human chorionic gonadotropin, soluble tumor necrosis factor receptor-2, tumor necrosis factor-alpha, selectin and angiogenin in the chronic hypertension group; interleukin-6, placental growth factor, soluble fms-like tyrosine kinase plus endoglin to placental growth factor ratio in the multiple gestation group; and angiogenin in the previous preeclampsia group."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24769011"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Differences between those who did and did not develop preeclampsia were noted in vascular cell adhesion molecule in the diabetes group; human chorionic gonadotropin, soluble tumor necrosis factor receptor-2, tumor necrosis factor-alpha, selectin and angiogenin in the chronic hypertension group; interleukin-6, placental growth factor, soluble fms-like tyrosine kinase plus endoglin to placental growth factor ratio in the multiple gestation group; and angiogenin in the previous preeclampsia group."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24769011"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ANG"}, "span_text": {"type": "literal", "value": "Differences between those who did and did not develop preeclampsia were noted in vascular cell adhesion molecule in the diabetes group; human chorionic gonadotropin, soluble tumor necrosis factor receptor-2, tumor necrosis factor-alpha, selectin and angiogenin in the chronic hypertension group; interleukin-6, placental growth factor, soluble fms-like tyrosine kinase plus endoglin to placental growth factor ratio in the multiple gestation group; and angiogenin in the previous preeclampsia group."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24769011"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VCAM1"}, "span_text": {"type": "literal", "value": "Differences between those who did and did not develop preeclampsia were noted in vascular cell adhesion molecule in the diabetes group; human chorionic gonadotropin, soluble tumor necrosis factor receptor-2, tumor necrosis factor-alpha, selectin and angiogenin in the chronic hypertension group; interleukin-6, placental growth factor, soluble fms-like tyrosine kinase plus endoglin to placental growth factor ratio in the multiple gestation group; and angiogenin in the previous preeclampsia group."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24769011"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Differences between those who did and did not develop preeclampsia were noted in vascular cell adhesion molecule in the diabetes group; human chorionic gonadotropin, soluble tumor necrosis factor receptor-2, tumor necrosis factor-alpha, selectin and angiogenin in the chronic hypertension group; interleukin-6, placental growth factor, soluble fms-like tyrosine kinase plus endoglin to placental growth factor ratio in the multiple gestation group; and angiogenin in the previous preeclampsia group."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24769011"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Serum soluble FMS-like tyrosine kinase 1 and placental growth factor concentration as predictors of preeclampsia in high risk pregnant women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24763231"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Soluble fms-like tyrosine kinase-1 (sFlt-1) and placental growth factor (PlGF) contribute in the development of preeclampsia and are suggested as prediction markers in healthy pregnant women but limited data is available in women with major preeclampsia risk factors."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24763231"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Serum soluble FMS-like tyrosine kinase 1 and placental growth factor concentration as predictors of preeclampsia in high risk pregnant women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24763231"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Role of maternal plasma levels of placental growth factor for the prediction of maternal complications in preeclampsia according to the gestational age at onset."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24752879"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "This study aimed to describe the distribution of placental growth factor (PlGF) plasma levels in pregnancies complicated by preeclampsia (PE) according to the gestational age at clinical onset and to assess PlGF's predictive role for maternal complications."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24752879"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CABP5"}, "span_text": {"type": "literal", "value": "In this work we compared the level, localization and binding partners of a calcium binding protein, S100A6, in extracellular matrix of Wharton's jelly of healthy and preeclamptic patients."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24746261"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TCF4"}, "span_text": {"type": "literal", "value": "Storkhead box 1 (STOX1) is a winged-helix transcription factor that is implicated in the genetic forms of a high-prevalence human gestational disease, pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24738702"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:STOX1"}, "span_text": {"type": "literal", "value": "Storkhead box 1 (STOX1) is a winged-helix transcription factor that is implicated in the genetic forms of a high-prevalence human gestational disease, pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24738702"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "How placental growth factor detection might improve diagnosis and management of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24724534"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FSTL3"}, "span_text": {"type": "literal", "value": "The purpose of this study was to examine circulating maternal follistatin-like 3 (FSTL-3) by gestational age and obesity in pregnancy and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24700053"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FSTL3"}, "span_text": {"type": "literal", "value": "Follistatin-like 3 across gestation in preeclampsia and uncomplicated pregnancies among lean and obese women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24700053"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD3"}, "span_text": {"type": "literal", "value": "The effects of superoxide dismutase mimetic MnTMPyP on the altered blood-brain barrier integrity in experimental preeclampsia with or without seizures in rats."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24680906"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD3"}, "span_text": {"type": "literal", "value": "We investigated the effects of a cell-permeable superoxide dismutase mimetic, manganese(III) tetrakis(1-methyl-4-pyridyl)porphyrin (MnTMPyP) on blood-brain barrier (BBB) integrity following pentylenetetrazole (PTZ)-induced seizures in experimental preeclampsia symptoms induced by N(omega)-nitro-l-arginine methyl ester (l-NAME) in pregnant rats."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24680906"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD1"}, "span_text": {"type": "literal", "value": "We investigated the effects of a cell-permeable superoxide dismutase mimetic, manganese(III) tetrakis(1-methyl-4-pyridyl)porphyrin (MnTMPyP) on blood-brain barrier (BBB) integrity following pentylenetetrazole (PTZ)-induced seizures in experimental preeclampsia symptoms induced by N(omega)-nitro-l-arginine methyl ester (l-NAME) in pregnant rats."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24680906"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD1"}, "span_text": {"type": "literal", "value": "The effects of superoxide dismutase mimetic MnTMPyP on the altered blood-brain barrier integrity in experimental preeclampsia with or without seizures in rats."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24680906"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Angiogenic marker levels, including placental growth factor, soluble vascular endothelial growth factor receptor fms-like tyrosine kinase receptor-1 and endoglin, were not significantly different between women with preeclampsia and women with a normotensive pregnancy, either at delivery or postpartum."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24664365"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Angiogenic marker levels, including placental growth factor, soluble vascular endothelial growth factor receptor fms-like tyrosine kinase receptor-1 and endoglin, were not significantly different between women with preeclampsia and women with a normotensive pregnancy, either at delivery or postpartum."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24664365"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Angiogenic marker levels, including placental growth factor, soluble vascular endothelial growth factor receptor fms-like tyrosine kinase receptor-1 and endoglin, were not significantly different between women with preeclampsia and women with a normotensive pregnancy, either at delivery or postpartum."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24664365"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Angiogenic marker levels, including placental growth factor, soluble vascular endothelial growth factor receptor fms-like tyrosine kinase receptor-1 and endoglin, were not significantly different between women with preeclampsia and women with a normotensive pregnancy, either at delivery or postpartum."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24664365"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Angiogenic marker levels, including placental growth factor, soluble vascular endothelial growth factor receptor fms-like tyrosine kinase receptor-1 and endoglin, were not significantly different between women with preeclampsia and women with a normotensive pregnancy, either at delivery or postpartum."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24664365"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Angiogenic marker levels, including placental growth factor, soluble vascular endothelial growth factor receptor fms-like tyrosine kinase receptor-1 and endoglin, were not significantly different between women with preeclampsia and women with a normotensive pregnancy, either at delivery or postpartum."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24664365"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TLR4"}, "span_text": {"type": "literal", "value": "Fibrinogen, an endogenous ligand of Toll-like receptor 4, activates monocytes in pre-eclamptic patients."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24661950"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "Orchestrating the organizers: catechol-O-methyltransferase and endothelial nitric oxide synthase stress in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24648026"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:COMT"}, "span_text": {"type": "literal", "value": "Orchestrating the organizers: catechol-O-methyltransferase and endothelial nitric oxide synthase stress in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24648026"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "To compare the maternal serum concentrations of placental growth factor (PlGF)-1 and PlGF-2 in the first, second and third trimesters in normal pregnancies and in those complicated by pre-eclampsia (PE) or the delivery of small for gestational age (SGA) neonates after 37 weeks."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24642536"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Maternal serum placental growth factor isoforms 1 and 2 at 11-13, 20-24 and 30-34 weeks' gestation in late-onset pre-eclampsia and small for gestational age neonates."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24642536"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "The preeclampsia serum spectra showed higher levels of low and very-low density lipoproteins and lower levels of high-density lipoproteins when compared to both non-pregnant and normal pregnant women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24637620"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AFP"}, "span_text": {"type": "literal", "value": "High levels of alpha fetoprotein (AFP), human chorionic gonadotropin, inhibin (multiple of the median, \u226595th percentile), and low unconjugated estriol (multiple of the median, \u22645th percentile), were associated with severe preeclampsia (relative risk, 2.5-11.7)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24631701"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Combination of plasma-soluble fms-like tyrosine kinase 1 and uterine artery Doppler for the prediction of preeclampsia in cases of elderly gravida."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24621465"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MTHFR"}, "span_text": {"type": "literal", "value": "Polymorphisms of the methylenetetrahydrofolate reductase gene (C677T and A1298C) in nulliparous women complicated with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24611473"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "We prospectively collected data regarding past history of PE/gestational hypertension (GH), blood pressure levels at 16-23 weeks and plasma levels of soluble fms-like tyrosine kinase 1 (sFlt-1) and placental growth factor (PlGF) twice at 19-31 weeks, which were measured using an automated electrochemiluminescence immunoassay."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24599015"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:RGS20"}, "span_text": {"type": "literal", "value": "We recently demonstrated an association between preeclampsia and the CG or GG genotype of the C1114G polymorphism (rs4606) of the regulator of G protein signaling 2 gene."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24593135"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:RGS21"}, "span_text": {"type": "literal", "value": "We recently demonstrated an association between preeclampsia and the CG or GG genotype of the C1114G polymorphism (rs4606) of the regulator of G protein signaling 2 gene."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24593135"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Different profile of serum leptin between early onset and late onset preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24591763"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "This study was designed to clarify the role of leptin and adiponectin in preeclampsia (PE) pathogenesis and different subtypes of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24591763"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "There was no difference in subcutaneous adipocyte lipolysis rates between preeclampsia and healthy controls, but subcutaneous adipocytes had lower sensitivity to insulin in preeclampsia, independent of cell diameter (P<0.05)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24591340"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Reduced insulin suppression of subcutaneous adipocyte lipolysis may increase the burden of plasma fatty acids that the mother has to process in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24591340"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "In preeclampsia, maternal third trimester subcutaneous adipocyte lipolysis is more resistant to suppression by insulin than in healthy pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24591340"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "The aim of present study was to assess the maternal serum endothelial nitric oxide synthase (eNOS), NOSTRIN (eNOS-trafficking inducer) and asymmetric dimethylarginine (ADMA) levels in pregnancies with intrauterine growth restriction (IUGR) in the presence or absence of preeclampsia and to compare the results with preeclamptic pregnant women with appropriate-for-gestational-age weight infants."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24588201"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Preeclamptic patients have increased soluble fms-like tyrosine kinase-1 and soluble endoglin serum levels and this increase is directly correlated with uterine artery resistance, especially in those with early-onset preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24580069"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Concentrations of soluble fms-like tyrosine kinase-1 and soluble endoglin were significantly higher in preeclamptic than control women (p < 0.0001 and p < 0.0001, respectively), especially in those with early-onset (<34 weeks) preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24580069"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Concentrations of soluble fms-like tyrosine kinase-1 and soluble endoglin were significantly higher in preeclamptic than control women (p < 0.0001 and p < 0.0001, respectively), especially in those with early-onset (<34 weeks) preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24580069"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Preeclamptic patients have increased soluble fms-like tyrosine kinase-1 and soluble endoglin serum levels and this increase is directly correlated with uterine artery resistance, especially in those with early-onset preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24580069"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "Polymorphisms of the endothelial nitric oxide synthase gene in preeclampsia in a Han Chinese population."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24577249"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "To study whether human chorionic gonadotropin concentrations during pregnancy or combinations of human chorionic gonadotropin and other angiogenic factors, soluble fms-like tyrosine kinase 1 and placental growth factor (PlGF), are associated with preeclampsia risk."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24575980"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "To study whether human chorionic gonadotropin concentrations during pregnancy or combinations of human chorionic gonadotropin and other angiogenic factors, soluble fms-like tyrosine kinase 1 and placental growth factor (PlGF), are associated with preeclampsia risk."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24575980"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Soluble Fms-like tyrosine kinase-1 to placental growth factor ratio in mid-pregnancy as a predictor of preterm preeclampsia in asymptomatic pregnant women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24535301"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Soluble Fms-like tyrosine kinase-1 to placental growth factor ratio in mid-pregnancy as a predictor of preterm preeclampsia in asymptomatic pregnant women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24535301"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "This study aims to evaluate the performance of the soluble Fms-like tyrosine kinase-1/placental growth factor (sFlt-1/PlGF) ratio to predict early-onset, preterm and severe preeclampsia at mid-pregnancy in asymptomatic women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24535301"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "This study aims to evaluate the performance of the soluble Fms-like tyrosine kinase-1/placental growth factor (sFlt-1/PlGF) ratio to predict early-onset, preterm and severe preeclampsia at mid-pregnancy in asymptomatic women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24535301"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LGALS7"}, "span_text": {"type": "literal", "value": "Galectin-7 serum concentration was significantly elevated in women (weeks 10-12 and 17-20) who subsequently developed pre-eclampsia compared to women with healthy pregnancies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24534543"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LGALS7"}, "span_text": {"type": "literal", "value": "Galectin-7 serum levels are altered prior to the onset of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24534543"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LGALS7"}, "span_text": {"type": "literal", "value": "Galectin-7 is a promising prospective serum biomarker for pre-eclampsia and likely has important functions in placentation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24534543"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGT"}, "span_text": {"type": "literal", "value": "The aim of this study is to investigate the relation between urinary angiotensinogen (UAGT) levels, an indicator of local renin-angiotensin system (RAS) activity in the kidney, and blood pressure and urinary protein excretion in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24532824"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGT"}, "span_text": {"type": "literal", "value": "Association between urinary angiotensinogen, hypertension and proteinuria in pregnant women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24532824"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HMOX1"}, "span_text": {"type": "literal", "value": "Heme oxygenase (Hmox) is an endogenous system that offers protection against placental cytotoxic damage associated with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24503248"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HMOX1"}, "span_text": {"type": "literal", "value": "Therapeutic potential of statins and the induction of heme oxygenase-1 in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24503248"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HMOX2"}, "span_text": {"type": "literal", "value": "Heme oxygenase (Hmox) is an endogenous system that offers protection against placental cytotoxic damage associated with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24503248"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Assessment of pregestational insulin resistance as a risk factor of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24480896"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FSTL3"}, "span_text": {"type": "literal", "value": "To determine whether serum Follistatin-like-3 was enhanced in second trimester of pregnant women who subsequently developed preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24475769"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FSTL3"}, "span_text": {"type": "literal", "value": "However, there was no significant difference of Follistatin-like-3 in women with mild or severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24475769"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FSTL3"}, "span_text": {"type": "literal", "value": "Serum Follistatin-like-3 was elevated in second trimester of pregnant women who subsequently developed preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24475769"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FSTL3"}, "span_text": {"type": "literal", "value": "Follistatin-like-3 was significantly elevated in preeclampsia group compared with control."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24475769"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FSTL3"}, "span_text": {"type": "literal", "value": "The elevation of Follistatin-like-3 was demonstrated in late second trimester of pregnancy destined to developing preeclampsia, suggesting its causal role in the pathogenesis and prediction of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24475769"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "We studied whether serum hCG-h at 14-17\u2009weeks of pregnancy also predicts preeclampsia alone or combined with placental growth factor (PlGF) and soluble vascular endothelial growth factor 1 (sVEGFR-1)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24464955"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Our primary objective was to establish a cutoff value for the soluble fms-like tyrosine kinase 1(sFlt-1)/placental growth factor (PlGF) ratio measured using the Elecsys assay to predict late-onset preeclampsia in low-risk pregnancies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24444293"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Soluble fms-like tyrosine kinase (sFlt-1) is an important mediator in the pathogenesis of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24440566"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "New insights into the pathogenesis of pre-eclampsia have revealed a major role for VEGF (vascular endothelial growth factor), VEGF-inactivating sFlt-1 (soluble fms-like tyrosine kinase-1) and AT1 (angiotensin II type 1) receptor autoantibodies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24400721"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "New insights into the pathogenesis of pre-eclampsia have revealed a major role for VEGF (vascular endothelial growth factor), VEGF-inactivating sFlt-1 (soluble fms-like tyrosine kinase-1) and AT1 (angiotensin II type 1) receptor autoantibodies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24400721"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "New insights into the pathogenesis of pre-eclampsia have revealed a major role for VEGF (vascular endothelial growth factor), VEGF-inactivating sFlt-1 (soluble fms-like tyrosine kinase-1) and AT1 (angiotensin II type 1) receptor autoantibodies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24400721"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "New insights into the pathogenesis of pre-eclampsia have revealed a major role for VEGF (vascular endothelial growth factor), VEGF-inactivating sFlt-1 (soluble fms-like tyrosine kinase-1) and AT1 (angiotensin II type 1) receptor autoantibodies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24400721"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "In women with pre-eclampsia, placental tissue overproduces two main anti-angiogenic proteins which enter into the maternal circulation: soluble Fms- such as tyrosine kinase 1 (sFlt1 or sVEGFR1) and soluble endoglin (sEng)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24389217"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NGF"}, "span_text": {"type": "literal", "value": "Milk nerve growth factor (NGF) levels were lower in preeclampsia group as compared to control group at 1.5 (20%) and 3.5 months (27.7%)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24374257"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:BDNF"}, "span_text": {"type": "literal", "value": "Milk brain derived neurotrophic factor (BDNF) levels were lower at 1.5 months (10.5%) in the preeclampsia group as compared to control group."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24374257"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "To assess whether glycemic control, soluble fms-like tyrosine kinase 1 (sFlt1) and placental growth factor (PlGF) were associated with the development of preeclampsia (PE) or gestational hypertension (GHTN) in women with preexisting diabetes."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24354578"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Differential expressions of stromal cell-derived factor-1\u03b1 and vascular endothelial growth factor in the placental bed of pregnancies complicated by preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24354491"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SDF2"}, "span_text": {"type": "literal", "value": "Differential expressions of stromal cell-derived factor-1\u03b1 and vascular endothelial growth factor in the placental bed of pregnancies complicated by preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24354491"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Differential expressions of stromal cell-derived factor-1\u03b1 and vascular endothelial growth factor in the placental bed of pregnancies complicated by preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24354491"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Differential expressions of stromal cell-derived factor-1\u03b1 and vascular endothelial growth factor in the placental bed of pregnancies complicated by preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24354491"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "The aim of this study is to examine the differential expression of stromal cell-derived factor-1\u03b1 (SDF-1\u03b1)/CXCR4 and vascular endothelial growth factor (VEGF) in the third trimester placental bed of normotensive controls and preeclamptic patients."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24354491"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "The aim of this study is to examine the differential expression of stromal cell-derived factor-1\u03b1 (SDF-1\u03b1)/CXCR4 and vascular endothelial growth factor (VEGF) in the third trimester placental bed of normotensive controls and preeclamptic patients."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24354491"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SDF4"}, "span_text": {"type": "literal", "value": "Differential expressions of stromal cell-derived factor-1\u03b1 and vascular endothelial growth factor in the placental bed of pregnancies complicated by preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24354491"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "The aim of this study is to examine the differential expression of stromal cell-derived factor-1\u03b1 (SDF-1\u03b1)/CXCR4 and vascular endothelial growth factor (VEGF) in the third trimester placental bed of normotensive controls and preeclamptic patients."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24354491"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOTCH2"}, "span_text": {"type": "literal", "value": "The results suggest that Notch2 and Notch3 may play some roles in the pathogenesis of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24336671"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOTCH2"}, "span_text": {"type": "literal", "value": "Western blotting showed a significant increase in Notch3 expression and a significant decrease in Notch2 expression in placentas from patients with early-onset severe preeclampsia relative to those in normal placentas."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24336671"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOTCH2"}, "span_text": {"type": "literal", "value": "Real-time RT-PCR showed that messenger RNA levels of Notch2 and Delta-like4 (Dll4) in placentas from patients with early-onset severe preeclampsia are lower than that of normal placentas."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24336671"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Accordingly, we further revealed that LIGHT functions through these 2 receptors to induce secretion of soluble fms-like tyrosine kinase-1 and endothelin-1, 2 well-accepted pathogenic factors in preeclampsia, and thereby plays an important role in hypertension and proteinuria in pregnant mice."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24324043"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Accordingly, we further revealed that LIGHT functions through these 2 receptors to induce secretion of soluble fms-like tyrosine kinase-1 and endothelin-1, 2 well-accepted pathogenic factors in preeclampsia, and thereby plays an important role in hypertension and proteinuria in pregnant mice."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24324043"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Relationship between nulliparity and preeclampsia may be explained by altered circulating soluble fms-like tyrosine kinase 1."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24304210"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AFP"}, "span_text": {"type": "literal", "value": "The identification of alpha-fetoprotein in preeclamptic umbilical cord blood plasma supported the validity of this screen as alpha-fetoprotein has anti-estrogenic properties and has previously been linked to preeclampsia as well as a reduced breast cancer risk."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24296084"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GSN"}, "span_text": {"type": "literal", "value": "Additionally, expression of 8 proteins (gelsolin, complement C5, keratin type I cytoskeletal 10, pigment epithelium-derived factor, complement factor B, complement component C7, hemoglobin subunit gamma-2 and alpha-fetoprotein) were up-regulated in preeclampsia with a fold change of \u22652.0 when compared to normotensive pregnancies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24296084"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:C5"}, "span_text": {"type": "literal", "value": "Additionally, expression of 8 proteins (gelsolin, complement C5, keratin type I cytoskeletal 10, pigment epithelium-derived factor, complement factor B, complement component C7, hemoglobin subunit gamma-2 and alpha-fetoprotein) were up-regulated in preeclampsia with a fold change of \u22652.0 when compared to normotensive pregnancies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24296084"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CFB"}, "span_text": {"type": "literal", "value": "Additionally, expression of 8 proteins (gelsolin, complement C5, keratin type I cytoskeletal 10, pigment epithelium-derived factor, complement factor B, complement component C7, hemoglobin subunit gamma-2 and alpha-fetoprotein) were up-regulated in preeclampsia with a fold change of \u22652.0 when compared to normotensive pregnancies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24296084"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CASC4"}, "span_text": {"type": "literal", "value": "The findings of this pilot study may provide new insights into the mechanistic link between preeclampsia and potentially reduced breast cancer susceptibility in adult life."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24296084"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AFP"}, "span_text": {"type": "literal", "value": "Additionally, expression of 8 proteins (gelsolin, complement C5, keratin type I cytoskeletal 10, pigment epithelium-derived factor, complement factor B, complement component C7, hemoglobin subunit gamma-2 and alpha-fetoprotein) were up-regulated in preeclampsia with a fold change of \u22652.0 when compared to normotensive pregnancies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24296084"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HMOX1"}, "span_text": {"type": "literal", "value": "To evaluate the peripheral blood mononuclear cell (PBMC) expression levels of hemeoxygenase 1 (HMOX-1), superoxide dismutase 1 (SOD-1), vascular endothelial growth factor A (VEGF-A), transforming growth factor beta 1 (TGF-\u03b21), interleukin (IL)-6, IL-15 and AdipoQ genes to study their association with preeclampsia (PE)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24295154"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD1"}, "span_text": {"type": "literal", "value": "To evaluate the peripheral blood mononuclear cell (PBMC) expression levels of hemeoxygenase 1 (HMOX-1), superoxide dismutase 1 (SOD-1), vascular endothelial growth factor A (VEGF-A), transforming growth factor beta 1 (TGF-\u03b21), interleukin (IL)-6, IL-15 and AdipoQ genes to study their association with preeclampsia (PE)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24295154"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGFB1"}, "span_text": {"type": "literal", "value": "To evaluate the peripheral blood mononuclear cell (PBMC) expression levels of hemeoxygenase 1 (HMOX-1), superoxide dismutase 1 (SOD-1), vascular endothelial growth factor A (VEGF-A), transforming growth factor beta 1 (TGF-\u03b21), interleukin (IL)-6, IL-15 and AdipoQ genes to study their association with preeclampsia (PE)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24295154"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "In this study, we used a murine model of preeclampsia based on adenovirus over-expression of the anti-angiogenic factor soluble Fms-like tyrosine kinase 1, and demonstrated that adult offspring born to preeclamptic dams perform poorly on assays testing vestibular function, balance, and coordination, and that prenatal pravastatin treatment prevents impairment of fetal programming."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24287098"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "There is also a circulating soluble form of endoglin (sEng; 65\u00a0kDa); its levels in the serum of women with preeclampsia are increased and correlated with disease severity."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24252708"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "Plasma sAxl concentrations in the severe preeclampsia patients correlated positively with systolic and diastolic blood pressures (r=0.628, P<0.05 vs. r=0.394, P<0.05, respectively) and proteinuria (r=0.583, P<0.05), but inversely with plasma albumin (r=-0.444, P<0.05), gestation of delivery (r=-0.554, P<0.05), and birth weight (r=-0.476, P<0.05)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24239956"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Vascular endothelial growth factor +936C/T, -634G/C, -2578C/A, and -1154G/A polymorphisms with risk of preeclampsia: a meta-analysis."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24223772"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Vascular endothelial growth factor +936C/T, -634G/C, -2578C/A, and -1154G/A polymorphisms with risk of preeclampsia: a meta-analysis."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24223772"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Vascular endothelial growth factor +936C/T, -634G/C, -2578C/A, and -1154G/A polymorphisms with risk of preeclampsia: a meta-analysis."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24223772"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SDC1"}, "span_text": {"type": "literal", "value": "Placental syndecan-1 and sulphated glycosaminoglycans are decreased in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24222257"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SDC1"}, "span_text": {"type": "literal", "value": "This study aimed to determine the concentrations of glycosaminoglycans and the proteoglycan syndecan-1 within villous trophoblast and to investigate changes associated with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24222257"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SDC1"}, "span_text": {"type": "literal", "value": "Syndecan-1 expression was localised to syncytiotrophoblast and median concentrations were lower in preeclampsia compared to PPROM material (preeclampsia median = 41.7, PPROM 74.4 ng/mg tissue) but not significantly different to concentrations in spontaneous preterm labour."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24222257"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SDC1"}, "span_text": {"type": "literal", "value": "Multivariate analysis revealed that decreased sGAG and syndecan-1 in preeclampsia were independent of labour, gestational age and birthweight centile."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24222257"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:THBS1"}, "span_text": {"type": "literal", "value": "Our results suggest that thrombospondin-1, angiostatin and vasostatin may play a role in the pathophysiology of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24205998"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGM4"}, "span_text": {"type": "literal", "value": "Tissue transglutaminase contributes to the pathogenesis of preeclampsia and stabilizes placental angiotensin receptor type 1 by ubiquitination-preventing isopeptide modification."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24191290"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGM3"}, "span_text": {"type": "literal", "value": "Tissue transglutaminase contributes to the pathogenesis of preeclampsia and stabilizes placental angiotensin receptor type 1 by ubiquitination-preventing isopeptide modification."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24191290"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGM1"}, "span_text": {"type": "literal", "value": "Tissue transglutaminase contributes to the pathogenesis of preeclampsia and stabilizes placental angiotensin receptor type 1 by ubiquitination-preventing isopeptide modification."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24191290"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGM1"}, "span_text": {"type": "literal", "value": "A pathogenic role for TG2 in preeclampsia is suggested by in vivo experiments in which cystamine, a potent transglutaminase inhibitor, or small interfering RNA-mediated TG2 knockdown significantly attenuated autoantibody-induced hypertension and proteinuria in pregnant mice."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24191290"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGM3"}, "span_text": {"type": "literal", "value": "A pathogenic role for TG2 in preeclampsia is suggested by in vivo experiments in which cystamine, a potent transglutaminase inhibitor, or small interfering RNA-mediated TG2 knockdown significantly attenuated autoantibody-induced hypertension and proteinuria in pregnant mice."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24191290"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGM5"}, "span_text": {"type": "literal", "value": "A pathogenic role for TG2 in preeclampsia is suggested by in vivo experiments in which cystamine, a potent transglutaminase inhibitor, or small interfering RNA-mediated TG2 knockdown significantly attenuated autoantibody-induced hypertension and proteinuria in pregnant mice."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24191290"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGM2"}, "span_text": {"type": "literal", "value": "A pathogenic role for TG2 in preeclampsia is suggested by in vivo experiments in which cystamine, a potent transglutaminase inhibitor, or small interfering RNA-mediated TG2 knockdown significantly attenuated autoantibody-induced hypertension and proteinuria in pregnant mice."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24191290"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGM2"}, "span_text": {"type": "literal", "value": "Tissue transglutaminase contributes to the pathogenesis of preeclampsia and stabilizes placental angiotensin receptor type 1 by ubiquitination-preventing isopeptide modification."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24191290"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGM4"}, "span_text": {"type": "literal", "value": "A pathogenic role for TG2 in preeclampsia is suggested by in vivo experiments in which cystamine, a potent transglutaminase inhibitor, or small interfering RNA-mediated TG2 knockdown significantly attenuated autoantibody-induced hypertension and proteinuria in pregnant mice."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24191290"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGM5"}, "span_text": {"type": "literal", "value": "Tissue transglutaminase contributes to the pathogenesis of preeclampsia and stabilizes placental angiotensin receptor type 1 by ubiquitination-preventing isopeptide modification."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24191290"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Diagnostic accuracy of placental growth factor in women with suspected preeclampsia: a prospective multicenter study."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24190934"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Placental growth factor (PlGF) is an angiogenic factor, a secondary marker of associated placental dysfunction in preeclampsia, with known low plasma concentrations in the disease."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24190934"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "In conclusion, consumption calcium supplement plus low-dose aspirin during pregnancy for 9 weeks in pregnant women at risk for pre-eclampsia resulted in a significant difference serum hs-CRP and increased levels of plasma TAC and total GSH as compared to the placebo group, but could not affect serum insulin levels and HOMA-IR score."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24187901"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "A randomized controlled clinical trial investigating the effect of calcium supplement plus low-dose aspirin on hs-CRP, oxidative stress and insulin resistance in pregnant women at risk for pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24187901"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "To evaluate the performance of the mean uterine artery pulsatility index (UtA-PI) and the automated measurement of the soluble fms-like tyrosine kinase-1 (sFlt-1)/placental growth factor (PlGF) ratio for the prognostic assessment of both maternal and perinatal outcomes, and the time-to-delivery interval in early-onset (\u2264\u200934\u2009+\u20090\u2009weeks) pre-eclampsia (PE) cases with attempted expectant management."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24185845"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "New gestational phase-specific cutoff values for the use of the soluble fms-like tyrosine kinase-1/placental growth factor ratio as a diagnostic test for preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24166751"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "To establish gestational phase adapted cutoffs for the use of the soluble fms-like tyrosine kinase-1 (sFlt-1)/placental growth factor (PlGF) ratio as a diagnostic tool for preeclampsia in the clinical setting, a multicenter case-control study including a total of 1149 patients was performed."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24166751"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "New gestational phase-specific cutoff values for the use of the soluble fms-like tyrosine kinase-1/placental growth factor ratio as a diagnostic test for preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24166751"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TLR4"}, "span_text": {"type": "literal", "value": "The role of progesterone in the Toll-like receptor 4 (TLR4)-MyD88-dependent signaling pathway in pre-eclampsia was studied."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24142728"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "This suggests a role of leptin in the pathophysiology of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24139888"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Placental leptin in HIV-associated preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24139888"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Both ELISA and immunohistochemistry of the placental exchange villi indicated that leptin levels were higher in preeclampsia compared to normotensive pregnancies (p<0.001)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24139888"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "The adipocyte hormone leptin has been implicated in the pathophysiology of preeclampsia and in enhancing immunity."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24139888"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGT"}, "span_text": {"type": "literal", "value": "Female mice overexpressing human angiotensinogen and human renin were used as a model of preeclampsia superimposed on chronic hypertension."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24101664"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Alterations in circulating angiogenic factors (soluble fms-like tyrosine kinase-1 and placental growth factor) in preeclampsia correlate with the diagnosis and adverse outcomes, particularly when the disease presents prematurely (<34 weeks)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24076553"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Alterations in circulating angiogenic factors (soluble fms-like tyrosine kinase-1 and placental growth factor) in preeclampsia correlate with the diagnosis and adverse outcomes, particularly when the disease presents prematurely (<34 weeks)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24076553"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Women with previous pre-eclampsia had higher levels of NE at rest (P=0.02), which did not associate significantly with insulin sensitivity or overall vasodilatory capacity."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24048293"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "These data support the hypothesis that AT1-AA, via activation of endothelin-1 and oxidative stress and interaction with endogenous ANGII, is an important mechanism whereby MAP and renal vascular responses are enhanced during preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24041954"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TTR"}, "span_text": {"type": "literal", "value": "By using in vitro approaches and a humanized mouse model, we provide evidence for a causal link between dysregulated transthyretin and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24035612"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TTR"}, "span_text": {"type": "literal", "value": "Transthyretin is dysregulated in preeclampsia, and its native form prevents the onset of disease in a preclinical mouse model."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24035612"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TTR"}, "span_text": {"type": "literal", "value": "Our findings suggest that a focus on transthyretin structure and function is a novel strategy to understand and combat preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24035612"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TTR"}, "span_text": {"type": "literal", "value": "Herein, we provide evidence that transthyretin, a transporter of thyroxine and retinol, is aggregated in preeclampsia and is present at reduced levels in sera of preeclamptic women, as detected by proteomic screen."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24035612"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TTR"}, "span_text": {"type": "literal", "value": "We demonstrate that transthyretin aggregates form deposits in preeclampsia placental tissue and cause apoptosis."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24035612"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Placental growth factor and soluble fms-like tyrosine kinase-1 are useful markers for the prediction of preeclampsia but not for small for gestational age neonates: a longitudinal study."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24035323"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Placental growth factor and soluble fms-like tyrosine kinase-1 are useful markers for the prediction of preeclampsia but not for small for gestational age neonates: a longitudinal study."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24035323"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "To determine maternal serum concentrations of placental growth factor (PlGF) and soluble fms-like tyrosine kinase-1 (sFlt-1) longitudinally in normal pregnancies, pregnancies that developed preeclampsia and pregnancies that deliver a small for gestational age (SGA) infant, in order to evaluate them as markers for the prediction of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/24035323"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TCF4"}, "span_text": {"type": "literal", "value": "We previously suggested links between specific XPD mutations in the fetal genome and the risk of placental maldevelopment and preeclampsia, possibly due to impairment of Transcription Factor (TF)IIH-mediated functions in placenta."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23989136"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "Increased B-type natriuretic peptide levels in early-onset versus late-onset preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23979127"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HMOX1"}, "span_text": {"type": "literal", "value": "On the vascular side, the upregulation of carbon monoxide CO, metabolite of heme oxygenase-1 (HO-1; by inhibiting soluble Flt-1, SFlt-1, and soluble endoglin, SEng, release), explains the very promising protective and potentially therapeutic effect of pravastatin in preeclampsia and the paradoxical strong protective effect of cigarette smoking on preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23972718"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "On the vascular side, the upregulation of carbon monoxide CO, metabolite of heme oxygenase-1 (HO-1; by inhibiting soluble Flt-1, SFlt-1, and soluble endoglin, SEng, release), explains the very promising protective and potentially therapeutic effect of pravastatin in preeclampsia and the paradoxical strong protective effect of cigarette smoking on preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23972718"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Placentation and vascular remodeling are multistep processes, and hypoxia, placental oxidative stress, excessive or atypical maternal immune response to trophoblasts, exaggerated inflammation, and increased production of anti-angiogenic factors such as the soluble form of the vascular endothelial growth factor (VEGF) receptor (sFlt-1) and soluble endoglin (sENG) may play a role in poor placentation in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23969229"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Placentation and vascular remodeling are multistep processes, and hypoxia, placental oxidative stress, excessive or atypical maternal immune response to trophoblasts, exaggerated inflammation, and increased production of anti-angiogenic factors such as the soluble form of the vascular endothelial growth factor (VEGF) receptor (sFlt-1) and soluble endoglin (sENG) may play a role in poor placentation in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23969229"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Placentation and vascular remodeling are multistep processes, and hypoxia, placental oxidative stress, excessive or atypical maternal immune response to trophoblasts, exaggerated inflammation, and increased production of anti-angiogenic factors such as the soluble form of the vascular endothelial growth factor (VEGF) receptor (sFlt-1) and soluble endoglin (sENG) may play a role in poor placentation in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23969229"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Onset threshold of the plasma levels of soluble fms-like tyrosine kinase 1/placental growth factor ratio for predicting the imminent onset of preeclampsia within 4 weeks after blood sampling at 19-31 weeks of gestation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23966056"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Onset threshold of the plasma levels of soluble fms-like tyrosine kinase 1/placental growth factor ratio for predicting the imminent onset of preeclampsia within 4 weeks after blood sampling at 19-31 weeks of gestation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23966056"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Our aim was to evaluate the onset threshold of plasma levels of the soluble fms-like tyrosine kinase 1 (sFlt-1)/placental growth factor (PlGF) ratio for predicting the imminent onset of preeclampsia (PE) within 4 weeks after blood sampling."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23966056"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF2"}, "span_text": {"type": "literal", "value": "Under healthy conditions, insulin and insulin-like growth factor-integrated pathways not only promote cell metabolism and proliferation, but also regulate endothelial synthesis and release of vasodilators (e.g., nitric oxide, NO) and opposing vasoconstrictors (e.g., endothelin-1) to maintain vascular homeostasis. d-chiro inositol phosphoglycans (DCI), second messengers of insulin, are increased during preeclampsia and contribute directly to insulin resistance."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23962711"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Under healthy conditions, insulin and insulin-like growth factor-integrated pathways not only promote cell metabolism and proliferation, but also regulate endothelial synthesis and release of vasodilators (e.g., nitric oxide, NO) and opposing vasoconstrictors (e.g., endothelin-1) to maintain vascular homeostasis. d-chiro inositol phosphoglycans (DCI), second messengers of insulin, are increased during preeclampsia and contribute directly to insulin resistance."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23962711"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF1"}, "span_text": {"type": "literal", "value": "Under healthy conditions, insulin and insulin-like growth factor-integrated pathways not only promote cell metabolism and proliferation, but also regulate endothelial synthesis and release of vasodilators (e.g., nitric oxide, NO) and opposing vasoconstrictors (e.g., endothelin-1) to maintain vascular homeostasis. d-chiro inositol phosphoglycans (DCI), second messengers of insulin, are increased during preeclampsia and contribute directly to insulin resistance."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23962711"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Under healthy conditions, insulin and insulin-like growth factor-integrated pathways not only promote cell metabolism and proliferation, but also regulate endothelial synthesis and release of vasodilators (e.g., nitric oxide, NO) and opposing vasoconstrictors (e.g., endothelin-1) to maintain vascular homeostasis. d-chiro inositol phosphoglycans (DCI), second messengers of insulin, are increased during preeclampsia and contribute directly to insulin resistance."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23962711"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "The aim of this study was to assess whether vascular endothelial growth factor (VEGF) polymorphisms are associated with susceptibility to pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23957473"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "The aim of this study was to assess whether vascular endothelial growth factor (VEGF) polymorphisms are associated with susceptibility to pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23957473"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Associations between vascular endothelial growth factor gene polymorphisms and pre-eclampsia susceptibility: a meta-analysis."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23957473"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Associations between vascular endothelial growth factor gene polymorphisms and pre-eclampsia susceptibility: a meta-analysis."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23957473"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Associations between vascular endothelial growth factor gene polymorphisms and pre-eclampsia susceptibility: a meta-analysis."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23957473"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "The aim of this study was to assess whether vascular endothelial growth factor (VEGF) polymorphisms are associated with susceptibility to pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23957473"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "In summary, sustained euglycemic hyperinsulinemia, comparable with insulin levels in preeclamptic women, can raise blood pressure in pregnancy independent of recognized placental factors associated with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23955606"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CTSD"}, "span_text": {"type": "literal", "value": "Cathepsin D levels are reduced in patients with preeclampsia in Korean population."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23954850"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CTSD"}, "span_text": {"type": "literal", "value": "We conclude that a reduced cathepsin D level is an important factor that may contribute to the pathogenesis of preeclampsia, possibly by inhibiting normal trophoblastic invasion."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23954850"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CTSD"}, "span_text": {"type": "literal", "value": "Cathepsin D levels were significantly lower in preeclamptic patients than normotensive pregnant patients (p=0.033)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23954850"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CTSD"}, "span_text": {"type": "literal", "value": "The serum levels of cathepsin D were not positively correlated with preeclampsia severity or the incidence of delivery of small for gestational age infants."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23954850"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL1B"}, "span_text": {"type": "literal", "value": "Identification of interleukin-1 beta, but no other inflammatory proteins, as an early onset pre-eclampsia biomarker in first trimester serum by bead-based multiplexed immunoassays."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23943085"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LAP3"}, "span_text": {"type": "literal", "value": "The authors conclude that both aminopeptidase A and placental leucine aminopeptidase could be potentially safe and effective drugs for patients and their babies in the treatment of preeclampsia and preterm labor."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23931642"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Preeclampsia is difficult to diagnose in pregnant women with underlying CKD, and serum markers such as soluble fms-like tyrosine kinase 1 (sFlt1) and placental growth factor (PIGF) may lead the way for definitive diagnosis."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23928386"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Leptin to adiponectin ratio in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23923407"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Maternal plasma concentrations of placental growth factor (PlGF), soluble fms-like tyrosine kinase 1 (sFlt-1), and soluble endoglin (sEng) were available at 26 weeks of gestation in 540 women with type 1 diabetes enrolled in the Diabetes and Preeclampsia Intervention Trial."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23920083"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "The aim of this study was to investigate the value of placental growth factor (PLGF), soluble fms-like tyrosine kinase-1 (sFlt-1) and sFlt-1/PLGF ratio, in predicting symptomatic preeclampsia (PE)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23905610"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Advanced oxidation protein products enhances soluble Fms-like tyrosine kinase 1 expression in trophoblasts: a possible link between oxidative stress and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23899470"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Women with previous preeclampsia more often had urate and soluble fms-like tyrosine kinase values above the 75th percentile (odds ratio [OR], 2.4; P\u00a0= .03, and OR, 2.4; P\u00a0= .04, respectively) and high-density lipoprotein cholesterol values below the 25th percentile (OR, 2.3; P\u00a0= .04)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23899451"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Women with previous preeclampsia more often had urate and soluble fms-like tyrosine kinase values above the 75th percentile (odds ratio [OR], 2.4; P\u00a0= .03, and OR, 2.4; P\u00a0= .04, respectively) and high-density lipoprotein cholesterol values below the 25th percentile (OR, 2.3; P\u00a0= .04)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23899451"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Women with preeclampsia with low birthweight offspring were associated with asymmetric dimethylarginine, L-arginine, and homoarginine above the 75th percentile, whereas the women with preeclampsia with normal-weight offspring were associated with urate and soluble fms-like tyrosine kinase above the 75th percentile."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23899451"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "1) lipoprotein receptors/transporters in the placenta would be upregulated in preeclampsia, associated with increased maternal and fetal lipoprotein concentrations; and 2) expression of these would be reduced in preeclamptic placentae from women delivering small-for-gestational-age (SGA) infants."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23898049"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "Antihypertensive effects of inducible nitric oxide synthase inhibition in experimental pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23890248"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOE"}, "span_text": {"type": "literal", "value": "Association of the apolipoprotein E variants with susceptibility to pregnancy with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23865355"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOE"}, "span_text": {"type": "literal", "value": "Apolipoprotein E (ApoE) polymorphism plays a significant role in the development of several diseases, but its role in the preeclampsia disease incidence is not clear."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23865355"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGT"}, "span_text": {"type": "literal", "value": "To investigate the association of angiotensinogen (AGT) gene polymorphisms and angiogenic factors with preeclampsia (PE) in Chinese women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23860016"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGT"}, "span_text": {"type": "literal", "value": "Association of angiotensinogen gene polymorphisms and angiogenic factors with preeclampsia in Chinese women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23860016"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "The group with preeclampsia had a higher UAD pulsatility index (p\u2009=\u20090.0003), more frequent bilateral notches (p\u2009=\u2009.0001), lower PlGF levels (239.90 vs 302.00 pg/mL; p\u2009=\u20090.0015), and higher triglyceride (1.95 vs 1.70 mmol/l; p\u2009=\u20090.0068) and leptin levels (37.40 vs 22.55 ng/mL; p\u2009=\u2009< 0.001)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23847040"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Second-trimester UAD findings, and PlGF, triglyceride and leptin levels could help to predict preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23847040"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APLN"}, "span_text": {"type": "literal", "value": "Decreased expression of apelin in placentas from severe pre-eclampsia patients."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23844873"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APLN"}, "span_text": {"type": "literal", "value": "A functional role of the apelin--APJ system is likely in early gestation, and this raises the possibility that a dysfunctional apelin--APJ system contributes to the onset of pre-eclampsia via decreased angiogenic activity in placental implantation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23844873"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APLN"}, "span_text": {"type": "literal", "value": "Apelin protein levels are also lower in pre-eclamptic placentas than the controls but higher in the maternal circulation in pre-eclampsia patients."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23844873"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APLN"}, "span_text": {"type": "literal", "value": "We compared the expression of apelin, examined using quantitative reverse-transcription polymerase chain reaction, western blotting, enzyme-linked immunosorbent assay and immunostaining, between pre-eclamptic patients and normotensive controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23844873"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ANXA1"}, "span_text": {"type": "literal", "value": "Considering the relation among vitamin D deficiency, increased risk of PE, and the role of annexin A1 in the resolution of inflammation, production of antibody against annexin A1 and DBP may be considered a new auto-immune hypothesis in pre-eclampsia that calls for further investigation in future work."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23830177"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ANXA1"}, "span_text": {"type": "literal", "value": "Presence of auto-antibody against two placental proteins, annexin A1 and vitamin D binding protein, in sera of women with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23830177"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Membrane and soluble forms of endoglin in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23826920"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "In this review, the alterations in vasculogenesis and angiogenesis that occur during preeclampsia, the cellular and molecular mechanisms that lead to increased membrane bound endoglin expression and soluble endoglin release, including hypoxia and oxidative stress, and the possible pathogenic role of soluble endoglin in this disease have been analyzed."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23826920"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD3"}, "span_text": {"type": "literal", "value": "The antioxidant activity of the enzyme superoxide dismutase was found elevated in women with and without preeclampsia (p>0.05), with significant reduction in activity in the postpartum period (p < 0.05) in both groups studied (p>0.05)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23822702"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD1"}, "span_text": {"type": "literal", "value": "The antioxidant activity of the enzyme superoxide dismutase was found elevated in women with and without preeclampsia (p>0.05), with significant reduction in activity in the postpartum period (p < 0.05) in both groups studied (p>0.05)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23822702"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD1"}, "span_text": {"type": "literal", "value": "Enzyme activity of superoxide dismutase and zincemia in women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23822702"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD3"}, "span_text": {"type": "literal", "value": "This study assessed the relationship between the activity of superoxide dismutase, the zincemia and the preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23822702"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD3"}, "span_text": {"type": "literal", "value": "Enzyme activity of superoxide dismutase and zincemia in women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23822702"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD1"}, "span_text": {"type": "literal", "value": "This study assessed the relationship between the activity of superoxide dismutase, the zincemia and the preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23822702"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SDC1"}, "span_text": {"type": "literal", "value": "Maternal serum syndecan-1 concentration was lower in preeclampsia (median, 673 ng/ml; interquartile range, 459-1,161 ng/ml) than in controls (1,158 ng/ml; 622-1,480 ng/ml)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23807541"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SDC1"}, "span_text": {"type": "literal", "value": "Syncytiotrophoblastic syndecan-1 expression depends on the differentiation of villous trophoblasts, and trophoblastic syndecan-1 release is decreased in preeclampsia and HELLP syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23807541"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SDC1"}, "span_text": {"type": "literal", "value": "Maternal sera from patients with preeclampsia (n = 49) and controls (n = 32) were immunoassayed for syndecan-1."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23807541"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SDC1"}, "span_text": {"type": "literal", "value": "Our aim was to examine placental syndecan-1 expression in preeclampsia with or without hemolysis, elevated liver enzymes, and low platelet count (HELLP) syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23807541"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SDC1"}, "span_text": {"type": "literal", "value": "Changes of placental syndecan-1 expression in preeclampsia and HELLP syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23807541"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SDC1"}, "span_text": {"type": "literal", "value": "Syndecan-1 immunoscores were higher in late-onset preeclampsia (p = 0.0001) and early-onset preeclampsia with or without HELLP syndrome (p = 0.02 for both) than in controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23807541"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Soluble fms-like tyrosine kinase-1 and soluble endoglin in HIV-associated preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23806447"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Soluble fms-like tyrosine kinase-1 and soluble endoglin in HIV-associated preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23806447"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADM"}, "span_text": {"type": "literal", "value": "Consistent with studies of plasma adrenomedullin and adverse pregnancy outcomes, we found associations between variants in the adrenomedullin signaling pathway and birth weight, glycemic regulation, and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23797962"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADM2"}, "span_text": {"type": "literal", "value": "We measured the extent to which genetic polymorphisms in the adrenomedullin signaling pathway are associated with birth weight, glycemic regulation, and preeclampsia risk."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23797962"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADM"}, "span_text": {"type": "literal", "value": "We measured the extent to which genetic polymorphisms in the adrenomedullin signaling pathway are associated with birth weight, glycemic regulation, and preeclampsia risk."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23797962"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADM2"}, "span_text": {"type": "literal", "value": "Consistent with studies of plasma adrenomedullin and adverse pregnancy outcomes, we found associations between variants in the adrenomedullin signaling pathway and birth weight, glycemic regulation, and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23797962"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:BDNF"}, "span_text": {"type": "literal", "value": "Differential regulation of brain-derived neurotrophic factor in term and preterm preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23793470"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL10"}, "span_text": {"type": "literal", "value": "Tumor necrosis factor-alpha, interleukin-6, and interleukin-10 levels are altered in preeclampsia: a systematic review and meta-analysis."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23790133"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL6"}, "span_text": {"type": "literal", "value": "Tumor necrosis factor-alpha, interleukin-6, and interleukin-10 levels are altered in preeclampsia: a systematic review and meta-analysis."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23790133"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TCF4"}, "span_text": {"type": "literal", "value": "We discuss here the molecular mechanisms of action of these transcription factors and how they can be related to the placental dysfunction in the context of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23785430"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PDE5A"}, "span_text": {"type": "literal", "value": "There is currently no effective treatment for preeclampsia, but the phosphodiesterase-5 (PDE-5) inhibitor sildenafil has been suggested, as PDE-5 is enriched in the uterus, and its antagonism could improve uteroplacental function."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23785075"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "To assess maternal leptin levels as a marker for preeclampsia (PE) and to explore the possibility of leptin being a marker of severity of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23771185"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Maternal serum leptin as a marker of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23771185"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Maternal serum leptin is significantly elevated in preeclampsia, also it can be used as a marker for the presence of preeclampsia and to differentiate patients with mild preeclampsia from those with severe disease."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23771185"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Leptin levels were found to be significantly higher among all preeclampsia patients when compared to the control group; whether at admission or at the time of delivery."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23771185"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "At the time of delivery, mean serum leptin in control group decreased to 4.7 ng/ml while in preeclampsia patients it increased up to 22 ng/ml in mild cases and 42.6 ng/ml in severe cases."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23771185"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HGF"}, "span_text": {"type": "literal", "value": "Because of the biologic activities, Interleukin-1 receptor 4, hepatocyte growth factor, urokinase plasminogen activator receptor and interleukin-8 in maternal and/or cord blood could play a role in the pathogenesis of hypertension and proteinuria in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23769550"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HGF"}, "span_text": {"type": "literal", "value": "Moreover, in cord blood samples hepatocyte growth factor and interleukin-8 were significantly higher in preeclampsia patients."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23769550"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HGF"}, "span_text": {"type": "literal", "value": "Interleukin-1 receptor 4, hepatocyte growth factor, and urokinase plasminogen activator receptor were significantly elevated in the blood of preeclampsia patients."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23769550"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GP2"}, "span_text": {"type": "literal", "value": "These results support a role of plasma glycoprotein interaction in monocyte-endothelial cell adhesion and could suggest a novel therapeutic target for severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23757314"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AVP"}, "span_text": {"type": "literal", "value": "In contrast, the levels measured after arginine vasopressin was administered during the first trimester indicated an exaggerated response in the group with preeclampsia as compared with the control group (1494 +/- 388 [+/- SEM] percent vs. 545 +/- 55 percent of base line; P less than 0.0002), which was sustained through the second and third trimesters."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/2374565"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AVP"}, "span_text": {"type": "literal", "value": "Platelet intracellular calcium responses to arginine vasopressin during the first trimester were a sensitive predictor of the subsequent development of preeclampsia (P less than 0.00009)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/2374565"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AVP"}, "span_text": {"type": "literal", "value": "We therefore propose that an increase in the sensitivity of platelet calcium to arginine vasopressin can be used as an early predictor of subsequent preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/2374565"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AVP"}, "span_text": {"type": "literal", "value": "Our findings indicate that preeclampsia is characterized by the absence of the normal pregnancy-related decrease in vascular resistance, which is preceded in most instances by an exaggerated response of platelet intracellular calcium to arginine vasopressin early in pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/2374565"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TPO"}, "span_text": {"type": "literal", "value": "In one trial of 115 women, levothyroxine therapy to treat pregnant euthyroid (normal thyroid function) women with thyroid peroxidase antibodies was not shown to reduce pre-eclampsia significantly (risk ratio (RR) 0.61; 95% confidence interval (CI) 0.11 to 3.48) but did significantly reduce preterm birth by 72% (RR 0.28; 95% CI 0.10 to 0.80)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23728666"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TPO"}, "span_text": {"type": "literal", "value": "This review found no difference between levothyroxine therapy and a control for treating pregnant euthyroid women with thyroid peroxidase antibodies for the outcome of pre-eclampsia, however a reduction in preterm birth and a trend towards reduced miscarriage with levothyroxine was shown."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23728666"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "The effects of magnesium sulfate on placental vascular endothelial growth factor expression in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23725083"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "The effects of magnesium sulfate on placental vascular endothelial growth factor expression in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23725083"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "The effects of magnesium sulfate on placental vascular endothelial growth factor expression in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23725083"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IER5"}, "span_text": {"type": "literal", "value": "The expression of immediate early response gene X-1 in preeclampsia placenta and its pro-apoptotic role in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23725081"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IER2"}, "span_text": {"type": "literal", "value": "The expression of immediate early response gene X-1 in preeclampsia placenta and its pro-apoptotic role in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23725081"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IER3"}, "span_text": {"type": "literal", "value": "The expression of immediate early response gene X-1 in preeclampsia placenta and its pro-apoptotic role in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23725081"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CASP3"}, "span_text": {"type": "literal", "value": "Placental apoptosis in preeclampsia, intrauterine growth retardation, and HELLP syndrome: an immunohistochemical study with caspase-3 and bcl-2."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23724505"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CASP3"}, "span_text": {"type": "literal", "value": "Apoptotic marker caspase-3 is significantly increased in the villous trophoblasts of patients with preeclampsia, HELLP syndrome, and IUGR indicating increased placental apoptosis."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23724505"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CASP3"}, "span_text": {"type": "literal", "value": "To examine the placental expression of caspase-3 and bcl-2 in pregnancies complicated by preeclampsia, IUGR, and HELLP syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23724505"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "The aim of the study was to investigate the expression of genes coding for vascular endothelial growth factor (VEGF) and placenta growth factor (PlGF) as well as their receptors, fms-like tyrosine kinase receptor 1 (VEGFR-1/Flt-1) and VEGF receptor 2 (VEGFR-2/KDR) in the placentae of patients with pregnancies complicated by preeclampsia (PE) and intrauterine growth restriction (IUGR)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23719118"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "The aim of the study was to investigate the expression of genes coding for vascular endothelial growth factor (VEGF) and placenta growth factor (PlGF) as well as their receptors, fms-like tyrosine kinase receptor 1 (VEGFR-1/Flt-1) and VEGF receptor 2 (VEGFR-2/KDR) in the placentae of patients with pregnancies complicated by preeclampsia (PE) and intrauterine growth restriction (IUGR)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23719118"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "The aim of the study was to investigate the expression of genes coding for vascular endothelial growth factor (VEGF) and placenta growth factor (PlGF) as well as their receptors, fms-like tyrosine kinase receptor 1 (VEGFR-1/Flt-1) and VEGF receptor 2 (VEGFR-2/KDR) in the placentae of patients with pregnancies complicated by preeclampsia (PE) and intrauterine growth restriction (IUGR)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23719118"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "The aim of the study was to investigate the expression of genes coding for vascular endothelial growth factor (VEGF) and placenta growth factor (PlGF) as well as their receptors, fms-like tyrosine kinase receptor 1 (VEGFR-1/Flt-1) and VEGF receptor 2 (VEGFR-2/KDR) in the placentae of patients with pregnancies complicated by preeclampsia (PE) and intrauterine growth restriction (IUGR)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23719118"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CP"}, "span_text": {"type": "literal", "value": "Oxidative stress parameters and ceruloplasmin levels in patients with severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23698219"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "To evaluate the soluble fms-like tyrosine kinase-1 (sFlt-1), placental growth factor (PlGF), and sFlt-1/PlGF ratio for the prediction of early- and late-onset preeclampsia in a high-risk cohort."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23663420"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Seemingly disparate disease conditions, including hereditary hemorrhagic telangiectasia, pre-eclampsia, and cardiac fibrosis, have now been associated with endoglin."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23662065"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Vascular endothelial growth factor and its receptors in the placental villi of pregnant patients with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23658926"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Vascular endothelial growth factor and its receptors in the placental villi of pregnant patients with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23658926"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Vascular endothelial growth factor and its receptors in the placental villi of pregnant patients with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23658926"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:BDNF"}, "span_text": {"type": "literal", "value": "The aim of the study was to investigate the circulating levels of ciliary neurotrophic factor (CNTF) and brain-derived neurotrophic factor (BDNF) in maternal serum and umbilical cord blood from respective pregnancies in pre-eclampsia (PE) cases and a control cohort."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23654315"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "The aim of the study was to estimate the levels of vascular endothelial growth factor (VEGF) and endothelin-1 (ET-1) in maternal serum from normal pregnant women and women with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23654314"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Vascular endothelial growth factor and endothelin-1 levels in normal pregnant women and pregnant women with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23654314"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "The aim of the study was to estimate the levels of vascular endothelial growth factor (VEGF) and endothelin-1 (ET-1) in maternal serum from normal pregnant women and women with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23654314"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "The aim of the study was to estimate the levels of vascular endothelial growth factor (VEGF) and endothelin-1 (ET-1) in maternal serum from normal pregnant women and women with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23654314"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Vascular endothelial growth factor and endothelin-1 levels in normal pregnant women and pregnant women with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23654314"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "The aim of the study was to estimate the levels of vascular endothelial growth factor (VEGF) and endothelin-1 (ET-1) in maternal serum from normal pregnant women and women with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23654314"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Vascular endothelial growth factor and endothelin-1 levels in normal pregnant women and pregnant women with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23654314"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Vascular endothelial growth factor and endothelin-1 levels in normal pregnant women and pregnant women with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23654314"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADM2"}, "span_text": {"type": "literal", "value": "Prior studies have demonstrated that women with preeclampsia have lower placental adrenomedullin (AM) expression, and cigarette smoke extract (CSE) treatment of placental trophoblast cells in culture increases AM cellular production."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23653390"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADM"}, "span_text": {"type": "literal", "value": "Prior studies have demonstrated that women with preeclampsia have lower placental adrenomedullin (AM) expression, and cigarette smoke extract (CSE) treatment of placental trophoblast cells in culture increases AM cellular production."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23653390"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Our study for the first time indicated that BChE activity might be involved in the pathogenesis of preeclampsia through influence on lipid and lipoprotein metabolism and oxidative stress."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23650977"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "To determine the butyrylcholinesterase (BChE) activity and phenotypes in preeclampsia and its possible association with lipid and lipoprotein metabolism and oxidative stress in preeclamptic women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23650977"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Butyrylcholinesterase (BChE) activity is associated with the risk of preeclampsia: influence on lipid and lipoprotein metabolism and oxidative stress."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23650977"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "After adjustment for age, we observed significantly higher means for body mass index, blood pressure, total and low-density lipoprotein cholesterol, triglycerides, glucose, and lower mean high-density lipoprotein cholesterol (all P<.01) in women with previous early-onset preeclampsia compared with the reference group."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23635741"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Women with morbid obesity (BMI > or = 40 kg/m2) had significantly higher levels of serum leptin (p < 0.01) and a value of 40 ng/ml of this hormone seems to be predictive of developing preeclampsia in this group of patients."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23631287"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "For those women with PGBMI > or = 40 kg/m2 and leptin > or = 40 ng/ml in the second trimester, the Odds Ratio (OR) to develop preeclampsia was of 47.95% CI (4.1-527.2)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23631287"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ICAM1"}, "span_text": {"type": "literal", "value": "The objective of the study was to examine the associations of maternal plasma levels of 25-hydroxyvitamin D [25(OH)D] with angiogenesis and endothelial dysfunction indicators: soluble fms-like tyrosine kinase-1 (sFlt-1), placental growth factor (PlGF), intercellular adhesion molecule-1 (ICAM-1), vascular adhesion molecule-1 (VCAM-1), and risk of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23618499"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "The objective of the study was to examine the associations of maternal plasma levels of 25-hydroxyvitamin D [25(OH)D] with angiogenesis and endothelial dysfunction indicators: soluble fms-like tyrosine kinase-1 (sFlt-1), placental growth factor (PlGF), intercellular adhesion molecule-1 (ICAM-1), vascular adhesion molecule-1 (VCAM-1), and risk of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23618499"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EFNB2"}, "span_text": {"type": "literal", "value": "Because ephrin-B2 and EPHB4 has been previously shown to play a crucial role in trophoblast invasion into maternal spiral artery and vascular patterning during early human placental development, the miR-17-ephrin-B2/EPHB4 pathway seems to be a novel miRNA pathway for regulating normal and aberrant placental development during preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23575145"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "First-trimester serum soluble fms-like tyrosine kinase-1, free vascular endothelial growth factor, placental growth factor and uterine artery Doppler in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23558430"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "First-trimester serum soluble fms-like tyrosine kinase-1, free vascular endothelial growth factor, placental growth factor and uterine artery Doppler in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23558430"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "First-trimester serum soluble fms-like tyrosine kinase-1, free vascular endothelial growth factor, placental growth factor and uterine artery Doppler in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23558430"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "First-trimester serum soluble fms-like tyrosine kinase-1, free vascular endothelial growth factor, placental growth factor and uterine artery Doppler in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23558430"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "First-trimester serum soluble fms-like tyrosine kinase-1, free vascular endothelial growth factor, placental growth factor and uterine artery Doppler in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23558430"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "To compare the first-trimester serum concentrations of soluble fms-like tyrosine kinase-1 (sFlt-1), free vascular endothelial growth factor (free-VEGF), placental growth factor (PlGF), and uterine artery pulsatility index (PI) in women who later developed preeclampsia (PE)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23558430"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL4"}, "span_text": {"type": "literal", "value": "Interleukin-4 deficiency induces mild preeclampsia in mice."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23552130"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Variation in endoglin pathway genes is associated with preeclampsia: a case-control candidate gene association study."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23548068"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "This study investigated if endoglin (ENG) pathway genetic variation was also associated with the development of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23548068"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF1"}, "span_text": {"type": "literal", "value": "In conclusion, we demonstrated that biomarker combinations centered on insulin-like growth factor acid labile subunit have the potential to predict preeclampsia in healthy nulliparous women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23547239"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF2"}, "span_text": {"type": "literal", "value": "In conclusion, we demonstrated that biomarker combinations centered on insulin-like growth factor acid labile subunit have the potential to predict preeclampsia in healthy nulliparous women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23547239"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FGF16"}, "span_text": {"type": "literal", "value": "Serum levels of the adipokine fibroblast growth factor-21 are increased in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23545215"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FGF5"}, "span_text": {"type": "literal", "value": "Serum levels of the adipokine fibroblast growth factor-21 are increased in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23545215"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FGF18"}, "span_text": {"type": "literal", "value": "Serum levels of the adipokine fibroblast growth factor-21 are increased in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23545215"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FGF4"}, "span_text": {"type": "literal", "value": "Serum levels of the adipokine fibroblast growth factor-21 are increased in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23545215"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FGF13"}, "span_text": {"type": "literal", "value": "Serum levels of the adipokine fibroblast growth factor-21 are increased in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23545215"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FGF7"}, "span_text": {"type": "literal", "value": "Serum levels of the adipokine fibroblast growth factor-21 are increased in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23545215"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FGF22"}, "span_text": {"type": "literal", "value": "Serum levels of the adipokine fibroblast growth factor-21 are increased in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23545215"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FGF14"}, "span_text": {"type": "literal", "value": "Serum levels of the adipokine fibroblast growth factor-21 are increased in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23545215"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Preeclampsia is associated with altered levels of angiogenic factors, like vascular endothelial growth factor (VEGF) and soluble endoglin."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23522390"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Preeclampsia is associated with altered levels of angiogenic factors, like vascular endothelial growth factor (VEGF) and soluble endoglin."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23522390"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Preeclampsia is associated with altered levels of angiogenic factors, like vascular endothelial growth factor (VEGF) and soluble endoglin."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23522390"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Preeclampsia is associated with altered levels of angiogenic factors, like vascular endothelial growth factor (VEGF) and soluble endoglin."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23522390"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX2"}, "span_text": {"type": "literal", "value": "Pre-eclampsia is associated with lower serum selenium concentrations and glutathione peroxidase expression/activity; total thyroid hormones are also lower."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23518454"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX3"}, "span_text": {"type": "literal", "value": "Pre-eclampsia is associated with lower serum selenium concentrations and glutathione peroxidase expression/activity; total thyroid hormones are also lower."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23518454"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX1"}, "span_text": {"type": "literal", "value": "Pre-eclampsia is associated with lower serum selenium concentrations and glutathione peroxidase expression/activity; total thyroid hormones are also lower."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23518454"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "To determine whether maternal serum placental growth factor (PlGF) estimation in early second trimester (20-22 weeks of gestation) can predict the occurrence of early onset preeclampsia and/or early onset intrauterine growth restriction (IUGR)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23496304"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Can maternal serum placental growth factor estimation in early second trimester predict the occurrence of early onset preeclampsia and/or early onset intrauterine growth restriction?"}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23496304"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGT"}, "span_text": {"type": "literal", "value": "We studied phenotypes of the circulating renin-angiotensin-aldosterone system and circadian BP during preeclampsia depending on polymorphism of angiotensinogen gene M235T."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23484199"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGT"}, "span_text": {"type": "literal", "value": "The TT genotype or T allele of angiotensinogen M235T gene polymorphism is associated with the risk of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23484199"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGT"}, "span_text": {"type": "literal", "value": "Genophenotypic analysis of angiotensinogen gene M235T polymorphism and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23484199"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGT"}, "span_text": {"type": "literal", "value": "Plasma aldosterone level is lower in patients with preeclampsia, but this is not related to angiotensinogen M235T gene polymorphism."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23484199"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOM"}, "span_text": {"type": "literal", "value": "To investigate potential roles of inducible nitric oxide synthase (iNOS) and apolipoprotein (apoE) in inflammation and apoptosis promoting pathological changes in preeclampsia in pregnant mice with apoE and/or iNOS knock out."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23472151"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOE"}, "span_text": {"type": "literal", "value": "Roles of apolipoprotein E (ApoE) and inducible nitric oxide synthase (iNOS) in inflammation and apoptosis in preeclampsia pathogenesis and progression."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23472151"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOF"}, "span_text": {"type": "literal", "value": "To investigate potential roles of inducible nitric oxide synthase (iNOS) and apolipoprotein (apoE) in inflammation and apoptosis promoting pathological changes in preeclampsia in pregnant mice with apoE and/or iNOS knock out."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23472151"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOE"}, "span_text": {"type": "literal", "value": "To investigate potential roles of inducible nitric oxide synthase (iNOS) and apolipoprotein (apoE) in inflammation and apoptosis promoting pathological changes in preeclampsia in pregnant mice with apoE and/or iNOS knock out."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23472151"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOO"}, "span_text": {"type": "literal", "value": "To investigate potential roles of inducible nitric oxide synthase (iNOS) and apolipoprotein (apoE) in inflammation and apoptosis promoting pathological changes in preeclampsia in pregnant mice with apoE and/or iNOS knock out."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23472151"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PRL"}, "span_text": {"type": "literal", "value": "Circulating angiogenic factors and urinary prolactin as predictors of adverse outcomes in women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23460287"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Aldosterone, vascular endothelial growth factor, and preeclampsia: a mystery solved?"}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23460279"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Aldosterone, vascular endothelial growth factor, and preeclampsia: a mystery solved?"}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23460279"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Aldosterone, vascular endothelial growth factor, and preeclampsia: a mystery solved?"}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23460279"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Vascular endothelial growth factor-A and aldosterone: relevance to normal pregnancy and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23460276"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Vascular endothelial growth factor-A and aldosterone: relevance to normal pregnancy and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23460276"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "These findings may explain why aldosterone increases so markedly during normal gestation and why preeclampsia, a condition characterized by high soluble fms-like tyrosine kinase-1, is associated with inappropriately low aldosterone levels in spite of relatively lower plasma volumes."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23460276"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Vascular endothelial growth factor-A and aldosterone: relevance to normal pregnancy and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23460276"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "To investigate the potential value of maternal serum concentrations of free \u03b2-human chorionic gonadotrophin (\u03b2-hCG), pregnancy-associated plasma protein-A (PAPP-A) and placental growth factor (PlGF) at 30-33 weeks of gestation in the prediction of pre-eclampsia (PE) developing at or after 34 weeks."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23445908"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Maternal serum placental growth factor, pregnancy-associated plasma protein-a and free \u03b2-human chorionic gonadotrophin at 30-33 weeks in the prediction of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23445908"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Characterisation of syncytiotrophoblast vesicles in normal pregnancy and pre-eclampsia: expression of Flt-1 and endoglin."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23437230"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VWF"}, "span_text": {"type": "literal", "value": "This study aimed to assess the von Willebrand factor (VWF) antigen levels and its proteolytic enzyme ADAMTS13 activity in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23433535"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MIR376C"}, "span_text": {"type": "literal", "value": "Is microRNA-376c a biomarker or mediator of preeclampsia?"}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23424230"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CFI"}, "span_text": {"type": "literal", "value": "The present cross-sectional study compared the plasma concentrations of complement factors C3a and C5a between normotensive pregnancies and pregnancies complicated with either preeclampsia or gestational hypertension alone."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23415845"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CFI"}, "span_text": {"type": "literal", "value": "Elevated complement factor C5a in maternal and umbilical cord plasma in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23415845"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CFD"}, "span_text": {"type": "literal", "value": "Elevated complement factor C5a in maternal and umbilical cord plasma in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23415845"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CFH"}, "span_text": {"type": "literal", "value": "Elevated complement factor C5a in maternal and umbilical cord plasma in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23415845"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CFB"}, "span_text": {"type": "literal", "value": "Elevated complement factor C5a in maternal and umbilical cord plasma in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23415845"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CFB"}, "span_text": {"type": "literal", "value": "The present cross-sectional study compared the plasma concentrations of complement factors C3a and C5a between normotensive pregnancies and pregnancies complicated with either preeclampsia or gestational hypertension alone."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23415845"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CFD"}, "span_text": {"type": "literal", "value": "The present cross-sectional study compared the plasma concentrations of complement factors C3a and C5a between normotensive pregnancies and pregnancies complicated with either preeclampsia or gestational hypertension alone."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23415845"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CFH"}, "span_text": {"type": "literal", "value": "The present cross-sectional study compared the plasma concentrations of complement factors C3a and C5a between normotensive pregnancies and pregnancies complicated with either preeclampsia or gestational hypertension alone."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23415845"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MTHFR"}, "span_text": {"type": "literal", "value": "Methylenetetrahydrofolate reductase (MTHFR) gene C677T polymorphism and risk of preeclampsia: an updated meta-analysis based on 51 studies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23395424"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MTHFR"}, "span_text": {"type": "literal", "value": "The methylenetetrahydrofolate reductase (MTHFR) gene C677T polymorphism has been considered to be associated with preeclampsia (PE), but the results from previous studies were conflicting."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23395424"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "The purpose of this study was to analyze whether maternal serum placental growth factor (PlGF) could predict early onset preeclampsia (<32 weeks of gestation) in overweight/obese pregnant women, and whether it could do it more effectively than in normal/underweight pregnant women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23394804"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Serum placental growth factor as a predictor of early onset preeclampsia in overweight/obese pregnant women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23394804"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Repeated measures of placental growth factor, placental protein 13, and a disintegrin and metalloprotease 12 at first and second trimesters for preeclampsia screening."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23386402"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "To determine the utility of cross-trimester repeated measures of placental protein 13 (PP13), A disintegrin and metalloprotease 12 (ADAM12), and placental growth factor (PlGF) for preeclampsia (PE) screening."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23386402"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "The polymorphism for endothelial nitric oxide synthase gene, the level of nitric oxide and the risk for pre-eclampsia: a meta-analysis."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23375994"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Wild-type female mice crossed with transgenic male mice reproduce accurately the symptoms of severe PE: gestational hypertension, proteinuria, and elevated plasma levels of soluble fms-like tyrosine kinase 1 and soluble endoglin."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23357179"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Wild-type female mice crossed with transgenic male mice reproduce accurately the symptoms of severe PE: gestational hypertension, proteinuria, and elevated plasma levels of soluble fms-like tyrosine kinase 1 and soluble endoglin."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23357179"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADM"}, "span_text": {"type": "literal", "value": "The aim of the present study was to compare maternal circulating levels of endothelial dysfunction mediators, including the vascular actions of adrenomedullin (AM) and calcitonin gene-related peptide (CGRP), the angiogenic factor of soluble intracellular adhesion molecule-1 (sICAM-1) and the pro-oxidant activity factor of total homocysteine (tHcy), in the plasma of normal and pre-eclampsia pregnancies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23356193"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADM2"}, "span_text": {"type": "literal", "value": "The aim of the present study was to compare maternal circulating levels of endothelial dysfunction mediators, including the vascular actions of adrenomedullin (AM) and calcitonin gene-related peptide (CGRP), the angiogenic factor of soluble intracellular adhesion molecule-1 (sICAM-1) and the pro-oxidant activity factor of total homocysteine (tHcy), in the plasma of normal and pre-eclampsia pregnancies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23356193"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Plasma samples drawn at HAART initiation and 1 month later from 60 women without preeclampsia and at HAART initiation for all 11 preeclamptic women were assayed for placental growth factor (PlGF) and soluble FMS toll-like tyrosine kinase-1 (sFlt-1)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23344545"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MTHFR"}, "span_text": {"type": "literal", "value": "The association between methylenetetrahydrofolate reductase C677T polymorphism and pre-eclampsia risk: appraisal of a recent meta-analysis."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23344126"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NGF"}, "span_text": {"type": "literal", "value": "The present study examines the levels of maternal plasma and milk neurotrophins [(nerve growth factor (NGF) and brain derived neurotrophic factor (BDNF)] in women with preeclampsia and compares them with normotensive women who served as controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23337827"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:BDNF"}, "span_text": {"type": "literal", "value": "The present study examines the levels of maternal plasma and milk neurotrophins [(nerve growth factor (NGF) and brain derived neurotrophic factor (BDNF)] in women with preeclampsia and compares them with normotensive women who served as controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23337827"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:BDNF"}, "span_text": {"type": "literal", "value": "Higher levels of brain derived neurotrophic factor but similar nerve growth factor in human milk in women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23337827"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NGF"}, "span_text": {"type": "literal", "value": "Higher levels of brain derived neurotrophic factor but similar nerve growth factor in human milk in women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23337827"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "To determine whether maternal plasma concentrations of placental growth factor (PlGF), soluble endoglin (sEng), and soluble vascular endothelial growth factor receptor-1 (sVEGFR-1) at 30-34 weeks of gestation can identify patients at risk for stillbirth, late preeclampsia, and delivery of small-for-gestational-age (SGA) neonates."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23333542"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "The intensity of endoglin and VEGFR1 expression was maximum in the syncytiotrophoblast and extravillous cytotrophoblast cells in severe pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23330145"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "Endothelial nitric oxide synthase gene polymorphisms and risk of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23329567"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HMOX2"}, "span_text": {"type": "literal", "value": "Intriguingly, it now appears that the heme oxygenase system can be dramatically altered by pathological disorders of pregnancy, in particular preeclampsia, perhaps functionally in the symptomatic phase of the disorder."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23328500"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HMOX1"}, "span_text": {"type": "literal", "value": "Intriguingly, it now appears that the heme oxygenase system can be dramatically altered by pathological disorders of pregnancy, in particular preeclampsia, perhaps functionally in the symptomatic phase of the disorder."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23328500"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HMOX2"}, "span_text": {"type": "literal", "value": "Heme oxygenase in pregnancy and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23328500"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HMOX1"}, "span_text": {"type": "literal", "value": "Heme oxygenase in pregnancy and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23328500"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MTHFR"}, "span_text": {"type": "literal", "value": "Association between the methylenetetrahydrofolate reductase C677T polymorphism and susceptibility to preeclampsia: the need for data clarification in a recent meta-analysis."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23324864"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Impaired autophagy by soluble endoglin, under physiological hypoxia in early pregnant period, is involved in poor placentation in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23321791"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GAS7"}, "span_text": {"type": "literal", "value": "Serum levels of growth arrest specific protein 6 are increased in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23318499"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GAS2"}, "span_text": {"type": "literal", "value": "Serum levels of growth arrest specific protein 6 are increased in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23318499"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GAS6"}, "span_text": {"type": "literal", "value": "Serum levels of growth arrest specific protein 6 are increased in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23318499"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GAS8"}, "span_text": {"type": "literal", "value": "Serum levels of growth arrest specific protein 6 are increased in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23318499"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "In addition, there were higher serum leptin levels in individuals with the GC + CC genotype both in the total cohort and in women with preeclampsia than in those with the GG genotype."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23315873"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "The aim of this study was to investigate the relationship between the leptin receptor (LEPR) polymorphism/serum leptin level and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23315873"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "The serum leptin levels of preeclampsia cases were significantly higher than those of controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23315873"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEPR"}, "span_text": {"type": "literal", "value": "High leptin level and leptin receptor Lys656Asn variant are risk factors for preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23315873"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "High leptin level and leptin receptor Lys656Asn variant are risk factors for preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23315873"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEPR"}, "span_text": {"type": "literal", "value": "The aim of this study was to investigate the relationship between the leptin receptor (LEPR) polymorphism/serum leptin level and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23315873"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Furthermore, high leptin level and the LEPR variant are risk factors for preeclampsia in Chinese women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23315873"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "To evaluate the usefulness of the mean pulsatility index of the uterine arteries (mPI-UtA) and automated measurement of the soluble fms-like tyrosine kinase 1 (sFlt-1)/placental growth factor (PlGF) ratio on suspicion or at diagnosis of pre-eclampsia (PE)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23303638"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Vascular endothelial dysfunction in preeclampsia has been partially attributed to changes in endothelin-1 (ET-1)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23297376"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Angiotensin receptor agonistic autoantibody-mediated soluble fms-like tyrosine kinase-1 induction contributes to impaired adrenal vasculature and decreased aldosterone production in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23283357"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "AT1-AA are detectable in animal models of preeclampsia and are responsible for elevation of soluble fms-related tyrosine kinase-1 (sFlt1) and soluble endoglin (sEng), oxidative stress, and endothelin-1, all of which are enhanced in preeclamptic women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23279165"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Hypomethylation of the LEP gene in placenta and elevated maternal leptin concentration in early onset pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23274423"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "In pre-eclampsia, placental leptin is up-regulated and leptin is elevated in maternal plasma."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23274423"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "This is the first study to characterize MT-MMP protein localization in human placenta and indicates that MMP-14 is the only MT-MMP that contributes to soluble endoglin production in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23261267"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Soluble endoglin is an anti-angiogenic factor released from placenta that has been linked to severe pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23261267"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CD40LG"}, "span_text": {"type": "literal", "value": "The expression and concentration of CD40 ligand in normal pregnancy, preeclampsia, and hemolytic anemia, elevated liver enzymes and low platelet count (HELLP) syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23241952"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:COMT"}, "span_text": {"type": "literal", "value": "2-methoxyoestradiol levels and placental catechol-O-methyltransferase expression in patients with late-onset preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23233290"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:COMT"}, "span_text": {"type": "literal", "value": "Deficiencies in placental catechol-O-methyltransferase (COMT) and circulating 2-methoxyoestradiol (2-ME) have been shown to be related to early onset preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23233290"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Increased oxidized low-density lipoprotein causes blood-brain barrier disruption in early-onset preeclampsia through LOX-1."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23230281"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Is serum placental growth factor more effective as a biomarker in predicting early onset preeclampsia in early second trimester than in first trimester of pregnancy?"}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23224699"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "To determine whether maternal serum placental growth factor (PlGF) is more effective as a biomarker in predicting the occurrence of early onset preeclampsia in first trimester or early second trimester of pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23224699"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "Role of corin and atrial natriuretic peptide in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23211473"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Placental growth factor for the prediction of adverse outcomes in patients with suspected preeclampsia or intrauterine growth restriction."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23209675"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Risks for preeclampsia and small for gestational age: predictive values of placental growth factor, soluble fms-like tyrosine kinase-1, and inhibin A in singleton and multiple-gestation pregnancies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23208763"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Risks for preeclampsia and small for gestational age: predictive values of placental growth factor, soluble fms-like tyrosine kinase-1, and inhibin A in singleton and multiple-gestation pregnancies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23208763"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "To determine the accuracy of placental growth factor (PlGF), soluble fms-like tyrosine kinase-1 (sFlt-1), and inhibin A in singleton and multiple-gestation pregnancies for predicting preeclampsia (PE) and small for gestational age (SGA)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23208763"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Of special interest was the 30% down-regulation (P=0.05) of the antiangiogenic factor and preeclampsia risk marker fms-like tyrosine kinase-1 (sFLT1) in the placenta tissues obtained from the 930 vs. 480 mg/d choline intake group."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23195033"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "To investigate whether fetal endothelial cell proliferation and migration are modulated by the A2A adenosine receptor (A2AAR), nitric oxide (NO) and the vascular endothelial growth factor (VEGF) signaling pathway, we isolated human umbilical vein endothelial cells from normal pregnancy (n = 23), preterm delivery (n = 4), and late-onset (LOPE, n = 10) and early-onset preeclampsia (EOPE, n = 8)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23179048"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "To investigate whether fetal endothelial cell proliferation and migration are modulated by the A2A adenosine receptor (A2AAR), nitric oxide (NO) and the vascular endothelial growth factor (VEGF) signaling pathway, we isolated human umbilical vein endothelial cells from normal pregnancy (n = 23), preterm delivery (n = 4), and late-onset (LOPE, n = 10) and early-onset preeclampsia (EOPE, n = 8)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23179048"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "To investigate whether fetal endothelial cell proliferation and migration are modulated by the A2A adenosine receptor (A2AAR), nitric oxide (NO) and the vascular endothelial growth factor (VEGF) signaling pathway, we isolated human umbilical vein endothelial cells from normal pregnancy (n = 23), preterm delivery (n = 4), and late-onset (LOPE, n = 10) and early-onset preeclampsia (EOPE, n = 8)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23179048"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGT"}, "span_text": {"type": "literal", "value": "Synergistic effects of angiotensinogen -217 G\u2192A and T704C (M235T) variants on the risk of severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23178514"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL6"}, "span_text": {"type": "literal", "value": "Serum levels of neopterin, tumor necrosis factor-alpha and Interleukin-6 in preeclampsia: relationship with disease severity."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23161044"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Maternal serum soluble endoglin at 30-33 weeks in the prediction of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23154616"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL10"}, "span_text": {"type": "literal", "value": "To investigate the expression of tumor necrosis factor-alpha (TNF-\u03b1), interleukin-6 (IL-6) and interleukin-10 (IL-10) in villous trophoblast, syncytial knots and decidua placentas from pregnancies complicated with preeclampsia (PE), Hemolysis, Elevated Liver enzymes and Low Platelet count (HELLP) syndrome and gestational age-matched controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23131093"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL6"}, "span_text": {"type": "literal", "value": "To investigate the expression of tumor necrosis factor-alpha (TNF-\u03b1), interleukin-6 (IL-6) and interleukin-10 (IL-10) in villous trophoblast, syncytial knots and decidua placentas from pregnancies complicated with preeclampsia (PE), Hemolysis, Elevated Liver enzymes and Low Platelet count (HELLP) syndrome and gestational age-matched controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23131093"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VTN"}, "span_text": {"type": "literal", "value": "Increased expression levels of vitronectin in the maternal\u2011fetal interface of placenta in early-onset severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23124223"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "The purpose of this study was to compare plasma soluble endoglin (sEng) levels with standard clinical evaluation or plasma levels of other angiogenic proteins [soluble fms-like tyrosine kinase 1 (sFlt1) and placental growth factor (PlGF)] in predicting short-term adverse maternal and perinatal outcomes in women with suspected preeclampsia presenting prior to 34 weeks."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23110221"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Soluble endoglin was strongly correlated with sFlt1 and PlGF levels, suggesting common pathogenic pathways leading to preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23110221"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Plasma concentrations of soluble endoglin versus standard evaluation in patients with suspected preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23110221"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MTHFR"}, "span_text": {"type": "literal", "value": "We aimed to investigate the association between methylenetetrahydrofolate reductase (MTHFR) C677T and endothelial nitric oxide synthase (eNOS) G894T polymorphisms with lipid peroxidation, total antioxidant capacity (TAC) and the risk of preeclampsia in preeclamptic women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23103710"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "To investigate the association of polymorphisms in the vascular endothelial growth factor (VEGF) family genes (VEGFA rs699947, VEGFA rs3025039, PGF rs1042886, KDR rs2071559 and KDR rs2305948) with preeclampsia in Sinhalese women in Sri-Lanka."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23102494"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Vascular endothelial growth factor family gene polymorphisms in preeclampsia in Sinhalese women in Sri-Lanka."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23102494"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Vascular endothelial growth factor family gene polymorphisms in preeclampsia in Sinhalese women in Sri-Lanka."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23102494"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "To investigate the association of polymorphisms in the vascular endothelial growth factor (VEGF) family genes (VEGFA rs699947, VEGFA rs3025039, PGF rs1042886, KDR rs2071559 and KDR rs2305948) with preeclampsia in Sinhalese women in Sri-Lanka."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23102494"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Vascular endothelial growth factor family gene polymorphisms in preeclampsia in Sinhalese women in Sri-Lanka."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23102494"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "To investigate the association of polymorphisms in the vascular endothelial growth factor (VEGF) family genes (VEGFA rs699947, VEGFA rs3025039, PGF rs1042886, KDR rs2071559 and KDR rs2305948) with preeclampsia in Sinhalese women in Sri-Lanka."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23102494"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL10"}, "span_text": {"type": "literal", "value": "Relationship between interleukin-10 polymorphism and maternal serum leptin level in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23088578"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Relationship between interleukin-10 polymorphism and maternal serum leptin level in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23088578"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL10"}, "span_text": {"type": "literal", "value": "The aim of this study was to evaluate the role of interleukin-10 polymorphism along with leptin in the pathogenesis of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23088578"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "The aim of this study was to evaluate the role of interleukin-10 polymorphism along with leptin in the pathogenesis of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23088578"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "The serum leptin was found to be significantly higher in preeclampsia group and with a more significant increase in AA genotype."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23088578"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CCNE1"}, "span_text": {"type": "literal", "value": "Importantly, the levels of cyclin\u00a0E1 and VEGF-A were negatively correlated with the level of miR-16 expression in decidua-derived mesenchymal stem cells from the patients with severe pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23083510"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "Plasma concentrations of total and free thyroxine (TT4 and FT4), total and free triiodothyronine (TT3 and FT3), thyroid-stimulating hormone (TSH), plasma albumin and urate were measured in 39 proteinuric pre-eclamptic patients presenting before labour."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/2306430"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Vascular endothelial growth factor (VEGF) has been reported to be altered in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23056578"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Vascular endothelial growth factor (VEGF) has been reported to be altered in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23056578"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Vascular endothelial growth factor (VEGF) has been reported to be altered in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23056578"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "To measure plasma nitric oxide (NO), asymmetric dimethylarginine (ADMA) and vascular endothelial growth factor (VEGF) levels and VEGF gene polymorphisms in fetal circulation in severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23039092"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "To measure plasma nitric oxide (NO), asymmetric dimethylarginine (ADMA) and vascular endothelial growth factor (VEGF) levels and VEGF gene polymorphisms in fetal circulation in severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23039092"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Feto-placental nitric oxide, asymmetric dimethylarginine and vascular endothelial growth factor (VEGF) levels and VEGF gene polymorphisms in severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23039092"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Feto-placental nitric oxide, asymmetric dimethylarginine and vascular endothelial growth factor (VEGF) levels and VEGF gene polymorphisms in severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23039092"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "To measure plasma nitric oxide (NO), asymmetric dimethylarginine (ADMA) and vascular endothelial growth factor (VEGF) levels and VEGF gene polymorphisms in fetal circulation in severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23039092"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Feto-placental nitric oxide, asymmetric dimethylarginine and vascular endothelial growth factor (VEGF) levels and VEGF gene polymorphisms in severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23039092"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Anti-angiogenic endoglin is significantly higher in PE and HELLP syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23020582"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "To investigate the serum level distribution of angiogenic markers (PlGF, endoglin, sFlt-1) and acute-phase proteins (SAA, CRP) in patients with HELLP syndrome or preeclampsia (PE) including matched controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23020582"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Moreover, as these reproductive disorders often come with metabolic complications such as insulin and glucose resistance, the insulin-sensitizing effects of adiponectin may explain the observed association of this adipokine with PCOS, GDM, and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23017719"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Here, we tested whether maternal serum levels of placental growth factor (PlGF) and soluble FMS-like tyrosine kinase-1 (sFlt-1), markers of preeclampsia, could be used to discriminate between 34 patients with preeclampsia, 23 patients with CKD during pregnancy, and 38 healthy pregnant women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23014459"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL6"}, "span_text": {"type": "literal", "value": "Analysis of polymorphisms in interleukin-10, interleukin-6, and interleukin-1 receptor antagonist in Mexican-Mestizo women with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23013217"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL1RN"}, "span_text": {"type": "literal", "value": "Due to the fact that studies seeking associations of polymorphisms in regulatory regions of cytokine genes with pre-eclampsia (PE) have not always been consistent in different population analyses, the aim of this study was to investigate the possible association between rs1800896 of interleukin-10 (IL-10), rs1800795 of interleukin-6 (IL-6), and the variable number of tandem repeats (VNTR) in intron 2 of interleukin-1 receptor antagonist (IL-1Ra), as well as gene-gene interactions between these three polymorphisms with the presence of PE in Mexican-Mestizo women and one Amerindian population from M\u00e9xico (Maya)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23013217"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL10"}, "span_text": {"type": "literal", "value": "Due to the fact that studies seeking associations of polymorphisms in regulatory regions of cytokine genes with pre-eclampsia (PE) have not always been consistent in different population analyses, the aim of this study was to investigate the possible association between rs1800896 of interleukin-10 (IL-10), rs1800795 of interleukin-6 (IL-6), and the variable number of tandem repeats (VNTR) in intron 2 of interleukin-1 receptor antagonist (IL-1Ra), as well as gene-gene interactions between these three polymorphisms with the presence of PE in Mexican-Mestizo women and one Amerindian population from M\u00e9xico (Maya)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23013217"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL1RN"}, "span_text": {"type": "literal", "value": "Analysis of polymorphisms in interleukin-10, interleukin-6, and interleukin-1 receptor antagonist in Mexican-Mestizo women with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23013217"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL10"}, "span_text": {"type": "literal", "value": "Analysis of polymorphisms in interleukin-10, interleukin-6, and interleukin-1 receptor antagonist in Mexican-Mestizo women with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23013217"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL6"}, "span_text": {"type": "literal", "value": "Due to the fact that studies seeking associations of polymorphisms in regulatory regions of cytokine genes with pre-eclampsia (PE) have not always been consistent in different population analyses, the aim of this study was to investigate the possible association between rs1800896 of interleukin-10 (IL-10), rs1800795 of interleukin-6 (IL-6), and the variable number of tandem repeats (VNTR) in intron 2 of interleukin-1 receptor antagonist (IL-1Ra), as well as gene-gene interactions between these three polymorphisms with the presence of PE in Mexican-Mestizo women and one Amerindian population from M\u00e9xico (Maya)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/23013217"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VWF"}, "span_text": {"type": "literal", "value": "von Willebrand factor multimeric levels and patterns in patients with severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/2300343"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Endothelin-1: a key pathological factor in pre-eclampsia?"}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22995748"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:WASF3"}, "span_text": {"type": "literal", "value": "In this study, we characterized HtrA4, a previously uncharacterized HtrA protein family member, in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22964307"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:WASF1"}, "span_text": {"type": "literal", "value": "In this study, we characterized HtrA4, a previously uncharacterized HtrA protein family member, in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22964307"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GP2"}, "span_text": {"type": "literal", "value": "The expression of the anti-inflammatory glycoprotein progranulin and the hypoxia-induced transcription factor 1\u03b1 (HIF-1\u03b1) in the villous trophoblast was compared between placentae from patients with preeclampsia (PE), fetal growth restriction (FGR), and normal controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22945272"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HMOX2"}, "span_text": {"type": "literal", "value": "Differential expression of HSP90\u03b1 and heme oxygenase in cord blood RBC during preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22935040"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HMOX2"}, "span_text": {"type": "literal", "value": "This study aims to analyze the regulation relationship between HSP90\u03b1 and heme oxygenase-2 (HO-2) in cord blood RBC during preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22935040"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HMOX1"}, "span_text": {"type": "literal", "value": "Differential expression of HSP90\u03b1 and heme oxygenase in cord blood RBC during preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22935040"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MTHFR"}, "span_text": {"type": "literal", "value": "Meta-analysis of the methylenetetrahydrofolate reductase C677T polymorphism and susceptibility to pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22914556"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MTHFR"}, "span_text": {"type": "literal", "value": "A number of studies have investigated the association between the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and the risk of pre-eclampsia (PE) in various populations and have delivered inconsistent results."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22914556"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL1RN"}, "span_text": {"type": "literal", "value": "Placental secretion of interleukin-1 and interleukin-1 receptor antagonist in preeclampsia: effect of magnesium sulfate."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22909148"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Preeclampsia is characterized by an imbalance in angiogenic factors such as soluble fms-like tyrosine kinase-1 (sFlt-1) and placental growth factor (PlGF)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22902831"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Changes in circulating concentrations of soluble fms-like tyrosine kinase-1 and placental growth factor measured by automated electrochemiluminescence immunoassays methods are predictors of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22902831"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Changes in circulating concentrations of soluble fms-like tyrosine kinase-1 and placental growth factor measured by automated electrochemiluminescence immunoassays methods are predictors of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22902831"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:C3AR1"}, "span_text": {"type": "literal", "value": "The aim of this study was to determine the expression of the anaphylatoxin receptors complement C3a receptor (C3aR) and C5a receptor (C5aR) in the placentas of pregnancies complicated by severe early onset preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22901903"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LOC100505909"}, "span_text": {"type": "literal", "value": "Prediction of preeclampsia by combining serum histidine-rich glycoprotein and uterine artery Doppler."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22895448"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HRG"}, "span_text": {"type": "literal", "value": "Prediction of preeclampsia by combining serum histidine-rich glycoprotein and uterine artery Doppler."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22895448"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Differential diagnosis of preeclampsia: remember the soluble fms-like tyrosine kinase 1/placental growth factor ratio."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22892815"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Differential diagnosis of preeclampsia: remember the soluble fms-like tyrosine kinase 1/placental growth factor ratio."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22892815"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:COMT"}, "span_text": {"type": "literal", "value": "To determine whether maternal plasma levels of 2-methoxyestradiol (2-ME) are decreased early in pregnancies that subsequently develop pre-eclampsia (PE) and whether this difference could be attributed to the presence of Val158Met catechol-O-methyltransferase (COMT) polymorphism in the placenta."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22886584"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "To study associations of placental growth factor (PlGF) and soluble fms-like tyrosine kinase 1 (sFlt-1) in maternal circulation with the risk of preeclampsia with and without fetal growth restriction."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22882089"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGT"}, "span_text": {"type": "literal", "value": "There are controversies in reports on the association of the angiotensinogen (AGT) gene polymorphisms with the risk of developing pre-eclampsia (PE)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22881375"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGT"}, "span_text": {"type": "literal", "value": "Angiotensinogen gene M235T and T174M polymorphisms and susceptibility of pre-eclampsia: a meta-analysis."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22881375"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADM"}, "span_text": {"type": "literal", "value": "Adrenomedullin (ADM), a peptide with vasodilatory natriuretic and diuretic properties, is secreted in many tissues and shows multidirectional activity ADM activity may play an important role in the pathophysiology of gestational hypertension (GH) and preeclampsia (PE) by involvement in compensation of failed utero-placental unit circulation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22880472"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADM2"}, "span_text": {"type": "literal", "value": "Contribution of maternal-fetal adrenomedullin polymorphism to gestational hypertension and preedlampsia--gene-gene interaction pilot study."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22880472"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADM"}, "span_text": {"type": "literal", "value": "Contribution of maternal-fetal adrenomedullin polymorphism to gestational hypertension and preedlampsia--gene-gene interaction pilot study."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22880472"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADM2"}, "span_text": {"type": "literal", "value": "Adrenomedullin (ADM), a peptide with vasodilatory natriuretic and diuretic properties, is secreted in many tissues and shows multidirectional activity ADM activity may play an important role in the pathophysiology of gestational hypertension (GH) and preeclampsia (PE) by involvement in compensation of failed utero-placental unit circulation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22880472"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:C3AR1"}, "span_text": {"type": "literal", "value": "Autoantibody-mediated complement C3a receptor activation contributes to the pathogenesis of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22868393"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Moreover, it appears that endothelin-1 signaling may play a central role in the hypertension associated with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22848831"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TLR3"}, "span_text": {"type": "literal", "value": "Placental Toll-like receptor 3 and Toll-like receptor 7/8 activation contributes to preeclampsia in humans and mice."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22848646"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TLR7"}, "span_text": {"type": "literal", "value": "Placental Toll-like receptor 3 and Toll-like receptor 7/8 activation contributes to preeclampsia in humans and mice."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22848646"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TTR"}, "span_text": {"type": "literal", "value": "Human placental transthyretin in fetal growth restriction in combination with preeclampsia and the HELLP syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22847813"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TTR"}, "span_text": {"type": "literal", "value": "Objective was to investigate the localization and abundance of transthyretin (TTR) in placentas of pregnancies suffering from fetal growth restriction with and without preeclampsia and HELLP."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22847813"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "We sought to determine if endothelial microparticles (EMPs), markers of endothelial damage, are associated with soluble fms-like tyrosine kinase 1 (sFlt1), soluble endoglin, and placental growth factor (PlGF) in women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22840727"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "We sought to determine if endothelial microparticles (EMPs), markers of endothelial damage, are associated with soluble fms-like tyrosine kinase 1 (sFlt1), soluble endoglin, and placental growth factor (PlGF) in women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22840727"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "We analyzed demographic and clinical data from a postpartum screening (blood pressure, microalbuminuria and fasting plasma levels of glucose, insulin, and lipid profile) from 683 primiparous women with a history of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22825090"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Thrombin enhances soluble Fms-like tyrosine kinase 1 expression in trophoblasts; possible involvement in the pathogenesis of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22819145"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Placental growth factor (PlGF) MoM was significantly reduced in women who later developed early- or late-onset pre-eclampsia compared with controls (median (interquartile range), 0.69 (0.33-1.46) and 1.10 (0.39-1.56), respectively, vs 1.19 (0.65-1.84), P\u2009<\u20090.05)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22807133"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Carotid intima-media thickness (CIMT) and brachial artery flow-mediated dilatation (FMD) measured by ultrasonography, and lipid profile and insulin resistance evaluated by biochemical assays were compared between 34 women with a history of severe preeclampsia and 42 women with a prior normal pregnancy at least 12-24 months postpartum."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22806171"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TLR4"}, "span_text": {"type": "literal", "value": "Oxidative damage, inflammation, and Toll-like receptor 4 pathway are increased in preeclamptic patients: a case-control study."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22792416"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HMOX1"}, "span_text": {"type": "literal", "value": "It is well known that oxLDL activates nuclear factor erythroid 2-related factor 2 (Nrf2), a master regulator of antioxidant and cytoprotective genes such as heme oxygenase-1 (HO-1), which play an important role in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22791762"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Plasma level of hydroxysteroid (17-\u03b2) dehydrogenase 1 in the second trimester is an independent risk factor for predicting preeclampsia after adjusting for the effects of mean blood pressure, bilateral notching and plasma level of soluble fms-like tyrosine kinase 1/placental growth factor ratio."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22786566"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Mean blood pressure (MBP), bilateral notching (BN) in the uterine artery and increased circulating levels of soluble fms-like tyrosine kinase-1/placental growth factor (sFlt-1/PlGF) ratio are predictors of preeclampsia (PE)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22786566"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Mean blood pressure (MBP), bilateral notching (BN) in the uterine artery and increased circulating levels of soluble fms-like tyrosine kinase-1/placental growth factor (sFlt-1/PlGF) ratio are predictors of preeclampsia (PE)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22786566"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Plasma level of hydroxysteroid (17-\u03b2) dehydrogenase 1 in the second trimester is an independent risk factor for predicting preeclampsia after adjusting for the effects of mean blood pressure, bilateral notching and plasma level of soluble fms-like tyrosine kinase 1/placental growth factor ratio."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22786566"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "Inhibition of nitric oxide synthase with N-omega-nitro-l-arginine methyl ester (l-NAME) has been employed as an experimental model of human preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22781706"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "First-trimester maternal serum metastin, placental growth factor and chitotriosidase levels in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22770630"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Soluble endoglin is an anti-angiogenic protein released from placenta and thought to play a central role in causing the endothelial dysfunction and maternal organ injury seen in severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22768148"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "We conclude MMP-15 is up-regulated in preeclampsia, but does not cleave endoglin to produce soluble endoglin."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22768148"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "This find identifies a specific drug target for severe preeclampsia; interfering with MMP-14 mediated cleavage of endoglin could decrease soluble endoglin production, ameliorating clinical disease."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22768148"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "MMP-15 is upregulated in preeclampsia, but does not cleave endoglin to produce soluble endoglin."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22768148"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CRH"}, "span_text": {"type": "literal", "value": "Aberrant expression of corticotropin-releasing hormone in pre-eclampsia induces expression of FasL in maternal macrophages and extravillous trophoblast apoptosis."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22763913"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "We hypothesized that pre-eclampsia (PE) can be predicted early in primiparas by measuring serum levels of soluble fms-like tyrosine kinase-1 (sFlt-1) and placental growth factor (PlGF)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22686711"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Prediction of pre-eclampsia during early pregnancy in primiparas with soluble fms-like tyrosine kinase-1 and placental growth factor."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22686711"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Prediction of pre-eclampsia during early pregnancy in primiparas with soluble fms-like tyrosine kinase-1 and placental growth factor."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22686711"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MPO"}, "span_text": {"type": "literal", "value": "Evaluation of the relationship between adenosine deaminase, myeloperoxidase, cholinesterase, preeclampsia severity, and neonatal outcomes."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22681531"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MPO"}, "span_text": {"type": "literal", "value": "We aimed to evaluate whole blood adenosine deaminase (ADA), myeloperoxidase (MPO), butyrylcholinesterase (BChE), and acetylcholinesterase (AChE) activities and to investigate whether there was a correlation between these enzymes and severity of preeclampsia and neonatal outcomes."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22681531"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOE"}, "span_text": {"type": "literal", "value": "Apolipoprotein E genotypes, lipid peroxidation, and antioxidant status among mild and severe preeclamptic women from western Iran: protective role of apolipoprotein \u03b52 allele in severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22676395"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOF"}, "span_text": {"type": "literal", "value": "Apolipoprotein E genotypes, lipid peroxidation, and antioxidant status among mild and severe preeclamptic women from western Iran: protective role of apolipoprotein \u03b52 allele in severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22676395"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOM"}, "span_text": {"type": "literal", "value": "Apolipoprotein E genotypes, lipid peroxidation, and antioxidant status among mild and severe preeclamptic women from western Iran: protective role of apolipoprotein \u03b52 allele in severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22676395"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOO"}, "span_text": {"type": "literal", "value": "Apolipoprotein E genotypes, lipid peroxidation, and antioxidant status among mild and severe preeclamptic women from western Iran: protective role of apolipoprotein \u03b52 allele in severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22676395"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOE"}, "span_text": {"type": "literal", "value": "The aim of this study was to examine the association of apolipoprotein E (APOE) genotypes and oxidative stress with the risk of mild and severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22676395"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APLN"}, "span_text": {"type": "literal", "value": "Decreased maternal plasma apelin concentrations in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22676366"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APLN"}, "span_text": {"type": "literal", "value": "Plasma apelin concentrations, measured at delivery, were lower in preeclampsia cases compared with controls (mean \u00b1 standard deviation:"}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22676366"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APLN"}, "span_text": {"type": "literal", "value": "After controlling for confounding by maternal age, smoking status, and pre-pregnancy body mass index, odds of preeclampsia were 48% lower for women with high versus low plasma apelin (\u22650.73 vs. <0.73 ng/mL) concentrations."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22676366"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APLN"}, "span_text": {"type": "literal", "value": "Reduced circulating apelin peptides may be associated with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22676366"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FCN3"}, "span_text": {"type": "literal", "value": "In this study, we measured plasma levels of ficolin-2 and ficolin-3 in 60 pre-eclamptic patients, 60 healthy pregnant women and 59 healthy non-pregnant women by enzyme-linked immunosorbent assay (ELISA)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22670778"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FCN2"}, "span_text": {"type": "literal", "value": "Furthermore, pre-eclamptic patients had significantly lower ficolin-2 and ficolin-3 concentrations than healthy non-pregnant and pregnant women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22670778"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FCN2"}, "span_text": {"type": "literal", "value": "Circulating ficolin-2 and ficolin-3 in normal pregnancy and pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22670778"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FCN3"}, "span_text": {"type": "literal", "value": "Furthermore, pre-eclamptic patients had significantly lower ficolin-2 and ficolin-3 concentrations than healthy non-pregnant and pregnant women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22670778"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FCN2"}, "span_text": {"type": "literal", "value": "There is a further decrease in plasma ficolin-2 concentrations in pre-eclampsia, which might contribute to the development of the maternal syndrome of the disease through impaired removal of the trophoblast-derived material released into the maternal circulation by the hypoxic and oxidatively stressed pre-eclamptic placenta."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22670778"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FCN2"}, "span_text": {"type": "literal", "value": "In this study, we measured plasma levels of ficolin-2 and ficolin-3 in 60 pre-eclamptic patients, 60 healthy pregnant women and 59 healthy non-pregnant women by enzyme-linked immunosorbent assay (ELISA)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22670778"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FCN3"}, "span_text": {"type": "literal", "value": "Circulating ficolin-2 and ficolin-3 in normal pregnancy and pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22670778"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "An imbalance of the antiangiogenic and proangiogenic factors, soluble receptor fms-like tyrosine kinase 1 and placental growth factor (PGF), is thought to contribute to the pathophysiology of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22647886"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "An imbalance of the antiangiogenic and proangiogenic factors, soluble receptor fms-like tyrosine kinase 1 and placental growth factor (PGF), is thought to contribute to the pathophysiology of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22647886"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Maternal plasma PGF and soluble receptor fms-like tyrosine kinase 1 were quantified by specific immunoassays in cross-sectional samples from 130 preeclamptic subjects and 342 normotensive controls at delivery and longitudinally in samples from 50 women who developed preeclampsia and 250 normotensive controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22647886"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Low placental growth factor across pregnancy identifies a subset of women with preterm preeclampsia: type 1 versus type 2 preeclampsia?"}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22647886"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "To determine whether exogenous vascular endothelial growth factor (VEGF) supplementation to sera from women with preeclampsia can restore the podocyte barrier-forming capacity disrupted after stimulation with sera from these women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22639941"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "To determine whether exogenous vascular endothelial growth factor (VEGF) supplementation to sera from women with preeclampsia can restore the podocyte barrier-forming capacity disrupted after stimulation with sera from these women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22639941"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "To determine whether exogenous vascular endothelial growth factor (VEGF) supplementation to sera from women with preeclampsia can restore the podocyte barrier-forming capacity disrupted after stimulation with sera from these women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22639941"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Preeclampsia was associated with decreased antithrombin, IL-4 and placental growth factor levels and with increased C3a, pentraxin-3, and sFlt-1 levels, with more marked differences in the EOP group."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22626009"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "The trophoblast and angiogenesis markers ADAM-12, pregnancy-associated plasma protein-A, placental protein 13, placental growth factor, soluble fms-like tyrosine kinase-1, and endoglin were measured in a case-control subset of 174 women with preeclampsia and 509 women in the control group."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22617589"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "The trophoblast and angiogenesis markers ADAM-12, pregnancy-associated plasma protein-A, placental protein 13, placental growth factor, soluble fms-like tyrosine kinase-1, and endoglin were measured in a case-control subset of 174 women with preeclampsia and 509 women in the control group."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22617589"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "First-trimester concentrations (multiples of the median) of ADAM-12 (1.14 compared with 1.04; P=.003), pregnancy-associated plasma protein-A (0.94 compared with 0.98; P=.04), and placental growth factor (0.83 compared with 1.04; P<.001) were significantly different in women who had development of preeclampsia compared with women in the control group."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22617589"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "The trophoblast and angiogenesis markers ADAM-12, pregnancy-associated plasma protein-A, placental protein 13, placental growth factor, soluble fms-like tyrosine kinase-1, and endoglin were measured in a case-control subset of 174 women with preeclampsia and 509 women in the control group."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22617589"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Neither in the first nor in the second trimester were soluble fms-like tyrosine kinase-1 concentrations significantly associated with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22617584"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "First-trimester low placental growth factor was associated with fetal growth restriction (odds ratio [OR] 2.62, CI 1.68-4.08) and preeclampsia (OR 2.46, CI 1.49-4.08)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22617584"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Polymorphisms of the endothelial nitric oxide synthase (eNOS), matrix metalloproteinase-9 (MMP-9) and vascular endothelial growth factor (VEGF) genes were shown to be associated with hypertensive disorders of pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22573202"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Polymorphisms of the endothelial nitric oxide synthase (eNOS), matrix metalloproteinase-9 (MMP-9) and vascular endothelial growth factor (VEGF) genes were shown to be associated with hypertensive disorders of pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22573202"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Polymorphisms of the endothelial nitric oxide synthase (eNOS), matrix metalloproteinase-9 (MMP-9) and vascular endothelial growth factor (VEGF) genes were shown to be associated with hypertensive disorders of pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22573202"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGT"}, "span_text": {"type": "literal", "value": "These proteins included clusterin, fibrinogen, fibronectin, and angiotensinogen, increased levels of which are known to be associated with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22570525"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FSTL3"}, "span_text": {"type": "literal", "value": "Alterations of maternal serum and placental follistatin-like 3 and myostatin in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22568578"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Linking placental ischemia and hypertension in preeclampsia: role of endothelin 1."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22566502"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "There were significant differences (P = 0.034) between the supplementation and control group in the incidence of pre-eclampsia (2.0% [one case] and 14.5% [eight cases], respectively) and mRNA level of superoxide-dismutase, heme oxygenase-1, vascular endothelial growth factor receptor-1, endoglin and placental growth factor after supplementation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22563751"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "There were significant differences (P = 0.034) between the supplementation and control group in the incidence of pre-eclampsia (2.0% [one case] and 14.5% [eight cases], respectively) and mRNA level of superoxide-dismutase, heme oxygenase-1, vascular endothelial growth factor receptor-1, endoglin and placental growth factor after supplementation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22563751"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "There were significant differences (P = 0.034) between the supplementation and control group in the incidence of pre-eclampsia (2.0% [one case] and 14.5% [eight cases], respectively) and mRNA level of superoxide-dismutase, heme oxygenase-1, vascular endothelial growth factor receptor-1, endoglin and placental growth factor after supplementation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22563751"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "There were significant differences (P = 0.034) between the supplementation and control group in the incidence of pre-eclampsia (2.0% [one case] and 14.5% [eight cases], respectively) and mRNA level of superoxide-dismutase, heme oxygenase-1, vascular endothelial growth factor receptor-1, endoglin and placental growth factor after supplementation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22563751"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HMOX1"}, "span_text": {"type": "literal", "value": "There were significant differences (P = 0.034) between the supplementation and control group in the incidence of pre-eclampsia (2.0% [one case] and 14.5% [eight cases], respectively) and mRNA level of superoxide-dismutase, heme oxygenase-1, vascular endothelial growth factor receptor-1, endoglin and placental growth factor after supplementation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22563751"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD3"}, "span_text": {"type": "literal", "value": "There were significant differences (P = 0.034) between the supplementation and control group in the incidence of pre-eclampsia (2.0% [one case] and 14.5% [eight cases], respectively) and mRNA level of superoxide-dismutase, heme oxygenase-1, vascular endothelial growth factor receptor-1, endoglin and placental growth factor after supplementation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22563751"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "There were significant differences (P = 0.034) between the supplementation and control group in the incidence of pre-eclampsia (2.0% [one case] and 14.5% [eight cases], respectively) and mRNA level of superoxide-dismutase, heme oxygenase-1, vascular endothelial growth factor receptor-1, endoglin and placental growth factor after supplementation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22563751"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD1"}, "span_text": {"type": "literal", "value": "There were significant differences (P = 0.034) between the supplementation and control group in the incidence of pre-eclampsia (2.0% [one case] and 14.5% [eight cases], respectively) and mRNA level of superoxide-dismutase, heme oxygenase-1, vascular endothelial growth factor receptor-1, endoglin and placental growth factor after supplementation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22563751"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Monte Carlo simulation was used to estimate the pre-eclampsia screening performance of a pre-eclampsia detection algorithm using the Quadruple test markers with or without the addition of PlGF and/or endoglin."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22547409"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Median PlGF was 33% lower (95% confidence interval 24-41%) and endoglin 31% (20-43%) higher in pre-eclampsia than in unaffected pregnancies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22547409"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Including information on parity, pre-eclampsia in a previous pregnancy, family history (woman's mother) and assuming a pre-eclampsia prevalence of 2%, the detection rates for a 5% false-positive rate were 39% with the Quadruple test markers, 48% with addition of endoglin, 49% with addition of PlGF, and 54% with addition of both."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22547409"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "To estimate the pre-eclampsia screening performance of placental growth factor (PlGF) and endoglin with second-trimester Quadruple test markers used for antenatal Down's syndrome screening."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22547409"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Screening for pre-eclampsia using serum placental growth factor and endoglin with Down's syndrome Quadruple test markers."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22547409"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "To estimate the pre-eclampsia screening performance of placental growth factor (PlGF) and endoglin with second-trimester Quadruple test markers used for antenatal Down's syndrome screening."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22547409"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Screening for pre-eclampsia using serum placental growth factor and endoglin with Down's syndrome Quadruple test markers."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22547409"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Adding PlGF to the Quadruple test markers increased the pre-eclampsia detection rate from 34% to 45% at a 5% false-positive rate - it increased it to 43% with endoglin and to 50% with both."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22547409"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APLN"}, "span_text": {"type": "literal", "value": "The serum levels of apelin were higher in the pregnant women with preeclampsia; however, there was no positive relationship between serum salusin-alpha and salusin-beta levels and the disease."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22533552"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APLN"}, "span_text": {"type": "literal", "value": "The purpose of this study was to investigate the relationship between the serum apelin, salusin-alpha and salusin-beta levels and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22533552"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APLN"}, "span_text": {"type": "literal", "value": "Serum levels of apelin, salusin-alpha and salusin-beta in normal pregnancy and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22533552"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APLN"}, "span_text": {"type": "literal", "value": "No statistically significant difference was detected between the mild and severe preeclampsia groups in terms of the mean serum apelin levels."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22533552"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Endothelin-1 induces endoplasmic reticulum stress by activating the PLC-IP(3) pathway: implications for placental pathophysiology in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22503784"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Preeclampsia (PE), new-onset hypertension with proteinuria during pregnancy, is associated with increased reactive oxygen species, the vasoactive peptide endothelin-1 (ET-1), T and B lymphocytes, soluble antiangiogenic factors sFlt-1 and sEndoglin (sFlt-1 and sEng), and agonistic autoantibodies to the angiotensin II type I receptor (AT1-AA)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22498426"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "The search included a combination of terms such as VEGF-A, placental growth factor (PlGF), kinase insert domain receptor, fms-like-tyrosine-kinase receptor 1, soluble fms-like-tyrosine-kinase receptor 1, pre-eclampsia, small-for-gestational-age infants, preterm birth, recurrent miscarriage, placenta, prediction and polymorphisms."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22495259"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TBXAS1"}, "span_text": {"type": "literal", "value": "Reduced methylation of the thromboxane synthase gene is correlated with its increased vascular expression in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22493072"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TBXAS1"}, "span_text": {"type": "literal", "value": "Our study suggests that epigenetic mechanisms and release of tumor necrosis factor-\u03b1 by infiltrating neutrophils could contribute to the increased expression of thromboxane synthase in maternal systemic blood vessels, contributing to the hypertension and coagulation abnormalities associated with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22493072"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "An imbalance between anti-angiogenic factors (e.g. soluble vascular endothelial growth factor receptor-1 (s-FLT1) and soluble endoglin (s-Eng)) and pro-angiogenic factors (e.g. placental growth factor (PlGF)) as well as increased oxidized low-density lipoprotein (ox-LDL) concentrations have been associated with preeclampsia (PE)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22486210"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CD200"}, "span_text": {"type": "literal", "value": "It seems possible that higher expressions of CD200 molecule on CD1c(+) myeloid and BDCA-2(+) lymphoid DCs in pre-eclampsia may constitute the tolerogenic mechanism secondary to the pro-inflammatory response that is observed in this syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22462561"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CD200"}, "span_text": {"type": "literal", "value": "However, the expressions of CD200 molecule on CD1c(+) myeloid and BDCA-2(+) lymphoid DCs were significantly higher in pre-eclampsia when compared to the healthy third trimester pregnant women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22462561"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TFPI2"}, "span_text": {"type": "literal", "value": "Preeclampsia: the role of tissue factor and tissue factor pathway inhibitor."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22461171"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TFPI"}, "span_text": {"type": "literal", "value": "Preeclampsia: the role of tissue factor and tissue factor pathway inhibitor."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22461171"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Plasma lipoproteins and preeclampsia in women with type 1 diabetes: a prospective study."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22438226"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "To investigate the capacity of circulating placental growth factor (PlGF), vascular endothelial growth factor (VEGF), soluble fms-like tyrosine kinase-1 (sFLT1) and soluble endoglin (sENG) to predict pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22433027"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms-like tyrosine kinase 1 and soluble endoglin in the prediction of pre-eclampsia: a systematic review and meta-analysis."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22433027"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "To investigate the capacity of circulating placental growth factor (PlGF), vascular endothelial growth factor (VEGF), soluble fms-like tyrosine kinase-1 (sFLT1) and soluble endoglin (sENG) to predict pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22433027"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "To investigate the capacity of circulating placental growth factor (PlGF), vascular endothelial growth factor (VEGF), soluble fms-like tyrosine kinase-1 (sFLT1) and soluble endoglin (sENG) to predict pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22433027"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms-like tyrosine kinase 1 and soluble endoglin in the prediction of pre-eclampsia: a systematic review and meta-analysis."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22433027"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms-like tyrosine kinase 1 and soluble endoglin in the prediction of pre-eclampsia: a systematic review and meta-analysis."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22433027"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms-like tyrosine kinase 1 and soluble endoglin in the prediction of pre-eclampsia: a systematic review and meta-analysis."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22433027"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms-like tyrosine kinase 1 and soluble endoglin in the prediction of pre-eclampsia: a systematic review and meta-analysis."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22433027"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms-like tyrosine kinase 1 and soluble endoglin in the prediction of pre-eclampsia: a systematic review and meta-analysis."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22433027"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "To investigate the capacity of circulating placental growth factor (PlGF), vascular endothelial growth factor (VEGF), soluble fms-like tyrosine kinase-1 (sFLT1) and soluble endoglin (sENG) to predict pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22433027"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Concentrations of androgens (testosterone p\u00a0=\u00a00.06 and androstenedione p\u00a0=\u00a00.08) and the anti-angiogenic factors soluble fms-like kinase 1 (p\u00a0=\u00a00.004) and soluble endoglin (p\u00a0=\u00a00.004) were higher in the maternal circulation of women diagnosed with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22418778"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF1"}, "span_text": {"type": "literal", "value": "Steroid sex hormones, angiogenic factors, and components of the insulin-like growth factor axis were measured in maternal and umbilical cord sera from 48 pregnancies complicated by preeclampsia and 43 uncomplicated pregnancies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22418778"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF2"}, "span_text": {"type": "literal", "value": "Steroid sex hormones, angiogenic factors, and components of the insulin-like growth factor axis were measured in maternal and umbilical cord sera from 48 pregnancies complicated by preeclampsia and 43 uncomplicated pregnancies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22418778"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CALR"}, "span_text": {"type": "literal", "value": "Overexpression of calreticulin in pre-eclamptic placentas: effect on apoptosis, cell invasion and severity of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22415851"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Immunoperoxidase staining for VEGFR1 and Endoglin was more intense in mirror syndrome compared to gestational-age matched controls,and at a similar level to a case of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22401877"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL6"}, "span_text": {"type": "literal", "value": "Serum sEng, sFlt-1, placenta growth factor, interleukin-6 (IL-6), calprotectin, and plasma \u03b1-defensins concentrations were measured by ELISA in 88 women of similar gestational age stratified as: severe preeclampsia (sPE, n\u00a0=\u00a045), maternal systemic inflammatory response (SIR, n\u00a0=\u00a016) secondary to chorioamnionitis, pyelonephritis or appendicitis; and normotensive controls (CRL, n\u00a0=\u00a027)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22398973"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CRH"}, "span_text": {"type": "literal", "value": "Of particular interest is the role of corticotropin releasing hormone, urocortins and activins in the maintaining physiological pregnancy and in the pathogenesis of diseases (preterm birth and preeclampsia)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22394300"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:UCN"}, "span_text": {"type": "literal", "value": "Of particular interest is the role of corticotropin releasing hormone, urocortins and activins in the maintaining physiological pregnancy and in the pathogenesis of diseases (preterm birth and preeclampsia)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22394300"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Lectin-like oxidized low-density lipoprotein 1 receptor in a reduced uteroplacental perfusion pressure rat model of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22392901"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:COMT"}, "span_text": {"type": "literal", "value": "The ability of sildenafil citrate to increase uterine artery vasodilation, thereby decreasing uterine artery resistance and, hence, ameliorated preeclampsia and fetal growth restriction, was tested in a mouse model of preeclampsia, the catechol-O-methyl transferase knockout mouse (COMT(-/-))."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22392899"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Decreased expressions of vascular endothelial growth factor and visfatin in the placental bed of pregnancies complicated by preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22380724"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Decreased expressions of vascular endothelial growth factor and visfatin in the placental bed of pregnancies complicated by preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22380724"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "The aim of the present study was to examine the expression of vascular endothelial growth factor (VEGF) and visfatin in the third trimester placental bed of pregnancies with and without preeclampsia (PE)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22380724"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "The aim of the present study was to examine the expression of vascular endothelial growth factor (VEGF) and visfatin in the third trimester placental bed of pregnancies with and without preeclampsia (PE)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22380724"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "The aim of the present study was to examine the expression of vascular endothelial growth factor (VEGF) and visfatin in the third trimester placental bed of pregnancies with and without preeclampsia (PE)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22380724"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Decreased expressions of vascular endothelial growth factor and visfatin in the placental bed of pregnancies complicated by preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22380724"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CALR"}, "span_text": {"type": "literal", "value": "Calreticulin was also further increased during the hypertensive disorder of human pregnancy, pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22377355"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CALR"}, "span_text": {"type": "literal", "value": "Increased calreticulin may also contribute to altered functions of both cell types during pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22377355"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CALR"}, "span_text": {"type": "literal", "value": "To clarify the roles of circulating calreticulin in pregnancy and pre-eclampsia, the aim of this study was to determine the effects of exogenous calreticulin on two cell types that are relevant to normal human pregnancy and to pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22377355"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TCF4"}, "span_text": {"type": "literal", "value": "Down-regulation of the transcription factor Snail in placental progenitor cell lineages, either by intrinsic defects and/or by extrinsic and maternal factors, may affect normal placenta development and function and thus contribute to the pathology of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22360878"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TCF4"}, "span_text": {"type": "literal", "value": "Down-regulation of the transcription factor snail in the placentas of patients with preeclampsia and in a rat model of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22360878"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Gestational diabetes mellitus was positively associated with fasting glucose and insulin, even after adjustment for potential confounders, whereas hypertensive disorders of pregnancy were associated with body mass index, waist circumference, blood pressure, lipids, and insulin."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22344039"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "We sought to determine whether haptoglobin (Hp) phenotype is related to preeclampsia risk, or to plasma concentrations of soluble endoglin (sEng), soluble fms-like tyrosine kinase 1 (sFlt-1), and placental growth factor (PlGF)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22340942"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:DIO1"}, "span_text": {"type": "literal", "value": "The effect of the D1-C785T polymorphism in the type 1 iodothyronine deiodinase gene on the circulating thyroid hormone levels in Romanian women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22339181"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:DIO3"}, "span_text": {"type": "literal", "value": "The effect of the D1-C785T polymorphism in the type 1 iodothyronine deiodinase gene on the circulating thyroid hormone levels in Romanian women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22339181"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:DIO2"}, "span_text": {"type": "literal", "value": "The effect of the D1-C785T polymorphism in the type 1 iodothyronine deiodinase gene on the circulating thyroid hormone levels in Romanian women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22339181"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Circulating levels of sFlt1 and the ratio of sFlt1 to placental growth factor were higher before clinical diagnosis at 20 weeks' gestation in women who subsequently developed early onset preeclampsia between 28 and 34 weeks compared with levels in women who never developed preeclampsia (P=0.001) or who developed late-onset preeclampsia (P=0.001)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22311907"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Circulating levels of sFlt1, soluble endoglin, and the ratio of sFlt1:placental growth factor were also significantly higher, and placental growth factor levels were significantly lower at the time of clinical diagnosis of superimposed preeclampsia in women with either early or late-onset superimposed preeclampsia compared with levels at similar gestational ages in those with uncomplicated chronic hypertension."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22311907"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Circulating levels of sFlt1, soluble endoglin, and the ratio of sFlt1:placental growth factor were also significantly higher, and placental growth factor levels were significantly lower at the time of clinical diagnosis of superimposed preeclampsia in women with either early or late-onset superimposed preeclampsia compared with levels at similar gestational ages in those with uncomplicated chronic hypertension."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22311907"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "This approach provides a novel method for the development of potential therapeutics to reduce circulating soluble endoglin and ameliorate the clinical features of severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22296769"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "To determine whether this is also the mechanism responsible for soluble endoglin release in preeclampsia, we investigated the expression of MMP-14 within the placenta and the effects of its inhibition on soluble endoglin release."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22296769"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Soluble endoglin is an anti-angiogenic protein that is released from the placenta and contributes to both maternal endothelial dysfunction and the clinical features of severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22296769"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "These findings indicate that MMP-14 is the likely cleavage protease of endoglin in the setting of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22296769"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL6"}, "span_text": {"type": "literal", "value": "Comparison of interleukin-6 levels in maternal and umbilical cord blood in early- and late-onset preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22296277"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:DDAH1"}, "span_text": {"type": "literal", "value": "Severely decreased activity of placental dimethylarginine dimethylaminohydrolase in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22285683"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "To determine the effectiveness of the combined use of uterine artery Doppler velocimetry (UADV) and estimation of maternal serum placental growth factor (PlGF) levels in early second trimester (20-22 weeks of gestation) in identifying pregnant women at risk of developing pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22280827"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Combination of uterine artery Doppler velocimetry and maternal serum placental growth factor estimation in predicting occurrence of pre-eclampsia in early second trimester pregnancy: a prospective cohort study."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22280827"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Uteroplacental arterio-venous difference in soluble VEGFR-1 (sFlt-1), but not in soluble endoglin concentrations in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22264588"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MPO"}, "span_text": {"type": "literal", "value": "Myeloperoxidase in the plasma and placenta of normal pregnant women and women with pregnancies complicated by preeclampsia and intrauterine growth restriction."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22264587"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Endothelin-1, as a final common pathway in the pathogenic cascade of preeclampsia, presents an intriguing new therapeutic approach for preeclamptic patients."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22257796"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Furthermore, mounting evidence implicates the signaling protein endothelin-1 as the final converging factor in the multifaceted cascades that are responsible for the symptomatic manifestation of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22257796"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "We investigated the effect of polymorphism at +813 locus of vascular endothelial growth factor (VEGF) gene on predisposition to preterm labour and pre-eclampsia (PE)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22257487"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Vascular endothelial growth factor gene +813CC polymorphism of foetus is associated with preterm labour but not with pre-eclampsia in Turkish pregnant women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22257487"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "We investigated the effect of polymorphism at +813 locus of vascular endothelial growth factor (VEGF) gene on predisposition to preterm labour and pre-eclampsia (PE)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22257487"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "We investigated the effect of polymorphism at +813 locus of vascular endothelial growth factor (VEGF) gene on predisposition to preterm labour and pre-eclampsia (PE)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22257487"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Vascular endothelial growth factor gene +813CC polymorphism of foetus is associated with preterm labour but not with pre-eclampsia in Turkish pregnant women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22257487"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Vascular endothelial growth factor gene +813CC polymorphism of foetus is associated with preterm labour but not with pre-eclampsia in Turkish pregnant women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22257487"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "There was no difference in Akt/PKB phosphorylation, after stimulation with insulin, between placentas of normal and preeclampsia patients."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22249794"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "The aim here was to investigate insulin stimulation of the Akt/PKB pathway in the placenta, in normal and preeclampsia parturients."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22249794"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Insulin stimulation of Akt/PKB phosphorylation in the placenta of preeclampsia patients."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22249794"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Our objectives in this study are to economically assess, from the payer perspective, routine screening for pre-eclampsia using placental markers -placental protein 13 and placental growth factor - and uterine artery Doppler compared with standard care."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22234821"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "The BNP, adiponectin, and leptin levels were significantly higher in preeclampsia patients compared with controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22234370"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "Potential interaction of brain natriuretic peptide with hyperadiponectinemia in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22234370"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Adiponectin mRNA expression was increased significantly in adipose tissues of preeclampsia patients compared with controls and was also increased significantly in normal-weight preeclampsia patients compared with overweight preeclampsia patients, whereas leptin was not."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22234370"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Resveratrol prevented the up-regulation of early growth response protein-1 (Egr-1), a transcription factor necessary for induction of the vascular endothelial growth factor receptor-1 gene and caused up-regulation of heme oxygenase-1, a cytoprotective enzyme found to be dysfunctional in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22197494"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Soluble vascular endothelial growth factor receptor-1 (also know as soluble fms-like tyrosine kinase [sFlt]-1) is a key causative factor of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22197494"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Resveratrol prevented the up-regulation of early growth response protein-1 (Egr-1), a transcription factor necessary for induction of the vascular endothelial growth factor receptor-1 gene and caused up-regulation of heme oxygenase-1, a cytoprotective enzyme found to be dysfunctional in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22197494"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HMOX1"}, "span_text": {"type": "literal", "value": "Resveratrol prevented the up-regulation of early growth response protein-1 (Egr-1), a transcription factor necessary for induction of the vascular endothelial growth factor receptor-1 gene and caused up-regulation of heme oxygenase-1, a cytoprotective enzyme found to be dysfunctional in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22197494"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Soluble vascular endothelial growth factor receptor-1 (also know as soluble fms-like tyrosine kinase [sFlt]-1) is a key causative factor of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22197494"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Soluble vascular endothelial growth factor receptor-1 (also know as soluble fms-like tyrosine kinase [sFlt]-1) is a key causative factor of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22197494"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Resveratrol prevented the up-regulation of early growth response protein-1 (Egr-1), a transcription factor necessary for induction of the vascular endothelial growth factor receptor-1 gene and caused up-regulation of heme oxygenase-1, a cytoprotective enzyme found to be dysfunctional in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22197494"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TCF4"}, "span_text": {"type": "literal", "value": "Resveratrol prevented the up-regulation of early growth response protein-1 (Egr-1), a transcription factor necessary for induction of the vascular endothelial growth factor receptor-1 gene and caused up-regulation of heme oxygenase-1, a cytoprotective enzyme found to be dysfunctional in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22197494"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HMOX1"}, "span_text": {"type": "literal", "value": "In summary, resveratrol can inhibit sFlt-1 release and up-regulate heme oxygenase-1; thus, may offer therapeutic potential in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22197494"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HADH"}, "span_text": {"type": "literal", "value": "We found that long-chain 3-hydroxyacyl-CoA dehydrogenase levels and fatty acid oxidation capacity were significantly reduced in placentas from women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22189170"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FABP4"}, "span_text": {"type": "literal", "value": "Maternal serum fatty acid binding protein 4 (FABP4) and the development of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22188744"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL1B"}, "span_text": {"type": "literal", "value": "Chitotriosidase, interleukin-1 beta and tumor necrosis factor alpha levels in mild preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22183425"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:RETN"}, "span_text": {"type": "literal", "value": "Serum resistin, pregnancy-associated plasma protein A (PAPP-A), and uterine artery pulsatility index (PI) at 11 to 13 weeks were measured in 480 singleton pregnancies, including 240 with normal outcome, 60 that subsequently developed preeclampsia (PE), 60 that developed gestational diabetes mellitus (GDM), 60 that delivered large for gestational age (LGA) neonates, and 60 that delivered small for gestational age (SGA) neonates."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22146093"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX1"}, "span_text": {"type": "literal", "value": "Regarding the glutathione REDOX cycle, we found the following in GH, CH and preeclampsia compared with PCW: a decrease in its reduced form (2.6\u00b10.6, 2.7\u00b10.8, 2.7\u00b10.9, 3.3\u00b11.3\u2009\u03bcmol\u2009l(-1), P<0.003), a parallel increase in the oxidized form (185.6\u00b168.9, 194.7\u00b175.0, 184.3\u00b178.3, 85.1\u00b127.5\u2009\u03bcmol\u2009l(-1), P<0.0001) and an increment in glutathione peroxidase (85.9\u00b122.0, 86.4\u00b120.9, 82.1\u00b123.5 and 77.2\u00b119.7\u2009U\u2009g(-1) Hb, P<0.04) and glutathione reductase (6384.3\u00b11261.9, 6724.6\u00b11154.1, 6287.9\u00b11399.9 and 6044.4\u00b11208.4\u2009mU\u2009g(-1) Hb, P<0.01, respectively)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22113354"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX2"}, "span_text": {"type": "literal", "value": "Regarding the glutathione REDOX cycle, we found the following in GH, CH and preeclampsia compared with PCW: a decrease in its reduced form (2.6\u00b10.6, 2.7\u00b10.8, 2.7\u00b10.9, 3.3\u00b11.3\u2009\u03bcmol\u2009l(-1), P<0.003), a parallel increase in the oxidized form (185.6\u00b168.9, 194.7\u00b175.0, 184.3\u00b178.3, 85.1\u00b127.5\u2009\u03bcmol\u2009l(-1), P<0.0001) and an increment in glutathione peroxidase (85.9\u00b122.0, 86.4\u00b120.9, 82.1\u00b123.5 and 77.2\u00b119.7\u2009U\u2009g(-1) Hb, P<0.04) and glutathione reductase (6384.3\u00b11261.9, 6724.6\u00b11154.1, 6287.9\u00b11399.9 and 6044.4\u00b11208.4\u2009mU\u2009g(-1) Hb, P<0.01, respectively)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22113354"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD1"}, "span_text": {"type": "literal", "value": "Lower activity of superoxide dismutase and higher levels of catalase were found in GH, CH and preeclampsia compared with PCW (964.4\u00b1116.5, 970.0\u00b1120.4, 971.2\u00b1137.5 and 1063.4\u00b1133.7\u2009U\u2009g(-1) Hb, P<0.001; and 313.0\u00b171.7, 292.2\u00b145.3, 297.1\u00b147.2, 215.5\u00b126.2\u2009U\u2009mg(-1) Hb, P<0.0001; respectively)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22113354"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD3"}, "span_text": {"type": "literal", "value": "Lower activity of superoxide dismutase and higher levels of catalase were found in GH, CH and preeclampsia compared with PCW (964.4\u00b1116.5, 970.0\u00b1120.4, 971.2\u00b1137.5 and 1063.4\u00b1133.7\u2009U\u2009g(-1) Hb, P<0.001; and 313.0\u00b171.7, 292.2\u00b145.3, 297.1\u00b147.2, 215.5\u00b126.2\u2009U\u2009mg(-1) Hb, P<0.0001; respectively)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22113354"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CAT"}, "span_text": {"type": "literal", "value": "Lower activity of superoxide dismutase and higher levels of catalase were found in GH, CH and preeclampsia compared with PCW (964.4\u00b1116.5, 970.0\u00b1120.4, 971.2\u00b1137.5 and 1063.4\u00b1133.7\u2009U\u2009g(-1) Hb, P<0.001; and 313.0\u00b171.7, 292.2\u00b145.3, 297.1\u00b147.2, 215.5\u00b126.2\u2009U\u2009mg(-1) Hb, P<0.0001; respectively)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22113354"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX3"}, "span_text": {"type": "literal", "value": "Regarding the glutathione REDOX cycle, we found the following in GH, CH and preeclampsia compared with PCW: a decrease in its reduced form (2.6\u00b10.6, 2.7\u00b10.8, 2.7\u00b10.9, 3.3\u00b11.3\u2009\u03bcmol\u2009l(-1), P<0.003), a parallel increase in the oxidized form (185.6\u00b168.9, 194.7\u00b175.0, 184.3\u00b178.3, 85.1\u00b127.5\u2009\u03bcmol\u2009l(-1), P<0.0001) and an increment in glutathione peroxidase (85.9\u00b122.0, 86.4\u00b120.9, 82.1\u00b123.5 and 77.2\u00b119.7\u2009U\u2009g(-1) Hb, P<0.04) and glutathione reductase (6384.3\u00b11261.9, 6724.6\u00b11154.1, 6287.9\u00b11399.9 and 6044.4\u00b11208.4\u2009mU\u2009g(-1) Hb, P<0.01, respectively)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22113354"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Finally, as the removal of circulating sFlt-1 (soluble Fms-like tyrosine kinase receptor-1) from pre-eclamptic patients significantly improves the clinical outcome, it fulfils the Hill's experiment principle, which states that removal of the cause by an appropriate experimental regimen should ameliorate the condition."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22103497"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Effects of pravastatin on mediators of vascular function in a mouse model of soluble Fms-like tyrosine kinase-1-induced preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22083058"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "Endothelial nitric oxide synthase gene polymorphisms (G894T, 4b/a and T-786C) and preeclampsia: meta-analysis of 18 case-control studies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22054068"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "Polymorphisms of the endothelial nitric oxide synthase (NOS3) gene in preeclampsia: a candidate-gene association study."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22051068"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "The endothelial nitric oxide synthase gene (NOS3) has been proposed as a candidate gene for preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22051068"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "The aim of this research was to investigate whether the nitric oxide synthase (NOS) inhibitor L-NAME may cause down-regulation of LCHAD in the pathogenesis of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22040569"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Effect on the production of soluble endoglin from human choriocarcinoma cells by preeclampsia sera."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22040284"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:THBS1"}, "span_text": {"type": "literal", "value": "Circulating levels of thrombospondin-1 are decreased in HELLP syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22035632"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:THBS1"}, "span_text": {"type": "literal", "value": "Circulating thrombospondin-1 levels are decreased in HELLP syndrome and they seem to reflect disease severity, lower levels representing a more severe state."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22035632"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Interplay between vascular endothelial growth factor (VEGF) and nuclear factor erythroid 2-related factor-2 (Nrf2): implications for preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22033923"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Interplay between vascular endothelial growth factor (VEGF) and nuclear factor erythroid 2-related factor-2 (Nrf2): implications for preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22033923"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Interplay between vascular endothelial growth factor (VEGF) and nuclear factor erythroid 2-related factor-2 (Nrf2): implications for preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22033923"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "Results of functional network analysis indicated that ENG may play a role in the pathogenesis of preeclampsia through its interference with the endothelial nitric oxide synthase-regulated vasodilation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22030040"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "However, placental endoglin (ENG) was expressed at a significantly higher level in preeclampsia than in superimposed preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22030040"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "They have been implicated in preeclampsia because they modulate trophoblast invasion and regulate the expression of the endoglin (CD105) gene, a marker of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22029530"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Placental growth factor (PlGF) is a proposed first-trimester screening marker for pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22028208"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Either vascular endothelial growth factor C (VEGFC) or CYR61 plays an important role in placental development and may be involved in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22023263"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL6"}, "span_text": {"type": "literal", "value": "A meta-analysis of tumor necrosis factor-alpha, interleukin-6, and interleukin-10 in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22019000"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL10"}, "span_text": {"type": "literal", "value": "A meta-analysis of tumor necrosis factor-alpha, interleukin-6, and interleukin-10 in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22019000"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "This review summarizes the relevant research on the similarities and differences between early- and late-onset preeclampsia as it relates to pathogenesis and biomarkers, including differences in vascular endothelial growth factor, placental growth factor, vascular endothelial growth factor receptor-1, epidermal growth factor, transforming growth factor-\u03b2, vascular cell adhesion molecule, toll-like receptor, plasma pentraxin 3, soluble endoglin, and lipid peroxidation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22018452"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "This review summarizes the relevant research on the similarities and differences between early- and late-onset preeclampsia as it relates to pathogenesis and biomarkers, including differences in vascular endothelial growth factor, placental growth factor, vascular endothelial growth factor receptor-1, epidermal growth factor, transforming growth factor-\u03b2, vascular cell adhesion molecule, toll-like receptor, plasma pentraxin 3, soluble endoglin, and lipid peroxidation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22018452"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VCAM1"}, "span_text": {"type": "literal", "value": "This review summarizes the relevant research on the similarities and differences between early- and late-onset preeclampsia as it relates to pathogenesis and biomarkers, including differences in vascular endothelial growth factor, placental growth factor, vascular endothelial growth factor receptor-1, epidermal growth factor, transforming growth factor-\u03b2, vascular cell adhesion molecule, toll-like receptor, plasma pentraxin 3, soluble endoglin, and lipid peroxidation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22018452"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "This review summarizes the relevant research on the similarities and differences between early- and late-onset preeclampsia as it relates to pathogenesis and biomarkers, including differences in vascular endothelial growth factor, placental growth factor, vascular endothelial growth factor receptor-1, epidermal growth factor, transforming growth factor-\u03b2, vascular cell adhesion molecule, toll-like receptor, plasma pentraxin 3, soluble endoglin, and lipid peroxidation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22018452"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "This review summarizes the relevant research on the similarities and differences between early- and late-onset preeclampsia as it relates to pathogenesis and biomarkers, including differences in vascular endothelial growth factor, placental growth factor, vascular endothelial growth factor receptor-1, epidermal growth factor, transforming growth factor-\u03b2, vascular cell adhesion molecule, toll-like receptor, plasma pentraxin 3, soluble endoglin, and lipid peroxidation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22018452"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "This review summarizes the relevant research on the similarities and differences between early- and late-onset preeclampsia as it relates to pathogenesis and biomarkers, including differences in vascular endothelial growth factor, placental growth factor, vascular endothelial growth factor receptor-1, epidermal growth factor, transforming growth factor-\u03b2, vascular cell adhesion molecule, toll-like receptor, plasma pentraxin 3, soluble endoglin, and lipid peroxidation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22018452"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Markers of insulin resistance and sedentary lifestyle are predictors of preeclampsia in women with adverse obstetric results."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22011958"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Excess soluble vascular endothelial growth factor receptor-1 in amniotic fluid impairs lung growth in rats: linking preeclampsia with bronchopulmonary dysplasia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22003089"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Excess soluble vascular endothelial growth factor receptor-1 in amniotic fluid impairs lung growth in rats: linking preeclampsia with bronchopulmonary dysplasia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22003089"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Excess soluble vascular endothelial growth factor receptor-1 in amniotic fluid impairs lung growth in rats: linking preeclampsia with bronchopulmonary dysplasia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22003089"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "The soluble fms-like tyrosine kinase (sFlt-1)/placental growth factor (PlGF) ratio is a reliable tool in the assessment of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22000672"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "The soluble fms-like tyrosine kinase (sFlt-1)/placental growth factor (PlGF) ratio is a reliable tool in the assessment of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/22000672"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Midgestation maternal serum 25-hydroxyvitamin D level and soluble fms-like tyrosine kinase 1/placental growth factor ratio as predictors of severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21986503"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "25(OH)D alone was comparable to vascular endothelial growth factor and soluble fms-like tyrosine kinase 1/placental growth factor ratio as a predictive marker for severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21986503"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "25(OH)D alone was comparable to vascular endothelial growth factor and soluble fms-like tyrosine kinase 1/placental growth factor ratio as a predictive marker for severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21986503"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "In conclusion, combining midpregnancy 25(OH)D level with soluble fms-like tyrosine kinase 1/placental growth factor ratio provides a better prediction for the development of severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21986503"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "25(OH)D alone was comparable to vascular endothelial growth factor and soluble fms-like tyrosine kinase 1/placental growth factor ratio as a predictive marker for severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21986503"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Midgestation maternal serum 25-hydroxyvitamin D level and soluble fms-like tyrosine kinase 1/placental growth factor ratio as predictors of severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21986503"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "25(OH)D alone was comparable to vascular endothelial growth factor and soluble fms-like tyrosine kinase 1/placental growth factor ratio as a predictive marker for severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21986503"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "In conclusion, combining midpregnancy 25(OH)D level with soluble fms-like tyrosine kinase 1/placental growth factor ratio provides a better prediction for the development of severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21986503"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "25(OH)D alone was comparable to vascular endothelial growth factor and soluble fms-like tyrosine kinase 1/placental growth factor ratio as a predictive marker for severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21986503"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PON1"}, "span_text": {"type": "literal", "value": "Serum paraoxonase 1 (PON1) activity and the oxidation of lipoproteins were investigated in 35 women with pre-eclampsia and in 35 healthy control women with normal pregnancies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21986144"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "In conclusion, lipids and oxidized lipoproteins may play important roles in the pathogenesis of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21986144"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Serum levels of lipids, lipoproteins and paraoxonase activity in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21986144"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Serum paraoxonase 1 (PON1) activity and the oxidation of lipoproteins were investigated in 35 women with pre-eclampsia and in 35 healthy control women with normal pregnancies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21986144"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TFPI"}, "span_text": {"type": "literal", "value": "Role of protein S and tissue factor pathway inhibitor in the development of activated protein C resistance early in pregnancy in women with a history of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21979881"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TFPI2"}, "span_text": {"type": "literal", "value": "Role of protein S and tissue factor pathway inhibitor in the development of activated protein C resistance early in pregnancy in women with a history of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21979881"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "The results support the theory that adiponectin might be part of a feedback mechanism improving insulin sensitivity and cardiovascular health in pre-eclamptic patients."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21972480"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Leptin, adiponectin and other adipokines in gestational diabetes mellitus and pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21951069"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Threshold of soluble fms-like tyrosine kinase 1/placental growth factor ratio for the imminent onset of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21947468"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "It has not been clarified whether thresholds of soluble fms-like tyrosine kinase 1 (sFlt-1), placental growth factor (PlGF), soluble endoglin, and the sFlt-1/PlGF ratio for the imminent onset of preeclampsia (PE) exist."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21947468"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "It has not been clarified whether thresholds of soluble fms-like tyrosine kinase 1 (sFlt-1), placental growth factor (PlGF), soluble endoglin, and the sFlt-1/PlGF ratio for the imminent onset of preeclampsia (PE) exist."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21947468"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Threshold of soluble fms-like tyrosine kinase 1/placental growth factor ratio for the imminent onset of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21947468"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "A plasma albumin level below 20 g/L was not found to be an independent marker for severe preeclampsia because all women with a low plasma albumin level had other adverse conditions."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21923989"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "Preeclampsia: should plasma albumin level be a criterion for severity?"}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21923989"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "A literature search of PubMed and Ovid MEDLINE was conducted using the keywords endoglin, gene, and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21921088"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Additional articles were identified/selected for evaluation via PubMed e-mail updates (keywords: endoglin and preeclampsia) and review of article reference lists obtained from the search."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21921088"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "A systematic review of endoglin gene expression in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21921088"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "To synthesize scientific literature that addresses the role of endoglin (ENG) gene expression in preeclampsia (PE)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21921088"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Serum leptin levels were significantly higher in preeclamptic patients and healthy pregnant women than in healthy non-pregnant women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21906313"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Furthermore, elevated serum leptin level and sFlt-1/PlGF ratio had an additive (joint) effect in the risk of preeclampsia, as shown by the substantially higher odds ratios of their combination than of either alone."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21906313"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "In this study, we determined circulating levels of C-reactive protein, several cytokines, chemokines, adhesion molecules and angiogenic factors along with those of leptin in healthy non-pregnant and pregnant women and preeclamptic patients, and investigated whether serum leptin levels were related to the clinical characteristics and measured laboratory parameters of the study participants."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21906313"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "In preeclamptic patients, a significant positive correlation was observed between serum concentrations of leptin and IP-10."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21906313"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Serum leptin levels in relation to circulating cytokines, chemokines, adhesion molecules and angiogenic factors in normal pregnancy and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21906313"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Additionally, preeclamptic patients had significantly higher leptin levels as compared to healthy pregnant women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21906313"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Simultaneous measurement of leptin with several inflammatory molecules and angiogenic factors in this study enabled us to investigate their relationship, which can help to understand the role of circulating leptin in normal pregnancy and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21906313"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Placental growth factor and soluble Fms-like tyrosine kinase-1 may be potential diagnostic markers of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21903191"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Placental growth factor and soluble Fms-like tyrosine kinase-1 may be potential diagnostic markers of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21903191"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "We compared performances of 2 immunoassays, the Triage placental growth factor assay and the Elecsys soluble Fms-like tyrosine kinase-1/placental growth factor ratio in diagnosing preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21903191"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "We compared performances of 2 immunoassays, the Triage placental growth factor assay and the Elecsys soluble Fms-like tyrosine kinase-1/placental growth factor ratio in diagnosing preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21903191"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "Endothelial nitric oxide synthase haplotypes are associated with preeclampsia in Maya mestizo women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21897002"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "Serum total proteins (TP), albumin, globulin, malondialdehyde, protein carbonyls (PC) and protein bound sialic acid (PBSA) were measured in gestational hypertensive, pre-eclamptic, eclamptic and healthy pregnant women (n=20/group)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21893473"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "CONCLUSIONS: \u2002 Urinary placental growth factor is a simple non-invasive test, which is discriminatory for pre-eclampsia in the third trimester of pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21883135"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Urinary placental growth factor differentiates the hypertensive disorders of pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21883135"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ANXA2"}, "span_text": {"type": "literal", "value": "We compared the expression of annexin A2 in pre-eclampsia with that in normal pregnancies and investigated its relationship to placental thrombin formation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21868071"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ANXA2"}, "span_text": {"type": "literal", "value": "High titers of anti- annexin A2 antibodies were more frequently detected in pre-eclampsia group."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21868071"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ANXA2"}, "span_text": {"type": "literal", "value": "Alterations of profibrinolytic receptor annexin A2 in pre-eclampsia: a possible role in placental thrombin formation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21868071"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ANXA2"}, "span_text": {"type": "literal", "value": "The expression of annexin A2 mRNA in placentas was significantly decreased in pre-eclampsia compared to normal pregnancies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21868071"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ANXA2"}, "span_text": {"type": "literal", "value": "Levels of annexin A2 protein in placentas as well as in peripheral maternal blood were also significantly reduced in patients with pre-eclampsia compared with healthy pregnant women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21868071"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "[Genetic variability of endothelin-1 system in gestational hypertension and preeclampsia]."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21851036"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ANGPT1"}, "span_text": {"type": "literal", "value": "Do serum angiopoietin-1, angiopoietin-2, and their receptor Tie-2 and 4G/5G variant of PAI-1 gene have a role in the pathogenesis of preeclampsia?"}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21849906"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EPHX1"}, "span_text": {"type": "literal", "value": "There may be an association between epoxide hydrolase enzyme polymorphism and the risk of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21841461"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EPHX2"}, "span_text": {"type": "literal", "value": "There may be an association between epoxide hydrolase enzyme polymorphism and the risk of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21841461"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EPHX3"}, "span_text": {"type": "literal", "value": "There may be an association between epoxide hydrolase enzyme polymorphism and the risk of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21841461"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EPHX4"}, "span_text": {"type": "literal", "value": "There may be an association between epoxide hydrolase enzyme polymorphism and the risk of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21841461"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Erythrocyte Na+-Li+ counter-transport activity and digoxin-like substances in insulin dependent diabetic women with preexisting preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21840615"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ICAM1"}, "span_text": {"type": "literal", "value": "Monoclonal antibody to intercellular adhesion molecule-1 as a novel therapy for preeclampsia: preliminary results from a rat model."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21830843"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FGFR4"}, "span_text": {"type": "literal", "value": "Fibroblast growth factor receptor 4 Gly388 Arg polymorphism is not associated with pre-eclampsia in Turkish women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21827571"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FGFR4"}, "span_text": {"type": "literal", "value": "The aim of this study was to assess the association between human fibroblast growth factor receptor 4 (FGFR4) Gly(388) Arg polymorphism and pre-eclampsia (PE) by carrying out a case-control study in Turkish women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21827571"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MPO"}, "span_text": {"type": "literal", "value": "Genetic variation of myeloperoxidase gene contributes to preeclampsia: a preliminary association study in Turkish population."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21827295"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PON1"}, "span_text": {"type": "literal", "value": "This study was aimed to determine the possible association between L55M and Q192R polymorphisms of paraoxonase-1 gene as well as serum PON1 and arylesterase (ARE) activities in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21820612"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PON1"}, "span_text": {"type": "literal", "value": "Association of L55M and Q192R polymorphisms of paraoxonase-1 gene with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21820612"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Soluble fms-like tyrosine kinase 1 (sFlt-1), an alternatively spliced variant of the vascular endothelial growth factor receptor 1, induces a preeclampsia-like phenotype in experimental models and circulates at elevated levels in human preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21810665"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Soluble fms-like tyrosine kinase 1 (sFlt-1), an alternatively spliced variant of the vascular endothelial growth factor receptor 1, induces a preeclampsia-like phenotype in experimental models and circulates at elevated levels in human preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21810665"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Pilot study of extracorporeal removal of soluble fms-like tyrosine kinase 1 in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21810665"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Soluble fms-like tyrosine kinase 1 (sFlt-1), an alternatively spliced variant of the vascular endothelial growth factor receptor 1, induces a preeclampsia-like phenotype in experimental models and circulates at elevated levels in human preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21810665"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EZR"}, "span_text": {"type": "literal", "value": "Eleven proteins were found which decreased in pre-eclampsia (actin, glutathione S-transferase, peroxiredoxin 6, aldose reductase, heat shock protein 60 (Hsp60), two molecular forms of heat shock protein 70 (Hsp70) \u03b2-tubulin, subunit proteasome, ezrin, protein disulfide isomerase, and phosphoglycerate mutase 1)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21800423"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PRDX6"}, "span_text": {"type": "literal", "value": "Eleven proteins were found which decreased in pre-eclampsia (actin, glutathione S-transferase, peroxiredoxin 6, aldose reductase, heat shock protein 60 (Hsp60), two molecular forms of heat shock protein 70 (Hsp70) \u03b2-tubulin, subunit proteasome, ezrin, protein disulfide isomerase, and phosphoglycerate mutase 1)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21800423"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "Endothelial nitric oxide synthase gene polymorphisms in preeclampsia with or without eclampsia in a Turkish population."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21793998"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "The levels of endoglin were the highest in pregnancy complicated by fetal intrauterine growth restriction (IUGR) in the course of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21793708"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "The aim of this study was to determine the maternal serum endoglin concentration in pregnancies with intrauterine growth restriction (IUGR) in the presence or absence of preeclampsia and to compare the results with preeclamptic pregnant women with appropriate-for-gestational-age weight infants and with healthy pregnant controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21793708"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "The positive correlation between endoglin and blood pressure and inverse correlation between endoglin and infant birth weight and additionally higher levels of ENG in patients with pregnancy complicated by HELLP syndrome (hemolysis, increased liver enzymes, low platelet count) or eclampsia suggest that endoglin may be a marker of severity of these pregnancy disorders."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21793708"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Our results suggest that increased endoglin concentration may be at least responsible for the pathogenesis of preeclampsia and/or intrauterine fetal growth restriction."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21793708"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Our study revealed increased levels of endoglin in the serum of women with normotensive pregnancy complicated by isolated IUGR, and in both groups of preeclamptic patients with and without IUGR."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21793708"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Endoglin in pregnancy complicated by fetal intrauterine growth restriction in normotensive and preeclamptic pregnant women: a comparison between preeclamptic patients with appropriate-for-gestational-age weight infants and healthy pregnant women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21793708"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "We attempted to calculate in 38 pregnant women with preeclampsia (group A) plasma levels of the main inhibitor to nitric oxide synthase (NOS), which is ADMA, and to compare our findings with the levels of ADMA in 36 non preeclamptic pregnant women (group C) and also with the levels in 29 pregnant women who had a history of preeclampsia in previous pregnancies (group B)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21793273"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL10"}, "span_text": {"type": "literal", "value": "Exogenous interleukin 10 treatment had beneficial effects on endothelial function and may be beneficial in women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21768525"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GNLY"}, "span_text": {"type": "literal", "value": "Recent data show that serum granulysin levels are elevated in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21763002"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Pentraxin 3 (PTX3) and ratio of soluble fms-like tyrosine kinase-1 (sFlt-1) to placental growth factor (PlGF) were elevated in women with preeclampsia during pregnancy (p<0.001)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21751969"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Placental growth factor is one of the many angiogenic factors, which shows significant altered levels in preeclampsia compared to normal pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21735190"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "The occurrence of hypertension or pre-eclampsia led to a further increase in lipids in very-low-density lipoproteins."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/217273"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADM2"}, "span_text": {"type": "literal", "value": "The possible role of adrenomedullin in the etiology of gestational hypertension and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21721459"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADM2"}, "span_text": {"type": "literal", "value": "Nowadays the possible role of vasoactive peptide adrenomedullin (ADM) is considered in the etiology of preeclampsia (PE), where ADM is indicated to be a protective factor decreasing blood pressure."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21721459"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADM"}, "span_text": {"type": "literal", "value": "The possible role of adrenomedullin in the etiology of gestational hypertension and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21721459"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADM"}, "span_text": {"type": "literal", "value": "Nowadays the possible role of vasoactive peptide adrenomedullin (ADM) is considered in the etiology of preeclampsia (PE), where ADM is indicated to be a protective factor decreasing blood pressure."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21721459"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IDO2"}, "span_text": {"type": "literal", "value": "Impact of indoleamine 2,3-dioxygenase on the antioxidant system in the placentas of severely pre-eclamptic patients."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21718232"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IDO1"}, "span_text": {"type": "literal", "value": "Impact of indoleamine 2,3-dioxygenase on the antioxidant system in the placentas of severely pre-eclamptic patients."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21718232"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CP"}, "span_text": {"type": "literal", "value": "The mean antioxidant activity of ceruloplasmin was 562.54+/-139.79 in mild preeclampsia group, 556.21+/-190.94 in severe preeclampsia group and 427.62+/-162.14 in control group."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21717864"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CP"}, "span_text": {"type": "literal", "value": "In a cross-sectional and descriptive-analytic study performed on 60 patients with preeclampsia (30 with mild and 30 with severe preeclampsia) and 30 women with normal pregnancy (control) in Tabriz al-Zahra Hospital, serum level and antioxidant activity of ceruloplasmin was evaluated."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21717864"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CP"}, "span_text": {"type": "literal", "value": "The mean serum level of ceruloplasmin was 0.62+/-0.16 g L-1 in mild preeclampsia group, 0.61+/-0.23 g L-1 in severe preeclampsia group and 0.47+/-0.16 g L-1 in control group."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21717864"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CP"}, "span_text": {"type": "literal", "value": "Serum level of ceruloplasmin is significantly lower in normal pregnancy than mild and severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21717864"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CP"}, "span_text": {"type": "literal", "value": "Antioxidant activity of ceruloplasmin is significantly lower in normal pregnancy than mild and severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21717864"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CP"}, "span_text": {"type": "literal", "value": "Serum level and antioxidant activity of ceruloplasmin in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21717864"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "To assess first trimester placental growth factor (PlGF) and pregnancy-associated plasma protein-A (PAPP-A) as screening markers for early-onset pre-eclampsia (PE) and intra-uterine growth restriction (IUGR)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21717483"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "Lack of relationship between endothelial nitric oxide synthase gene 4b/a and T-786C polymorphisms with preeclampsia in southeast of Iran."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21713426"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HMOX1"}, "span_text": {"type": "literal", "value": "Administration of a PPAR-\u03b3 agonist prevented the development of several of the pathophysiological characteristics associated with the RUPP model of preeclampsia, via a heme oxygenase 1-dependent pathway."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21690483"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "Alterations in cyclic GMP levels in preeclampsia may reflect increased B-type natriuretic peptide levels and not impaired nitric oxide activity."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21683071"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:THBS3"}, "span_text": {"type": "literal", "value": "Circulating levels of the anti-angiogenic thrombospondin 2 are elevated in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21682699"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:THBS4"}, "span_text": {"type": "literal", "value": "Circulating levels of the anti-angiogenic thrombospondin 2 are elevated in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21682699"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:THBS1"}, "span_text": {"type": "literal", "value": "Circulating levels of the anti-angiogenic thrombospondin 2 are elevated in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21682699"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOM"}, "span_text": {"type": "literal", "value": "Complement component C4A and apolipoprotein A-I in plasmas as biomarkers of the severe, early-onset preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21677994"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOE"}, "span_text": {"type": "literal", "value": "Complement component C4A and apolipoprotein A-I in plasmas as biomarkers of the severe, early-onset preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21677994"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOO"}, "span_text": {"type": "literal", "value": "Complement component C4A and apolipoprotein A-I in plasmas as biomarkers of the severe, early-onset preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21677994"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOF"}, "span_text": {"type": "literal", "value": "Complement component C4A and apolipoprotein A-I in plasmas as biomarkers of the severe, early-onset preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21677994"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Serum adiponectin and leptin in relation to risk for preeclampsia: results from a large case-control study."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21632080"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL6"}, "span_text": {"type": "literal", "value": "Elevated serum levels of interleukin-6, interleukin-1\u03b2 and human chorionic gonadotropin in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21623995"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD1"}, "span_text": {"type": "literal", "value": "This study investigated serum uric acid levels, monocyte production of TNF-\u03b1, superoxide anion (O(2)(-)) and hydrogen peroxide (H(2)O(2)), as well as superoxide dismutase (SOD) and catalase (CAT) activities in erythrocytes from 30 women with pre-eclampsia (PE) compared with 30 normotensive (NT) pregnant women in the last trimester of pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21623992"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD3"}, "span_text": {"type": "literal", "value": "This study investigated serum uric acid levels, monocyte production of TNF-\u03b1, superoxide anion (O(2)(-)) and hydrogen peroxide (H(2)O(2)), as well as superoxide dismutase (SOD) and catalase (CAT) activities in erythrocytes from 30 women with pre-eclampsia (PE) compared with 30 normotensive (NT) pregnant women in the last trimester of pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21623992"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CAT"}, "span_text": {"type": "literal", "value": "This study investigated serum uric acid levels, monocyte production of TNF-\u03b1, superoxide anion (O(2)(-)) and hydrogen peroxide (H(2)O(2)), as well as superoxide dismutase (SOD) and catalase (CAT) activities in erythrocytes from 30 women with pre-eclampsia (PE) compared with 30 normotensive (NT) pregnant women in the last trimester of pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21623992"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Postpartum maternal soluble fms-like tyrosine kinase 1 (P=0.05) and high-sensitivity C-reactive protein (P=0.02) were elevated in the preeclampsia group compared with controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21606387"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "No association between polymorphisms/haplotypes of the vascular endothelial growth factor gene and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21575227"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "No association between polymorphisms/haplotypes of the vascular endothelial growth factor gene and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21575227"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "No association between polymorphisms/haplotypes of the vascular endothelial growth factor gene and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21575227"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SHBG"}, "span_text": {"type": "literal", "value": "Serum levels of T, sex hormone binding globulin (SHBG) and testosterone/sex hormone binding globulin-ratio (T/SHBG-ratio) were determined during the first and second trimester in pregnancy from 91 pregnant women who later developed preeclampsia and from 182 healthy controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21574855"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGT"}, "span_text": {"type": "literal", "value": "To find association of angiotensin-converting enzyme (ACE) insertion/deletion (I/D), angiotensinogen (AGT) T704C, methylenetetrahydrofolate reductase (MTHFR) C677T and factor V Leiden (FVL) G1691A polymorphisms with pre-eclampsia (PE) in North Indian women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21564405"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MTHFR"}, "span_text": {"type": "literal", "value": "To find association of angiotensin-converting enzyme (ACE) insertion/deletion (I/D), angiotensinogen (AGT) T704C, methylenetetrahydrofolate reductase (MTHFR) C677T and factor V Leiden (FVL) G1691A polymorphisms with pre-eclampsia (PE) in North Indian women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21564405"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Regardless of mechanism and pathophysiology of preeclampsia, we found high serum level of lipoprotein (a) in preeclampsia patients."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21548547"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Lipoprotein (a) level in pre-eclampsia patients."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21548547"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "The mean (+/- SD) serum lipoprotein(a) concentration in normal pregnancies and preeclampsia were found to be 12.91 +/- 4.94 and 56.65 +/- 22.62."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21548547"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGT"}, "span_text": {"type": "literal", "value": "Low urinary angiotensinogen levels were useful for identifying preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21538910"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Serum placental growth factor and fms-like tyrosine kinase 1 during first trimester in Chinese women with pre-eclampsia--a case-control study."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21534854"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "To investigate the association between first trimester maternal placental growth factor (PlGF) and fms-like tyrosine kinase 1 (sFlt-1) levels with subsequent development of pre-eclampsia (PE)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21534854"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Serum placental growth factor and fms-like tyrosine kinase 1 during first trimester in Chinese women with pre-eclampsia--a case-control study."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21534854"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "To investigate the association between first trimester maternal placental growth factor (PlGF) and fms-like tyrosine kinase 1 (sFlt-1) levels with subsequent development of pre-eclampsia (PE)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21534854"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:COMT"}, "span_text": {"type": "literal", "value": "Severe early-onset preeclampsia is not associated with a change in placental catechol O-methyltransferase (COMT) expression."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21531374"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Decreased circulating soluble Tie2 levels in preeclampsia may result from inhibition of vascular endothelial growth factor (VEGF) signaling."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21525162"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Decreased circulating soluble Tie2 levels in preeclampsia may result from inhibition of vascular endothelial growth factor (VEGF) signaling."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21525162"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Decreased circulating soluble Tie2 levels in preeclampsia may result from inhibition of vascular endothelial growth factor (VEGF) signaling."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21525162"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TCF4"}, "span_text": {"type": "literal", "value": "Western blotting was used to study transcription factor activated protein 1 (AP-1) (JunB and FosB subunits) and nuclear factor (NF)-\u03baB p65 in the HTR-8/SVneo cells and placentas from patients with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21515911"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:THBS1"}, "span_text": {"type": "literal", "value": "The goal of this study was to search for an association between a desintegrin-like and metalloprotease thrombospondin type 1 motif, member 13 (ADAMTS13) levels and the occurrence of preeclampsia, its characteristics (time-onset and severity), and its consequences (occurrence of fetal growth restriction or preterm delivery)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21512165"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:THBS4"}, "span_text": {"type": "literal", "value": "The goal of this study was to search for an association between a desintegrin-like and metalloprotease thrombospondin type 1 motif, member 13 (ADAMTS13) levels and the occurrence of preeclampsia, its characteristics (time-onset and severity), and its consequences (occurrence of fetal growth restriction or preterm delivery)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21512165"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:THBS3"}, "span_text": {"type": "literal", "value": "The goal of this study was to search for an association between a desintegrin-like and metalloprotease thrombospondin type 1 motif, member 13 (ADAMTS13) levels and the occurrence of preeclampsia, its characteristics (time-onset and severity), and its consequences (occurrence of fetal growth restriction or preterm delivery)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21512165"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL6"}, "span_text": {"type": "literal", "value": "This association was independent of VWF levels and preeclampsia risk factors but dependent on interleukin-6 and C-reactive protein levels for ADAMTS13 activity."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21512165"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VWF"}, "span_text": {"type": "literal", "value": "Von Willebrand factor and ADAMTS13: a candidate couple for preeclampsia pathophysiology."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21512165"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL6"}, "span_text": {"type": "literal", "value": "The aim of this study was to evaluate the association between periodontal disease and pre-eclampsia, and the correlation of the two conditions with interleukin-6 (IL-6) and tumor necrosis factor-\u03b1(TNF\u03b1) mRNA expression."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21501170"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP4"}, "span_text": {"type": "literal", "value": "Pregnancy-associated plasma protein A2 (PAPPA2) is an insulin-like growth factor-binding protein (IGFBP) protease expressed at high levels in the placenta and upregulated in pregnancies complicated by preeclampsia and HELLP (Hemolytic anemia, Elevated Liver enzymes, and Low Platelet count) syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21496272"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP3"}, "span_text": {"type": "literal", "value": "Pregnancy-associated plasma protein A2 (PAPPA2) is an insulin-like growth factor-binding protein (IGFBP) protease expressed at high levels in the placenta and upregulated in pregnancies complicated by preeclampsia and HELLP (Hemolytic anemia, Elevated Liver enzymes, and Low Platelet count) syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21496272"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP7"}, "span_text": {"type": "literal", "value": "Pregnancy-associated plasma protein A2 (PAPPA2) is an insulin-like growth factor-binding protein (IGFBP) protease expressed at high levels in the placenta and upregulated in pregnancies complicated by preeclampsia and HELLP (Hemolytic anemia, Elevated Liver enzymes, and Low Platelet count) syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21496272"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP5"}, "span_text": {"type": "literal", "value": "Pregnancy-associated plasma protein A2 (PAPPA2) is an insulin-like growth factor-binding protein (IGFBP) protease expressed at high levels in the placenta and upregulated in pregnancies complicated by preeclampsia and HELLP (Hemolytic anemia, Elevated Liver enzymes, and Low Platelet count) syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21496272"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP2"}, "span_text": {"type": "literal", "value": "Pregnancy-associated plasma protein A2 (PAPPA2) is an insulin-like growth factor-binding protein (IGFBP) protease expressed at high levels in the placenta and upregulated in pregnancies complicated by preeclampsia and HELLP (Hemolytic anemia, Elevated Liver enzymes, and Low Platelet count) syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21496272"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "VEGFR1 and VEGFR2 are functional receptors for placental growth factor (PlGF) and VEGF, respectively, and PlGF-VEGFR1 and VEGF-VEGFR2 interactions are disturbed in many preeclamptic patients by excess amount of soluble form of VEGFR1 (also named sFlt1), a natural PlGF/VEGF antagonist."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21490787"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CASP3"}, "span_text": {"type": "literal", "value": "Apoptosis and expression of Bcl-2, Bax, p53, caspase-3, and Fas, Fas ligand in placentas complicated by preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21485723"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CASP3"}, "span_text": {"type": "literal", "value": "Increased apoptosis in preeclampsia may not be associated with significant alterations in Fas, Fas ligand, caspase-3, p53, Bcl-2 and Bax expression."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21485723"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CASP3"}, "span_text": {"type": "literal", "value": "To determine whether preeclampsia is associated with an increase in placental apoptosis and altered expression of mediators of apoptosis such as Fas, Fas ligand, caspase-3, p53, Bcl-2 and Bax."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21485723"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Autoantibody-mediated IL-6-dependent endothelin-1 elevation underlies pathogenesis in a mouse model of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21482739"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "To establish whether a spot urinary albumin: creatinine ratio (ACR) measured before 20 weeks of gestation can predict subsequent pre-eclampsia when urinary albumin is measured by high-performance liquid chromatography (HPLC)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21481153"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "Prediction of pre-eclampsia in early pregnancy by estimating the spot urinary albumin: creatinine ratio using high-performance liquid chromatography."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21481153"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL18"}, "span_text": {"type": "literal", "value": "In the present study, we aimed to determine whether alterations in the expression of IDO, forkhead box P3 (Foxp3) and interleukin-18 (IL-18) contribute to the pathogenesis of preeclampsia, by measuring their levels in preeclamptic placentae and in placentae from healthy pregnant women as a control."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21461563"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IDO1"}, "span_text": {"type": "literal", "value": "Low levels of indoleamine 2,3-dioxygenase (IDO) and diminished numbers of regulatory T cells (Tregs) have been separately reported to participate in the pathogenesis of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21461563"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IDO1"}, "span_text": {"type": "literal", "value": "Reduced expression of indoleamine 2,3-dioxygenase participates in pathogenesis of preeclampsia via regulatory T cells."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21461563"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IDO2"}, "span_text": {"type": "literal", "value": "Reduced expression of indoleamine 2,3-dioxygenase participates in pathogenesis of preeclampsia via regulatory T cells."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21461563"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IDO2"}, "span_text": {"type": "literal", "value": "Low levels of indoleamine 2,3-dioxygenase (IDO) and diminished numbers of regulatory T cells (Tregs) have been separately reported to participate in the pathogenesis of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21461563"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Maternal insulin resistance and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21458622"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "The purpose of this study was to determine whether mid-trimester insulin resistance is associated with subsequent preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21458622"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AFP"}, "span_text": {"type": "literal", "value": "In general, tests in early pregnancy for predicting later development of pre-eclampsia have better specificity than sensitivity, as Body Mass Index greater than 34, alpha-fetoprotein, fibronectin and uterine artery Doppler (bilateral notching) all have specificities above 90%."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21454131"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "The relationship between circulating endothelin-1, soluble fms-like tyrosine kinase-1 and soluble endoglin in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21451568"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "The relationship between circulating endothelin-1, soluble fms-like tyrosine kinase-1 and soluble endoglin in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21451568"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "The relationship between circulating endothelin-1, soluble fms-like tyrosine kinase-1 and soluble endoglin in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21451568"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CFH"}, "span_text": {"type": "literal", "value": "We sequenced genes encoding three complement regulatory proteins--membrane cofactor protein (MCP), complement factor I (CFI), and complement factor H (CFH)--in 40 patients who had preeclampsia and found heterozygous mutations in seven (18%)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21445332"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CFI"}, "span_text": {"type": "literal", "value": "We sequenced genes encoding three complement regulatory proteins--membrane cofactor protein (MCP), complement factor I (CFI), and complement factor H (CFH)--in 40 patients who had preeclampsia and found heterozygous mutations in seven (18%)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21445332"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "A list of genes which are differentially expressed between preeclampsia and CON included well known preeclampsia markers, such as Flt-1, leptin, HTRA1 and SIGLEC6."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21430563"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PDPN"}, "span_text": {"type": "literal", "value": "Altered nephrin and podoplanin distribution is associated with disturbed polarity protein PARD-3 and PARD-6 expressions in podocytes from preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21422051"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "The purpose of this study was to determine the role of the combined use of uterine artery Doppler velocimetry (UADV) and maternal serum placental growth factor (PlGF), vascular endothelial growth factor receptor-1 soluble fms-like tyrosine kinase-1 also called soluble (sVEGFR-1), and nitric oxide (NO) products concentrations for the prediction of preeclampsia in high-risk women and to compare these parameters between patients with mild and severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21413896"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "The purpose of this study was to determine the role of the combined use of uterine artery Doppler velocimetry (UADV) and maternal serum placental growth factor (PlGF), vascular endothelial growth factor receptor-1 soluble fms-like tyrosine kinase-1 also called soluble (sVEGFR-1), and nitric oxide (NO) products concentrations for the prediction of preeclampsia in high-risk women and to compare these parameters between patients with mild and severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21413896"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "The purpose of this study was to determine the role of the combined use of uterine artery Doppler velocimetry (UADV) and maternal serum placental growth factor (PlGF), vascular endothelial growth factor receptor-1 soluble fms-like tyrosine kinase-1 also called soluble (sVEGFR-1), and nitric oxide (NO) products concentrations for the prediction of preeclampsia in high-risk women and to compare these parameters between patients with mild and severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21413896"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "The purpose of this study was to determine the role of the combined use of uterine artery Doppler velocimetry (UADV) and maternal serum placental growth factor (PlGF), vascular endothelial growth factor receptor-1 soluble fms-like tyrosine kinase-1 also called soluble (sVEGFR-1), and nitric oxide (NO) products concentrations for the prediction of preeclampsia in high-risk women and to compare these parameters between patients with mild and severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21413896"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "The purpose of this study was to determine the role of the combined use of uterine artery Doppler velocimetry (UADV) and maternal serum placental growth factor (PlGF), vascular endothelial growth factor receptor-1 soluble fms-like tyrosine kinase-1 also called soluble (sVEGFR-1), and nitric oxide (NO) products concentrations for the prediction of preeclampsia in high-risk women and to compare these parameters between patients with mild and severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21413896"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HMOX1"}, "span_text": {"type": "literal", "value": "Loss of Akt activity increases circulating soluble endoglin release in preeclampsia: identification of inter-dependency between Akt-1 and heme oxygenase-1."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21411816"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Loss of Akt activity increases circulating soluble endoglin release in preeclampsia: identification of inter-dependency between Akt-1 and heme oxygenase-1."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21411816"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PLAC1"}, "span_text": {"type": "literal", "value": "Plasma mRNA concentrations of placenta-specific 1 (PLAC1) and pregnancy associated plasma protein A (PAPP-A) are higher in early-onset than late-onset pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21392164"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PLAC1"}, "span_text": {"type": "literal", "value": "Some mRNA concentrations are observed to increase in the maternal circulation in association with pre-eclampsia, including placenta-specific 1 (PLAC1) and pregnancy associated plasma protein A (PAPP-A), which were previously proposed as predictive markers for pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21392164"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL2"}, "span_text": {"type": "literal", "value": "Decreased NO and increased cytokine (tumor necrosis factor-\u03b1, interleukin-2, and interferon-\u03b3) levels were found in preeclampsia (p < 0.001)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21376097"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP3"}, "span_text": {"type": "literal", "value": "Maternal serum insulin-like growth factor-binding protein-3 (IGFBP-3) at 11-13 weeks in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21368777"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP3"}, "span_text": {"type": "literal", "value": "The objective of this study was to determine if the maternal serum concentration of insulin-like growth factor-binding protein-3 (IGFBP-3) at 11-13 week's gestation is altered in pregnancies that subsequently develop preeclampsia (PE)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21368777"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:COMT"}, "span_text": {"type": "literal", "value": "Catechol-O-methyltransferase (COMT) is an enzyme involved in catecholamine and estrogen degradation and has recently been ascribed a role in development of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21355050"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "This study was undertaken to determine whether there is a link between soluble vascular endothelial growth factor receptor-1 expression, villous hypermaturity, and clinical severity of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21334711"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Placental expression of vascular endothelial growth factor receptor-1/soluble vascular endothelial growth factor receptor-1 correlates with severity of clinical preeclampsia and villous hypermaturity."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21334711"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "This study was undertaken to determine whether there is a link between soluble vascular endothelial growth factor receptor-1 expression, villous hypermaturity, and clinical severity of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21334711"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Placental expression of vascular endothelial growth factor receptor-1/soluble vascular endothelial growth factor receptor-1 correlates with severity of clinical preeclampsia and villous hypermaturity."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21334711"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Overexpression of soluble vascular endothelial growth factor receptor-1 has been linked to preeclampsia and is thought to be secondary to placental insufficiency caused by hypoxia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21334711"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Placental expression of vascular endothelial growth factor receptor-1/soluble vascular endothelial growth factor receptor-1 correlates with severity of clinical preeclampsia and villous hypermaturity."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21334711"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "This study was undertaken to determine whether there is a link between soluble vascular endothelial growth factor receptor-1 expression, villous hypermaturity, and clinical severity of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21334711"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Overexpression of soluble vascular endothelial growth factor receptor-1 has been linked to preeclampsia and is thought to be secondary to placental insufficiency caused by hypoxia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21334711"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Overexpression of soluble vascular endothelial growth factor receptor-1 has been linked to preeclampsia and is thought to be secondary to placental insufficiency caused by hypoxia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21334711"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "As compared to control vessels, isolated rings of umbilical arteries from patients with preeclampsia demonstrated unaltered responsiveness to endothelin-1 (EC50=2.2 and 3.2 nmol/l, respectively), but exhibited an impaired response to the relaxant effect of sodium nitroprusside (EC50=1.5 vs. 32.4 nmol/l, P<.001) following endothelin-1-induced constriction."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21330936"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Reduced uteroplacental perfusion, the initiating event in preeclampsia, is associated with enhanced endothelin-1 (ET-1) production which feeds the vasoconstriction of uterine artery."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21298073"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Soluble Flt1 and soluble endoglin, secreted by the placenta, are increased in the maternal circulation weeks before the onset of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21266263"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Recent studies have suggested that the clinical syndrome of preeclampsia, which recovers rapidly after delivery of the placenta, is caused by impaired vascular endothelial growth factor signaling that disturbs the status of vascular dilatation as well as the symbiosis between the glomerular endothelium and the podocytes."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21266261"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Recent studies have suggested that the clinical syndrome of preeclampsia, which recovers rapidly after delivery of the placenta, is caused by impaired vascular endothelial growth factor signaling that disturbs the status of vascular dilatation as well as the symbiosis between the glomerular endothelium and the podocytes."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21266261"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Recent studies have suggested that the clinical syndrome of preeclampsia, which recovers rapidly after delivery of the placenta, is caused by impaired vascular endothelial growth factor signaling that disturbs the status of vascular dilatation as well as the symbiosis between the glomerular endothelium and the podocytes."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21266261"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HPSE"}, "span_text": {"type": "literal", "value": "Heparanase or LMWH has the ability to liberate sFlt1 from its retention, so this process may be a potential target for preeclampsia treatment."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21262445"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HRG"}, "span_text": {"type": "literal", "value": "Histidine-rich glycoprotein (HRG) is a protein interacting with both these biological systems and the purpose of this prospective, longitudinal cohort study was to analyze whether there is a difference in circulating levels of HRG during pregnancy in women developing preeclampsia compared to normal healthy pregnancies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21252863"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HRG"}, "span_text": {"type": "literal", "value": "Histidine-rich glycoprotein as an early biomarker of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21252863"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LOC100505909"}, "span_text": {"type": "literal", "value": "Histidine-rich glycoprotein as an early biomarker of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21252863"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LOC100505909"}, "span_text": {"type": "literal", "value": "Histidine-rich glycoprotein (HRG) is a protein interacting with both these biological systems and the purpose of this prospective, longitudinal cohort study was to analyze whether there is a difference in circulating levels of HRG during pregnancy in women developing preeclampsia compared to normal healthy pregnancies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21252863"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "The evaluation of the oxidative state of low-density lipoproteins in intrauterine growth restriction and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21250891"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "To evaluate the oxidative state of lipoproteins in pregnancies complicated by intrauterine growth restriction (IUGR) in comparison to preeclampsia (PE) and healthy pregnant control subjects (CN)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21250891"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CA1"}, "span_text": {"type": "literal", "value": "Serum anti-carbonic anhydrase II antibodies and oxidant-antioxidant balance in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21244564"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CA7"}, "span_text": {"type": "literal", "value": "Serum anti-carbonic anhydrase II antibodies and oxidant-antioxidant balance in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21244564"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CA8"}, "span_text": {"type": "literal", "value": "Serum anti-carbonic anhydrase II antibodies and oxidant-antioxidant balance in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21244564"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CA1"}, "span_text": {"type": "literal", "value": "PROBLEM\u2002 The aim of this study was to investigate the presence of anti-carbonic anhydrase II antibodies (anti-CA II) antibodies in pre-eclampsia and the relationships between the autoantibodies, total antioxidant capacity (TAC) and total oxidant capacity (TOC), malondialdehyde (MDA) and oxidative stres index (OSI) parameters."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21244564"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CA4"}, "span_text": {"type": "literal", "value": "PROBLEM\u2002 The aim of this study was to investigate the presence of anti-carbonic anhydrase II antibodies (anti-CA II) antibodies in pre-eclampsia and the relationships between the autoantibodies, total antioxidant capacity (TAC) and total oxidant capacity (TOC), malondialdehyde (MDA) and oxidative stres index (OSI) parameters."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21244564"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CA2"}, "span_text": {"type": "literal", "value": "Serum anti-carbonic anhydrase II antibodies and oxidant-antioxidant balance in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21244564"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CA7"}, "span_text": {"type": "literal", "value": "PROBLEM\u2002 The aim of this study was to investigate the presence of anti-carbonic anhydrase II antibodies (anti-CA II) antibodies in pre-eclampsia and the relationships between the autoantibodies, total antioxidant capacity (TAC) and total oxidant capacity (TOC), malondialdehyde (MDA) and oxidative stres index (OSI) parameters."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21244564"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CA2"}, "span_text": {"type": "literal", "value": "PROBLEM\u2002 The aim of this study was to investigate the presence of anti-carbonic anhydrase II antibodies (anti-CA II) antibodies in pre-eclampsia and the relationships between the autoantibodies, total antioxidant capacity (TAC) and total oxidant capacity (TOC), malondialdehyde (MDA) and oxidative stres index (OSI) parameters."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21244564"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CA4"}, "span_text": {"type": "literal", "value": "Serum anti-carbonic anhydrase II antibodies and oxidant-antioxidant balance in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21244564"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CA8"}, "span_text": {"type": "literal", "value": "PROBLEM\u2002 The aim of this study was to investigate the presence of anti-carbonic anhydrase II antibodies (anti-CA II) antibodies in pre-eclampsia and the relationships between the autoantibodies, total antioxidant capacity (TAC) and total oxidant capacity (TOC), malondialdehyde (MDA) and oxidative stres index (OSI) parameters."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21244564"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HMGB1"}, "span_text": {"type": "literal", "value": "High mobility group box 1 (HMGB1) levels in the placenta and in serum in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21241404"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HMGB1"}, "span_text": {"type": "literal", "value": "High mobility group box 1 (HMGB1) is a molecule known to act as a 'danger signal' by participating in various inflammatory processes, but data in regard to preeclampsia are sparse."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21241404"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ANXA5"}, "span_text": {"type": "literal", "value": "To study the expression of Annexin A5 (A5) in relation to preeclampsia using immunohistochemical Tissue Microarray (TMA) technique."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21216005"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LAP3"}, "span_text": {"type": "literal", "value": "Placental leucine aminopeptidase- and aminopeptidase A- deficient mice offer insight concerning the mechanisms underlying preterm labor and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21188170"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Pravastatin induces placental growth factor (PGF) and ameliorates preeclampsia in a mouse model."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21187414"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Pre-eclampsia (PE) is a serious hypertensive disorder of pregnancy characterized by excessive production of a soluble form of the vascular endothelial growth factor (VEGF) receptor-1, termed soluble fms-like tyrosine kinase-1 (sFlt-1)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21183928"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Recombinant vascular endothelial growth factor 121 attenuates autoantibody-induced features of pre-eclampsia in pregnant mice."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21183928"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Pre-eclampsia (PE) is a serious hypertensive disorder of pregnancy characterized by excessive production of a soluble form of the vascular endothelial growth factor (VEGF) receptor-1, termed soluble fms-like tyrosine kinase-1 (sFlt-1)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21183928"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Recombinant vascular endothelial growth factor 121 attenuates autoantibody-induced features of pre-eclampsia in pregnant mice."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21183928"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Pre-eclampsia (PE) is a serious hypertensive disorder of pregnancy characterized by excessive production of a soluble form of the vascular endothelial growth factor (VEGF) receptor-1, termed soluble fms-like tyrosine kinase-1 (sFlt-1)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21183928"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Recombinant vascular endothelial growth factor 121 attenuates autoantibody-induced features of pre-eclampsia in pregnant mice."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21183928"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "In addition to confirming changes in expression of soluble factors associated with preeclampsia such as sFLT1 (soluble fms-like tyrosine kinase-1), sENG (soluble endoglin), and INHA (inhibin alpha), we also find changes in immune-associated signaling pathways, offering a potential upstream explanation for the shallow trophoblast invasion and inadequate uterine remodeling typically observed in pathogenesis of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21183218"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SIAE"}, "span_text": {"type": "literal", "value": "Transcriptional profiling of human placentas from pregnancies complicated by preeclampsia reveals disregulation of sialic acid acetylesterase and immune signalling pathways."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21183218"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "In addition to confirming changes in expression of soluble factors associated with preeclampsia such as sFLT1 (soluble fms-like tyrosine kinase-1), sENG (soluble endoglin), and INHA (inhibin alpha), we also find changes in immune-associated signaling pathways, offering a potential upstream explanation for the shallow trophoblast invasion and inadequate uterine remodeling typically observed in pathogenesis of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21183218"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VWF"}, "span_text": {"type": "literal", "value": "Von Willebrand factor antigen and ADAMTS13 activity assay in pregnant women and severe preeclamptic patients."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21181371"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VWF"}, "span_text": {"type": "literal", "value": "The present study examined von Willebrand factor (vWF) levels and ADAMTS13 activity in pregnant and severe preeclamptic women in order to shed light on the prothrombotic state in severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21181371"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VWF"}, "span_text": {"type": "literal", "value": "Maternal and cord plasma concentrations of tissue factor (TF), tissue factor pathway inhibitor (TFPI), von willebrand factor (vWF), soluble P-selectin (sP-selectin), fibrinopeptide A (FPA), D-dimer, and antithrombin III (AT-III) were measured by enzyme-linked immunosorbent assay (ELISA) in 46 women with preeclampsia and 40 normotensive pregnant women before and after delivery."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21174589"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TFPI2"}, "span_text": {"type": "literal", "value": "Maternal and cord plasma concentrations of tissue factor (TF), tissue factor pathway inhibitor (TFPI), von willebrand factor (vWF), soluble P-selectin (sP-selectin), fibrinopeptide A (FPA), D-dimer, and antithrombin III (AT-III) were measured by enzyme-linked immunosorbent assay (ELISA) in 46 women with preeclampsia and 40 normotensive pregnant women before and after delivery."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21174589"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TFPI"}, "span_text": {"type": "literal", "value": "Maternal and cord plasma concentrations of tissue factor (TF), tissue factor pathway inhibitor (TFPI), von willebrand factor (vWF), soluble P-selectin (sP-selectin), fibrinopeptide A (FPA), D-dimer, and antithrombin III (AT-III) were measured by enzyme-linked immunosorbent assay (ELISA) in 46 women with preeclampsia and 40 normotensive pregnant women before and after delivery."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21174589"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Retinol-binding protein 4 and insulin resistance in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21173508"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Insulin resistance is associated with gestational hypertension and not with preeclampsia: a population-based screening study."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21160156"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX1"}, "span_text": {"type": "literal", "value": "Altered placental glutathione peroxidase mRNA expression in preeclampsia according to the presence or absence of labor."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21145108"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX3"}, "span_text": {"type": "literal", "value": "Increased placental oxidative stress in preeclampsia (PE) has been associated in part to a decrease in glutathione peroxidase (GPX) antioxidant activity."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21145108"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX2"}, "span_text": {"type": "literal", "value": "Altered placental glutathione peroxidase mRNA expression in preeclampsia according to the presence or absence of labor."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21145108"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX1"}, "span_text": {"type": "literal", "value": "Increased placental oxidative stress in preeclampsia (PE) has been associated in part to a decrease in glutathione peroxidase (GPX) antioxidant activity."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21145108"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX3"}, "span_text": {"type": "literal", "value": "Altered placental glutathione peroxidase mRNA expression in preeclampsia according to the presence or absence of labor."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21145108"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX2"}, "span_text": {"type": "literal", "value": "Increased placental oxidative stress in preeclampsia (PE) has been associated in part to a decrease in glutathione peroxidase (GPX) antioxidant activity."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21145108"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FBLN1"}, "span_text": {"type": "literal", "value": "51 proteins were differentially expressed between preeclampsia and healthy pregnant women including chorionic somatommammptropin hormone (CSH) and fibulin-1."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21145106"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VCAM1"}, "span_text": {"type": "literal", "value": "Serum levels of interleukin (IL)-1beta, IL-1 receptor antagonist (IL-1ra), IL-2, IL-4, IL-6, IL-8, IL-10, IL-12p40, IL-12p70, IL-18, interferon (IFN)-gamma, tumor necrosis factor (TNF)-alpha, transforming growth factor (TGF)-beta1, interferon-gamma-inducible protein (IP)-10, monocyte chemotactic protein (MCP)-1, intercellular adhesion molecule (ICAM)-1 and vascular cell adhesion molecule (VCAM)-1 were measured in 60 preeclamptic patients, 60 healthy pregnant women and 59 healthy non-pregnant women by multiplex suspension array and ELISA."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21126355"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ICAM2"}, "span_text": {"type": "literal", "value": "Serum levels of interleukin (IL)-1beta, IL-1 receptor antagonist (IL-1ra), IL-2, IL-4, IL-6, IL-8, IL-10, IL-12p40, IL-12p70, IL-18, interferon (IFN)-gamma, tumor necrosis factor (TNF)-alpha, transforming growth factor (TGF)-beta1, interferon-gamma-inducible protein (IP)-10, monocyte chemotactic protein (MCP)-1, intercellular adhesion molecule (ICAM)-1 and vascular cell adhesion molecule (VCAM)-1 were measured in 60 preeclamptic patients, 60 healthy pregnant women and 59 healthy non-pregnant women by multiplex suspension array and ELISA."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21126355"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VWF"}, "span_text": {"type": "literal", "value": "The purpose of this study was to determine circulating levels of cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia in a comprehensive manner, and to investigate their relationship to the clinical features and laboratory parameters of the study participants, including markers of overall inflammation (C-reactive protein), endothelial activation (von Willebrand factor antigen) and endothelial injury (fibronectin), oxidative stress (malondialdehyde) and trophoblast debris (cell-free fetal DNA)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21126355"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ICAM1"}, "span_text": {"type": "literal", "value": "Serum levels of interleukin (IL)-1beta, IL-1 receptor antagonist (IL-1ra), IL-2, IL-4, IL-6, IL-8, IL-10, IL-12p40, IL-12p70, IL-18, interferon (IFN)-gamma, tumor necrosis factor (TNF)-alpha, transforming growth factor (TGF)-beta1, interferon-gamma-inducible protein (IP)-10, monocyte chemotactic protein (MCP)-1, intercellular adhesion molecule (ICAM)-1 and vascular cell adhesion molecule (VCAM)-1 were measured in 60 preeclamptic patients, 60 healthy pregnant women and 59 healthy non-pregnant women by multiplex suspension array and ELISA."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21126355"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ICAM5"}, "span_text": {"type": "literal", "value": "Serum levels of interleukin (IL)-1beta, IL-1 receptor antagonist (IL-1ra), IL-2, IL-4, IL-6, IL-8, IL-10, IL-12p40, IL-12p70, IL-18, interferon (IFN)-gamma, tumor necrosis factor (TNF)-alpha, transforming growth factor (TGF)-beta1, interferon-gamma-inducible protein (IP)-10, monocyte chemotactic protein (MCP)-1, intercellular adhesion molecule (ICAM)-1 and vascular cell adhesion molecule (VCAM)-1 were measured in 60 preeclamptic patients, 60 healthy pregnant women and 59 healthy non-pregnant women by multiplex suspension array and ELISA."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21126355"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VWF"}, "span_text": {"type": "literal", "value": "Increased IP-10, MCP-1, ICAM-1 and VCAM-1 concentrations of preeclamptic patients showed significant correlations with blood pressure values, renal and liver function parameters, as well as with CRP, malondialdehyde, von Willebrand factor antigen and fibronectin levels."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21126355"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TLR4"}, "span_text": {"type": "literal", "value": "Expression of Toll-like receptor 4 in neonatal cord blood mononuclear cells in patients with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21063844"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TLR4"}, "span_text": {"type": "literal", "value": "The expression of Toll-like receptor 4 (TLR4) in neonatal cord blood mononuclear cells (MNCs) and serum TNF-\u03b1 were investigated in order to explore the roles of TLR4 in the pathogenesis of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21063844"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "The objective of the study was to determine whether eclampsia has a different circulating profile of angiogenic (placental growth factor [PlGF]) and antiangiogenic factors (soluble vascular endothelial growth factor receptor-1 [sVEGFR-1] and soluble endoglin [sEng]) from severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21062661"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:COMT"}, "span_text": {"type": "literal", "value": "Disruption of the Catechol-O-methyltransferase (COMT) gene has been shown to be involved in pre-eclampsia (PE)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/21047975"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Vascular endothelial growth factor (VEGF) receptor inhibition resulted in a decrease in angiogenesis in both healthy hypoxic cells and cells from women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20962332"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Vascular endothelial growth factor (VEGF) receptor inhibition resulted in a decrease in angiogenesis in both healthy hypoxic cells and cells from women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20962332"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Vascular endothelial growth factor (VEGF) receptor inhibition resulted in a decrease in angiogenesis in both healthy hypoxic cells and cells from women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20962332"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Soluble fms-Like tyrosine kinase 1 (sFlt1), endoglin and placental growth factor (PlGF) in preeclampsia among high risk pregnancies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20948996"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Soluble fms-Like tyrosine kinase 1 (sFlt1), endoglin and placental growth factor (PlGF) in preeclampsia among high risk pregnancies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20948996"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "The aim of this study was to compare the maternal serum concentrations of the vascular endothelial growth factor (VEGF) in patients whose pregnancies were complicated by pre-eclampsia or HELLP syndrome with those of healthy pregnant controls and to study its relationship with the hormonal and nutritive function of the placenta."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20941502"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Influence of the vascular endothelial growth factor on the development of severe pre-eclampsia or HELLP syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20941502"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "The aim of this study was to compare the maternal serum concentrations of the vascular endothelial growth factor (VEGF) in patients whose pregnancies were complicated by pre-eclampsia or HELLP syndrome with those of healthy pregnant controls and to study its relationship with the hormonal and nutritive function of the placenta."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20941502"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Influence of the vascular endothelial growth factor on the development of severe pre-eclampsia or HELLP syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20941502"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Influence of the vascular endothelial growth factor on the development of severe pre-eclampsia or HELLP syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20941502"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "The aim of this study was to compare the maternal serum concentrations of the vascular endothelial growth factor (VEGF) in patients whose pregnancies were complicated by pre-eclampsia or HELLP syndrome with those of healthy pregnant controls and to study its relationship with the hormonal and nutritive function of the placenta."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20941502"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGT"}, "span_text": {"type": "literal", "value": "Specifically, we demonstrate the oxidative switch of angiotensinogen to its more active sulphydryl-bridged form in the maternal circulation in pre-eclampsia-the hypertensive crisis of pregnancy that threatens the health and survival of both mother and child."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20927107"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "The different concentrations of commercial albumin and albumin in urine samples from three mild preeclampsia patients were determined according to the peak of LSPR extinction spectra."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20926512"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AR"}, "span_text": {"type": "literal", "value": "Association between genetic polymorphisms in androgen receptor gene and the risk of preeclampsia in Korean women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20922474"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AR"}, "span_text": {"type": "literal", "value": "To investigate associations between the androgen receptor (AR) polymorphisms as CAG repeats, GGC repeats and c.211G>A polymorphism and the risk of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20922474"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF2"}, "span_text": {"type": "literal", "value": "Maternal serum insulin-like growth factor-I at 11-13 weeks in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20865795"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF1"}, "span_text": {"type": "literal", "value": "Maternal serum insulin-like growth factor-I at 11-13 weeks in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20865795"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NGF"}, "span_text": {"type": "literal", "value": "Nerve growth factor, birth outcome and pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20863878"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ANGPT1"}, "span_text": {"type": "literal", "value": "The aim of this study was to determine the difference and correlation of placental mRNA expression and maternal/umbilical cord plasma concentrations of vascular endothelial growth factor A (VEGF-A), angiopoietin-1, and angiopoietin-2 between women with severe preeclampsia and normal pregnancies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20863203"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "In women with prior preeclampsia, premenopause was not associated with insulin resistance, but signs of hyperandrogenism were present if FSH was within a premenopausal level."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20846066"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "First-trimester placental protein 13 and placental growth factor: markers for identification of women destined to develop early-onset pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20840693"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "OBJECTIVE: \u2002To investigate the predictive value of maternal serum pregnancy-associated plasma protein A (PAPP-A), free \u03b2 subunit of human chorionic gonadotrophin (f\u03b2-hCG), placental protein 13 (PP13), placental growth factor (PlGF) and a desintegrin and metalloproteinase 12 (ADAM12), for first-trimester identification of early-onset pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20840693"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Decreased proportion of peripheral blood vascular endothelial growth factor-expressing T and natural killer cells in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20833383"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "The purpose of this study was to determine the proportion of circulating T and natural killer (NK) cells that express intracellular vascular endothelial growth factor (VEGF) in women with preeclampsia compared to those with a normal pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20833383"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "The purpose of this study was to determine the proportion of circulating T and natural killer (NK) cells that express intracellular vascular endothelial growth factor (VEGF) in women with preeclampsia compared to those with a normal pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20833383"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Decreased proportion of peripheral blood vascular endothelial growth factor-expressing T and natural killer cells in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20833383"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "The purpose of this study was to determine the proportion of circulating T and natural killer (NK) cells that express intracellular vascular endothelial growth factor (VEGF) in women with preeclampsia compared to those with a normal pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20833383"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Decreased proportion of peripheral blood vascular endothelial growth factor-expressing T and natural killer cells in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20833383"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "To test these hypotheses, we used an animal model of pre-eclampsia in rats: pregnant rats treated with l-nitro-arginine methyl ester, an inhibitor of nitric oxide synthase."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20832451"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CSF2"}, "span_text": {"type": "literal", "value": "Granulocyte-macrophage colony-stimulating factor is known to regulate the differentiation of both macrophages and dendritic cells, prompting both in vivo and in vitro evaluation of granulocyte-macrophage colony-stimulating factor expression in human decidua as well as in a mouse model of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20829438"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CSF2"}, "span_text": {"type": "literal", "value": "Evaluation of a murine model of preeclampsia revealed that the decidua of affected animals displayed higher levels of immunoreactive granulocyte-macrophage colony-stimulating factor as well as increased numbers of both macrophages and dendritic cells when compared to control animals."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20829438"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CSF1"}, "span_text": {"type": "literal", "value": "Granulocyte-macrophage colony-stimulating factor is known to regulate the differentiation of both macrophages and dendritic cells, prompting both in vivo and in vitro evaluation of granulocyte-macrophage colony-stimulating factor expression in human decidua as well as in a mouse model of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20829438"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CSF1"}, "span_text": {"type": "literal", "value": "Moreover, both tumor necrosis factor-\u03b1 and interleukin-1 \u03b2, cytokines that are implicated in the genesis of preeclampsia, markedly up-regulated granulocyte-macrophage colony-stimulating factor production in cultured first-trimester human decidual cells."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20829438"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CSF2"}, "span_text": {"type": "literal", "value": "Moreover, both tumor necrosis factor-\u03b1 and interleukin-1 \u03b2, cytokines that are implicated in the genesis of preeclampsia, markedly up-regulated granulocyte-macrophage colony-stimulating factor production in cultured first-trimester human decidual cells."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20829438"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CSF1"}, "span_text": {"type": "literal", "value": "Because granulocyte-macrophage colony-stimulating factor is a potent inducer of differentiation and activation of both macrophages and dendritic cells, these findings suggest that this factor plays a crucial role in the pathogenesis of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20829438"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CSF2"}, "span_text": {"type": "literal", "value": "Because granulocyte-macrophage colony-stimulating factor is a potent inducer of differentiation and activation of both macrophages and dendritic cells, these findings suggest that this factor plays a crucial role in the pathogenesis of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20829438"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CSF1"}, "span_text": {"type": "literal", "value": "Evaluation of a murine model of preeclampsia revealed that the decidua of affected animals displayed higher levels of immunoreactive granulocyte-macrophage colony-stimulating factor as well as increased numbers of both macrophages and dendritic cells when compared to control animals."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20829438"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TTR"}, "span_text": {"type": "literal", "value": "Does transthyretin function as one of contributors for preeclampsia?"}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20826058"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGT"}, "span_text": {"type": "literal", "value": "We used transgenic female mice overexpressing human angiotensinogen, which develop preeclampsia when mated with human renin-overexpressing males."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20811291"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TCF4"}, "span_text": {"type": "literal", "value": "Activating protein-1 family of transcription factors in the human placenta complicated by preeclampsia with and without fetal growth restriction."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20800894"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "To evaluate whether the measurement of maternal serum inhibin A, activin A and placental growth factor (PlGF) at 12 + 0 to 16 + 0 weeks of gestation alone or in combination with second-trimester uterine artery Doppler pulsatility index (PI) is useful in predicting pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20737451"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Inhibin A, activin A, placental growth factor and uterine artery Doppler pulsatility index in the prediction of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20737451"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:COMT"}, "span_text": {"type": "literal", "value": "Genetic polymorphism of catechol-O-methyltransferase and cytochrome P450c17\u03b1 in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20729792"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL6"}, "span_text": {"type": "literal", "value": "Interleukin-6 (IL-6) is one of the main proinflammatory mediators of hypertension and endothelial dysfunction in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20715974"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL6"}, "span_text": {"type": "literal", "value": "Magnesium sulfate normalizes placental interleukin-6 secretion in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20715974"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Are insulin resistance index, IGF-1 and metabolic syndrome components correlates with severe preeclampsia?"}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20701471"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LAIR2"}, "span_text": {"type": "literal", "value": "A global gene expression microarray analysis of surplus chorionic villus sampling (CVS) tissues identified leukocyte-associated immunoglobulin-like receptor 2 (LAIR2) as down-regulated in the first trimester of pregnancies destined for preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20692035"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "A combined screening model with clinical characteristics, pregnancy-associated plasma protein-A, Inhibin-A, and placental growth factor could detect 75% of early-onset preeclampsia at a 10% false-positive rate."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20691410"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "A combination of clinical characteristics and first-trimester maternal serum biomarkers (pregnancy-associated plasma protein-A, Inhibin-A, and placental growth factor) provides an accurate screening for early-onset preeclampsia in nulliparous women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20691410"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Preeclampsia is characterized by high levels of circulating antiangiogenic factors such as soluble fms-like tyrosine kinase-1 and soluble endoglin, which induce maternal endothelial dysfunction."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20685551"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Preeclampsia is characterized by high levels of circulating antiangiogenic factors such as soluble fms-like tyrosine kinase-1 and soluble endoglin, which induce maternal endothelial dysfunction."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20685551"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "The aim of this study was to evaluate the role of cytokines in pre-eclampsia and to study the relationship between endothelin-1 and cytokines with the severity of the disease."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20678167"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL2"}, "span_text": {"type": "literal", "value": "Increased endothelin-1 and cytokines [tumor necrosis factor-\u03b1, interleukin-2 (IL-2) and \u03b3-interferon (IFN-\u03b3)] levels were found in pre-eclampsia (P < 0.001)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20678167"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Increased endothelin-1 and cytokines [tumor necrosis factor-\u03b1, interleukin-2 (IL-2) and \u03b3-interferon (IFN-\u03b3)] levels were found in pre-eclampsia (P < 0.001)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20678167"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "We conclude that pre-eclampsia is associated with increased levels of both endothelin-1 and circulating inflammatory cytokines, which points toward the role of endothelial and inflammatory components."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20678167"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "Amino-terminal pro-brain natriuretic peptide (NT-proBNP) is a biomarker of cardiac filling pressures in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20674138"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "To evaluate if amino-terminal pro-brain natriuretic peptide (NT-proBNP) plasma levels reflect intracardiac filling pressures in pre-eclamptic patients."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20674138"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Soluble endoglin for the prediction of preeclampsia in a high risk cohort."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20670156"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "To evaluate soluble endoglin (sEng) and the soluble fms-like tyrosine kinase 1 (sFlt1) to placental growth factor (PlGF) ratio for the prediction of preeclampsia in high-risk women, and to evaluate differences in sEng between women with high-risk singleton and multiple gestation pregnancies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20670156"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:RETN"}, "span_text": {"type": "literal", "value": "Serum resistin levels were significantly elevated in women with preeclampsia compared to normal pregnant women and non-pregnant women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20670155"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:RETN"}, "span_text": {"type": "literal", "value": "Comparison of serum levels and the placental expression of resistin between patients with preeclampsia and normal pregnant women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20670155"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:RETN"}, "span_text": {"type": "literal", "value": "The placenta may not be the origin of the resistin that contributes to increased serum levels in women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20670155"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:RETN"}, "span_text": {"type": "literal", "value": "The aim of this study was to evaluate serum resistin levels in women with preeclampsia compared to those in normal pregnant women and normal non-pregnant women, and to examine placental resistin expression."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20670155"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP2"}, "span_text": {"type": "literal", "value": "Altered levels of insulin-like growth factor binding protein proteases in preeclampsia and intrauterine growth restriction."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20658698"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP5"}, "span_text": {"type": "literal", "value": "Altered levels of insulin-like growth factor binding protein proteases in preeclampsia and intrauterine growth restriction."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20658698"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP7"}, "span_text": {"type": "literal", "value": "Altered levels of insulin-like growth factor binding protein proteases in preeclampsia and intrauterine growth restriction."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20658698"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP4"}, "span_text": {"type": "literal", "value": "Altered levels of insulin-like growth factor binding protein proteases in preeclampsia and intrauterine growth restriction."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20658698"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP3"}, "span_text": {"type": "literal", "value": "Altered levels of insulin-like growth factor binding protein proteases in preeclampsia and intrauterine growth restriction."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20658698"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:COMT"}, "span_text": {"type": "literal", "value": "We first address the 'angiogenic imbalance' theory, which hypothesizes that pre-eclampsia results from an imbalance of factors that promote or antagonize angiogenesis, such as soluble fms-like tyrosine kinase (sFlt1), 2-methoxyestradiol (2-ME) and catechol-O-methyltransferase (COMT)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20646932"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "We first address the 'angiogenic imbalance' theory, which hypothesizes that pre-eclampsia results from an imbalance of factors that promote or antagonize angiogenesis, such as soluble fms-like tyrosine kinase (sFlt1), 2-methoxyestradiol (2-ME) and catechol-O-methyltransferase (COMT)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20646932"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "At 10 to 17 weeks, women who developed preterm preeclampsia had lower serum PlGF (P=0.003), higher soluble endoglin (P=0.006), and higher sFlt-1:PlGF ratio (P=0.005) compared with women who later developed term preeclampsia, gestational hypertension, or normotensive pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20644016"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:STOX1"}, "span_text": {"type": "literal", "value": "Variation in the Storkhead box-1 (STOX1) gene has previously been associated with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20643876"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Insulin resistance relates to microvascular reactivity 23 years after preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20637782"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "Ischemia-modified albumin as an oxidative stress marker in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20617896"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:UCN"}, "span_text": {"type": "literal", "value": "Hypoxia and preeclampsia: increased expression of urocortin 2 and urocortin 3."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20616367"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:UCN2"}, "span_text": {"type": "literal", "value": "Hypoxia and preeclampsia: increased expression of urocortin 2 and urocortin 3."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20616367"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TPO"}, "span_text": {"type": "literal", "value": "In one trial of 115 women, levothyroxine therapy to treat pregnant euthyroid women with thyroid peroxidase antibodies was not shown to reduce pre-eclampsia significantly (risk ratio (RR) 0.61; 95% confidence interval (CI) 0.11 to 3.48) but did significantly reduce preterm birth by 72% (RR 0.28; 95% CI 0.10 to 0.80)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20614463"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IDO2"}, "span_text": {"type": "literal", "value": "Indoleamine 2,3-dioxygenase gene in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20584013"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IDO1"}, "span_text": {"type": "literal", "value": "Indoleamine 2,3-dioxygenase gene in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20584013"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Using pravastatin to improve the vascular reactivity in a mouse model of soluble fms-like tyrosine kinase-1-induced preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20567176"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "This study examined the association of expression of vascular endothelial growth factor (VEGF), a promoter of angiogenesis, with endothelium dysfunction in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20556584"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "This study examined the association of expression of vascular endothelial growth factor (VEGF), a promoter of angiogenesis, with endothelium dysfunction in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20556584"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "This study examined the association of expression of vascular endothelial growth factor (VEGF), a promoter of angiogenesis, with endothelium dysfunction in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20556584"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MPO"}, "span_text": {"type": "literal", "value": "To assess the plasma and serum maternal total antioxidant status, circulating levels of lipid peroxidation breakdown products (MDA), protein oxidation markers (AOPPs), myeloperoxidase (MPO) and lipid hydroperoxide (LHP) in preeclampsia, gestational diabetes mellitus (GDM) patients and compare them with noncomplicated normal pregnancies between 24 and 36 weeks of gestation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20537747"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGT"}, "span_text": {"type": "literal", "value": "Therefore, our objective was to determine whether the genes for placental renin (REN) and maternal angiotensinogen (AGT) interact to influence the risk of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20537141"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGT"}, "span_text": {"type": "literal", "value": "Maternal angiotensinogen (AGT) haplotypes, fetal renin (REN) haplotypes and risk of preeclampsia; estimation of gene-gene interaction from family-triad data."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20537141"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "The purpose of this study was to determine whether increased serum soluble fms-like tyrosine kinase-1 (sFlt-1) and decreased placental growth factor (PlGF) levels in pre-eclampsia are related to the clinical features and laboratory parameters of the patients, including markers of inflammation, endothelial activation and injury, oxidative stress and trophoblast debris."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20535121"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "However, serum concentrations of thrombomodulin (median 3.6 vs. 5.2 ng/mL; P = 0.006), E-selectin (median 32.0 vs. 42.9 ng/mL; P = 0.02), and especially endoglin (median 5.0 vs. 76.2 ng/mL; P < 0.0001) were significantly increased in severe preeclamptic patients."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20533384"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Relationship between leptin and lipids during pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20527637"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "This study concluded that serum leptin levels during pre-eclampsia are strongly associated with total cholesterol whereas association with other variables is insignificant."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20527637"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "With severity of pre-eclampsia when leptin level rises, total cholesterol also rises."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20527637"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "To assess the relation between serum leptin levels and lipid profile in women with pre-eclampsia and to evaluate their atherogenic role in the pathophysiology of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20527637"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LCN2"}, "span_text": {"type": "literal", "value": "Plasma lipocalin-2 levels in pregnant women with pre-eclampsia, and their relation with severity of disease."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20504246"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:B2M"}, "span_text": {"type": "literal", "value": "In this nested case-control study, maternal serum concentrations of cystatin C, beta2-microglobulin, serum amyloid A, C-reactive protein (CRP), and neopterin were measured, and resistance index of uterine artery blood flow was assessed in 45 women in whom preeclampsia subsequently developed and in 125 women with normal pregnancy outcome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20502295"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:B2M"}, "span_text": {"type": "literal", "value": "Univariable logistic regression showed that women with subsequent preeclampsia had increased levels of cystatin C, beta2-microglobulin, neopterin, CRP, and resistance index."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20502295"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "We sought to evaluate the association between soluble fms-like tyrosine kinase 1 (sFlt1) and endoglin (ENG) and preeclampsia in an urban population, to develop a discriminatory model, and evaluate the association of these biomarkers with small for gestational age (SGA)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20482287"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "The increase in levels of soluble vascular endothelial growth factor receptor 1, an antiangiogenic agent known to inhibit placental vascularization, is an important cellular factor implicated in the onset of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20479331"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "The increase in levels of soluble vascular endothelial growth factor receptor 1, an antiangiogenic agent known to inhibit placental vascularization, is an important cellular factor implicated in the onset of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20479331"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Upregulation of urotensin II receptor in preeclampsia causes in vitro placental release of soluble vascular endothelial growth factor receptor 1 in hypoxia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20479331"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Upregulation of urotensin II receptor in preeclampsia causes in vitro placental release of soluble vascular endothelial growth factor receptor 1 in hypoxia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20479331"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Upregulation of urotensin II receptor in preeclampsia causes in vitro placental release of soluble vascular endothelial growth factor receptor 1 in hypoxia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20479331"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "The increase in levels of soluble vascular endothelial growth factor receptor 1, an antiangiogenic agent known to inhibit placental vascularization, is an important cellular factor implicated in the onset of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20479331"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Contrary to our hypothesis, insulin resistance was higher as inflammation increased in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20462373"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "A cytokine panel, glucose and insulin were measured in 37 preeclampsia plasma samples."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20462373"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "No dichotomous subsets of preeclampsia by inflammation versus insulin resistance were detected."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20462373"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "The preeclampsia biomarkers soluble fms-like tyrosine kinase-1 and placental growth factor: current knowledge, clinical implications and future application."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20457483"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "In this article we will highlight the diagnostic potential of the novel biomarkers soluble fms-like tyrosine kinase-1 and placental growth factor and discuss the opportunities and challenges involved in bringing these preeclampsia biomarkers from bench to bedside."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20457483"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "In this article we will highlight the diagnostic potential of the novel biomarkers soluble fms-like tyrosine kinase-1 and placental growth factor and discuss the opportunities and challenges involved in bringing these preeclampsia biomarkers from bench to bedside."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20457483"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "The preeclampsia biomarkers soluble fms-like tyrosine kinase-1 and placental growth factor: current knowledge, clinical implications and future application."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20457483"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GRK4"}, "span_text": {"type": "literal", "value": "G protein-coupled receptor kinase 4 gene variants are not associated with preeclampsia in Northern Han Chinese."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20448640"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL6"}, "span_text": {"type": "literal", "value": "Maternal and umbilical serum levels of interleukin-6, interleukin-8, and tumor necrosis factor-alpha in normal pregnancies and in pregnancies complicated by preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20441409"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL6"}, "span_text": {"type": "literal", "value": "The aim of this study was to investigate the relationship of maternal and umbilical cord interleukin-6 (IL-6), interleukin-8 (IL-8), tumor necrosis factor-alpha (TNF-alpha) serum levels with the existence and severity of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20441409"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Soluble endoglin in preeclamptic patients with or without HELLP syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20430360"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGFB2"}, "span_text": {"type": "literal", "value": "In pre-eclampsia, high interferon (IFN)-gamma concentrations are present, along with transforming growth factor-beta cytokines, which retard migration of cytotrophoblasts."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20388637"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGFB1"}, "span_text": {"type": "literal", "value": "In pre-eclampsia, high interferon (IFN)-gamma concentrations are present, along with transforming growth factor-beta cytokines, which retard migration of cytotrophoblasts."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20388637"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGFB3"}, "span_text": {"type": "literal", "value": "In pre-eclampsia, high interferon (IFN)-gamma concentrations are present, along with transforming growth factor-beta cytokines, which retard migration of cytotrophoblasts."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20388637"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CRH"}, "span_text": {"type": "literal", "value": "Among markers of pregnancy complications, corticotropin-releasing hormone (CRH) mRNA, long pentraxin 3 (PTX3) protein and fetal and total DNA had been reported to be increased in the plasma of women with overt preeclampsia (PE)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20374043"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Maternal serum markers including inhibin A, activin A, soluble FMS-Like tyrosine kinase 1, endoglin, pregnancy associated plasma protein A and others, when used alone have proved poor predictors of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20373592"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Maternal serum markers including inhibin A, activin A, soluble FMS-Like tyrosine kinase 1, endoglin, pregnancy associated plasma protein A and others, when used alone have proved poor predictors of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20373592"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "Pregnant C57BL/6J mice were divided into control and preeclampsia (PE) groups, and injected subcutaneously with the nitric oxide synthase inhibitor L-arginine methyl ester (L-NAME) 50 mgxkg(-1)d(-1)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20368091"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TFPI2"}, "span_text": {"type": "literal", "value": "Changes of plasma and placental tissue factor pathway inhibitor-2 in women with preeclampsia and normal pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20347477"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Serum endoglin was significantly higher in pre-eclamptic women in the third trimester than in controls (median 35.15 versus 10.35 ng/ml, respectively) and in women with severe compared with mild pre-eclampsia (median 51.68 versus 20.99 ng/ml, respectively)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20233512"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Serum levels of endoglin were measured in pre-eclamptic women in their third trimester and in women in their second trimester who later developed pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20233512"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Placental endoglin was also significantly higher in pre-eclamptic women than controls (median 26.24 versus 9.21 ng/mg, respectively) and in women with severe compared with mild pre-eclampsia (median 28.77 versus 13.38 ng/mg, respectively)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20233512"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "These findings suggest that endoglin plays an important role in the pathogenesis of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20233512"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Pregnant women in the second trimester who eventually developed pre-eclampsia had significantly higher serum endoglin than age- and gestational age-matched controls (median 5.90 versus 5.20 ng/ml, respectively)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20233512"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Alterations of serum and placental endoglin in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20233512"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Pre-pregnancy body mass index and first trimester maternal plasma leptin levels were significantly higher among women with preeclampsia (p=0.015 and p<0.001, respectively)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20230327"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD1"}, "span_text": {"type": "literal", "value": "Effects of labor on placental expression of superoxide dismutases in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20226522"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD3"}, "span_text": {"type": "literal", "value": "Effects of labor on placental expression of superoxide dismutases in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20226522"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD1"}, "span_text": {"type": "literal", "value": "A decreased antioxidant activity for superoxide dismutases (SODs) in the placenta was reported in preeclampsia (PE)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20226522"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD3"}, "span_text": {"type": "literal", "value": "A decreased antioxidant activity for superoxide dismutases (SODs) in the placenta was reported in preeclampsia (PE)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20226522"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TFPI2"}, "span_text": {"type": "literal", "value": "The relationship between plasma and placental tissue factor, and tissue factor pathway inhibitors in severe pre-eclampsia patients."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20226500"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TFPI"}, "span_text": {"type": "literal", "value": "The relationship between plasma and placental tissue factor, and tissue factor pathway inhibitors in severe pre-eclampsia patients."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20226500"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TFPI"}, "span_text": {"type": "literal", "value": "Plasma tissue factor (TF) and tissue factor pathway inhibitor (TFPI) expression from pre-eclampsia patients and healthy pregnant controls were determined by ELISA."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20226500"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TFPI2"}, "span_text": {"type": "literal", "value": "Plasma tissue factor (TF) and tissue factor pathway inhibitor (TFPI) expression from pre-eclampsia patients and healthy pregnant controls were determined by ELISA."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20226500"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "To test this hypothesis, levels of plasma vascular endothelial growth factor (VEGF), placental growth factor (PlGF), soluble fms-like tyrosine kinase-1 (sFlt-1), the oxidative stress marker malondialdehyde (MDA) and fatty acids were estimated in women with preeclampsia and their cord samples and compared with those in normotensive women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20224572"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "To test this hypothesis, levels of plasma vascular endothelial growth factor (VEGF), placental growth factor (PlGF), soluble fms-like tyrosine kinase-1 (sFlt-1), the oxidative stress marker malondialdehyde (MDA) and fatty acids were estimated in women with preeclampsia and their cord samples and compared with those in normotensive women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20224572"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "To test this hypothesis, levels of plasma vascular endothelial growth factor (VEGF), placental growth factor (PlGF), soluble fms-like tyrosine kinase-1 (sFlt-1), the oxidative stress marker malondialdehyde (MDA) and fatty acids were estimated in women with preeclampsia and their cord samples and compared with those in normotensive women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20224572"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "To test this hypothesis, levels of plasma vascular endothelial growth factor (VEGF), placental growth factor (PlGF), soluble fms-like tyrosine kinase-1 (sFlt-1), the oxidative stress marker malondialdehyde (MDA) and fatty acids were estimated in women with preeclampsia and their cord samples and compared with those in normotensive women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20224572"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "In black women, the fms-like tyrosine kinase 1 rs12584067 (odds ratio [OR], 1.55; 95% confidence interval [CI], 1.01-2.36; P=.05) and rs7335588 (OR, 1.61; 95% CI, 1.06-2.43; P=.01) and the vascular endothelial growth factor C rs1485766 (OR, 1.56; 95% CI, 1.05-2.30; P=.03) and rs6838834 (OR, 1.60; 95% CI, 1.05-2.45; P=.03) single nucleotide polymorphisms were associated with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20223440"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Allelic variations in the fms-like tyrosine kinase 1 and vascular endothelial growth factor C genes are associated with preeclampsia in both ethnic groups."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20223440"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "In white women, the fms-like tyrosine kinase 1 rs722503 (OR, 2.12; 95% CI, 1.07-4.19; P=.03), fms-like tyrosine kinase 4 rs307826 (OR, 3.06; 95% CI, 1.18-7.91; P=.01), and vascular endothelial growth factor C rs7664413 (OR, 2.04; 95% CI, 0.99-4.17; P=.04) single nucleotide polymorphisms were associated with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20223440"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "In white women, the fms-like tyrosine kinase 1 rs722503 (OR, 2.12; 95% CI, 1.07-4.19; P=.03), fms-like tyrosine kinase 4 rs307826 (OR, 3.06; 95% CI, 1.18-7.91; P=.01), and vascular endothelial growth factor C rs7664413 (OR, 2.04; 95% CI, 0.99-4.17; P=.04) single nucleotide polymorphisms were associated with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20223440"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Allelic variations in the fms-like tyrosine kinase 1 and vascular endothelial growth factor C genes are associated with preeclampsia in both ethnic groups."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20223440"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "In black women, the fms-like tyrosine kinase 1 rs12584067 (odds ratio [OR], 1.55; 95% confidence interval [CI], 1.01-2.36; P=.05) and rs7335588 (OR, 1.61; 95% CI, 1.06-2.43; P=.01) and the vascular endothelial growth factor C rs1485766 (OR, 1.56; 95% CI, 1.05-2.30; P=.03) and rs6838834 (OR, 1.60; 95% CI, 1.05-2.45; P=.03) single nucleotide polymorphisms were associated with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20223440"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOF"}, "span_text": {"type": "literal", "value": "Pre-eclamptic patients had lower post-partum high-density lipoprotein (P=0.02), higher triglyceride (P<0.001), higher free fatty acid (P=0.02) and higher apolipoprotein B levels (P=0.01) than the control group."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20220770"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOE"}, "span_text": {"type": "literal", "value": "Pre-eclamptic patients had lower post-partum high-density lipoprotein (P=0.02), higher triglyceride (P<0.001), higher free fatty acid (P=0.02) and higher apolipoprotein B levels (P=0.01) than the control group."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20220770"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Pre-eclamptic patients had lower post-partum high-density lipoprotein (P=0.02), higher triglyceride (P<0.001), higher free fatty acid (P=0.02) and higher apolipoprotein B levels (P=0.01) than the control group."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20220770"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOM"}, "span_text": {"type": "literal", "value": "Pre-eclamptic patients had lower post-partum high-density lipoprotein (P=0.02), higher triglyceride (P<0.001), higher free fatty acid (P=0.02) and higher apolipoprotein B levels (P=0.01) than the control group."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20220770"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOO"}, "span_text": {"type": "literal", "value": "Pre-eclamptic patients had lower post-partum high-density lipoprotein (P=0.02), higher triglyceride (P<0.001), higher free fatty acid (P=0.02) and higher apolipoprotein B levels (P=0.01) than the control group."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20220770"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL6"}, "span_text": {"type": "literal", "value": "Nicotine suppresses interleukin-6 production from vascular endothelial cells: a possible therapeutic role of nicotine for preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20220107"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Our data potentially suggest that Endoglin level correlates with the clinical symptoms of preeclampsia and preeclamptic pregnancies with FGR."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20214506"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Antiangiogenic factors, soluble endoglin (sEndoglin), sFlt-1, and placental growth factor (PIGF) were analyzed in healthy and preeclamptic women (including seven with FGR) at three different time points. sEndoglin or sFlt-1 but not PIGF levels were significantly higher in women with preeclampsia at admission."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20214506"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LCN2"}, "span_text": {"type": "literal", "value": "Serum levels of the adipokine lipocalin-2 are increased in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20208456"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Maternal plasma soluble endoglin at 11-13 weeks' gestation in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20205159"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "To examine the performance of screening for pre-eclampsia (PE) by a combination of maternal factors, soluble endoglin (sEng), pregnancy associated plasma protein-A (PAPP-A), placental growth factor (PlGF) and uterine artery lowest pulsatility index (L-PI) at 11-13 weeks' gestation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20205159"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Among these were genes not previously associated with pre-eclampsia as bradykinin B1 receptor and a 14-3-3 protein, but also genes that have already been connected with pre-eclampsia, for example, inhibin beta A subunit and leptin."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20204130"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Post-treatment plasma leptin levels in both the mild and severe preeclampsia groups (range 10.2-23.5 and 11.3-24.4, respectively) were statistically similar to those of the control group (range 9.1-20.7)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20200774"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "However, the exact mechanism underlying the increased plasma leptin levels in preeclampsia and the functional role of leptin in the development of hypertension need to be further clarified."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20200774"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Plasma leptin concentrations were found to be elevated in women diagnosed with severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20200774"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "This study was carried out to investigate changes in the plasma leptin concentrations during preeclampsia treatment and to determine whether antihypertensive treatments, aimed at decreasing leptin levels, would improve foetal outcomes."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20200774"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Leptin has a promising future as a valuable marker to identity women with a high risk for preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20200774"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Pre-treatment plasma leptin levels were significantly increased in the severe preeclampsia group (range 18.3-49.5) compared to the the mild preeclampsia group (range 20.7-45.4) and normal controls (range 8.6-19.2)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20200774"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Leptin levels and antihypertensive treatment in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20200774"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL18"}, "span_text": {"type": "literal", "value": "Plasma interleukin-18 (IL-18) levels are correlated with antioxidant vitamin coenzyme Q(10) in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20199352"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IDO1"}, "span_text": {"type": "literal", "value": "Genetic variation in the indoleamine 2,3-dioxygenase gene in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20192952"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IDO1"}, "span_text": {"type": "literal", "value": "To investigate the contribution of genomic variations in the indoleamine 2,3-dioxygenase (IDO) gene to the onset of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20192952"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IDO2"}, "span_text": {"type": "literal", "value": "Genetic variation in the indoleamine 2,3-dioxygenase gene in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20192952"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IDO2"}, "span_text": {"type": "literal", "value": "To investigate the contribution of genomic variations in the indoleamine 2,3-dioxygenase (IDO) gene to the onset of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20192952"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL10"}, "span_text": {"type": "literal", "value": "Tumor necrosis factor alpha, interleukin-6 and interleukin-10 polymorphisms in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20178529"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL6"}, "span_text": {"type": "literal", "value": "Tumor necrosis factor alpha, interleukin-6 and interleukin-10 polymorphisms in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20178529"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Women with a history of hypertensive disorders in pregnancy (preeclampsia or gestational hypertension) had higher BMI, higher blood pressure, and unfavorable levels of total cholesterol, low-density lipoprotein cholesterol, and triglycerides."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20168095"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MAPK14"}, "span_text": {"type": "literal", "value": "The purpose of this study was to evaluate the interaction between Hsp27 and mitogen-activated protein kinase (MAPK) (p38, extracellular signal-regulated kinase [ERK], and c-Jun N-terminal kinase) in the human placenta derived from patients with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20149037"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MAPK10"}, "span_text": {"type": "literal", "value": "The purpose of this study was to evaluate the interaction between Hsp27 and mitogen-activated protein kinase (MAPK) (p38, extracellular signal-regulated kinase [ERK], and c-Jun N-terminal kinase) in the human placenta derived from patients with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20149037"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MAPK12"}, "span_text": {"type": "literal", "value": "The purpose of this study was to evaluate the interaction between Hsp27 and mitogen-activated protein kinase (MAPK) (p38, extracellular signal-regulated kinase [ERK], and c-Jun N-terminal kinase) in the human placenta derived from patients with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20149037"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MAPK9"}, "span_text": {"type": "literal", "value": "The purpose of this study was to evaluate the interaction between Hsp27 and mitogen-activated protein kinase (MAPK) (p38, extracellular signal-regulated kinase [ERK], and c-Jun N-terminal kinase) in the human placenta derived from patients with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20149037"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MAPK11"}, "span_text": {"type": "literal", "value": "The purpose of this study was to evaluate the interaction between Hsp27 and mitogen-activated protein kinase (MAPK) (p38, extracellular signal-regulated kinase [ERK], and c-Jun N-terminal kinase) in the human placenta derived from patients with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20149037"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MAPK8"}, "span_text": {"type": "literal", "value": "The purpose of this study was to evaluate the interaction between Hsp27 and mitogen-activated protein kinase (MAPK) (p38, extracellular signal-regulated kinase [ERK], and c-Jun N-terminal kinase) in the human placenta derived from patients with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20149037"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MAPK1"}, "span_text": {"type": "literal", "value": "The purpose of this study was to evaluate the interaction between Hsp27 and mitogen-activated protein kinase (MAPK) (p38, extracellular signal-regulated kinase [ERK], and c-Jun N-terminal kinase) in the human placenta derived from patients with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20149037"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MAPK13"}, "span_text": {"type": "literal", "value": "The purpose of this study was to evaluate the interaction between Hsp27 and mitogen-activated protein kinase (MAPK) (p38, extracellular signal-regulated kinase [ERK], and c-Jun N-terminal kinase) in the human placenta derived from patients with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20149037"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MAPK15"}, "span_text": {"type": "literal", "value": "The purpose of this study was to evaluate the interaction between Hsp27 and mitogen-activated protein kinase (MAPK) (p38, extracellular signal-regulated kinase [ERK], and c-Jun N-terminal kinase) in the human placenta derived from patients with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20149037"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MAPK6"}, "span_text": {"type": "literal", "value": "The purpose of this study was to evaluate the interaction between Hsp27 and mitogen-activated protein kinase (MAPK) (p38, extracellular signal-regulated kinase [ERK], and c-Jun N-terminal kinase) in the human placenta derived from patients with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20149037"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:OSM"}, "span_text": {"type": "literal", "value": "Oncostatin M as a target biological molecule of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20149034"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:OSM"}, "span_text": {"type": "literal", "value": "Given the presence of the cytokinetic effects of Oncostatin M (OSM), we hypothesized that placental expression of OSM and serum OSM levels are elevated in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20149034"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX1"}, "span_text": {"type": "literal", "value": "This case-control study was conducted in Khartoum hospital, Sudan to investigate the levels of antioxidant enzymes (glutathione peroxidase, catalase and superoxide dismutase) in erythrocytes and plasma antioxidant vitamins (retinol and alpha-tocopherol) in Sudanese women with pre-eclampsia (37), in comparison with well-matched pregnant controls women with normal pregnancy (38)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20143973"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD3"}, "span_text": {"type": "literal", "value": "Women with mild pre-eclampsia (diastolic blood pressure, DBP < 110) have slightly higher levels of erythrocyte glutathione peroxidase, and lower levels of catalase and superoxide dismutase compared with women with severe pre-eclampsia (DBP > or = 110)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20143973"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX2"}, "span_text": {"type": "literal", "value": "Women with mild pre-eclampsia (diastolic blood pressure, DBP < 110) have slightly higher levels of erythrocyte glutathione peroxidase, and lower levels of catalase and superoxide dismutase compared with women with severe pre-eclampsia (DBP > or = 110)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20143973"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CAT"}, "span_text": {"type": "literal", "value": "Women with mild pre-eclampsia (diastolic blood pressure, DBP < 110) have slightly higher levels of erythrocyte glutathione peroxidase, and lower levels of catalase and superoxide dismutase compared with women with severe pre-eclampsia (DBP > or = 110)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20143973"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD1"}, "span_text": {"type": "literal", "value": "Women with mild pre-eclampsia (diastolic blood pressure, DBP < 110) have slightly higher levels of erythrocyte glutathione peroxidase, and lower levels of catalase and superoxide dismutase compared with women with severe pre-eclampsia (DBP > or = 110)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20143973"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX2"}, "span_text": {"type": "literal", "value": "This case-control study was conducted in Khartoum hospital, Sudan to investigate the levels of antioxidant enzymes (glutathione peroxidase, catalase and superoxide dismutase) in erythrocytes and plasma antioxidant vitamins (retinol and alpha-tocopherol) in Sudanese women with pre-eclampsia (37), in comparison with well-matched pregnant controls women with normal pregnancy (38)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20143973"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CAT"}, "span_text": {"type": "literal", "value": "This case-control study was conducted in Khartoum hospital, Sudan to investigate the levels of antioxidant enzymes (glutathione peroxidase, catalase and superoxide dismutase) in erythrocytes and plasma antioxidant vitamins (retinol and alpha-tocopherol) in Sudanese women with pre-eclampsia (37), in comparison with well-matched pregnant controls women with normal pregnancy (38)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20143973"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD3"}, "span_text": {"type": "literal", "value": "This case-control study was conducted in Khartoum hospital, Sudan to investigate the levels of antioxidant enzymes (glutathione peroxidase, catalase and superoxide dismutase) in erythrocytes and plasma antioxidant vitamins (retinol and alpha-tocopherol) in Sudanese women with pre-eclampsia (37), in comparison with well-matched pregnant controls women with normal pregnancy (38)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20143973"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX3"}, "span_text": {"type": "literal", "value": "This case-control study was conducted in Khartoum hospital, Sudan to investigate the levels of antioxidant enzymes (glutathione peroxidase, catalase and superoxide dismutase) in erythrocytes and plasma antioxidant vitamins (retinol and alpha-tocopherol) in Sudanese women with pre-eclampsia (37), in comparison with well-matched pregnant controls women with normal pregnancy (38)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20143973"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX3"}, "span_text": {"type": "literal", "value": "Women with mild pre-eclampsia (diastolic blood pressure, DBP < 110) have slightly higher levels of erythrocyte glutathione peroxidase, and lower levels of catalase and superoxide dismutase compared with women with severe pre-eclampsia (DBP > or = 110)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20143973"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD1"}, "span_text": {"type": "literal", "value": "This case-control study was conducted in Khartoum hospital, Sudan to investigate the levels of antioxidant enzymes (glutathione peroxidase, catalase and superoxide dismutase) in erythrocytes and plasma antioxidant vitamins (retinol and alpha-tocopherol) in Sudanese women with pre-eclampsia (37), in comparison with well-matched pregnant controls women with normal pregnancy (38)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20143973"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX1"}, "span_text": {"type": "literal", "value": "Women with mild pre-eclampsia (diastolic blood pressure, DBP < 110) have slightly higher levels of erythrocyte glutathione peroxidase, and lower levels of catalase and superoxide dismutase compared with women with severe pre-eclampsia (DBP > or = 110)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20143973"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGTR1"}, "span_text": {"type": "literal", "value": "We found that IgG obtained from sera of healthy pregnant women and patients with preeclampsia were unable to induce luciferase activity in both HEK-293 and Chinese hamster ovary cells expressing functional angiotensin II receptor type 1."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20139770"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NFATC3"}, "span_text": {"type": "literal", "value": "Using a cross-sectional design, we determined the presence of AT1R-AA in 525 pregnant women (99 healthy pregnant, 96 with mild preeclampsia, and 330 with severe preeclampsia) by a new bioassay that employs human embryonic kidney-293 cells stably expressing the recombinant rat AT1R and a 4x nuclear factor of activated T cells responsive luciferase construct as well as by the reference assay in Chinese hamster ovary (CHO) cells."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20139770"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NFATC1"}, "span_text": {"type": "literal", "value": "Using a cross-sectional design, we determined the presence of AT1R-AA in 525 pregnant women (99 healthy pregnant, 96 with mild preeclampsia, and 330 with severe preeclampsia) by a new bioassay that employs human embryonic kidney-293 cells stably expressing the recombinant rat AT1R and a 4x nuclear factor of activated T cells responsive luciferase construct as well as by the reference assay in Chinese hamster ovary (CHO) cells."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20139770"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NFAT5"}, "span_text": {"type": "literal", "value": "Using a cross-sectional design, we determined the presence of AT1R-AA in 525 pregnant women (99 healthy pregnant, 96 with mild preeclampsia, and 330 with severe preeclampsia) by a new bioassay that employs human embryonic kidney-293 cells stably expressing the recombinant rat AT1R and a 4x nuclear factor of activated T cells responsive luciferase construct as well as by the reference assay in Chinese hamster ovary (CHO) cells."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20139770"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "Maternal serum ischemia-modified albumin: a biomarker to distinguish between normal pregnancy and preeclampsia?"}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20132025"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "To determine whether a biological marker of ischemia, ischemia-modified albumin (IMA), alone or normalized to albumin serum concentration, was modified during the course of pregnancy and so could be used for discrimination between normal pregnancy and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20132025"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOE"}, "span_text": {"type": "literal", "value": "A strong correlation between plasma levels of reduced vitamin E and CoQ(10), corrected for apolipoprotein B, was observed only in preeclampsia (r = 0.69, p < 0.0001)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20132021"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOO"}, "span_text": {"type": "literal", "value": "A strong correlation between plasma levels of reduced vitamin E and CoQ(10), corrected for apolipoprotein B, was observed only in preeclampsia (r = 0.69, p < 0.0001)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20132021"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOF"}, "span_text": {"type": "literal", "value": "A strong correlation between plasma levels of reduced vitamin E and CoQ(10), corrected for apolipoprotein B, was observed only in preeclampsia (r = 0.69, p < 0.0001)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20132021"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOM"}, "span_text": {"type": "literal", "value": "A strong correlation between plasma levels of reduced vitamin E and CoQ(10), corrected for apolipoprotein B, was observed only in preeclampsia (r = 0.69, p < 0.0001)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20132021"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "The proteinase-activated receptor 2 (PAR-2) expression is increased in endothelial cells derived from women with preeclampsia, characterized by widespread maternal endothelial damage, which occurs as a consequence of elevated soluble vascular endothelial growth factor receptor-1 (sVEGFR-1; commonly known as sFlt-1) in the maternal circulation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20124108"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "The proteinase-activated receptor 2 (PAR-2) expression is increased in endothelial cells derived from women with preeclampsia, characterized by widespread maternal endothelial damage, which occurs as a consequence of elevated soluble vascular endothelial growth factor receptor-1 (sVEGFR-1; commonly known as sFlt-1) in the maternal circulation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20124108"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "The proteinase-activated receptor 2 (PAR-2) expression is increased in endothelial cells derived from women with preeclampsia, characterized by widespread maternal endothelial damage, which occurs as a consequence of elevated soluble vascular endothelial growth factor receptor-1 (sVEGFR-1; commonly known as sFlt-1) in the maternal circulation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20124108"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TTR"}, "span_text": {"type": "literal", "value": "Nephelometric analysis of the serum samples determined the mean concentration of transthyretin in the preeclampsia group were lower (0.16 mg/mL; range:"}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20116281"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TTR"}, "span_text": {"type": "literal", "value": "Densitometric analysis of the transthyretin bands showed lower intensities in the preeclampsia samples with respect to those of the controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20116281"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Maternal plasma soluble fms-like tyrosine kinase-1 and free vascular endothelial growth factor at 11 to 13 weeks of gestation in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20101671"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Maternal plasma soluble fms-like tyrosine kinase-1 and free vascular endothelial growth factor at 11 to 13 weeks of gestation in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20101671"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Maternal plasma soluble fms-like tyrosine kinase-1 and free vascular endothelial growth factor at 11 to 13 weeks of gestation in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20101671"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Maternal plasma soluble fms-like tyrosine kinase-1 and free vascular endothelial growth factor at 11 to 13 weeks of gestation in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20101671"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "To investigate the maternal plasma concentration of soluble fms-like tyrosine kinase-1 (sFlt-1) and free vascular endothelial growth factor (free-VEGF) at 11 to 13 weeks of gestation in patients destined to develop preeclampsia (PE) and to examine whether any possible differences in maternal plasma levels are related to uterine artery pulsatility index (PI) and maternal serum placental growth factor (PlGF)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20101671"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Plasma soluble endoglin concentration in pre-eclampsia is associated with an increased impedance to flow in the maternal and fetal circulations."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20101637"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Significant elevation of leptin can be detected in AF 2 months earlier than the appearance of symptoms; thus, it may be used as a predictive marker for preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20080845"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Our objective was to determine the differences in soluble endoglin (sEndoglin), soluble fms-like tyrosine kinase receptor-1 (sFLT1), leptin, adiponectin, and endothelin 1 concentrations between normal and preeclampsia amniotic fluid (AF)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20080845"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Increased AF concentrations of sFLT1, sEndoglin, endothelin 1, and leptin were found in women who later developed preeclampsia. sFLT1, sEndoglin, leptin, and adiponectin were significantly higher in the preeclampsia with IUGR than those without IUGR."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20080845"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Increased AF concentrations of sFLT1, sEndoglin, endothelin 1, and leptin were found in women who later developed preeclampsia. sFLT1, sEndoglin, leptin, and adiponectin were significantly higher in the preeclampsia with IUGR than those without IUGR."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20080845"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Our objective was to determine the differences in soluble endoglin (sEndoglin), soluble fms-like tyrosine kinase receptor-1 (sFLT1), leptin, adiponectin, and endothelin 1 concentrations between normal and preeclampsia amniotic fluid (AF)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20080845"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL6"}, "span_text": {"type": "literal", "value": "Women with preeclampsia had significantly lower plasma concentrations of adiponectin (10.2+/-2.0 vs. 7.3+/-2.2 microg ml(-1), P<0.01), but higher concentrations of leptin, plasminogen activator inhibitor-1, interleukin-6, vascular cell adhesion molecule-1, E-selectin and C-reactive protein."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20075929"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Women with preeclampsia had significantly lower plasma concentrations of adiponectin (10.2+/-2.0 vs. 7.3+/-2.2 microg ml(-1), P<0.01), but higher concentrations of leptin, plasminogen activator inhibitor-1, interleukin-6, vascular cell adhesion molecule-1, E-selectin and C-reactive protein."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20075929"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VCAM1"}, "span_text": {"type": "literal", "value": "Women with preeclampsia had significantly lower plasma concentrations of adiponectin (10.2+/-2.0 vs. 7.3+/-2.2 microg ml(-1), P<0.01), but higher concentrations of leptin, plasminogen activator inhibitor-1, interleukin-6, vascular cell adhesion molecule-1, E-selectin and C-reactive protein."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20075929"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "To determine the interrelationships during early pregnancy of complement-activation fragments Bb, C3a and sC5b-9, and angiogenesis-related factors placental growth factor (PiGF), soluble fms-like tyrosine kinase-1 (sFlt-1) and soluble endoglin (sEng), and their associations with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20074261"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IFNGR1"}, "span_text": {"type": "literal", "value": "Contribution of interferon-gamma receptor 1 gene polymorphisms to pre-eclampsia in China."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20070287"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Angiotensin receptor agonistic autoantibody-mediated tumor necrosis factor-alpha induction contributes to increased soluble endoglin production in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20065159"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGFB3"}, "span_text": {"type": "literal", "value": "The aim of this study was to investigate whether c.869T>C (Leu10Pro) and c.915G>C (Arg25Pro) polymorphisms in exon1 of the transforming growth factor-beta1 (TGF-beta1) gene are associated with development of pre-eclampsia (PE) in Korean women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20055790"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGFB2"}, "span_text": {"type": "literal", "value": "The aim of this study was to investigate whether c.869T>C (Leu10Pro) and c.915G>C (Arg25Pro) polymorphisms in exon1 of the transforming growth factor-beta1 (TGF-beta1) gene are associated with development of pre-eclampsia (PE) in Korean women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20055790"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGFB1"}, "span_text": {"type": "literal", "value": "Transforming growth factor-beta 1 gene polymorphisms in Korean patients with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20055790"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGFB1"}, "span_text": {"type": "literal", "value": "The aim of this study was to investigate whether c.869T>C (Leu10Pro) and c.915G>C (Arg25Pro) polymorphisms in exon1 of the transforming growth factor-beta1 (TGF-beta1) gene are associated with development of pre-eclampsia (PE) in Korean women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20055790"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Relation between first trimester maternal serum leptin levels and body mass index in normotensive and pre-eclamptic pregnancies--role of leptin as a marker of pre-eclampsia: a prospective case-control study."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20050765"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Leptin treated as a continuous variable is a significant predictor of pre-eclampsia (adjusted OR:"}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20050765"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "We measured first trimester plasma leptin concentrations in 37 women who subsequently developed pre-eclampsia and 53 normotensive controls to determine the interrelation between leptin and body mass index (BMI) in both groups."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20050765"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Increased leptin concentration can definitely contribute to the prediction of pre-eclampsia in lean women, but this is not the case in overweight women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20050765"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Increased leptin concentration (>or=25.3 ng/ml ) in lean women is associated with a 18.8-fold increased risk of pre-eclampsia (adjusted OR:"}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20050765"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "We further investigated the association between the risks for pre-eclampsia with maternal leptin levels."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20050765"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL2"}, "span_text": {"type": "literal", "value": "Decreased NO levels whereas increased tumor necrosis factor-alpha, interleukin (IL)-6 and interleukin-2 were found in pre-eclampsia (P < 0.001)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20047583"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Although soluble fms-like tyrosine kinase 1 (sFlt-1), an antagonist of vascular endothelial growth factor and placental growth factor, has been implicated in the pathogenesis of hypertension during preeclampsia, the mechanisms whereby enhanced sFlt-1 production leads to hypertension remain unclear."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20026766"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Although soluble fms-like tyrosine kinase 1 (sFlt-1), an antagonist of vascular endothelial growth factor and placental growth factor, has been implicated in the pathogenesis of hypertension during preeclampsia, the mechanisms whereby enhanced sFlt-1 production leads to hypertension remain unclear."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20026766"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Both sFlt-1 and endothelin 1 productions are elevated in women with preeclampsia and in placental ischemic animal models of preeclampsia; however, the importance of endothelin 1 and sFlt-1 interactions in the control of blood pressure during pregnancy is unknown."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20026766"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Although soluble fms-like tyrosine kinase 1 (sFlt-1), an antagonist of vascular endothelial growth factor and placental growth factor, has been implicated in the pathogenesis of hypertension during preeclampsia, the mechanisms whereby enhanced sFlt-1 production leads to hypertension remain unclear."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20026766"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Although soluble fms-like tyrosine kinase 1 (sFlt-1), an antagonist of vascular endothelial growth factor and placental growth factor, has been implicated in the pathogenesis of hypertension during preeclampsia, the mechanisms whereby enhanced sFlt-1 production leads to hypertension remain unclear."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20026766"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Maternal serum placental growth factor and soluble fms-like tyrosine kinase 1 as early predictors of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20021269"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Maternal serum placental growth factor and soluble fms-like tyrosine kinase 1 as early predictors of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20021269"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Serum concentrations of soluble fms-like tyrosine kinase 1 (sFlt-1), placental growth factor (PlGF), soluble endoglin (sEng), adiponectin and leptin were measured in women with pre-eclampsia and in normotensive controls matched for age, gestational week, parity and body mass index."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20015306"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Serum concentrations of soluble fms-like tyrosine kinase 1 (sFlt-1), placental growth factor (PlGF), soluble endoglin (sEng), adiponectin and leptin were measured in women with pre-eclampsia and in normotensive controls matched for age, gestational week, parity and body mass index."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20015306"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Free leptin index and PAPP-A: a first trimester maternal serum screening test for pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20013873"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL1B"}, "span_text": {"type": "literal", "value": "Our objective was to examine neutrophil Toll-like receptor (TLR), cryopyrin, nuclear factor-kappaB (NF-kappaB) subunit and interleukin-1beta (IL-1beta), and inflammatory cytokine profiles in women with pre-eclampsia or normotensive IUGR, as well as in normal pregnancy and non-pregnancy controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/20002372"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "The present study was designed to compare the serum leptin levels in normal pregnancies with those pregnancies which are complicated by pre-eclampsia and to investigate the possibility of leptin being a marker of severity of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19999227"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Evaluation of serum leptin levels during normal pregnancy and in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19999227"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "From this study it was concluded that the levels of serum leptin were higher in pre-eclamptic group when compared to controls during the third trimester of pregnancy indicating the possible role of leptin in the pathogenesis of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19999227"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "When comparison was made on the basis of severity of pre-eclampsia, the serum leptin levels were found to be increased in severe group as compared to mild group."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19999227"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Also the elevated level of leptin may help in the prediction of the disease and may serve as a marker of severity of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19999227"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Notably, only AT(1)-AA, and not soluble fms-like tyrosine kinase-1, levels are elevated in gestational hypertensive patients."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19996068"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Intriguingly, among severe preeclamptic patients, we discovered that the titer of AT(1)-AA is significantly correlated with the clinical features of PE: systolic blood pressure (r=0.56), proteinuria (r=0.70), and soluble fms-like tyrosine kinase-1 level (r=0.71), respectively."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19996068"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "The role of urinary soluble endoglin in the diagnosis of pre-eclampsia: comparison with soluble fms-like tyrosine kinase 1 to placental growth factor ratio."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19943826"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GP2"}, "span_text": {"type": "literal", "value": "Endoglin, an anti-angiogenic glycoprotein expressed on endothelial cells, has been proposed recently as a biomarker of pre-eclampsia (PE)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19943826"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Endoglin, an anti-angiogenic glycoprotein expressed on endothelial cells, has been proposed recently as a biomarker of pre-eclampsia (PE)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19943826"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "The role of urinary soluble endoglin in the diagnosis of pre-eclampsia: comparison with soluble fms-like tyrosine kinase 1 to placental growth factor ratio."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19943826"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "The role of urinary soluble endoglin in the diagnosis of pre-eclampsia: comparison with soluble fms-like tyrosine kinase 1 to placental growth factor ratio."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19943826"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PRKCA"}, "span_text": {"type": "literal", "value": "Protein kinase C-alpha activation induces NF-kB-dependent VCAM-1 expression in cultured human umbilical vein endothelial cells treated with sera from preeclamptic patients."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19940486"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "We initially examined Endoglin and Hydroxy-nonenal-(HNE)-modified proteins in the placentas and amnion obtained from women with pre-eclampsia (n = 8), and healthy controls (n = 8) by immunohistochemistry."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19939849"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Both in women who developed pre-eclampsia and in normotensive controls the increase in thyroid stimulating hormone concentration between baseline and predelivery specimens was strongly associated with increasing quarters of predelivery soluble fms-like tyrosine kinase 1 (P for trend 0.002 and <0.001, respectively)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19920004"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Increased serum concentration of soluble fms-like tyrosine kinase 1 during pre-eclampsia is associated with subclinical hypothyroidism during pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19920004"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Thyroid function tests and human chorionic gonadotrophin and soluble fms-like tyrosine kinase 1 concentrations in the Calcium for Pre-eclampsia Prevention cohort and odds ratios for levels of thyroid stimulating hormone above the reference range, according to pre-eclampsia status in singleton pregnancies before the Nord-Trondelag Health Study."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19920004"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Pre-eclampsia, soluble fms-like tyrosine kinase 1, and the risk of reduced thyroid function: nested case-control and population based study."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19920004"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TCF4"}, "span_text": {"type": "literal", "value": "Imbalance of T-cell transcription factors contributes to the Th1 type immunity predominant in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19912158"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Changes in the maternal plasma concentrations of angiogenic (placental growth factor (PlGF) and vascular endothelial growth factor (VEGF)) and anti-angiogenic factors (sEng and vascular endothelial growth factor receptor-1 (sVEGFR-1)) precede the clinical presentation of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19900040"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Changes in the maternal plasma concentrations of angiogenic (placental growth factor (PlGF) and vascular endothelial growth factor (VEGF)) and anti-angiogenic factors (sEng and vascular endothelial growth factor receptor-1 (sVEGFR-1)) precede the clinical presentation of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19900040"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Changes in the maternal plasma concentrations of angiogenic (placental growth factor (PlGF) and vascular endothelial growth factor (VEGF)) and anti-angiogenic factors (sEng and vascular endothelial growth factor receptor-1 (sVEGFR-1)) precede the clinical presentation of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19900040"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Changes in the maternal plasma concentrations of angiogenic (placental growth factor (PlGF) and vascular endothelial growth factor (VEGF)) and anti-angiogenic factors (sEng and vascular endothelial growth factor receptor-1 (sVEGFR-1)) precede the clinical presentation of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19900040"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Variable expression of soluble fms-like tyrosine kinase 1 in patients at high risk for preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19895348"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Soluble and membranous vascular endothelial growth factor receptor-2 in pregnancies complicated by pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19881969"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Soluble and membranous vascular endothelial growth factor receptor-2 in pregnancies complicated by pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19881969"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Soluble and membranous vascular endothelial growth factor receptor-2 in pregnancies complicated by pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19881969"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "There is a paucity of information on the serum soluble vascular endothelial growth factor receptor-2 (sVEGFR-2) concentrations, membranous VEGFR-2 expression and the mechanism involved in their modulations during the clinical onset of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19881969"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "There is a paucity of information on the serum soluble vascular endothelial growth factor receptor-2 (sVEGFR-2) concentrations, membranous VEGFR-2 expression and the mechanism involved in their modulations during the clinical onset of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19881969"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "There is a paucity of information on the serum soluble vascular endothelial growth factor receptor-2 (sVEGFR-2) concentrations, membranous VEGFR-2 expression and the mechanism involved in their modulations during the clinical onset of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19881969"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HRG"}, "span_text": {"type": "literal", "value": "Fibrinogen and histidine-rich glycoprotein in early-onset preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19878090"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LOC100505909"}, "span_text": {"type": "literal", "value": "To determine whether plasma levels of fibrinogen and the placental tissue distributions of fibrinogen and histidine-rich glycoprotein (HRG) differ between early- and late-onset preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19878090"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LOC100505909"}, "span_text": {"type": "literal", "value": "Fibrinogen and histidine-rich glycoprotein in early-onset preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19878090"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HRG"}, "span_text": {"type": "literal", "value": "To determine whether plasma levels of fibrinogen and the placental tissue distributions of fibrinogen and histidine-rich glycoprotein (HRG) differ between early- and late-onset preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19878090"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ANGPT1"}, "span_text": {"type": "literal", "value": "Maternal serum angiopoietin-1 and -2 and tie-2 in early pregnancy ending in preeclampsia or intrauterine growth retardation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19875484"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "To compare whether albumin/creatinine ratios obtained from random or 8-hour urine collected in different periods of day differ in prediction of albumin excretion > or =2 g in 24-hour urine collection in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19860361"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "Albumin/creatinine ratio for prediction of 24-hour albumin excretion of > or =2 g in manifest preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19860361"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "We tested the hypothesis that the cardiac biomarker N-terminal pro-brain natriuretic peptide would be elevated in hypertensive disorders of pregnancy, with an increase in levels of this biomarker across increasing gradations of disease severity."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19856261"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "Cases were subclassified into gestational hypertension ( N = 20) and mild ( N = 15) and severe preeclampsia ( N = 48), and N-terminal pro-brain natriuretic peptide levels were compared between these subgroups."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19856261"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "N-terminal pro-brain natriuretic peptide levels were higher in cases than in controls (81 pg/mL versus 37 pg/mL, P < 0.001), with a graded increase in levels from gestational hypertension (64 pg/mL) to preeclampsia (89 pg/mL) to severe preeclampsia (157 pg/mL; P < 0.001)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19856261"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "Each log increase in N-terminal pro-brain natriuretic peptide doubled the risk of preeclampsia (odds ratio = 2.10 P < 0.001)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19856261"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "N-terminal pro-brain natriuretic Peptide as a biomarker for hypertensive disorders of pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19856261"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "N-terminal pro-brain natriuretic peptide levels were increased in hypertensive disorders of pregnancy and discriminate between subcategories of disease."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19856261"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "The angiogenic and antiangiogenic factors soluble fms-like tyrosine kinase (sFlt)-1 and placental growth factor (PIGF) have been implicated in the mechanisms of disease responsible for preeclampsia (PE)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19850276"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADM2"}, "span_text": {"type": "literal", "value": "The aim of the study was to investigate the role of malondialdehyde, nitric oxide and adrenomedullin in the etiopathogenesis of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19843001"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADM"}, "span_text": {"type": "literal", "value": "The aim of the study was to investigate the role of malondialdehyde, nitric oxide and adrenomedullin in the etiopathogenesis of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19843001"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADM2"}, "span_text": {"type": "literal", "value": "In women with preeclampsia the plasma concentrations of malondialdehyde was higher while nitric oxide and adrenomedullin concentrations were lower compared to control subjects."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19843001"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADM"}, "span_text": {"type": "literal", "value": "In women with preeclampsia the plasma concentrations of malondialdehyde was higher while nitric oxide and adrenomedullin concentrations were lower compared to control subjects."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19843001"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADM"}, "span_text": {"type": "literal", "value": "The changes of plasma malondialdehyde, nitric oxide, and adrenomedullin levels in patients with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19843001"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADM2"}, "span_text": {"type": "literal", "value": "The changes of plasma malondialdehyde, nitric oxide, and adrenomedullin levels in patients with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19843001"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "The levels of inhibin A, PlGF, and endoglin in the second trimester can be combined using a predictive model to provide individualized risk estimates for early onset preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19842088"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Inhibin A, PlGF, and endoglin were consistently associated with preeclampsia, especially for early onset disease."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19842088"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "The role of nitric oxide synthase inhibition by asymmetric dimethylarginine in the pathophysiology of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19828999"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGT"}, "span_text": {"type": "literal", "value": "Because hypertension is an important risk factor for preeclampsia, we investigated whether hypertensive mice that overexpress human renin and angiotensinogen develop superimposed preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19822800"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGT"}, "span_text": {"type": "literal", "value": "Mice overexpressing both human angiotensinogen and human renin as a model of superimposed preeclampsia on chronic hypertension."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19822800"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "The first aim of our study was to develop a pregnant mouse model for preeclampsia using adenoviral vector containing mouse full-length soluble fms-like tyrosine kinase 1 (sFlt-1) but not truncated sFlt-1."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19786649"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "The second aim was to evaluate effects of recombinant mouse (rm) vascular endothelial growth factor (VEGF) and rm placental growth factor (PlGF) on a preeclampsia model induced by adenoviral vector containing mouse full-length sFlt-1."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19786649"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "The second aim was to evaluate effects of recombinant mouse (rm) vascular endothelial growth factor (VEGF) and rm placental growth factor (PlGF) on a preeclampsia model induced by adenoviral vector containing mouse full-length sFlt-1."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19786649"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "The second aim was to evaluate effects of recombinant mouse (rm) vascular endothelial growth factor (VEGF) and rm placental growth factor (PlGF) on a preeclampsia model induced by adenoviral vector containing mouse full-length sFlt-1."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19786649"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "The second aim was to evaluate effects of recombinant mouse (rm) vascular endothelial growth factor (VEGF) and rm placental growth factor (PlGF) on a preeclampsia model induced by adenoviral vector containing mouse full-length sFlt-1."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19786649"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "The purpose of this study was to assess the utility of soluble vascular endothelial growth factor 1 (sVEGF R1) and placental growth factor (PlGF) levels in the clinical diagnosis of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19762001"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PRL"}, "span_text": {"type": "literal", "value": "We hypothesize that the pathophysiology of PPCM and pre-eclampsia share the same molecular pathway: increased activity of trophoblastic matrix metalloproteinases at the feto-maternal interface may aggravate proteolysis of full-length prolactin, and subsequently the formed 16kDa prolactin fragments may contribute to deterioration of PPCM and pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19748190"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PRL"}, "span_text": {"type": "literal", "value": "Prolactin fragmentation by trophoblastic matrix metalloproteinases as a possible contributor to peripartum cardiomyopathy and pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19748190"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Placental endothelin-1 synthesis is reduced in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19730395"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Maternal EDN1 G5665T polymorphism influences circulating endothelin-1 levels and plays a role in determination of preeclampsia phenotype."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19730395"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Placental endothelin-1/beta-actin mRNA ratio was significantly reduced (0.91 +/- 0.77 vs. 3.20 +/- 1.68; P < 0.001) and endothelin-1 staining was lower (P < 0.001) in placental endothelium in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19730395"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "We prospectively evaluated whether endothelin-1 levels are increased in preeclampsia, to verify if placenta is the source, and any association between the maternal EDN1 G5665T single-nucleotide polymorphism and circulating endothelin-1 levels and preeclampsia manifestation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19730395"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "The preeclampsia group showed higher circulating endothelin-1 levels (1.45 +/- 0.55 vs. 0.91 +/- 0.42 pg/ml; P < 0.0001), reduced frequency of GG genotype (34 vs. 49%; P = 0.025) and increased T allele frequency (0.43 vs. 0.28; P = 0.04)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19730395"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Abnormal endothelin-1 synthesis and/or release can explain abnormalities seen in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19730395"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Maternal endothelin-1 is elevated and correlates with the severity of blood pressure elevation in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19730395"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "A significant association was noted between endothelin-1 levels and blood pressure in the entire cohort and in the group with preeclampsia (P < 0.001)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19730395"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "The combination of elevated maternal and reduced placental endothelin-1 may be an adaptive response to reduced uteroplacental flow in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19730395"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGT"}, "span_text": {"type": "literal", "value": "The aim of these investigations was to study three candidate genes for pre-eclampsia--epidermal growth factor (EGF), transforming growth factor alpha, and angiotensinogen--in pregnant Sinhalese women from Sri Lanka, the first such study undertaken in this ethnic group."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19708171"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGFA"}, "span_text": {"type": "literal", "value": "The aim of these investigations was to study three candidate genes for pre-eclampsia--epidermal growth factor (EGF), transforming growth factor alpha, and angiotensinogen--in pregnant Sinhalese women from Sri Lanka, the first such study undertaken in this ethnic group."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19708171"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Agonistic autoantibodies to the angiotensin II type I receptor (AT1-AA) and endothelin -1 (ET-1) are suggested to be important links between placental ischemia and hypertension during preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19704104"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CFH"}, "span_text": {"type": "literal", "value": "We sought to determine serum complement 3 (C3) levels and its regulatory protein complement factor H (FH) in the HELLP syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19703145"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX2"}, "span_text": {"type": "literal", "value": "In preeclampsia and eclampsia malondialdehyde, a product of lipid peroxidation, was significantly increased while enzymatic antioxidants like superoxide dismutase, glutathione peroxidase, glutathione reductase and catalase were significantly reduced as compared to normal pregnant women and non-pregnant controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19688954"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX3"}, "span_text": {"type": "literal", "value": "In preeclampsia and eclampsia malondialdehyde, a product of lipid peroxidation, was significantly increased while enzymatic antioxidants like superoxide dismutase, glutathione peroxidase, glutathione reductase and catalase were significantly reduced as compared to normal pregnant women and non-pregnant controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19688954"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CAT"}, "span_text": {"type": "literal", "value": "In preeclampsia and eclampsia malondialdehyde, a product of lipid peroxidation, was significantly increased while enzymatic antioxidants like superoxide dismutase, glutathione peroxidase, glutathione reductase and catalase were significantly reduced as compared to normal pregnant women and non-pregnant controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19688954"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD3"}, "span_text": {"type": "literal", "value": "In preeclampsia and eclampsia malondialdehyde, a product of lipid peroxidation, was significantly increased while enzymatic antioxidants like superoxide dismutase, glutathione peroxidase, glutathione reductase and catalase were significantly reduced as compared to normal pregnant women and non-pregnant controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19688954"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX1"}, "span_text": {"type": "literal", "value": "In preeclampsia and eclampsia malondialdehyde, a product of lipid peroxidation, was significantly increased while enzymatic antioxidants like superoxide dismutase, glutathione peroxidase, glutathione reductase and catalase were significantly reduced as compared to normal pregnant women and non-pregnant controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19688954"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD1"}, "span_text": {"type": "literal", "value": "In preeclampsia and eclampsia malondialdehyde, a product of lipid peroxidation, was significantly increased while enzymatic antioxidants like superoxide dismutase, glutathione peroxidase, glutathione reductase and catalase were significantly reduced as compared to normal pregnant women and non-pregnant controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19688954"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GLO1"}, "span_text": {"type": "literal", "value": "Moreover, glyoxalase I and II, enzymes that detoxify MG, and glutathione reductase, which generates reduced glutathione, a cofactor for glyoxalase, are also reduced in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19687346"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PON1"}, "span_text": {"type": "literal", "value": "When stratified by disease severity, paraoxonase 1 activity (paraoxon) was highest in women with severe preeclampsia (21.6 +/- 9.1 versus 15.6 +/- 8.0 dA/min, P = 0.002)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19685420"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PON1"}, "span_text": {"type": "literal", "value": "Association of midgestational paraoxonase 1 activity with pregnancies complicated by preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19685420"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PON1"}, "span_text": {"type": "literal", "value": "The antioxidant enzyme paraoxonase 1 is a marker of oxidative stress and has been implicated in the pathogenesis of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19685420"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PON1"}, "span_text": {"type": "literal", "value": "Midgestational paraoxonase 1 activity is higher in women with preeclampsia before clinical signs of the disease are present."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19685420"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PON1"}, "span_text": {"type": "literal", "value": "Prospective studies are needed to determine the significance of paraoxonase 1 in the pathogenesis of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19685420"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PON1"}, "span_text": {"type": "literal", "value": "Our objective was to determine if an association exists between low paraoxonase 1 activity at midgestation and the development of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19685420"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PON1"}, "span_text": {"type": "literal", "value": "Paraoxonase 1 activity (paraoxon) was significantly higher in women with preeclampsia compared with controls (19.4 +/- 9.4 versus 15.6 +/- 8.0 change in absorbance per minute (dA/min), P = 0.009)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19685420"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GGT7"}, "span_text": {"type": "literal", "value": "Erythrocytes, leukocytes, thrombocytes, hemoglobin, hematocrit, aspartate aminotransferase, alanine aminotransferase, gamma-glutamyl transferase, alkaline phosphatase, total bilirubin, urea, creatinine, uric acid, body mass index, parity, and age were evaluated to predict the occurrence of preeclampsia based on multivariate logistic regression model."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19658035"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GGT2"}, "span_text": {"type": "literal", "value": "Erythrocytes, leukocytes, thrombocytes, hemoglobin, hematocrit, aspartate aminotransferase, alanine aminotransferase, gamma-glutamyl transferase, alkaline phosphatase, total bilirubin, urea, creatinine, uric acid, body mass index, parity, and age were evaluated to predict the occurrence of preeclampsia based on multivariate logistic regression model."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19658035"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GGT1"}, "span_text": {"type": "literal", "value": "Erythrocytes, leukocytes, thrombocytes, hemoglobin, hematocrit, aspartate aminotransferase, alanine aminotransferase, gamma-glutamyl transferase, alkaline phosphatase, total bilirubin, urea, creatinine, uric acid, body mass index, parity, and age were evaluated to predict the occurrence of preeclampsia based on multivariate logistic regression model."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19658035"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VTN"}, "span_text": {"type": "literal", "value": "Aberrant processing of plasma vitronectin and high-molecular-weight kininogen precedes the onset of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19657137"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VTN"}, "span_text": {"type": "literal", "value": "Vitronectin and HK may prove to be useful as early markers of fibrinolytic activity and neutrophil activation, which are known to be associated with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19657137"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VTN"}, "span_text": {"type": "literal", "value": "Difference gel electrophoresis (DIGE) identified the plasma proteins vitronectin (VN) and high-molecular-weight kininogen (HK) in association with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19657137"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Leptin gene (TTTC)(n) microsatellite polymorphism in pre-eclampsia and HELLP syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19634986"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Measurements of the levels of circulating angiogenic factors such as soluble fms-like tyrosine kinase 1, soluble endoglin, vascular endothelial growth factor, and placental growth factor suggest that gestational proteinuria is a mild variant of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19633554"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Measurements of the levels of circulating angiogenic factors such as soluble fms-like tyrosine kinase 1, soluble endoglin, vascular endothelial growth factor, and placental growth factor suggest that gestational proteinuria is a mild variant of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19633554"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Measurements of the levels of circulating angiogenic factors such as soluble fms-like tyrosine kinase 1, soluble endoglin, vascular endothelial growth factor, and placental growth factor suggest that gestational proteinuria is a mild variant of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19633554"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Measurements of the levels of circulating angiogenic factors such as soluble fms-like tyrosine kinase 1, soluble endoglin, vascular endothelial growth factor, and placental growth factor suggest that gestational proteinuria is a mild variant of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19633554"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Measurements of the levels of circulating angiogenic factors such as soluble fms-like tyrosine kinase 1, soluble endoglin, vascular endothelial growth factor, and placental growth factor suggest that gestational proteinuria is a mild variant of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19633554"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Measurements of the levels of circulating angiogenic factors such as soluble fms-like tyrosine kinase 1, soluble endoglin, vascular endothelial growth factor, and placental growth factor suggest that gestational proteinuria is a mild variant of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19633554"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Women with mild preeclampsia had higher triglyceride levels and a higher total cholesterol to high-density lipoprotein ratio than control subjects (200 +/- 79.5 mg/dL vs 164 +/- 56.2 mg/dL; P = .02; and 3.31 +/- 1.06 mg/dL vs 2.91 +/- 0.59; P = .02)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19631926"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Women with severe preeclampsia had lower levels of low-density lipoprotein than control subjects (85.5 +/- 21.3 mg/dL vs 102 +/- 30.0 mg/dL; P = .04) and a less atherogenic lipid profile than control subjects."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19631926"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "The link between insulin resistance and preeclampsia: new perspectives."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19628283"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "In preeclampsia, there is exacerbation of physiological changes associated with pregnancy such as insulin resistance, altered immune responses and inflammatory pathway activation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19628283"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "We describe two patients with severe early onset preeclampsia associated with partial mole or sacrococcygeal teratoma who had an excess of circulating concentrations of the antiangiogenic factors soluble vascular endothelial growth factor receptor-1 and soluble endoglin."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19622952"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "We describe two patients with severe early onset preeclampsia associated with partial mole or sacrococcygeal teratoma who had an excess of circulating concentrations of the antiangiogenic factors soluble vascular endothelial growth factor receptor-1 and soluble endoglin."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19622952"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "We describe two patients with severe early onset preeclampsia associated with partial mole or sacrococcygeal teratoma who had an excess of circulating concentrations of the antiangiogenic factors soluble vascular endothelial growth factor receptor-1 and soluble endoglin."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19622952"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "We describe two patients with severe early onset preeclampsia associated with partial mole or sacrococcygeal teratoma who had an excess of circulating concentrations of the antiangiogenic factors soluble vascular endothelial growth factor receptor-1 and soluble endoglin."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19622952"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "We conclude by summarizing newer findings regarding the anti-angiogenic expression of soluble fms-like tyrosine kinase (sFlt-1) and its role in the development of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19586664"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Preeclampsia and soluble fms-like tyrosine kinase 1."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19584199"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TCF4"}, "span_text": {"type": "literal", "value": "In 2005 a positional cloning project led to the discovery of the STOX1 transcription factor, and mutations of this gene were proposed as causal for preeclampsia in Dutch families."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19577309"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TCF4"}, "span_text": {"type": "literal", "value": "Re-evaluation of the role of STOX1 transcription factor in placental development and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19577309"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:RBP2"}, "span_text": {"type": "literal", "value": "Alterations in serum adipocyte fatty acid binding protein and retinol binding protein-4 in normal pregnancy and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19573524"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:RBP3"}, "span_text": {"type": "literal", "value": "We measured circulating adipocyte fatty acid binding protein (AFABP) and retinol binding protein-4 (RBP-4) in patients with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19573524"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:RBP7"}, "span_text": {"type": "literal", "value": "We measured circulating adipocyte fatty acid binding protein (AFABP) and retinol binding protein-4 (RBP-4) in patients with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19573524"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:RBP3"}, "span_text": {"type": "literal", "value": "Alterations in serum adipocyte fatty acid binding protein and retinol binding protein-4 in normal pregnancy and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19573524"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:RBP2"}, "span_text": {"type": "literal", "value": "We measured circulating adipocyte fatty acid binding protein (AFABP) and retinol binding protein-4 (RBP-4) in patients with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19573524"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FABP7"}, "span_text": {"type": "literal", "value": "Alterations in serum adipocyte fatty acid binding protein and retinol binding protein-4 in normal pregnancy and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19573524"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:RBP1"}, "span_text": {"type": "literal", "value": "Alterations in serum adipocyte fatty acid binding protein and retinol binding protein-4 in normal pregnancy and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19573524"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FABP9"}, "span_text": {"type": "literal", "value": "We measured circulating adipocyte fatty acid binding protein (AFABP) and retinol binding protein-4 (RBP-4) in patients with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19573524"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FABP7"}, "span_text": {"type": "literal", "value": "We measured circulating adipocyte fatty acid binding protein (AFABP) and retinol binding protein-4 (RBP-4) in patients with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19573524"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FABP4"}, "span_text": {"type": "literal", "value": "We measured circulating adipocyte fatty acid binding protein (AFABP) and retinol binding protein-4 (RBP-4) in patients with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19573524"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:RBP7"}, "span_text": {"type": "literal", "value": "Alterations in serum adipocyte fatty acid binding protein and retinol binding protein-4 in normal pregnancy and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19573524"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FABP5"}, "span_text": {"type": "literal", "value": "We measured circulating adipocyte fatty acid binding protein (AFABP) and retinol binding protein-4 (RBP-4) in patients with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19573524"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FABP9"}, "span_text": {"type": "literal", "value": "Alterations in serum adipocyte fatty acid binding protein and retinol binding protein-4 in normal pregnancy and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19573524"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FABP5"}, "span_text": {"type": "literal", "value": "Alterations in serum adipocyte fatty acid binding protein and retinol binding protein-4 in normal pregnancy and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19573524"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FABP3"}, "span_text": {"type": "literal", "value": "Alterations in serum adipocyte fatty acid binding protein and retinol binding protein-4 in normal pregnancy and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19573524"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FABP3"}, "span_text": {"type": "literal", "value": "We measured circulating adipocyte fatty acid binding protein (AFABP) and retinol binding protein-4 (RBP-4) in patients with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19573524"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FABP4"}, "span_text": {"type": "literal", "value": "Alterations in serum adipocyte fatty acid binding protein and retinol binding protein-4 in normal pregnancy and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19573524"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:RBP1"}, "span_text": {"type": "literal", "value": "We measured circulating adipocyte fatty acid binding protein (AFABP) and retinol binding protein-4 (RBP-4) in patients with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19573524"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Because preeclampsia is characterized by an imbalance in angiogenic factors, we assessed pregnancy levels of placental growth factor (PlGF), soluble fms-like tyrosine kinase-1 (sFlt-1), and soluble endoglin (s-endoglin) and subsequent breast cancer risk."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19567504"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Because preeclampsia is characterized by an imbalance in angiogenic factors, we assessed pregnancy levels of placental growth factor (PlGF), soluble fms-like tyrosine kinase-1 (sFlt-1), and soluble endoglin (s-endoglin) and subsequent breast cancer risk."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19567504"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Because preeclampsia is characterized by an imbalance in angiogenic factors, we assessed pregnancy levels of placental growth factor (PlGF), soluble fms-like tyrosine kinase-1 (sFlt-1), and soluble endoglin (s-endoglin) and subsequent breast cancer risk."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19567504"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Preeclampsia (PE) is characterized by widespread endothelial damage with hypertension, proteinuria, glomeruloendotheliosis and elevated soluble Flt-1 (sFlt-1), a natural occurring antagonist of vascular endothelial growth factor (VEGF)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19538465"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Preeclampsia (PE) is characterized by widespread endothelial damage with hypertension, proteinuria, glomeruloendotheliosis and elevated soluble Flt-1 (sFlt-1), a natural occurring antagonist of vascular endothelial growth factor (VEGF)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19538465"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Preeclampsia (PE) is characterized by widespread endothelial damage with hypertension, proteinuria, glomeruloendotheliosis and elevated soluble Flt-1 (sFlt-1), a natural occurring antagonist of vascular endothelial growth factor (VEGF)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19538465"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CP"}, "span_text": {"type": "literal", "value": "In addition, I detail the potential protective actions of placental ceruloplasmin in preeclampsia, recently described by our group to be a sensitive marker of syncytial hypoxia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19535132"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EZR"}, "span_text": {"type": "literal", "value": "In this study, the authors have examined podocyte-specific protein expressions for nephrin, glomerular epithelial protein 1 (GLEPP-1), and ezrin in kidney biopsy tissue sections from women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19528353"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EZR"}, "span_text": {"type": "literal", "value": "The findings were (1) nephrin and GLEPP-1 were mainly expressed in glomerular podocytes; (2) ezrin was expressed in both glomerular podocytes and tubular epithelial cells; (3) compared to tissue sections from nonhypertensive and chronic hypertensive participants, nephrin and GLEPP-1 expressions were much reduced in tissue sections from preeclampsia and ezrin expression was reduced in podocytes; (4) enhanced VEGF, Flt-1, and nitrotyrosine, but reduced CuZn-SOD, expressions were observed in both glomerular podocytes and endothelial cells in tissue sections from preeclampsia; and (5) the expression pattern for nephrin, GLEPP-1, ezrin, VEGF, Flt-1, and CuZn-SOD were similar between tissue sections from nonhypertensive and chronic hypertensive participants."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19528353"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Production of placental anti-angiogenic factors, specifically soluble fms-related tyrosine kinase 1 and soluble endoglin, have been shown to be upregulated in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19509125"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FLT1"}, "span_text": {"type": "literal", "value": "Production of placental anti-angiogenic factors, specifically soluble fms-related tyrosine kinase 1 and soluble endoglin, have been shown to be upregulated in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19509125"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Maternal plasma concentrations of the antiangiogenic factor, soluble fms-like tyrosine kinase-1 (sFlt-1) were elevated (P < 0.0001) whereas placental growth factor (PlGF) was reduced (P < 0.01) in women with preeclampsia, but these factors did not correlate with CFU-EC counts."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19498340"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Maternal plasma concentrations of the antiangiogenic factor, soluble fms-like tyrosine kinase-1 (sFlt-1) were elevated (P < 0.0001) whereas placental growth factor (PlGF) was reduced (P < 0.01) in women with preeclampsia, but these factors did not correlate with CFU-EC counts."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19498340"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "These findings suggest that increased maternal levels of leptin and visfatin may be involved in the pathogenesis of pre-eclampsia, and measurement of these adipokines may be useful in assessment of the severity of disease."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19488934"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Serum leptin levels were positively correlated with plasma visfatin level in cases of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19488934"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Plasma visfatin levels and serum leptin levels were higher in patients with pre-eclampsia than in the normotensive pregnant women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19488934"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Visfatin and leptin levels of pre-eclamptic patients with abnormal Doppler velocimetry were significantly higher than they were in those with normal Doppler velocimetry."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19488934"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Increased visfatin and leptin in pregnancies complicated by pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19488934"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "To evaluate the role of the adipokines, visfatin and leptin in the pathophysiology of pre-eclampsia and how their concentrations correlate with the severity of the disease and abnormal Doppler velocimetry."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19488934"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADIPOR2"}, "span_text": {"type": "literal", "value": "Adiponectin and its receptors, adiponectin receptor 1 (Adipo-R1) and adiponectin receptor 2 (Adipo-R2), may contribute to preeclampsia; however, the reports up to date are conflicting."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19487733"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADIPOR1"}, "span_text": {"type": "literal", "value": "Expressions of adiponectin receptors in placenta and their correlation with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19487733"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADIPOR2"}, "span_text": {"type": "literal", "value": "Expressions of adiponectin receptors in placenta and their correlation with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19487733"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADIPOR1"}, "span_text": {"type": "literal", "value": "Adiponectin and its receptors, adiponectin receptor 1 (Adipo-R1) and adiponectin receptor 2 (Adipo-R2), may contribute to preeclampsia; however, the reports up to date are conflicting."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19487733"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GP2"}, "span_text": {"type": "literal", "value": "Preeclampsia is associated with decreased serum alpha(2)-HS glycoprotein (fetuin-A) concentration."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19478814"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GP2"}, "span_text": {"type": "literal", "value": "The purpose of this study was to determine serum alpha(2)-HS glycoprotein (AHSG) concentration and its diagnostic accuracy in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19478814"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ANGPT1"}, "span_text": {"type": "literal", "value": "The purpose of this prospective, longitudinal cohort study was to determine whether a ratio between Angiopoietin-1 (Ang-1) and Angiopoietin-2 (Ang-2) can be used to predict preeclampsia in a low-risk population."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19478794"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Normal pregnancy-induced insulin resistance is further enhanced in pregnancy complications, associated with disturbed placental function, such as gestational diabetes mellitus, preeclampsia, and intrauterine growth restriction."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19474287"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GDF10"}, "span_text": {"type": "literal", "value": "Circulating and placental growth-differentiation factor 15 in preeclampsia and in pregnancy complicated by diabetes mellitus."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19470878"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GDF15"}, "span_text": {"type": "literal", "value": "Circulating and placental growth-differentiation factor 15 in preeclampsia and in pregnancy complicated by diabetes mellitus."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19470878"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PON1"}, "span_text": {"type": "literal", "value": "Paraoxonase 1 (PON1) is thought to influence serum homocysteine concentrations, at least in part, due to its homocysteine thiolactonase activity and to play a role in preeclampsia and atherosclerosis."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19454176"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADD1"}, "span_text": {"type": "literal", "value": "Angiotensin-converting enzyme and adducin-1 polymorphisms in women with preeclampsia and gestational hypertension."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19443911"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADD1"}, "span_text": {"type": "literal", "value": "The angiotensin-converting enzyme (ACE) insertion/deletion (I/D) polymorphism and the Adducin-1 (ADD1) G460W nonsense single nucleotide polymorphism (SNP) have previously been associated to hypertension, whereas their association with preeclampsia (PE) and gestational hypertension (GH) is still controversial."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19443911"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "The systemic inflammatory activation that occurs in preeclampsia as a consequence of the immunological dysfunction can exacerbate placental insulin resistance leading to an over-expression of P-IPG as a counterregulatory mechanism to insulin resistance."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19443128"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Preeclampsia is a severe complication of human pregnancy and an insulin resistant state has been demonstrated in this multisystem disorder, although its bases remain unclear."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19443128"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Is there a link between insulin resistance and inflammatory activation in preeclampsia?"}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19443128"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "In this article we propose a new working theory on insulin resistance and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19443128"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "To determine placental gene expression of calcitonin gene-related peptide (CGRP), calcitonin receptor-like receptor (CRLR), receptor activity modifying protein 1 (RAMP1), and endothelial and inducible nitric oxide synthases (eNOS and iNOS) in mild preeclampsia, and to assess the effects of magnesium sulfate (MgSO4)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19441274"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "Placental gene expression of calcitonin gene-related peptide and nitric oxide synthases in preeclampsia: effects of magnesium sulfate."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19441274"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CALCRL"}, "span_text": {"type": "literal", "value": "To determine placental gene expression of calcitonin gene-related peptide (CGRP), calcitonin receptor-like receptor (CRLR), receptor activity modifying protein 1 (RAMP1), and endothelial and inducible nitric oxide synthases (eNOS and iNOS) in mild preeclampsia, and to assess the effects of magnesium sulfate (MgSO4)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19441274"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL4"}, "span_text": {"type": "literal", "value": "The study was conducted to investigate interferon gamma (IFN-gamma), interleukin-4 (IL-4) and interleukin-10 (IL-10) in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19437232"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL10"}, "span_text": {"type": "literal", "value": "The study was conducted to investigate interferon gamma (IFN-gamma), interleukin-4 (IL-4) and interleukin-10 (IL-10) in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19437232"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CAGE1"}, "span_text": {"type": "literal", "value": "To determine the relationship between the cancer antigen-125 (CA-125) and C-reactive protein (CRP) with preeclampsia and eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19437230"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL6"}, "span_text": {"type": "literal", "value": "To assess the levels and clinical significance of high sensitive(hs)-CRP (C-reactive protein), IL-6(interleukin-6), TNF-alpha(tumor necrosis factor-alpha), homocysteine, folic acid and vitamin B12 in normotensive healthy pregnant women, mild and severe preeclamptic patients, and to evaluate the correlations between these markers and the severity of preeclampsia and fetal birth weight."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19437229"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TAC3"}, "span_text": {"type": "literal", "value": "Moreover, we found increased proteolytic cleavage of the tachykinin 3 precursor during the pregnancy syndrome of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19433124"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "In preeclampsia, GCM1 and its target genes syncytin 1 and placental growth factor, important for syncytiotrophoblast formation and placental vasculogenesis, are all decreased."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19416964"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HPX"}, "span_text": {"type": "literal", "value": "During normal pregnancy, in contrast to preeclampsia, plasma hemopexin activity is increased together with a decreased vascular angiotensin II receptor (AT(1)) expression."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19414647"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HPX"}, "span_text": {"type": "literal", "value": "Inhibition of hemopexin activity during preeclampsia may result in an enhanced AT(1) receptor expression and a contracted vascular bed."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19414647"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HPX"}, "span_text": {"type": "literal", "value": "Vascular contraction and preeclampsia: downregulation of the Angiotensin receptor 1 by hemopexin in vitro."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19414647"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Maternal circulating levels of activin A, inhibin A, sFlt-1 and endoglin at parturition in normal pregnancy and pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19412349"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Maternal circulating levels of anti-angiogenic factors such as soluble fms-like tyrosine kinase-1 (sFlt-1), endoglin (sEng) and placental proteins like activin A and inhibin A are increased before the onset of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19412349"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Maternal circulating levels of anti-angiogenic factors such as soluble fms-like tyrosine kinase-1 (sFlt-1), endoglin (sEng) and placental proteins like activin A and inhibin A are increased before the onset of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19412349"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CAT"}, "span_text": {"type": "literal", "value": "Significantly lower concentrations of HO-1, HO-2, SOD and catalase are found in the cellular component of blood from pre-eclamptic patients."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19399816"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HMOX1"}, "span_text": {"type": "literal", "value": "Lower values in the pre-eclampsia group were found for heme oxygenase (HO)-1, HO-2, catalase and superoxide dismutase (SOD)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19399816"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CAT"}, "span_text": {"type": "literal", "value": "Lower values in the pre-eclampsia group were found for heme oxygenase (HO)-1, HO-2, catalase and superoxide dismutase (SOD)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19399816"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD1"}, "span_text": {"type": "literal", "value": "Lower values in the pre-eclampsia group were found for heme oxygenase (HO)-1, HO-2, catalase and superoxide dismutase (SOD)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19399816"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD3"}, "span_text": {"type": "literal", "value": "Lower values in the pre-eclampsia group were found for heme oxygenase (HO)-1, HO-2, catalase and superoxide dismutase (SOD)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19399816"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HMOX2"}, "span_text": {"type": "literal", "value": "Lower values in the pre-eclampsia group were found for heme oxygenase (HO)-1, HO-2, catalase and superoxide dismutase (SOD)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19399816"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "The expression of endothelial nitric oxide synthase traffic inducer (NOSTRIN) was examined in the umbilical vessels of the patients with pre-eclampsia (PE) to explore its possible role in the pathogenesis of PE."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19399414"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "The mean maternal leptin level was significantly higher in pre-eclamptic patients when compared to non-preeclamptic and control groups."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19390804"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CP"}, "span_text": {"type": "literal", "value": "Plasma levels of C-reactive protein and ceruloplasmin were increased in pregnant women with and without preeclampsia compared to non-pregnant women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19390201"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CDK5"}, "span_text": {"type": "literal", "value": "In recent years, loss of function of cdkn1c (a tight-binding inhibitor of G1 cyclin/cyclin-dependent kinase complexes and a negative regulator of cell proliferation) has been observed in several mouse models of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19386358"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CDK7"}, "span_text": {"type": "literal", "value": "In recent years, loss of function of cdkn1c (a tight-binding inhibitor of G1 cyclin/cyclin-dependent kinase complexes and a negative regulator of cell proliferation) has been observed in several mouse models of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19386358"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CDK4"}, "span_text": {"type": "literal", "value": "In recent years, loss of function of cdkn1c (a tight-binding inhibitor of G1 cyclin/cyclin-dependent kinase complexes and a negative regulator of cell proliferation) has been observed in several mouse models of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19386358"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CDK6"}, "span_text": {"type": "literal", "value": "In recent years, loss of function of cdkn1c (a tight-binding inhibitor of G1 cyclin/cyclin-dependent kinase complexes and a negative regulator of cell proliferation) has been observed in several mouse models of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19386358"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CDK9"}, "span_text": {"type": "literal", "value": "In recent years, loss of function of cdkn1c (a tight-binding inhibitor of G1 cyclin/cyclin-dependent kinase complexes and a negative regulator of cell proliferation) has been observed in several mouse models of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19386358"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CDK3"}, "span_text": {"type": "literal", "value": "In recent years, loss of function of cdkn1c (a tight-binding inhibitor of G1 cyclin/cyclin-dependent kinase complexes and a negative regulator of cell proliferation) has been observed in several mouse models of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19386358"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CDK2"}, "span_text": {"type": "literal", "value": "In recent years, loss of function of cdkn1c (a tight-binding inhibitor of G1 cyclin/cyclin-dependent kinase complexes and a negative regulator of cell proliferation) has been observed in several mouse models of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19386358"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CDK8"}, "span_text": {"type": "literal", "value": "In recent years, loss of function of cdkn1c (a tight-binding inhibitor of G1 cyclin/cyclin-dependent kinase complexes and a negative regulator of cell proliferation) has been observed in several mouse models of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19386358"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Increased plasma soluble fms-like tyrosine kinase 1 and endoglin levels in pregnancies complicated with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19350449"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Increased maternal plasma levels of proinflammatory cytokines as well as the anti-angiogenic agents soluble fms-like tyrosine kinase 1 (sFlt-1) and endoglin (sEng) are associated with promoting vascular dysfunction leading to the maternal syndrome of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19350449"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Increased maternal plasma levels of proinflammatory cytokines as well as the anti-angiogenic agents soluble fms-like tyrosine kinase 1 (sFlt-1) and endoglin (sEng) are associated with promoting vascular dysfunction leading to the maternal syndrome of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19350449"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Increased plasma soluble fms-like tyrosine kinase 1 and endoglin levels in pregnancies complicated with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19350449"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Placental growth factor: a predictive marker for preeclampsia?"}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19346754"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Serum levels of placental growth factor (PLGF), a factor promoting angiogenesis, in patients with preeclampsia are significantly lower than in nonpreeclamptic pregnancies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19346754"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "A recently evolved novel trophoblast-enriched secreted form of fms-like tyrosine kinase-1 variant is up-regulated in hypoxia and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19336504"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL15"}, "span_text": {"type": "literal", "value": "Elevated serum levels of interleukin-15, interleukin-16, and human chorionic gonadotropin in women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19327213"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL15"}, "span_text": {"type": "literal", "value": "We sought to investigate the relationship between serum levels of interleukin 15 (IL-15), interleukin 16 (IL-16), and human chorionic gonadotropin (beta-hCG) in women with a normal pregnancy and with preeclampsia, and their association with disease severity."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19327213"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "The purpose of this study was to test the hypothesis that prepregnancy obesity and soluble fms-like tyrosine kinase-1 (sFlt-1)-induced preeclampsia lead to altered vascular function in the offspring later in life."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19318153"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX1"}, "span_text": {"type": "literal", "value": "Specific systemic antioxidant response to preeclampsia in late pregnancy: the study of intracellular glutathione peroxidases in maternal and fetal blood."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19285650"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX3"}, "span_text": {"type": "literal", "value": "Specific systemic antioxidant response to preeclampsia in late pregnancy: the study of intracellular glutathione peroxidases in maternal and fetal blood."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19285650"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX2"}, "span_text": {"type": "literal", "value": "Specific systemic antioxidant response to preeclampsia in late pregnancy: the study of intracellular glutathione peroxidases in maternal and fetal blood."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19285650"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ESR2"}, "span_text": {"type": "literal", "value": "The estrogen receptor alpha gene (ESR1) seems to be a potential candidate in altering risk for preeclampsia due to important estrogenic biological effects."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19284296"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ESR2"}, "span_text": {"type": "literal", "value": "The objective of this study was to investigate the relationship of the gene polymorphisms of the estrogen receptor alpha with preeclampsia in a southwest Chinese population."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19284296"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ESR2"}, "span_text": {"type": "literal", "value": "Genotype distribution of estrogen receptor alpha polymorphisms in pregnant women from healthy and preeclampsia populations and its relation to blood pressure levels."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19284296"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "The adipokines adiponectin and leptin may contribute to preeclampsia; however, the reports are conflicting."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19276406"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "This study aimed to establish a method of screening for pregnancy hypertension by a combination of maternal variables, including mean arterial pressure, uterine artery pulsatility index, pregnancy-associated plasma protein-A, and placental growth factor in early pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19273739"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CD40LG"}, "span_text": {"type": "literal", "value": "Upregulation of the CD40-CD40 ligand system in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19272596"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CD40LG"}, "span_text": {"type": "literal", "value": "To investigate the CD40-CD40 ligand (CD40L) system in women with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19272596"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "This study aimed to analyze the differences of soluble endoglin (sEng) and transforming growth factor-beta1 (TGF-beta1) according to preeclamptic complications and to investigate the correlation between these factors and the clinical symptoms of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19253312"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGFB1"}, "span_text": {"type": "literal", "value": "Soluble endoglin and transforming growth factor-beta1 in women who subsequently developed preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19253312"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGFB3"}, "span_text": {"type": "literal", "value": "This study aimed to analyze the differences of soluble endoglin (sEng) and transforming growth factor-beta1 (TGF-beta1) according to preeclamptic complications and to investigate the correlation between these factors and the clinical symptoms of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19253312"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGFB1"}, "span_text": {"type": "literal", "value": "This study aimed to analyze the differences of soluble endoglin (sEng) and transforming growth factor-beta1 (TGF-beta1) according to preeclamptic complications and to investigate the correlation between these factors and the clinical symptoms of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19253312"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGFB3"}, "span_text": {"type": "literal", "value": "Soluble endoglin and transforming growth factor-beta1 in women who subsequently developed preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19253312"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGFB2"}, "span_text": {"type": "literal", "value": "Soluble endoglin and transforming growth factor-beta1 in women who subsequently developed preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19253312"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGFB2"}, "span_text": {"type": "literal", "value": "This study aimed to analyze the differences of soluble endoglin (sEng) and transforming growth factor-beta1 (TGF-beta1) according to preeclamptic complications and to investigate the correlation between these factors and the clinical symptoms of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19253312"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Soluble endoglin and transforming growth factor-beta1 in women who subsequently developed preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19253312"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "This study included 62 preeclampsia and compared the soluble fms-like tyrosine kinase-1 (sFlt-1), soluble endoglin (sEng), and placental growth factor (PlGF) concentrations among patients with different clinical manifestations of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19242927"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "This study included 62 preeclampsia and compared the soluble fms-like tyrosine kinase-1 (sFlt-1), soluble endoglin (sEng), and placental growth factor (PlGF) concentrations among patients with different clinical manifestations of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19242927"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "This study included 62 preeclampsia and compared the soluble fms-like tyrosine kinase-1 (sFlt-1), soluble endoglin (sEng), and placental growth factor (PlGF) concentrations among patients with different clinical manifestations of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19242927"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EPO"}, "span_text": {"type": "literal", "value": "To investigate the possible effect of preeclampsia on erythropoietin metabolism, we measured plasma and urine erythropoietin concentrations and complete blood count in 19 women with preeclampsia and nine healthy gravidas."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/1923199"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EPO"}, "span_text": {"type": "literal", "value": "Based on our results, the erythropoietin response to anemia appears to be intact in preeclampsia, at least in the absence of renal failure."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/1923199"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EPO"}, "span_text": {"type": "literal", "value": "Erythropoietin in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/1923199"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CD40LG"}, "span_text": {"type": "literal", "value": "Flow cytometric investigation of CD40-CD40 ligand system in preeclampsia and normal pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19221099"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "First trimester urinary placental growth factor and development of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19220238"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "To compare urinary placental growth factor (PlGF) concentration at 11(+0) to 13(+6) weeks of gestation in women who subsequently develop pre-eclampsia with normotensive controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19220238"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Because, alterations in circulating sFlt1 and soluble endoglin precede the onset of clinical disease, these factors may be useful to screen or identify patients at risk for preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19217486"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Although the etiology of preeclampsia is still unclear, the clinical phenotypes of preeclampsia have been demonstrated to be related to high circulating levels of anti-angiogenic proteins secreted by the placenta such as soluble Fms-like tyrosine kinase 1 (sFlt1) and soluble endoglin."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19217486"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Although the etiology of preeclampsia is still unclear, the clinical phenotypes of preeclampsia have been demonstrated to be related to high circulating levels of anti-angiogenic proteins secreted by the placenta such as soluble Fms-like tyrosine kinase 1 (sFlt1) and soluble endoglin."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19217486"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:RBP1"}, "span_text": {"type": "literal", "value": "The objective of the study was to investigate serum levels of the adipokine retinol-binding protein 4 (RBP4) in patients with preeclampsia (PE) as compared with healthy controls of similar gestational age."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19217438"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:RBP7"}, "span_text": {"type": "literal", "value": "The objective of the study was to investigate serum levels of the adipokine retinol-binding protein 4 (RBP4) in patients with preeclampsia (PE) as compared with healthy controls of similar gestational age."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19217438"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:RBP1"}, "span_text": {"type": "literal", "value": "Serum levels of retinol-binding protein 4 in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19217438"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:RBP3"}, "span_text": {"type": "literal", "value": "Serum levels of retinol-binding protein 4 in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19217438"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:RBP2"}, "span_text": {"type": "literal", "value": "The objective of the study was to investigate serum levels of the adipokine retinol-binding protein 4 (RBP4) in patients with preeclampsia (PE) as compared with healthy controls of similar gestational age."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19217438"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:RBP7"}, "span_text": {"type": "literal", "value": "Serum levels of retinol-binding protein 4 in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19217438"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:RBP2"}, "span_text": {"type": "literal", "value": "Serum levels of retinol-binding protein 4 in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19217438"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:RBP3"}, "span_text": {"type": "literal", "value": "The objective of the study was to investigate serum levels of the adipokine retinol-binding protein 4 (RBP4) in patients with preeclampsia (PE) as compared with healthy controls of similar gestational age."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19217438"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Women with a history of severe pre-eclampsia had characteristics of metabolic syndrome and had lower insulin sensitivity compared with those who had had normal pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19215548"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "The euglycemic hyperinsulinemic clamp technique was used to assess insulin sensitivity at least 6 months after delivery in 13 women who had had severe pre-eclampsia and 26 age- and body mass index-matched controls who had had normal pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19215548"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "The pre-eclampsia group had lower insulin sensitivity index than the controls (5.4 +/- 2.5 mg/kg/min/mU/L vs 8.1 +/- 4.0 mg/kg/min/mU/L, P = 0.036)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19215548"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Insulin resistance in women with a history of severe pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19215548"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "This study investigated whether post-partum insulin resistance existed in women with a history of severe pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19215548"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Increases in soluble fms-like tyrosine kinase 1 (sFlt-1) and soluble endoglin (sEng) contribute to the pathogenesis of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19215236"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Increases in soluble fms-like tyrosine kinase 1 (sFlt-1) and soluble endoglin (sEng) contribute to the pathogenesis of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19215236"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VWF"}, "span_text": {"type": "literal", "value": "The aim of the present study was to determine circulating antihuman Hsp60, antimycobacterial Hsp65, and antihuman Hsp70 antibody levels in healthy pregnant women and preeclamptic patients and to investigate their relationship to the clinical characteristics of the study subjects, as well as to the markers of inflammation (C-reactive protein (CRP)), endothelial activation (von Willebrand factor antigen), or endothelial injury (fibronectin), oxidative stress (malondialdehyde) and to serum Hsp70 levels."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19205928"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CD40LG"}, "span_text": {"type": "literal", "value": "The expression and concentration of CD40 ligand in normal pregnancy and pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19201484"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL18"}, "span_text": {"type": "literal", "value": "Serum levels of YKL-40 and interleukin-18 and their relationship to disease severity in patients with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19200605"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VWF"}, "span_text": {"type": "literal", "value": "Increased plasma von Willebrand factor antigen levels but normal von Willebrand factor cleaving protease (ADAMTS13) activity in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19190814"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "It was recently reported that both a high soluble fms-like tyrosine kinase 1 (sFlt1): placental growth factor (PlGF) ratio (sFlt1:PlGF ratio) and high soluble endoglin (sEng) levels are related to the later occurrence of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19165674"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "It was recently reported that both a high soluble fms-like tyrosine kinase 1 (sFlt1): placental growth factor (PlGF) ratio (sFlt1:PlGF ratio) and high soluble endoglin (sEng) levels are related to the later occurrence of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19165674"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "It was recently reported that both a high soluble fms-like tyrosine kinase 1 (sFlt1): placental growth factor (PlGF) ratio (sFlt1:PlGF ratio) and high soluble endoglin (sEng) levels are related to the later occurrence of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19165674"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Plasma homocysteine concentrations and insulin resistance in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19165666"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "The correlation between insulin resistance and homocysteine levels in patients with preeclampsia indicate that insulin resistance in preeclampsia is related to endothelial dysfunction."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19165666"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Soluble fms-like tyrosine kinase-1 (sFlt1) is a truncated splice variant of Flt1, which is upregulated in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19147226"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "One possible explanation is that these two conditions share several common metabolic abnormalities as risk factors, including obesity, insulin resistance, and lipid abnormalities that may lead to preeclampsia and CVD at different times of a woman's life."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19124425"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MTHFR"}, "span_text": {"type": "literal", "value": "The objective of our study was to determine whether methylenetetrahydrofolate reductase (Mthfr)-deficient mice develop preeclampsia (PE)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19110222"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD1"}, "span_text": {"type": "literal", "value": "The aim of our study was to examine whether two missense polymorphisms of the extracellular superoxide dismutase (SOD3) gene (Arg213Gly and Ala40Thr) are associated with pre-eclampsia in a Caucasian population from Hungary."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19108943"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD3"}, "span_text": {"type": "literal", "value": "Association of extracellular superoxide dismutase (SOD3) Ala40Thr gene polymorphism with pre-eclampsia complicated by severe fetal growth restriction."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19108943"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD3"}, "span_text": {"type": "literal", "value": "The aim of our study was to examine whether two missense polymorphisms of the extracellular superoxide dismutase (SOD3) gene (Arg213Gly and Ala40Thr) are associated with pre-eclampsia in a Caucasian population from Hungary."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19108943"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD1"}, "span_text": {"type": "literal", "value": "Association of extracellular superoxide dismutase (SOD3) Ala40Thr gene polymorphism with pre-eclampsia complicated by severe fetal growth restriction."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19108943"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Small dense low-density lipoprotein (LDL; which is susceptible for oxidation) is increased in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19104003"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:OLR1"}, "span_text": {"type": "literal", "value": "Increased lectin-like oxidized low-density lipoprotein receptor-1 expression in the maternal vasculature of women with preeclampsia: role for peroxynitrite."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19104003"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CAT"}, "span_text": {"type": "literal", "value": "Catalase activity, serum trace element and heavy metal concentrations, and vitamin A, D and E levels in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19094444"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Numerous known key modulators of preeclampsia (such as Endoglin, Syncytin, human chorionic gonadotrophin -hCG-, and Glial Cell Missing Homolog -GCM1-) were modified in these transformed choriocarcinoma cells."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19079545"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "The following conditions of endothelial injury were found to induce loss of nephrin.(1) Preeclampsia, in which the associated proteinuria is induced by the soluble variant of vascular endothelial growth factor, which stimulates production of endothelin 1 (ET1) in endothelial cells."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19077682"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "The following conditions of endothelial injury were found to induce loss of nephrin.(1) Preeclampsia, in which the associated proteinuria is induced by the soluble variant of vascular endothelial growth factor, which stimulates production of endothelin 1 (ET1) in endothelial cells."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19077682"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "The following conditions of endothelial injury were found to induce loss of nephrin.(1) Preeclampsia, in which the associated proteinuria is induced by the soluble variant of vascular endothelial growth factor, which stimulates production of endothelin 1 (ET1) in endothelial cells."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19077682"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "The following conditions of endothelial injury were found to induce loss of nephrin.(1) Preeclampsia, in which the associated proteinuria is induced by the soluble variant of vascular endothelial growth factor, which stimulates production of endothelin 1 (ET1) in endothelial cells."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19077682"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Recent clinical studies indicate that an excess of angiostatic factors, such as soluble endoglin (sEng), is related to the occurrence of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19075097"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TFPI2"}, "span_text": {"type": "literal", "value": "The aim of this study was to determine the maternal plasma concentrations of TF and its primary inhibitor, tissue factor pathway inhibitor (TFPI), in women who delivered small for gestational age (SGA) neonates, and in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19065458"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TFPI"}, "span_text": {"type": "literal", "value": "The aim of this study was to determine the maternal plasma concentrations of TF and its primary inhibitor, tissue factor pathway inhibitor (TFPI), in women who delivered small for gestational age (SGA) neonates, and in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19065458"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Vascular endothelial growth factor (VEGF) is relevant for normal pregnancy, and abnormalities in VEGF functions are associated with hypertensive disorders of pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19060000"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Vascular endothelial growth factor genotypes and haplotypes are associated with pre-eclampsia but not with gestational hypertension."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19060000"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Vascular endothelial growth factor (VEGF) is relevant for normal pregnancy, and abnormalities in VEGF functions are associated with hypertensive disorders of pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19060000"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Vascular endothelial growth factor (VEGF) is relevant for normal pregnancy, and abnormalities in VEGF functions are associated with hypertensive disorders of pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19060000"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Vascular endothelial growth factor genotypes and haplotypes are associated with pre-eclampsia but not with gestational hypertension."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19060000"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Vascular endothelial growth factor genotypes and haplotypes are associated with pre-eclampsia but not with gestational hypertension."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19060000"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADORA3"}, "span_text": {"type": "literal", "value": "Adenosine A3 receptors expression in trophoblast is upregulated in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19050327"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CTRC"}, "span_text": {"type": "literal", "value": "To determine which pathway, angiotensin-converting enzyme or nonangiotensin-converting enzyme angiotensin-generating enzyme/chymase, might be involved in preeclampsia conditioned medium induced angiotensin II generation, angiotensin-converting enzyme inhibitor captopril and chymotrypsin inhibitors were applied to the cell culture either separately or in combination."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19050326"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CTRC"}, "span_text": {"type": "literal", "value": "Angiotensin II receptor-1 expression was also upregulated in cells treated with preeclampsia conditioned medium or chymotrypsin."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19050326"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:BECN1"}, "span_text": {"type": "literal", "value": "The objective of this study is to investigate the expression of autophagy-related proteins (LC3 and beclin-1) in human placentas and the changes they undergo in the placentas from pregnancies complicated by preeclampsia (PE) and to explore the regulatory mechanisms of these proteins in JEG-3 cells in response to hypoxia or cytokine treatment.The presence of autophagosomes was confirmed with electron microscopy and the expression of LC3 and beclin-1 by immunoimaging methods in human placental trophoblasts."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19050324"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:BECN1"}, "span_text": {"type": "literal", "value": "Autophagy-related proteins, LC3 and Beclin-1, in placentas from pregnancies complicated by preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19050324"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:COMT"}, "span_text": {"type": "literal", "value": "Low catechol-O-methyltransferase and 2-methoxyestradiol in preeclampsia: more than a unifying hypothesis."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19039028"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "There is mounting evidence that an imbalance between angiogenic factors, such as VEGF (vascular endothelial growth factor) or PlGF (placental growth factor), and factors inhibiting angiogenesis, such as sFlt1 (soluble fms-like tyrosine kinase 1) and sEng (soluble endoglin), are closely related to the pathogenesis of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19032146"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "There is mounting evidence that an imbalance between angiogenic factors, such as VEGF (vascular endothelial growth factor) or PlGF (placental growth factor), and factors inhibiting angiogenesis, such as sFlt1 (soluble fms-like tyrosine kinase 1) and sEng (soluble endoglin), are closely related to the pathogenesis of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19032146"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "There is mounting evidence that an imbalance between angiogenic factors, such as VEGF (vascular endothelial growth factor) or PlGF (placental growth factor), and factors inhibiting angiogenesis, such as sFlt1 (soluble fms-like tyrosine kinase 1) and sEng (soluble endoglin), are closely related to the pathogenesis of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19032146"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "There is mounting evidence that an imbalance between angiogenic factors, such as VEGF (vascular endothelial growth factor) or PlGF (placental growth factor), and factors inhibiting angiogenesis, such as sFlt1 (soluble fms-like tyrosine kinase 1) and sEng (soluble endoglin), are closely related to the pathogenesis of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19032146"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "There is mounting evidence that an imbalance between angiogenic factors, such as VEGF (vascular endothelial growth factor) or PlGF (placental growth factor), and factors inhibiting angiogenesis, such as sFlt1 (soluble fms-like tyrosine kinase 1) and sEng (soluble endoglin), are closely related to the pathogenesis of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19032146"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "There is mounting evidence that an imbalance between angiogenic factors, such as VEGF (vascular endothelial growth factor) or PlGF (placental growth factor), and factors inhibiting angiogenesis, such as sFlt1 (soluble fms-like tyrosine kinase 1) and sEng (soluble endoglin), are closely related to the pathogenesis of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19032146"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "To explore the possibility of serum leptin being a marker of severity of pre-eclampsia, so that risk of imminent eclampsia and eclampsia can be reduced."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19024177"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "It has been observed that Mean +/- SEM value of serum leptin level was much higher in severe pre-eclamptics (76.418 +/- 5.056) than in women with mild pre-eclampsia (40.856 +/- 2.807)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19024177"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Elevated plasma leptin concentration appears to be a marker of pre-eclampsia independently or along with other parameters of pre-eclampsia could be used to reduce the severity of pre-eclampsia thus avoiding risk effects of pre-eclampsia to mother and foetus."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19024177"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Role of serum leptin level as a marker of severity of pre eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19024177"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VWF"}, "span_text": {"type": "literal", "value": "Association between von Willebrand factor gene polymorphism and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19021456"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VWF"}, "span_text": {"type": "literal", "value": "The aims of this study were to assess whether the Msp I polymorphism of von Willebrand factor (vWF)(intron 19) gene differs between patients with preeclampsia and normal pregnancies in Chinese Han population, and to study the relationship between the Msp I polymorphism in the vWF(intron 19) gene and severity of preeclampsia symptoms within the preeclampsia group."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19021456"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD3"}, "span_text": {"type": "literal", "value": "Superoxide dismutase activity was decreased and arginase activity was significantly increased in pre-eclamptic patients when compared to normotensive pregnant women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19012693"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD3"}, "span_text": {"type": "literal", "value": "We suggested that in pre-eclampsia excessive arginase and low superoxide dismutase activity leads to a decrease nitric oxide levels and oxidative stress, and this may promote microvascular oxidative damage and endothelial dysfunction."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19012693"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD1"}, "span_text": {"type": "literal", "value": "Superoxide dismutase activity was decreased and arginase activity was significantly increased in pre-eclamptic patients when compared to normotensive pregnant women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19012693"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD1"}, "span_text": {"type": "literal", "value": "We suggested that in pre-eclampsia excessive arginase and low superoxide dismutase activity leads to a decrease nitric oxide levels and oxidative stress, and this may promote microvascular oxidative damage and endothelial dysfunction."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19012693"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Recent findings suggest that soluble Flt-1 may contribute to the pathogenesis of preeclampsia by binding and neutralizing vascular endothelial growth factors (VEGF) and placental growth factor (PlGF)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19010535"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Recent findings suggest that soluble Flt-1 may contribute to the pathogenesis of preeclampsia by binding and neutralizing vascular endothelial growth factors (VEGF) and placental growth factor (PlGF)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19010535"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Recent findings suggest that soluble Flt-1 may contribute to the pathogenesis of preeclampsia by binding and neutralizing vascular endothelial growth factors (VEGF) and placental growth factor (PlGF)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19010535"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Recent findings suggest that soluble Flt-1 may contribute to the pathogenesis of preeclampsia by binding and neutralizing vascular endothelial growth factors (VEGF) and placental growth factor (PlGF)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19010535"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "To test the hypothesis that vascular endothelial growth factor receptor 1 (Flt1) is negatively correlated with apoptosis in preeclampsia placentae, and to examine the effects of antihypertensive medication on apoptosis."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19003637"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "To test the hypothesis that vascular endothelial growth factor receptor 1 (Flt1) is negatively correlated with apoptosis in preeclampsia placentae, and to examine the effects of antihypertensive medication on apoptosis."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19003637"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "To test the hypothesis that vascular endothelial growth factor receptor 1 (Flt1) is negatively correlated with apoptosis in preeclampsia placentae, and to examine the effects of antihypertensive medication on apoptosis."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19003637"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CFH"}, "span_text": {"type": "literal", "value": "Complement factor H variant Y402H is not a risk factor for preeclampsia in the Finnish population."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19003634"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CFH"}, "span_text": {"type": "literal", "value": "We studied 110 women with preeclampsia and 99 controls for complement factor H variations by sequencing."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/19003634"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Soluble and membranous vascular endothelial growth factor receptor-1 in pregnancies complicated by pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18992679"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Soluble and membranous vascular endothelial growth factor receptor-1 in pregnancies complicated by pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18992679"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Soluble and membranous vascular endothelial growth factor receptor-1 in pregnancies complicated by pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18992679"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL6R"}, "span_text": {"type": "literal", "value": "Altered interleukin-6 receptor, IL-6R and gp130, production and expression and decreased SOCS-3 expression in placentas from women with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18986700"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Elevated anti-angiogenic factors such as soluble fms-like tyrosine kinase 1 (sFlt1), a soluble form of vascular endothelial growth factor receptor, and endoglin, a co-receptor for TGFbeta1, confer high risk of pre-eclampsia in healthy pregnant women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18985316"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Elevated anti-angiogenic factors such as soluble fms-like tyrosine kinase 1 (sFlt1), a soluble form of vascular endothelial growth factor receptor, and endoglin, a co-receptor for TGFbeta1, confer high risk of pre-eclampsia in healthy pregnant women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18985316"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Elevated anti-angiogenic factors such as soluble fms-like tyrosine kinase 1 (sFlt1), a soluble form of vascular endothelial growth factor receptor, and endoglin, a co-receptor for TGFbeta1, confer high risk of pre-eclampsia in healthy pregnant women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18985316"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Elevated anti-angiogenic factors such as soluble fms-like tyrosine kinase 1 (sFlt1), a soluble form of vascular endothelial growth factor receptor, and endoglin, a co-receptor for TGFbeta1, confer high risk of pre-eclampsia in healthy pregnant women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18985316"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Elevated endoglin levels in women with type 1 diabetes may confer a predisposition to pre-eclampsia and may contribute to the high incidence of pre-eclampsia in this patient group."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18985316"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Elevated anti-angiogenic factors such as soluble fms-like tyrosine kinase 1 (sFlt1), a soluble form of vascular endothelial growth factor receptor, and endoglin, a co-receptor for TGFbeta1, confer high risk of pre-eclampsia in healthy pregnant women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18985316"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "Proteomic profiling of urine identifies specific fragments of SERPINA1 and albumin as biomarkers of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18984079"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "Proteomics-based characterization of urine in preeclampsia identified a proteomic fingerprint composed of SERPINA1 and albumin fragments, which can accurately diagnose preeclampsia and shows promise to discriminate it from other hypertensive proteinuric diseases."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18984079"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FGF7"}, "span_text": {"type": "literal", "value": "To investigate placental expression of insulin-like growth factor-I (IGF-I), fibroblast growth factor-basic (FGF-b), and neural cell adhesion molecule (N-CAM) in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18979395"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NCAM1"}, "span_text": {"type": "literal", "value": "To investigate placental expression of insulin-like growth factor-I (IGF-I), fibroblast growth factor-basic (FGF-b), and neural cell adhesion molecule (N-CAM) in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18979395"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF2"}, "span_text": {"type": "literal", "value": "Placental expression of insulin-like growth factor-I, fibroblast growth factor-basic, and neural cell adhesion molecule in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18979395"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FGF4"}, "span_text": {"type": "literal", "value": "Placental expression of insulin-like growth factor-I, fibroblast growth factor-basic, and neural cell adhesion molecule in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18979395"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FGF14"}, "span_text": {"type": "literal", "value": "To investigate placental expression of insulin-like growth factor-I (IGF-I), fibroblast growth factor-basic (FGF-b), and neural cell adhesion molecule (N-CAM) in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18979395"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF2"}, "span_text": {"type": "literal", "value": "To investigate placental expression of insulin-like growth factor-I (IGF-I), fibroblast growth factor-basic (FGF-b), and neural cell adhesion molecule (N-CAM) in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18979395"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FGF22"}, "span_text": {"type": "literal", "value": "To investigate placental expression of insulin-like growth factor-I (IGF-I), fibroblast growth factor-basic (FGF-b), and neural cell adhesion molecule (N-CAM) in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18979395"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FGF18"}, "span_text": {"type": "literal", "value": "Placental expression of insulin-like growth factor-I, fibroblast growth factor-basic, and neural cell adhesion molecule in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18979395"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FGF16"}, "span_text": {"type": "literal", "value": "To investigate placental expression of insulin-like growth factor-I (IGF-I), fibroblast growth factor-basic (FGF-b), and neural cell adhesion molecule (N-CAM) in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18979395"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FGF7"}, "span_text": {"type": "literal", "value": "Placental expression of insulin-like growth factor-I, fibroblast growth factor-basic, and neural cell adhesion molecule in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18979395"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FGF13"}, "span_text": {"type": "literal", "value": "To investigate placental expression of insulin-like growth factor-I (IGF-I), fibroblast growth factor-basic (FGF-b), and neural cell adhesion molecule (N-CAM) in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18979395"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FGF22"}, "span_text": {"type": "literal", "value": "Placental expression of insulin-like growth factor-I, fibroblast growth factor-basic, and neural cell adhesion molecule in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18979395"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF1"}, "span_text": {"type": "literal", "value": "To investigate placental expression of insulin-like growth factor-I (IGF-I), fibroblast growth factor-basic (FGF-b), and neural cell adhesion molecule (N-CAM) in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18979395"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FGF16"}, "span_text": {"type": "literal", "value": "Placental expression of insulin-like growth factor-I, fibroblast growth factor-basic, and neural cell adhesion molecule in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18979395"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FGF5"}, "span_text": {"type": "literal", "value": "To investigate placental expression of insulin-like growth factor-I (IGF-I), fibroblast growth factor-basic (FGF-b), and neural cell adhesion molecule (N-CAM) in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18979395"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NCAM1"}, "span_text": {"type": "literal", "value": "Placental expression of insulin-like growth factor-I, fibroblast growth factor-basic, and neural cell adhesion molecule in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18979395"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FGF4"}, "span_text": {"type": "literal", "value": "To investigate placental expression of insulin-like growth factor-I (IGF-I), fibroblast growth factor-basic (FGF-b), and neural cell adhesion molecule (N-CAM) in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18979395"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FGF14"}, "span_text": {"type": "literal", "value": "Placental expression of insulin-like growth factor-I, fibroblast growth factor-basic, and neural cell adhesion molecule in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18979395"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF1"}, "span_text": {"type": "literal", "value": "Placental expression of insulin-like growth factor-I, fibroblast growth factor-basic, and neural cell adhesion molecule in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18979395"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FGF5"}, "span_text": {"type": "literal", "value": "Placental expression of insulin-like growth factor-I, fibroblast growth factor-basic, and neural cell adhesion molecule in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18979395"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FGF18"}, "span_text": {"type": "literal", "value": "To investigate placental expression of insulin-like growth factor-I (IGF-I), fibroblast growth factor-basic (FGF-b), and neural cell adhesion molecule (N-CAM) in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18979395"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FGF13"}, "span_text": {"type": "literal", "value": "Placental expression of insulin-like growth factor-I, fibroblast growth factor-basic, and neural cell adhesion molecule in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18979395"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Alteration of serum soluble endoglin levels after the onset of preeclampsia is more pronounced in women with early-onset."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18971528"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "It has been established that serum soluble endoglin (sEng) increases in women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18971528"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Is there any link between severe pre-eclampsia and defined polymorphisms in leptin and adiponectin genes?"}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18958929"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "The aim of this study was to investigate whether the two common polymorphisms of the leptin (LEP) and adiponectin (APM1) genes are associated with the development of pre-eclampsia and its related traits (gestational hypertension, proteinuria and various measures of reduced fetal growth ) in the Czech pre-eclamptic population."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18958929"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Maternal serum placental growth factor at 11 + 0 to 13 + 6 weeks of gestation in the prediction of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18956425"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "To investigate the potential value of maternal serum placental growth factor (PlGF) in first-trimester screening for pre-eclampsia (PE)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18956425"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "Treatment of a case of severe pre-eclampsia with concentrated serum albumin, salt-poor."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18883079"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "Polymorphisms in the endothelial nitric oxide synthase (eNOS) gene have been inconsistently associated with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18855535"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Urine protein, platelet count, serum nitric oxide metabolites, endothelin-1, 6-keto-PGF-1alpha, and TXB2 were significantly different between control and the preeclampsia model group (p < 0.05), but not between control and the VEGF treatment or VEGF prophylactic groups (p > 0.05 for all)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18855264"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX2"}, "span_text": {"type": "literal", "value": "Reduced glutathione peroxidases could be associated with increased generation of toxic lipid peroxides contributing to the endothelial dysfunction and hypertension of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18852388"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX1"}, "span_text": {"type": "literal", "value": "Oxidative stress associated with preeclampsia may be a consequence of reduced antioxidant defense pathways specifically involving glutathione peroxidases, perhaps linked to reduced selenium availability."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18852388"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX3"}, "span_text": {"type": "literal", "value": "The placental glutathione peroxidase activity and immunohistochemical staining were also reduced in the preeclampsia placentae."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18852388"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX3"}, "span_text": {"type": "literal", "value": "Oxidative stress associated with preeclampsia may be a consequence of reduced antioxidant defense pathways specifically involving glutathione peroxidases, perhaps linked to reduced selenium availability."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18852388"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX2"}, "span_text": {"type": "literal", "value": "The placental glutathione peroxidase activity and immunohistochemical staining were also reduced in the preeclampsia placentae."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18852388"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX2"}, "span_text": {"type": "literal", "value": "Oxidative stress associated with preeclampsia may be a consequence of reduced antioxidant defense pathways specifically involving glutathione peroxidases, perhaps linked to reduced selenium availability."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18852388"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX3"}, "span_text": {"type": "literal", "value": "Reduced glutathione peroxidases could be associated with increased generation of toxic lipid peroxides contributing to the endothelial dysfunction and hypertension of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18852388"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX1"}, "span_text": {"type": "literal", "value": "The placental glutathione peroxidase activity and immunohistochemical staining were also reduced in the preeclampsia placentae."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18852388"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX1"}, "span_text": {"type": "literal", "value": "Reduced glutathione peroxidases could be associated with increased generation of toxic lipid peroxides contributing to the endothelial dysfunction and hypertension of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18852388"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Vasoactivity to and endogenous release of vascular endothelial growth factor in the in vitro perfused human placental lobule from pregnancies complicated by preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18845336"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Vasoactivity to and endogenous release of vascular endothelial growth factor in the in vitro perfused human placental lobule from pregnancies complicated by preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18845336"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Vasoactivity to and endogenous release of vascular endothelial growth factor in the in vitro perfused human placental lobule from pregnancies complicated by preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18845336"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL6"}, "span_text": {"type": "literal", "value": "A role for interleukin-6 in spreading endothelial cell activation after phagocytosis of necrotic trophoblastic material: implications for the pathogenesis of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18825657"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "To determine whether maternal serum concentrations of placental growth factor (PlGF) and soluble endoglin (sEng) are altered in women who subsequently develop pre-eclampsia (PE) or have small-for-gestational-age (SGA) infants, and whether these changes are associated with maternal endothelial dysfunction."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18814185"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "To determine whether maternal serum concentrations of placental growth factor (PlGF) and soluble endoglin (sEng) are altered in women who subsequently develop pre-eclampsia (PE) or have small-for-gestational-age (SGA) infants, and whether these changes are associated with maternal endothelial dysfunction."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18814185"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGFB1"}, "span_text": {"type": "literal", "value": "Platelets and transforming growth factor-beta(1) (TGF-beta(1)) are thought to be involved in the pathogenesis of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18805591"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL18"}, "span_text": {"type": "literal", "value": "The aim of this brief communication was to determine the correlation between pre-eclampsia (PE), Helicobacter pylori pathogenic strains seropositivity, and interleukin-18 (IL-18) levels."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18777510"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Our objective was to determine whether measurement of placenta growth factor (PLGF), inhibin A, or soluble fms-like tyrosine kinase-1 (sFlt-1) at 2 times during pregnancy would usefully predict subsequent preeclampsia (PE) in women at high risk."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18771979"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "First-trimester serum levels of soluble endoglin and soluble fms-like tyrosine kinase-1 as first-trimester markers for late-onset preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18771978"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "The aim of this investigation was to assess soluble endoglin (sEng) and soluble fms-like tyrosine kinase-1 (sFlt1) as first-trimester serum markers to predict preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18771978"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "First-trimester serum levels of soluble endoglin and soluble fms-like tyrosine kinase-1 as first-trimester markers for late-onset preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18771978"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "The aim of this investigation was to assess soluble endoglin (sEng) and soluble fms-like tyrosine kinase-1 (sFlt1) as first-trimester serum markers to predict preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18771978"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOE"}, "span_text": {"type": "literal", "value": "An altered pattern of circulating apolipoprotein E3 isoforms is implicated in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18725658"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CFH"}, "span_text": {"type": "literal", "value": "Proteins whose concentrations were selectively associated with preeclampsia included apolipoprotein E (apoE), apoC-II, complement factor C3c, fibrinogen, transthyretin, and complement factor H-related protein 2."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18725658"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CFHR1"}, "span_text": {"type": "literal", "value": "Proteins whose concentrations were selectively associated with preeclampsia included apolipoprotein E (apoE), apoC-II, complement factor C3c, fibrinogen, transthyretin, and complement factor H-related protein 2."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18725658"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOE"}, "span_text": {"type": "literal", "value": "Proteins whose concentrations were selectively associated with preeclampsia included apolipoprotein E (apoE), apoC-II, complement factor C3c, fibrinogen, transthyretin, and complement factor H-related protein 2."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18725658"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CFHR5"}, "span_text": {"type": "literal", "value": "Proteins whose concentrations were selectively associated with preeclampsia included apolipoprotein E (apoE), apoC-II, complement factor C3c, fibrinogen, transthyretin, and complement factor H-related protein 2."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18725658"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CFI"}, "span_text": {"type": "literal", "value": "Proteins whose concentrations were selectively associated with preeclampsia included apolipoprotein E (apoE), apoC-II, complement factor C3c, fibrinogen, transthyretin, and complement factor H-related protein 2."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18725658"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CFHR3"}, "span_text": {"type": "literal", "value": "Proteins whose concentrations were selectively associated with preeclampsia included apolipoprotein E (apoE), apoC-II, complement factor C3c, fibrinogen, transthyretin, and complement factor H-related protein 2."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18725658"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CFD"}, "span_text": {"type": "literal", "value": "Proteins whose concentrations were selectively associated with preeclampsia included apolipoprotein E (apoE), apoC-II, complement factor C3c, fibrinogen, transthyretin, and complement factor H-related protein 2."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18725658"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TTR"}, "span_text": {"type": "literal", "value": "Proteins whose concentrations were selectively associated with preeclampsia included apolipoprotein E (apoE), apoC-II, complement factor C3c, fibrinogen, transthyretin, and complement factor H-related protein 2."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18725658"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CFHR2"}, "span_text": {"type": "literal", "value": "Proteins whose concentrations were selectively associated with preeclampsia included apolipoprotein E (apoE), apoC-II, complement factor C3c, fibrinogen, transthyretin, and complement factor H-related protein 2."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18725658"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CFB"}, "span_text": {"type": "literal", "value": "Proteins whose concentrations were selectively associated with preeclampsia included apolipoprotein E (apoE), apoC-II, complement factor C3c, fibrinogen, transthyretin, and complement factor H-related protein 2."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18725658"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MTHFR"}, "span_text": {"type": "literal", "value": "Methylenetetrahydrofolate reductase C677T and glutathione S-transferase P1 A313G are associated with a reduced risk of preeclampsia in Maya-Mestizo women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18712057"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MTHFR"}, "span_text": {"type": "literal", "value": "The aim of this study was to investigate whether or not the 5,10-methylenetetrahydrofolate reductase (MTHFR) C677T and glutathione S-transferase P1 (GSTP1) A313G polymorphisms are associated with preeclampsia in Maya-Mestizo women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18712057"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TLR4"}, "span_text": {"type": "literal", "value": "Toll-like receptor 4 gene polymorphisms and preeclampsia: lack of association in a Caucasian population."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18712040"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TLR4"}, "span_text": {"type": "literal", "value": "As Toll-like receptor 4 (TLR4) has an essential role in innate immune response, which is exaggeratedly activated in preeclampsia, our aim was to investigate whether two single nucleotide polymorphisms (SNPs) of the TLR4 gene--Asp299Gly (A896G) and Thr399Ile (C1196T)--are associated with preeclampsia in a Caucasian population from Hungary."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18712040"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL10"}, "span_text": {"type": "literal", "value": "Considering that certain cytokines may change during pre-eclampsia (PE), because of functional polymorphisms in their genes, our purpose was to determine the association between tumor necrosis factor-alpha (TNF-alpha) and interleukin-10 (IL-10) gene polymorphisms and development of PE."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18705845"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL10"}, "span_text": {"type": "literal", "value": "Association of tumor necrosis factor-alpha and interleukin-10 gene polymorphisms in Iranian patients with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18705845"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Our results can not exclude a soluble maternal factor in the serum of women with preeclampsia accounting for increased leptin expression in placental tissue in addition to hypoxia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18696355"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Leptin concentrations were increased in the serum of patients with preeclampsia and gestational diabetes."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18696355"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LDHD"}, "span_text": {"type": "literal", "value": "Furthermore, serum levels of blood urea nitrogen, creatinine, bilirubin and CRP, serum alanine aminotransferase and lactate dehydrogenase (LDH) activities, as well as plasma levels of VWF:Ag, fibronectin, cell-free fetal DNA and malondialdehyde were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18686014"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VWF"}, "span_text": {"type": "literal", "value": "The aim of the present study was to examine whether increased serum Hsp70 levels are related to clinical characteristics and standard laboratory parameters of preeclamptic patients, as well as to markers of inflammation (C-reactive protein), endothelial activation (von Willebrand factor antigen) or endothelial injury (fibronectin), trophoblast debris (cell-free fetal DNA) and oxidative stress (malondialdehyde)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18686014"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LDHB"}, "span_text": {"type": "literal", "value": "Furthermore, serum levels of blood urea nitrogen, creatinine, bilirubin and CRP, serum alanine aminotransferase and lactate dehydrogenase (LDH) activities, as well as plasma levels of VWF:Ag, fibronectin, cell-free fetal DNA and malondialdehyde were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18686014"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LDHA"}, "span_text": {"type": "literal", "value": "Furthermore, serum levels of blood urea nitrogen, creatinine, bilirubin and CRP, serum alanine aminotransferase and lactate dehydrogenase (LDH) activities, as well as plasma levels of VWF:Ag, fibronectin, cell-free fetal DNA and malondialdehyde were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18686014"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CP"}, "span_text": {"type": "literal", "value": "Placental expression of ceruloplasmin in pregnancies complicated by severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18679377"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "The levels of leptin in maternal and newborn's blood were elevated in both mild and severe preeclamptic patients (p < 0.05)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18663995"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Here, we compared the levels of leptin and ghrelin in maternal serum and in arterial and venous cord blood between healthy pregnant women and those suffering from mild and severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18663995"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Preeclampsia, a common complication of pregnancy, is associated with alteration in the concentration of leptin in maternal blood."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18663995"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "OBJECTIVE: the aim of this study was a comparative analysis of the maternal and umbilical cord Vascular Endothelial Growth Factor A (VEGF-A) and its soluble Receptor type 1 (sVEGF-R1) serum concentrations in pregnancies complicated by preeclampsia with and without intrauterine growth retardation (IUGR) and in normotensive pregnancies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18663270"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "OBJECTIVE: the aim of this study was a comparative analysis of the maternal and umbilical cord Vascular Endothelial Growth Factor A (VEGF-A) and its soluble Receptor type 1 (sVEGF-R1) serum concentrations in pregnancies complicated by preeclampsia with and without intrauterine growth retardation (IUGR) and in normotensive pregnancies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18663270"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "OBJECTIVE: the aim of this study was a comparative analysis of the maternal and umbilical cord Vascular Endothelial Growth Factor A (VEGF-A) and its soluble Receptor type 1 (sVEGF-R1) serum concentrations in pregnancies complicated by preeclampsia with and without intrauterine growth retardation (IUGR) and in normotensive pregnancies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18663270"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGTR1"}, "span_text": {"type": "literal", "value": "Numerous recent studies have shown that women with pre-eclampsia possess autoantibodies, termed AT(1)-AAs, that bind and activate the angiotensin II receptor type 1a (AT(1) receptor)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18660815"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL4"}, "span_text": {"type": "literal", "value": "Interleukin-4 -590 (C>T), toll-like receptor-2 +2258 (G>A) and matrix metalloproteinase-9 -1562 (C>T) polymorphisms in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18651887"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL6"}, "span_text": {"type": "literal", "value": "We have described elevated levels of inflammatory markers (tumor necrosis factor alpha, interleukin-6, and C-reactive protein) in preeclamptic patients and demonstrated that Latin-American women present a higher degree of inflammation than women from developed countries."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18645342"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "We have results that suggest that chronic subclinical infections and insulin resistance are the most probable causes of the increased inflammation in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18645342"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Appropriate prenatal care programs, including screening and treatment of urinary, vaginal, and periodontal infections in early pregnancy and prevention of factors that predispose to insulin resistance, such as excessive weight gain during pregnancy, may reduce the incidence of preeclampsia in Latin-American women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18645342"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Preeclampsia (PE) is a significant cause of fetal and maternal mortality around the world and there is evidence that insulin resistance has been implicated in the pathophysiology of PE."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18645256"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGT"}, "span_text": {"type": "literal", "value": "Genetic analysis of the angiotensinogen gene in pre-eclampsia: study of german women and review of the literature."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18645251"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGT"}, "span_text": {"type": "literal", "value": "To evaluate the influence of the angiotensinogen (AGT) gene on the individual predisposition to pre-eclampsia, we screened the AGT gene for pathogenic mutations and an association of identified polymorphisms in German women with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18645251"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Dinucleotide repeat polymorphism in Fms-like tyrosine kinase-1 (Flt-1) gene is not associated with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18631405"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Recently, it was shown that misregulation of fms-like tyrosine kinase-1 (Flt-1) in the peripheral blood mononuclear cells of pregnant women results in over-expression of the soluble splice variant of Flt-1, sFlt-1, producing an additional (extra-placental) source of sFlt-1 that can contribute to the etiology of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18631405"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Release of inositol phosphoglycan P-type by the human placenta following insulin stimulus: a multiple comparison between preeclampsia, intrauterine growth restriction, and gestational hypertension."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18609357"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Abnormal release of P-IPG from placentas of IUGR and gestational hypertensive mothers seems to confirm an association between these disorders of human pregnancy and insulin resistance."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18609357"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Endoglin, PlGF and sFlt-1 as markers for predicting pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18607829"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "To evaluate the ability of endoglin, placental growth factor (PlGF) and the soluble form of vascular endothelial growth factor receptor (sFlt-1) measurements in gestational weeks 24-28 were used to predict pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18607829"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "To evaluate the ability of endoglin, placental growth factor (PlGF) and the soluble form of vascular endothelial growth factor receptor (sFlt-1) measurements in gestational weeks 24-28 were used to predict pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18607829"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "To evaluate the ability of endoglin, placental growth factor (PlGF) and the soluble form of vascular endothelial growth factor receptor (sFlt-1) measurements in gestational weeks 24-28 were used to predict pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18607829"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "To evaluate the ability of endoglin, placental growth factor (PlGF) and the soluble form of vascular endothelial growth factor receptor (sFlt-1) measurements in gestational weeks 24-28 were used to predict pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18607829"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "To evaluate the ability of endoglin, placental growth factor (PlGF) and the soluble form of vascular endothelial growth factor receptor (sFlt-1) measurements in gestational weeks 24-28 were used to predict pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18607829"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Endoglin, PlGF and sFlt-1 might be used as markers for predicting pre-eclampsia, but sFlt-1:PlGF seems to be more accurate."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18607829"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MPO"}, "span_text": {"type": "literal", "value": "Increased myeloperoxidase in the placenta and circulation of women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18591459"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "In the present study we investigated whether insulin sensitivity is decreased in women with previous preeclampsia and whether it is associated with endothelium-dependent and/or -independent vasodilation and/or features of metabolic syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18574072"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "The present study indicates a relation between insulin sensitivity with vascular dilatory function in women with previous preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18574072"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Gestational weeks at the onset of preeclamptic hypertension (P=0.02) and proteinuria (P=0.02) associated positively with insulin sensitivity together with first-trimester body mass index (P=0.008) and maximum diastolic blood pressure during preeclampsia (P=0.005)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18574072"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Furthermore, early onset preeclampsia correlates with impaired insulin sensitivity later in life."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18574072"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Here, we hypothesized that lower concentrations of markers of NO formation exist in hypertensive disorders of pregnancy and that inverse relationships exist between these markers and soluble fms-like tyrosine kinase-1 or soluble endogline."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18574068"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "As expected, we found higher circulating soluble fms-like tyrosine kinase-1 and soluble endogline concentrations in preeclampsia compared with gestational hypertensive subjects or with healthy pregnancies (both P<0.05)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18574068"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Here, we hypothesized that lower concentrations of markers of NO formation exist in hypertensive disorders of pregnancy and that inverse relationships exist between these markers and soluble fms-like tyrosine kinase-1 or soluble endogline."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18574068"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "As expected, we found higher circulating soluble fms-like tyrosine kinase-1 and soluble endogline concentrations in preeclampsia compared with gestational hypertensive subjects or with healthy pregnancies (both P<0.05)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18574068"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Nitric oxide formation is inversely related to serum levels of antiangiogenic factors soluble fms-like tyrosine kinase-1 and soluble endogline in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18574068"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Nitric oxide formation is inversely related to serum levels of antiangiogenic factors soluble fms-like tyrosine kinase-1 and soluble endogline in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18574068"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LGALS1"}, "span_text": {"type": "literal", "value": "To test this hypothesis, we studied placental galectin-1 mRNA and protein expression and localization in women with preeclampsia (PE) and in those who delivered a small-for-gestational age (SGA) neonate."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18570123"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LGALS1"}, "span_text": {"type": "literal", "value": "Severe preeclampsia is characterized by increased placental expression of galectin-1."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18570123"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Fetal lipoprotein changes in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18568462"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "The objective of this study was to investigate the relationship between cigarette smoking and the angiogenic factors soluble fms-like tyrosine kinase-1 (sFlt-1) and placental growth factor (PlGF) in pregnant women with and without preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18566591"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "The objective of this study was to investigate the relationship between cigarette smoking and the angiogenic factors soluble fms-like tyrosine kinase-1 (sFlt-1) and placental growth factor (PlGF) in pregnant women with and without preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18566591"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGT"}, "span_text": {"type": "literal", "value": "Genetic variants of the angiotensinogen gene have been linked to both hypertension and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18562701"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGT"}, "span_text": {"type": "literal", "value": "Preeclampsia risk and angiotensinogen polymorphisms M235T and AGT -217 in African American and Caucasian women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18562701"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGT"}, "span_text": {"type": "literal", "value": "The frequency of angiotensinogen polymorphisms M235T and AGT -217 is different by race; however, these polymorphisms are not associated with an increased risk of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18562701"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PDE5A"}, "span_text": {"type": "literal", "value": "The present study was conducted to research the smooth muscle responses in the pre-eclampsia model with suramin treated rats and the effect of phosphodiesterase-5 (PDE5) inhibitor on these responses."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18538317"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "A novel human-specific soluble vascular endothelial growth factor receptor 1: cell-type-specific splicing and implications to vascular endothelial growth factor homeostasis and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18515749"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "A novel human-specific soluble vascular endothelial growth factor receptor 1: cell-type-specific splicing and implications to vascular endothelial growth factor homeostasis and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18515749"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "A novel human-specific soluble vascular endothelial growth factor receptor 1: cell-type-specific splicing and implications to vascular endothelial growth factor homeostasis and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18515749"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "The objective was to estimate the most effective and accurate predictive biomarker among levels and ratios of angiogenesis-related factors, including soluble fms-like tyrosine kinase 1 (sFlt-1), soluble endoglin, placental growth factor (PlGF), and transforming growth factor-beta1 (TGF-beta1), in women who subsequently developed preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18515525"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "The objective was to estimate the most effective and accurate predictive biomarker among levels and ratios of angiogenesis-related factors, including soluble fms-like tyrosine kinase 1 (sFlt-1), soluble endoglin, placental growth factor (PlGF), and transforming growth factor-beta1 (TGF-beta1), in women who subsequently developed preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18515525"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGFB2"}, "span_text": {"type": "literal", "value": "The objective was to estimate the most effective and accurate predictive biomarker among levels and ratios of angiogenesis-related factors, including soluble fms-like tyrosine kinase 1 (sFlt-1), soluble endoglin, placental growth factor (PlGF), and transforming growth factor-beta1 (TGF-beta1), in women who subsequently developed preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18515525"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "After adjusting for potential confounding factors, the risks for developing preeclampsia were as follows: odds ratio (OR) 6.9 [95% confidence interval 2.3-20.7] for sFlt-1 level, 7.1 [2.3-21.7] for soluble endoglin level, 6.8 [2.4-19.4] for sFlt-1/PlGF, 38.8 [9.8-154.3] for soluble endoglin/TGF-beta1, and 74.8 [17.6-316.7] for the combined ratio."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18515525"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "A nested cohort study was conducted to estimate the levels of sFlt-1, soluble endoglin, PlGF, and TGF-beta1 in plasma collected in the second trimester from 40 women who subsequently developed preeclampsia and 100 contemporaneous normotensive women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18515525"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGFB3"}, "span_text": {"type": "literal", "value": "The objective was to estimate the most effective and accurate predictive biomarker among levels and ratios of angiogenesis-related factors, including soluble fms-like tyrosine kinase 1 (sFlt-1), soluble endoglin, placental growth factor (PlGF), and transforming growth factor-beta1 (TGF-beta1), in women who subsequently developed preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18515525"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Levels of sFlt-1 and soluble endoglin were significantly higher in women with preeclampsia than in normotensive women, whereas levels of PlGF and TGF-beta1 were lower (P<.001)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18515525"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGFB1"}, "span_text": {"type": "literal", "value": "The objective was to estimate the most effective and accurate predictive biomarker among levels and ratios of angiogenesis-related factors, including soluble fms-like tyrosine kinase 1 (sFlt-1), soluble endoglin, placental growth factor (PlGF), and transforming growth factor-beta1 (TGF-beta1), in women who subsequently developed preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18515525"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "In women with preeclampsia, sFlt-1/PlGF, soluble endoglin/TGF-beta1, and the combined ratio of (sFlt-1+soluble endoglin)/(PlGF+TGF-beta1) were significantly higher than in normotensive women (P<.001) and even greater in severe preeclampsia with preterm delivery compared with mild preeclampsia with term delivery (P<.05)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18515525"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "The objective was to estimate the most effective and accurate predictive biomarker among levels and ratios of angiogenesis-related factors, including soluble fms-like tyrosine kinase 1 (sFlt-1), soluble endoglin, placental growth factor (PlGF), and transforming growth factor-beta1 (TGF-beta1), in women who subsequently developed preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18515525"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CRH"}, "span_text": {"type": "literal", "value": "Corticotropin-releasing hormone in maternal and cord plasma in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/1851489"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Circulating leptin and angiogenic factors in preeclampsia patients."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18490835"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "In the prediction of pre-eclampsia, significant contributions were provided by log urine albumin concentration, log ACR, ethnic origin, BMI, age, family and history of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18485165"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "Regression analysis was used first to determine which of the factors among the maternal characteristics were significant predictors of urine albumin concentration and ACR in the unaffected group and second to determine the contribution of urine albumin concentration and ACR in the prediction of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18485165"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "Urine albumin concentration and albumin-to-creatinine ratio at 11(+0) to 13(+6) weeks in the prediction of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18485165"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "In the prediction of pre-eclampsia, urine albumin concentration at 11(+0) to 13(+6) weeks does not provide additional value to maternal variables."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18485165"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "The median urine albumin concentration and the median ACR in the pre-eclampsia group were significantly higher than those in the unaffected group."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18485165"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "To determine the performance of screening for pre-eclampsia by maternal characteristics, urine albumin concentration and albumin-to-creatinine ratio (ACR) at 11(+0) to 13(+6) weeks."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18485165"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "Maternal variables, urine albumin concentrations and ACR of 51 women who developed pre-eclampsia were compared with 2364 women who were unaffected by hypertensive disorders."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18485165"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "Serum IMA and albumin concentrations were assessed in 12 patients with preeclampsia, 12 normal pregnant controls, and 12 nonpregnant controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18484421"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "Ischemia modified albumin in normal pregnancy and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18484421"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "It is speculated that hypoxia-driven disruption of the angiogenic balance involving vascular endothelial growth factor (VEGF)/placenta-derived growth factor (PLGF) and soluble Fms-like tyrosine kinase-1 (sFLT-1, the soluble form of VEGF receptor 1) might contribute to some of the maternal symptoms of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18469803"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:COMT"}, "span_text": {"type": "literal", "value": "Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18469803"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "It is speculated that hypoxia-driven disruption of the angiogenic balance involving vascular endothelial growth factor (VEGF)/placenta-derived growth factor (PLGF) and soluble Fms-like tyrosine kinase-1 (sFLT-1, the soluble form of VEGF receptor 1) might contribute to some of the maternal symptoms of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18469803"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "It is speculated that hypoxia-driven disruption of the angiogenic balance involving vascular endothelial growth factor (VEGF)/placenta-derived growth factor (PLGF) and soluble Fms-like tyrosine kinase-1 (sFLT-1, the soluble form of VEGF receptor 1) might contribute to some of the maternal symptoms of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18469803"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "It is speculated that hypoxia-driven disruption of the angiogenic balance involving vascular endothelial growth factor (VEGF)/placenta-derived growth factor (PLGF) and soluble Fms-like tyrosine kinase-1 (sFLT-1, the soluble form of VEGF receptor 1) might contribute to some of the maternal symptoms of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18469803"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL1B"}, "span_text": {"type": "literal", "value": "Pro-inflammatory cytokines associated with the genesis of preeclampsia (i.e., tumor necrosis factor-alpha and interleukin-1beta) enhanced IL-6 mRNA levels and increased secreted IL-6 levels in first trimester leukocyte-free decidual cell incubations, as measured by real time quantitative RT-PCR, ELISA, and Western blotting."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18467705"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Circulating and placental endoglin concentrations in pregnancies complicated by intrauterine growth restriction and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18462791"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PRL"}, "span_text": {"type": "literal", "value": "Urinary prolactin as a reliable marker for preeclampsia, its severity, and the occurrence of adverse pregnancy outcomes."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18460570"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "The presence of a normal-sized placenta with no histological evidence of preeclampsia and retrospective analyses of maternal antiangiogenic biomarkers (soluble fms-like tyrosine kinase-1 and soluble endoglin) that were within normal levels for pregnancy suggest an alternative diagnosis."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18455853"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "The presence of a normal-sized placenta with no histological evidence of preeclampsia and retrospective analyses of maternal antiangiogenic biomarkers (soluble fms-like tyrosine kinase-1 and soluble endoglin) that were within normal levels for pregnancy suggest an alternative diagnosis."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18455853"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Preeclampsia is associated with an increased release of factors from the placental syncytium into maternal blood, including the antiangiogenic factors soluble fms-like tyrosine kinase-1 and soluble endoglin, the antifibrinolytic factor plasminogen activator inhibitor-1, prostanoids, lipoperoxides, cytokines, and microparticles."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18443340"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Preeclampsia is associated with an increased release of factors from the placental syncytium into maternal blood, including the antiangiogenic factors soluble fms-like tyrosine kinase-1 and soluble endoglin, the antifibrinolytic factor plasminogen activator inhibitor-1, prostanoids, lipoperoxides, cytokines, and microparticles."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18443340"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FABP7"}, "span_text": {"type": "literal", "value": "Serum levels of the adipokine adipocyte fatty acid-binding protein are increased in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18437151"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FABP4"}, "span_text": {"type": "literal", "value": "Serum levels of the adipokine adipocyte fatty acid-binding protein are increased in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18437151"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FABP5"}, "span_text": {"type": "literal", "value": "Serum levels of the adipokine adipocyte fatty acid-binding protein are increased in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18437151"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FABP9"}, "span_text": {"type": "literal", "value": "Serum levels of the adipokine adipocyte fatty acid-binding protein are increased in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18437151"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FABP3"}, "span_text": {"type": "literal", "value": "Serum levels of the adipokine adipocyte fatty acid-binding protein are increased in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18437151"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CALR"}, "span_text": {"type": "literal", "value": "In order to clarify the role of this protein in normal human pregnancy and in pre-eclampsia, this study has measured expression of calreticulin in maternal blood and in placenta in patients with pre-eclampsia and in control pregnancies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18417548"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CALR"}, "span_text": {"type": "literal", "value": "Calreticulin mRNA and protein expression in placenta were not changed between pre-eclampsia and control pregnancies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18417548"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CALR"}, "span_text": {"type": "literal", "value": "Calreticulin in human pregnancy and pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18417548"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CALR"}, "span_text": {"type": "literal", "value": "These novel results indicate that calreticulin is increased in peripheral maternal blood early in pregnancy and remains elevated throughout normal gestation and that there is a further increase in calreticulin in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18417548"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Prospective studies during pregnancy suggest that inflammation, dyslipidemia, and insulin resistance are associated with increased risk of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18413489"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Pre-eclampsia is a pregnancy disorder characterized by a maternal endothelial cell dysfunction associated with low levels of circulating placental growth factor (PlGF) and increased levels of total vascular endothelial growth factor (VEGF), soluble VEGF receptor-1 (sVEGFR-1), and soluble endoglin, a transforming growth factor beta1 and 3 coreceptor."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18413304"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGFB3"}, "span_text": {"type": "literal", "value": "Pre-eclampsia is a pregnancy disorder characterized by a maternal endothelial cell dysfunction associated with low levels of circulating placental growth factor (PlGF) and increased levels of total vascular endothelial growth factor (VEGF), soluble VEGF receptor-1 (sVEGFR-1), and soluble endoglin, a transforming growth factor beta1 and 3 coreceptor."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18413304"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGFB1"}, "span_text": {"type": "literal", "value": "Pre-eclampsia is a pregnancy disorder characterized by a maternal endothelial cell dysfunction associated with low levels of circulating placental growth factor (PlGF) and increased levels of total vascular endothelial growth factor (VEGF), soluble VEGF receptor-1 (sVEGFR-1), and soluble endoglin, a transforming growth factor beta1 and 3 coreceptor."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18413304"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGFB2"}, "span_text": {"type": "literal", "value": "Pre-eclampsia is a pregnancy disorder characterized by a maternal endothelial cell dysfunction associated with low levels of circulating placental growth factor (PlGF) and increased levels of total vascular endothelial growth factor (VEGF), soluble VEGF receptor-1 (sVEGFR-1), and soluble endoglin, a transforming growth factor beta1 and 3 coreceptor."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18413304"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Pre-eclampsia is a pregnancy disorder characterized by a maternal endothelial cell dysfunction associated with low levels of circulating placental growth factor (PlGF) and increased levels of total vascular endothelial growth factor (VEGF), soluble VEGF receptor-1 (sVEGFR-1), and soluble endoglin, a transforming growth factor beta1 and 3 coreceptor."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18413304"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Pre-eclampsia is a pregnancy disorder characterized by a maternal endothelial cell dysfunction associated with low levels of circulating placental growth factor (PlGF) and increased levels of total vascular endothelial growth factor (VEGF), soluble VEGF receptor-1 (sVEGFR-1), and soluble endoglin, a transforming growth factor beta1 and 3 coreceptor."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18413304"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Pre-eclampsia is a pregnancy disorder characterized by a maternal endothelial cell dysfunction associated with low levels of circulating placental growth factor (PlGF) and increased levels of total vascular endothelial growth factor (VEGF), soluble VEGF receptor-1 (sVEGFR-1), and soluble endoglin, a transforming growth factor beta1 and 3 coreceptor."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18413304"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Pre-eclampsia is a pregnancy disorder characterized by a maternal endothelial cell dysfunction associated with low levels of circulating placental growth factor (PlGF) and increased levels of total vascular endothelial growth factor (VEGF), soluble VEGF receptor-1 (sVEGFR-1), and soluble endoglin, a transforming growth factor beta1 and 3 coreceptor."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18413304"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "To clarify the possible role of elevated atrial natriuretic peptide (ANP) in the pathophysiology of preeclampsia, we measured ANP, renin activity (PRA), angiotensin II (Ang II), TXB2 (a stable metabolite of TXA2) and 6-keto-PGF1 alpha (a stable end product of PGI2) concentrations in the plasma of 19 normal pregnant women and 35 severe preeclamptic patients at term."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/1839873"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD3"}, "span_text": {"type": "literal", "value": "Polymorphisms in copper/zinc superoxide dismutase (CuZn-SOD), manganese superoxide dismutase (MnSOD), glutathione-S-transferase M1 (GSTM1), and glutathione-S-transferase T1 (GSTT1) in the umbilical cord tissue were assayed by polymerase chain reaction (PCR) in 23 nulliparous preeclampsia cases and 32 nulliparous normotensive controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18387669"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD1"}, "span_text": {"type": "literal", "value": "Polymorphisms in copper/zinc superoxide dismutase (CuZn-SOD), manganese superoxide dismutase (MnSOD), glutathione-S-transferase M1 (GSTM1), and glutathione-S-transferase T1 (GSTT1) in the umbilical cord tissue were assayed by polymerase chain reaction (PCR) in 23 nulliparous preeclampsia cases and 32 nulliparous normotensive controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18387669"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL10"}, "span_text": {"type": "literal", "value": "To investigate the frequency of the interleukin-10 (IL-10)-1082 G/A single nucleotide polymorphism in women with intrauterine fetal death (IUFD), pre-eclampsia (PE), preterm delivery (PD), and small for gestational age (SGA) infants."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18382869"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADM"}, "span_text": {"type": "literal", "value": "The aim of this study was to evaluate whether maternal circulating adrenomedullin (AM) values in patients with preeclampsia are different from those in normotensive pregnant women at different gestational ages."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18382699"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADM2"}, "span_text": {"type": "literal", "value": "The aim of this study was to evaluate whether maternal circulating adrenomedullin (AM) values in patients with preeclampsia are different from those in normotensive pregnant women at different gestational ages."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18382699"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL6"}, "span_text": {"type": "literal", "value": "In addition, high levels of interleukin-6 and fibrinogen were associated with a history of early-onset preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18382655"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL6"}, "span_text": {"type": "literal", "value": "Combined positivity for any of the TLR4 and NOD2 allelic variants and high levels of interleukin-6 was 6.9-fold more common in women with a history of early-onset preeclampsia (95% CI 2.1-23.2) compared to controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18382655"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TLR4"}, "span_text": {"type": "literal", "value": "We examined whether allelic variants of the innate immune receptors Toll-like receptor 4 (TLR4) and nucleotide-binding oligomerization domain 2 (NOD2), that impair the inflammatory response to endotoxin, are related to preeclampsia and HELLP syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18382655"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "A hypothesis for preeclampsia: adenosine and inducible nitric oxide synthase in human placental microvascular endothelium."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18359514"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL6"}, "span_text": {"type": "literal", "value": "To investigate the frequency of the interleukin-6 (IL-6) -174 G/C single nucleotide polymorphism (SNP) in women with intrauterine fetal death (IUFD), pre-eclampsia (PE), preterm delivery (PD), and small for gestational age (SGA) infants."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18336388"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "Plasma concentration of atrial natriuretic peptide in normal pregnant women and in pregnant women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/1832132"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "Plasma concentration of atrial natriuretic peptide (ANP) was determined in pregnant women with preeclampsia, in normal pregnant and in nonpregnant women by a specific radioimmunoassay."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/1832132"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HMOX1"}, "span_text": {"type": "literal", "value": "Decidual expression and maternal serum levels of heme oxygenase 1 are increased in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18307065"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Soluble Fms-like tyrosine kinase associated with preeclampsia in pregnancy in systemic lupus erythematosus."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18278839"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Serum levels of soluble fms-like tyrosine kinase (sFlt-1) increase in pre-eclampsia (PE)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18275574"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NFAT5"}, "span_text": {"type": "literal", "value": "Autoantibody from women with preeclampsia induces soluble Fms-like tyrosine kinase-1 production via angiotensin type 1 receptor and calcineurin/nuclear factor of activated T-cells signaling."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18259044"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NFATC1"}, "span_text": {"type": "literal", "value": "Overall, our studies demonstrate that an autoantibody from women with preeclampsia induces sFlt-1 production via angiotensin receptor activation and downstream calcineurin/nuclear factor of activated T-cells signaling."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18259044"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NFATC3"}, "span_text": {"type": "literal", "value": "Autoantibody from women with preeclampsia induces soluble Fms-like tyrosine kinase-1 production via angiotensin type 1 receptor and calcineurin/nuclear factor of activated T-cells signaling."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18259044"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NFATC3"}, "span_text": {"type": "literal", "value": "Overall, our studies demonstrate that an autoantibody from women with preeclampsia induces sFlt-1 production via angiotensin receptor activation and downstream calcineurin/nuclear factor of activated T-cells signaling."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18259044"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Autoantibody from women with preeclampsia induces soluble Fms-like tyrosine kinase-1 production via angiotensin type 1 receptor and calcineurin/nuclear factor of activated T-cells signaling."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18259044"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NFAT5"}, "span_text": {"type": "literal", "value": "Overall, our studies demonstrate that an autoantibody from women with preeclampsia induces sFlt-1 production via angiotensin receptor activation and downstream calcineurin/nuclear factor of activated T-cells signaling."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18259044"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NFATC1"}, "span_text": {"type": "literal", "value": "Autoantibody from women with preeclampsia induces soluble Fms-like tyrosine kinase-1 production via angiotensin type 1 receptor and calcineurin/nuclear factor of activated T-cells signaling."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18259044"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Recent evidence indicates that maternal endothelial dysfunction in preeclampsia results from increased soluble Fms-like tyrosine kinase-1 (sFlt-1), a circulating antiangiogenic protein."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18259044"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "No association of the genetic polymorphisms of endothelial nitric oxide synthase, dimethylarginine dimethylaminohydrolase, and vascular endothelial growth factor with preeclampsia in Korean populations."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18251679"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "No association of the genetic polymorphisms of endothelial nitric oxide synthase, dimethylarginine dimethylaminohydrolase, and vascular endothelial growth factor with preeclampsia in Korean populations."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18251679"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:DDAH1"}, "span_text": {"type": "literal", "value": "No association of the genetic polymorphisms of endothelial nitric oxide synthase, dimethylarginine dimethylaminohydrolase, and vascular endothelial growth factor with preeclampsia in Korean populations."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18251679"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "No association of the genetic polymorphisms of endothelial nitric oxide synthase, dimethylarginine dimethylaminohydrolase, and vascular endothelial growth factor with preeclampsia in Korean populations."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18251679"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "No association of the genetic polymorphisms of endothelial nitric oxide synthase, dimethylarginine dimethylaminohydrolase, and vascular endothelial growth factor with preeclampsia in Korean populations."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18251679"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "This report summarizes studies by our laboratory to investigate possible roles for calcium, sodium, membrane pumps, and the vasoactive hormones, atrial natriuretic peptide (hANP) and endothelin, in modulating the change in vascular reactivity characteristic of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/1825148"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Pre-eclampsia is associated with altered plasma concentrations of the pro- and anti-angiogenic factors placental growth factor (PlGF), vascular endothelial growth factor-A (VEGF-A) and soluble fms-like tyrosine kinase 1 (sFlt1)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18231881"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Pre-eclampsia is associated with altered plasma concentrations of the pro- and anti-angiogenic factors placental growth factor (PlGF), vascular endothelial growth factor-A (VEGF-A) and soluble fms-like tyrosine kinase 1 (sFlt1)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18231881"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Pre-eclampsia is associated with altered plasma concentrations of the pro- and anti-angiogenic factors placental growth factor (PlGF), vascular endothelial growth factor-A (VEGF-A) and soluble fms-like tyrosine kinase 1 (sFlt1)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18231881"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Pre-eclampsia is associated with altered plasma concentrations of the pro- and anti-angiogenic factors placental growth factor (PlGF), vascular endothelial growth factor-A (VEGF-A) and soluble fms-like tyrosine kinase 1 (sFlt1)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18231881"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Pre-eclampsia is associated with altered plasma concentrations of the pro- and anti-angiogenic factors placental growth factor (PlGF), vascular endothelial growth factor-A (VEGF-A) and soluble fms-like tyrosine kinase 1 (sFlt1)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18231881"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ICAM1"}, "span_text": {"type": "literal", "value": "Cytokine regulation of intercellular adhesion molecule-1 expression on trophoblasts in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18230913"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Circulating high-molecular-weight adiponectin is upregulated in preeclampsia and is related to insulin sensitivity and renal function."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18230826"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Placental soluble fms-like tyrosine kinase-1 may contribute to the pathogenesis of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18226624"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Circulatory soluble endoglin and its predictive value for preeclampsia in second-trimester pregnancies with abnormal uterine perfusion."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18226617"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Soluble endoglin (sEng) is increased dramatically in preeclampsia and acts synergistically with soluble fms-like tyrosine kinase 1 (sFlt1) to promote the preeclamptic phenotype."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18226617"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Soluble endoglin (sEng) is increased dramatically in preeclampsia and acts synergistically with soluble fms-like tyrosine kinase 1 (sFlt1) to promote the preeclamptic phenotype."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18226617"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IDO2"}, "span_text": {"type": "literal", "value": "We have previously demonstrated that mRNA expression and enzyme activity levels of placental indoleamine 2,3-dioxygenase (IDO), which degrades L-tryptophan and blocks the proliferation of T cells, are significantly low in patients with severe pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18226121"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IDO1"}, "span_text": {"type": "literal", "value": "We have previously demonstrated that mRNA expression and enzyme activity levels of placental indoleamine 2,3-dioxygenase (IDO), which degrades L-tryptophan and blocks the proliferation of T cells, are significantly low in patients with severe pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18226121"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Adiponectin and leptin, two adipose-tissue-derived proteins, have been reported to be elevated in women with established PE (pre-eclampsia)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18211260"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Soluble fms-like tyrosine kinase 1 (sFlt1), which is a circulating antiangiogenic molecule of placental origin, plays a central role in preeclampsia by antagonizing placental growth factor (PlGF) and vascular endothelial growth factor signaling in the maternal vasculature."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18191808"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Soluble fms-like tyrosine kinase 1 (sFlt1), which is a circulating antiangiogenic molecule of placental origin, plays a central role in preeclampsia by antagonizing placental growth factor (PlGF) and vascular endothelial growth factor signaling in the maternal vasculature."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18191808"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Soluble fms-like tyrosine kinase 1 (sFlt1), which is a circulating antiangiogenic molecule of placental origin, plays a central role in preeclampsia by antagonizing placental growth factor (PlGF) and vascular endothelial growth factor signaling in the maternal vasculature."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18191808"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Soluble fms-like tyrosine kinase 1 (sFlt1), which is a circulating antiangiogenic molecule of placental origin, plays a central role in preeclampsia by antagonizing placental growth factor (PlGF) and vascular endothelial growth factor signaling in the maternal vasculature."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18191808"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Soluble fms-like tyrosine kinase 1 (sFlt1), which is a circulating antiangiogenic molecule of placental origin, plays a central role in preeclampsia by antagonizing placental growth factor (PlGF) and vascular endothelial growth factor signaling in the maternal vasculature."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18191808"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VWF"}, "span_text": {"type": "literal", "value": "Women with pre-eclampsia had higher levels of tissue factor pathway inhibitor (TFPI), prothrombin F(1+2) fragment (F(1+2)), factor XIIa, soluble vascular cell adhesion molecule 1, von Willebrand factor and plasminogen activator inhibitor 1 than controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18182033"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TFPI"}, "span_text": {"type": "literal", "value": "Women with pre-eclampsia had higher levels of tissue factor pathway inhibitor (TFPI), prothrombin F(1+2) fragment (F(1+2)), factor XIIa, soluble vascular cell adhesion molecule 1, von Willebrand factor and plasminogen activator inhibitor 1 than controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18182033"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TFPI2"}, "span_text": {"type": "literal", "value": "Women with pre-eclampsia had higher levels of tissue factor pathway inhibitor (TFPI), prothrombin F(1+2) fragment (F(1+2)), factor XIIa, soluble vascular cell adhesion molecule 1, von Willebrand factor and plasminogen activator inhibitor 1 than controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18182033"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GAPDH"}, "span_text": {"type": "literal", "value": "Fetal CRH mRNA levels were higher in pre-eclampsia [mean 0.75 (SD 2.77) CRH/glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA ratio] than in control pregnancies [0.20 (0.74), P = 0.014]."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18182033"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VCAM1"}, "span_text": {"type": "literal", "value": "Women with pre-eclampsia had higher levels of tissue factor pathway inhibitor (TFPI), prothrombin F(1+2) fragment (F(1+2)), factor XIIa, soluble vascular cell adhesion molecule 1, von Willebrand factor and plasminogen activator inhibitor 1 than controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18182033"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "The use of insulin sensitizing drugs to decrease hyperinsulinemic insulin resistance has been proposed during pregnancy to reduce the risk of developing preeclampsia or gestational diabetes."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18181085"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "In the second study, we found that women with a past history of preeclampsia exhibited insulin resistance combined with reduced vascular elasticity."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18180874"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "A role for the anti-angiogenic factors soluble vascular endothelial growth factor receptor-1 (sVEGFR-1) and soluble endoglin in preeclampsia has been proposed."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18175243"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "A role for the anti-angiogenic factors soluble vascular endothelial growth factor receptor-1 (sVEGFR-1) and soluble endoglin in preeclampsia has been proposed."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18175243"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "A role for the anti-angiogenic factors soluble vascular endothelial growth factor receptor-1 (sVEGFR-1) and soluble endoglin in preeclampsia has been proposed."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18175243"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Low maternal concentrations of soluble vascular endothelial growth factor receptor-2 in preeclampsia and small for gestational age."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18175243"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Low maternal concentrations of soluble vascular endothelial growth factor receptor-2 in preeclampsia and small for gestational age."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18175243"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Low maternal concentrations of soluble vascular endothelial growth factor receptor-2 in preeclampsia and small for gestational age."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18175243"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "A role for the anti-angiogenic factors soluble vascular endothelial growth factor receptor-1 (sVEGFR-1) and soluble endoglin in preeclampsia has been proposed."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18175243"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "The soluble form of vascular endothelial growth factor receptor-1 (sVEGFR-1), an antagonist to vascular endothelial growth factor and placental growth factor, has been implicated in the pathophysiology of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18175242"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "The soluble form of vascular endothelial growth factor receptor-1 (sVEGFR-1), an antagonist to vascular endothelial growth factor and placental growth factor, has been implicated in the pathophysiology of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18175242"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "The soluble form of vascular endothelial growth factor receptor-1 (sVEGFR-1), an antagonist to vascular endothelial growth factor and placental growth factor, has been implicated in the pathophysiology of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18175242"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "The soluble form of vascular endothelial growth factor receptor-1 (sVEGFR-1), an antagonist to vascular endothelial growth factor and placental growth factor, has been implicated in the pathophysiology of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18175242"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "These observations provide support for the participation of the soluble receptor of vascular endothelial growth factor in the pathophysiology of SGA with abnormal uterine artery Doppler velocimetry and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18175242"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "These observations provide support for the participation of the soluble receptor of vascular endothelial growth factor in the pathophysiology of SGA with abnormal uterine artery Doppler velocimetry and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18175242"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "These observations provide support for the participation of the soluble receptor of vascular endothelial growth factor in the pathophysiology of SGA with abnormal uterine artery Doppler velocimetry and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18175242"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18175241"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Accumulating evidence suggests that an imbalance between pro-angiogenic (i.e., vascular endothelial growth factor (VEGF) and placental growth factor (PlGF)) and anti-angiogenic factors (i.e., soluble VEGF receptor-1 (sVEGFR-1, also referred to as sFlt1)) is involved in the pathophysiology of preeclampsia (PE)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18175241"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Accumulating evidence suggests that an imbalance between pro-angiogenic (i.e., vascular endothelial growth factor (VEGF) and placental growth factor (PlGF)) and anti-angiogenic factors (i.e., soluble VEGF receptor-1 (sVEGFR-1, also referred to as sFlt1)) is involved in the pathophysiology of preeclampsia (PE)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18175241"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Accumulating evidence suggests that an imbalance between pro-angiogenic (i.e., vascular endothelial growth factor (VEGF) and placental growth factor (PlGF)) and anti-angiogenic factors (i.e., soluble VEGF receptor-1 (sVEGFR-1, also referred to as sFlt1)) is involved in the pathophysiology of preeclampsia (PE)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18175241"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18175241"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18175241"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Accumulating evidence suggests that an imbalance between pro-angiogenic (i.e., vascular endothelial growth factor (VEGF) and placental growth factor (PlGF)) and anti-angiogenic factors (i.e., soluble VEGF receptor-1 (sVEGFR-1, also referred to as sFlt1)) is involved in the pathophysiology of preeclampsia (PE)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18175241"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18175241"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18175241"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "We investigated concentrations of vascular endothelial growth factor (VEGF), VEGF receptor-1 (VEGFR-1), and endoglin in subjects with preeclampsia, compared with normal pregnancies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18166325"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "We investigated concentrations of vascular endothelial growth factor (VEGF), VEGF receptor-1 (VEGFR-1), and endoglin in subjects with preeclampsia, compared with normal pregnancies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18166325"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Concentrations of VEGF, VEGFR-1, and endoglin mRNA of women with preeclampsia were significantly increased."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18166325"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "We investigated concentrations of vascular endothelial growth factor (VEGF), VEGF receptor-1 (VEGFR-1), and endoglin in subjects with preeclampsia, compared with normal pregnancies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18166325"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "We investigated concentrations of vascular endothelial growth factor (VEGF), VEGF receptor-1 (VEGFR-1), and endoglin in subjects with preeclampsia, compared with normal pregnancies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18166325"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "The mRNA concentrations of VEGF, VEGFR-1, and endoglin were observed to correlate directly with the severity of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18166325"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "Elevated ADMA concentration before clinical onset of preeclampsia suggests a role of this nitric oxide synthase inhibitor in the pathophysiologic condition of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18166322"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LY9"}, "span_text": {"type": "literal", "value": "Our aim was to study genetic variability in the gene encoding cytotoxic T-lymphocyte antigen (CTLA-4) and individual susceptibility to the development of preeclampsia or placental abruption."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18076363"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL1B"}, "span_text": {"type": "literal", "value": "Interleukin-1beta (IL-1beta), a pro-inflammatory cytokine, has been implicated in the genesis of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18069648"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "To investigate potential differences in the prediction of early- vs. late-onset pre-eclampsia and/or intrauterine growth restriction (PE/IUGR) by second-trimester uterine artery Doppler examination, and measurement of maternal serum placental growth factor (PlGF) and soluble fms-like tyrosine kinase 1 (sFlt1)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18058842"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "To investigate potential differences in the prediction of early- vs. late-onset pre-eclampsia and/or intrauterine growth restriction (PE/IUGR) by second-trimester uterine artery Doppler examination, and measurement of maternal serum placental growth factor (PlGF) and soluble fms-like tyrosine kinase 1 (sFlt1)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18058842"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VWF"}, "span_text": {"type": "literal", "value": "The role of von Willebrand factor in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/1803615"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TFPI2"}, "span_text": {"type": "literal", "value": "Total plasma tissue factor pathway inhibitor levels in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18035057"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TFPI"}, "span_text": {"type": "literal", "value": "Total plasma tissue factor pathway inhibitor levels in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18035057"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Pre-eclampsia (PE) is a serious cardiovascular complication in pregnancy which shares risk factors with the metabolic syndrome including insulin resistance and obesity."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18034779"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Many risk factors are shared by CVD and preeclampsia, including endothelial dysfunction, obesity, hypertension, hyperglycemia, insulin resistance, and dyslipidemia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18030186"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "In pregnant women with preeclampsia, likewise, plasma leptin levels in SGA group (n = 15) were significantly higher than those in AGA group (n = 25, P<0.05)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18000344"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "However, it is still controversial whether the increase in maternal plasma leptin levels is associated with fetal growth restriction without complication of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18000344"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "We previously demonstrated that severe preeclampsia up-regulated leptin mRNA expression in the placenta and elevated maternal plasma leptin concentrations."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/18000344"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD3"}, "span_text": {"type": "literal", "value": "We also measured the concentrations of tumour necrosis factor-alpha (TNF-alpha), nitric oxide (NO) and superoxide dismutase (SOD) in patients with pre-eclampsia to evaluate their relations to the single nucleotide polymorphisms (SNPs) observed."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17991113"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "The objective of this study was to investigate the association between inducible nitric oxide synthase (iNOS) genotypes and pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17991113"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "Inducible nitric oxide synthase (iNOS) gene polymorphism in pre-eclampsia: a pilot study in North India."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17991113"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD1"}, "span_text": {"type": "literal", "value": "We also measured the concentrations of tumour necrosis factor-alpha (TNF-alpha), nitric oxide (NO) and superoxide dismutase (SOD) in patients with pre-eclampsia to evaluate their relations to the single nucleotide polymorphisms (SNPs) observed."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17991113"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "The purpose of this study was to determine whether the levels of soluble fms-like tyrosine kinase-1 (sFlt-1) and placenta growth factor (PlGF) are altered during the second trimester in the plasma of women who subsequently develop preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17982238"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TPBG"}, "span_text": {"type": "literal", "value": "When stratified according to mild or severe preeclampsia, 19.2-fold and 41.8-fold increases in pregnancy-specific beta1 glycoprotein and 8.3-fold and 10.6-fold increases in trophoblast glycoprotein were observed, respectively."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17978129"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG9"}, "span_text": {"type": "literal", "value": "In the preeclampsia group, pregnancy-specific beta1 glycoprotein correlated with severity of proteinuria (P<.001) and systolic blood pressure (P=.01)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17978129"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG2"}, "span_text": {"type": "literal", "value": "In the preeclampsia group, pregnancy-specific beta1 glycoprotein correlated with severity of proteinuria (P<.001) and systolic blood pressure (P=.01)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17978129"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG9"}, "span_text": {"type": "literal", "value": "The mRNA expression of pregnancy-specific beta1 glycoprotein and trophoblast glycoprotein is up-regulated in cells circulating within blood from women with preeclampsia, and pregnancy-specific beta1 glycoprotein expression is positively correlated with the clinical severity of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17978129"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG4"}, "span_text": {"type": "literal", "value": "In the preeclampsia group, pregnancy-specific beta1 glycoprotein correlated with severity of proteinuria (P<.001) and systolic blood pressure (P=.01)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17978129"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG1"}, "span_text": {"type": "literal", "value": "When stratified according to mild or severe preeclampsia, 19.2-fold and 41.8-fold increases in pregnancy-specific beta1 glycoprotein and 8.3-fold and 10.6-fold increases in trophoblast glycoprotein were observed, respectively."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17978129"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG11"}, "span_text": {"type": "literal", "value": "When stratified according to mild or severe preeclampsia, 19.2-fold and 41.8-fold increases in pregnancy-specific beta1 glycoprotein and 8.3-fold and 10.6-fold increases in trophoblast glycoprotein were observed, respectively."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17978129"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG4"}, "span_text": {"type": "literal", "value": "When stratified according to mild or severe preeclampsia, 19.2-fold and 41.8-fold increases in pregnancy-specific beta1 glycoprotein and 8.3-fold and 10.6-fold increases in trophoblast glycoprotein were observed, respectively."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17978129"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG2"}, "span_text": {"type": "literal", "value": "The mRNA expression of pregnancy-specific beta1 glycoprotein and trophoblast glycoprotein is up-regulated in cells circulating within blood from women with preeclampsia, and pregnancy-specific beta1 glycoprotein expression is positively correlated with the clinical severity of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17978129"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG5"}, "span_text": {"type": "literal", "value": "In the preeclampsia group, pregnancy-specific beta1 glycoprotein correlated with severity of proteinuria (P<.001) and systolic blood pressure (P=.01)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17978129"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG6"}, "span_text": {"type": "literal", "value": "In the preeclampsia group, pregnancy-specific beta1 glycoprotein correlated with severity of proteinuria (P<.001) and systolic blood pressure (P=.01)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17978129"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG8"}, "span_text": {"type": "literal", "value": "The mRNA expression of pregnancy-specific beta1 glycoprotein and trophoblast glycoprotein is up-regulated in cells circulating within blood from women with preeclampsia, and pregnancy-specific beta1 glycoprotein expression is positively correlated with the clinical severity of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17978129"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG6"}, "span_text": {"type": "literal", "value": "When stratified according to mild or severe preeclampsia, 19.2-fold and 41.8-fold increases in pregnancy-specific beta1 glycoprotein and 8.3-fold and 10.6-fold increases in trophoblast glycoprotein were observed, respectively."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17978129"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG3"}, "span_text": {"type": "literal", "value": "The mRNA expression of pregnancy-specific beta1 glycoprotein and trophoblast glycoprotein is up-regulated in cells circulating within blood from women with preeclampsia, and pregnancy-specific beta1 glycoprotein expression is positively correlated with the clinical severity of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17978129"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG9"}, "span_text": {"type": "literal", "value": "When stratified according to mild or severe preeclampsia, 19.2-fold and 41.8-fold increases in pregnancy-specific beta1 glycoprotein and 8.3-fold and 10.6-fold increases in trophoblast glycoprotein were observed, respectively."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17978129"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG3"}, "span_text": {"type": "literal", "value": "In the preeclampsia group, pregnancy-specific beta1 glycoprotein correlated with severity of proteinuria (P<.001) and systolic blood pressure (P=.01)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17978129"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG4"}, "span_text": {"type": "literal", "value": "The mRNA expression of pregnancy-specific beta1 glycoprotein and trophoblast glycoprotein is up-regulated in cells circulating within blood from women with preeclampsia, and pregnancy-specific beta1 glycoprotein expression is positively correlated with the clinical severity of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17978129"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG6"}, "span_text": {"type": "literal", "value": "The mRNA expression of pregnancy-specific beta1 glycoprotein and trophoblast glycoprotein is up-regulated in cells circulating within blood from women with preeclampsia, and pregnancy-specific beta1 glycoprotein expression is positively correlated with the clinical severity of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17978129"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG2"}, "span_text": {"type": "literal", "value": "When stratified according to mild or severe preeclampsia, 19.2-fold and 41.8-fold increases in pregnancy-specific beta1 glycoprotein and 8.3-fold and 10.6-fold increases in trophoblast glycoprotein were observed, respectively."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17978129"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG8"}, "span_text": {"type": "literal", "value": "When stratified according to mild or severe preeclampsia, 19.2-fold and 41.8-fold increases in pregnancy-specific beta1 glycoprotein and 8.3-fold and 10.6-fold increases in trophoblast glycoprotein were observed, respectively."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17978129"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG8"}, "span_text": {"type": "literal", "value": "In the preeclampsia group, pregnancy-specific beta1 glycoprotein correlated with severity of proteinuria (P<.001) and systolic blood pressure (P=.01)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17978129"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TPBG"}, "span_text": {"type": "literal", "value": "The mRNA expression of pregnancy-specific beta1 glycoprotein and trophoblast glycoprotein is up-regulated in cells circulating within blood from women with preeclampsia, and pregnancy-specific beta1 glycoprotein expression is positively correlated with the clinical severity of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17978129"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG1"}, "span_text": {"type": "literal", "value": "In the preeclampsia group, pregnancy-specific beta1 glycoprotein correlated with severity of proteinuria (P<.001) and systolic blood pressure (P=.01)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17978129"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG5"}, "span_text": {"type": "literal", "value": "The mRNA expression of pregnancy-specific beta1 glycoprotein and trophoblast glycoprotein is up-regulated in cells circulating within blood from women with preeclampsia, and pregnancy-specific beta1 glycoprotein expression is positively correlated with the clinical severity of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17978129"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG11"}, "span_text": {"type": "literal", "value": "In the preeclampsia group, pregnancy-specific beta1 glycoprotein correlated with severity of proteinuria (P<.001) and systolic blood pressure (P=.01)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17978129"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG3"}, "span_text": {"type": "literal", "value": "When stratified according to mild or severe preeclampsia, 19.2-fold and 41.8-fold increases in pregnancy-specific beta1 glycoprotein and 8.3-fold and 10.6-fold increases in trophoblast glycoprotein were observed, respectively."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17978129"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG1"}, "span_text": {"type": "literal", "value": "The mRNA expression of pregnancy-specific beta1 glycoprotein and trophoblast glycoprotein is up-regulated in cells circulating within blood from women with preeclampsia, and pregnancy-specific beta1 glycoprotein expression is positively correlated with the clinical severity of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17978129"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG5"}, "span_text": {"type": "literal", "value": "When stratified according to mild or severe preeclampsia, 19.2-fold and 41.8-fold increases in pregnancy-specific beta1 glycoprotein and 8.3-fold and 10.6-fold increases in trophoblast glycoprotein were observed, respectively."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17978129"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG11"}, "span_text": {"type": "literal", "value": "The mRNA expression of pregnancy-specific beta1 glycoprotein and trophoblast glycoprotein is up-regulated in cells circulating within blood from women with preeclampsia, and pregnancy-specific beta1 glycoprotein expression is positively correlated with the clinical severity of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17978129"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "After adjustment for smoking; previous pre-eclampsia; parity; maternal age, education, and socioeconomic position; and duration between baseline measurements and delivery, positive associations were found between prepregnancy serum levels of triglycerides, cholesterol, low density lipoprotein cholesterol, non-high density lipoprotein cholesterol, and blood pressure and risk of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17975256"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Decreased concentrations of the circulating angiogenic factors, free placental growth factor (PLGF) and free vascular endothelial growth factor (VEGF), and increased concentrations of the anti-angiogenic factor, soluble fms-like tyrosine kinase 1 (sFLT-1) have been observed during clinical preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17970705"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Altered angiogenesis in preeclampsia: evaluation of a new test system for measuring placental growth factor."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17970705"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Decreased concentrations of the circulating angiogenic factors, free placental growth factor (PLGF) and free vascular endothelial growth factor (VEGF), and increased concentrations of the anti-angiogenic factor, soluble fms-like tyrosine kinase 1 (sFLT-1) have been observed during clinical preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17970705"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Decreased concentrations of the circulating angiogenic factors, free placental growth factor (PLGF) and free vascular endothelial growth factor (VEGF), and increased concentrations of the anti-angiogenic factor, soluble fms-like tyrosine kinase 1 (sFLT-1) have been observed during clinical preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17970705"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Decreased concentrations of the circulating angiogenic factors, free placental growth factor (PLGF) and free vascular endothelial growth factor (VEGF), and increased concentrations of the anti-angiogenic factor, soluble fms-like tyrosine kinase 1 (sFLT-1) have been observed during clinical preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17970705"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Decreased concentrations of the circulating angiogenic factors, free placental growth factor (PLGF) and free vascular endothelial growth factor (VEGF), and increased concentrations of the anti-angiogenic factor, soluble fms-like tyrosine kinase 1 (sFLT-1) have been observed during clinical preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17970705"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "RESULTS: MDA, TC and AI were significantly elevated (p < 0.001), and HDL-C, AOA and albumin levels were significantly decreased (p < 0.001) in preeclamptic patients compared to the control group."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17962143"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Increased production of antiangiogenic factors soluble endoglin (sEng) and soluble fms-like tyrosine kinase receptor-1 (sFlt-1) by the placenta contributes to the pathophysiology in preeclampsia (PE)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17956952"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Increased production of antiangiogenic factors soluble endoglin (sEng) and soluble fms-like tyrosine kinase receptor-1 (sFlt-1) by the placenta contributes to the pathophysiology in preeclampsia (PE)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17956952"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GP2"}, "span_text": {"type": "literal", "value": "Lack of platelet activation reflected by circulating soluble glycoprotein V in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17944057"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VCAM1"}, "span_text": {"type": "literal", "value": "We sought to examine whether the maternal serum concentration of soluble vascular cell adhesion molecule 1 (sVCAM-1) and intercellular adhesion molecule 1 (sICAM-1) at 11+0-13+6 weeks of gestation could improve the prediction for subsequent development of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17943642"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ICAM1"}, "span_text": {"type": "literal", "value": "We sought to examine whether the maternal serum concentration of soluble vascular cell adhesion molecule 1 (sVCAM-1) and intercellular adhesion molecule 1 (sICAM-1) at 11+0-13+6 weeks of gestation could improve the prediction for subsequent development of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17943642"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Soluble Flt1 and soluble endoglin, secreted by the placenta, are increased in the maternal circulation weeks before the onset of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17937587"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "The balance between proangiogenic and antiangiogenic factors, such as vascular endothelial growth factor, placental growth factor, and soluble fms-like tyrosine kinase-1 (sFlt-1), is altered in preeclampsia, and this dysregulation of angiogenic factors may be important in the pathogenesis of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17923588"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "The balance between proangiogenic and antiangiogenic factors, such as vascular endothelial growth factor, placental growth factor, and soluble fms-like tyrosine kinase-1 (sFlt-1), is altered in preeclampsia, and this dysregulation of angiogenic factors may be important in the pathogenesis of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17923588"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "The balance between proangiogenic and antiangiogenic factors, such as vascular endothelial growth factor, placental growth factor, and soluble fms-like tyrosine kinase-1 (sFlt-1), is altered in preeclampsia, and this dysregulation of angiogenic factors may be important in the pathogenesis of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17923588"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "The balance between proangiogenic and antiangiogenic factors, such as vascular endothelial growth factor, placental growth factor, and soluble fms-like tyrosine kinase-1 (sFlt-1), is altered in preeclampsia, and this dysregulation of angiogenic factors may be important in the pathogenesis of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17923588"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "The balance between proangiogenic and antiangiogenic factors, such as vascular endothelial growth factor, placental growth factor, and soluble fms-like tyrosine kinase-1 (sFlt-1), is altered in preeclampsia, and this dysregulation of angiogenic factors may be important in the pathogenesis of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17923588"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Among the biochemical determinations, a high value of the homeostasis model assessment of insulin resistance was calculated at 1.3 (1.1-2.1) median [interquartile range (IQR)] in the pre-eclamptic toxaemia group and 1.0 (0.7-1.3) in controls (P < 0.01), and when adjusted for body mass index there was still a significant difference between groups (P < 0.05)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17921826"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Excess soluble vascular endothelial growth factor receptor, fms-like tyrosine kinase-1 (sFlt-1), and reduced placental growth factor (PlGF) mediate the genesis of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17904960"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Excess soluble vascular endothelial growth factor receptor, fms-like tyrosine kinase-1 (sFlt-1), and reduced placental growth factor (PlGF) mediate the genesis of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17904960"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Excess soluble vascular endothelial growth factor receptor, fms-like tyrosine kinase-1 (sFlt-1), and reduced placental growth factor (PlGF) mediate the genesis of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17904960"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Excess soluble vascular endothelial growth factor receptor, fms-like tyrosine kinase-1 (sFlt-1), and reduced placental growth factor (PlGF) mediate the genesis of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17904960"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Excess soluble vascular endothelial growth factor receptor, fms-like tyrosine kinase-1 (sFlt-1), and reduced placental growth factor (PlGF) mediate the genesis of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17904960"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGT"}, "span_text": {"type": "literal", "value": "While renin expressions increased in the local cord blood of pre-eclampsia in comparison to the normal cord blood, unpredictable decrements in the angiotensinogen and ACE expressions were observed within the same pre-eclamptic samples."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17851801"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGT"}, "span_text": {"type": "literal", "value": "The mean expression ratios of pre-eclamptic patients were 0.0061 \u00b1 0.00068, 0.035 \u00b1 0.008, and 0.030 \u00b1 0.006 for renin, angiotensinogen and ACE genes, respectively."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17851801"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD3"}, "span_text": {"type": "literal", "value": "The activities of total superoxide dismutase (total SOD), manganese superoxide dismutase (Mn-SOD), catalase (CAT), glutathione transferase(GST), aminolevulinic acid dehydratase (ALAD), and the concentrations of glutathione (GSH), were determined in the plasma and red blood cells of non-pregnant (n=20), normal healthy pregnant women during different trimesters of pregnancy (n=90), and pregnant women with pre-eclampsia (n=7)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17851796"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD1"}, "span_text": {"type": "literal", "value": "The activities of total superoxide dismutase (total SOD), manganese superoxide dismutase (Mn-SOD), catalase (CAT), glutathione transferase(GST), aminolevulinic acid dehydratase (ALAD), and the concentrations of glutathione (GSH), were determined in the plasma and red blood cells of non-pregnant (n=20), normal healthy pregnant women during different trimesters of pregnancy (n=90), and pregnant women with pre-eclampsia (n=7)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17851796"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CAT"}, "span_text": {"type": "literal", "value": "The activities of total superoxide dismutase (total SOD), manganese superoxide dismutase (Mn-SOD), catalase (CAT), glutathione transferase(GST), aminolevulinic acid dehydratase (ALAD), and the concentrations of glutathione (GSH), were determined in the plasma and red blood cells of non-pregnant (n=20), normal healthy pregnant women during different trimesters of pregnancy (n=90), and pregnant women with pre-eclampsia (n=7)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17851796"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "The purpose of this study was to evaluate potential associations between vascular endothelial growth factor (VEGF) gene polymorphisms and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17826416"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Vascular endothelial growth factor gene +936 C/T polymorphism is associated with preeclampsia in Korean women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17826416"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "The purpose of this study was to evaluate potential associations between vascular endothelial growth factor (VEGF) gene polymorphisms and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17826416"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "The purpose of this study was to evaluate potential associations between vascular endothelial growth factor (VEGF) gene polymorphisms and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17826416"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Vascular endothelial growth factor gene +936 C/T polymorphism is associated with preeclampsia in Korean women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17826416"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Vascular endothelial growth factor gene +936 C/T polymorphism is associated with preeclampsia in Korean women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17826416"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Recombinant vascular endothelial growth factor 121 attenuates hypertension and improves kidney damage in a rat model of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17724276"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "We reproduced a previously characterized model of preeclampsia by adenoviral overexpression of the soluble vascular endothelial growth factor (VEGF) receptor sFlt-1 (also referred to as sVEGFR-1) in pregnant and nonpregnant Sprague-Dawley rats."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17724276"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "We reproduced a previously characterized model of preeclampsia by adenoviral overexpression of the soluble vascular endothelial growth factor (VEGF) receptor sFlt-1 (also referred to as sVEGFR-1) in pregnant and nonpregnant Sprague-Dawley rats."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17724276"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Recombinant vascular endothelial growth factor 121 attenuates hypertension and improves kidney damage in a rat model of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17724276"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "We reproduced a previously characterized model of preeclampsia by adenoviral overexpression of the soluble vascular endothelial growth factor (VEGF) receptor sFlt-1 (also referred to as sVEGFR-1) in pregnant and nonpregnant Sprague-Dawley rats."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17724276"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Recombinant vascular endothelial growth factor 121 attenuates hypertension and improves kidney damage in a rat model of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17724276"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGTR1"}, "span_text": {"type": "literal", "value": "To investigate whether polymorphisms of angiotensin converting enzyme gene (ACE) and angiotensin II receptor type 1 gene (AT1R) are associated with etiology of preeclampsia and renal impact in women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17710578"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GH2"}, "span_text": {"type": "literal", "value": "Placental growth hormone is increased in the maternal and fetal serum of patients with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17701665"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GH1"}, "span_text": {"type": "literal", "value": "Placental growth hormone is increased in the maternal and fetal serum of patients with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17701665"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "The purpose of this study was to determine whether second-trimester soluble fms-like tyrosine kinase-1 and placenta growth factor (PlGF) are altered in patients who have preeclampsia develop compared with controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17689655"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Placenta growth factor was significantly lower in patients in the second trimester who later had severe preeclampsia develop but soluble fms-like tyrosine kinase-1 was unchanged compared with healthy pregnancies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17689655"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Median maternal serum and amniotic fluid soluble endoglin concentrations were elevated in preeclampsia, compared with control pregnancies (66.9 ng/mL vs 15.1 ng/mL; P < .001, and 1.9 ng/mL vs 0.6 ng/mL; P < .001)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17689641"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Circulating concentrations of soluble endoglin (CD105) in fetal and maternal serum and in amniotic fluid in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17689641"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "We confirmed elevated soluble endoglin in maternal circulation in preeclampsia, which correlated with soluble fms-like tyrosine kinase 1 concentrations and soluble fms-like tyrosine kinase 1/placental growth factor ratio."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17689641"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "The fetus appears not to contribute to elevated circulating maternal soluble endoglin concentrations in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17689641"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "We confirmed elevated soluble endoglin in maternal circulation in preeclampsia, which correlated with soluble fms-like tyrosine kinase 1 concentrations and soluble fms-like tyrosine kinase 1/placental growth factor ratio."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17689641"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "We confirmed elevated soluble endoglin in maternal circulation in preeclampsia, which correlated with soluble fms-like tyrosine kinase 1 concentrations and soluble fms-like tyrosine kinase 1/placental growth factor ratio."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17689641"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "We explored whether concentrations of soluble endoglin in fetal serum and amniotic fluid and in maternal serum were elevated in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17689641"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Low concentrations of soluble endoglin were found in fetal circulation, which did not differ between preeclampsia and control pregnancies (5.0 ng/mL vs 4.7 ng/mL; P = .2)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17689641"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Soluble endoglin as a second-trimester marker for preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17689640"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "The objective of this investigation was to characterize soluble endoglin (sEng) concentrations in second-trimester serum of women who either develop preeclampsia or have a normal pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17689640"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Soluble endoglin is elevated in second-trimester maternal serum in patients destined to develop severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17689640"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "Alterations of vascular smooth muscle and platelet intracellular cations [Ca2+]i, [Mg2+]i and [H+]i relative to plasma concentrations of these ions in nitric oxide synthase (NOS) blockade-induced models of pre-eclampsia have been evaluated in the present study."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17689514"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Recently, the soluble form of vascular endothelial growth factor (VEGF) receptor-1 (sVEGFR-1), an antagonist to VEGF and placental growth factor (PlGF) (two important angiogenic factors), has been implicated in the pathophysiology of preeclampsia and small for gestational age (SGA) without preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17674262"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Recently, the soluble form of vascular endothelial growth factor (VEGF) receptor-1 (sVEGFR-1), an antagonist to VEGF and placental growth factor (PlGF) (two important angiogenic factors), has been implicated in the pathophysiology of preeclampsia and small for gestational age (SGA) without preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17674262"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Recently, the soluble form of vascular endothelial growth factor (VEGF) receptor-1 (sVEGFR-1), an antagonist to VEGF and placental growth factor (PlGF) (two important angiogenic factors), has been implicated in the pathophysiology of preeclampsia and small for gestational age (SGA) without preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17674262"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Recently, the soluble form of vascular endothelial growth factor (VEGF) receptor-1 (sVEGFR-1), an antagonist to VEGF and placental growth factor (PlGF) (two important angiogenic factors), has been implicated in the pathophysiology of preeclampsia and small for gestational age (SGA) without preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17674262"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGFB3"}, "span_text": {"type": "literal", "value": "To evaluate the placental expression of transforming growth factor-beta3 (TGF-beta3) in patients with HELLP syndrome and pre-eclampsia compared to controls, and its correlation to Doppler velocimetry analysis of the utero-placental blood flow."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17671384"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGFB2"}, "span_text": {"type": "literal", "value": "Placental overexpression of transforming growth factor-beta3 in the HELLP syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17671384"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGFB1"}, "span_text": {"type": "literal", "value": "To evaluate the placental expression of transforming growth factor-beta3 (TGF-beta3) in patients with HELLP syndrome and pre-eclampsia compared to controls, and its correlation to Doppler velocimetry analysis of the utero-placental blood flow."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17671384"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGFB2"}, "span_text": {"type": "literal", "value": "To evaluate the placental expression of transforming growth factor-beta3 (TGF-beta3) in patients with HELLP syndrome and pre-eclampsia compared to controls, and its correlation to Doppler velocimetry analysis of the utero-placental blood flow."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17671384"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGFB1"}, "span_text": {"type": "literal", "value": "Placental overexpression of transforming growth factor-beta3 in the HELLP syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17671384"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGFB3"}, "span_text": {"type": "literal", "value": "Placental overexpression of transforming growth factor-beta3 in the HELLP syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17671384"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "Orosomucoid excretion can probably be used as a prognostic tool in combination with other screening methods, and seems to be a more sensitive marker for evolving pre-eclampsia than albumin."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17653877"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "Pre-eclampsia is associated with a pre-symptomatic increase in the urine excretion of orosomucoid, and orosomucoid excretion precedes that of albumin."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17653877"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:B2M"}, "span_text": {"type": "literal", "value": "Cystatin C, beta-2-microglobulin and beta-trace protein in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17653875"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:B2M"}, "span_text": {"type": "literal", "value": "In this study, the maternal plasma levels of beta2-microglobulin, beta-trace protein and cystatin C were all significantly elevated in pre-eclampsia compared to those of healthy pregnant women, and displayed similar diagnostic performance for diagnosing pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17653875"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:B2M"}, "span_text": {"type": "literal", "value": "The plasma levels of cystatin C and beta-2-microglobulin are further increased in pre-eclampsia, and the cystatin C level has been reported to be a reliable marker for the disease."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17653875"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:B2M"}, "span_text": {"type": "literal", "value": "The aim of this investigation was to study the plasma levels of beta-trace protein, beta-2-microglobulin and cystatin C in pre-eclampsia, and to determine the diagnostic performance of these proteins compared to that of urate and creatinine."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17653875"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGFB1"}, "span_text": {"type": "literal", "value": "Blood samples from women whose pregnancy was complicated by eclampsia (n=37) or pre-eclampsia (n=49) and healthy controls (n=86) were analyzed for the presence of polymorphisms at codons 10 and 25 of the transforming growth factor-beta 1 gene."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17653872"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "Polymorphisms in the endothelial nitric oxide synthase gene may be protective against preeclampsia in a Chinese population."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17636229"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Effects of magnesium sulphate on placental expression of endothelin 1 and its receptors in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17631287"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "To investigate the effects of magnesium sulphate (MgSO(4)) on placental expression of endothelin 1 (ET-1) and its receptors in preeclampsia (PE)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17631287"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Reduced plasma adiponectin and elevated leptin in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17585917"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "To clarify the role of adipocytokine, adiponectin, and leptin in the pathogenesis of pre-eclampsia (PE) and determine the relationships between plasma adiponectin and leptin levels."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17585917"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Soluble fms-like tyrosine kinase 1 (sFlt1), an endogenous anti-angiogenic factor that is a potent vascular endothelial growth factor (VEGF) antagonist, is highly elevated in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17570933"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "More severe forms of preeclampsia, including the HELLP syndrome, may be explained by a concomitant elevation in both sFlt1 and soluble endoglin, another anti-angiogenic factor."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17570933"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Soluble fms-like tyrosine kinase 1 (sFlt1), an endogenous anti-angiogenic factor that is a potent vascular endothelial growth factor (VEGF) antagonist, is highly elevated in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17570933"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Soluble fms-like tyrosine kinase 1 (sFlt1), an endogenous anti-angiogenic factor that is a potent vascular endothelial growth factor (VEGF) antagonist, is highly elevated in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17570933"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Soluble fms-like tyrosine kinase 1 (sFlt1), an endogenous anti-angiogenic factor that is a potent vascular endothelial growth factor (VEGF) antagonist, is highly elevated in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17570933"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL2"}, "span_text": {"type": "literal", "value": "Maternal serum interleukin-10, interleukin-2 and interleukin-6 in pre-eclampsia and eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17565548"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL6"}, "span_text": {"type": "literal", "value": "Maternal serum interleukin-10, interleukin-2 and interleukin-6 in pre-eclampsia and eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17565548"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL10"}, "span_text": {"type": "literal", "value": "Maternal serum interleukin-10, interleukin-2 and interleukin-6 in pre-eclampsia and eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17565548"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SELP"}, "span_text": {"type": "literal", "value": "CONCLUSION: CRH, PLAC1, and selectin-P are distributed differently in preeclampsia cases compared to controls and correlate with signs of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17554801"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SELP"}, "span_text": {"type": "literal", "value": "Cell-free mRNA concentrations of CRH, PLAC1, and selectin-P are increased in the plasma of pregnant women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17554801"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "More recently, soluble endoglin, another circulating anti-angiogenic protein was found to synergize with sFlt-1 and contribute to the pathogenesis of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17553534"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL10"}, "span_text": {"type": "literal", "value": "Absence of an association of tumor necrosis factor (TNF)-alpha G308A, interleukin-6 (IL-6) G174C and interleukin-10 (IL-10) G1082A polymorphism in women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17544514"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL6"}, "span_text": {"type": "literal", "value": "Absence of an association of tumor necrosis factor (TNF)-alpha G308A, interleukin-6 (IL-6) G174C and interleukin-10 (IL-10) G1082A polymorphism in women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17544514"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Placental growth factor and soluble FMS-like tyrosine kinase-1 in early-onset and late-onset preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17540809"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "To estimate whether alterations in plasma levels of the proangiogenic proteins placental growth factor (PlGF) and vascular endothelial growth factor-A (VEGF-A), and the antiangiogenic protein soluble fms-like tyrosine kinase-1 (sFlt1) were more pronounced in early-onset than in late-onset preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17540809"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "To estimate whether alterations in plasma levels of the proangiogenic proteins placental growth factor (PlGF) and vascular endothelial growth factor-A (VEGF-A), and the antiangiogenic protein soluble fms-like tyrosine kinase-1 (sFlt1) were more pronounced in early-onset than in late-onset preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17540809"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "To estimate whether alterations in plasma levels of the proangiogenic proteins placental growth factor (PlGF) and vascular endothelial growth factor-A (VEGF-A), and the antiangiogenic protein soluble fms-like tyrosine kinase-1 (sFlt1) were more pronounced in early-onset than in late-onset preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17540809"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "To estimate whether alterations in plasma levels of the proangiogenic proteins placental growth factor (PlGF) and vascular endothelial growth factor-A (VEGF-A), and the antiangiogenic protein soluble fms-like tyrosine kinase-1 (sFlt1) were more pronounced in early-onset than in late-onset preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17540809"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Placental growth factor and soluble FMS-like tyrosine kinase-1 in early-onset and late-onset preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17540809"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "To estimate whether alterations in plasma levels of the proangiogenic proteins placental growth factor (PlGF) and vascular endothelial growth factor-A (VEGF-A), and the antiangiogenic protein soluble fms-like tyrosine kinase-1 (sFlt1) were more pronounced in early-onset than in late-onset preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17540809"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Preeclampsia, insulin signalling and immunological dysfunction: a fetal, maternal or placental disorder?"}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17537518"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "The over-expression of P-IPG during preeclampsia may be a counter-regulatory mechanism to insulin resistance since these molecules mimic insulin action."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17537518"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "We report the results observed in an open pilot study in ten preeclamptic patients treated with daily albumin infusions (0.4 to 1 g/kg) from 7 to 36 days."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/1752073"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "Repeated albumin infusions do not lower blood pressure in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/1752073"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "Synergistic effect of renin-angiotensin system and nitric oxide synthase genes polymorphisms in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17520398"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "The aim of this study was to assess if interactions among different polymorphisms of the renin-angiotensin system and nitric oxide synthase are involved in the pathogenesis of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17520398"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "Since lack of such remodelling and abnormal placentation are specific features of pre-eclampsia, it has been suggested that abnormal function of both components of the renin-angiotensin system and endothelial nitric oxide synthase may be involved in its pathogenesis."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17520398"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "However, previous studies of the association between pre-eclampsia and polymorphisms of single genes encoding renin-angiotensin system components and endothelial nitric oxide synthase have yielded conflicting results."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17520398"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "Synergism of angiotensin-converting enzyme I/D and other polymorphisms of renin-angiotensin system components and nitric oxide synthase may be a risk factor for pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17520398"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Concentrations of soluble fms-like tyrosine kinase 1 (sFlt1) and soluble endoglin (sEng) increase in maternal blood with the approach of clinical preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17515455"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Concentrations of soluble fms-like tyrosine kinase 1 (sFlt1) and soluble endoglin (sEng) increase in maternal blood with the approach of clinical preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17515455"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ESR2"}, "span_text": {"type": "literal", "value": "Association between estrogen receptor alpha (ESR1) gene polymorphisms and severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17510501"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GH2"}, "span_text": {"type": "literal", "value": "Sixty-seven women with normal pregnancy, 13 with preeclampsia (PE) and 11 with intrauterine fetal growth restriction (IUGR) underwent Doppler sonography of the placental and nonplacental uterine and cubital artery and blood sampling. hGH-V was measured with a highly sensitive sandwich-type immunofluorometric assay and pituitary growth hormone (hGH-N) and insulinlike growth factor I (IGF-I) with a chemiluminescence assay."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17506372"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GH1"}, "span_text": {"type": "literal", "value": "Sixty-seven women with normal pregnancy, 13 with preeclampsia (PE) and 11 with intrauterine fetal growth restriction (IUGR) underwent Doppler sonography of the placental and nonplacental uterine and cubital artery and blood sampling. hGH-V was measured with a highly sensitive sandwich-type immunofluorometric assay and pituitary growth hormone (hGH-N) and insulinlike growth factor I (IGF-I) with a chemiluminescence assay."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17506372"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Plasma immunoreactive endothelin-1 concentration was measured by radioimmunoassay in blood from women with normal pregnancy and preeclampsia and in cord blood from normal pregnancies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/1750465"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Placental ischemia and soluble fms-like tyrosine kinase 1: cause or consequence of preeclampsia?"}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17495934"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Elevated circulating soluble fms-like tyrosine kinase 1 (sFLT-1) is associated with the development of the clinical signs and symptoms of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17495934"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HPX"}, "span_text": {"type": "literal", "value": "Enhanced hemopexin activity may be associated with normal pregnancy, but not with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17469012"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HPX"}, "span_text": {"type": "literal", "value": "Plasma hemopexin activity in pregnancy and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17469012"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HPX"}, "span_text": {"type": "literal", "value": "Decreased hemopexin in pre-eclamptic patients may be due to enhanced plasma ATP, which is possibly promoted by diminished activity of vascular ecto-apyrase."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17469012"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Endothelin-1 levels were measured in conditioned medium of women with preeclampsia HUVECs were treated with different concentrations of VEGF(165) and at various time intervals."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17469009"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Additionally, the circulating levels of total and free VEGF, matrix metalloproteinase-2 (MMP-2), and endothelin-1 were measured in 20 preeclamptic patients and 20 healthy pregnant controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17469009"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Total VEGF, MMP-2, and endothelin-1 concentrations were higher in preeclampsia and showed significant positive correlations between them."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17469009"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Alterations in placental growth factor levels before and after the onset of preeclampsia are more pronounced in women with early onset severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17460385"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "It has been established that the serum placental growth factor (PlGF) decreases and the soluble fms-like tyrosine kinase-1 (sFlt-1) increases in women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17460385"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "It has been established that the serum placental growth factor (PlGF) decreases and the soluble fms-like tyrosine kinase-1 (sFlt-1) increases in women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17460385"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CD40LG"}, "span_text": {"type": "literal", "value": "The mean soluble CD40 ligand levels were 1.08 +/- 0.43 ng/mL in patients with preeclampsia and 0.76 +/- 0.24 ng/mL in healthy pregnant women, which was statistically significant (P = .01)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17456631"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CD40LG"}, "span_text": {"type": "literal", "value": "Increased concentration of soluble CD40 ligand in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17456631"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CD40LG"}, "span_text": {"type": "literal", "value": "The plasma level of soluble CD40 ligand was investigated during preeclamptic (n =20) and normal pregnancies (n = 20) to emphasize inflammatory response in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17456631"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Maternal leptin concentrations are similar in African Americans and Caucasians in normal pregnancy, preeclampsia and small-for-gestational-age infants."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17454222"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Leptin concentrations were measured in African American women in order to assess leptin's role in the increased frequency and severity of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17454222"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Differences in the frequency and severity of preeclampsia in African Americans cannot be explained by higher leptin concentrations."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17454222"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "The previously recognized pattern of increased leptin concentrations in preeclampsia was replicated."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17454222"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "The present study demonstrated a protective effect of GSE in experimental preeclampsia since the deleterious effect induced by L-NAME that is, increased in stillbirth, hypertension and insulin resistance were significantly reduced by oral treatment with the extract."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17454221"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Women with a history of preeclampsia exhibited more risk factors for future cardiovascular disease such as dyslipidemia, hypertension, obesity, and increased insulin resistance compared with women with a history of uncomplicated pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17454217"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "In order to investigate the possible association of the -231 G > A polymorphism in the endothelin-1 type A receptor gene (EDNRA), previously shown to be associated with other conditions characterized by vasospasm, we examined 77 Caucasian preeclamptic women and 67 matched controls including normotensive subjects without history of thromboembolic event, abnormalities in blood pressure, proteinuria, edema and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17437213"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Alterations in the endothelin-1 (ET-1) system are considered to take part in triggering the vasoconstriction seen in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17437213"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Investigation of endothelin-1 type A receptor gene polymorphism (-231 G > A) in preeclampsia susceptibility."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17437213"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Recent reports have demonstrated that soluble endoglin (sEng), an antiangiogenic protein thought to impair TGF-beta binding to receptors, and soluble vascular endothelial growth factor receptor (sVEGFR)-1 play important roles in the pathophysiology of preeclampsia (PE)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17426083"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Recent reports have demonstrated that soluble endoglin (sEng), an antiangiogenic protein thought to impair TGF-beta binding to receptors, and soluble vascular endothelial growth factor receptor (sVEGFR)-1 play important roles in the pathophysiology of preeclampsia (PE)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17426083"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Recent reports have demonstrated that soluble endoglin (sEng), an antiangiogenic protein thought to impair TGF-beta binding to receptors, and soluble vascular endothelial growth factor receptor (sVEGFR)-1 play important roles in the pathophysiology of preeclampsia (PE)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17426083"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Correlation between soluble endoglin, vascular endothelial growth factor receptor-1, and adipocytokines in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17426083"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Correlation between soluble endoglin, vascular endothelial growth factor receptor-1, and adipocytokines in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17426083"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Recent reports have demonstrated that soluble endoglin (sEng), an antiangiogenic protein thought to impair TGF-beta binding to receptors, and soluble vascular endothelial growth factor receptor (sVEGFR)-1 play important roles in the pathophysiology of preeclampsia (PE)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17426083"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Correlation between soluble endoglin, vascular endothelial growth factor receptor-1, and adipocytokines in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17426083"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Correlation between soluble endoglin, vascular endothelial growth factor receptor-1, and adipocytokines in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17426083"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "New evidence suggests that vascular endothelial growth factor and its receptors, antagonists, and reduced placental growth factor may play a role in the development of proteinuria and other renal injury-mediated manifestations in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17420664"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "New evidence suggests that vascular endothelial growth factor and its receptors, antagonists, and reduced placental growth factor may play a role in the development of proteinuria and other renal injury-mediated manifestations in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17420664"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "New evidence suggests that vascular endothelial growth factor and its receptors, antagonists, and reduced placental growth factor may play a role in the development of proteinuria and other renal injury-mediated manifestations in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17420664"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "New evidence suggests that vascular endothelial growth factor and its receptors, antagonists, and reduced placental growth factor may play a role in the development of proteinuria and other renal injury-mediated manifestations in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17420664"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Here, we determined the ratio of serum concentration of soluble fms-like tyrosine kinase 1 (sFlt-1), a natural inhibitor of pro-angiogenic vascular endothelial growth factor (VEGF) relative to angiopoietin-2 (Ang-2), a natural antagonist of angiopoietin-1 (Ang-1) involved in promoting angiogenesis in the presence of VEGF, in women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17409768"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Here, we determined the ratio of serum concentration of soluble fms-like tyrosine kinase 1 (sFlt-1), a natural inhibitor of pro-angiogenic vascular endothelial growth factor (VEGF) relative to angiopoietin-2 (Ang-2), a natural antagonist of angiopoietin-1 (Ang-1) involved in promoting angiogenesis in the presence of VEGF, in women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17409768"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Here, we determined the ratio of serum concentration of soluble fms-like tyrosine kinase 1 (sFlt-1), a natural inhibitor of pro-angiogenic vascular endothelial growth factor (VEGF) relative to angiopoietin-2 (Ang-2), a natural antagonist of angiopoietin-1 (Ang-1) involved in promoting angiogenesis in the presence of VEGF, in women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17409768"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Here, we determined the ratio of serum concentration of soluble fms-like tyrosine kinase 1 (sFlt-1), a natural inhibitor of pro-angiogenic vascular endothelial growth factor (VEGF) relative to angiopoietin-2 (Ang-2), a natural antagonist of angiopoietin-1 (Ang-1) involved in promoting angiogenesis in the presence of VEGF, in women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17409768"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ANGPT1"}, "span_text": {"type": "literal", "value": "Here, we determined the ratio of serum concentration of soluble fms-like tyrosine kinase 1 (sFlt-1), a natural inhibitor of pro-angiogenic vascular endothelial growth factor (VEGF) relative to angiopoietin-2 (Ang-2), a natural antagonist of angiopoietin-1 (Ang-1) involved in promoting angiogenesis in the presence of VEGF, in women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17409768"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "It has been shown that the level of soluble fms-like tyrosine kinase-1 (sFlt-1) is elevated in pregnant women who are destined to have preeclampsia, and a role for sFlt-1 in its pathogenesis has been suggested."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17403433"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "The purpose of this study was to evaluate the relationship between natriuretic peptides (NT-proANP and NT-proBNP) and hemodynamic parameters in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17403408"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "Natriuretic peptides and hemodynamics in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17403408"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Preeclampsia has been proposed to be an antiangiogenic state that may be detected by the determination of the concentrations of the soluble vascular endothelial growth factor receptor-1 (sVEGFR-1) and placental growth factor (PlGF) in maternal blood even before the clinical development of the disease."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17403407"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Preeclampsia has been proposed to be an antiangiogenic state that may be detected by the determination of the concentrations of the soluble vascular endothelial growth factor receptor-1 (sVEGFR-1) and placental growth factor (PlGF) in maternal blood even before the clinical development of the disease."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17403407"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Preeclampsia has been proposed to be an antiangiogenic state that may be detected by the determination of the concentrations of the soluble vascular endothelial growth factor receptor-1 (sVEGFR-1) and placental growth factor (PlGF) in maternal blood even before the clinical development of the disease."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17403407"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Preeclampsia has been proposed to be an antiangiogenic state that may be detected by the determination of the concentrations of the soluble vascular endothelial growth factor receptor-1 (sVEGFR-1) and placental growth factor (PlGF) in maternal blood even before the clinical development of the disease."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17403407"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Identification of patients at risk for early onset and/or severe preeclampsia with the use of uterine artery Doppler velocimetry and placental growth factor."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17403407"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "We also aimed to compare the test characteristics of podocyturia to those angiogenic factors that have been shown to play an important role in the pathogenesis of preeclampsia (s-Flt-1, PlGF, and endoglin)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17403404"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ACE"}, "span_text": {"type": "literal", "value": "Reduced plasma levels of angiotensin-(1-7) and renin activity in preeclamptic patients are associated with the angiotensin I- converting enzyme deletion/deletion genotype."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17401503"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ACE2"}, "span_text": {"type": "literal", "value": "Reduced plasma levels of angiotensin-(1-7) and renin activity in preeclamptic patients are associated with the angiotensin I- converting enzyme deletion/deletion genotype."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17401503"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Thrombin regulates soluble fms-like tyrosine kinase-1 (sFlt-1) expression in first trimester decidua: implications for preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17392178"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Soluble Flt-1 (sFlt-1; also known as soluble vascular endothelial growth factor receptor-1 [VEGFR-1]) and soluble endoglin (sEng) are elevated in preeclampsia, and their administration to pregnant rats elicits preeclampsia-like symptoms."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17389265"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Soluble Flt-1 (sFlt-1; also known as soluble vascular endothelial growth factor receptor-1 [VEGFR-1]) and soluble endoglin (sEng) are elevated in preeclampsia, and their administration to pregnant rats elicits preeclampsia-like symptoms."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17389265"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Soluble Flt-1 (sFlt-1; also known as soluble vascular endothelial growth factor receptor-1 [VEGFR-1]) and soluble endoglin (sEng) are elevated in preeclampsia, and their administration to pregnant rats elicits preeclampsia-like symptoms."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17389265"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Soluble Flt-1 (sFlt-1; also known as soluble vascular endothelial growth factor receptor-1 [VEGFR-1]) and soluble endoglin (sEng) are elevated in preeclampsia, and their administration to pregnant rats elicits preeclampsia-like symptoms."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17389265"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "The -786T/C polymorphism of the endothelial nitric oxide synthase gene in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17382454"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TCF4"}, "span_text": {"type": "literal", "value": "In the context of other findings, this review highlights: (i) the disparity in expression of pro-apoptotic transcription factor p53 in the syncytiotrophoblast in pre-eclampsia, (ii) the importance of reactive oxygen species and hypoxia in initiating villous trophoblast apoptosis and (iii) the concept that aberrant intervillous haemodynamics, as opposed to oxygen per se, initiates excessive syncytiotrophoblast shedding."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17379302"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Furthermore, soluble fms-like tyrosine kinase 1 (sFLT-1) has been shown to have a role in the maternal syndrome of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17377512"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "BO increased blood levels of CGRP and decreased levels of endothelin-1; both are known to play important roles in regulation of blood pressure in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17353120"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Low placenta growth factor and high soluble fms-like tyrosine kinase-1 increase from first to second trimester are strong predictors of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17346536"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Low placenta growth factor and high soluble fms-like tyrosine kinase-1 increase combined yielded extremely high relative risk of preterm preeclampsia (odds ratio, 35.3, 95% CI, 7.6-164.2), compared with the combination of high (placenta growth factor) and low (soluble fms-like tyrosine kinase-1) increase."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17346536"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "This study was undertaken to assess changes in placenta growth factor and soluble fms-like tyrosine kinase-1 as predictors of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17346536"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Compared with controls, women with preterm preeclampsia had lower soluble fms-like tyrosine kinase-1 in the first, but higher in second trimester."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17346536"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FGF16"}, "span_text": {"type": "literal", "value": "Umbilical vein basic fibroblast growth factor (bFGF) levels were lower in women with pre-eclampsia than in those with IUGR (P < 0.05)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17330322"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Placental growth factor (PlGF) levels in the umbilical vein were below the detection limit in nearly all samples of IUGR fetuses and lower than in those with pre-eclampsia (P < 0.001)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17330322"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Maternal soluble fms-like tyrosine kinase-1 (sFlt-1) levels were higher in women with pre-eclampsia than in those with IUGR (P < 0.0001)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17330322"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FGF13"}, "span_text": {"type": "literal", "value": "Umbilical vein basic fibroblast growth factor (bFGF) levels were lower in women with pre-eclampsia than in those with IUGR (P < 0.05)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17330322"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FGF18"}, "span_text": {"type": "literal", "value": "Umbilical vein basic fibroblast growth factor (bFGF) levels were lower in women with pre-eclampsia than in those with IUGR (P < 0.05)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17330322"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FGF5"}, "span_text": {"type": "literal", "value": "Umbilical vein basic fibroblast growth factor (bFGF) levels were lower in women with pre-eclampsia than in those with IUGR (P < 0.05)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17330322"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FGF4"}, "span_text": {"type": "literal", "value": "Umbilical vein basic fibroblast growth factor (bFGF) levels were lower in women with pre-eclampsia than in those with IUGR (P < 0.05)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17330322"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FGF7"}, "span_text": {"type": "literal", "value": "Umbilical vein basic fibroblast growth factor (bFGF) levels were lower in women with pre-eclampsia than in those with IUGR (P < 0.05)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17330322"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FGF22"}, "span_text": {"type": "literal", "value": "Umbilical vein basic fibroblast growth factor (bFGF) levels were lower in women with pre-eclampsia than in those with IUGR (P < 0.05)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17330322"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FGF14"}, "span_text": {"type": "literal", "value": "Umbilical vein basic fibroblast growth factor (bFGF) levels were lower in women with pre-eclampsia than in those with IUGR (P < 0.05)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17330322"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:RETN"}, "span_text": {"type": "literal", "value": "Resistin and ApN were measured in 30 healthy nonpregnant women, 73 pregnant women [10-41 weeks of gestation; 18 with gestational diabetes mellitus (GDM), five with pregnancy-induce hypertension (PIH), nine with pre-eclampsia (PE), eight with chronic hypertension (CH) and 33 normal] and 40 foetal samples (20-41 weeks of gestation; 18 from GDM mothers and 22 from normal mothers)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17302882"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "To evaluate the role of vascular endothelial growth factor (VEGF) in the pathogenesis of preeclampsia, we measured total VEGF, free VEGF and soluble Flt-1 (sFlt-1) concentrations and determined their relationships."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17297258"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "To evaluate the role of vascular endothelial growth factor (VEGF) in the pathogenesis of preeclampsia, we measured total VEGF, free VEGF and soluble Flt-1 (sFlt-1) concentrations and determined their relationships."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17297258"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "To evaluate the role of vascular endothelial growth factor (VEGF) in the pathogenesis of preeclampsia, we measured total VEGF, free VEGF and soluble Flt-1 (sFlt-1) concentrations and determined their relationships."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17297258"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "The levels of circulating vascular endothelial growth factor and soluble Flt-1 in pregnancies complicated by preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17297258"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "The levels of circulating vascular endothelial growth factor and soluble Flt-1 in pregnancies complicated by preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17297258"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "The levels of circulating vascular endothelial growth factor and soluble Flt-1 in pregnancies complicated by preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17297258"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:G6PD"}, "span_text": {"type": "literal", "value": "Glucose-6-phosphate dehydrogenase activity in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17286978"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LDHA"}, "span_text": {"type": "literal", "value": "Differential expression of lactate dehydrogenase isozymes (LDH) in human placenta with high expression of LDH-A(4) isozyme in the endothelial cells of pre-eclampsia villi."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17275903"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LDHB"}, "span_text": {"type": "literal", "value": "In this study, we further investigated the role of hypoxia in primary trophoblast cells and a cultured cell line, JEG3 cells, to obtain a better understanding of how it affects the activities of lactate dehydrogenase, lactate production and regulatory genes, as a possible model for preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17275903"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LDHD"}, "span_text": {"type": "literal", "value": "In this study, we further investigated the role of hypoxia in primary trophoblast cells and a cultured cell line, JEG3 cells, to obtain a better understanding of how it affects the activities of lactate dehydrogenase, lactate production and regulatory genes, as a possible model for preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17275903"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LDHA"}, "span_text": {"type": "literal", "value": "In this study, we further investigated the role of hypoxia in primary trophoblast cells and a cultured cell line, JEG3 cells, to obtain a better understanding of how it affects the activities of lactate dehydrogenase, lactate production and regulatory genes, as a possible model for preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17275903"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LDHB"}, "span_text": {"type": "literal", "value": "Differential expression of lactate dehydrogenase isozymes (LDH) in human placenta with high expression of LDH-A(4) isozyme in the endothelial cells of pre-eclampsia villi."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17275903"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LDHD"}, "span_text": {"type": "literal", "value": "Differential expression of lactate dehydrogenase isozymes (LDH) in human placenta with high expression of LDH-A(4) isozyme in the endothelial cells of pre-eclampsia villi."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17275903"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "The levels of sFlt1 and soluble endoglin in our patient's serum before delivery were 116.5 ng/mL (normal pregnancy 19.3 ng/mL and preeclampsia 66.0 ng/mL, representing mean values before delivery) and 107.4 ng/mL (normal pregnancy 18.7 ng/mL and preeclampsia 52.6 ng/mL, representing mean values before delivery), respectively."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17267891"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Angiogenic factors like placental growth factor and its antiangiogenic antagonist soluble fms-like tyrosine kinase 1 (sFlt1) are closely related to the pathogenesis of preeclampsia and intrauterine growth restriction."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17261644"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Using both factors, sFlt1 and placental growth factor, early onset preeclampsia can be predicted with 83% sensitivity and 95% specificity."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17261644"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Angiogenic factors like placental growth factor and its antiangiogenic antagonist soluble fms-like tyrosine kinase 1 (sFlt1) are closely related to the pathogenesis of preeclampsia and intrauterine growth restriction."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17261644"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Circulating levels of the antiangiogenic marker soluble FMS-like tyrosine kinase 1 are elevated in women with pregestational diabetes and preeclampsia: angiogenic markers in preeclampsia and preexisting diabetes."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17259514"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SYNPO"}, "span_text": {"type": "literal", "value": "Glomerular expression of nephrin and synaptopodin, but not podocin, is decreased in kidney sections from women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17255128"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TJP2"}, "span_text": {"type": "literal", "value": "We sought to test the hypothesis that proteinuria in preeclampsia is associated with dysregulated expression of the podocyte cytoskeleton and/or tight junction proteins."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17255128"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SYNPO2"}, "span_text": {"type": "literal", "value": "Glomerular expression of nephrin and synaptopodin, but not podocin, is decreased in kidney sections from women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17255128"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Recent studies have demonstrated that soluble vascular endothelial growth factor receptor 1 (sFlt-1) levels are elevated in preeclampsia compared with normal pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17255128"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Recent studies have demonstrated that soluble vascular endothelial growth factor receptor 1 (sFlt-1) levels are elevated in preeclampsia compared with normal pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17255128"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TJP1"}, "span_text": {"type": "literal", "value": "We sought to test the hypothesis that proteinuria in preeclampsia is associated with dysregulated expression of the podocyte cytoskeleton and/or tight junction proteins."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17255128"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Recent studies have demonstrated that soluble vascular endothelial growth factor receptor 1 (sFlt-1) levels are elevated in preeclampsia compared with normal pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17255128"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SYNPO2"}, "span_text": {"type": "literal", "value": "We conclude that down-regulation of nephrin and synaptopodin is associated with proteinuria in women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17255128"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SYNPO"}, "span_text": {"type": "literal", "value": "We conclude that down-regulation of nephrin and synaptopodin is associated with proteinuria in women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17255128"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Plasma immunoreactive endothelin-1 in pregnant women with and without pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/1725408"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:A2M"}, "span_text": {"type": "literal", "value": "To achieve this, humoral immunochemical parameters such as three classes of immunoglobulin (IgA, IgG and IgM) and three acute phase proteins (alpha 2-macroglobulin, haptoglobin and transferrin) were measured by single radial immunodifussion method in 32 pregnant women with preeclampsia, 36 pregnant women without preeclampsia and 24 non-pregnant women (controls)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17220952"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:A2M"}, "span_text": {"type": "literal", "value": "In women with preeclampsia, the levels of IgG, IgA, transferrin and alpha 2-macroglobulin were significantly reduced compared with subjects with normal pregnancy, but the level of haptoglobin was significantly raised in preeclampsia compared with women having normal pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17220952"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "Patients with prior pre-eclampsia had diabetic nephropathy more often than patients with a normotensive pregnancy (diabetic nephropathy vs normal albumin excretion rate:"}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17216281"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EPHX3"}, "span_text": {"type": "literal", "value": "To assess the association between human epoxide hydrolase exon 3 and 4 polymorphisms and pre-eclampsia by carrying out a case-control study in Turkish women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17212663"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EPHX4"}, "span_text": {"type": "literal", "value": "To assess the association between human epoxide hydrolase exon 3 and 4 polymorphisms and pre-eclampsia by carrying out a case-control study in Turkish women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17212663"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EPHX1"}, "span_text": {"type": "literal", "value": "To assess the association between human epoxide hydrolase exon 3 and 4 polymorphisms and pre-eclampsia by carrying out a case-control study in Turkish women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17212663"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EPHX2"}, "span_text": {"type": "literal", "value": "To assess the association between human epoxide hydrolase exon 3 and 4 polymorphisms and pre-eclampsia by carrying out a case-control study in Turkish women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17212663"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Insulin resistance and serum concentrations of the antiangiogenic soluble fms-like tyrosine kinase 1 (sFlt-1) are also increased in women with preeclampsia compared with normal pregnancy. sFlt-1 and insulin resistance decrease substantially after delivery; however, significant group differences persist postpartum."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17210828"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Soluble endoglin is an accurate predictor and a pathogenic molecule in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17210583"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TTR"}, "span_text": {"type": "literal", "value": "Oxidized transthyretin in amniotic fluid as an early marker of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17203960"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "After week 25 placental growth factor and sFlt-1 levels varied consistently between the normal pregnancy group and women destined to develop preeclampsia, achieving significance in women who developed severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17197602"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Third-trimester increases in sFlt-1 and decreases in placental growth factor levels are associated with preeclampsia, specifically severe disease, based on retrospective data."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17197602"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "To evaluate claims that elevated soluble fms-like tyrosine kinase-1 receptor (sFlt-1) and decreased placental growth factor predict preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17197602"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "To evaluate claims that elevated soluble fms-like tyrosine kinase-1 receptor (sFlt-1) and decreased placental growth factor predict preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17197602"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Studies identified and included were those reporting blood and urine levels of sFlt-1 or placental growth factor obtained before gestational week 30 or overt preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17197602"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EPHX2"}, "span_text": {"type": "literal", "value": "The results of two previous studies on genetic polymorphisms in glutathione S-transferases P1, M1 and T1, epoxide hydrolase (EPHX) and cytochrome P4501A1 (CYP1A1) in 167 women with a history of pre-eclampsia and in 110 controls were combined. chi(2) analyses were used for statistical evaluation of the number of polymorphisms between cases and controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17167268"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EPHX3"}, "span_text": {"type": "literal", "value": "The results of two previous studies on genetic polymorphisms in glutathione S-transferases P1, M1 and T1, epoxide hydrolase (EPHX) and cytochrome P4501A1 (CYP1A1) in 167 women with a history of pre-eclampsia and in 110 controls were combined. chi(2) analyses were used for statistical evaluation of the number of polymorphisms between cases and controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17167268"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EPHX1"}, "span_text": {"type": "literal", "value": "The results of two previous studies on genetic polymorphisms in glutathione S-transferases P1, M1 and T1, epoxide hydrolase (EPHX) and cytochrome P4501A1 (CYP1A1) in 167 women with a history of pre-eclampsia and in 110 controls were combined. chi(2) analyses were used for statistical evaluation of the number of polymorphisms between cases and controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17167268"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EPHX4"}, "span_text": {"type": "literal", "value": "The results of two previous studies on genetic polymorphisms in glutathione S-transferases P1, M1 and T1, epoxide hydrolase (EPHX) and cytochrome P4501A1 (CYP1A1) in 167 women with a history of pre-eclampsia and in 110 controls were combined. chi(2) analyses were used for statistical evaluation of the number of polymorphisms between cases and controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17167268"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Other factors associated with CP were being small or large for gestational age at birth, abruptio placentae (OR 8.6, 95% CI 5.6-13.3), maternal insulin-dependent diabetes mellitus type 1 (OR 2.1, 95% CI 1.4-3.1), preeclampsia (OR 1.5, 95% CI 1.3-2.4), being a twin (OR 1.4, 95% CI 1.1-1.6), maternal age older than 40 years (OR 1.4, 95% CI 1.1-1.8) or 35-39 years (OR 1.2, 95% CI 1.1-1.4), primiparity (OR 1.2, 95% CI 1.1-1.3), and smoking (OR 1.2, 95% CI 1.1-1.3)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17138786"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ANXA5"}, "span_text": {"type": "literal", "value": "We tested this hypothesis by analysing the effect of functional polymorphisms in the genes coding for MMP9, MMP3 and annexin A5 on the risk of preeclampsia using a case-control design."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17137622"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ANXA5"}, "span_text": {"type": "literal", "value": "In 163 women with preeclampsia and 163 controls we studied the association with polymorphisms in the MMP9 (-1562 C/T), MMP3 (-1612 5A/6A) and annexin A5 (-1 C/T) genes using logistic regression analysis."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17137622"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Specifically, preeclampsia is associated with increased insulin resistance, hypertriglyceridemia, high circulating free fatty acids, low high-density lipoprotein particles, and high maternal and fetal plasma amino acid concentrations."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17127255"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "High serum concentrations of sFlt1 and low concentrations of free vascular endothelial growth factor and free placental growth factor have been observed during and prior to clinical manifestation of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17127249"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "High serum concentrations of sFlt1 and low concentrations of free vascular endothelial growth factor and free placental growth factor have been observed during and prior to clinical manifestation of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17127249"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "High serum concentrations of sFlt1 and low concentrations of free vascular endothelial growth factor and free placental growth factor have been observed during and prior to clinical manifestation of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17127249"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Although the etiology of preeclampsia is still unclear, recent studies suggest that its major phenotypes, hypertension and proteinuria, may be due to an excess of circulating anti-angiogenic growth factors, most notably soluble fms-like tyrosine kinase 1 (sFlt1) and soluble endoglin (sEng). sFlt1 is an endogenous protein that is produced by the placenta. sFlt1 is able to bind to the angiogenic growth factors vascular endothelial growth factor and placental growth factor, thereby neutralizing their functions."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17127249"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "High serum concentrations of sFlt1 and low concentrations of free vascular endothelial growth factor and free placental growth factor have been observed during and prior to clinical manifestation of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17127249"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Although the etiology of preeclampsia is still unclear, recent studies suggest that its major phenotypes, hypertension and proteinuria, may be due to an excess of circulating anti-angiogenic growth factors, most notably soluble fms-like tyrosine kinase 1 (sFlt1) and soluble endoglin (sEng). sFlt1 is an endogenous protein that is produced by the placenta. sFlt1 is able to bind to the angiogenic growth factors vascular endothelial growth factor and placental growth factor, thereby neutralizing their functions."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17127249"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Although the etiology of preeclampsia is still unclear, recent studies suggest that its major phenotypes, hypertension and proteinuria, may be due to an excess of circulating anti-angiogenic growth factors, most notably soluble fms-like tyrosine kinase 1 (sFlt1) and soluble endoglin (sEng). sFlt1 is an endogenous protein that is produced by the placenta. sFlt1 is able to bind to the angiogenic growth factors vascular endothelial growth factor and placental growth factor, thereby neutralizing their functions."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17127249"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Although the etiology of preeclampsia is still unclear, recent studies suggest that its major phenotypes, hypertension and proteinuria, may be due to an excess of circulating anti-angiogenic growth factors, most notably soluble fms-like tyrosine kinase 1 (sFlt1) and soluble endoglin (sEng). sFlt1 is an endogenous protein that is produced by the placenta. sFlt1 is able to bind to the angiogenic growth factors vascular endothelial growth factor and placental growth factor, thereby neutralizing their functions."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17127249"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Although the etiology of preeclampsia is still unclear, recent studies suggest that its major phenotypes, hypertension and proteinuria, may be due to an excess of circulating anti-angiogenic growth factors, most notably soluble fms-like tyrosine kinase 1 (sFlt1) and soluble endoglin (sEng). sFlt1 is an endogenous protein that is produced by the placenta. sFlt1 is able to bind to the angiogenic growth factors vascular endothelial growth factor and placental growth factor, thereby neutralizing their functions."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17127249"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Although the etiology of preeclampsia is still unclear, recent studies suggest that its major phenotypes, hypertension and proteinuria, may be due to an excess of circulating anti-angiogenic growth factors, most notably soluble fms-like tyrosine kinase 1 (sFlt1) and soluble endoglin (sEng). sFlt1 is an endogenous protein that is produced by the placenta. sFlt1 is able to bind to the angiogenic growth factors vascular endothelial growth factor and placental growth factor, thereby neutralizing their functions."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17127249"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "While speculative at this point, our overall hypothesis is that an excess of antiangiogenic factors [such as the soluble receptors, soluble fms-like tyrosine kinase (sFlt-1) and soluble endoglin] interfere with nitric oxide-driven mobilization or activity of EPCs in the maternal circulation, contributing to the widespread endothelial dysfunction underlying the clinical manifestations of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17127248"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "While speculative at this point, our overall hypothesis is that an excess of antiangiogenic factors [such as the soluble receptors, soluble fms-like tyrosine kinase (sFlt-1) and soluble endoglin] interfere with nitric oxide-driven mobilization or activity of EPCs in the maternal circulation, contributing to the widespread endothelial dysfunction underlying the clinical manifestations of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17127248"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Recently, inositol phosphoglycan P-type, a putative second messenger of insulin action, has been implicated in the pathophysiology of preeclampsia and is increased in the placenta, amniotic fluid, and maternal urine of preeclamptic women compared with normal pregnant women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17116762"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Brachial arterial reactivity and factors related to endothelial dysfunction, such as circulating cholesterol, uric acid, nitrites, l-arginine, asymmetrical dimethylarginine, vascular endothelial growth factor, and soluble vascular endothelial growth factor receptor-1, in women with previous healthy pregnancies (n=22), patients with severe preeclampsia (n=25), or patients with recurrent pregnancy loss (n=29), at day 10 of the luteal phase of an ovulatory cycle an average of 11 to 27 months after pregnancy were evaluated."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17116761"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Brachial arterial reactivity and factors related to endothelial dysfunction, such as circulating cholesterol, uric acid, nitrites, l-arginine, asymmetrical dimethylarginine, vascular endothelial growth factor, and soluble vascular endothelial growth factor receptor-1, in women with previous healthy pregnancies (n=22), patients with severe preeclampsia (n=25), or patients with recurrent pregnancy loss (n=29), at day 10 of the luteal phase of an ovulatory cycle an average of 11 to 27 months after pregnancy were evaluated."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17116761"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Brachial arterial reactivity and factors related to endothelial dysfunction, such as circulating cholesterol, uric acid, nitrites, l-arginine, asymmetrical dimethylarginine, vascular endothelial growth factor, and soluble vascular endothelial growth factor receptor-1, in women with previous healthy pregnancies (n=22), patients with severe preeclampsia (n=25), or patients with recurrent pregnancy loss (n=29), at day 10 of the luteal phase of an ovulatory cycle an average of 11 to 27 months after pregnancy were evaluated."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17116761"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MPO"}, "span_text": {"type": "literal", "value": "This study aimed to investigate the activity of myeloperoxidase (MPO), and its association with advanced oxidation protein products (AOPP), in women with pre-eclampsia and eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17116052"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MPO"}, "span_text": {"type": "literal", "value": "Serum advanced oxidation protein products, myeloperoxidase and ascorbic acid in pre-eclampsia and eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17116052"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "There are controversies in reports on the association of polymorphisms in endothelial nitric oxide synthase, angiotensinogen, angiotensin receptor type 1 and angiotensin-converting enzyme genes with an increased risk of developing preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17112651"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGT"}, "span_text": {"type": "literal", "value": "There are controversies in reports on the association of polymorphisms in endothelial nitric oxide synthase, angiotensinogen, angiotensin receptor type 1 and angiotensin-converting enzyme genes with an increased risk of developing preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17112651"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:DCN"}, "span_text": {"type": "literal", "value": "The content of decorin, biglycan and versican in the umbilical cord vein wall is elevated in pre-eclampsia in comparison to the corresponding control vessel."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17097211"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VCAN"}, "span_text": {"type": "literal", "value": "The content of decorin, biglycan and versican in the umbilical cord vein wall is elevated in pre-eclampsia in comparison to the corresponding control vessel."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17097211"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CTSB"}, "span_text": {"type": "literal", "value": "Alterations of serum cathepsins B and L in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17094954"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Heparin-mediated extracorporeal low density lipoprotein precipitation as a possible therapeutic approach in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17081803"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Variants of the leptin receptor gene (LEPR) may modulate the effect of elevated serum leptin levels in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17071538"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEPR"}, "span_text": {"type": "literal", "value": "Variants of the leptin receptor gene (LEPR) may modulate the effect of elevated serum leptin levels in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17071538"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TFPI"}, "span_text": {"type": "literal", "value": "To clarify the role played by tissue factor pathway inhibitor (TFPI) in pregnancy hypertension."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17070527"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TFPI"}, "span_text": {"type": "literal", "value": "Total and free tissue factor pathway inhibitor in pregnancy hypertension."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17070527"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TFPI2"}, "span_text": {"type": "literal", "value": "Total and free tissue factor pathway inhibitor in pregnancy hypertension."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17070527"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TFPI2"}, "span_text": {"type": "literal", "value": "To clarify the role played by tissue factor pathway inhibitor (TFPI) in pregnancy hypertension."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17070527"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Maternal plasma homocysteine, low-density lipoprotein, and triglyceride were significantly higher, while high-density lipoprotein was significantly lower in pregnancies with pre-eclampsia as compared with the uncomplicated pregnancy group (p<0.001 for all)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17068675"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Fetuses exposed to pre-eclampsia in utero had lower birth weight, smaller abdominal circumference (p<0.002; p<0.03 respectively) and higher levels of low-density lipoprotein, homocysteine, and fibrinogen (p<0.01; p<0.001; p<0.001, respectively), compared with fetuses of normotensive, pregnancies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17068675"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "We evaluated the prognostic value of serum endostatin and vascular endothelial growth factor (VEGF) for diagnosis of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17037236"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Serum endostatin and vascular endothelial growth factor levels in patients with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17037236"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Serum endostatin and vascular endothelial growth factor levels in patients with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17037236"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "We evaluated the prognostic value of serum endostatin and vascular endothelial growth factor (VEGF) for diagnosis of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17037236"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Serum endostatin and vascular endothelial growth factor levels in patients with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17037236"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "We evaluated the prognostic value of serum endostatin and vascular endothelial growth factor (VEGF) for diagnosis of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17037236"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Adiponectin and insulin resistance in early- and late-onset pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17010118"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "To evaluate the importance of adiponectin and insulin resistance in early- and late-onset pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/17010118"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GH2"}, "span_text": {"type": "literal", "value": "Increased human placental growth hormone at midtrimester pregnancies may be an index of intrauterine growth retardation related to preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16996762"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GH1"}, "span_text": {"type": "literal", "value": "Increased human placental growth hormone at midtrimester pregnancies may be an index of intrauterine growth retardation related to preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16996762"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Cord blood lipoprotein profile after magnesium sulphate treatment in pre-eclamptic patients."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16982494"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "To determine lipoprotein metabolism alterations in magnesium-exposed neonates of women with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16982494"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GNLY"}, "span_text": {"type": "literal", "value": "Granulysin were elevated in preeclampsia cases compared with controls (3.01+/-0.18 vs. 2.22+/-0.14 ng/mL, p<0.01)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16973142"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GNLY"}, "span_text": {"type": "literal", "value": "After adjusting for age, body-mass-index and race, women with higher granulysin concentrations (> or =1.89 ng/mL) experienced a 2.9-fold (95%CI 1.1-7.8) increased preeclampsia risk compared with women with lower granulysin (<1.89 ng/mL)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16973142"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GNLY"}, "span_text": {"type": "literal", "value": "Plasma granulysin concentrations and preeclampsia risk."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16973142"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VWF"}, "span_text": {"type": "literal", "value": "Acute activation of the endothelium results in increased levels of active von Willebrand factor in hemolysis, elevated liver enzymes and low platelets (HELLP) syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16968329"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MTHFR"}, "span_text": {"type": "literal", "value": "When we analyzed the polymorphisms independently and the development of preeclampsia, no association was observed [methylenetetrahydrofolate reductase (MTHFR) 677TT genotype, OR 2.07, 95% confidence interval (CI) 0.99-4.30; prothrombin mutation (F II) (GA or AA genotypes) OR 8.11, 95% CI 0.89-73.92; factor V Leiden (FV Leiden) OR 3.94, 95% CI 0.35-44.23; plasminogen activator inhibitor (PAI-1) 4G/4G genotype, OR 1.63, 95% CI 0.87-3.05] not even with severe preeclampsia subgroup analysis."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16963292"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Beginning at 17 weeks through 20 weeks of gestation, soluble endoglin levels were significantly higher in women in whom preterm preeclampsia later developed than in controls (10.2 ng per milliliter vs. 5.8 ng per milliliter, P<0.001), and at 25 through 28 weeks of gestation, the levels were significantly higher in women in whom term preeclampsia developed than in controls (8.5 ng per milliliter vs. 5.9 ng per milliliter, P<0.001)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16957146"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Rising circulating levels of soluble endoglin and ratios of sFlt1:PlGF herald the onset of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16957146"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Since soluble endoglin, another antiangiogenic protein, acts together with sFlt1 to induce a severe preeclampsia-like syndrome in pregnant rats, we examined whether it is associated with preeclampsia in women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16957146"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Alterations in circulating soluble fms-like tyrosine kinase 1 (sFlt1), an antiangiogenic protein, and placental growth factor (PlGF), a proangiogenic protein, appear to be involved in the pathogenesis of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16957146"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Circulating soluble endoglin levels increased markedly beginning 2 to 3 months before the onset of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16957146"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Soluble endoglin and other circulating antiangiogenic factors in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16957146"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Alterations in circulating soluble fms-like tyrosine kinase 1 (sFlt1), an antiangiogenic protein, and placental growth factor (PlGF), a proangiogenic protein, appear to be involved in the pathogenesis of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16957146"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "The preeclampsia group was younger and had higher values for blood pressure, insulin resistance, common femoral artery intima-media thickness, and skin autofluorescence of the leg."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16949402"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PON1"}, "span_text": {"type": "literal", "value": "Human paraoxonase-1 (PON-1) is thought to play a role in preeclampsia and atherosclerosis, mainly through a reduction in low-density lipoprotein oxidation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16949193"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Human paraoxonase-1 (PON-1) is thought to play a role in preeclampsia and atherosclerosis, mainly through a reduction in low-density lipoprotein oxidation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16949193"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Paraoxonase gene polymorphism, serum lipid, and oxidized low-density lipoprotein in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16949193"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "The levels of serum cholesterol and high-density lipoprotein were significantly lower in preeclampsia patients compared with that of the control women (p=0.05, and p<0.01, respectively)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16949193"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Oxidized low-density lipoprotein (LDL) is very important in endothelial dysfunction of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16949193"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "Expression of kallikrein, bradykinin b2 receptor, and endothelial nitric oxide synthase in placenta in normal gestation, preeclampsia, and placenta accreta."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16943589"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL15"}, "span_text": {"type": "literal", "value": "Elevated serum levels of interleukin-15 and interleukin-16 in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16938352"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEPR"}, "span_text": {"type": "literal", "value": "To delineate the changes in serum levels of adiponectin, leptin and soluble leptin receptor, and in the free leptin index in women with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16919629"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "To delineate the changes in serum levels of adiponectin, leptin and soluble leptin receptor, and in the free leptin index in women with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16919629"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Serum adiponectin, leptin and soluble leptin receptor in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16919629"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEPR"}, "span_text": {"type": "literal", "value": "Serum adiponectin, leptin and soluble leptin receptor in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16919629"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Women with pre-eclampsia had significantly higher levels of serum adiponectin and leptin, and a higher free leptin index than controls (P<0.01, P<0.001 and P<0.001, respectively)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16919629"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "The study demonstrated elevated serum levels of adiponectin and leptin as well as a higher free leptin index in women with pre-eclampsia, suggesting these as important factors contributing to this complication of pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16919629"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:UCN"}, "span_text": {"type": "literal", "value": "Maternal and fetal urocortin levels were significantly (both P < 0.001) higher in gestational hypertension, pre-eclampsia and PE/IUGR women than in controls, and correlated with Doppler velocimetry patterns."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16915033"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:UCN"}, "span_text": {"type": "literal", "value": "Maternal and fetal urocortin levels are increased in hypertensive disorders of pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16915033"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:UCN"}, "span_text": {"type": "literal", "value": "We evaluated maternal and fetal plasma levels and placental mRNA expression of urocortin, a placental vasoactive neuropeptide, in singleton pregnancies (n = 70) complicated by hypertensive disorders classified as gestational hypertension (n = 36), pre-eclampsia (n = 19), and pre-eclampsia complicated by intrauterine growth restriction (PE/IUGR, n = 15), and in 70 healthy normotensive singleton pregnancies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16915033"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "Endothelial nitric oxide synthase gene influences the risk of pre-eclampsia, the recurrence of negative pregnancy events, and the maternal-fetal flow."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16915032"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Placental leptin expression, placental protein and maternal plasma concentration were higher in pre-eclampsia than in controls but not in women with growth-restricted infants."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16870954"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "The objective of this study was to investigate the relationship between placental leptin gene expression, placental leptin protein concentration and maternal plasma leptin concentration among control pregnant women, women with pre-eclampsia and women with growth-restricted infants."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16870954"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "This study suggests that despite similar failed placental bed vascular remodelling in pre-eclampsia and intrauterine growth restriction (IUGR), leptin gene expression is higher only in preterm pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16870954"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Relationships between maternal plasma leptin, placental leptin mRNA and protein in normal pregnancy, pre-eclampsia and intrauterine growth restriction without pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16870954"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Soluble endoglin (sEng) joins the soluble fms-like tyrosine kinase (sFlt) receptor as a pre-eclampsia molecule."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16870672"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Soluble endoglin (sEng) joins the soluble fms-like tyrosine kinase (sFlt) receptor as a pre-eclampsia molecule."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16870672"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MTHFR"}, "span_text": {"type": "literal", "value": "The aim of our study was to examine genetic variability in the gene encoding methylenetetrahydrofolate reductase (MTHFR) and individual susceptibility to the placental abruption or preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16867914"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "The up-regulated genes included leptin and inhibin A, which are well-known biological markers for pre-eclampsia, as well as FLT1, which was recently proved to be tightly linked with the etiology of this disease."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16860862"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "Women with pre-eclampsia scheduled for quantitative albumin measurement with a 24-hour urine collection."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16827832"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "1) To assess the correlation between urine albumin/creatinine ratio (ACR) and 24-hour urine albumin excretion in women with pre-eclampsia, 2) to study the influence of potential confounders on this correlation and 3) to assess the variability of ACR between voids during a 24-hour period."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16827832"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Increased insulin levels observed in mild preeclamptic patients were independent of overweight-related hyperinsulinemia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16824935"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "However, insulin levels at 60, 120 and 180 min were significantly higher (p = 0.009, p = 0.009, p = 0.046, respectively) in overweight patients with preeclampsia than in those without."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16824935"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "In contrast, the AUC of insulin was significantly higher in preeclamptic patients in both overweight (p = 0.004) and non-overweight (p = 0.024) groups than in overweight and non-overweight groups without preeclampsia, respectively."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16824935"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Insulin levels at 60 and 180 min were also higher (p = 0.024, p = 0.023, respectively) in non-overweight patients with preeclampsia than in those without."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16824935"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Increased insulin levels independent of gestational overweight in women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16824935"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PDE5A"}, "span_text": {"type": "literal", "value": "Phosphodiesterase-5 inhibitors and omental and placental small artery function in normal pregnancy and pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16815471"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Evaluation of placenta growth factor and soluble Fms-like tyrosine kinase 1 receptor levels in mild and severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16813756"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "The purpose of this study was to determine if maternal serum concentrations of placenta growth factor (PlGF) and soluble Fms-like tyrosine kinase 1 receptor (s-Flt1) are more abnormal in patients with severe preeclampsia compared with mild preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16813756"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADIPOR2"}, "span_text": {"type": "literal", "value": "Therefore, we investigated relative mRNA expression of selected adipocytokine genes (leptin, leptin receptors (LEPRA, LEPRB, LEPRC, LEPRD) and adiponectin receptors (ADIPOR1, ADIPOR2)) in placental tissues from women with pre-eclampsia (n = 6) or CHBP (n = 8)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16785148"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Therefore, we investigated relative mRNA expression of selected adipocytokine genes (leptin, leptin receptors (LEPRA, LEPRB, LEPRC, LEPRD) and adiponectin receptors (ADIPOR1, ADIPOR2)) in placental tissues from women with pre-eclampsia (n = 6) or CHBP (n = 8)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16785148"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEPR"}, "span_text": {"type": "literal", "value": "Therefore, we investigated relative mRNA expression of selected adipocytokine genes (leptin, leptin receptors (LEPRA, LEPRB, LEPRC, LEPRD) and adiponectin receptors (ADIPOR1, ADIPOR2)) in placental tissues from women with pre-eclampsia (n = 6) or CHBP (n = 8)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16785148"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Compared with controls, significant increases in leptin mRNA expression were seen in placentas from pre-eclamptic patients on the maternal (p = 0.01) and fetal (p = 0.02) sides, and in placentas from CHBP mothers on the fetal side (p = 0.001)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16785148"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEPR"}, "span_text": {"type": "literal", "value": "Leptin and leptin receptor gene expression has been studied in placentas obtained from pre-eclamptic patients, but not in those with chronic high blood pressure (CHBP)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16785148"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADIPOR1"}, "span_text": {"type": "literal", "value": "Therefore, we investigated relative mRNA expression of selected adipocytokine genes (leptin, leptin receptors (LEPRA, LEPRB, LEPRC, LEPRD) and adiponectin receptors (ADIPOR1, ADIPOR2)) in placental tissues from women with pre-eclampsia (n = 6) or CHBP (n = 8)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16785148"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Leptin and leptin receptor gene expression has been studied in placentas obtained from pre-eclamptic patients, but not in those with chronic high blood pressure (CHBP)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16785148"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "We measured serum concentrations of adiponectin and angiogenic factors, vascular endothelial growth factor, placental growth factor, and the soluble vascular endothelial growth factor receptors, soluble fms-like tyrosine Kinase 1 (sFlt-1) and soluble fetal liver kinase 1 (sFlk-1), in women with pre-eclampsia and healthy pregnant women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16769024"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "We measured serum concentrations of adiponectin and angiogenic factors, vascular endothelial growth factor, placental growth factor, and the soluble vascular endothelial growth factor receptors, soluble fms-like tyrosine Kinase 1 (sFlt-1) and soluble fetal liver kinase 1 (sFlk-1), in women with pre-eclampsia and healthy pregnant women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16769024"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Significant correlations were found among the circulating adiponectin and angiogenic factors placental growth factor (R = 0.772, P = .0012) and sFlt-1 (R = 0.787, P = .0005); while, no correlation was found between adiponectin and sFlk-1 (R = 0.3, P = .3434) in patients with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16769024"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "We measured serum concentrations of adiponectin and angiogenic factors, vascular endothelial growth factor, placental growth factor, and the soluble vascular endothelial growth factor receptors, soluble fms-like tyrosine Kinase 1 (sFlt-1) and soluble fetal liver kinase 1 (sFlk-1), in women with pre-eclampsia and healthy pregnant women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16769024"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "We measured serum concentrations of adiponectin and angiogenic factors, vascular endothelial growth factor, placental growth factor, and the soluble vascular endothelial growth factor receptors, soluble fms-like tyrosine Kinase 1 (sFlt-1) and soluble fetal liver kinase 1 (sFlk-1), in women with pre-eclampsia and healthy pregnant women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16769024"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Overweight women with pre-eclampsia appeared to have lower levels of adiponectin and sFlt1 and higher levels of placental growth factor than women with pre-eclampsia who were of normal weight."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16769024"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Vascular endothelial growth factor expression is unaltered in placentae and myometrial resistance arteries from pre-eclamptic patients."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16752232"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "To clearly understand the role of vascular endothelial growth factor in pre-eclampsia, further studies are required to determine the sites of increased vascular endothelial growth factor synthesis."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16752232"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "This study suggests that the placenta and perivascular smooth muscle are not the origin of the increased total vascular endothelial growth factor in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16752232"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "With placentae tissue samples and small pieces of myometrium from the controls (n=10) and pre-eclampsia patients (n=7), vascular endothelial growth factor immunohistochemistry and mRNA in situ hybridization were performed."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16752232"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "The purpose of this study is to determine whether there is any difference for vascular endothelial growth factor expression in placentae and myometrial resistance arteries from control and pre-eclamptic patients to clarify the source of the increased total vascular endothelial growth factor in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16752232"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "The purpose of this study is to determine whether there is any difference for vascular endothelial growth factor expression in placentae and myometrial resistance arteries from control and pre-eclamptic patients to clarify the source of the increased total vascular endothelial growth factor in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16752232"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "With placentae tissue samples and small pieces of myometrium from the controls (n=10) and pre-eclampsia patients (n=7), vascular endothelial growth factor immunohistochemistry and mRNA in situ hybridization were performed."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16752232"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "This study suggests that the placenta and perivascular smooth muscle are not the origin of the increased total vascular endothelial growth factor in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16752232"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "With placentae tissue samples and small pieces of myometrium from the controls (n=10) and pre-eclampsia patients (n=7), vascular endothelial growth factor immunohistochemistry and mRNA in situ hybridization were performed."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16752232"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "The purpose of this study is to determine whether there is any difference for vascular endothelial growth factor expression in placentae and myometrial resistance arteries from control and pre-eclamptic patients to clarify the source of the increased total vascular endothelial growth factor in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16752232"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Vascular endothelial growth factor expression is unaltered in placentae and myometrial resistance arteries from pre-eclamptic patients."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16752232"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "To clearly understand the role of vascular endothelial growth factor in pre-eclampsia, further studies are required to determine the sites of increased vascular endothelial growth factor synthesis."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16752232"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "To clearly understand the role of vascular endothelial growth factor in pre-eclampsia, further studies are required to determine the sites of increased vascular endothelial growth factor synthesis."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16752232"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Vascular endothelial growth factor expression is unaltered in placentae and myometrial resistance arteries from pre-eclamptic patients."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16752232"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "However, there were no differences in vascular endothelial growth factor expression between the groups in the presence of elevated serum levels of total vascular endothelial growth factor in pre-eclamptic patients (median 18.2 ng/ml versus 4.9 ng/ml)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16752232"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "However, there were no differences in vascular endothelial growth factor expression between the groups in the presence of elevated serum levels of total vascular endothelial growth factor in pre-eclamptic patients (median 18.2 ng/ml versus 4.9 ng/ml)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16752232"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "This study suggests that the placenta and perivascular smooth muscle are not the origin of the increased total vascular endothelial growth factor in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16752232"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "However, there were no differences in vascular endothelial growth factor expression between the groups in the presence of elevated serum levels of total vascular endothelial growth factor in pre-eclamptic patients (median 18.2 ng/ml versus 4.9 ng/ml)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16752232"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ENG"}, "span_text": {"type": "literal", "value": "Soluble endoglin contributes to the pathogenesis of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16751767"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Analysis of placental growth factor in placentas of normal pregnant women and women with hypertensive disorders of pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16711023"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "To investigate the expressions of placental growth factor (PLGF) in placenta with hypertensive disorders of pregnancy (HDP), 45 women with HDP and 20 normally pregnant women were studied."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16711023"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PRCP"}, "span_text": {"type": "literal", "value": "There is no published study on prolylcarboxypeptidase gene and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16681991"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGT"}, "span_text": {"type": "literal", "value": "The roles of renin-angiotensin system gene polymorphisms including angiotensinogen, angiotensin-converting enzyme, renin and angiotensin II receptor, type 1 genes in the pathogenesis of preeclampsia have been extensively studied, but most association studies produced either negative or inconsistent results."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16681991"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PRCP"}, "span_text": {"type": "literal", "value": "Gene expression assays lent further support for the functional significance of prolylcarboxypeptidase in the etiology of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16681991"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PRCP"}, "span_text": {"type": "literal", "value": "Our data showed that prolylcarboxypeptidase D allele coupled with chronic hypertension was associated with a significantly increased risk of preeclampsia in both black and non-black women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16681991"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PRCP"}, "span_text": {"type": "literal", "value": "Prolylcarboxypeptidase gene, chronic hypertension, and risk of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16681991"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PRCP"}, "span_text": {"type": "literal", "value": "We investigated the independent and joint association of five polymorphisms in angiotensinogen, angiotensin-converting enzyme, and prolylcarboxypeptidase gene and chronic hypertension with the risk of preeclampsia in 125 preeclamptic and 1040 non-preeclamptic black women enrolled at the Boston Medical Center."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16681991"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGTR1"}, "span_text": {"type": "literal", "value": "The roles of renin-angiotensin system gene polymorphisms including angiotensinogen, angiotensin-converting enzyme, renin and angiotensin II receptor, type 1 genes in the pathogenesis of preeclampsia have been extensively studied, but most association studies produced either negative or inconsistent results."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16681991"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PRCP"}, "span_text": {"type": "literal", "value": "Prolylcarboxypeptidase E112D (rs2298668) D allele along and jointly with chronic hypertension were associated with a significantly increased risk of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16681991"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGT"}, "span_text": {"type": "literal", "value": "We investigated the independent and joint association of five polymorphisms in angiotensinogen, angiotensin-converting enzyme, and prolylcarboxypeptidase gene and chronic hypertension with the risk of preeclampsia in 125 preeclamptic and 1040 non-preeclamptic black women enrolled at the Boston Medical Center."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16681991"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CADM1"}, "span_text": {"type": "literal", "value": "We stimulated those cells for 1.5-6.0 hours with sera from patients with preeclampsia and then determined the expression of intercellular cell adhesion molecules (ICAM)-1 and vascular cell adhesion molecules (VCAM)-1 on endothelial cells by flow cytometry."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16674015"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CADM3"}, "span_text": {"type": "literal", "value": "We stimulated those cells for 1.5-6.0 hours with sera from patients with preeclampsia and then determined the expression of intercellular cell adhesion molecules (ICAM)-1 and vascular cell adhesion molecules (VCAM)-1 on endothelial cells by flow cytometry."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16674015"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VCAM1"}, "span_text": {"type": "literal", "value": "We stimulated those cells for 1.5-6.0 hours with sera from patients with preeclampsia and then determined the expression of intercellular cell adhesion molecules (ICAM)-1 and vascular cell adhesion molecules (VCAM)-1 on endothelial cells by flow cytometry."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16674015"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Most of them were related to an imbalance of reactive oxygen metabolites in placenta, abnormal trophoblast invasion, disorders of lipoprotein metabolism and signal transduction, or some that have been reported to have close correlation to the pathology of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16651850"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "This study was undertaken to determine whether maternal serum concentration of the angiogenic factor vascular endothelial growth factor (VEGF) and its circulating antagonist, soluble fms-like tyrosine kinase 1 (sFlt-1), which have been implicated in the pathogenesis of preeclampsia (PE), are altered in pregnancies that subsequently develop PE and in those with established fetal growth restriction (FGR)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16643817"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "This study was undertaken to determine whether maternal serum concentration of the angiogenic factor vascular endothelial growth factor (VEGF) and its circulating antagonist, soluble fms-like tyrosine kinase 1 (sFlt-1), which have been implicated in the pathogenesis of preeclampsia (PE), are altered in pregnancies that subsequently develop PE and in those with established fetal growth restriction (FGR)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16643817"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "This study was undertaken to determine whether maternal serum concentration of the angiogenic factor vascular endothelial growth factor (VEGF) and its circulating antagonist, soluble fms-like tyrosine kinase 1 (sFlt-1), which have been implicated in the pathogenesis of preeclampsia (PE), are altered in pregnancies that subsequently develop PE and in those with established fetal growth restriction (FGR)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16643817"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "This study was undertaken to determine whether maternal serum concentration of the angiogenic factor vascular endothelial growth factor (VEGF) and its circulating antagonist, soluble fms-like tyrosine kinase 1 (sFlt-1), which have been implicated in the pathogenesis of preeclampsia (PE), are altered in pregnancies that subsequently develop PE and in those with established fetal growth restriction (FGR)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16643817"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Elevated expression of soluble vascular endothelial growth factor receptor-1 (sFlt-1) in preeclampsia plays a major role in the pathogenesis of this serious disorder of human pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16627691"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Elevated expression of soluble vascular endothelial growth factor receptor-1 (sFlt-1) in preeclampsia plays a major role in the pathogenesis of this serious disorder of human pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16627691"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Elevated expression of soluble vascular endothelial growth factor receptor-1 (sFlt-1) in preeclampsia plays a major role in the pathogenesis of this serious disorder of human pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16627691"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Vascular endothelial growth factor, its receptors, and the tie receptors in the placental bed of women with preeclampsia, diabetes, and intrauterine growth retardation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16625496"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Vascular endothelial growth factor, its receptors, and the tie receptors in the placental bed of women with preeclampsia, diabetes, and intrauterine growth retardation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16625496"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Vascular endothelial growth factor, its receptors, and the tie receptors in the placental bed of women with preeclampsia, diabetes, and intrauterine growth retardation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16625496"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:F12"}, "span_text": {"type": "literal", "value": "Study of association between hypertensive disorders of pregnancy and the human coagulation factor XI gene."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16613788"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:F11"}, "span_text": {"type": "literal", "value": "Study of association between hypertensive disorders of pregnancy and the human coagulation factor XI gene."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16613788"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CRH"}, "span_text": {"type": "literal", "value": "Minimal alteration in the ratio of circulatory fetal DNA to fetal corticotropin-releasing hormone mRNA level in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16601331"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PLAC1"}, "span_text": {"type": "literal", "value": "Increased plasma mRNAs of placenta-specific 1 (PLAC1) and glial cells-missing 1 (GCM1) in mothers with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16594548"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CD40LG"}, "span_text": {"type": "literal", "value": "Serum-soluble CD40 ligand in normal pregnancy and in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16582129"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CD40LG"}, "span_text": {"type": "literal", "value": "The higher levels of soluble CD40 ligand detected in women with preeclampsia may indicate an exaggerated activation of platelets and endothelial cells."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16582129"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CD40LG"}, "span_text": {"type": "literal", "value": "Significantly higher levels of soluble CD40 ligand were detected in the nonpregnant women (23,767 +/- 15,637 pg/mL) and in the women with preeclampsia (21,025 +/- 45,386 pg/mL) than in the normotensive pregnant women (8,292 +/- 5,926 pg/mL) (P = .026)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16582129"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CD40LG"}, "span_text": {"type": "literal", "value": "Findings that estradiol (E2) has an inhibitory effect on inflammation and platelet function and that serum E2 levels are low in women with preeclampsia prompted us to investigate the association between soluble CD40 ligand and serum E2 levels in normal pregnancy and in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16582129"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Despite a significant increase in postpartum serum arginine levels due to treatment, no differences were found in the corresponding levels of nitric oxide, endothelin-1, cyclic guanosine 3'5' monophosphate, or asymmetric-dimethyl-arginine between the two groups with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16582128"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Compared with the gravid control group, women with preeclampsia exhibited significantly increased serum levels of endothelin-1, cyclic guanosine 3'5' monophosphate, and asymmetric-dimethyl-arginine before delivery."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16582128"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TFPI"}, "span_text": {"type": "literal", "value": "There have been controversies whether maternal serum placental protein 5 (PP5)/tissue factor pathway inhibitor (TFPI)-2 is increased in the patients with preeclampsia and/or intrauterine growth restriction (IUGR)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16580726"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TFPI2"}, "span_text": {"type": "literal", "value": "There have been controversies whether maternal serum placental protein 5 (PP5)/tissue factor pathway inhibitor (TFPI)-2 is increased in the patients with preeclampsia and/or intrauterine growth restriction (IUGR)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16580726"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPC3"}, "span_text": {"type": "literal", "value": "Paradoxical discrepancy between the serum level and the placental intensity of PP5/TFPI-2 in preeclampsia and/or intrauterine growth restriction: possible interaction and correlation with glypican-3 hold the key."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16580726"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "The purpose of this study was to determine whether serum fms-like tyrosine kinase 1 (sFlt1) concentration during preeclampsia were associated with mid trimester blood pressure, other maternal characteristics, or pregnancy outcomes."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16580293"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Placental and circulatory soluble fms-like tyrosine kinase 1 (sFlt1) has proven to be elevated in pregnant women with preeclampsia, a disease characterized by hypertension, proteinuria, and endothelial dysfunction."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16569734"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Relation between circulating angiotensin II type 1 receptor agonistic autoantibodies and soluble fms-like tyrosine kinase 1 in the pathogenesis of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16569734"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CALM2"}, "span_text": {"type": "literal", "value": "In conclusion downregulation of RELA and calmodulin 2 might represent an attempt by the placenta to compensate for elevations in intracellular calcium, possibly caused by hypoxia and/or apoptosis, in both pregnancies with uterine artery notching and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16556680"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "The terms preeclampsia, eclampsia, pregnancy-induced hypertension or toxemia were combined with dyslipidemia, hyperlipidemia, hypertriglyceridemia, lipids, cholesterol, triglycerides (TG) or lipoprotein."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16553649"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "In late-onset preeclampsia, those patients with abnormal uterine artery Doppler indices had higher soluble fms-like tyrosine kinase-1 and vascular cell adhesion molecule-1 levels."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16545329"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "In early-onset preeclampsia and intrauterine growth restriction, placental growth factor was lower and soluble fms-like tyrosine kinase-1 and vascular cell adhesion molecule-1 higher than in control subjects, although all changes were more pronounced in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16545329"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "In early-onset preeclampsia and intrauterine growth restriction, placental growth factor was lower and soluble fms-like tyrosine kinase-1 and vascular cell adhesion molecule-1 higher than in control subjects, although all changes were more pronounced in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16545329"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VCAM1"}, "span_text": {"type": "literal", "value": "In late-onset preeclampsia, those patients with abnormal uterine artery Doppler indices had higher soluble fms-like tyrosine kinase-1 and vascular cell adhesion molecule-1 levels."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16545329"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VCAM1"}, "span_text": {"type": "literal", "value": "In early-onset preeclampsia and intrauterine growth restriction, placental growth factor was lower and soluble fms-like tyrosine kinase-1 and vascular cell adhesion molecule-1 higher than in control subjects, although all changes were more pronounced in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16545329"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "To analyze whether leptin levels of the amniotic fluid elevate during early pregnancy in women destined to develop preeclampsia and to evaluate the relationship between amniotic fluid leptin levels and gestational age, maternal body mass index, and fetal sex."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16532910"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Elevated amniotic fluid leptin levels in pregnant women who are destined to develop preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16532910"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Median leptin concentrations were significantly higher (p < 0.001) in the women with preeclampsia (7.3+/-0.7 ng/ml) than in the normotensive pregnant women (4.1 +/- 0.3 ng/ml), independent of fetal sex."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16532910"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Several lines of evidence support the hypothesis that vascular endothelial growth factor (VEGF) plays an important role in the pathogenesis of pre-eclampsia (PE)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16517614"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Genetic polymorphisms of vascular endothelial growth factor in severe pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16517614"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Several lines of evidence support the hypothesis that vascular endothelial growth factor (VEGF) plays an important role in the pathogenesis of pre-eclampsia (PE)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16517614"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Genetic polymorphisms of vascular endothelial growth factor in severe pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16517614"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Several lines of evidence support the hypothesis that vascular endothelial growth factor (VEGF) plays an important role in the pathogenesis of pre-eclampsia (PE)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16517614"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Genetic polymorphisms of vascular endothelial growth factor in severe pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16517614"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADM2"}, "span_text": {"type": "literal", "value": "Increased adrenomedullin protein content and mRNA expression in human fetal membranes but not placental tissue in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16517613"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADM2"}, "span_text": {"type": "literal", "value": "The relationship between Pre-eclampsia (PE) and placental production of Adrenomedullin (AdM) is not completely understood."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16517613"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADM"}, "span_text": {"type": "literal", "value": "Increased adrenomedullin protein content and mRNA expression in human fetal membranes but not placental tissue in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16517613"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADM"}, "span_text": {"type": "literal", "value": "The relationship between Pre-eclampsia (PE) and placental production of Adrenomedullin (AdM) is not completely understood."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16517613"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Recent evidence suggests that disturbances in angiogenic factors (such as vascular endothelial growth factor and placental growth factor) signaling and endothelial health may play a major role in the pathogenesis of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16511996"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Recent evidence suggests that disturbances in angiogenic factors (such as vascular endothelial growth factor and placental growth factor) signaling and endothelial health may play a major role in the pathogenesis of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16511996"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Recent evidence suggests that disturbances in angiogenic factors (such as vascular endothelial growth factor and placental growth factor) signaling and endothelial health may play a major role in the pathogenesis of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16511996"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Recent evidence suggests that disturbances in angiogenic factors (such as vascular endothelial growth factor and placental growth factor) signaling and endothelial health may play a major role in the pathogenesis of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16511996"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CLDN1"}, "span_text": {"type": "literal", "value": "During preeclampsia, the amounts of occludin and ZO-1 exhibit no significant variation, whereas those of claudins 1, 3, and 5 diminish, suggesting the presence of leakier TJs in the endothelia of the preeclamptic placenta, possibly in response to the decreased perfusion of this organ during preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16508790"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:OCLN"}, "span_text": {"type": "literal", "value": "During preeclampsia, the amounts of occludin and ZO-1 exhibit no significant variation, whereas those of claudins 1, 3, and 5 diminish, suggesting the presence of leakier TJs in the endothelia of the preeclamptic placenta, possibly in response to the decreased perfusion of this organ during preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16508790"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TJP1"}, "span_text": {"type": "literal", "value": "Endothelia of term human placentae display diminished expression of tight junction proteins during preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16508790"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TJP2"}, "span_text": {"type": "literal", "value": "Endothelia of term human placentae display diminished expression of tight junction proteins during preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16508790"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:DDAH1"}, "span_text": {"type": "literal", "value": "Placental dysfunction of the asymmetric dimethylarginine (ADMA) degrading enzyme dimethylarginine dimethylaminohydrolase (DDAH) has been suggested as one of the initiating events in the development of preeclampsia (PE)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16508323"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:DDAH1"}, "span_text": {"type": "literal", "value": "No compensatory upregulation of placental dimethylarginine dimethylaminohydrolase activity in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16508323"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VCAM1"}, "span_text": {"type": "literal", "value": "We examined the relationship of maternal plasma concentrations of soluble vascular cell adhesion molecule-1 (sVCAM-1), a specific marker of endothelial dysfunction, and risk of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16500507"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VCAM1"}, "span_text": {"type": "literal", "value": "Elevated soluble vascular cell adhesion molecule-1, elevated Homocyst(e)inemia, and hypertriglyceridemia in relation to preeclampsia risk."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16500507"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Compared with women with normal pregnancies, placental growth factor concentrations were lower, and soluble fms-like tyrosine kinase 1 concentrations were higher in women with preeclampsia and gestational proteinuria; soluble fms-like tyrosine kinase 1 concentrations were also higher in women with preeclampsia superimposed on chronic glomerulonephritis."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16458660"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "There were obvious differences in the levels of circulating angiogenic factors placental growth factor and soluble fms-like tyrosine kinase 1 among preeclampsia, gestational proteinuria, and controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16458660"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "There were obvious differences in the levels of circulating angiogenic factors placental growth factor and soluble fms-like tyrosine kinase 1 among preeclampsia, gestational proteinuria, and controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16458660"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Compared with women with normal pregnancies, placental growth factor concentrations were lower, and soluble fms-like tyrosine kinase 1 concentrations were higher in women with preeclampsia and gestational proteinuria; soluble fms-like tyrosine kinase 1 concentrations were also higher in women with preeclampsia superimposed on chronic glomerulonephritis."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16458660"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPL"}, "span_text": {"type": "literal", "value": "Functional variants of the lipoprotein lipase gene and the risk of preeclampsia among non-Hispanic Caucasian women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16451134"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "PET (pre-eclamptic toxaemia) has recently been linked with alterations in production of a VEGFR1 [VEGF (vascular endothelial growth factor) receptor 1] splice variant that acts as a circulating inhibitor."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16451124"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "PET (pre-eclamptic toxaemia) has recently been linked with alterations in production of a VEGFR1 [VEGF (vascular endothelial growth factor) receptor 1] splice variant that acts as a circulating inhibitor."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16451124"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "PET (pre-eclamptic toxaemia) has recently been linked with alterations in production of a VEGFR1 [VEGF (vascular endothelial growth factor) receptor 1] splice variant that acts as a circulating inhibitor."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16451124"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Preeclampsia in lean normotensive normotolerant pregnant women can be predicted by simple insulin sensitivity indexes."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16446386"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "The aim of our study was to evaluate 3 insulin sensitivity (IS) indexes (fasting homeostasis model assessment IS [ISHOMA], quantitative insulin sensitivity check index [ISQUICKI], and oral glucose IS [OGIS]) early and late in pregnancy in a large number of normotensive pregnant women with a normal glucose tolerance and to test the ability of these indexes to predict the risk of subsequent preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16446386"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Insulin resistance in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16446385"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CTSA"}, "span_text": {"type": "literal", "value": "Overall, the distribution and abnormal expression levels in pre-eclamptic placentas indicate that cysteine cathepsins may play important roles during normal placentation and in the etiology of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16440214"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CTSA"}, "span_text": {"type": "literal", "value": "Several cysteine cathepsins exhibit deregulated expression levels in placentas from pregnancies complicated by pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16440214"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL1B"}, "span_text": {"type": "literal", "value": "Regulation of monocyte chemoattractant protein-1 expression by tumor necrosis factor-alpha and interleukin-1beta in first trimester human decidual cells: implications for preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16436659"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGFB2"}, "span_text": {"type": "literal", "value": "Considering that cytokines are involved in preeclampsia (PE) pathogenesis and that cytokine gene polymorphism may affect cytokine production, our purpose was to investigate the association of PE with tumor necrosis factor (TNF)-alpha (-308), transforming growth factor-beta1 (+10; 25), interleukin (IL)-10 (-1082), IL-6 (-174), and interferon-gamma (+874) polymorphisms."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16433832"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGFB3"}, "span_text": {"type": "literal", "value": "Considering that cytokines are involved in preeclampsia (PE) pathogenesis and that cytokine gene polymorphism may affect cytokine production, our purpose was to investigate the association of PE with tumor necrosis factor (TNF)-alpha (-308), transforming growth factor-beta1 (+10; 25), interleukin (IL)-10 (-1082), IL-6 (-174), and interferon-gamma (+874) polymorphisms."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16433832"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGFB1"}, "span_text": {"type": "literal", "value": "Considering that cytokines are involved in preeclampsia (PE) pathogenesis and that cytokine gene polymorphism may affect cytokine production, our purpose was to investigate the association of PE with tumor necrosis factor (TNF)-alpha (-308), transforming growth factor-beta1 (+10; 25), interleukin (IL)-10 (-1082), IL-6 (-174), and interferon-gamma (+874) polymorphisms."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16433832"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL6"}, "span_text": {"type": "literal", "value": "Polymorphisms of interleukin-6, hepatic lipase and calpain-10 genes, and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16427731"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CAPN10"}, "span_text": {"type": "literal", "value": "Polymorphisms of interleukin-6, hepatic lipase and calpain-10 genes, and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16427731"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL6"}, "span_text": {"type": "literal", "value": "We determined whether single nucleotide polymorphisms (SNPs) in interleukin-6 (IL-6), hepatic lipase (HL) and calpain-10 (CAPN-10) genes contribute to susceptibility to develop preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16427731"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CAPN10"}, "span_text": {"type": "literal", "value": "We determined whether single nucleotide polymorphisms (SNPs) in interleukin-6 (IL-6), hepatic lipase (HL) and calpain-10 (CAPN-10) genes contribute to susceptibility to develop preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16427731"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "It has been reported that the concentration of free placental growth factor (PIGF) is decreased and that of soluble fms-like tyrosine kinase 1 (sFlt-1) is increased before the onset of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16419645"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "It has been reported that the concentration of free placental growth factor (PIGF) is decreased and that of soluble fms-like tyrosine kinase 1 (sFlt-1) is increased before the onset of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16419645"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TCF4"}, "span_text": {"type": "literal", "value": "Three mechanisms in the pathogenesis of pre-eclampsia suggested by over-represented transcription factor-binding sites detected with comparative promoter analysis."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16403800"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Recent reports of increased serum levels of soluble fms-like tyrosine kinase 1 (sFlt-1) and decreased levels of placental growth factor (PlGF) suggest the key role of angiogenic factors in development of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16395263"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Low urinary placental growth factor is a marker of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16395263"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Recent reports of increased serum levels of soluble fms-like tyrosine kinase 1 (sFlt-1) and decreased levels of placental growth factor (PlGF) suggest the key role of angiogenic factors in development of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16395263"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EPO"}, "span_text": {"type": "literal", "value": "Erythropoietin and activin A concentrations were significantly elevated in preeclampsia (100.4 vs. 44.5 pg/ml, p = 0.023, and 7.4 vs. 1.85 ng/ml, p = 0.029, respectively)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16354996"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Oxidized low-density lipoprotein (Oxidized LDL) and the risk of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16343047"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "In a case-control study of 99 women with preeclampsia and 99 controls, we assessed maternal plasma oxidized low-density lipoprotein (oxidized LDL) in relation to preeclampsia risk."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16343047"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FBN1"}, "span_text": {"type": "literal", "value": "Contractile cells and fibrillin-1 distribution is disturbed in terminal villi of placentae from patients with preeclampsia and systemic lupus erythematosus."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16338469"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "A positive correlation between 8-isoprostane and previously analyzed placenta-derived sFlt1 (soluble fms-like tyrosine kinase 1) levels in the maternal circulation was found in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16337725"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Pregnancy exaggerates atherogeniclike responses, including insulin resistance and dyslipidemia, manifesting as preeclampsia or gestational diabetes."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16333011"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "A putative second messenger of insulin, inositol phosphoglycan P type (P-IPG), was previously shown to be highly increased during active preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16332940"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Acquired alterations in activation of proteins involved in insulin signaling may play a role in the complex pathogenesis of preeclampsia, probably as a consequence of the immunological dysfunction that occurs in this syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16332940"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "RESULTS: P-IPG extracted from human term placentas upon incubation with insulin was found to be far lower in those with preeclampsia than controls (P < 0.001)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16332940"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "These findings highlight the importance of P-IPG in active preeclampsia and demonstrate a substantially different response to the insulin stimulus of human PE placentas."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16332940"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Women with a history of pre-eclampsia have persistent insulin resistance after pregnancy associated with increased sympathetic activity of the cardiovascular system, and coronary artery disease later in life."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16331111"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Pre-eclampsia is characterized by increased insulin resistance, sympathetic overactivity and a particular lipid profile."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16331111"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "A case-control study of oxidized low density lipoproteins and preeclampsia risk."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16316839"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Preeclampsia is an inflammatory disorder where altered levels of vascular endothelial growth factor (VEGF) and the circulating soluble fms-like tyrosine kinase 1 (sFlt-1) have a pathogenic role."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16269656"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Soluble vascular endothelial growth factor receptor-1 (sFLT-1) mediates downregulation of FLT-1 and prevents activated neutrophils from women with preeclampsia from additional migration by VEGF."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16269656"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Soluble vascular endothelial growth factor receptor-1 (sFLT-1) mediates downregulation of FLT-1 and prevents activated neutrophils from women with preeclampsia from additional migration by VEGF."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16269656"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Preeclampsia is an inflammatory disorder where altered levels of vascular endothelial growth factor (VEGF) and the circulating soluble fms-like tyrosine kinase 1 (sFlt-1) have a pathogenic role."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16269656"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Preeclampsia is an inflammatory disorder where altered levels of vascular endothelial growth factor (VEGF) and the circulating soluble fms-like tyrosine kinase 1 (sFlt-1) have a pathogenic role."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16269656"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Soluble vascular endothelial growth factor receptor-1 (sFLT-1) mediates downregulation of FLT-1 and prevents activated neutrophils from women with preeclampsia from additional migration by VEGF."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16269656"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Preeclampsia is an inflammatory disorder where altered levels of vascular endothelial growth factor (VEGF) and the circulating soluble fms-like tyrosine kinase 1 (sFlt-1) have a pathogenic role."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16269656"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Vascular endothelial growth factor (VEGF) promotes placental vascularization, which is inadequate in preeclampsia and intrauterine growth retardation (IUGR)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16263826"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Maternal serum-soluble vascular endothelial growth factor receptor-1 in early pregnancy ending in preeclampsia or intrauterine growth retardation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16263826"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Vascular endothelial growth factor (VEGF) promotes placental vascularization, which is inadequate in preeclampsia and intrauterine growth retardation (IUGR)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16263826"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Vascular endothelial growth factor (VEGF) promotes placental vascularization, which is inadequate in preeclampsia and intrauterine growth retardation (IUGR)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16263826"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Maternal serum-soluble vascular endothelial growth factor receptor-1 in early pregnancy ending in preeclampsia or intrauterine growth retardation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16263826"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Maternal serum-soluble vascular endothelial growth factor receptor-1 in early pregnancy ending in preeclampsia or intrauterine growth retardation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16263826"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SHBG"}, "span_text": {"type": "literal", "value": "First trimester sex hormone-binding globulin and subsequent development of preeclampsia or other adverse pregnancy outcomes."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16263602"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SHBG"}, "span_text": {"type": "literal", "value": "To investigate whether first trimester maternal serum sex hormone-binding globulin (SHBG) concentrations are altered in women who subsequently develop preeclampsia or other pregnancy complications."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16263602"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "We assessed whether plasma triglyceride (TG) levels can distinguish a subgroup of preeclamptic women with alterations in lipoprotein profile from those with normal lipid metabolism and can be used to identify 2 distinct pathogenic groups in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16253640"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "The presence of a proatherogenic lipoprotein profile, previously described in preeclampsia, is characterized by increased small dense LDL and is exclusive to a subset of preeclamptic patients with high TG levels."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16253640"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VCAM1"}, "span_text": {"type": "literal", "value": "Vascular cell adhesion molecule-1 levels were significantly elevated in preeclamptic patients in comparison with those in control subjects regardless of TG levels."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16253640"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Atherogenic lipoprotein subfraction profile in preeclamptic women with and without high triglycerides: different pathophysiologic subsets in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16253640"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MTHFR"}, "span_text": {"type": "literal", "value": "A total of 808 white patients who developed preeclampsia (cases) and 808 women with previous uneventful pregnancies (controls) matched for age and parity were evaluated for inherited and acquired thrombophilia (factor V Leiden; factor II G20210A; methylenetetrahydrofolate reductase C677T; protein S, protein C, and antithrombin III deficiency; anticardiolipin antibodies; lupus anticoagulant; and hyperhomocysteinemia)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16246971"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MTHFR"}, "span_text": {"type": "literal", "value": "In women with mild preeclampsia (402 cases), only prothrombin and homozygous methylenetetrahydrofolate reductase gene mutations were significantly more prevalent than in the controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16246971"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Recent data suggest that excess circulating soluble fms-like tyrosine kinase-1 (sFlt-1) may causally relate to preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16242694"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Placental growth factor in the cerebrospinal fluid of women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16242694"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "High serum soluble fms-like tyrosine kinase-1 and low serum free placental growth factor and free vascular endothelial growth factor have been observed in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16230516"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "High serum soluble fms-like tyrosine kinase-1 and low serum free placental growth factor and free vascular endothelial growth factor have been observed in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16230516"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "High serum soluble fms-like tyrosine kinase-1 and low serum free placental growth factor and free vascular endothelial growth factor have been observed in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16230516"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "High serum soluble fms-like tyrosine kinase-1 and low serum free placental growth factor and free vascular endothelial growth factor have been observed in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16230516"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Although the etiology of preeclampsia is still unclear, recent studies suggest that its major phenotypes, high blood pressure and proteinuria, are due in part to excess circulating soluble fms-like tyrosine kinase-1 concentrations."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16230516"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "High serum soluble fms-like tyrosine kinase-1 and low serum free placental growth factor and free vascular endothelial growth factor have been observed in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16230516"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Lymphokine-activated killer cells induced from decidual lymphocytes reduce the angiogenic activity of trophoblasts by enhancing the release of soluble fms-like tyrosine kinase-1 from trophoblasts: an implication for the pathophysiology of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16229897"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Adjusted mean 24-hour urine insulin excretion was, however, calculated using analysis of covariance, with adjustment models for pre-eclampsia considering body mass index, race and smoking status; and for gestational hypertension, gestational age at specimen collection, height, body mass index and smoking."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16225566"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Adjusted 24-hour urine insulin excretion at baseline (mean 17 weeks of gestation) was greater in women who developed pre-eclampsia than in normotensive controls (mean [SE]:"}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16225566"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "The data suggest that early hyperinsulinaemia, a marker of insulin resistance, may predispose to mild pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16225566"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Twenty-four-hour urine insulin as a measure of hyperinsulinaemia/insulin resistance before onset of pre-eclampsia and gestational hypertension."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16225566"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Among women who developed pre-eclampsia, adjusted urine insulin excretion was greater than controls only in women with mild pre-eclampsia and not in severe pre-eclampsia (mild pre-eclampsia vs controls:"}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16225566"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "To evaluate levels of 24-hour urine insulin excretion before the onset of pre-eclampsia and gestational hypertension."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16225566"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "No association between insulin resistance and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16203596"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Our results indicate that preeclampsia is not associated with hyperinsulinaemia and/or insulin resistance, in either the fasting or the postprandial state."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16203596"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "There was a significantly increased of UtA pulsatility index (PI), plasma levels of soluble fms-like tyrosine kinase 1 (sFlt1), PAI-1/PAI-2 ratio, and F-2 isoprostane in women who subsequently developed preeclampsia compared with control pregnancies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16202744"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AR"}, "span_text": {"type": "literal", "value": "Preeclampsia and androgen receptor gene CAG repeat length: results from both children and women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16195823"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AR"}, "span_text": {"type": "literal", "value": "We studied whether the CAG (encoding glutamine) repeat length polymorphism in the first exon of the androgen receptor (AR) gene is predictive of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16195823"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Here, we determined the serum concentration of angiopoietin-2 (Ang-2), a natural antagonist of angiopoietin-1 (Ang-1) involved in promoting angiogenesis in the presence of angiogenic stimuli such as vascular endothelial growth factor (VEGF), in women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16182107"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ANGPT1"}, "span_text": {"type": "literal", "value": "Here, we determined the serum concentration of angiopoietin-2 (Ang-2), a natural antagonist of angiopoietin-1 (Ang-1) involved in promoting angiogenesis in the presence of angiogenic stimuli such as vascular endothelial growth factor (VEGF), in women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16182107"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Here, we determined the serum concentration of angiopoietin-2 (Ang-2), a natural antagonist of angiopoietin-1 (Ang-1) involved in promoting angiogenesis in the presence of angiogenic stimuli such as vascular endothelial growth factor (VEGF), in women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16182107"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Here, we determined the serum concentration of angiopoietin-2 (Ang-2), a natural antagonist of angiopoietin-1 (Ang-1) involved in promoting angiogenesis in the presence of angiogenic stimuli such as vascular endothelial growth factor (VEGF), in women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16182107"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD3"}, "span_text": {"type": "literal", "value": "When neutrophils were pretreated with superoxide dismutase, nitrite release by neutrophils did not differ between normal pregnancy and preeclampsia, suggesting that excess superoxide anion in preeclampsia could reduce bioavailability of nitric oxide through neutrophil autocrine function."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16172429"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD1"}, "span_text": {"type": "literal", "value": "When neutrophils were pretreated with superoxide dismutase, nitrite release by neutrophils did not differ between normal pregnancy and preeclampsia, suggesting that excess superoxide anion in preeclampsia could reduce bioavailability of nitric oxide through neutrophil autocrine function."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16172429"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CAT"}, "span_text": {"type": "literal", "value": "Hydrogen peroxide was important in neutrophil-mediated endothelial cell injury in preeclampsia as catalase inhibited endothelial cell injury."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16172429"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "An elevated maternal plasma, but not amniotic fluid, soluble fms-like tyrosine kinase-1 (sFlt-1) at the time of mid-trimester genetic amniocentesis is a risk factor for preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16157098"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "The purpose of this study was to determine if an elevated concentration of soluble fms-like tyrosine kinase-1(sFlt-1) in maternal plasma and amniotic fluid is a risk factor for the subsequent development of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16157098"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:RETN"}, "span_text": {"type": "literal", "value": "There was no association between resistin levels and preeclampsia or maternal BMI."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16157097"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Women with severe preeclampsia and BMI > or = 25 kg/m2 have decreased adiponectin and increased leptin levels, while normal weight women with preeclampsia have increased adiponectin levels."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16157097"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "The levels of leptin, adiponectin, and resistin in normal weight, overweight, and obese pregnant women with and without preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16157097"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "In patients with severe preeclampsia, overweight, and obese women had increased leptin levels (33.4 +/- 14.8 vs 23.0 +/- 10.8 ng/mL respectively, P = .02), and decreased adiponectin levels (8.4 +/- 5.3 vs 12.6 +/- 6.0 ng/mL, P = .03) compared with normal weight women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16157097"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:RETN"}, "span_text": {"type": "literal", "value": "The levels of leptin, adiponectin, and resistin in normal weight, overweight, and obese pregnant women with and without preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16157097"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Women with preeclampsia had higher, unaltered or lower lipoprotein (a) concentrations as compared to normal pregnant controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16154035"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "In this article the literature on lipoprotein (a) during normal pregnancy and pregnancy complicated by preeclampsia or intrauterine growth restriction is reviewed."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16154035"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGFB2"}, "span_text": {"type": "literal", "value": "We examined the relationship between maternal plasma transforming growth factor-beta1 (TGF-beta1) concentrations and risk of preeclampsia among women delivering at Harare Maternity Hospital in Zimbabwe."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16147848"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGFB1"}, "span_text": {"type": "literal", "value": "We examined the relationship between maternal plasma transforming growth factor-beta1 (TGF-beta1) concentrations and risk of preeclampsia among women delivering at Harare Maternity Hospital in Zimbabwe."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16147848"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGFB3"}, "span_text": {"type": "literal", "value": "We examined the relationship between maternal plasma transforming growth factor-beta1 (TGF-beta1) concentrations and risk of preeclampsia among women delivering at Harare Maternity Hospital in Zimbabwe."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16147848"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EPHX3"}, "span_text": {"type": "literal", "value": "Two polymorphisms affecting the function of the biotransformation enzymes epoxide hydrolase and glutathione S-transferase P1 were shown previously to be associated with pre-eclampsia in a Dutch population."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16147638"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EPHX1"}, "span_text": {"type": "literal", "value": "Maternal and fetal single nucleotide polymorphisms in the epoxide hydrolase and gluthatione S-transferase P1 genes are not associated with pre-eclampsia in the Coloured population of the Western Cape, South Africa."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16147638"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EPHX1"}, "span_text": {"type": "literal", "value": "Two polymorphisms affecting the function of the biotransformation enzymes epoxide hydrolase and glutathione S-transferase P1 were shown previously to be associated with pre-eclampsia in a Dutch population."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16147638"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EPHX4"}, "span_text": {"type": "literal", "value": "Two polymorphisms affecting the function of the biotransformation enzymes epoxide hydrolase and glutathione S-transferase P1 were shown previously to be associated with pre-eclampsia in a Dutch population."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16147638"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EPHX4"}, "span_text": {"type": "literal", "value": "Maternal and fetal single nucleotide polymorphisms in the epoxide hydrolase and gluthatione S-transferase P1 genes are not associated with pre-eclampsia in the Coloured population of the Western Cape, South Africa."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16147638"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EPHX3"}, "span_text": {"type": "literal", "value": "Maternal and fetal single nucleotide polymorphisms in the epoxide hydrolase and gluthatione S-transferase P1 genes are not associated with pre-eclampsia in the Coloured population of the Western Cape, South Africa."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16147638"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EPHX2"}, "span_text": {"type": "literal", "value": "Two polymorphisms affecting the function of the biotransformation enzymes epoxide hydrolase and glutathione S-transferase P1 were shown previously to be associated with pre-eclampsia in a Dutch population."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16147638"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EPHX2"}, "span_text": {"type": "literal", "value": "Maternal and fetal single nucleotide polymorphisms in the epoxide hydrolase and gluthatione S-transferase P1 genes are not associated with pre-eclampsia in the Coloured population of the Western Cape, South Africa."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16147638"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:RETN"}, "span_text": {"type": "literal", "value": "Thus increased plasma concentrations of adiponectin and resistin in preeclampsia may not relate to altered expression levels in adipose tissue and placenta, whereas both plasma and placenta mRNA levels of leptin are increased in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16144822"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Thus increased plasma concentrations of adiponectin and resistin in preeclampsia may not relate to altered expression levels in adipose tissue and placenta, whereas both plasma and placenta mRNA levels of leptin are increased in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16144822"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SHBG"}, "span_text": {"type": "literal", "value": "The values of DHEA-S, androstenedione and sex hormone binding globulin were lower in the group with preeclampsia but the difference did not reach statistical significance."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16139944"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SHBG"}, "span_text": {"type": "literal", "value": "The levels of serum total and free testosterone, dehydroepiandrosterone sulfate, androstenedione and sex hormone binding globulin were estimated in 28 patients during the third trimester of pregnancy with established preeclampsia and 25 normotensive women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16139944"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TCF4"}, "span_text": {"type": "literal", "value": "This includes transcription factors, non-coding RNA, epigenetic features, as well as genes functionally or genetically linked with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16139262"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CRH"}, "span_text": {"type": "literal", "value": "Parallel assessment of circulatory fetal DNA and corticotropin-releasing hormone mRNA in early- and late-onset preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16120955"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Circulating oxidized low-density lipoprotein and paraoxonase activity in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16088195"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "The objective of this study was to investigate the association of oxidized low-density lipoprotein (oxLDL) and paraoxonase (PON1) activity in women with either preeclampsia or normotensive (NT) pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16088195"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EPO"}, "span_text": {"type": "literal", "value": "Controversy exists in the literature regarding the association between erythropoietin levels and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16080010"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EPO"}, "span_text": {"type": "literal", "value": "Erythropoietin concentration among patients with and without preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16080010"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EPO"}, "span_text": {"type": "literal", "value": "Erythropoietin concentration was higher among patients with preeclampsia, but did not reach significance (24.8 +/- 8.9 mU/ml vs. 19.9 +/- 9.9 mU/ml; P-0.19)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16080010"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EPO"}, "span_text": {"type": "literal", "value": "This study was aimed to compare serum erythropoietin concentrations among patients with and without preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16080010"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EPO"}, "span_text": {"type": "literal", "value": "Further prospective studies are needed to investigate the association between preeclampsia and erythropoietin."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16080010"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EPO"}, "span_text": {"type": "literal", "value": "A nonsignificant trend towards higher maternal serum levels of erythropoietin was demonstrated among patients with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16080010"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "To investigate the relationship of neonatal platelet count and preeclampsia to levels of soluble fms-like tyrosine kinase 1 (sFlt-1), placental growth factor (PlGF), and vascular endothelial growth factor (VEGF) in the cord blood of preterm infants."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16061605"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "To investigate the relationship of neonatal platelet count and preeclampsia to levels of soluble fms-like tyrosine kinase 1 (sFlt-1), placental growth factor (PlGF), and vascular endothelial growth factor (VEGF) in the cord blood of preterm infants."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16061605"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "To investigate the relationship of neonatal platelet count and preeclampsia to levels of soluble fms-like tyrosine kinase 1 (sFlt-1), placental growth factor (PlGF), and vascular endothelial growth factor (VEGF) in the cord blood of preterm infants."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16061605"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "To investigate the relationship of neonatal platelet count and preeclampsia to levels of soluble fms-like tyrosine kinase 1 (sFlt-1), placental growth factor (PlGF), and vascular endothelial growth factor (VEGF) in the cord blood of preterm infants."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16061605"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "To investigate the relationship of neonatal platelet count and preeclampsia to levels of soluble fms-like tyrosine kinase 1 (sFlt-1), placental growth factor (PlGF), and vascular endothelial growth factor (VEGF) in the cord blood of preterm infants."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16061605"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGT"}, "span_text": {"type": "literal", "value": "Among these are the angiotensinogen (AGT) gene variant Met235Threo, which has been associated with pre-eclampsia and the endothelial nitric oxide synthase (eNOS) polymorphism Glu298Asp, which has been associated with both pre-eclampsia and abruptio placentae, a condition that often co-exists with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16059745"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "The Glu298Asp variant of the endothelial nitric oxide synthase gene is associated with an increased risk for abruptio placentae in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16059745"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGT"}, "span_text": {"type": "literal", "value": "To clarify whether the homozygous deletion (DD) genotype of angiotensin-converting enzyme gene ( ACE) is a genetic risk factor for preeclampsia in Japanese women, we performed ACE genotyping in patients with preeclampsia and healthy pregnant women, and analyzed the relationship between preeclampsia and ACE genotype, taking into account some well-known contributing factors for preeclampsia, such as primiparity, positive family history of hypertension, prepregnancy body mass index < 24, and heterozygosity and homozygosity of T235 (MT+TT) genotypes of the angiotensinogen ( AGT) gene."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16052407"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "It is reported that expression of vascular endothelial growth factor (VEGF) in trophoblasts increases in cases with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16052402"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "It is reported that expression of vascular endothelial growth factor (VEGF) in trophoblasts increases in cases with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16052402"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "It is reported that expression of vascular endothelial growth factor (VEGF) in trophoblasts increases in cases with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16052402"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Potential atherogenic roles of lipids, lipoprotein(a) and lipid peroxidation in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16048794"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "To evaluate changes in lipid profile, serum levels of malondialdehyde (MDA) and lipoprotein(a) (Lp(a)) and placental MDA in preeclamptic women, and to evaluate the atherogenic role of these changes in the pathophysiology of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16048794"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Those who developed preeclampsia, when compared with those who remained nonpreeclamptic, were not more insulin resistant in either the third trimester or 15 months postpartum."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16043744"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Insulin resistance and preeclampsia in gestational diabetes mellitus."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16043744"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Leptin concentration is significantly raised in fetoplacental tissues from women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16036403"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Raised leptin concentrations in feto-placental tissues from women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16036403"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Its role in preeclampsia remains unclear and it is not possible to say from this study if the raised levels of leptin evident in placentas from preeclamptic women are a cause or consequence of preeclampsia, although the latter seems more likely."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16036403"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Leptin concentrations were significantly higher in all the three tissues from preeclamptic women when compared to the corresponding tissues from normotensive controls (0.52 +/- 0.1 vs. 1.15 +/- 0.41; 0.99 +/- 0.16 vs. 2.19 +/- 0.71; and 10.28 +/- 1.06 vs. 13.95 +/- 1.13 in the amnion, chorion laeve, and placenta, respectively, from normotensive pregnant women and women with preeclampsia; p < 0.05)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16036403"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL6"}, "span_text": {"type": "literal", "value": "Interleukin-6 concentrations in the placenta and blood in normal pregnancies and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16034713"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:DPP8"}, "span_text": {"type": "literal", "value": "Changes in placental dipeptidyl peptidase IV in preeclampsia with intrauterine growth restriction."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16034711"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:DPP9"}, "span_text": {"type": "literal", "value": "Changes in placental dipeptidyl peptidase IV in preeclampsia with intrauterine growth restriction."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16034711"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:DPP4"}, "span_text": {"type": "literal", "value": "Changes in placental dipeptidyl peptidase IV in preeclampsia with intrauterine growth restriction."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16034711"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:DPP7"}, "span_text": {"type": "literal", "value": "Changes in placental dipeptidyl peptidase IV in preeclampsia with intrauterine growth restriction."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16034711"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:DPP3"}, "span_text": {"type": "literal", "value": "Changes in placental dipeptidyl peptidase IV in preeclampsia with intrauterine growth restriction."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16034711"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Furthermore, conditions associated with increased insulin resistance, such as gestational diabetes and preeclampsia, may be influenced by this hormone."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16033679"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AFP"}, "span_text": {"type": "literal", "value": "Screening for pre-eclampsia by using maternal serum inhibin A, activin A, human chorionic gonadotropin, unconjugated estriol, and alpha-fetoprotein levels and uterine artery Doppler in the second trimester of pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16029293"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AFP"}, "span_text": {"type": "literal", "value": "To analyse the predictive power of maternal serum inhibin A, activin A, human chorionic gonadotropin (hCG), unconjugated estriol (uE(3)), alpha-fetoprotein (AFP) levels and uterine artery Doppler in the second trimester of pregnancy in screening for pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16029293"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL10"}, "span_text": {"type": "literal", "value": "Placental deficiency of interleukin-10 (IL-10) in preeclampsia and its relationship to an IL10 promoter polymorphism."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16026832"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Characterization of changes in leptin and leptin receptors in a rat model of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16021089"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEPR"}, "span_text": {"type": "literal", "value": "Characterization of changes in leptin and leptin receptors in a rat model of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16021089"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "No response to endothelin-1 was found among women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16021085"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Contribution of endogenous endothelin-1 to basal vascular tone during normal pregnancy and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16021085"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL1B"}, "span_text": {"type": "literal", "value": "Both black and white women with preeclampsia were more likely than normotensive control subjects to carry the interleukin-1alpha-producing-4845 G/G genotype (black odds ratio, 11.6; 95% CI, 1.5-89.3; white odds ratio, 1.7; 95% CI, 0.7-3.9), -889 C/C genotype (black odds ratio, 5.1; 95% CI, 0.6-41.6; white odds ratio, 1.9; 95% CI, 0.8-4.7), and the interleukin-1alpha-4845/interleukin-1alpha-889/interleukin-1beta-3957 GCC/GCC haplotype (black odds ratio, 3.4; 95% CI, 1.3-8.7; white odds ratio, 2.1; 95% CI, 1.4-3.2)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16021081"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL1A"}, "span_text": {"type": "literal", "value": "Both black and white women with preeclampsia were more likely than normotensive control subjects to carry the interleukin-1alpha-producing-4845 G/G genotype (black odds ratio, 11.6; 95% CI, 1.5-89.3; white odds ratio, 1.7; 95% CI, 0.7-3.9), -889 C/C genotype (black odds ratio, 5.1; 95% CI, 0.6-41.6; white odds ratio, 1.9; 95% CI, 0.8-4.7), and the interleukin-1alpha-4845/interleukin-1alpha-889/interleukin-1beta-3957 GCC/GCC haplotype (black odds ratio, 3.4; 95% CI, 1.3-8.7; white odds ratio, 2.1; 95% CI, 1.4-3.2)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16021081"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Soluble fms-like tyrosine kinase 1 concentrations decrease more slowly after delivery in women with preeclampsia, consistent with a decreased rate of excretion or continued production."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16021077"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Mean serum soluble fms-like tyrosine kinase 1 concentrations were increased in women who developed preeclampsia, compared with normal pregnant women, and this increase was most pronounced in severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16021077"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Increased soluble fms-like tyrosine kinase 1 is more likely to be present in women with severe preeclampsia, but it is not present in all women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16021077"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Lastly, soluble fms-like tyrosine kinase 1 decreased rapidly after delivery, but this decrease was significantly slower in women with severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16021077"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Maternal serum soluble fms-like tyrosine kinase 1 concentrations are not increased in early pregnancy and decrease more slowly postpartum in women who develop preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16021077"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "However, many women with preeclampsia had soluble fms-like tyrosine kinase 1 concentrations similar to normal pregnant women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16021077"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "We measured maternal serum soluble fms-like tyrosine kinase 1 concentrations across pregnancy and immediately postpartum in women who developed preeclampsia and normal pregnant women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16021077"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Increased soluble fms-like tyrosine kinase 1 is not an early-pregnancy event among women who later develop preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/16021077"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Finally, the effects of TS are apparently unrelated to blood levels of NO, calcitonin gene-related peptide, and endothelin-1, which have been reported to modulate systolic blood pressure in the L-NAME-induced pre-eclampsia model."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15997172"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP7"}, "span_text": {"type": "literal", "value": "Because the secreted form of ADAM12 cleaves insulin-like growth factor binding protein (IGFBP)-3 and IGFBP-5, the IGF axis may play a role in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15994630"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP3"}, "span_text": {"type": "literal", "value": "Because the secreted form of ADAM12 cleaves insulin-like growth factor binding protein (IGFBP)-3 and IGFBP-5, the IGF axis may play a role in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15994630"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP2"}, "span_text": {"type": "literal", "value": "Because the secreted form of ADAM12 cleaves insulin-like growth factor binding protein (IGFBP)-3 and IGFBP-5, the IGF axis may play a role in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15994630"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP5"}, "span_text": {"type": "literal", "value": "Because the secreted form of ADAM12 cleaves insulin-like growth factor binding protein (IGFBP)-3 and IGFBP-5, the IGF axis may play a role in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15994630"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP4"}, "span_text": {"type": "literal", "value": "Because the secreted form of ADAM12 cleaves insulin-like growth factor binding protein (IGFBP)-3 and IGFBP-5, the IGF axis may play a role in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15994630"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL6"}, "span_text": {"type": "literal", "value": "The increased osteoclastic activity in preeclampsia may be attributed to increased RANKL induced by increased interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), and transforming growth factor beta2 (TGF-beta2) production."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15979546"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGFB2"}, "span_text": {"type": "literal", "value": "The increased osteoclastic activity in preeclampsia may be attributed to increased RANKL induced by increased interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), and transforming growth factor beta2 (TGF-beta2) production."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15979546"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGFB3"}, "span_text": {"type": "literal", "value": "The increased osteoclastic activity in preeclampsia may be attributed to increased RANKL induced by increased interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), and transforming growth factor beta2 (TGF-beta2) production."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15979546"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGFB1"}, "span_text": {"type": "literal", "value": "The increased osteoclastic activity in preeclampsia may be attributed to increased RANKL induced by increased interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), and transforming growth factor beta2 (TGF-beta2) production."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15979546"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:RXRA"}, "span_text": {"type": "literal", "value": "We studied placental PPARdelta, PPARgamma, and retinoid X receptor alpha (RXRalpha) expression in healthy pregnancy and in preeclampsia (PET) and intrauterine growth restriction (IUGR)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15979543"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PPARD"}, "span_text": {"type": "literal", "value": "Human placental peroxisome proliferator-activated receptor delta and gamma expression in healthy pregnancy and in preeclampsia and intrauterine growth restriction."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15979543"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "We measured serum adiponectin concentrations and insulin sensitivity (intravenous glucose tolerance test/minimal model) in 22 women with preeclampsia and 15 normotensive controls with similar pre-pregnancy body mass index (BMI) (range 18-29 kg/m(2)) between 29 and 39 weeks of gestation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15979355"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Surprisingly, recent evidence suggests that adiponectin concentrations are increased during preeclampsia, which is characterized by insulin resistance."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15979355"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Adiponectin concentrations in maternal serum: elevated in preeclampsia but unrelated to insulin sensitivity."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15979355"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Adiponectin concentrations were unrelated to insulin sensitivity both in preeclamptic and normotensive subjects; insulin sensitivity was decreased in preeclampsia (P = .01)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15979355"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TCF4"}, "span_text": {"type": "literal", "value": "The hypoxia inducible transcription factors, HIF-1alpha and -2alpha proteins, are overexpressed in placentae from women with preeclampsia (Biol Reprod 2001;64:499-506; Biol Reprod 2001;64:1019-1020)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15955559"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TFPI2"}, "span_text": {"type": "literal", "value": "METHOD: DNA arrays were validated by showing the up-regulation of several genes typical for preeclampsia such as chorionic gonadotrophin beta-chain, tissue factor pathway inhibitor, and intercellular adhesion molecule-1."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15954879"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ICAM1"}, "span_text": {"type": "literal", "value": "METHOD: DNA arrays were validated by showing the up-regulation of several genes typical for preeclampsia such as chorionic gonadotrophin beta-chain, tissue factor pathway inhibitor, and intercellular adhesion molecule-1."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15954879"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TFPI"}, "span_text": {"type": "literal", "value": "METHOD: DNA arrays were validated by showing the up-regulation of several genes typical for preeclampsia such as chorionic gonadotrophin beta-chain, tissue factor pathway inhibitor, and intercellular adhesion molecule-1."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15954879"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ICAM1"}, "span_text": {"type": "literal", "value": "To determine whether the free fatty acids (FFAs), oleic, linoleic, and palmitic acid, found elevated before 20 weeks of pregnancy in those women who later develop preeclampsia, induced changes in expression of the vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1), or E-selectin in cultured human umbilical cord vein endothelial cells (HUVEC), and integrin subunit CD11b, L-selectin or intracellular reactive oxygen species (ROS) in leukocytes."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15954878"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VCAM1"}, "span_text": {"type": "literal", "value": "To determine whether the free fatty acids (FFAs), oleic, linoleic, and palmitic acid, found elevated before 20 weeks of pregnancy in those women who later develop preeclampsia, induced changes in expression of the vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1), or E-selectin in cultured human umbilical cord vein endothelial cells (HUVEC), and integrin subunit CD11b, L-selectin or intracellular reactive oxygen species (ROS) in leukocytes."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15954878"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "We hypothesized that umbilical vein serum soluble fms-like tyrosine kinase 1 (sFlt1) concentration was augmented in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15935542"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Circulating concentrations of sFlt1 (soluble fms-like tyrosine kinase 1) in fetal and maternal serum during pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15935542"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOM"}, "span_text": {"type": "literal", "value": "Association of apolipoprotein J gene 866C-->T polymorphism with preeclampsia and essential hypertension."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15925890"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOE"}, "span_text": {"type": "literal", "value": "Association of apolipoprotein J gene 866C-->T polymorphism with preeclampsia and essential hypertension."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15925890"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOF"}, "span_text": {"type": "literal", "value": "Association of apolipoprotein J gene 866C-->T polymorphism with preeclampsia and essential hypertension."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15925890"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOO"}, "span_text": {"type": "literal", "value": "Association of apolipoprotein J gene 866C-->T polymorphism with preeclampsia and essential hypertension."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15925890"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Mid-trimester maternal serum activin A and fibronectin levels and average S/D ratios were significantly higher whereas placental growth factor levels were significantly lower in women who subsequently developed preeclampsia than remained normotensive (p<0.001)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15919391"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Placental growth factor, activin A, fibronectin and uterine artery Doppler are all potentially useful as predictors of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15919391"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "The best cut-off values for predicting preeclampsia of placental growth factor, activin A and fibronectin based on ROC curve analysis were 90 pg/ml, 14 ng/ml and 370 mg/l respectively."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15919391"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "The areas under the curve equal to 0.993, 0.972, 0.872 and 0.813 for placental growth factor, activin A, fibronectin and uterine artery Doppler respectively were determined for the prediction of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15919391"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Prediction of preeclampsia with maternal mid-trimester placental growth factor, activin A, fibronectin and uterine artery Doppler velocimetry."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15919391"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "It is improbable that high serum lipoprotein(a) levels are risk factors for the development of pre-eclampsia; however, elevated triglyceride-rich lipoproteins might cause endothelial damage leading to pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15916667"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Lipoprotein(a) levels in women with pre-eclampsia and in normotensive pregnant women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15916667"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "To determine if plasma lipoprotein(a) levels are elevated in pre-eclampsia and if so, their association with the severity of the disease."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15916667"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VCAN"}, "span_text": {"type": "literal", "value": "Pre-eclampsia is associated with a lower level of all proteoglycan core proteins, especially those of higher molecular mass (such as versican), although the same set of core proteins were found in normal and pre-eclamptic Wharton's jelly."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15912205"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CP"}, "span_text": {"type": "literal", "value": "Furthermore, there were significant correlations between serum malondialdehyde and ceruloplasmin and vitamin E/total cholesterol in women with severe preeclampsia, and changes in serum and placental lipid peroxides and serum iron concentrations were significantly associated with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15898124"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CP"}, "span_text": {"type": "literal", "value": "Lipid peroxides in serum and placental tissue, and iron, copper and ceruloplasmin levels in serum were significantly increased, and transferrin, TIBC, vitamin E/total cholesterol and total carotene/total cholesterol ratios in serum were significantly decreased especially in women with severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15898124"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ESR2"}, "span_text": {"type": "literal", "value": "Association study using single nucleotide polymorphisms in the estrogen receptor beta (ESR2) gene for preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15894829"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "Six hundred fifty-seven women affected by pre-eclampsia and their families were genotyped at 28 single-nucleotide polymorphisms in the genes encoding angiotensinogen, the angiotensin receptors, factor V Leiden variant, methylene tetrahydrofolate reductase, nitric oxide synthase, and TNFalpha."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15889386"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGT"}, "span_text": {"type": "literal", "value": "Six hundred fifty-seven women affected by pre-eclampsia and their families were genotyped at 28 single-nucleotide polymorphisms in the genes encoding angiotensinogen, the angiotensin receptors, factor V Leiden variant, methylene tetrahydrofolate reductase, nitric oxide synthase, and TNFalpha."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15889386"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "An excess of the soluble receptor, fms-like tyrosine kinase 1 (sFlt-1) may contribute to maternal vascular dysfunction in women with preeclampsia by binding and thereby reducing concentrations of free vascular endothelial growth factor and placental growth factor (PlGF) in the circulation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15886253"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "An excess of the soluble receptor, fms-like tyrosine kinase 1 (sFlt-1) may contribute to maternal vascular dysfunction in women with preeclampsia by binding and thereby reducing concentrations of free vascular endothelial growth factor and placental growth factor (PlGF) in the circulation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15886253"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational-age neonates: relationship to circulating placental growth factor."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15886253"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "An excess of the soluble receptor, fms-like tyrosine kinase 1 (sFlt-1) may contribute to maternal vascular dysfunction in women with preeclampsia by binding and thereby reducing concentrations of free vascular endothelial growth factor and placental growth factor (PlGF) in the circulation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15886253"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "An excess of the soluble receptor, fms-like tyrosine kinase 1 (sFlt-1) may contribute to maternal vascular dysfunction in women with preeclampsia by binding and thereby reducing concentrations of free vascular endothelial growth factor and placental growth factor (PlGF) in the circulation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15886253"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational-age neonates: relationship to circulating placental growth factor."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15886253"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "An excess of the soluble receptor, fms-like tyrosine kinase 1 (sFlt-1) may contribute to maternal vascular dysfunction in women with preeclampsia by binding and thereby reducing concentrations of free vascular endothelial growth factor and placental growth factor (PlGF) in the circulation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15886253"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "To investigate the expression of endothelial nitric oxide synthase traffic inducer (NOSTRIN) in the placenta of women with pre-eclampsia (PE) and discuss its role in the pathogenesis of PE."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15847871"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "Expression of endothelial nitric oxide synthase traffic inducer in the placentas of women with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15847871"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VCAM1"}, "span_text": {"type": "literal", "value": "Soluble vascular cell adhesion molecule-1 (VCAM-1) is known to be elevated in serum of patients with preeclampsia, but there are no data available on the significance of urinary VCAM-1 excretion in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15843265"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "The comparison of amino-terminal probrain natriuretic peptide levels in preeclampsia and normotensive pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15843261"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "The purpose of this study was to evaluate the levels of amino-terminal probrain natriuretic peptide (Nt pro-BNP) in preeclampsia in comparison with normotensive pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15843261"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Urinary placental growth factor and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15840857"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Endothelin-1 triggers placental oxidative stress pathways: putative role in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15840756"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Leptin may be involved in the pathology of preeclampsia, and elevated maternal serum leptin levels may be a marker for the early stages of preeclampsia in pregnant women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15838751"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "The objective of this study was to evaluate the change in maternal serum leptin levels in preeclampsia and to study the relationship between maternal serum leptin and thyroid-stimulating hormone (TSH), body mass index (BMI), newborn weight, and proteinuria."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15838751"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Elevated serum uric acid levels in gestational hypertension are correlated with insulin resistance."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15838747"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "In contrast, uric acid levels did not correlate with insulin sensitivity in patients with preeclampsia and controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15838747"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Insulin resistance is associated with the elevated uric acid levels found in nonproteinuric gestational hypertensive disease."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15838747"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "The purpose of this study was to assess a possible correlation between insulin resistance and uric acid levels in gestational hypertension (GH) and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15838747"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15804781"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15804781"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15804781"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL6"}, "span_text": {"type": "literal", "value": "Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human mesangial cells and induce interleukin-6 and plasminogen activator inhibitor-1 secretion."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15797649"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CRH"}, "span_text": {"type": "literal", "value": "Preeclampsia is associated with impaired regulation of the placental nitric oxide-cyclic guanosine monophosphate pathway by corticotropin-releasing hormone (CRH) and CRH-related peptides."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15784708"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CP"}, "span_text": {"type": "literal", "value": "Maternal serum ceruloplasmin in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15777901"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL2"}, "span_text": {"type": "literal", "value": "Our purpose was to determine the levels of neopterin and interleukin-2 receptor (IL-2R) in pregnant women with severe preeclampsia, and assess the implications of these findings in the pathophysiology of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15756710"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL2"}, "span_text": {"type": "literal", "value": "Serum levels of neopterin and interleukin-2 receptor in women with severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15756710"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Serum levels of soluble fms-like tyrosine kinase 1 (sFlt-1), vascular endothelial growth factor (VEGF), and placental growth factor (PlGF) are altered in women with clinical preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15746665"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Serum levels of soluble fms-like tyrosine kinase 1 (sFlt-1), vascular endothelial growth factor (VEGF), and placental growth factor (PlGF) are altered in women with clinical preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15746665"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Serum levels of soluble fms-like tyrosine kinase 1 (sFlt-1), vascular endothelial growth factor (VEGF), and placental growth factor (PlGF) are altered in women with clinical preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15746665"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Serum levels of soluble fms-like tyrosine kinase 1 (sFlt-1), vascular endothelial growth factor (VEGF), and placental growth factor (PlGF) are altered in women with clinical preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15746665"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Serum levels of soluble fms-like tyrosine kinase 1 (sFlt-1), vascular endothelial growth factor (VEGF), and placental growth factor (PlGF) are altered in women with clinical preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15746665"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Compared to women with uncomplicated pregnancies, those with a history of preeclampsia had significantly elevated levels of fasting serum triglycerides, insulin and glucose, and a higher fasting insulin resistance index, suggesting that women with prior preeclampsia were relatively insulin resistant."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15735370"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Lipid peroxidation, antioxidant defense, status of trace metals and leptin levels in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15734086"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD3"}, "span_text": {"type": "literal", "value": "Polymorphisms in the cytochrome P450 (CYP)1A1 (MspI), CYP1A1(Ile/Val), glutathione S-transferase (GST)M1, GSTT1, myeloperoxidase (MPO), and manganese superoxide dismutase (MnSOD) genes were evaluated by polymerase chain reaction (PCR) or PCR-restriction fragment length polymorphism (RFLP) in 214 healthy controls with an uncomplicated obstetric history, and in 121 preeclampsia patients."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15734083"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD1"}, "span_text": {"type": "literal", "value": "Polymorphisms in the cytochrome P450 (CYP)1A1 (MspI), CYP1A1(Ile/Val), glutathione S-transferase (GST)M1, GSTT1, myeloperoxidase (MPO), and manganese superoxide dismutase (MnSOD) genes were evaluated by polymerase chain reaction (PCR) or PCR-restriction fragment length polymorphism (RFLP) in 214 healthy controls with an uncomplicated obstetric history, and in 121 preeclampsia patients."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15734083"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MPO"}, "span_text": {"type": "literal", "value": "Polymorphisms in the cytochrome P450 (CYP)1A1 (MspI), CYP1A1(Ile/Val), glutathione S-transferase (GST)M1, GSTT1, myeloperoxidase (MPO), and manganese superoxide dismutase (MnSOD) genes were evaluated by polymerase chain reaction (PCR) or PCR-restriction fragment length polymorphism (RFLP) in 214 healthy controls with an uncomplicated obstetric history, and in 121 preeclampsia patients."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15734083"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "The aim of this study was to investigate the changes in serum levels of leptin, cytokines and lipoproteins in women with pre-eclampsia and to evaluate their clinical significance in the pathogenesis of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15726915"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "We found that the pre-eclampsia associated with increases in serum levels of leptin, TNF-alpha, cytokines, triglycerides, total cholesterol and LDL-cholesterol was associated with a significant reduction in serum levels of HDL-cholesterol and Apo-A."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15726915"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "The aim of this study was to investigate the changes in serum levels of leptin, cytokines and lipoproteins in women with pre-eclampsia and to evaluate their clinical significance in the pathogenesis of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15726915"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGFB2"}, "span_text": {"type": "literal", "value": "PL74, a novel member of the transforming growth factor-beta superfamily, is overexpressed in preeclampsia and causes apoptosis in trophoblast cells."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15705926"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGFB1"}, "span_text": {"type": "literal", "value": "PL74, a novel member of the transforming growth factor-beta superfamily, is overexpressed in preeclampsia and causes apoptosis in trophoblast cells."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15705926"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGFB3"}, "span_text": {"type": "literal", "value": "PL74, a novel member of the transforming growth factor-beta superfamily, is overexpressed in preeclampsia and causes apoptosis in trophoblast cells."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15705926"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGT"}, "span_text": {"type": "literal", "value": "We used rats transgenic for the human angiotensinogen (hAogen) gene and the human renin (hRen) gene and crossed the strains to produce a model of preeclampsia in the dams."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15699466"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Serum leptin levels and uterine Doppler flow velocimetry at 20 weeks' gestation as markers for the development of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15697078"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Serum levels of leptin, a protein regulating body weight and secreted by the placenta, are higher in women with severe pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15697078"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Serum leptin levels do not seem to be a useful early marker for the development of pre-eclampsia in the presence of altered uterine blood flow, and may be a late compensatory mechanism or reflect a generalized response of the trophoblast to hypoxic stimuli."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15697078"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "We investigated whether alterations of uterine arteries' Doppler flow velocimetry during the early second-trimester scan were accompanied by changes in leptin levels, and whether these changes might be an early risk factor for pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15697078"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL18"}, "span_text": {"type": "literal", "value": "Serum and placental interleukin-18 are elevated in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15694969"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Insulin resistance increases during the normal course of pregnancy, and is considered an important cause of complications including gestational diabetes mellitus, pregnancy-induced hypertension and preeclampsia (PE)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15694968"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "The potential similar role for nitric oxide synthase involvement in both placental malaria and pre-eclampsia is considered."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15694963"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ANG"}, "span_text": {"type": "literal", "value": "To investigate the role of the angiogenic factors, vascular endothelial growth factor (VEGF) and angiogenin in the pathophysiology of preeclampsia and how their concentrations correlate with the severity of the disease and fetal outcome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15694084"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ANG"}, "span_text": {"type": "literal", "value": "Maternal serum VEGF and angiogenin levels were significantly increased in cases of mild and severe preeclampsia compared to controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15694084"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Angiogenin and vascular endothelial growth factor in pregnancies complicated by preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15694084"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ANG"}, "span_text": {"type": "literal", "value": "Elevated levels of both VEGF and angiogenin could confirm the existence of vascular reactivity and endothelial disturbance in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15694084"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "To investigate the role of the angiogenic factors, vascular endothelial growth factor (VEGF) and angiogenin in the pathophysiology of preeclampsia and how their concentrations correlate with the severity of the disease and fetal outcome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15694084"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Angiogenin and vascular endothelial growth factor in pregnancies complicated by preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15694084"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Angiogenin and vascular endothelial growth factor in pregnancies complicated by preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15694084"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ANG"}, "span_text": {"type": "literal", "value": "Angiogenin and vascular endothelial growth factor in pregnancies complicated by preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15694084"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "To investigate the role of the angiogenic factors, vascular endothelial growth factor (VEGF) and angiogenin in the pathophysiology of preeclampsia and how their concentrations correlate with the severity of the disease and fetal outcome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15694084"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "To investigate the role of the angiogenic factors, vascular endothelial growth factor (VEGF) and angiogenin in the pathophysiology of preeclampsia and how their concentrations correlate with the severity of the disease and fetal outcome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15694084"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD3"}, "span_text": {"type": "literal", "value": "Effect of quercetine and glutathione on the level of superoxide dismutase, catalase, malonyldialdehyde, blood pressure and neonatal outcome in a rat model of pre-eclampsia induced by NG-nitro-L-arginine-methyl ester."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15653201"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CAT"}, "span_text": {"type": "literal", "value": "Effect of quercetine and glutathione on the level of superoxide dismutase, catalase, malonyldialdehyde, blood pressure and neonatal outcome in a rat model of pre-eclampsia induced by NG-nitro-L-arginine-methyl ester."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15653201"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD1"}, "span_text": {"type": "literal", "value": "Effect of quercetine and glutathione on the level of superoxide dismutase, catalase, malonyldialdehyde, blood pressure and neonatal outcome in a rat model of pre-eclampsia induced by NG-nitro-L-arginine-methyl ester."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15653201"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "To anticipate the impact of antioxidant use on lipid peroxidation products, free oxygen radical scavengers, blood pressure (BP), proteinuria and neonatal outcome (as seen in percentage survival, litter birth weight) in a rat model of pre-eclampsia induced by NG-nitro-L-arginine-methyl-ester (L-NAME), an inhibitor of nitric oxide synthase (NOS)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15653201"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "To study the role of insulin resistance in preeclampsia, we compared fasting insulin and glucose changes during the second and third trimesters in preeclamptic women with a normal control group."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15646160"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Women who develop preeclampsia have higher insulin levels before clinical evidence of disease than women who remain normotensive during pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15646160"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Urinary placental growth factor and risk of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15632339"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "We previously demonstrated that high serum levels of soluble fms-like tyrosine kinase 1 (sFlt1), an antiangiogenic protein, and low levels of placental growth factor (PlGF), a proangiogenic protein, predict subsequent development of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15632339"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "We previously demonstrated that high serum levels of soluble fms-like tyrosine kinase 1 (sFlt1), an antiangiogenic protein, and low levels of placental growth factor (PlGF), a proangiogenic protein, predict subsequent development of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15632339"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CALCRL"}, "span_text": {"type": "literal", "value": "The present study was designed to investigate the expression of CGRP receptor components, calcitonin receptor-like receptor (CRLR), and receptor activity modifying protein 1 (RAMP1), and the relaxation response to CGRP in fetoplacental vessels from normotensive pregnant women and women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15623815"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "The results suggest that, in GDM, increased severity of insulin resistance and related features of the 'metabolic syndrome', rather than lipid abnormalities, are precursors to the development of pre-eclampsia and hence are likely to be implicated in the pathophysiology of this disorder."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15614032"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "At diagnosis of GDM, total cholesterol, low-density lipoprotein and high-density lipoprotein cholesterol and triglycerides were not different in women who subsequently developed pre-eclampsia (GDM-PE)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15614032"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Pre-eclampsia is accompanied by high circulating levels of soluble VEGF receptor-1, which forms inactive complexes with VEGF and placental growth factor (PlGF)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15609074"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SHBG"}, "span_text": {"type": "literal", "value": "Second-trimester sex hormone-binding globulin and subsequent development of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15590441"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SHBG"}, "span_text": {"type": "literal", "value": "To investigate whether maternal plasma sex hormone-binding globulin (SHBG) concentrations are reduced in women who subsequently develop pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15590441"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Altered angiogenesis and insulin resistance are associated with preeclampsia and cardiovascular disease (CVD), and women with preeclampsia appear to be at increased risk of future CVD."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15579783"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "We measured fasting insulin, glucose, vascular endothelial growth factor, and its circulating inhibitor, soluble fms-like tyrosine kinase (sFlt-1) in 29 normotensive women with a history of preeclampsia and 32 women with prior normotensive pregnancies at 18.0 +/- 9.7 months postpartum."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15579783"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "We measured fasting insulin, glucose, vascular endothelial growth factor, and its circulating inhibitor, soluble fms-like tyrosine kinase (sFlt-1) in 29 normotensive women with a history of preeclampsia and 32 women with prior normotensive pregnancies at 18.0 +/- 9.7 months postpartum."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15579783"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "We measured fasting insulin, glucose, vascular endothelial growth factor, and its circulating inhibitor, soluble fms-like tyrosine kinase (sFlt-1) in 29 normotensive women with a history of preeclampsia and 32 women with prior normotensive pregnancies at 18.0 +/- 9.7 months postpartum."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15579783"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Preeclampsia and future cardiovascular disease: potential role of altered angiogenesis and insulin resistance."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15579783"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "We measured fasting insulin, glucose, vascular endothelial growth factor, and its circulating inhibitor, soluble fms-like tyrosine kinase (sFlt-1) in 29 normotensive women with a history of preeclampsia and 32 women with prior normotensive pregnancies at 18.0 +/- 9.7 months postpartum."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15579783"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "We measured fasting insulin, glucose, vascular endothelial growth factor, and its circulating inhibitor, soluble fms-like tyrosine kinase (sFlt-1) in 29 normotensive women with a history of preeclampsia and 32 women with prior normotensive pregnancies at 18.0 +/- 9.7 months postpartum."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15579783"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CTSD"}, "span_text": {"type": "literal", "value": "Preeclampsia is associated with a reduction in the activity of cathepsin D in human umbilical cord."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15563888"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CTSD"}, "span_text": {"type": "literal", "value": "It was decided to evaluate the activity of cathepsin D within umbilical cord arteries, veins and Wharton's jelly and its alterations in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15563888"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "The aim of this study was to assess the concentration of oxidized low density lipoprotein (oxLDL), a novel marker for lipid peroxidation, and that of the thiobarbituric acid reactive substances (TBARS) in the pathogenesis of severe preeclampsia and to investigate the influence of gestational age on these parameters."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15548151"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Low plasma levels of oxidized low density lipoprotein in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15548151"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Few investigators have simultaneously evaluated leptin, soluble leptin receptor (SLR) and leptin gene polymorphisms in preeclampsia cases and controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15544427"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Larger studies would be needed to confirm and further clarify the relations between functional variants in the leptin gene and preeclampsia risk."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15544427"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Leptin, soluble leptin receptor and leptin gene polymorphism in relation to preeclampsia risk."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15544427"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEPR"}, "span_text": {"type": "literal", "value": "Few investigators have simultaneously evaluated leptin, soluble leptin receptor (SLR) and leptin gene polymorphisms in preeclampsia cases and controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15544427"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEPR"}, "span_text": {"type": "literal", "value": "Leptin, soluble leptin receptor and leptin gene polymorphism in relation to preeclampsia risk."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15544427"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Is there any link between insulin resistance and inflammation in established preeclampsia?"}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15536597"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Both insulin resistance and inflammation may contribute to the onset of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15536597"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "We conclude that insulin resistance and the inflammatory markers studied were not associated in established preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15536597"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "The role of lipoprotein (a) in pregnancies complicated by pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15533635"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "In this paper, we discuss three hypotheses about the mechanisms by which lipoprotein (a) may be associated with pre-eclampsia:"}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15533635"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Soluble vascular endothelial growth factor receptor-1 (sFlt-1) is increased throughout gestation in patients who have preeclampsia develop."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15507947"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "This study was undertaken to analyze prospectively circulating vascular endothelial growth factor (VEGF) and its soluble receptor, (s) Flt-1, throughout normotensive and preeclamptic pregnancies and to assess the importance of these proteins in the development of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15507947"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Soluble vascular endothelial growth factor receptor-1 (sFlt-1) is increased throughout gestation in patients who have preeclampsia develop."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15507947"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Soluble vascular endothelial growth factor receptor-1 (sFlt-1) is increased throughout gestation in patients who have preeclampsia develop."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15507947"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "This study was undertaken to analyze prospectively circulating vascular endothelial growth factor (VEGF) and its soluble receptor, (s) Flt-1, throughout normotensive and preeclamptic pregnancies and to assess the importance of these proteins in the development of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15507947"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "This study was undertaken to analyze prospectively circulating vascular endothelial growth factor (VEGF) and its soluble receptor, (s) Flt-1, throughout normotensive and preeclamptic pregnancies and to assess the importance of these proteins in the development of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15507947"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TCF4"}, "span_text": {"type": "literal", "value": "Although enhanced apoptosis is well known in placentas with preeclampsia, the role of transcription factor nuclear factor-kappa B (NF-kappa B) in the process is still being debated."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15502418"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CASP3"}, "span_text": {"type": "literal", "value": "In this work, we investigate the relationship between NF-kappa B expression and trophoblastic cell apoptosis in pregnancies complicated with preeclampsia or intrauterine growth restriction (IUGR) by immunohistochemical analysis of NF-kappa B and three apoptosis related markers: bcl-2, caspase-3, and M30 CytoDeath antibody that identifies early apoptotic changes in the cytoskeleton related to action of caspase."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15502418"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CASP3"}, "span_text": {"type": "literal", "value": "The three conclusions from the statistical analysis of the data are obtained; (i) Significantly higher expression of NF-kappa B in IUGR-complicated (p = 0.003) and preeclamptic placentas (p = 0.004) than the control placentas, (ii) significantly higher M30 index and caspase 3 expression in IUGR and preeclampsia placentas (p = 0.003), and (iii) decreased expression of bcl-2 in IUGR and preeclampsia placentas (p = 0.001)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15502418"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:DDAH1"}, "span_text": {"type": "literal", "value": "Association between pre-eclampsia (PEE1) and the dimethylarginine dimethylaminohydrolase (DDAH) 1 and 2 genes, which play a role in the regulation of nitric oxide synthesis and release, was studied."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15501905"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOM"}, "span_text": {"type": "literal", "value": "Serum MDA and DeltaMDA levels of apolipoprotein B-containing lipoproteins were significantly higher in both mild and severe preeclampsia groups than in the normal pregnant group."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15498527"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Oxidizability of apolipoprotein B-containing lipoproteins and serum paraoxonase/arylesterase activities in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15498527"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOO"}, "span_text": {"type": "literal", "value": "Enhancement in oxidizability of apolipoprotein B-containing lipoproteins accompanying with dyslipidemia and increased serum MDA levels suggests that those lipoproteins play a role in the pathogenesis of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15498527"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOO"}, "span_text": {"type": "literal", "value": "The aim of the present study was to evaluate oxidizability of apolipoprotein B-containing lipoproteins and serum paraoxonase/arylesterase activities in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15498527"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOO"}, "span_text": {"type": "literal", "value": "Serum MDA and DeltaMDA levels of apolipoprotein B-containing lipoproteins were significantly higher in both mild and severe preeclampsia groups than in the normal pregnant group."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15498527"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOE"}, "span_text": {"type": "literal", "value": "Oxidizability of apolipoprotein B-containing lipoproteins and serum paraoxonase/arylesterase activities in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15498527"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Lipoprotein oxidation has been implicated in the pathogenesis of preeclampsia and paraoxonase, an antioxidant enzyme shown to protect lipoproteins from being oxidized."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15498527"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOF"}, "span_text": {"type": "literal", "value": "Enhancement in oxidizability of apolipoprotein B-containing lipoproteins accompanying with dyslipidemia and increased serum MDA levels suggests that those lipoproteins play a role in the pathogenesis of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15498527"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOM"}, "span_text": {"type": "literal", "value": "The aim of the present study was to evaluate oxidizability of apolipoprotein B-containing lipoproteins and serum paraoxonase/arylesterase activities in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15498527"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOE"}, "span_text": {"type": "literal", "value": "Serum MDA and DeltaMDA levels of apolipoprotein B-containing lipoproteins were significantly higher in both mild and severe preeclampsia groups than in the normal pregnant group."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15498527"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOM"}, "span_text": {"type": "literal", "value": "Oxidizability of apolipoprotein B-containing lipoproteins and serum paraoxonase/arylesterase activities in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15498527"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOM"}, "span_text": {"type": "literal", "value": "Enhancement in oxidizability of apolipoprotein B-containing lipoproteins accompanying with dyslipidemia and increased serum MDA levels suggests that those lipoproteins play a role in the pathogenesis of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15498527"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOF"}, "span_text": {"type": "literal", "value": "Serum MDA and DeltaMDA levels of apolipoprotein B-containing lipoproteins were significantly higher in both mild and severe preeclampsia groups than in the normal pregnant group."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15498527"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Enhancement in oxidizability of apolipoprotein B-containing lipoproteins accompanying with dyslipidemia and increased serum MDA levels suggests that those lipoproteins play a role in the pathogenesis of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15498527"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Serum MDA and DeltaMDA levels of apolipoprotein B-containing lipoproteins were significantly higher in both mild and severe preeclampsia groups than in the normal pregnant group."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15498527"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOF"}, "span_text": {"type": "literal", "value": "The aim of the present study was to evaluate oxidizability of apolipoprotein B-containing lipoproteins and serum paraoxonase/arylesterase activities in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15498527"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOF"}, "span_text": {"type": "literal", "value": "Oxidizability of apolipoprotein B-containing lipoproteins and serum paraoxonase/arylesterase activities in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15498527"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "The aim of the present study was to evaluate oxidizability of apolipoprotein B-containing lipoproteins and serum paraoxonase/arylesterase activities in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15498527"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOE"}, "span_text": {"type": "literal", "value": "Enhancement in oxidizability of apolipoprotein B-containing lipoproteins accompanying with dyslipidemia and increased serum MDA levels suggests that those lipoproteins play a role in the pathogenesis of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15498527"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOE"}, "span_text": {"type": "literal", "value": "The aim of the present study was to evaluate oxidizability of apolipoprotein B-containing lipoproteins and serum paraoxonase/arylesterase activities in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15498527"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOO"}, "span_text": {"type": "literal", "value": "Oxidizability of apolipoprotein B-containing lipoproteins and serum paraoxonase/arylesterase activities in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15498527"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP3"}, "span_text": {"type": "literal", "value": "The present study was carried out to compare serum levels of leptin, insulin-like growth factor-I (IGF-I), insulin-like growth factor binding protein-3 (IGFBP-3), homeostasis model assessment--(pancreatic beta-cell function) (HOMA-(%B)) and homeostasis model assessment--(tissue insulin sensitivity) (HOMA-(%S)) in women with mild and severe pre-eclampsia and normotensive pregnant women; and to evaluate the possible relationships between these parameters in the pathogenesis of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15497497"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF2"}, "span_text": {"type": "literal", "value": "Serum levels of leptin, insulin-like growth factor-I and insulin-like growth factor binding protein-3 in women with pre-eclampsia, and their relationship to insulin resistance."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15497497"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP3"}, "span_text": {"type": "literal", "value": "Serum levels of leptin, insulin-like growth factor-I and insulin-like growth factor binding protein-3 in women with pre-eclampsia, and their relationship to insulin resistance."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15497497"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Therefore we think that hyperleptinemia, low IGF-I or IGFBP-3, and insulin resistance may contribute to the pathogenesis of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15497497"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Serum levels of leptin, insulin-like growth factor-I and insulin-like growth factor binding protein-3 in women with pre-eclampsia, and their relationship to insulin resistance."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15497497"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "We conclude that pre-eclampsia is associated with insulin resistance; and that existing hyperinsulinemia and insulin resistance in women with pre-eclampsia seem not to correlate with leptin and birth weight, but may correlate positively with IGF-1 and IGFBP-3."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15497497"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF1"}, "span_text": {"type": "literal", "value": "Serum levels of leptin, insulin-like growth factor-I and insulin-like growth factor binding protein-3 in women with pre-eclampsia, and their relationship to insulin resistance."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15497497"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF2"}, "span_text": {"type": "literal", "value": "The present study was carried out to compare serum levels of leptin, insulin-like growth factor-I (IGF-I), insulin-like growth factor binding protein-3 (IGFBP-3), homeostasis model assessment--(pancreatic beta-cell function) (HOMA-(%B)) and homeostasis model assessment--(tissue insulin sensitivity) (HOMA-(%S)) in women with mild and severe pre-eclampsia and normotensive pregnant women; and to evaluate the possible relationships between these parameters in the pathogenesis of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15497497"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "The present study was carried out to compare serum levels of leptin, insulin-like growth factor-I (IGF-I), insulin-like growth factor binding protein-3 (IGFBP-3), homeostasis model assessment--(pancreatic beta-cell function) (HOMA-(%B)) and homeostasis model assessment--(tissue insulin sensitivity) (HOMA-(%S)) in women with mild and severe pre-eclampsia and normotensive pregnant women; and to evaluate the possible relationships between these parameters in the pathogenesis of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15497497"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "The present study was carried out to compare serum levels of leptin, insulin-like growth factor-I (IGF-I), insulin-like growth factor binding protein-3 (IGFBP-3), homeostasis model assessment--(pancreatic beta-cell function) (HOMA-(%B)) and homeostasis model assessment--(tissue insulin sensitivity) (HOMA-(%S)) in women with mild and severe pre-eclampsia and normotensive pregnant women; and to evaluate the possible relationships between these parameters in the pathogenesis of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15497497"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF1"}, "span_text": {"type": "literal", "value": "The present study was carried out to compare serum levels of leptin, insulin-like growth factor-I (IGF-I), insulin-like growth factor binding protein-3 (IGFBP-3), homeostasis model assessment--(pancreatic beta-cell function) (HOMA-(%B)) and homeostasis model assessment--(tissue insulin sensitivity) (HOMA-(%S)) in women with mild and severe pre-eclampsia and normotensive pregnant women; and to evaluate the possible relationships between these parameters in the pathogenesis of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15497497"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "We conclude that pre-eclampsia is associated with insulin resistance; and that existing hyperinsulinemia and insulin resistance in women with pre-eclampsia seem not to correlate with leptin and birth weight, but may correlate positively with IGF-1 and IGFBP-3."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15497497"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Serum levels of leptin, insulin-like growth factor-I and insulin-like growth factor binding protein-3 in women with pre-eclampsia, and their relationship to insulin resistance."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15497497"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "Plasma albumin level as an indicator of severity of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15491066"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "Serum albumin levels may serve as an indicator of the severity of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15491066"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15472115"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Preeclampsia is an inflammatory disorder in which serum levels of vascular endothelial growth factor (VEGF) and its soluble receptor-1 (sVEGFR-1, also known as sFlt-1) are elevated."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15472115"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15472115"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Preeclampsia is an inflammatory disorder in which serum levels of vascular endothelial growth factor (VEGF) and its soluble receptor-1 (sVEGFR-1, also known as sFlt-1) are elevated."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15472115"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15472115"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Preeclampsia is an inflammatory disorder in which serum levels of vascular endothelial growth factor (VEGF) and its soluble receptor-1 (sVEGFR-1, also known as sFlt-1) are elevated."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15472115"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ICAM1"}, "span_text": {"type": "literal", "value": "The IL-1beta (C-511T), IL-6 (G-174C), TNF-alpha (G-308A), E-selectin (S128R), intercellular adhesion molecule-1 (K469E), and C-reactive protein (C1059G) polymorphisms were not associated with risk of developing preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15452036"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TCF4"}, "span_text": {"type": "literal", "value": "Placentas from women with preeclampsia overexpress the hypoxia-inducible transcription factor proteins, HIF-1alpha and -2alpha (Rajakumar 2001, Biol Reprod 64; p499-506 and p1019-1020)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15451190"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "The effects of concentrated salt-poor albumin on the metabolism and excretion of water and electrolytes in nephrosis and toxemia of pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15436668"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CRH"}, "span_text": {"type": "literal", "value": "Circulating corticotropin-releasing hormone mRNA in maternal plasma: relationship with gestational age and severity of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15388664"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MTHFR"}, "span_text": {"type": "literal", "value": "Association of pre-eclampsia with hyperhomocysteinaemia and methylenetetrahydrofolate reductase gene C677T polymorphism in a Turkish population."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15387863"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEPR"}, "span_text": {"type": "literal", "value": "This study investigated the expression profile of placental leptin and leptin receptor isoforms in preeclampsia, using placental tissue from normal pregnancies that were matched in gestational age and birth weight as controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15381908"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Expression of placental leptin and leptin receptors in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15381908"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "RT-PCR showed significantly higher levels of mRNA transcripts of leptin in severe preeclampsia (p < 0.05), but not mild preeclampsia (p > 0.05), compared with normal controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15381908"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Both the severe and mild preeclampsia groups showed significantly higher immunostaining for leptin compared with normal controls (p < 0.05), but there was no significant difference between the severe and mild preeclampsia groups (p > 0.05)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15381908"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "This study investigated the expression profile of placental leptin and leptin receptor isoforms in preeclampsia, using placental tissue from normal pregnancies that were matched in gestational age and birth weight as controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15381908"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "In conclusion, we confirmed an up-regulated expression of leptin in placental tissue in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15381908"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "The leptin signal probably does not play a major primary role in the pathogenesis of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15381908"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEPR"}, "span_text": {"type": "literal", "value": "There was no significant difference in immunostaining for leptin receptor between both severe and mild preeclampsia compared with controls (p > 0.05)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15381908"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEPR"}, "span_text": {"type": "literal", "value": "Expression of placental leptin and leptin receptors in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15381908"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:RETN"}, "span_text": {"type": "literal", "value": "In conclusion, we found an increase in serum resistin in the third trimester of normal pregnancy, but this increase was not present in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15377276"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:RETN"}, "span_text": {"type": "literal", "value": "Alterations of serum resistin in normal pregnancy and pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15377276"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:RETN"}, "span_text": {"type": "literal", "value": "Serum resistin level was significantly lower in women with pre-eclampsia than women in the third trimester of normal pregnancy (P<0.001), but was comparable with those of non-pregnant women and women in the first and second trimesters of pregnancy (P>0.05 for all)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15377276"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:RETN"}, "span_text": {"type": "literal", "value": "However, changes in serum resistin levels in normal pregnancy and in the setting of pre-eclampsia are far from understood."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15377276"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:RETN"}, "span_text": {"type": "literal", "value": "The purpose of the present study was to clarify the alterations in serum resistin level in normal pregnancy and pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15377276"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL22"}, "span_text": {"type": "literal", "value": "Molecules associated with the establishment of the placenta and essential in fetal-maternal interactions, like interleukin 2-receptor, insulinlike growth factor-1, and insulinlike growth factor binding protein-1, placenta growth factor, hepatocyte growth factor, inhibin A, activin A, and human chorionic gonadotrophin seem to be the most likely candidates for presymptomatic markers for preeclampsia and/or intrauterine growth restriction."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15369650"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL27"}, "span_text": {"type": "literal", "value": "Molecules associated with the establishment of the placenta and essential in fetal-maternal interactions, like interleukin 2-receptor, insulinlike growth factor-1, and insulinlike growth factor binding protein-1, placenta growth factor, hepatocyte growth factor, inhibin A, activin A, and human chorionic gonadotrophin seem to be the most likely candidates for presymptomatic markers for preeclampsia and/or intrauterine growth restriction."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15369650"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL26"}, "span_text": {"type": "literal", "value": "Molecules associated with the establishment of the placenta and essential in fetal-maternal interactions, like interleukin 2-receptor, insulinlike growth factor-1, and insulinlike growth factor binding protein-1, placenta growth factor, hepatocyte growth factor, inhibin A, activin A, and human chorionic gonadotrophin seem to be the most likely candidates for presymptomatic markers for preeclampsia and/or intrauterine growth restriction."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15369650"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL2"}, "span_text": {"type": "literal", "value": "Molecules associated with the establishment of the placenta and essential in fetal-maternal interactions, like interleukin 2-receptor, insulinlike growth factor-1, and insulinlike growth factor binding protein-1, placenta growth factor, hepatocyte growth factor, inhibin A, activin A, and human chorionic gonadotrophin seem to be the most likely candidates for presymptomatic markers for preeclampsia and/or intrauterine growth restriction."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15369650"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL24"}, "span_text": {"type": "literal", "value": "Molecules associated with the establishment of the placenta and essential in fetal-maternal interactions, like interleukin 2-receptor, insulinlike growth factor-1, and insulinlike growth factor binding protein-1, placenta growth factor, hepatocyte growth factor, inhibin A, activin A, and human chorionic gonadotrophin seem to be the most likely candidates for presymptomatic markers for preeclampsia and/or intrauterine growth restriction."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15369650"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HGF"}, "span_text": {"type": "literal", "value": "Molecules associated with the establishment of the placenta and essential in fetal-maternal interactions, like interleukin 2-receptor, insulinlike growth factor-1, and insulinlike growth factor binding protein-1, placenta growth factor, hepatocyte growth factor, inhibin A, activin A, and human chorionic gonadotrophin seem to be the most likely candidates for presymptomatic markers for preeclampsia and/or intrauterine growth restriction."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15369650"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VWF"}, "span_text": {"type": "literal", "value": "Preeclampsia, von Willebrand factor antigen, and endothelial cells."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/1536264"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "We conclude that increased endothelin-1 production may play a role in the pathogenesis of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/1536245"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Among the patients with preeclampsia there was no correlation between endothelin-1 levels and the mean arterial blood pressure."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/1536245"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Endothelin-1 levels were measured by means of radioimmunoassay in the serum of 26 pregnant women with hypertension (14 with pregnancy-induced preeclamptic toxemia, 12 with chronic hypertension) and in the serum of 17 control pregnant women and 18 control nonpregnant women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/1536245"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Leptin in the fetomaternal circulation is proposed to be a marker of acute stress in the fetus, and the fetus suffering from pre-eclampsia would be under chronic stress."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15346662"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Compelling evidence has been brought forth suggesting that fms-like tyrosine kinase 1 is a circulating factor that can cause preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15339993"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "Atrial natriuretic peptide concentrations and hemodynamic effects of acute plasma volume expansion in normal pregnancy and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/1533708"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MTHFR"}, "span_text": {"type": "literal", "value": "Polymorphisms in the thrombophilia genes [plasminogen activator inhibitor type 1 [PAI-1 -675(4G/5G)], thrombin activatable fibrinolysis inhibitor (TAFI -438G/A and 1040C/T), methylenetetrahydrofolate reductase (MTHFR 677C/T), factor V (FV Leiden R/Q506), prothrombin (FII 20210G/A) and factor XIIIA (FXIIIA V/L34)] were determined in 157 women with preeclampsia and 157 women with uncomplicated pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15333035"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "Increases in plasma atrial natriuretic peptide concentration antedate clinical evidence of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/1533228"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MTHFR"}, "span_text": {"type": "literal", "value": "Association of C677T polymorphism in the methylenetetrahydrofolate reductase gene with hypertension in pregnancy and pre-eclampsia: a meta-analysis."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15311088"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Fetal cord plasma lipoprotein status in uncomplicated human pregnancies and in pregnancies complicated by pre-eclampsia and intrauterine growth restriction."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15306192"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGT"}, "span_text": {"type": "literal", "value": "Associations of polymorphisms of the angiotensinogen M235 polymorphism and angiotensin-converting-enzyme intron 16 insertion/deletion polymorphism with preeclampsia in Korean women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15294367"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGT"}, "span_text": {"type": "literal", "value": "We performed a hospital-based case-control study on Korean women to investigate the association between preeclampsia and the angiotensinogen M235T polymorphism and also to determine the association between preeclampsia and the angiotensin-converting-enzyme intron 16 polymorphism."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15294367"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGT"}, "span_text": {"type": "literal", "value": "However, there has not been any study done on the association between preeclampsia and the angiotensinogen (AGT) M235T polymorphism and angiotensin-converting-enzyme (ACE) intron 16 insertion/deletion (I/D) polymorphism among Korean preeclampsia women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15294367"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Soluble vascular endothelial growth factor receptor 1 (sVEGFR-1), which antagonizes VEGF functions, has been implicated in the pathophysiology of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15284729"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15284729"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Soluble vascular endothelial growth factor receptor 1 (sVEGFR-1), which antagonizes VEGF functions, has been implicated in the pathophysiology of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15284729"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15284729"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15284729"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Soluble vascular endothelial growth factor receptor 1 (sVEGFR-1), which antagonizes VEGF functions, has been implicated in the pathophysiology of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15284729"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Cytotrophoblasts up-regulate soluble fms-like tyrosine kinase-1 expression under reduced oxygen: an implication for the placental vascular development and the pathophysiology of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15284201"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Elevated plasma leptin concentration and maternal overweight status appear to be independently associated with an increased risk of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15280145"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "We observed evidence of a strong linear component of trend in risk of pre-eclampsia with increasing maternal plasma leptin concentration."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15280145"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "We measured maternal plasma leptin concentrations in 55 women with pre-eclampsia and 487 normotensive women to determine whether elevated leptin concentrations were associated with the occurrence of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15280145"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Overweight women with elevated leptin concentrations experienced the highest risk of pre-eclampsia (OR 6.4; 95% CI 3.1-13.2) as compared with lean women with no leptin elevations."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15280145"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Each 10-ng/ml increase in leptin concentration was associated with a 30% increase in pre-eclampsia risk (OR 1.3; 95% CI 1.1-1.5)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15280145"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Relationship of maternal plasma leptin and risk of pre-eclampsia: a prospective study."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15280145"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Relative to women with leptin concentrations of < 27.4 ng/ml, those with elevated leptin concentrations (> or = 27.4 ng/ml) experienced a 2.3-fold increased risk of pre-eclampsia (OR 2.3; 95% CI 1.1-4.6)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15280145"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MTHFR"}, "span_text": {"type": "literal", "value": "A missense mutation 677 C-->T in the gene for methylenetetrahydrofolate reductase (MTHFR) has been associated with an increased pre-eclampsia risk in some, although not most, previously studied populations."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15280126"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MTHFR"}, "span_text": {"type": "literal", "value": "Methylenetetrahydrofolate reductase 677 C-->T polymorphism and plasma folate in relation to pre-eclampsia risk among Peruvian women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15280126"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Pre-eclampsia, characterised by insulin resistance, widespread endothelial damage and dysfunction, coagulation defects and increased systemic inflammatory response, shares many risk factors with CVD."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15262174"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Furthermore, it is uncertain whether women destined to develop pre-eclampsia have a pre-existing insulin resistance or whether it is acquired with the development of the disease."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15255279"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Insulin resistance occurs in pre-eclampsia, but the cause is unknown."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15255279"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Fasting plasma samples were obtained from ten women who subsequently developed pre-eclampsia and ten normal pregnant controls at 16, 20, 24, 28, 32 and 36 weeks' gestation to measure circulating levels of insulin, glucose and TNF-alpha."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15255279"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Insulin resistance and pre-eclampsia: a role for tumor necrosis factor-alpha?"}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15255279"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "We carried out this study to test the hypotheses that the increase in insulin resistance associated with pre-eclampsia is related to higher levels of tumor necrosis factor (TNF)-alpha, and that the increase in insulin resistance precedes the clinical onset of the disease."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15255279"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "In the group of women who developed pre-eclampsia, plasma levels of insulin and the FIRI were significantly higher than baseline from 20 and 24 weeks, respectively, but both were significantly higher than in the control group at 32 and 36 weeks."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15255279"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "These data suggest that insulin resistance in pre-eclampsia precedes the clinical onset of the disease, but that it is not related to elevated levels of TNF-alpha."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15255279"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX1"}, "span_text": {"type": "literal", "value": "Plasma xanthine oxidase, superoxide dismutase and glutathione peroxidase activities and uric acid levels in severe and mild pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15248180"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD3"}, "span_text": {"type": "literal", "value": "Plasma xanthine oxidase, superoxide dismutase and glutathione peroxidase activities and uric acid levels in severe and mild pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15248180"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD1"}, "span_text": {"type": "literal", "value": "The aim of the present study was to measure plasma uric acid (UA) levels and superoxide dismutase (SOD), glutathione peroxidase (GSH-Px) and xanthine oxidase (XO) activities and to evaluate the relationship between these parameters and the severity of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15248180"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX3"}, "span_text": {"type": "literal", "value": "Plasma xanthine oxidase, superoxide dismutase and glutathione peroxidase activities and uric acid levels in severe and mild pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15248180"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD1"}, "span_text": {"type": "literal", "value": "Plasma xanthine oxidase, superoxide dismutase and glutathione peroxidase activities and uric acid levels in severe and mild pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15248180"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD3"}, "span_text": {"type": "literal", "value": "The aim of the present study was to measure plasma uric acid (UA) levels and superoxide dismutase (SOD), glutathione peroxidase (GSH-Px) and xanthine oxidase (XO) activities and to evaluate the relationship between these parameters and the severity of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15248180"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX2"}, "span_text": {"type": "literal", "value": "Plasma xanthine oxidase, superoxide dismutase and glutathione peroxidase activities and uric acid levels in severe and mild pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15248180"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX2"}, "span_text": {"type": "literal", "value": "The aim of the present study was to measure plasma uric acid (UA) levels and superoxide dismutase (SOD), glutathione peroxidase (GSH-Px) and xanthine oxidase (XO) activities and to evaluate the relationship between these parameters and the severity of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15248180"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX1"}, "span_text": {"type": "literal", "value": "The aim of the present study was to measure plasma uric acid (UA) levels and superoxide dismutase (SOD), glutathione peroxidase (GSH-Px) and xanthine oxidase (XO) activities and to evaluate the relationship between these parameters and the severity of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15248180"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX3"}, "span_text": {"type": "literal", "value": "The aim of the present study was to measure plasma uric acid (UA) levels and superoxide dismutase (SOD), glutathione peroxidase (GSH-Px) and xanthine oxidase (XO) activities and to evaluate the relationship between these parameters and the severity of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15248180"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF2"}, "span_text": {"type": "literal", "value": "Longitudinal changes in maternal serum 1,25-dihydroxyvitamin D and insulin like growth factor I levels in pregnant women who developed preeclampsia: comparison with normotensive pregnant women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15225837"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF1"}, "span_text": {"type": "literal", "value": "This study was undertaken to determine the longitudinal changes of serum 1,25-dihydroxyvitamin D (1,25-(OH)(2)D) and insulin like growth factor I (IGF-I) levels at 20.7, 27.6, and 35.5 week periods of gestation in 40 pregnant women who remained normotensive (NT) and in 10 women who developed preeclampsia (PE)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15225837"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF1"}, "span_text": {"type": "literal", "value": "Longitudinal changes in maternal serum 1,25-dihydroxyvitamin D and insulin like growth factor I levels in pregnant women who developed preeclampsia: comparison with normotensive pregnant women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15225837"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF2"}, "span_text": {"type": "literal", "value": "This study was undertaken to determine the longitudinal changes of serum 1,25-dihydroxyvitamin D (1,25-(OH)(2)D) and insulin like growth factor I (IGF-I) levels at 20.7, 27.6, and 35.5 week periods of gestation in 40 pregnant women who remained normotensive (NT) and in 10 women who developed preeclampsia (PE)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15225837"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Auto antibodies against oxidized low density lipoprotein in severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15210040"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VCAM1"}, "span_text": {"type": "literal", "value": "Soluble vascular cell adhesion molecule-1 (sVCAM-1), a specific marker of endothelial dysfunction, is elevated in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15205565"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VCAM1"}, "span_text": {"type": "literal", "value": "Hyperhomocyst(e)inemia and elevated soluble vascular cell adhesion molecule-1 concentrations are associated with an increased risk of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15205565"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EFNA1"}, "span_text": {"type": "literal", "value": "In preeclampsia, where trophoblast invasion is shallow, we observed ephrin-A1 expression similar to normal placenta."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15193868"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EFNA1"}, "span_text": {"type": "literal", "value": "Failure of ephrin-A1 expression is unlikely to be the primary cause in defective migration of trophoblasts observed in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15193868"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LOC100505909"}, "span_text": {"type": "literal", "value": "Histidine-rich glycoprotein (HRG) in uncomplicated pregnancy and mild and moderate preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/1519219"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HRG"}, "span_text": {"type": "literal", "value": "Histidine-rich glycoprotein (HRG) in uncomplicated pregnancy and mild and moderate preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/1519219"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EPO"}, "span_text": {"type": "literal", "value": "The purpose of the present study was to compare fetal and neonatal outcomes with amniotic fluid erythropoietin (EPO) levels obtained in the antepartum period in pregnancies complicated by preeclampsia, pregnancy-induced hypertension or chronic hypertension."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15188798"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EPO"}, "span_text": {"type": "literal", "value": "Amniotic fluid and cord plasma erythropoietin levels in pregnancies complicated by preeclampsia, pregnancy-induced hypertension and chronic hypertension."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15188798"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PDE5A"}, "span_text": {"type": "literal", "value": "Our aim was to test that phosphodiesterase 5 (PDE5) inhibition could improve endothelium-dependent function in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15167831"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MTHFR"}, "span_text": {"type": "literal", "value": "A mutation in the 5,10-methylenetetrahydrofolate reductase gene is not associated with preeclampsia in women of southeast Mexico."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15163465"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Maternal serum and CSF leptin concentrations obtained in the third trimester of the gestation were compared in 16 women with mild preeclampsia and 23 normotensive pregnant women who underwent cesarean section."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15144331"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "To determine whether cerebrospinal fluid (CSF) and circulating levels of leptin differ between women with preeclampsia and women who had an uncomplicated pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15144331"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Cerebrospinal fluid leptin levels in preeclampsia: relation to maternal serum leptin levels."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15144331"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "CONCLUSIONS: CSF and serum leptin levels were similar in patients with preeclampsia and normotensive pregnant women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15144331"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "CSF leptin levels are inversely related to the serum leptin concentrations in preeclamptic patients (r = -0.87, p = 0.000)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15144331"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Mean CSF leptin concentrations were not significantly different between the two groups (preeclampsia 9.7 +/- 4.2 ng/mL, normotensive 13.6 +/- 4.3 ng/mL, p = 0.952)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15144331"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Similarly, mean serum leptin concentrations were similar between the two groups (mild preeclampsia 21.7 +/- 7.1 ng/mL, normotensive 18.3 +/- 6.7 ng/mL, p = 0.698)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15144331"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "We also found the endothelin-1 and antioxidant levels significantly elevated in preeclampsia patients compared with normotensive subjects, whereas no differences were seen between the groups regarding nitrite/nitrate levels."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15121565"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "No association of the Asp298 variant of the endothelial nitric oxide synthase gene with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15110896"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HFE"}, "span_text": {"type": "literal", "value": "Preeclampsia and the C282Y mutation in the hemochromatosis (HFE) gene."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15105363"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGTR1"}, "span_text": {"type": "literal", "value": "The angiotensin-converting enzyme (ACE) insertion/deletion, angiotensinogen M235T and angiotensin II receptor type 1 1166A<--C polymorphisms were assessed in study groups comprising 204 women with pre-eclampsia, 120 with eclampsia, 67 with early onset pre-eclampsia and 78 with gestational hypertension."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15097234"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGT"}, "span_text": {"type": "literal", "value": "The angiotensin-converting enzyme (ACE) insertion/deletion, angiotensinogen M235T and angiotensin II receptor type 1 1166A<--C polymorphisms were assessed in study groups comprising 204 women with pre-eclampsia, 120 with eclampsia, 67 with early onset pre-eclampsia and 78 with gestational hypertension."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15097234"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Elevated levels of the soluble vascular endothelial growth factor receptor 1, which binds and inhibits circulating forms of VEGF were identified in patients with preeclampsia; rats injected with this soluble receptor develop hypertension, endotheliosis and proteinuria, similar to the lesion seen in podocyte-specific haploinsufficient VEGF mice."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15090854"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Elevated levels of the soluble vascular endothelial growth factor receptor 1, which binds and inhibits circulating forms of VEGF were identified in patients with preeclampsia; rats injected with this soluble receptor develop hypertension, endotheliosis and proteinuria, similar to the lesion seen in podocyte-specific haploinsufficient VEGF mice."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15090854"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Elevated levels of the soluble vascular endothelial growth factor receptor 1, which binds and inhibits circulating forms of VEGF were identified in patients with preeclampsia; rats injected with this soluble receptor develop hypertension, endotheliosis and proteinuria, similar to the lesion seen in podocyte-specific haploinsufficient VEGF mice."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15090854"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL10"}, "span_text": {"type": "literal", "value": "Interleukin 10-2849AA genotype protects against pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15085177"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGT"}, "span_text": {"type": "literal", "value": "In conclusion, a molecular variant of ACE, but not angiotensinogen, gene is associated with preeclampsia in Korean women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15082899"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGT"}, "span_text": {"type": "literal", "value": "The frequency of T allele of angiotensinogen T174M gene was slightly increased, but not significantly, in preeclampsia (0.11) than in controls (0.07)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15082899"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGT"}, "span_text": {"type": "literal", "value": "We tested the hypothesis that angiotensin-converting enzyme (ACE) and angiotensinogen gene polymorphism influence the incidence, development and outcome of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15082899"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGT"}, "span_text": {"type": "literal", "value": "There was no difference in the frequency of a allele of angiotensinogen M235T between the groups (0.79:0.78 in preeclampsia : controls)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15082899"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGT"}, "span_text": {"type": "literal", "value": "Association of Angiotensin-converting enzyme and angiotensinogen gene polymorphisms with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15082899"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:G6PD"}, "span_text": {"type": "literal", "value": "Glucose 6 phosphate dehydrogenase (G6PD) deficiency is a possible risk factor for the development of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15082106"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TCF4"}, "span_text": {"type": "literal", "value": "Our results suggest that GCM1 is a distinct transcription factor involved in placental disease and altered expression of the GCM1 gene may contribute to the etiology of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15081636"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "High levels of urinary vascular endothelial growth factor in women with severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15077930"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "High levels of urinary vascular endothelial growth factor in women with severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15077930"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "High levels of urinary vascular endothelial growth factor in women with severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15077930"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGFB2"}, "span_text": {"type": "literal", "value": "In a case-control study of 100 preeclamptics and 100 controls, we assessed plasma transforming growth factor-beta1 (TGF-beta1) concentrations in relation to preeclampsia risk among Peruvian women with and without systemic inflammation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15062887"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGFB1"}, "span_text": {"type": "literal", "value": "Transforming growth factor-beta1 (TGF-beta1) in plasma is associated with preeclampsia risk in Peruvian women with systemic inflammation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15062887"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGFB1"}, "span_text": {"type": "literal", "value": "In a case-control study of 100 preeclamptics and 100 controls, we assessed plasma transforming growth factor-beta1 (TGF-beta1) concentrations in relation to preeclampsia risk among Peruvian women with and without systemic inflammation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15062887"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGFB3"}, "span_text": {"type": "literal", "value": "In a case-control study of 100 preeclamptics and 100 controls, we assessed plasma transforming growth factor-beta1 (TGF-beta1) concentrations in relation to preeclampsia risk among Peruvian women with and without systemic inflammation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15062887"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MTHFR"}, "span_text": {"type": "literal", "value": "Methylenetetrahydrofolate reductase gene polymorphisms in black South Africans and the association with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15059157"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MTHFR"}, "span_text": {"type": "literal", "value": "A methylenetetrahydrofolate reductase (MTHFR) polymorphism (1317T --> C) that occurs commonly in black African individuals prompted this study to establish whether this polymorphism, alone or in association with other MTHFR variants, is associated with preeclampsia in black South African women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15059157"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "To clarify the role of leptin and androgens in the pathogenesis of preeclampsia, we wanted to assess role of maternal leptin in women with severe and mild preeclampsia and the effects of sex steroid hormones on leptin production."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15059152"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "We concluded that the elevated plasma levels of leptin and testosterone could contribute to the endothelial dysfunction involved in the pathogenesis of preeclampsia, and that estradiol might lead to an increase in the plasma levels of leptin."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15059152"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Umbilical cord serum vascular endothelial growth factor (VEGF) levels in normal pregnancies and in pregnancies complicated by preterm delivery or pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15050460"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Umbilical cord serum vascular endothelial growth factor (VEGF) levels in normal pregnancies and in pregnancies complicated by preterm delivery or pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15050460"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "The aim of this study was to determine whether increased levels of vascular endothelial growth factor (VEGF) are implicated in the pathogenesis of pre-eclampsia and in preterm delivery."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15050460"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Umbilical cord serum vascular endothelial growth factor (VEGF) levels in normal pregnancies and in pregnancies complicated by preterm delivery or pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15050460"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "The aim of this study was to determine whether increased levels of vascular endothelial growth factor (VEGF) are implicated in the pathogenesis of pre-eclampsia and in preterm delivery."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15050460"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "The aim of this study was to determine whether increased levels of vascular endothelial growth factor (VEGF) are implicated in the pathogenesis of pre-eclampsia and in preterm delivery."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15050460"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "Increased endothelial permeability may be associated with decreased endothelial nitric oxide synthase expression and activity in endothelial cells from preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15042020"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "The purposes of this study were to examine endothelial nitric oxide synthase expression in endothelial cells and to determine whether the inhibition of endothelial nitric oxide synthase could impair endothelial barrier function in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15042020"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "Relative messenger RNA expression and protein expression for endothelial nitric oxide synthase were decreased significantly in endothelial cells from preeclampsia compared with cells from normal pregnancies (messenger RNA expression, 0.191+/-0.057 vs 0.508+/-0.061 [P <.01]; protein expression, 0.225+/-0.08 vs 0.786+/-0.098 [P<.01], respectively)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15042020"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Insulin resistance is greater and obesity is more common in women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15042014"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Secondary analysis was performed with relevant data from 194 pregnant women with type 1 and type 2 diabetes mellitus whose condition required insulin and who were enrolled previously in a multicenter trial of low-dose aspirin for the prevention of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15042013"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD3"}, "span_text": {"type": "literal", "value": "The purpose of this study was to determine plasma malondialdehyde (MDA), superoxide dismutase (SOD), soluble E-selectin (sE-selectin), fibronectin, endothelin-1 (ET-1) and nitric oxide (NO) levels in women with preeclampsia and to find out the relations of diastolic blood pressure with these variables."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15036705"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD3"}, "span_text": {"type": "literal", "value": "Plasma malondialdehyde, superoxide dismutase, sE-selectin, fibronectin, endothelin-1 and nitric oxide levels in women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15036705"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD1"}, "span_text": {"type": "literal", "value": "The purpose of this study was to determine plasma malondialdehyde (MDA), superoxide dismutase (SOD), soluble E-selectin (sE-selectin), fibronectin, endothelin-1 (ET-1) and nitric oxide (NO) levels in women with preeclampsia and to find out the relations of diastolic blood pressure with these variables."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15036705"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD1"}, "span_text": {"type": "literal", "value": "Plasma malondialdehyde, superoxide dismutase, sE-selectin, fibronectin, endothelin-1 and nitric oxide levels in women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15036705"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "The purpose of this study was to determine plasma malondialdehyde (MDA), superoxide dismutase (SOD), soluble E-selectin (sE-selectin), fibronectin, endothelin-1 (ET-1) and nitric oxide (NO) levels in women with preeclampsia and to find out the relations of diastolic blood pressure with these variables."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15036705"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Plasma malondialdehyde, superoxide dismutase, sE-selectin, fibronectin, endothelin-1 and nitric oxide levels in women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15036705"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Amniotic vascular endothelial growth factor (VEGF) and nitric oxide (NO) in women with subsequent preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15036704"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Amniotic vascular endothelial growth factor (VEGF) and nitric oxide (NO) in women with subsequent preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15036704"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Amniotic vascular endothelial growth factor (VEGF) and nitric oxide (NO) in women with subsequent preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15036704"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "To assess whether amniotic fluid concentrations of nitric oxide (NO) and vascular endothelial growth factor (VEGF) in early pregnancy correlate to subsequent preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15036704"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "To assess whether amniotic fluid concentrations of nitric oxide (NO) and vascular endothelial growth factor (VEGF) in early pregnancy correlate to subsequent preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15036704"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "To assess whether amniotic fluid concentrations of nitric oxide (NO) and vascular endothelial growth factor (VEGF) in early pregnancy correlate to subsequent preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15036704"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GNLY"}, "span_text": {"type": "literal", "value": "Serum granulysin is a marker for Th1 type immunity in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15030522"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GNLY"}, "span_text": {"type": "literal", "value": "The present results suggest that the serum granulysin levels would be a useful and novel serum marker to evaluate the Th1/Th2 balance, especially Th1 type immunity in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15030522"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GNLY"}, "span_text": {"type": "literal", "value": "In addition, the serum granulysin levels in pre-eclamptic patients were well associated with mean blood pressure, percentage of peripheral blood Th1 cells and Th1/Th2 ratios."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15030522"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GNLY"}, "span_text": {"type": "literal", "value": "In this study, we show that the serum levels of granulysin were significantly elevated in pre-eclamptic patients compared with those in normal pregnancy subjects."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15030522"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "Relationship between urinary albumin and albumin/creatinine ratio during normal pregnancy and pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15025425"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Altered angiogenesis and insulin resistance are additive insults that lead to preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15023932"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Altered angiogenesis and insulin resistance, which are intimately related at a molecular level, characterize preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15023932"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Insulin resistance and alterations in angiogenesis: additive insults that may lead to preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15023932"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "There was increased incidence of preeclampsia with an increase in albumin excretion and this was statistically significant (P value < 0.05)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15008291"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Serum levels of insulin, IGF-1, and IGFBP-1 in pre-eclampsia and eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15001368"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "To investigate whether the serum concentrations of insulin, insulin-like growth factor-1 (IGF-1), and insulin-like growth factor binding protein-1 (IGFBP-1) were altered in women with mild pre-eclampsia, severe pre-eclampsia, and eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15001368"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP7"}, "span_text": {"type": "literal", "value": "To investigate whether the serum concentrations of insulin, insulin-like growth factor-1 (IGF-1), and insulin-like growth factor binding protein-1 (IGFBP-1) were altered in women with mild pre-eclampsia, severe pre-eclampsia, and eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15001368"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP3"}, "span_text": {"type": "literal", "value": "To investigate whether the serum concentrations of insulin, insulin-like growth factor-1 (IGF-1), and insulin-like growth factor binding protein-1 (IGFBP-1) were altered in women with mild pre-eclampsia, severe pre-eclampsia, and eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15001368"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP4"}, "span_text": {"type": "literal", "value": "To investigate whether the serum concentrations of insulin, insulin-like growth factor-1 (IGF-1), and insulin-like growth factor binding protein-1 (IGFBP-1) were altered in women with mild pre-eclampsia, severe pre-eclampsia, and eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15001368"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP5"}, "span_text": {"type": "literal", "value": "To investigate whether the serum concentrations of insulin, insulin-like growth factor-1 (IGF-1), and insulin-like growth factor binding protein-1 (IGFBP-1) were altered in women with mild pre-eclampsia, severe pre-eclampsia, and eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15001368"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF1"}, "span_text": {"type": "literal", "value": "To investigate whether the serum concentrations of insulin, insulin-like growth factor-1 (IGF-1), and insulin-like growth factor binding protein-1 (IGFBP-1) were altered in women with mild pre-eclampsia, severe pre-eclampsia, and eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15001368"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP2"}, "span_text": {"type": "literal", "value": "To investigate whether the serum concentrations of insulin, insulin-like growth factor-1 (IGF-1), and insulin-like growth factor binding protein-1 (IGFBP-1) were altered in women with mild pre-eclampsia, severe pre-eclampsia, and eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/15001368"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Vascular endothelial growth factor (VEGF) plays a crucial role in physiological vasculogenesis and vascular permeability and has been implicated in the pathogenesis of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14997002"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Vascular endothelial growth factor (VEGF) plays a crucial role in physiological vasculogenesis and vascular permeability and has been implicated in the pathogenesis of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14997002"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Vascular endothelial growth factor gene polymorphisms and pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14997002"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Vascular endothelial growth factor (VEGF) plays a crucial role in physiological vasculogenesis and vascular permeability and has been implicated in the pathogenesis of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14997002"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Vascular endothelial growth factor gene polymorphisms and pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14997002"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Vascular endothelial growth factor gene polymorphisms and pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14997002"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "The relationship between insulin and insulin-like growth factor binding protein-1 is modified by pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14992166"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Although changes in insulin resistance and circulating level of IGFBP-1 occur in pre-eclampsia, little is known about the relationship between insulin and IGFBP-1 in pregnancies complicated by the disease."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14992166"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP5"}, "span_text": {"type": "literal", "value": "The relationship between insulin and insulin-like growth factor binding protein-1 is modified by pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14992166"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP2"}, "span_text": {"type": "literal", "value": "The relationship between insulin and insulin-like growth factor binding protein-1 is modified by pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14992166"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP4"}, "span_text": {"type": "literal", "value": "The relationship between insulin and insulin-like growth factor binding protein-1 is modified by pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14992166"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP3"}, "span_text": {"type": "literal", "value": "The relationship between insulin and insulin-like growth factor binding protein-1 is modified by pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14992166"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "In women developing pre-eclampsia, the relationship between insulin and IGFBP-1 was negative at 16 weeks and positive from 24 weeks."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14992166"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "In this study, we have investigated whether the relationship between insulin and IGFBP-1 is modified by pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14992166"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP7"}, "span_text": {"type": "literal", "value": "The relationship between insulin and insulin-like growth factor binding protein-1 is modified by pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14992166"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Maternal levels of insulin and IGFBP-1 were measured, at 4-weekly intervals between 16 and 36 weeks' gestation, in plasma samples obtained from ten normal pregnant controls and ten women who developed pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14992166"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "These data suggest that whereas the inverse relationship between insulin and IGFBP-1 is maintained during normal pregnancy, this relationship is reversed in women who develop pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14992166"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Insulin levels increased in both the normal controls and the women who developed pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14992166"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "The study published in this issue of Clinical Science by Prickett et al. shows that there is a differential expression of the precursor molecule of CNP (C-type natriuretic peptide), N-terminal proCNP, in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14989695"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CSF1"}, "span_text": {"type": "literal", "value": "This study investigated whether granulocyte-macrophage colony-stimulating factor (GM-CSF) levels in the placenta and blood in preeclampsia differed from those in normal pregnancies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14981389"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CSF1"}, "span_text": {"type": "literal", "value": "Elevation of granulocyte-macrophage colony-stimulating factor in the placenta and blood in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14981389"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CSF2"}, "span_text": {"type": "literal", "value": "Elevation of granulocyte-macrophage colony-stimulating factor in the placenta and blood in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14981389"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CSF2"}, "span_text": {"type": "literal", "value": "This study investigated whether granulocyte-macrophage colony-stimulating factor (GM-CSF) levels in the placenta and blood in preeclampsia differed from those in normal pregnancies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14981389"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Women with gestational hypertension and preeclampsia also had higher waist circumference, waist/hip ratio, and body mass index, as well as increased serum insulin levels and lower glucose/insulin ratio than women with previous normotensive pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14981067"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "Impairment of fetal endothelium-dependent relaxation in a rat model of preeclampsia by chronic nitric oxide synthase inhibition."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14980309"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "Increased lipolytic activity and high ratio of free fatty acids to albumin in sera from women with preeclampsia leads to triglyceride accumulation in cultured endothelial cells."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/1497049"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14764795"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14764795"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "In this prospective nested case-control study, we investigated whether first trimester serum levels of placental growth factor (PlGF), a potent angiogenic factor, and its soluble inhibitor, soluble fms-like tyrosine kinase 1 (sFlt1), distinguished women who developed PE (n = 40) from those who developed gestational hypertension (n = 40), delivered a small for gestational age (SGA) newborn (n = 40), or completed a full term normal pregnancy (n = 80)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14764795"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "In this prospective nested case-control study, we investigated whether first trimester serum levels of placental growth factor (PlGF), a potent angiogenic factor, and its soluble inhibitor, soluble fms-like tyrosine kinase 1 (sFlt1), distinguished women who developed PE (n = 40) from those who developed gestational hypertension (n = 40), delivered a small for gestational age (SGA) newborn (n = 40), or completed a full term normal pregnancy (n = 80)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14764795"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "Preeclampsia is associated with loss of neuronal nitric oxide synthase expression in vascular smooth muscle cells of the human umbilical cord."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14764055"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:COX6C"}, "span_text": {"type": "literal", "value": "The mean light density of cytochrome c oxidase subunit I mRNA in placental villi of normal pregnant women was 0.2638, and 0.1763 in women with preeclampsia, a statistically significant difference (P < 0.05)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14756730"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:COX6C"}, "span_text": {"type": "literal", "value": "Reduced amount of cytochrome c oxidase subunit I messenger RNA in placentas from pregnancies complicated by preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14756730"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:COX8A"}, "span_text": {"type": "literal", "value": "Reduced amount of cytochrome c oxidase subunit I messenger RNA in placentas from pregnancies complicated by preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14756730"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:COX5A"}, "span_text": {"type": "literal", "value": "The mean light density of cytochrome c oxidase subunit I mRNA in placental villi of normal pregnant women was 0.2638, and 0.1763 in women with preeclampsia, a statistically significant difference (P < 0.05)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14756730"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:COX5A"}, "span_text": {"type": "literal", "value": "Reduced amount of cytochrome c oxidase subunit I messenger RNA in placentas from pregnancies complicated by preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14756730"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:COX8C"}, "span_text": {"type": "literal", "value": "Reduced amount of cytochrome c oxidase subunit I messenger RNA in placentas from pregnancies complicated by preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14756730"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:COX8A"}, "span_text": {"type": "literal", "value": "The mean light density of cytochrome c oxidase subunit I mRNA in placental villi of normal pregnant women was 0.2638, and 0.1763 in women with preeclampsia, a statistically significant difference (P < 0.05)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14756730"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:COX8C"}, "span_text": {"type": "literal", "value": "The mean light density of cytochrome c oxidase subunit I mRNA in placental villi of normal pregnant women was 0.2638, and 0.1763 in women with preeclampsia, a statistically significant difference (P < 0.05)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14756730"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MTHFR"}, "span_text": {"type": "literal", "value": "Ethnic differences in the association of factor V Leiden mutation and the C677T methylenetetrahydrofolate reductase gene polymorphism with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14746952"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "L-arginine depletion in preeclampsia orients nitric oxide synthase toward oxidant species."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14744923"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Magnesium sulfate infusion in preeclampsia lowered endothelin-1 levels compared with preinfusion values (6.6 +/- 3.81 before and 4.75 +/- 2.28 after infusion, p < 0.02)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/1471664"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "A significant reduction of endothelin-1 plasma levels after magnesium sulfate therapy is limited to preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/1471664"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "We attempted to determine the effects of magnesium sulfate on: (1) endothelin-1 concentration in preeclampsia, preterm labor, and term pregnancy and (2) endothelin-1 release from human umbilical cord endothelial cells."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/1471664"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Severe preeclampsia is associated with high inhibin A levels and normal leptin levels at 7 to 13 weeks into pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14710054"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Leptin levels were correlated highly with body mass index in both groups but were not correlated with the subsequent onset of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14710054"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "The purpose of this study was to determine whether maternal serum inhibin A and leptin concentrations changed in the first trimester of pregnancy in patients in whom severe preeclampsia subsequently developed."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14710054"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MCAM"}, "span_text": {"type": "literal", "value": "The purpose of this study was to determine whether the expression of melanoma cell adhesion molecule (MCAM/CD146), like most other endothelial adhesion molecules, is reduced in the pregnancy disorder pre-eclampsia, and whether it is associated with the invasiveness of trophoblast."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14688802"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MCAM"}, "span_text": {"type": "literal", "value": "Pre-eclampsia is associated with the failure of melanoma cell adhesion molecule (MCAM/CD146) expression by intermediate trophoblast."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14688802"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOA4"}, "span_text": {"type": "literal", "value": "To evaluate the association of apolipoprotein (apo) E polymorphism and a cholesteryl ester transfer protein (CETP) polymorphism (CETP/TaqIB) with preeclampsia and with lipid/lipoprotein profile in pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14687732"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOA1"}, "span_text": {"type": "literal", "value": "To evaluate the association of apolipoprotein (apo) E polymorphism and a cholesteryl ester transfer protein (CETP) polymorphism (CETP/TaqIB) with preeclampsia and with lipid/lipoprotein profile in pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14687732"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CETP"}, "span_text": {"type": "literal", "value": "To evaluate the association of apolipoprotein (apo) E polymorphism and a cholesteryl ester transfer protein (CETP) polymorphism (CETP/TaqIB) with preeclampsia and with lipid/lipoprotein profile in pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14687732"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "The aim of this study was to clarify the time course of plasma endothelin-1 levels and platelet counts after elective cesarean section in women with preeclampsia, and to investigate the relationship between them postoperatively."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14685288"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Endothelin-1 production is stimulated after cesarean section, which is paralleled with postpartal thrombocytopenia only in patients with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14685288"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Changes in plasma endothelin-1 after elective cesarean section in women with preeclampsia and the relationship to thrombocytopenia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14685288"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "2) Women with preeclampsia showed a negative correlation between plasma endothelin-1 levels and platelet counts after cesarean section (r=0.46, p<0.01), while women without preeclampsia undergoing cesarean and vaginal deliveries did not."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14685288"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "1) In patients with preeclampsia, plasma endothelin-1 levels peaked on postoperative day 0 (p<0.05), and remained high, then fell to the preoperative level from day 5."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14685288"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG11"}, "span_text": {"type": "literal", "value": "In late gestation, maternal serum levels of placental protein hormones are changed in both preeclampsia and SGA, but no longitudinal pre-onset studies are available for pregnancy-associated plasma protein A (PAPP-A), pregnancy-specific beta1-glycoprotein (SP1) or human placental lactogen (HPL)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14678084"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG6"}, "span_text": {"type": "literal", "value": "In late gestation, maternal serum levels of placental protein hormones are changed in both preeclampsia and SGA, but no longitudinal pre-onset studies are available for pregnancy-associated plasma protein A (PAPP-A), pregnancy-specific beta1-glycoprotein (SP1) or human placental lactogen (HPL)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14678084"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG8"}, "span_text": {"type": "literal", "value": "In late gestation, maternal serum levels of placental protein hormones are changed in both preeclampsia and SGA, but no longitudinal pre-onset studies are available for pregnancy-associated plasma protein A (PAPP-A), pregnancy-specific beta1-glycoprotein (SP1) or human placental lactogen (HPL)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14678084"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG9"}, "span_text": {"type": "literal", "value": "In late gestation, maternal serum levels of placental protein hormones are changed in both preeclampsia and SGA, but no longitudinal pre-onset studies are available for pregnancy-associated plasma protein A (PAPP-A), pregnancy-specific beta1-glycoprotein (SP1) or human placental lactogen (HPL)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14678084"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG3"}, "span_text": {"type": "literal", "value": "In late gestation, maternal serum levels of placental protein hormones are changed in both preeclampsia and SGA, but no longitudinal pre-onset studies are available for pregnancy-associated plasma protein A (PAPP-A), pregnancy-specific beta1-glycoprotein (SP1) or human placental lactogen (HPL)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14678084"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG2"}, "span_text": {"type": "literal", "value": "In late gestation, maternal serum levels of placental protein hormones are changed in both preeclampsia and SGA, but no longitudinal pre-onset studies are available for pregnancy-associated plasma protein A (PAPP-A), pregnancy-specific beta1-glycoprotein (SP1) or human placental lactogen (HPL)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14678084"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG5"}, "span_text": {"type": "literal", "value": "In late gestation, maternal serum levels of placental protein hormones are changed in both preeclampsia and SGA, but no longitudinal pre-onset studies are available for pregnancy-associated plasma protein A (PAPP-A), pregnancy-specific beta1-glycoprotein (SP1) or human placental lactogen (HPL)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14678084"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG1"}, "span_text": {"type": "literal", "value": "In late gestation, maternal serum levels of placental protein hormones are changed in both preeclampsia and SGA, but no longitudinal pre-onset studies are available for pregnancy-associated plasma protein A (PAPP-A), pregnancy-specific beta1-glycoprotein (SP1) or human placental lactogen (HPL)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14678084"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG4"}, "span_text": {"type": "literal", "value": "In late gestation, maternal serum levels of placental protein hormones are changed in both preeclampsia and SGA, but no longitudinal pre-onset studies are available for pregnancy-associated plasma protein A (PAPP-A), pregnancy-specific beta1-glycoprotein (SP1) or human placental lactogen (HPL)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14678084"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TCF4"}, "span_text": {"type": "literal", "value": "Furthermore, many transcription factor genes were also up-regulated in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14648175"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "To investigate any correlation between plasma levels of lipid peroxides, antioxidant nutrient (alpha-tocopherol) and oxidized high-density lipoprotein (HDL) in patients with gestational diabetes and those with a normal pregnancy and the incidence of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14641698"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CSF1"}, "span_text": {"type": "literal", "value": "The purpose of this study was to determine whether the increase in serum macrophage colony-stimulating factor (M-CSF) levels preceded the onset of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14634568"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CSF2"}, "span_text": {"type": "literal", "value": "Elevation of serum macrophage colony-stimulating factor before the clinical manifestations of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14634568"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CSF2"}, "span_text": {"type": "literal", "value": "The purpose of this study was to determine whether the increase in serum macrophage colony-stimulating factor (M-CSF) levels preceded the onset of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14634568"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CSF1"}, "span_text": {"type": "literal", "value": "Elevation of serum macrophage colony-stimulating factor before the clinical manifestations of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14634568"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF1"}, "span_text": {"type": "literal", "value": "Serum insulin-like growth factors in normal pregnancy and in pregnancies complicated by preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14616273"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP3"}, "span_text": {"type": "literal", "value": "We have prospectively investigated maternal serum levels of IGF-I, IGF-II, and the main binding protein insulin-like growth factor binding protein 3 (IGFBP-3) in women with and without preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14616273"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF2"}, "span_text": {"type": "literal", "value": "Lower levels of insulin-like growth factor I (IGF-I) have been shown to be associated with preeclampsia and also with a reduced risk of breast cancer later in life."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14616273"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF2"}, "span_text": {"type": "literal", "value": "Serum insulin-like growth factors in normal pregnancy and in pregnancies complicated by preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14616273"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF1"}, "span_text": {"type": "literal", "value": "Lower levels of insulin-like growth factor I (IGF-I) have been shown to be associated with preeclampsia and also with a reduced risk of breast cancer later in life."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14616273"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CSF2"}, "span_text": {"type": "literal", "value": "Increased levels of serum macrophage colony-stimulating factor before the onset of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14605992"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CSF1"}, "span_text": {"type": "literal", "value": "Increased levels of serum macrophage colony-stimulating factor before the onset of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14605992"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14602804"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14602804"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14602804"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "However, the difference in the mean serum albumin levels (4.06 +/- 0.06 versus 3.71 +/- 0.33 gm/dl) was significantly higher in the pre-eclampsia group (p<0.05)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14601785"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "Serum albumin, creatinine, uric acid and hypertensive disorders of pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14601785"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "A large study is recommended to properly define the value of serum albumin levels in pregnancy in the prediction of pre-eclampsia in the light of the findings of this study."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14601785"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Low plasma volume in normotensive women with a history of pre-eclampsia and/or HELLP is associated with overweight, reduced vascular compliance and insulin resistance and a predisposition for recurrent pre-eclampsia and HELLP syndrome in a next pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14592585"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CP"}, "span_text": {"type": "literal", "value": "Antioxidant potential and transferrin, ceruloplasmin, and lipid peroxidation levels in women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14577518"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TXN"}, "span_text": {"type": "literal", "value": "Using immunohistochemistry and Western blotting, we investigated the oxidative stress- and redox-related molecules, such as 8-hydroxy-2'-deoxyguanosine (8-OHdG), 4-hydroxynonenal (4-HNE), thioredoxin (TRX) and redox factor-1 (ref-1) in the placenta in preeclampsia, intrauterine growth restriction (IUGR), preeclampsia + IUGR and in normal pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14574573"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MPO"}, "span_text": {"type": "literal", "value": "Preeclampsia and intrauterine growth retardation (IUGR) are associated with elevated concentrations of myeloperoxidase (MPO) and polymorphonuclear (PMN) elastase, which indicate maternal neutrophil activation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14572360"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ECE1"}, "span_text": {"type": "literal", "value": "The present study was aimed at analyzing endothelin-converting-enzyme activity, (which reflect the production rate of endothelin-1 (ET-1) from big endothelin-1 (big ET-1)), big endothelin-1, and endothelin-1 concentrations from women with preeclampsia compared to normal pregnant women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14572358"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ECE1"}, "span_text": {"type": "literal", "value": "The elevated endothelin-converting-enzyme activity postpartum may indicate an inherent endothelial dysfunction predisposing to preeclampsia or that preeclampsia may cause irreversible changes in endothelial function."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14572358"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Enhanced production of endothelin-1, due to endothelial cell dysfunction has been considered to be the cause of increased plasma levels of endothelin-1 in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14572358"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ECE1"}, "span_text": {"type": "literal", "value": "Likewise, endothelin-converting-enzyme activity was higher in the preeclampsia group (222 +/- 15 vs. 172 +/- 8 pmol ET/ml/h; p < 0.01)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14572358"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ECE2"}, "span_text": {"type": "literal", "value": "Endothelin converting enzyme (ECE) activity in normal pregnancy and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14572358"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "At diagnosis endothelin-1 was higher in women with preeclampsia than in the controls at 38 weeks (0.96 +/- 0.07 vs. 0.64 +/- 0.06 pmol/L; p < 0.001)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14572358"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ECE2"}, "span_text": {"type": "literal", "value": "The elevated endothelin-converting-enzyme activity postpartum may indicate an inherent endothelial dysfunction predisposing to preeclampsia or that preeclampsia may cause irreversible changes in endothelial function."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14572358"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ECE2"}, "span_text": {"type": "literal", "value": "Likewise, endothelin-converting-enzyme activity was higher in the preeclampsia group (222 +/- 15 vs. 172 +/- 8 pmol ET/ml/h; p < 0.01)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14572358"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "The present study was aimed at analyzing endothelin-converting-enzyme activity, (which reflect the production rate of endothelin-1 (ET-1) from big endothelin-1 (big ET-1)), big endothelin-1, and endothelin-1 concentrations from women with preeclampsia compared to normal pregnant women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14572358"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ECE2"}, "span_text": {"type": "literal", "value": "The present study was aimed at analyzing endothelin-converting-enzyme activity, (which reflect the production rate of endothelin-1 (ET-1) from big endothelin-1 (big ET-1)), big endothelin-1, and endothelin-1 concentrations from women with preeclampsia compared to normal pregnant women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14572358"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ECE1"}, "span_text": {"type": "literal", "value": "Endothelin converting enzyme (ECE) activity in normal pregnancy and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14572358"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL1RN"}, "span_text": {"type": "literal", "value": "Polymorphism in the interleukin 1 receptor antagonist gene in women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14568678"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL1RN"}, "span_text": {"type": "literal", "value": "We have determined whether genetic variability in the gene encoding interleukin 1 receptor antagonist (IL1Ra) contributes to individual differences in susceptibility to the development of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14568678"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOF"}, "span_text": {"type": "literal", "value": "Aim of this study was to evaluate implication of pregnancy induced hypertension on maternal plasma lipid, lipoprotein, apolipoprotein concentrations and lipid peroxidation products by a comparison of normal pregnancy vs. preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14563453"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Aim of this study was to evaluate implication of pregnancy induced hypertension on maternal plasma lipid, lipoprotein, apolipoprotein concentrations and lipid peroxidation products by a comparison of normal pregnancy vs. preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14563453"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOE"}, "span_text": {"type": "literal", "value": "Aim of this study was to evaluate implication of pregnancy induced hypertension on maternal plasma lipid, lipoprotein, apolipoprotein concentrations and lipid peroxidation products by a comparison of normal pregnancy vs. preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14563453"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOO"}, "span_text": {"type": "literal", "value": "Aim of this study was to evaluate implication of pregnancy induced hypertension on maternal plasma lipid, lipoprotein, apolipoprotein concentrations and lipid peroxidation products by a comparison of normal pregnancy vs. preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14563453"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOM"}, "span_text": {"type": "literal", "value": "Aim of this study was to evaluate implication of pregnancy induced hypertension on maternal plasma lipid, lipoprotein, apolipoprotein concentrations and lipid peroxidation products by a comparison of normal pregnancy vs. preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14563453"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Elevated concentrations of endostatin could play a role in the pathophysiology of preeclampsia by counteracting the effects of vascular endothelial growth factor."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14519482"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Changes in serum levels of angiogenic factors such as vascular endothelial growth factor or placental growth factor were associated with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14519482"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Changes in serum levels of angiogenic factors such as vascular endothelial growth factor or placental growth factor were associated with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14519482"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Elevated concentrations of endostatin could play a role in the pathophysiology of preeclampsia by counteracting the effects of vascular endothelial growth factor."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14519482"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Changes in serum levels of angiogenic factors such as vascular endothelial growth factor or placental growth factor were associated with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14519482"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Changes in serum levels of angiogenic factors such as vascular endothelial growth factor or placental growth factor were associated with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14519482"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Elevated concentrations of endostatin could play a role in the pathophysiology of preeclampsia by counteracting the effects of vascular endothelial growth factor."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14519482"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADM2"}, "span_text": {"type": "literal", "value": "Adrenomedullin is decreased in preeclampsia because of failed response to epidermal growth factor and impaired syncytialization."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14517225"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADM"}, "span_text": {"type": "literal", "value": "Adrenomedullin is decreased in preeclampsia because of failed response to epidermal growth factor and impaired syncytialization."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14517225"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MTHFR"}, "span_text": {"type": "literal", "value": "A group of 59 women with gestational hypertension were prospectively tested between 24 and 26 weeks of gestation for: (i) DNA analysis to search for gene mutations of Factor V Leiden, prothrombin, methylenetetrahydrofolate reductase and plasminogen activator inhibitor type 1 (PAI-I) polymorphism; (ii) maternal serum concentrations of homocysteine and PAI-1, activated protein resistance and Factor II:C activity levels; (iii) mean uterine arterial resistance index (RI) by Doppler velocimetry; and (iv) history of hypertensive disorders in relatives (the mother and/or the father)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14508198"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MAOA"}, "span_text": {"type": "literal", "value": "Placental monoamine-oxidase activity in toxaemia of pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/14496871"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "These data suggest an increased renal endothelin-1 breakdown in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/1384688"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CA8"}, "span_text": {"type": "literal", "value": "Effects of carbonic anhydrase inhibitors in toxemia of pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/13791974"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CA4"}, "span_text": {"type": "literal", "value": "Effects of carbonic anhydrase inhibitors in toxemia of pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/13791974"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CA7"}, "span_text": {"type": "literal", "value": "Effects of carbonic anhydrase inhibitors in toxemia of pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/13791974"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CA1"}, "span_text": {"type": "literal", "value": "Effects of carbonic anhydrase inhibitors in toxemia of pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/13791974"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CA2"}, "span_text": {"type": "literal", "value": "Effects of carbonic anhydrase inhibitors in toxemia of pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/13791974"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Insulin: a hormone for promoting intrauterine fetal growth in severe hypertensive toxemia of pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/13788491"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "A preliminary investigation of the changes in sterol distribution in relation to lipoproteins in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/13655142"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CA8"}, "span_text": {"type": "literal", "value": "Carbonic anhydrase inhibitors; their effect on water and electrolyte metabolism in toxemia of pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/13654826"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CA2"}, "span_text": {"type": "literal", "value": "Carbonic anhydrase inhibitors; their effect on water and electrolyte metabolism in toxemia of pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/13654826"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CA7"}, "span_text": {"type": "literal", "value": "Carbonic anhydrase inhibitors; their effect on water and electrolyte metabolism in toxemia of pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/13654826"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CA4"}, "span_text": {"type": "literal", "value": "Carbonic anhydrase inhibitors; their effect on water and electrolyte metabolism in toxemia of pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/13654826"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CA1"}, "span_text": {"type": "literal", "value": "Carbonic anhydrase inhibitors; their effect on water and electrolyte metabolism in toxemia of pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/13654826"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPT2"}, "span_text": {"type": "literal", "value": "Serum glutamic-oxalacetic transaminase and serum glutamic-pyruvic transaminase in toxemia of pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/13654473"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Reactivity to insulin in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/13419239"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CA2"}, "span_text": {"type": "literal", "value": "Effects of inhibition of renal carbonic anhydrase by diamox in normal and toxemic pregnancies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/13271876"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CA4"}, "span_text": {"type": "literal", "value": "Effects of inhibition of renal carbonic anhydrase by diamox in normal and toxemic pregnancies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/13271876"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CA1"}, "span_text": {"type": "literal", "value": "Effects of inhibition of renal carbonic anhydrase by diamox in normal and toxemic pregnancies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/13271876"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CA8"}, "span_text": {"type": "literal", "value": "Effects of inhibition of renal carbonic anhydrase by diamox in normal and toxemic pregnancies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/13271876"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CA7"}, "span_text": {"type": "literal", "value": "Effects of inhibition of renal carbonic anhydrase by diamox in normal and toxemic pregnancies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/13271876"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CTRC"}, "span_text": {"type": "literal", "value": "CONCLUSIONS: (1) Factor(s) released from both normal-TCs and PE-TCs promote ICAM and VCAM expression on ECs. (2) Factor(s) released from PE-TCs significantly increase EC P-selectin and E-selectin expression. (3) CI blocks the upregulation of P-selectin and E-selectin on ECs induced by factors released from PE placental cells, suggesting that chymotrypsin is responsible for the increased endothelial expression of P-selectin and E-selectin in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/13129682"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ESAM"}, "span_text": {"type": "literal", "value": "Soluble endothelial-cell adhesion molecules (ICAM, VCAM and PECAM) are markers of endothelial activation, and are elevated in the maternal circulation during pregnancy and even further increased in pregnancies complicated by pre-eclampsia (PE)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/13129682"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD1"}, "span_text": {"type": "literal", "value": "Study of serum levels of superoxide dismutase in preeclampsia and eclampsia: role of the test as a predictive tool."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12959150"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD3"}, "span_text": {"type": "literal", "value": "We found statistically significant difference (P < 0.05) in mean superoxide dismutase levels of normotensive pregnant women; and preeclamptic and eclamptic subjects, no statistically significant difference was found in between value of enzyme in preeclampsia and eclampsia (P > 0.05)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12959150"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD1"}, "span_text": {"type": "literal", "value": "To report serum levels of superoxide dismutase in women with preeclampsia and eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12959150"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD3"}, "span_text": {"type": "literal", "value": "To report serum levels of superoxide dismutase in women with preeclampsia and eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12959150"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD1"}, "span_text": {"type": "literal", "value": "Superoxide dismutase concentration was measured in a consecutive study in sera of women admitted in obstetric ward for preeclampsia and eclampsia, and compared with sera of normotensive, healthy pregnant women in third trimester."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12959150"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD3"}, "span_text": {"type": "literal", "value": "Study of serum levels of superoxide dismutase in preeclampsia and eclampsia: role of the test as a predictive tool."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12959150"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD3"}, "span_text": {"type": "literal", "value": "Superoxide dismutase concentration was measured in a consecutive study in sera of women admitted in obstetric ward for preeclampsia and eclampsia, and compared with sera of normotensive, healthy pregnant women in third trimester."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12959150"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD1"}, "span_text": {"type": "literal", "value": "We found statistically significant difference (P < 0.05) in mean superoxide dismutase levels of normotensive pregnant women; and preeclamptic and eclamptic subjects, no statistically significant difference was found in between value of enzyme in preeclampsia and eclampsia (P > 0.05)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12959150"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AFP"}, "span_text": {"type": "literal", "value": "The levels of midtrimester maternal serum alpha-fetoprotein (MSAFP), human chorionic gonadotropin (MShCG) and unconjugated estriol (MSuE3) of 74 patients with severe preeclampsia were compared with those of 32 patients who also developed HELLP syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12956840"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL10"}, "span_text": {"type": "literal", "value": "Placental tissue interleukin-10 receptor distribution in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12951965"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL10"}, "span_text": {"type": "literal", "value": "Reduced placental (trophoblast) cytokine interleukin-10 (IL-10) occurs in human pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12951965"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HGF"}, "span_text": {"type": "literal", "value": "Measurement of hepatocyte growth factor in peripheral blood between 14 and 21 weeks gestation may offer new possibilities in the early diagnosis and prediction of fetal birth weight but not of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12932865"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HGF"}, "span_text": {"type": "literal", "value": "Hepatocyte growth factor values in pregnancies that develop preeclampsia (n=12) were not significantly different from unaffected pregnancies (n=21, multiples of the median (MoM)=1.38, P=0.47)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12932865"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGT"}, "span_text": {"type": "literal", "value": "In conclusion, we found an association between the angiotensinogen variant 235T and preeclampsia as well as an interaction between the variant 235T and the two other genes studied."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12932862"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ELN"}, "span_text": {"type": "literal", "value": "The accumulation of collagen with simultaneous reduction in elastin content in the UCA may be the factor that reduces the elasticity of arterial wall and decreases the blood flow in the fetus of women with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12927692"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Endothelin-1 levels of preeclamptic patients before and after magnesium sulfate treatment were 16.9 +/- 2.3 fmol/ml and 14.6 +/- 1.9 fmol/ml respectively (p < 0.05)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12909003"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "The effect of treatment on endothelin-1 concentration and mean arterial pressure in preeclampsia and eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12909003"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Treatment had been found to have negative effects on endothelin-1 levels that is considered to play an important role on etiopathogenesis of eclampsia and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12909003"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Insulin resistance and obesity are risk factors for developing preeclampsia, as well as being conditions that would increase RAGE levels."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12909002"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "We examined the relationship between maternal plasma lipoprotein and antioxidant status with risk of preeclampsia among women delivering at Harare Maternity Hospital, Zimbabwe."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12878373"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SHBG"}, "span_text": {"type": "literal", "value": "By the 27th week, the association between progesterone and pre-eclampsia was strengthened (RR = 2.65, 95% CI, 1.46-4.81, per SD), and sex hormone-binding globulin levels were somewhat inversely related to pre-eclampsia (RR = 0.61, 95% CI, 0.31-1.20, per SD)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12869405"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "We recently identified a missense variant (Glu298Asp) within exon 7 of the endothelial nitric oxide synthase (eNOS) gene that is associated with severe preeclampsia in the Japanese population."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12867761"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "Genetic and environmental contributions to severe preeclampsia: lack of association with the endothelial nitric oxide synthase Glu298Asp variant in a developing country."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12867761"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "To investigate placental leptin production in placental insufficiency, placental leptin production was measured in women with severe preeclampsia (group 1) and in normotensive pregnancies associated with intrauterine growth restriction (group 2), compared to controls (group 3)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12865594"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "Placental endothelial nitric oxide synthase localization and expression in normal human pregnancy and pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12859429"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Models combining both vascular endothelial growth factor and placental growth factor provided the best performance for identifying patients at risk for developing severe, early-onset preeclampsia, according to both odds ratios and ROC analyses."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12798535"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Second-trimester maternal serum placental growth factor and vascular endothelial growth factor for predicting severe, early-onset preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12798535"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Combined analysis of placental growth factor and vascular endothelial growth factor is potentially useful as a tool for early identification of patients at risk for developing severe, early-onset preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12798535"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Combined analysis of placental growth factor and vascular endothelial growth factor is potentially useful as a tool for early identification of patients at risk for developing severe, early-onset preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12798535"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Models combining both vascular endothelial growth factor and placental growth factor provided the best performance for identifying patients at risk for developing severe, early-onset preeclampsia, according to both odds ratios and ROC analyses."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12798535"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Models combining both vascular endothelial growth factor and placental growth factor provided the best performance for identifying patients at risk for developing severe, early-onset preeclampsia, according to both odds ratios and ROC analyses."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12798535"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Combined analysis of placental growth factor and vascular endothelial growth factor is potentially useful as a tool for early identification of patients at risk for developing severe, early-onset preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12798535"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Second-trimester maternal serum placental growth factor and vascular endothelial growth factor for predicting severe, early-onset preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12798535"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Models combining both vascular endothelial growth factor and placental growth factor provided the best performance for identifying patients at risk for developing severe, early-onset preeclampsia, according to both odds ratios and ROC analyses."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12798535"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Second-trimester maternal serum placental growth factor and vascular endothelial growth factor for predicting severe, early-onset preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12798535"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Combined analysis of placental growth factor and vascular endothelial growth factor is potentially useful as a tool for early identification of patients at risk for developing severe, early-onset preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12798535"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Second-trimester maternal serum placental growth factor and vascular endothelial growth factor for predicting severe, early-onset preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12798535"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADM2"}, "span_text": {"type": "literal", "value": "Cerebrospinal fluid adrenomedullin levels in patients with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12780431"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADM"}, "span_text": {"type": "literal", "value": "Cerebrospinal fluid adrenomedullin levels in patients with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12780431"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP3"}, "span_text": {"type": "literal", "value": "To determine whether expressions of insulin-like growth factor-II (IGF-II) and insulin-like growth factor binding protein-1 (IGFBP-1) are altered in pre-eclamptic placenta and to elucidate the possible relationship between their expressions and a mechanism for inadequate trophoblast invasion in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12767569"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF1"}, "span_text": {"type": "literal", "value": "To determine whether expressions of insulin-like growth factor-II (IGF-II) and insulin-like growth factor binding protein-1 (IGFBP-1) are altered in pre-eclamptic placenta and to elucidate the possible relationship between their expressions and a mechanism for inadequate trophoblast invasion in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12767569"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP7"}, "span_text": {"type": "literal", "value": "To determine whether expressions of insulin-like growth factor-II (IGF-II) and insulin-like growth factor binding protein-1 (IGFBP-1) are altered in pre-eclamptic placenta and to elucidate the possible relationship between their expressions and a mechanism for inadequate trophoblast invasion in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12767569"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP5"}, "span_text": {"type": "literal", "value": "To determine whether expressions of insulin-like growth factor-II (IGF-II) and insulin-like growth factor binding protein-1 (IGFBP-1) are altered in pre-eclamptic placenta and to elucidate the possible relationship between their expressions and a mechanism for inadequate trophoblast invasion in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12767569"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP2"}, "span_text": {"type": "literal", "value": "To determine whether expressions of insulin-like growth factor-II (IGF-II) and insulin-like growth factor binding protein-1 (IGFBP-1) are altered in pre-eclamptic placenta and to elucidate the possible relationship between their expressions and a mechanism for inadequate trophoblast invasion in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12767569"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP4"}, "span_text": {"type": "literal", "value": "To determine whether expressions of insulin-like growth factor-II (IGF-II) and insulin-like growth factor binding protein-1 (IGFBP-1) are altered in pre-eclamptic placenta and to elucidate the possible relationship between their expressions and a mechanism for inadequate trophoblast invasion in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12767569"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF2"}, "span_text": {"type": "literal", "value": "To determine whether expressions of insulin-like growth factor-II (IGF-II) and insulin-like growth factor binding protein-1 (IGFBP-1) are altered in pre-eclamptic placenta and to elucidate the possible relationship between their expressions and a mechanism for inadequate trophoblast invasion in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12767569"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL18"}, "span_text": {"type": "literal", "value": "Interleukin-18 in the plasma of women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12748489"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "We tested the hypothesis that endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine (ADMA), the endogenous inhibitor of endothelial nitric oxide synthase, precede and contribute to the development of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12737861"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Hoping to get more insight into a role of vascular endothelial growth factor (VEGF), a putative substance involved in the development of preeclampsia, we measured concentrations of soluble VEGF receptor-1 (sVEGFR-1), a natural antagonist of VEGF, in serum from women with (n = 31) and without (n = 52) preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12727995"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12727995"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12727995"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12727995"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Hoping to get more insight into a role of vascular endothelial growth factor (VEGF), a putative substance involved in the development of preeclampsia, we measured concentrations of soluble VEGF receptor-1 (sVEGFR-1), a natural antagonist of VEGF, in serum from women with (n = 31) and without (n = 52) preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12727995"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Hoping to get more insight into a role of vascular endothelial growth factor (VEGF), a putative substance involved in the development of preeclampsia, we measured concentrations of soluble VEGF receptor-1 (sVEGFR-1), a natural antagonist of VEGF, in serum from women with (n = 31) and without (n = 52) preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12727995"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GP2"}, "span_text": {"type": "literal", "value": "Association of fibrin abnormalities with pre-eclampsia prompted this study to examine whether polymorphisms in the plasminogen activator inhibitor Type 1 and platelet glycoprotein IIIa genes constitute risk factors for this condition."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12716314"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CRH"}, "span_text": {"type": "literal", "value": "The concentration of circulating corticotropin-releasing hormone mRNA in maternal plasma is increased in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12709362"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Circulating levels of vascular endothelial growth factor (VEGF) are increased in women with pre-eclampsia, while circulating placental growth factor (PlGF) levels are decreased."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12708795"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Circulating levels of vascular endothelial growth factor (VEGF) are increased in women with pre-eclampsia, while circulating placental growth factor (PlGF) levels are decreased."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12708795"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Circulating levels of vascular endothelial growth factor (VEGF) are increased in women with pre-eclampsia, while circulating placental growth factor (PlGF) levels are decreased."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12708795"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Circulating levels of vascular endothelial growth factor (VEGF) are increased in women with pre-eclampsia, while circulating placental growth factor (PlGF) levels are decreased."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12708795"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "We wished to determine whether genetic variability in the gene encoding endothelial nitric oxide synthase (eNOS) modifies individual susceptibility to the development of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12699878"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "Endothelial nitric oxide synthase polymorphism in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12699878"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Women with a history of pre-eclampsia have significant differences in lipid parameters and an increased susceptibility to lipoprotein oxidation when compared with women who had a normal pregnancy one to three years after delivery."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12699802"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Increased susceptibility to low density lipoprotein oxidation in women with a history of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12699802"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "To evaluate the susceptibility to oxidation of low density lipoprotein (LDL) in women with a history of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12699802"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Amniotic fluid and maternal serum leptin levels in pregnant women who subsequently develop preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12694970"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "To study the correlation between amniotic fluid leptin levels and maternal serum leptin levels during the early second trimester, and to determine whether the ratios of amniotic fluid leptin levels to maternal serum leptin levels are elevated in pregnant women who subsequently develop preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12694970"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MTHFR"}, "span_text": {"type": "literal", "value": "To test the hypothesis that, regardless of the presence of the 677 C-T methylenetetrahydrofolate reductase (MTHFR) mutation, maternal homocysteine concentrations will not be significantly different in women who are taking prenatal vitamins containing folic acid, and to test this relationship in preeclampsia because homocysteine concentrations are higher in preeclamptic pregnancies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12681883"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOM"}, "span_text": {"type": "literal", "value": "Atherosis is accepted to underlie the pathogenesis of preeclampsia, therefore we aimed to determine malonyldialdehyde (MDA) levels as a marker of lipid peroxidation, and lipoprotein(a) (Lp(a)), apolipoprotein A-1 (Apo A-1) and apolipoprotein B (Apo B) levels as a marker of atherogenic profile in preeclamptic and normal pregnant women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12673475"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Atherosis is accepted to underlie the pathogenesis of preeclampsia, therefore we aimed to determine malonyldialdehyde (MDA) levels as a marker of lipid peroxidation, and lipoprotein(a) (Lp(a)), apolipoprotein A-1 (Apo A-1) and apolipoprotein B (Apo B) levels as a marker of atherogenic profile in preeclamptic and normal pregnant women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12673475"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOO"}, "span_text": {"type": "literal", "value": "Atherosis is accepted to underlie the pathogenesis of preeclampsia, therefore we aimed to determine malonyldialdehyde (MDA) levels as a marker of lipid peroxidation, and lipoprotein(a) (Lp(a)), apolipoprotein A-1 (Apo A-1) and apolipoprotein B (Apo B) levels as a marker of atherogenic profile in preeclamptic and normal pregnant women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12673475"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOE"}, "span_text": {"type": "literal", "value": "Atherosis is accepted to underlie the pathogenesis of preeclampsia, therefore we aimed to determine malonyldialdehyde (MDA) levels as a marker of lipid peroxidation, and lipoprotein(a) (Lp(a)), apolipoprotein A-1 (Apo A-1) and apolipoprotein B (Apo B) levels as a marker of atherogenic profile in preeclamptic and normal pregnant women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12673475"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOF"}, "span_text": {"type": "literal", "value": "Atherosis is accepted to underlie the pathogenesis of preeclampsia, therefore we aimed to determine malonyldialdehyde (MDA) levels as a marker of lipid peroxidation, and lipoprotein(a) (Lp(a)), apolipoprotein A-1 (Apo A-1) and apolipoprotein B (Apo B) levels as a marker of atherogenic profile in preeclamptic and normal pregnant women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12673475"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Plasma levels of VEGF, leptin and TNF-alpha were significantly greater in pre-eclampsia compared to normal pregnancy and non-pregnant controls (P<0.0001, ANOVA, for all three analyses)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12667958"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "In this study, we have investigated the relationship between filtration capacity (K(f)), an index of microvascular permeability, and maternal levels of VEGF, leptin and TNF-alpha, all of which are known permeability factors whose plasma levels are increased in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12667958"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "These data show that that microvascular filtration capacity is significantly increased in pre-eclampsia, and correlates with circulating levels of TNF-alpha but not leptin or VEGF."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12667958"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "There was a significant inverse correlation between plasma albumin concentration and filtration capacity in the normal pregnant (r=-0.94, P<0.0001) and non-pregnant (r=-0.87, P<0.0001) groups but not in the women with pre-eclampsia (r=-0.18, P=0.8)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12667958"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "This study has demonstrated that high levels of lipoprotein(a) interfere with uteroplacental circulation and play a role in the pathophysiology of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12661140"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "In this group there was a statistically significant higher prevalence of preeclampsia in comparison with women with a normal lipoprotein(a) level (p < 0.001)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12661140"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "The lipoprotein(a) level was significantly higher in severe (n = 13, median 60.5 mg/dl, P < 0.001] than in mild preeclampsia (n = 5, median 34 mg/dl)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12661140"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FST"}, "span_text": {"type": "literal", "value": "Inhibin, activin, follistatin, activin receptors and beta-glycan gene expression in the placental tissue of patients with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12651901"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FST"}, "span_text": {"type": "literal", "value": "The objective of this study was to quantify the relative expression of inhibin alpha, inhibin/activin beta(A), beta(B), beta(C), follistatin, activin receptors and beta-glycan genes in placental tissue of term pre-eclamptic patients and controls to investigate if these genes are up-regulated in the placenta in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12651901"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL10"}, "span_text": {"type": "literal", "value": "Preeclampsia is associated with a reduced interleukin-10 production from peripheral blood mononuclear cells."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12648438"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL10"}, "span_text": {"type": "literal", "value": "This study aims to investigate and compare in vitro, immune cell production of the immunosuppresor cytokine interleukin-10 (IL-10) and the proinflammatory cytokine tumor necrosis factor (TNF-alpha) between normal pregnancy (NP) and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12648438"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL10"}, "span_text": {"type": "literal", "value": "These findings suggest that under in vitro stimulated conditions preeclampsia is associated with an abnormality characterized by a diminished ability of peripheral immune cells to produce the immunosupressor cytokine interleukin-10."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12648438"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "This review summarizes recent findings regarding the putative changes of serum leptin levels during pre-eclampsia and the potential consequences on the vascular system."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12643450"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Recent studies have revealed that the placental production of leptin may be pathologically augmented under pre-eclampsia although conflicting data also have been reported."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12643450"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Leptin, leptin resistance and endothelial dysfunction in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12643450"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Nevertheless, hyperleptinemia and possible further augmentation under pre-eclampsia may predispose to the development of maternal leptin resistance, which may be a component of insulin resistance predisposing the onset of endothelial dysfunction."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12643450"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL6"}, "span_text": {"type": "literal", "value": "The purpose of this study was to determine whether plasma from women with severe preeclampsia stimulates the production of endothelial cell interleukin-6 production and whether vitamin E could inhibit this process."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12634650"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL6"}, "span_text": {"type": "literal", "value": "Increased vascular endothelial cell production of interleukin-6 in severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12634650"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IDO2"}, "span_text": {"type": "literal", "value": "Therefore, we studied tryptophan metabolism in pregnant women, with or without preeclampsia, as well as expression and function of placental indoleamine 2,3-dioxygenase."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12634647"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IDO1"}, "span_text": {"type": "literal", "value": "These observations suggest that in preeclampsia, reduced placental indoleamine 2,3-dioxygenase activity (and relatively elevated plasma tryptophan) could cause dysregulation of the inflammatory response that is intrinsic to normal pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12634647"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IDO2"}, "span_text": {"type": "literal", "value": "Decreased tryptophan catabolism by placental indoleamine 2,3-dioxygenase in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12634647"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IDO1"}, "span_text": {"type": "literal", "value": "The activity and mRNA expression level of indoleamine 2,3-dioxygenase in term placentas were significantly lower in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12634647"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IDO2"}, "span_text": {"type": "literal", "value": "The activity and mRNA expression level of indoleamine 2,3-dioxygenase in term placentas were significantly lower in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12634647"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IDO1"}, "span_text": {"type": "literal", "value": "Decreased tryptophan catabolism by placental indoleamine 2,3-dioxygenase in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12634647"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IDO2"}, "span_text": {"type": "literal", "value": "These observations suggest that in preeclampsia, reduced placental indoleamine 2,3-dioxygenase activity (and relatively elevated plasma tryptophan) could cause dysregulation of the inflammatory response that is intrinsic to normal pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12634647"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IDO1"}, "span_text": {"type": "literal", "value": "Therefore, we studied tryptophan metabolism in pregnant women, with or without preeclampsia, as well as expression and function of placental indoleamine 2,3-dioxygenase."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12634647"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Blood pressure, serum lipids, fasting insulin, and adrenal hormones in 12-year-old children born with maternal preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12629109"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Disorders of the lipoprotein metabolism are a major cause of endothelial dysfunction that may result in hypertension and proteinuria, clinical hallmarks of preeclampsia (PE)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12629100"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Triglyceride-rich lipoproteins are associated with hypertension in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12629100"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Studies with genistein and tyrphostin implicated tyrosine kinase-dependent mechanisms in the control of NADPH oxidase-associated increased reactive oxygen species production in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12629036"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Here, we confirm that placental soluble fms-like tyrosine kinase 1 (sFlt1), an antagonist of VEGF and placental growth factor (PlGF), is upregulated in preeclampsia, leading to increased systemic levels of sFlt1 that fall after delivery."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12618519"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Here, we confirm that placental soluble fms-like tyrosine kinase 1 (sFlt1), an antagonist of VEGF and placental growth factor (PlGF), is upregulated in preeclampsia, leading to increased systemic levels of sFlt1 that fall after delivery."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12618519"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TYK2"}, "span_text": {"type": "literal", "value": "Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12618519"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX1"}, "span_text": {"type": "literal", "value": "Glutathione peroxidase levels throughout normal pregnancy and in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12607764"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX2"}, "span_text": {"type": "literal", "value": "Glutathione peroxidase levels throughout normal pregnancy and in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12607764"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX3"}, "span_text": {"type": "literal", "value": "A linear regression analysis indicated that the plasma glutathione peroxidase concentration did not correlate with gestational age or the presence of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12607764"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX3"}, "span_text": {"type": "literal", "value": "Glutathione peroxidase levels throughout normal pregnancy and in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12607764"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX2"}, "span_text": {"type": "literal", "value": "There is no change in the glutathione peroxidase levels in pre-eclamptic patients."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12607764"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX2"}, "span_text": {"type": "literal", "value": "A linear regression analysis indicated that the plasma glutathione peroxidase concentration did not correlate with gestational age or the presence of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12607764"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX1"}, "span_text": {"type": "literal", "value": "There is no change in the glutathione peroxidase levels in pre-eclamptic patients."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12607764"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX1"}, "span_text": {"type": "literal", "value": "A linear regression analysis indicated that the plasma glutathione peroxidase concentration did not correlate with gestational age or the presence of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12607764"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX3"}, "span_text": {"type": "literal", "value": "There is no change in the glutathione peroxidase levels in pre-eclamptic patients."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12607764"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "We investigated the influence of acute hypoxia on the placental vascular endothelial growth factor system in vitro and in vivo in acute birth asphyxia compared with pregnancies that were complicated by preeclampsia and with healthy control subjects."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12592265"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "We investigated the influence of acute hypoxia on the placental vascular endothelial growth factor system in vitro and in vivo in acute birth asphyxia compared with pregnancies that were complicated by preeclampsia and with healthy control subjects."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12592265"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "In chronic placental hypoxia (preeclampsia), vascular endothelial growth factor and both receptors were found to be up-regulated."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12592265"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "We investigated the influence of acute hypoxia on the placental vascular endothelial growth factor system in vitro and in vivo in acute birth asphyxia compared with pregnancies that were complicated by preeclampsia and with healthy control subjects."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12592265"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "In chronic placental hypoxia (preeclampsia), vascular endothelial growth factor and both receptors were found to be up-regulated."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12592265"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Messenger RNA levels for vascular endothelial growth factor, flt-1, and KDR were measured by TaqMan real-time polymerase chain reaction in human placental choriocarcinoma cells (BeWo) that were exposed to hypoxia (1% oxygen, 5% carbon dioxide, 94% nitrogen) and in placental tissue of neonates with birth asphyxia (n = 20), newborn infants of mothers with preeclampsia (n = 20), and gestational age-matched control subjects."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12592265"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Messenger RNA levels for vascular endothelial growth factor, flt-1, and KDR were measured by TaqMan real-time polymerase chain reaction in human placental choriocarcinoma cells (BeWo) that were exposed to hypoxia (1% oxygen, 5% carbon dioxide, 94% nitrogen) and in placental tissue of neonates with birth asphyxia (n = 20), newborn infants of mothers with preeclampsia (n = 20), and gestational age-matched control subjects."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12592265"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "In chronic placental hypoxia (preeclampsia), vascular endothelial growth factor and both receptors were found to be up-regulated."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12592265"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Messenger RNA levels for vascular endothelial growth factor, flt-1, and KDR were measured by TaqMan real-time polymerase chain reaction in human placental choriocarcinoma cells (BeWo) that were exposed to hypoxia (1% oxygen, 5% carbon dioxide, 94% nitrogen) and in placental tissue of neonates with birth asphyxia (n = 20), newborn infants of mothers with preeclampsia (n = 20), and gestational age-matched control subjects."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12592265"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CAT"}, "span_text": {"type": "literal", "value": "To estimate the plasma concentrations of nitric oxide and lipid peroxides and those of catalase and superoxide dismutase in patients with pre-eclampsia and essential hypertension."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12583464"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD1"}, "span_text": {"type": "literal", "value": "To estimate the plasma concentrations of nitric oxide and lipid peroxides and those of catalase and superoxide dismutase in patients with pre-eclampsia and essential hypertension."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12583464"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD3"}, "span_text": {"type": "literal", "value": "The ratio between lipid peroxides and nitric oxide was elevated and the activity of superoxide dismutase reduced in patients with pre-eclampsia and uncontrolled essential hypertension."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12583464"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD1"}, "span_text": {"type": "literal", "value": "The ratio between lipid peroxides and nitric oxide was elevated and the activity of superoxide dismutase reduced in patients with pre-eclampsia and uncontrolled essential hypertension."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12583464"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD3"}, "span_text": {"type": "literal", "value": "To estimate the plasma concentrations of nitric oxide and lipid peroxides and those of catalase and superoxide dismutase in patients with pre-eclampsia and essential hypertension."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12583464"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGT"}, "span_text": {"type": "literal", "value": "A polymorphism of angiotensinogen Thr235 has been considered a risk factor for preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12576245"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Leptin levels may be abnormally high in pregnancies complicated by conditions such as diabetes mellitus and pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12572590"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF1"}, "span_text": {"type": "literal", "value": "A hypothesis for altered activity of insulin-like growth factor I in women with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12566194"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF2"}, "span_text": {"type": "literal", "value": "A hypothesis for altered activity of insulin-like growth factor I in women with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12566194"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "The results of our study also suggests an ethnic difference in plasma endothelin-1 activity when compared to result of studies carried out in Caucasian women with hypertensive disorders of pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12554242"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Endothelin-1 activity is increased with pre-eclampsia in black African women with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12554242"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "We examined maternal concentrations of vascular endothelial growth factor and placental growth factor in normal pregnancies and in pregnancies that were complicated by isolated idiopathic small-for-gestational-age (SGA) newborn infants, preeclampsia alone, or preeclampsia with SGA newborn infants at the time of clinical disease and before the onset of clinical signs."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12548214"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "We examined maternal concentrations of vascular endothelial growth factor and placental growth factor in normal pregnancies and in pregnancies that were complicated by isolated idiopathic small-for-gestational-age (SGA) newborn infants, preeclampsia alone, or preeclampsia with SGA newborn infants at the time of clinical disease and before the onset of clinical signs."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12548214"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "We examined maternal concentrations of vascular endothelial growth factor and placental growth factor in normal pregnancies and in pregnancies that were complicated by isolated idiopathic small-for-gestational-age (SGA) newborn infants, preeclampsia alone, or preeclampsia with SGA newborn infants at the time of clinical disease and before the onset of clinical signs."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12548214"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "In the cross-sectional study, serum placental growth factor was reduced in abnormal pregnancy relative to control subjects (SGA newborn infants, 18 [P =.04]; preeclampsia, 20; or preeclampsia with small- for-gestational-age newborn infants, 11 [P =.0001]) as early as 15 to 19 weeks of gestation in preeclampsia with SGA newborn infants."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12548214"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "We examined maternal concentrations of vascular endothelial growth factor and placental growth factor in normal pregnancies and in pregnancies that were complicated by isolated idiopathic small-for-gestational-age (SGA) newborn infants, preeclampsia alone, or preeclampsia with SGA newborn infants at the time of clinical disease and before the onset of clinical signs."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12548214"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Angiopoietin-1 inhibited the vascular endothelial growth factor-induced vascular leakage, which may have therapeutic implications in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12548213"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ANGPT1"}, "span_text": {"type": "literal", "value": "Angiopoietin-1 inhibited the vascular endothelial growth factor-induced vascular leakage, which may have therapeutic implications in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12548213"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Angiopoietin-1 inhibited the vascular endothelial growth factor-induced vascular leakage, which may have therapeutic implications in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12548213"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Permeability to Evans blue dye was evaluated in arteries after incubation with vascular endothelial growth factor, vascular endothelial growth factor plus angiopoietin-1, or vehicle, and in arteries that were obtained from women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12548213"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Angiopoietin-1 inhibited the vascular endothelial growth factor-induced vascular leakage, which may have therapeutic implications in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12548213"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ANGPT1"}, "span_text": {"type": "literal", "value": "Permeability to Evans blue dye was evaluated in arteries after incubation with vascular endothelial growth factor, vascular endothelial growth factor plus angiopoietin-1, or vehicle, and in arteries that were obtained from women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12548213"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Permeability to Evans blue dye was evaluated in arteries after incubation with vascular endothelial growth factor, vascular endothelial growth factor plus angiopoietin-1, or vehicle, and in arteries that were obtained from women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12548213"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Permeability to Evans blue dye was evaluated in arteries after incubation with vascular endothelial growth factor, vascular endothelial growth factor plus angiopoietin-1, or vehicle, and in arteries that were obtained from women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12548213"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGFB1"}, "span_text": {"type": "literal", "value": "Transforming growth factor beta(1) levels in platelet depleted plasma in African women with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12521499"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGFB3"}, "span_text": {"type": "literal", "value": "Transforming growth factor beta(1) levels in platelet depleted plasma in African women with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12521499"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGFB2"}, "span_text": {"type": "literal", "value": "Transforming growth factor beta(1) levels in platelet depleted plasma in African women with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12521499"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD1"}, "span_text": {"type": "literal", "value": "The plasma and placental levels of malondialdehyde, glutathione and superoxide dismutase in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12521411"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD3"}, "span_text": {"type": "literal", "value": "The plasma and placental levels of malondialdehyde, glutathione and superoxide dismutase in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12521411"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FGF4"}, "span_text": {"type": "literal", "value": "We examined serum concentrations of basic fibroblast growth factor (bFGF) in women with hypertensive disorders in pregnancy and analyzed whether serum concentrations of bFGF can be used as a discriminator between mild and severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12517330"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FGF7"}, "span_text": {"type": "literal", "value": "Basic fibroblast growth factor and hypertensive disorders in pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12517330"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FGF13"}, "span_text": {"type": "literal", "value": "Basic fibroblast growth factor and hypertensive disorders in pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12517330"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FGF7"}, "span_text": {"type": "literal", "value": "We examined serum concentrations of basic fibroblast growth factor (bFGF) in women with hypertensive disorders in pregnancy and analyzed whether serum concentrations of bFGF can be used as a discriminator between mild and severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12517330"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FGF18"}, "span_text": {"type": "literal", "value": "We examined serum concentrations of basic fibroblast growth factor (bFGF) in women with hypertensive disorders in pregnancy and analyzed whether serum concentrations of bFGF can be used as a discriminator between mild and severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12517330"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FGF16"}, "span_text": {"type": "literal", "value": "Basic fibroblast growth factor and hypertensive disorders in pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12517330"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FGF14"}, "span_text": {"type": "literal", "value": "Basic fibroblast growth factor and hypertensive disorders in pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12517330"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FGF5"}, "span_text": {"type": "literal", "value": "We examined serum concentrations of basic fibroblast growth factor (bFGF) in women with hypertensive disorders in pregnancy and analyzed whether serum concentrations of bFGF can be used as a discriminator between mild and severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12517330"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FGF22"}, "span_text": {"type": "literal", "value": "Basic fibroblast growth factor and hypertensive disorders in pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12517330"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FGF22"}, "span_text": {"type": "literal", "value": "We examined serum concentrations of basic fibroblast growth factor (bFGF) in women with hypertensive disorders in pregnancy and analyzed whether serum concentrations of bFGF can be used as a discriminator between mild and severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12517330"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FGF16"}, "span_text": {"type": "literal", "value": "We examined serum concentrations of basic fibroblast growth factor (bFGF) in women with hypertensive disorders in pregnancy and analyzed whether serum concentrations of bFGF can be used as a discriminator between mild and severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12517330"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FGF18"}, "span_text": {"type": "literal", "value": "Basic fibroblast growth factor and hypertensive disorders in pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12517330"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FGF5"}, "span_text": {"type": "literal", "value": "Basic fibroblast growth factor and hypertensive disorders in pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12517330"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FGF14"}, "span_text": {"type": "literal", "value": "We examined serum concentrations of basic fibroblast growth factor (bFGF) in women with hypertensive disorders in pregnancy and analyzed whether serum concentrations of bFGF can be used as a discriminator between mild and severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12517330"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FGF4"}, "span_text": {"type": "literal", "value": "Basic fibroblast growth factor and hypertensive disorders in pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12517330"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FGF13"}, "span_text": {"type": "literal", "value": "We examined serum concentrations of basic fibroblast growth factor (bFGF) in women with hypertensive disorders in pregnancy and analyzed whether serum concentrations of bFGF can be used as a discriminator between mild and severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12517330"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD3"}, "span_text": {"type": "literal", "value": "The activities of placental superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px), but not catalase, are lower than normal in preeclampsia, which could contribute to the uncontrolled placental production of lipid peroxides and thromboxane (TX)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12517328"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX1"}, "span_text": {"type": "literal", "value": "The activities of placental superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px), but not catalase, are lower than normal in preeclampsia, which could contribute to the uncontrolled placental production of lipid peroxides and thromboxane (TX)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12517328"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX3"}, "span_text": {"type": "literal", "value": "The activities of placental superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px), but not catalase, are lower than normal in preeclampsia, which could contribute to the uncontrolled placental production of lipid peroxides and thromboxane (TX)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12517328"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CAT"}, "span_text": {"type": "literal", "value": "These data mimic the changes in placental SOD, GSH-Px, catalase, TX and lipid peroxidation that occur in preeclampsia suggesting that maternal hyperlipidemia and increased iron levels may be responsible for placental oxidative stress and abnormalities in antioxidants and thromboxane."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12517328"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX2"}, "span_text": {"type": "literal", "value": "The activities of placental superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px), but not catalase, are lower than normal in preeclampsia, which could contribute to the uncontrolled placental production of lipid peroxides and thromboxane (TX)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12517328"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD1"}, "span_text": {"type": "literal", "value": "The activities of placental superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px), but not catalase, are lower than normal in preeclampsia, which could contribute to the uncontrolled placental production of lipid peroxides and thromboxane (TX)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12517328"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CAT"}, "span_text": {"type": "literal", "value": "The activities of placental superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px), but not catalase, are lower than normal in preeclampsia, which could contribute to the uncontrolled placental production of lipid peroxides and thromboxane (TX)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12517328"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOE"}, "span_text": {"type": "literal", "value": "Preeclampsia is associated with an abnormal lipid profile and high apolipoprotein E (Apo E) levels."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12517327"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "We investigated the involvement of these three lipoproteins in lipid disorders associated with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12517327"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LAP3"}, "span_text": {"type": "literal", "value": "1) Leucine aminopeptidase (LAP) was determined in maternal and fetal blood and in the placenta of mild and severe pre-eclamptic patients, then compared to the levels of normal pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/1251692"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LAP3"}, "span_text": {"type": "literal", "value": "Leucine aminopeptidase activity in maternal, cord blood and placenta of normal pregnancy and in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/1251692"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AFP"}, "span_text": {"type": "literal", "value": "Maternal serum activin, inhibin, human chorionic gonadotrophin and alpha-fetoprotein as second trimester predictors of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12504935"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AFP"}, "span_text": {"type": "literal", "value": "To compare the serum levels of human chorionic gonadotrophin (hCG), alpha-fetoprotein, activin A, inhibin A and inhibin isoforms containing pro and alphaC in the second trimester serum of women who subsequently developed hypertensive disorders of pregnancy with those who remained normotensive throughout pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12504935"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AFP"}, "span_text": {"type": "literal", "value": "Activin A levels in serum were significantly elevated in women who later developed pregnancy-induced hypertension (26% increase compared with controls) and hCG levels were significantly elevated in women who later developed pre-eclampsia (24% increase compared with controls). alpha-Fetoprotein, inhibin A and inhibin pro-alphaC levels were not significantly elevated in the patient groups compared with their controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12504935"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEPR"}, "span_text": {"type": "literal", "value": "As a step towards functional studies, we have characterized leptin receptors in human placenta from normal pregnancies and pregnancies associated with diabetes and pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12495664"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FST"}, "span_text": {"type": "literal", "value": "Placental activin A and inhibin A output is increased in pre-eclampsia, a condition characterized by placental hypoxaemia, whereas follistatin secretion is unaltered."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12495662"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Leptin, PLGF, SP1 and HPL levels were not altered in the term pre-eclampsia placenta."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12457454"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG11"}, "span_text": {"type": "literal", "value": "The aim of this study was to compare the levels of inhibin A, activin A: follistatin ratio, leptin, pregnancy-associated plasma protein-A (PAPP-A), human placental lactogen (HPL), placenta growth factor (PLGF) and pregnancy-specific beta1-glycoprotein (SP1) in placental extracts of normal pregnant women and pre-eclampsia patients at term."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12457454"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG1"}, "span_text": {"type": "literal", "value": "The aim of this study was to compare the levels of inhibin A, activin A: follistatin ratio, leptin, pregnancy-associated plasma protein-A (PAPP-A), human placental lactogen (HPL), placenta growth factor (PLGF) and pregnancy-specific beta1-glycoprotein (SP1) in placental extracts of normal pregnant women and pre-eclampsia patients at term."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12457454"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG6"}, "span_text": {"type": "literal", "value": "The aim of this study was to compare the levels of inhibin A, activin A: follistatin ratio, leptin, pregnancy-associated plasma protein-A (PAPP-A), human placental lactogen (HPL), placenta growth factor (PLGF) and pregnancy-specific beta1-glycoprotein (SP1) in placental extracts of normal pregnant women and pre-eclampsia patients at term."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12457454"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG2"}, "span_text": {"type": "literal", "value": "The aim of this study was to compare the levels of inhibin A, activin A: follistatin ratio, leptin, pregnancy-associated plasma protein-A (PAPP-A), human placental lactogen (HPL), placenta growth factor (PLGF) and pregnancy-specific beta1-glycoprotein (SP1) in placental extracts of normal pregnant women and pre-eclampsia patients at term."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12457454"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG8"}, "span_text": {"type": "literal", "value": "The aim of this study was to compare the levels of inhibin A, activin A: follistatin ratio, leptin, pregnancy-associated plasma protein-A (PAPP-A), human placental lactogen (HPL), placenta growth factor (PLGF) and pregnancy-specific beta1-glycoprotein (SP1) in placental extracts of normal pregnant women and pre-eclampsia patients at term."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12457454"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG9"}, "span_text": {"type": "literal", "value": "The aim of this study was to compare the levels of inhibin A, activin A: follistatin ratio, leptin, pregnancy-associated plasma protein-A (PAPP-A), human placental lactogen (HPL), placenta growth factor (PLGF) and pregnancy-specific beta1-glycoprotein (SP1) in placental extracts of normal pregnant women and pre-eclampsia patients at term."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12457454"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "The aim of this study was to compare the levels of inhibin A, activin A: follistatin ratio, leptin, pregnancy-associated plasma protein-A (PAPP-A), human placental lactogen (HPL), placenta growth factor (PLGF) and pregnancy-specific beta1-glycoprotein (SP1) in placental extracts of normal pregnant women and pre-eclampsia patients at term."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12457454"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG5"}, "span_text": {"type": "literal", "value": "The aim of this study was to compare the levels of inhibin A, activin A: follistatin ratio, leptin, pregnancy-associated plasma protein-A (PAPP-A), human placental lactogen (HPL), placenta growth factor (PLGF) and pregnancy-specific beta1-glycoprotein (SP1) in placental extracts of normal pregnant women and pre-eclampsia patients at term."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12457454"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG4"}, "span_text": {"type": "literal", "value": "The aim of this study was to compare the levels of inhibin A, activin A: follistatin ratio, leptin, pregnancy-associated plasma protein-A (PAPP-A), human placental lactogen (HPL), placenta growth factor (PLGF) and pregnancy-specific beta1-glycoprotein (SP1) in placental extracts of normal pregnant women and pre-eclampsia patients at term."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12457454"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PSG3"}, "span_text": {"type": "literal", "value": "The aim of this study was to compare the levels of inhibin A, activin A: follistatin ratio, leptin, pregnancy-associated plasma protein-A (PAPP-A), human placental lactogen (HPL), placenta growth factor (PLGF) and pregnancy-specific beta1-glycoprotein (SP1) in placental extracts of normal pregnant women and pre-eclampsia patients at term."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12457454"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FST"}, "span_text": {"type": "literal", "value": "The aim of this study was to compare the levels of inhibin A, activin A: follistatin ratio, leptin, pregnancy-associated plasma protein-A (PAPP-A), human placental lactogen (HPL), placenta growth factor (PLGF) and pregnancy-specific beta1-glycoprotein (SP1) in placental extracts of normal pregnant women and pre-eclampsia patients at term."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12457454"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Leptin and pre-eclampsia in black African parturients."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12452464"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "There is no difference in serum leptin levels between Black African women with pre-eclampsia and healthy normotensive pregnant women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12452464"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "There was no significant difference in the mean concentrations of leptin between women with and those without pre-eclampsia [26.66 (1.96) vs 25.89 (1.65) ng/mL, respectively, P = 0.95]."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12452464"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "To measure serum concentrations of the hormone leptin during late pregnancy in Black African women with pre-eclampsia, healthy normotensive pregnant women as controls and healthy normotensive non-pregnant women; secondly, to explore the relationship between leptin and obesity."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12452464"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "The aim of this study was to evaluate the relationship between the vascular resistance in uterine arteries and the maternal release of adenosine and endothelin-1 in twin gestations with and without preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12439550"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Maternal plasma adenosine and endothelin-1 levels in twin gestation complicated by preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12439550"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Insulin sensitivity in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12421023"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "As with other forms of secondary hypertension, and unlike essential hypertension, the pathophysiology of pre-eclampsia is not associated with insulin resistance."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12421023"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Insulin sensitivity (S1) was increased in the group with pre-eclampsia compared with the normotensive women (Mean +/- SEM):"}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12421023"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "To investigate whether pre-eclampsia is associated with an exaggeration of the insulin resistance in normotensive pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12421023"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Lipoprotein(a): a longitudinal versus a cross-sectional study in normal pregnancy and its levels in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12417294"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGT"}, "span_text": {"type": "literal", "value": "Angiotensinogen gene M235T variant and pre-eclampsia in Romanian pregnant women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12417054"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGT"}, "span_text": {"type": "literal", "value": "Our study shows that the M235T variant in the gene encoding angiotensinogen could be a risk factor in mild and severe pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12417054"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HBEGF"}, "span_text": {"type": "literal", "value": "Pre-eclampsia and expression of heparin-binding EGF-like growth factor."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12401248"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGFB1"}, "span_text": {"type": "literal", "value": "Transforming growth factor-beta 1 does not relate to hypertension in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12366387"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Preeclampsia disrupts the normal physiology of leptin."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12357421"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Therefore, preeclampsia may be thought to disrupt normal leptin physiology."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12357421"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PPARG"}, "span_text": {"type": "literal", "value": "To investigate peroxisome proliferator-activated receptor-gamma (PPARgamma) genotype frequencies in women with preeclampsia and elucidate its role in the pathogenesis of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12324185"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PPARG"}, "span_text": {"type": "literal", "value": "Polymorphism in the peroxisome proliferator-activated receptor-gamma gene in women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12324185"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD1"}, "span_text": {"type": "literal", "value": "The changes of trace elements, malondialdehyde levels and superoxide dismutase activities in pregnancy with or without preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12270770"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD3"}, "span_text": {"type": "literal", "value": "The changes of trace elements, malondialdehyde levels and superoxide dismutase activities in pregnancy with or without preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12270770"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Low-density lipoprotein particle diameter in normal pregnancy and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12238637"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "We investigated the changes of low-density lipoprotein (LDL) size and serum lipids during pregnancy and postpartum not only in normal pregnant women but also in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12238637"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF2"}, "span_text": {"type": "literal", "value": "The purpose of this study was to assess insulin, insulin sensitivity, and insulin-like growth factor-I in women with preeclampsia and gestational hypertension."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12237656"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF1"}, "span_text": {"type": "literal", "value": "Insulin resistance is present in women with gestational hypertension but not in women with preeclampsia and did not correlate with insulin-like growth factor-I."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12237656"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF2"}, "span_text": {"type": "literal", "value": "Insulin resistance is present in women with gestational hypertension but not in women with preeclampsia and did not correlate with insulin-like growth factor-I."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12237656"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF1"}, "span_text": {"type": "literal", "value": "The purpose of this study was to assess insulin, insulin sensitivity, and insulin-like growth factor-I in women with preeclampsia and gestational hypertension."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12237656"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Insulin resistance was measured with the short insulin-tolerance test in 20 women with preeclampsia, in 18 women with gestational hypertension, and in 20 normotensive control subjects."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12237656"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF2"}, "span_text": {"type": "literal", "value": "Women with gestational hypertension had a significant lower insulin sensitivity index (0.13 +/- 0.1) and a higher level of insulin-like growth factor-I (333.71 +/- 107.6 ng/mL) than women in the control group (0.21 +/- 0.1 [P <.05]; 218.11 +/- 82.3 ng/mL [P <.01]) and women with preeclampsia (0.21 +/- 0.12 [P <.05]; 234.78 +/- 92.76 ng/mL [P <.01])."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12237656"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "The purpose of this study was to assess insulin, insulin sensitivity, and insulin-like growth factor-I in women with preeclampsia and gestational hypertension."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12237656"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF1"}, "span_text": {"type": "literal", "value": "Women with gestational hypertension had a significant lower insulin sensitivity index (0.13 +/- 0.1) and a higher level of insulin-like growth factor-I (333.71 +/- 107.6 ng/mL) than women in the control group (0.21 +/- 0.1 [P <.05]; 218.11 +/- 82.3 ng/mL [P <.01]) and women with preeclampsia (0.21 +/- 0.12 [P <.05]; 234.78 +/- 92.76 ng/mL [P <.01])."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12237656"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Insulin resistance is present in women with gestational hypertension but not in women with preeclampsia and did not correlate with insulin-like growth factor-I."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12237656"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Women with gestational hypertension had a significant lower insulin sensitivity index (0.13 +/- 0.1) and a higher level of insulin-like growth factor-I (333.71 +/- 107.6 ng/mL) than women in the control group (0.21 +/- 0.1 [P <.05]; 218.11 +/- 82.3 ng/mL [P <.01]) and women with preeclampsia (0.21 +/- 0.12 [P <.05]; 234.78 +/- 92.76 ng/mL [P <.01])."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12237656"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PRL"}, "span_text": {"type": "literal", "value": "The possible role of prolactin in preeclampsia:"}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12208175"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VCAM1"}, "span_text": {"type": "literal", "value": "The present study was aimed at determining whether routine prenatal measurements of circulating soluble intercellular adhesion molecule (sICAM-1; CD54) and soluble vascular cell adhesion molecule (sVCAM-1; CD106) in midgestation have predictive value for the identification of pregnant women destined to develop preeclampsia or other complications of pregnancy during late gestation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12194917"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ICAM2"}, "span_text": {"type": "literal", "value": "The present study was aimed at determining whether routine prenatal measurements of circulating soluble intercellular adhesion molecule (sICAM-1; CD54) and soluble vascular cell adhesion molecule (sVCAM-1; CD106) in midgestation have predictive value for the identification of pregnant women destined to develop preeclampsia or other complications of pregnancy during late gestation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12194917"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ICAM5"}, "span_text": {"type": "literal", "value": "The present study was aimed at determining whether routine prenatal measurements of circulating soluble intercellular adhesion molecule (sICAM-1; CD54) and soluble vascular cell adhesion molecule (sVCAM-1; CD106) in midgestation have predictive value for the identification of pregnant women destined to develop preeclampsia or other complications of pregnancy during late gestation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12194917"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ICAM1"}, "span_text": {"type": "literal", "value": "The present study was aimed at determining whether routine prenatal measurements of circulating soluble intercellular adhesion molecule (sICAM-1; CD54) and soluble vascular cell adhesion molecule (sVCAM-1; CD106) in midgestation have predictive value for the identification of pregnant women destined to develop preeclampsia or other complications of pregnancy during late gestation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12194917"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HFE"}, "span_text": {"type": "literal", "value": "Given the high prevalence of heterozygosity for hemochromatosis with the associated reduced ability to exclude ingested iron, it would seem inadvisable, in the absence of evidence of iron deficiency, to give iron supplements to pregnant women at high risk for preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12193935"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "The concentration of endothelin-1 (ET-1), a potent mammalian vasoconstrictor peptide produced by the vascular endothelium, has been observed to be significantly increased in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12190954"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL6"}, "span_text": {"type": "literal", "value": "The aim of our study was to determine the correlation of abnormal umbilical artery interleukin-6 levels with pregnancies complicated by preterm delivery and pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12175716"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGFB3"}, "span_text": {"type": "literal", "value": "To detect the immunoreactivity of insulin-like growth factor-I, insulin-like growth factor-binding proteins-1 and -3 and transforming growth factor beta-3 in the umbilical cords of normal and preeclamptic patients."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12174164"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP5"}, "span_text": {"type": "literal", "value": "To detect the immunoreactivity of insulin-like growth factor-I, insulin-like growth factor-binding proteins-1 and -3 and transforming growth factor beta-3 in the umbilical cords of normal and preeclamptic patients."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12174164"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF2"}, "span_text": {"type": "literal", "value": "To detect the immunoreactivity of insulin-like growth factor-I, insulin-like growth factor-binding proteins-1 and -3 and transforming growth factor beta-3 in the umbilical cords of normal and preeclamptic patients."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12174164"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP4"}, "span_text": {"type": "literal", "value": "To detect the immunoreactivity of insulin-like growth factor-I, insulin-like growth factor-binding proteins-1 and -3 and transforming growth factor beta-3 in the umbilical cords of normal and preeclamptic patients."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12174164"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF1"}, "span_text": {"type": "literal", "value": "To detect the immunoreactivity of insulin-like growth factor-I, insulin-like growth factor-binding proteins-1 and -3 and transforming growth factor beta-3 in the umbilical cords of normal and preeclamptic patients."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12174164"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP2"}, "span_text": {"type": "literal", "value": "To detect the immunoreactivity of insulin-like growth factor-I, insulin-like growth factor-binding proteins-1 and -3 and transforming growth factor beta-3 in the umbilical cords of normal and preeclamptic patients."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12174164"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGFB3"}, "span_text": {"type": "literal", "value": "Immunohistochemical staining of IGF-I, IGF-binding proteins-1 and -3, and transforming growth factor beta-3 in the umbilical cords of preeclamptic patients."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12174164"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP3"}, "span_text": {"type": "literal", "value": "To detect the immunoreactivity of insulin-like growth factor-I, insulin-like growth factor-binding proteins-1 and -3 and transforming growth factor beta-3 in the umbilical cords of normal and preeclamptic patients."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12174164"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF2"}, "span_text": {"type": "literal", "value": "Changes in the intensity of insulin-like growth factor-I and its major binding protein and the transformation of growth factor-beta 3 may play a role in the pathogenesis of preeclampsia by altering the structure and responsiveness of the umbilical cord."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12174164"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP7"}, "span_text": {"type": "literal", "value": "To detect the immunoreactivity of insulin-like growth factor-I, insulin-like growth factor-binding proteins-1 and -3 and transforming growth factor beta-3 in the umbilical cords of normal and preeclamptic patients."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12174164"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF1"}, "span_text": {"type": "literal", "value": "Changes in the intensity of insulin-like growth factor-I and its major binding protein and the transformation of growth factor-beta 3 may play a role in the pathogenesis of preeclampsia by altering the structure and responsiveness of the umbilical cord."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12174164"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CADM1"}, "span_text": {"type": "literal", "value": "Plasma concentrations of soluble tumor necrosis factor receptor I and II, immunoreactive tumor necrosis factor-a and soluble cell adhesion molecule VCAM-1 were determined in 21 patients with severe proteinuric preeclampsia (23-35 weeks' gestation) and 21 gestational age-matched normotensive controls by enzyme-linked immunoassays."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12174154"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CADM1"}, "span_text": {"type": "literal", "value": "Immunoreactive tumor necrosis factor-alpha, soluble TNF-receptors and soluble cell adhesion molecule VCAM-1 were significantly increased in plasma of preeclamptic patients, and a statistically significant positive correlation was observed between immunoreactive tumor necrosis factor-alpha and TNFRII."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12174154"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CADM3"}, "span_text": {"type": "literal", "value": "In preeclamptic patients a statistically significant negative correlation was observed between TNFRII and platelet count, and between soluble cell adhesion molecule VCAM-1 and birthweight ratio."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12174154"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CADM1"}, "span_text": {"type": "literal", "value": "Soluble tumor necrosis factor receptor II and soluble cell adhesion molecule 1 as markers of tumor necrosis factor-alpha release in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12174154"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CADM3"}, "span_text": {"type": "literal", "value": "Plasma concentrations of soluble tumor necrosis factor receptor I and II, immunoreactive tumor necrosis factor-a and soluble cell adhesion molecule VCAM-1 were determined in 21 patients with severe proteinuric preeclampsia (23-35 weeks' gestation) and 21 gestational age-matched normotensive controls by enzyme-linked immunoassays."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12174154"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CADM1"}, "span_text": {"type": "literal", "value": "In preeclamptic patients a statistically significant negative correlation was observed between TNFRII and platelet count, and between soluble cell adhesion molecule VCAM-1 and birthweight ratio."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12174154"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CADM3"}, "span_text": {"type": "literal", "value": "These results show that plasma concentrations of soluble tumor necrosis factor receptor II and soluble cell adhesion molecule VCAM-1 reflect the release of tumor necrosis factor-alpha and provide sensitive markers of excessive release of this cytokine in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12174154"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CADM1"}, "span_text": {"type": "literal", "value": "These results show that plasma concentrations of soluble tumor necrosis factor receptor II and soluble cell adhesion molecule VCAM-1 reflect the release of tumor necrosis factor-alpha and provide sensitive markers of excessive release of this cytokine in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12174154"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CADM3"}, "span_text": {"type": "literal", "value": "Immunoreactive tumor necrosis factor-alpha, soluble TNF-receptors and soluble cell adhesion molecule VCAM-1 were significantly increased in plasma of preeclamptic patients, and a statistically significant positive correlation was observed between immunoreactive tumor necrosis factor-alpha and TNFRII."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12174154"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EPHX2"}, "span_text": {"type": "literal", "value": "The study also determined whether genetic variability in the gene encoding for microsomal epoxide hydrolase (EPHX) contributes to individual differences in susceptibility to the development of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12173035"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EPHX2"}, "span_text": {"type": "literal", "value": "This study determined whether genetic variability in exons 3 and 4 of the microsomal epoxide hydrolase gene jointly modifies individual preeclampsia risk."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12173035"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EPHX3"}, "span_text": {"type": "literal", "value": "Two exonic single nucleotide polymorphisms in the microsomal epoxide hydrolase gene are jointly associated with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12173035"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EPHX1"}, "span_text": {"type": "literal", "value": "The study also determined whether genetic variability in the gene encoding for microsomal epoxide hydrolase (EPHX) contributes to individual differences in susceptibility to the development of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12173035"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EPHX4"}, "span_text": {"type": "literal", "value": "The study also determined whether genetic variability in the gene encoding for microsomal epoxide hydrolase (EPHX) contributes to individual differences in susceptibility to the development of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12173035"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EPHX4"}, "span_text": {"type": "literal", "value": "This study determined whether genetic variability in exons 3 and 4 of the microsomal epoxide hydrolase gene jointly modifies individual preeclampsia risk."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12173035"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EPHX4"}, "span_text": {"type": "literal", "value": "Two exonic single nucleotide polymorphisms in the microsomal epoxide hydrolase gene are jointly associated with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12173035"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EPHX3"}, "span_text": {"type": "literal", "value": "This study determined whether genetic variability in exons 3 and 4 of the microsomal epoxide hydrolase gene jointly modifies individual preeclampsia risk."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12173035"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EPHX1"}, "span_text": {"type": "literal", "value": "Two exonic single nucleotide polymorphisms in the microsomal epoxide hydrolase gene are jointly associated with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12173035"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EPHX3"}, "span_text": {"type": "literal", "value": "The study also determined whether genetic variability in the gene encoding for microsomal epoxide hydrolase (EPHX) contributes to individual differences in susceptibility to the development of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12173035"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EPHX1"}, "span_text": {"type": "literal", "value": "This study determined whether genetic variability in exons 3 and 4 of the microsomal epoxide hydrolase gene jointly modifies individual preeclampsia risk."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12173035"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EPHX2"}, "span_text": {"type": "literal", "value": "Two exonic single nucleotide polymorphisms in the microsomal epoxide hydrolase gene are jointly associated with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12173035"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGFB1"}, "span_text": {"type": "literal", "value": "Plasma and placental levels of interleukin-10, transforming growth factor-beta1, and epithelial-cadherin in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12151158"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGFB2"}, "span_text": {"type": "literal", "value": "Plasma and placental levels of interleukin-10, transforming growth factor-beta1, and epithelial-cadherin in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12151158"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGFB3"}, "span_text": {"type": "literal", "value": "Plasma and placental levels of interleukin-10, transforming growth factor-beta1, and epithelial-cadherin in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12151158"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL10"}, "span_text": {"type": "literal", "value": "Plasma and placental levels of interleukin-10, transforming growth factor-beta1, and epithelial-cadherin in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12151158"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL4"}, "span_text": {"type": "literal", "value": "In preeclampsia, the proportion of interferon-gamma producing cells significantly increased, and the proportion of interleukin-4 producing cells was significantly decreased compared with normal pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12135693"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL6"}, "span_text": {"type": "literal", "value": "To test this hypothesis, we took blood samples from 26 women with pre-eclampsia (without fetal growth restriction), 13 women with fetal growth restriction (without pre-eclampsia) and 24 normal pregnant controls, and measured the circulating levels of three markers of endothelial cell activation (soluble VCAM, ICAM and E-selectin) and three cytokines [tumour necrosis factor-a (TNF-alpha), interleukin-6 (IL-6) and -8 (IL-8)]."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12135223"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AFP"}, "span_text": {"type": "literal", "value": "The levels of mid-trimester maternal serum alpha-fetoprotein (MSAFP), human chorionic gonadotrophin (hCG) and unconjugated oestriol (MSuE(3)) in patients with early and late onset severe pre-eclampsia were compared."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12124692"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CSF1"}, "span_text": {"type": "literal", "value": "Changes in blood macrophage colony-stimulating factor levels after cesarean section in normotensive pregnancy and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12120825"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CSF2"}, "span_text": {"type": "literal", "value": "Changes in blood macrophage colony-stimulating factor levels after cesarean section in normotensive pregnancy and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12120825"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Leptin, placenta growth factor, the plasminogen activator inhibitor (PAI-1)/PAI-2 ratio, and uric acid were predictive of the development of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12114900"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL2"}, "span_text": {"type": "literal", "value": "The conclusion is that interleukin-2 receptor serum levels diminish in normal pregnancy and rise in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12108028"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL2"}, "span_text": {"type": "literal", "value": "The purpose of this research was to assess interleukin-2 receptor serum levels in normal pregnancy and pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12108028"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL2"}, "span_text": {"type": "literal", "value": "Interleukin-2 receptor serum concentrations in normal pregnancy and pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12108028"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "The nitric oxide synthase (NOS) inhibitor, N-nitro-l-arginine methyl ester, significantly attenuated the responses to bradykinin in arteries from non-pregnant women and almost abolished responses in arteries from women with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12095405"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Further research is needed to determine if the rise in leptin plays a role in preeclampsia or whether it is a secondary and unrelated bystander."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12087498"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Leptin and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12087498"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Preeclampsia, a common complications of pregnancy, is associated with an increase in the concentration of leptin in the maternal blood, which precedes the clinical onset of the disease."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12087498"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "In this capacity, cellular hypoxia, diabetes, and preeclampsia are conditions that appear to be intimately linked to leptin dynamics."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12087496"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Leptin and TGF-beta(1) concentrations were lower and PAI-2 concentration higher in women destined to develop pre-eclampsia relative to controls (leptin: median (25-75 percentiles):"}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12061853"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGFB1"}, "span_text": {"type": "literal", "value": "In a prospective study of 2190 pregnant women we compared plasma leptin, transforming growth factor-beta(1) (TGF-beta(1)) and plasminogen activator inhibitor type 2 (PAI-2) concentrations at 18 weeks' gestation in 71 women with subsequent pre-eclampsia and 71 controls matched for age, parity and first trimester body mass index."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12061853"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Altered plasma concentrations of leptin, transforming growth factor-beta(1) and plasminogen activator inhibitor type 2 at 18 weeks of gestation in women destined to develop pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12061853"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "In a prospective study of 2190 pregnant women we compared plasma leptin, transforming growth factor-beta(1) (TGF-beta(1)) and plasminogen activator inhibitor type 2 (PAI-2) concentrations at 18 weeks' gestation in 71 women with subsequent pre-eclampsia and 71 controls matched for age, parity and first trimester body mass index."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12061853"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGFB1"}, "span_text": {"type": "literal", "value": "Altered plasma concentrations of leptin, transforming growth factor-beta(1) and plasminogen activator inhibitor type 2 at 18 weeks of gestation in women destined to develop pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12061853"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "OR (95 per cent CI) for pre-eclampsia for women in the upper quartile compared to women in the lower quartile were: leptin:"}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12061853"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MTHFR"}, "span_text": {"type": "literal", "value": "The methylenetetrahydrofolate reductase 677 C-->T polymorphism and preeclampsia in two populations."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12052604"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "In order to investigate the relationship between serum P-selectin and lipoprotein(a), and other lipid parameters, 28 preeclampsia [13 severe (group I) and 15 mild preeclampsia (group II), 15 healthy pregnant (group III) and 20 non-pregnant (group IV)] women were investigated."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12049188"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Correlation of P-selectin and lipoprotein(a), and other lipid parameters in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12049188"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Serum P-selectin and lipoprotein(a) levels revealed a significant and linear increase with the severity of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12049188"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Increased P-selectin levels and altered lipid and lipoprotein metabolism were reported in preeclampsia and during pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12049188"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Plasma levels of endothelin-1 declined to normal levels by the third postpartum day and the finding is consistent with the hypothesis that endothelin-1 is not the major vasoconstrictor in the pathophysiology of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12044343"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "The objective of this study is to compare the serum levels of fibronectin, nitric oxide (NO), cyclic guanosine-monophosphate, endothelin-1, and 6-keto-prostaglandin-F 1alpha in women with and without preeclampsia before and after delivery."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12044343"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "Mishandling of Cu by albumin contributes to oxidative stress in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12044332"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "To test the hypothesis that enhanced oxidative stress during pregnancies complicated by preeclampsia is associated with improper copper (Cu) binding by plasma albumin, resulting in enhanced Cu redox-cycling activity and that altered Cu binding, in turn, is caused by interactions of excessive amounts of free fatty acids with albumin."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12044332"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "Mishandling of copper by albumin: role in redox-cycling and oxidative stress in preeclampsia plasma."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12044332"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "We found that preeclampsia plasma (as compared to normal pregnancy plasma) (1) displays elevated endogenous ascorbate redox-cycling that is normalized by a Cu(II) chelator, cuprizone I, (2) has lowered capacity to bind and redox-regulate exogenously added Cu, and (3) responds to treatment with fatty-acid-free albumin by diminished ascorbate oxidizing activity."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12044332"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "In addition, because vascular endothelial growth factor (VEGF) has been implicated in the pathophysiology of preeclampsia and is involved in angiogenesis that requires the release of proteases to allow for migration of endothelial cells, we hypothesized that VEGF increases release of MMPs from endothelial cells."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12044329"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "In addition, because vascular endothelial growth factor (VEGF) has been implicated in the pathophysiology of preeclampsia and is involved in angiogenesis that requires the release of proteases to allow for migration of endothelial cells, we hypothesized that VEGF increases release of MMPs from endothelial cells."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12044329"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "In addition, because vascular endothelial growth factor (VEGF) has been implicated in the pathophysiology of preeclampsia and is involved in angiogenesis that requires the release of proteases to allow for migration of endothelial cells, we hypothesized that VEGF increases release of MMPs from endothelial cells."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12044329"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Serum antibodies to oxidized low-density lipoprotein in pregnant women with preeclampsia and chronic hypertension: lack of correlation with lipid peroxides."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12044328"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "To evaluate the circulating levels of antibodies to oxidized low-density lipoprotein (LDL) and their correlation with the lipid peroxide/vitamin E ratio in pregnant women with preeclampsia and chronic hypertension."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12044328"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LOC100128922"}, "span_text": {"type": "literal", "value": "Connexin expression is not altered in omental resistance vessels from women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12044320"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "We sought to test the hypothesis that a polymorphism of the endothelial nitric oxide synthase gene (NOS3) is associated with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12044319"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "An endothelial nitric oxide synthase gene polymorphism is associated with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12044319"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL4"}, "span_text": {"type": "literal", "value": "The proportions of interferon-gamma secreting cells increased and interleukin-4 secreting cells decreased significantly in preeclampsia, and the T-helper 1/T-helper 2 ratio in preeclampsia was significantly higher than in normal pregnancy (18.1 +/- 2.6 versus 9.9 +/- 1.5, P <.05)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/12039127"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "The aim of this study was to evaluate changes in lipids, apolipoproteins and lipoproteins in Portuguese pregnant women and their potential involvement in the pathophysiology of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11996963"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "We also revealed that leptin gene expression in the placenta was augmented in severe pre-eclampsia, and suggested that placental hypoxia may play a role in this augmentation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11978063"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MTHFR"}, "span_text": {"type": "literal", "value": "Frequency of factor V, prothrombin and methylenetetrahydrofolate reductase gene variants in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11961379"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MTHFR"}, "span_text": {"type": "literal", "value": "The association between thrombophilic variants (Leiden mutation of the factor V gene, G20210A mutation of the prothrombin gene and C677T polymorphism of the methylenetetrahydrofolate reductase (MTHFR) gene) with preeclampsia was investigated in a north-eastern Italian population."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11961379"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HSPG2"}, "span_text": {"type": "literal", "value": "Decreased heparan sulfate proteoglycan results in a decreased anionic charge of the glomerular basement membrane with increased heparan sulfate proteoglycan in the urine, and is believed to be responsible for the proteinuria in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11952459"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HSPG2"}, "span_text": {"type": "literal", "value": "Urinary heparan sulfate proteoglycan excretion in black African women with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11952459"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CSPG5"}, "span_text": {"type": "literal", "value": "To determine the urinary heparan and chondroitin sulfate proteoglycan levels in women with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11952459"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CSF2"}, "span_text": {"type": "literal", "value": "Influence of maternal preeclampsia on recombinant human granulocyte colony-stimulating factor effect in neutropenic neonates with suspected sepsis."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11950479"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CSF1"}, "span_text": {"type": "literal", "value": "To evaluate the effect of recombinant human granulocyte colony-stimulating factor (rhG-CSF) in preterm neonates with suspected sepsis and severe neutropenia (<1500 mm(3)), and to define the influence of maternal preeclampsia on rhG-CSF activity."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11950479"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CSF2"}, "span_text": {"type": "literal", "value": "To evaluate the effect of recombinant human granulocyte colony-stimulating factor (rhG-CSF) in preterm neonates with suspected sepsis and severe neutropenia (<1500 mm(3)), and to define the influence of maternal preeclampsia on rhG-CSF activity."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11950479"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CSF1"}, "span_text": {"type": "literal", "value": "Influence of maternal preeclampsia on recombinant human granulocyte colony-stimulating factor effect in neutropenic neonates with suspected sepsis."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11950479"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:F5"}, "span_text": {"type": "literal", "value": "The Leiden mutation in the coagulation factor V (F5) gene associated with preeclampsia in Caucasians has not been found in Japanese populations."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11950065"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:F5"}, "span_text": {"type": "literal", "value": "Association analysis of nine missense polymorphisms in the coagulation factor V gene with severe preeclampsia in pregnant Japanese women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11950065"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD3"}, "span_text": {"type": "literal", "value": "The superoxide dismutase (SOD) level, responsible for eliminating toxic superoxides, drops significantly in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11945083"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD1"}, "span_text": {"type": "literal", "value": "The superoxide dismutase (SOD) level, responsible for eliminating toxic superoxides, drops significantly in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11945083"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MAOA"}, "span_text": {"type": "literal", "value": "A feature of pre-eclampsia is that circulating levels of maternal serotonin (5-hydroxytryptamine) are elevated and placental monoamine oxidase-A (MAO-A) activity, the major factor in the regulation of serotonin levels in pregnancy, is reduced."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11945082"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Dysregulation of autocrine/paracrine function of leptin at feto-placento-maternal interface may be implicated in the pathogenesis of recurrent miscarriage gestational diabetes, pre-eclampsia and intra-uterine fetal growth retardation including disturbance of fetal bone turnover."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11945077"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11943725"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11943725"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11943725"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGFB1"}, "span_text": {"type": "literal", "value": "Transforming growth factor-beta 1 serum levels in pregnancy and pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11942909"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGFB2"}, "span_text": {"type": "literal", "value": "Isoforms of transforming growth factor-beta (TGF-beta1) are thought to be involved in the pathogenesis of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11942909"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGFB2"}, "span_text": {"type": "literal", "value": "Transforming growth factor-beta 1 serum levels in pregnancy and pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11942909"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGFB1"}, "span_text": {"type": "literal", "value": "Transforming growth factor-beta 1 serum levels were measured using a commercially available enzyme-linked immunosorbent assay in 44 women with pre-eclampsia and 44 healthy pregnant women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11942909"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGFB3"}, "span_text": {"type": "literal", "value": "Transforming growth factor-beta 1 serum levels in pregnancy and pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11942909"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGFB3"}, "span_text": {"type": "literal", "value": "Isoforms of transforming growth factor-beta (TGF-beta1) are thought to be involved in the pathogenesis of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11942909"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGFB1"}, "span_text": {"type": "literal", "value": "Isoforms of transforming growth factor-beta (TGF-beta1) are thought to be involved in the pathogenesis of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11942909"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ICAM1"}, "span_text": {"type": "literal", "value": "To determine if plasma and amniotic fluid levels of intercellular adhesion molecule-1 (ICAM-1) at 16 weeks' gestation could be predictive of preeclampsia or intrauterine growth retardation (IUGR)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11933682"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "We conclude that increased early pregnancy insulin resistance is independently associated with subsequent preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11932283"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "First trimester insulin resistance and subsequent preeclampsia: a prospective study."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11932283"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Insulin resistance is implicated in the pathogenesis of preeclampsia, but prospective data are limited."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11932283"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "We conducted a prospective, nested, case-control study to test the hypothesis that increased insulin resistance, marked by reduced first trimester SHBG levels, is associated with increased risk of subsequent preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11932283"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Moreover, a positive correlation was encountered (r = 0.6, p < 0.001) between platelet number and leptin levels for all the patients with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11913707"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "We determined the serum levels of leptin in 96 pregnant women with body mass index between 20 to 30, 30 normal (NP), 26 with mild preeclampsia (MPE), 27 with severe preeclampsia (SPE), 6 with chronic hypertension plus preeclampsia (CHT+PE) and 7 with chronic hypertension (CHT)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11913707"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADM2"}, "span_text": {"type": "literal", "value": "Adrenomedullin, calcitonin gene-related peptide and their receptors: evidence for a decreased placental mRNA content in preeclampsia and HELLP syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11905404"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADM2"}, "span_text": {"type": "literal", "value": "Our study was planned to examine placental mRNA amounts of vasodilatory adrenomedullin (AM), calcitonin gene-related peptide (CGRP) and their receptors (AM-R and CGRP-R) in preeclampsia and HELLP syndrome (hemolysis, elevated liver enzymes, low platelets)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11905404"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADM"}, "span_text": {"type": "literal", "value": "Our study was planned to examine placental mRNA amounts of vasodilatory adrenomedullin (AM), calcitonin gene-related peptide (CGRP) and their receptors (AM-R and CGRP-R) in preeclampsia and HELLP syndrome (hemolysis, elevated liver enzymes, low platelets)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11905404"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADM"}, "span_text": {"type": "literal", "value": "Adrenomedullin, calcitonin gene-related peptide and their receptors: evidence for a decreased placental mRNA content in preeclampsia and HELLP syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11905404"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Cord plasma leptin increased strongly with gestational age, both in the preeclampsia group and the control subjects (P <.01), but at each gestational age the preeclampsia group had higher leptin levels than control subjects (P <.01)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11904602"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "We found higher levels of umbilical cord plasma leptin in infants of mothers who had preeclampsia (compared with infants of control subjects) after adjusting for differences in gestational age, gender, and infant ponderal index."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11904602"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Umbilical cord plasma leptin is increased in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11904602"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "The objective of this study was to compare umbilical cord plasma leptin between infants of mothers who experienced preeclampsia and infants of control subjects and to study the relation between cord plasma leptin and infant obesity, as indicated by ponderal index."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11904602"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CSF1"}, "span_text": {"type": "literal", "value": "Increased levels of macrophage colony-stimulating factor in the placenta and blood in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11883744"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CSF2"}, "span_text": {"type": "literal", "value": "Increased levels of macrophage colony-stimulating factor in the placenta and blood in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11883744"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "We sought to determine whether maternal plasma lipoprotein(a) [Lp(a)] levels are elevated in the second trimester, before the development of preeclampsia and other obstetrical complications, in women at risk."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11864702"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "The elevated plasma lipoprotein(a) concentrations in preeclampsia do not precede the development of the disorder."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11864702"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "Poor glycemic control and increased urinary albumin excretion rate is associated with preeclampsia when ambulatory blood pressure is above cut-off values of 122/74 mmHg (systole/diastole)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11846705"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "The incidence of preeclampsia was significantly associated with increasing urinary albumin excretion rate, primiparity, and ambulatory blood pressure."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11846705"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "Twenty-four-hour ambulatory blood pressure was evaluated as a predictor of preeclampsia in women with insulin-dependent diabetes mellitus with respect to urinary albumin excretion rate and glycemic regulation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11846705"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "The relative risk of preeclampsia was significantly higher when ambulatory blood pressure was above the cut-off values and increased further with higher urinary albumin excretion rate."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11846705"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "Ambulatory blood pressure as predictor of preeclampsia in diabetic pregnancies with respect to urinary albumin excretion rate and glycemic regulation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11846705"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CADM1"}, "span_text": {"type": "literal", "value": "Differences in the profile of soluble cell adhesion molecules suggest variations in the degrees of endothelial activation between pre-eclampsia and small for gestational age fetuses."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11843391"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CADM3"}, "span_text": {"type": "literal", "value": "Differences in the profile of soluble cell adhesion molecules suggest variations in the degrees of endothelial activation between pre-eclampsia and small for gestational age fetuses."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11843391"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CADM1"}, "span_text": {"type": "literal", "value": "Compared with the healthy controls, soluble E-selectin was significantly increased in both small for gestational age fetuses and pre-eclampsia, whereas intercellular cell adhesion molecule-1 and vascular cell adhesion molecule-1 were increased only in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11843391"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CADM1"}, "span_text": {"type": "literal", "value": "To evaluate the activation profile of the endothelium in pregnancies complicated by small for gestational age fetuses compared with pre-eclampsia and normal pregnancy, by measuring the plasma levels of soluble adhesion molecules soluble E-selectin, intercellular cell adhesion molecule-1 and vascular cell adhesion molecule-1."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11843391"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CADM3"}, "span_text": {"type": "literal", "value": "Maternal endothelial soluble cell adhesion molecules with isolated small for gestational age fetuses: comparison with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11843391"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VCAM1"}, "span_text": {"type": "literal", "value": "Compared with the healthy controls, soluble E-selectin was significantly increased in both small for gestational age fetuses and pre-eclampsia, whereas intercellular cell adhesion molecule-1 and vascular cell adhesion molecule-1 were increased only in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11843391"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VCAM1"}, "span_text": {"type": "literal", "value": "In the pre-eclampsia group, a significant correlation was observed between vascular cell adhesion molecule-1 and blood pressure (r = 0.54, P = 0.039)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11843391"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CADM1"}, "span_text": {"type": "literal", "value": "Maternal endothelial soluble cell adhesion molecules with isolated small for gestational age fetuses: comparison with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11843391"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VCAM1"}, "span_text": {"type": "literal", "value": "To evaluate the activation profile of the endothelium in pregnancies complicated by small for gestational age fetuses compared with pre-eclampsia and normal pregnancy, by measuring the plasma levels of soluble adhesion molecules soluble E-selectin, intercellular cell adhesion molecule-1 and vascular cell adhesion molecule-1."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11843391"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "The relationships between leptin and inflammatory cytokines in women with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11843390"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Maternal serum leptin levels were higher in women with pre-eclampsia, but this difference was of borderline statistical significance (median 15.9 ng/mL; interquartile range (5.4-31.9) vs 30.5 ng/mL (13.9-64) (P = 0.05)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11843390"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "To compare maternal serum leptin concentration in women with pre-eclampsia and women with normal pregnancy, and to evaluate the relationships between leptin and several inflammatory cytokines."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11843390"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "In women with pre-eclampsia, only a significant correlation between maternal serum leptin level and TNF-alpha concentration (0.47, P = 0.01) was found."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11843390"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "The level of maternal serum leptin is increased and correlates positively with the level of TNF-alpha in women with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11843390"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Women with essential hypertension were otherwise similar to normotensive pregnancy but women with gestational hypertension had a reduced diet-induced thermogenesis and almost double insulin levels."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11843389"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Both gestational hypertension and pre-eclampsia appear to be associated with some degree of insulin resistance, greater than that occurring in normal pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11843389"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Women with pre-eclampsia had a similar body composition and insulin levels but reduced basal metabolic rate, diet-induced thermogenesis and glucose levels compared with normotensive pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11843389"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF1"}, "span_text": {"type": "literal", "value": "Newborn birth weight correlates with placental zinc, umbilical insulin-like growth factor I, and leptin levels in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11825630"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Newborn birth weight correlates with placental zinc, umbilical insulin-like growth factor I, and leptin levels in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11825630"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "The present study indicates that moderate preeclampsia is associated with low newborn birth weight, IGF-I, IGFBP-3, and high IGFBP-1 without significant changes in zinc and leptin levels."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11825630"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF2"}, "span_text": {"type": "literal", "value": "Newborn birth weight correlates with placental zinc, umbilical insulin-like growth factor I, and leptin levels in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11825630"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CD40LG"}, "span_text": {"type": "literal", "value": "Increased concentrations of soluble CD40 ligand, RANTES and GRO-alpha in preeclampsia--possible role of platelet activation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11816717"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FST"}, "span_text": {"type": "literal", "value": "To determine whether maternal serum activin A, inhibin A, and follistatin concentrations in idiopathic small for gestational age (SGA) pregnancies are similar to those in normal pregnancies or elevated as in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11814508"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FST"}, "span_text": {"type": "literal", "value": "Follistatin concentrations were only modestly (<twofold) elevated in preeclampsia (P <.001)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11814508"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FST"}, "span_text": {"type": "literal", "value": "Maternal serum activin A, inhibin A, and follistatin concentrations were determined in 1) nulliparous women with idiopathic SGA (birth weight <10th percentile; n = 18), preeclampsia (systolic blood pressure > or =140 mmHg or diastolic blood pressure > or =90 mmHg plus proteinuria > or =2+ or >0.3 g/24h; n = 22), and normotensive controls, matched for gestational age at sampling (n = 22), and 2) a longitudinal series of samples collected at five intervals throughout pregnancy from nulliparous women with idiopathic SGA (n = 19), preeclampsia (n = 22), preeclampsia plus SGA (n = 15), or who had uncomplicated pregnancies (n = 20)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11814508"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FST"}, "span_text": {"type": "literal", "value": "Serum activin A, inhibin A, and follistatin concentrations in preeclampsia or small for gestational age pregnancies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11814508"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "A lack of correlation between nitrite/nitrate and endothelin-1 probably indicates that in preeclampsia, a primary defense mechanism of the compensatory nitric oxide may be lost."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11814459"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:POSTN"}, "span_text": {"type": "literal", "value": "Our study suggests that human periostin may play a role in the pathogenesis of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11810094"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:POSTN"}, "span_text": {"type": "literal", "value": "Novel chemiluminescence assay for serum periostin levels in women with preeclampsia and in normotensive pregnant women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11810094"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:POSTN"}, "span_text": {"type": "literal", "value": "Serum periostin concentrations were elevated in patients with preeclampsia (mean +/- SD, 311.8 +/- 56.3 ng/mL) compared with normotensive pregnant women (218.8 +/- 37.3 ng/mL)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11810094"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:POSTN"}, "span_text": {"type": "literal", "value": "Although its function remains unclear, the expression of periostin as an adhesion molecule could suggest novel mechanisms in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11810094"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:POSTN"}, "span_text": {"type": "literal", "value": "We determined serum periostin concentrations in women with preeclampsia and in normotensive pregnant women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11810094"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP3"}, "span_text": {"type": "literal", "value": "To determine whether preeclampsia influences insulin-like growth factor-I (IGF-I), insulin-like growth factor binding protein-1 (IGFBP-1), and insulin-like growth factor binding protein-3 (IGFBP-3), independent of its effect on birth weight."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11777516"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP7"}, "span_text": {"type": "literal", "value": "Relationship of insulin-like growth factor-I and insulin-like growth factor binding proteins in umbilical cord plasma to preeclampsia and infant birth weight."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11777516"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP7"}, "span_text": {"type": "literal", "value": "To determine whether preeclampsia influences insulin-like growth factor-I (IGF-I), insulin-like growth factor binding protein-1 (IGFBP-1), and insulin-like growth factor binding protein-3 (IGFBP-3), independent of its effect on birth weight."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11777516"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP2"}, "span_text": {"type": "literal", "value": "To determine whether preeclampsia influences insulin-like growth factor-I (IGF-I), insulin-like growth factor binding protein-1 (IGFBP-1), and insulin-like growth factor binding protein-3 (IGFBP-3), independent of its effect on birth weight."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11777516"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP5"}, "span_text": {"type": "literal", "value": "Relationship of insulin-like growth factor-I and insulin-like growth factor binding proteins in umbilical cord plasma to preeclampsia and infant birth weight."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11777516"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF2"}, "span_text": {"type": "literal", "value": "To determine whether preeclampsia influences insulin-like growth factor-I (IGF-I), insulin-like growth factor binding protein-1 (IGFBP-1), and insulin-like growth factor binding protein-3 (IGFBP-3), independent of its effect on birth weight."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11777516"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF1"}, "span_text": {"type": "literal", "value": "To determine whether preeclampsia influences insulin-like growth factor-I (IGF-I), insulin-like growth factor binding protein-1 (IGFBP-1), and insulin-like growth factor binding protein-3 (IGFBP-3), independent of its effect on birth weight."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11777516"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF2"}, "span_text": {"type": "literal", "value": "Relationship of insulin-like growth factor-I and insulin-like growth factor binding proteins in umbilical cord plasma to preeclampsia and infant birth weight."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11777516"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP4"}, "span_text": {"type": "literal", "value": "To determine whether preeclampsia influences insulin-like growth factor-I (IGF-I), insulin-like growth factor binding protein-1 (IGFBP-1), and insulin-like growth factor binding protein-3 (IGFBP-3), independent of its effect on birth weight."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11777516"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF1"}, "span_text": {"type": "literal", "value": "Relationship of insulin-like growth factor-I and insulin-like growth factor binding proteins in umbilical cord plasma to preeclampsia and infant birth weight."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11777516"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP2"}, "span_text": {"type": "literal", "value": "Relationship of insulin-like growth factor-I and insulin-like growth factor binding proteins in umbilical cord plasma to preeclampsia and infant birth weight."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11777516"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP5"}, "span_text": {"type": "literal", "value": "To determine whether preeclampsia influences insulin-like growth factor-I (IGF-I), insulin-like growth factor binding protein-1 (IGFBP-1), and insulin-like growth factor binding protein-3 (IGFBP-3), independent of its effect on birth weight."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11777516"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP4"}, "span_text": {"type": "literal", "value": "Relationship of insulin-like growth factor-I and insulin-like growth factor binding proteins in umbilical cord plasma to preeclampsia and infant birth weight."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11777516"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP3"}, "span_text": {"type": "literal", "value": "Relationship of insulin-like growth factor-I and insulin-like growth factor binding proteins in umbilical cord plasma to preeclampsia and infant birth weight."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11777516"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:F5"}, "span_text": {"type": "literal", "value": "Evidence for an association of the R485K polymorphism in the coagulation factor V gene with severe preeclampsia from screening 35 polymorphisms in 27 candidate genes."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11776341"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "The serum levels were therefore determined in samples from 100 healthy women at term as well as in 45 samples of patients with preeclampsia (diastolic blood pressure >90 mmHg; urinary albumin excretion >300 mgL(-1))."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11763416"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GP2"}, "span_text": {"type": "literal", "value": "Thrombophilic polymorphisms in pre-eclampsia: altered frequency of the functional 98C>T polymorphism of glycoprotein IIIa."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11732486"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "The aim of this study was to investigate the relationship between plasma endothelin 1 (ET-1) levels and T helper (Th)-1:Th2 cell immunity in women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11729341"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPL"}, "span_text": {"type": "literal", "value": "The objective of this study was to evaluate the association between preeclampsia and mutations within the lipoprotein lipase (LPL) gene."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11711487"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPL"}, "span_text": {"type": "literal", "value": "Lipoprotein lipase gene mutations and the genetic susceptibility of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11711487"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ESR2"}, "span_text": {"type": "literal", "value": "Placentas from SHHF rats displayed altered expression of several genes whose protein products have been implicated in preeclampsia, including serotonin receptor, sodium channel, carbonic anhydrase, estrogen receptor regulator, major histocompatibility complex proteins, superoxide dismutase, and angiotensiogen."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11710786"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CA4"}, "span_text": {"type": "literal", "value": "Placentas from SHHF rats displayed altered expression of several genes whose protein products have been implicated in preeclampsia, including serotonin receptor, sodium channel, carbonic anhydrase, estrogen receptor regulator, major histocompatibility complex proteins, superoxide dismutase, and angiotensiogen."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11710786"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD1"}, "span_text": {"type": "literal", "value": "Placentas from SHHF rats displayed altered expression of several genes whose protein products have been implicated in preeclampsia, including serotonin receptor, sodium channel, carbonic anhydrase, estrogen receptor regulator, major histocompatibility complex proteins, superoxide dismutase, and angiotensiogen."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11710786"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CA8"}, "span_text": {"type": "literal", "value": "Placentas from SHHF rats displayed altered expression of several genes whose protein products have been implicated in preeclampsia, including serotonin receptor, sodium channel, carbonic anhydrase, estrogen receptor regulator, major histocompatibility complex proteins, superoxide dismutase, and angiotensiogen."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11710786"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CA7"}, "span_text": {"type": "literal", "value": "Placentas from SHHF rats displayed altered expression of several genes whose protein products have been implicated in preeclampsia, including serotonin receptor, sodium channel, carbonic anhydrase, estrogen receptor regulator, major histocompatibility complex proteins, superoxide dismutase, and angiotensiogen."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11710786"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CA1"}, "span_text": {"type": "literal", "value": "Placentas from SHHF rats displayed altered expression of several genes whose protein products have been implicated in preeclampsia, including serotonin receptor, sodium channel, carbonic anhydrase, estrogen receptor regulator, major histocompatibility complex proteins, superoxide dismutase, and angiotensiogen."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11710786"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CA2"}, "span_text": {"type": "literal", "value": "Placentas from SHHF rats displayed altered expression of several genes whose protein products have been implicated in preeclampsia, including serotonin receptor, sodium channel, carbonic anhydrase, estrogen receptor regulator, major histocompatibility complex proteins, superoxide dismutase, and angiotensiogen."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11710786"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD3"}, "span_text": {"type": "literal", "value": "Placentas from SHHF rats displayed altered expression of several genes whose protein products have been implicated in preeclampsia, including serotonin receptor, sodium channel, carbonic anhydrase, estrogen receptor regulator, major histocompatibility complex proteins, superoxide dismutase, and angiotensiogen."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11710786"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "For women with high triglycerides: non-high density lipoproteins cholesterol ratios (>90 centile) the OR (95% CI) for early onset pre-eclampsia was 7.1 (2.3-22.0) compared with those with low ratios (< or = 50 centile)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11702841"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGFB2"}, "span_text": {"type": "literal", "value": "Transforming growth factor-beta expression in human placenta and placental bed in third trimester normal pregnancy, preeclampsia, and fetal growth restriction."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11696443"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGFB1"}, "span_text": {"type": "literal", "value": "Transforming growth factor-beta expression in human placenta and placental bed in third trimester normal pregnancy, preeclampsia, and fetal growth restriction."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11696443"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGFB3"}, "span_text": {"type": "literal", "value": "Transforming growth factor-beta expression in human placenta and placental bed in third trimester normal pregnancy, preeclampsia, and fetal growth restriction."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11696443"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGT"}, "span_text": {"type": "literal", "value": "In addition, there was also a significant activation of placental expression of angiotensinogen mRNA in patients with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11694345"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL2"}, "span_text": {"type": "literal", "value": "Subsets of serum samples from 6 women with preeclampsia and 6 control subjects were then evaluated for their ability to induce apoptosis and to suppress interleukin-2 production."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11641657"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL2"}, "span_text": {"type": "literal", "value": "Interleukin-2 levels were higher in T cells incubated with sera from women in whom preeclampsia later developed compared with sera from normotensive pregnant women (27.7 ng/mL versus 72.5 ng/mL; P <.001)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11641657"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "This study examined the frequency of the Lys198Asn polymorphism in the endothelin-1 (ET-1) gene in women with pre-eclampsia and normal pregnancy; and its contribution to levels of plasma ET-1 and blood pressure."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11593097"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Nonetheless, no reports have dealt with the effect of antihypertensive treatment and leptin in preeclamptic patients."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11585975"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "These marked differences between treated and nontreated patients suggest that leptin levels may be modulated by a single antihypertensive treatment in preeclamptic patients with a discrete increase in blood pressure."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11585975"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Plasma leptin levels in preeclamptic patients have been reported to be similar compared to those of normotensive pregnant women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11585975"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Antihypertensive treatment decreased serum leptin levels in severe preeclampsia during pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11585975"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "Preeclampsia was defined as diastolic blood pressure of 90 mmHg or more on two occasions 4 hours apart, accompanied by proteinuria (more than 300 mg of total protein in a 24-hour urine collection or a positive test for albumin on reagent strip) in women with no pre-existing hypertensive or renal disease."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11576576"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "Preeclampsia and maladaptation to pregnancy: a role for atrial natriuretic peptide?"}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11576353"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ICAM1"}, "span_text": {"type": "literal", "value": "To investigate the differences in the expression of intercellular adhesion molecule-1 (ICAM-1) in the placenta and the concentration of soluble ICAM-1 between early-onset and late-onset preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11561831"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ICAM1"}, "span_text": {"type": "literal", "value": "The relationship between the level of expression of intercellular adhesion molecule-1 in placenta and onset of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11561831"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL6"}, "span_text": {"type": "literal", "value": "Differential levels of interleukin 6 in maternal and cord sera and placenta in women with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11549867"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ESR2"}, "span_text": {"type": "literal", "value": "Gene analysis of the N-terminal region of the estrogen receptor alpha in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11546557"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ESR2"}, "span_text": {"type": "literal", "value": "Alterations in the NH(2)-terminal region of the estrogen receptor alpha (ERalpha) gene expressed in placental bed tissue may be implicated in the development of preeclampsia, the pathogenesis of which involves the spiral arteries."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11546557"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "Albumin corrected calcium levels were significantly higher in patients with history of pre-eclampsia (2.41 mmol/l) and pregnancy induced hypertension (2.42 mmol/l) vs. control (2.33 mmol/l) as well as a significant difference in microalbuminuria levels (23% in pre-eclampsia, and 16% in pregnancy induced hypertension vs. 3% in control)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11533780"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "Association of polymorphism of methylene-tetrahydro-folate-reductase with urinary albumin excretion rate in type 1 diabetes mellitus but not with preeclampsia, retinopathy, and preterm delivery."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11531629"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Altered sensitivity to a novel vasoconstrictor endothelin-1 (1-31) in myometrium and umbilical artery of women with severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11527394"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Preeclampsia is associated with high body mass index, insulin resistance, and hypertriglyceridemia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11518908"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL6"}, "span_text": {"type": "literal", "value": "Umbilical cord plasma interleukin-6 and fetal growth restriction in preeclampsia: a prospective study in Norway."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11506847"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL6"}, "span_text": {"type": "literal", "value": "To study the association between umbilical plasma levels of interleukin-6 (IL-6) in relation to fetal growth in subgroups of preeclampsia, and in control pregnancies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11506847"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX1"}, "span_text": {"type": "literal", "value": "However, elevated glutathione peroxidase activity and TBARS are in line with increased oxidative stress in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11483923"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX2"}, "span_text": {"type": "literal", "value": "However, elevated glutathione peroxidase activity and TBARS are in line with increased oxidative stress in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11483923"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX2"}, "span_text": {"type": "literal", "value": "Whereas lipid hydroperoxides were undetectable (<0.02 micromol/L), plasma TBARS and glutathione peroxidase activity in plasma and erythrocytes were significantly increased in patients with HELLP syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11483923"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX3"}, "span_text": {"type": "literal", "value": "However, elevated glutathione peroxidase activity and TBARS are in line with increased oxidative stress in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11483923"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX3"}, "span_text": {"type": "literal", "value": "Whereas lipid hydroperoxides were undetectable (<0.02 micromol/L), plasma TBARS and glutathione peroxidase activity in plasma and erythrocytes were significantly increased in patients with HELLP syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11483923"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX1"}, "span_text": {"type": "literal", "value": "Whereas lipid hydroperoxides were undetectable (<0.02 micromol/L), plasma TBARS and glutathione peroxidase activity in plasma and erythrocytes were significantly increased in patients with HELLP syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11483923"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AFP"}, "span_text": {"type": "literal", "value": "To investigate whether an appropriate combination of maternal serum inhibin A, free beta-human chorionic gonadotropin (free beta-hCG), unconjugated estriol (uE3), and alpha-fetoprotein (AFP) may be an effective means of screening for pre-eclampsia in the second trimester of pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11480445"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOE"}, "span_text": {"type": "literal", "value": "To investigate the frequency of three apolipoprotein E (apoE) alleles among women with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11477126"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOE"}, "span_text": {"type": "literal", "value": "Apolipoprotein E alleles in women with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11477126"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "New scope in angiogenesis: role of vascular endothelial growth factor (VEGF), NO, lipid peroxidation, and vitamin E in the pathophysiology of pre-eclampsia among Egyptian females."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11440734"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "New scope in angiogenesis: role of vascular endothelial growth factor (VEGF), NO, lipid peroxidation, and vitamin E in the pathophysiology of pre-eclampsia among Egyptian females."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11440734"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "New scope in angiogenesis: role of vascular endothelial growth factor (VEGF), NO, lipid peroxidation, and vitamin E in the pathophysiology of pre-eclampsia among Egyptian females."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11440734"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TXN"}, "span_text": {"type": "literal", "value": "These results indicated that the pre-eclamptic placentae were exposed to oxidative stress and that the protein thiol/disulphide oxidoreductases were adaptively induced in pre-eclamptic placentae, suggesting possible roles for thioredoxin, glutaredoxin, and protein disulphide isomerase in protecting placental functions against oxidative stress caused by pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11440545"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GLRX2"}, "span_text": {"type": "literal", "value": "These results indicated that the pre-eclamptic placentae were exposed to oxidative stress and that the protein thiol/disulphide oxidoreductases were adaptively induced in pre-eclamptic placentae, suggesting possible roles for thioredoxin, glutaredoxin, and protein disulphide isomerase in protecting placental functions against oxidative stress caused by pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11440545"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GLRX"}, "span_text": {"type": "literal", "value": "These results indicated that the pre-eclamptic placentae were exposed to oxidative stress and that the protein thiol/disulphide oxidoreductases were adaptively induced in pre-eclamptic placentae, suggesting possible roles for thioredoxin, glutaredoxin, and protein disulphide isomerase in protecting placental functions against oxidative stress caused by pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11440545"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GLRX5"}, "span_text": {"type": "literal", "value": "These results indicated that the pre-eclamptic placentae were exposed to oxidative stress and that the protein thiol/disulphide oxidoreductases were adaptively induced in pre-eclamptic placentae, suggesting possible roles for thioredoxin, glutaredoxin, and protein disulphide isomerase in protecting placental functions against oxidative stress caused by pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11440545"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "The objectives were 1. to evaluate if the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine was altered in mild and severe forms of preeclampsia, and 2. to assess the relationship between dimethylarginines and the cytokine response in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11437716"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL6"}, "span_text": {"type": "literal", "value": "Plasma levels of interleukin-6 and -8 were also elevated in severe preeclampsia but no direct correlations were found between these cytokines and dimethylarginines."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11437716"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL6"}, "span_text": {"type": "literal", "value": "Interleukin-6 and -8 were significantly elevated in subjects with severe, but not mild, preeclampsia, whereas TNF-alpha and IL-10 were not significantly altered."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11437716"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL4"}, "span_text": {"type": "literal", "value": "Interleukin-4, -6, -8, -10 and tumor necrosis factor-alpha were analyzed by immunoassays in women with mild (n=8) and severe (n=17) preeclampsia and in normotensive pregnant controls (n=14)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11437716"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Both nitric oxide (NO) and endothelin-1 (ET-1) are important mediators in the regulation of vascular tone during pregnancy and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11411740"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "Angiotensinogen and endothelial nitric oxide synthase gene polymorphisms among Hispanic patients with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11408851"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "We looked for a relationship between this allele and the allele in the endothelial nitric oxide synthase gene (NOS3) that produces the A form (NOS3*A) with respect to preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11408851"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGT"}, "span_text": {"type": "literal", "value": "We sought to establish an association between preeclampsia and the methionine to threonine polymorphism at amino acid residue 235 (Met235Thr) in angiotensinogen in a Hispanic population."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11408851"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGT"}, "span_text": {"type": "literal", "value": "Angiotensinogen and endothelial nitric oxide synthase gene polymorphisms among Hispanic patients with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11408851"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PRL"}, "span_text": {"type": "literal", "value": "From the 31st to the 35th pregnancy week the preeclamptic patients showed increased basal serum prolactin and TSH levels compared to controls, but later in pregnancy the differences disappeared."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/113978"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PRL"}, "span_text": {"type": "literal", "value": "Following TRH stimulation, the serum prolactin and TSH responses were similar in women with and without preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/113978"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PRL"}, "span_text": {"type": "literal", "value": "Serum prolactin and thyroid stimulating hormone levels following thyreotropin releasing hormone stimulation in preeclamptic patients."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/113978"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PRL"}, "span_text": {"type": "literal", "value": "Serum prolactin and thyroid stimulating hormone (TSH) levels were measured following administration of thyreotropin releasing hormone (THR) in 17 preeclamptic patients and 18 normal pregnant controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/113978"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PRL"}, "span_text": {"type": "literal", "value": "A possible role of prolactin in the development of preeclampsia is discussed."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/113978"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "The albumin fraction contained 49.4% of total plasma S-nitrosothiols in the control samples and 53.7% and 56.8% of plasma S-nitrosothiols in normal pregnancy and preeclampsia, respectively."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11397789"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Maternal and fetal plasma leptin levels are dysregulated in pathological conditions such as gestational diabetes, pre-eclampsia and intra-uterine growth retardation, representing an effect or a cause of disturbances in the feto/placento/maternal unit."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11356133"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CBS"}, "span_text": {"type": "literal", "value": "Forty of 258 women with preeclampsia (15.5%) and 22 of 175 women with severe preeclampsia (12.6%) were heterozygous for the insertion of 68 bases at position 844 in the gene for cystathionine beta-synthase (CBS), versus 58 of 332 control subjects (17.5%)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11349190"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CBS"}, "span_text": {"type": "literal", "value": "Genetic susceptibility to preeclampsia: roles of cytosineto-thymine substitution at nucleotide 677 of the gene for methylenetetrahydrofolate reductase, 68-base pair insertion at nucleotide 844 of the gene for cystathionine beta-synthase, and factor V Leiden mutation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11349190"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MTHFR"}, "span_text": {"type": "literal", "value": "Genetic susceptibility to preeclampsia: roles of cytosineto-thymine substitution at nucleotide 677 of the gene for methylenetetrahydrofolate reductase, 68-base pair insertion at nucleotide 844 of the gene for cystathionine beta-synthase, and factor V Leiden mutation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11349190"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HMOX1"}, "span_text": {"type": "literal", "value": "In this study we tested the hypothesis that expression of heme oxygenases HO-1 and HO-2, which are responsible for the production of carbon monoxide, are reduced in the placenta and placental bed of pregnancies complicated by preeclampsia (PE) and fetal growth restriction (FGR) compared with control third-trimester pregnancies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11344084"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HMOX2"}, "span_text": {"type": "literal", "value": "In this study we tested the hypothesis that expression of heme oxygenases HO-1 and HO-2, which are responsible for the production of carbon monoxide, are reduced in the placenta and placental bed of pregnancies complicated by preeclampsia (PE) and fetal growth restriction (FGR) compared with control third-trimester pregnancies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11344084"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HMOX2"}, "span_text": {"type": "literal", "value": "Heme oxygenase expression in human placenta and placental bed: reduced expression of placenta endothelial HO-2 in preeclampsia and fetal growth restriction."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11344084"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HMOX1"}, "span_text": {"type": "literal", "value": "Heme oxygenase expression in human placenta and placental bed: reduced expression of placenta endothelial HO-2 in preeclampsia and fetal growth restriction."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11344084"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL1RN"}, "span_text": {"type": "literal", "value": "Statistical power to identify a difference in occurrence of interleukin-1 beta promoter, interleukin-1 beta exon 5, and interleukin-1 receptor antagonist gene polymorphisms in women with preeclampsia compared with controls was 21%, 15.9%, and 30.9%, respectively."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11339912"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL1RN"}, "span_text": {"type": "literal", "value": "Although the power of this study was limited, our data do not support a role for polymorphisms of the interleukin-1 beta and interleukin-1 receptor antagonist genes in the pathogenesis of preeclampsia among Hispanic women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11339912"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL1B"}, "span_text": {"type": "literal", "value": "Although the power of this study was limited, our data do not support a role for polymorphisms of the interleukin-1 beta and interleukin-1 receptor antagonist genes in the pathogenesis of preeclampsia among Hispanic women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11339912"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL1B"}, "span_text": {"type": "literal", "value": "Statistical power to identify a difference in occurrence of interleukin-1 beta promoter, interleukin-1 beta exon 5, and interleukin-1 receptor antagonist gene polymorphisms in women with preeclampsia compared with controls was 21%, 15.9%, and 30.9%, respectively."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11339912"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL1B"}, "span_text": {"type": "literal", "value": "Polymorphisms within the interleukin-1 beta gene cluster and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11339912"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL1B"}, "span_text": {"type": "literal", "value": "To identify associations between polymorphisms within the interleukin-1 beta gene cluster, all of which increase protein expression, and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11339912"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL1RN"}, "span_text": {"type": "literal", "value": "Among women with preeclampsia, those with polymorphism of interleukin-1 receptor antagonist gene had higher mean systolic blood pressure (BP) at admission (178 +/- 33.4 versus 159 +/- 19.5 mmHg, P =.039)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11339912"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL1B"}, "span_text": {"type": "literal", "value": "We genotyped a Hispanic population (69 women with preeclampsia and 47 controls) for two polymorphisms of the interleukin-1 beta gene (promoter region and exon 5) and one polymorphism of the interleukin-1 receptor antagonist gene in intron 2."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11339912"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL1RN"}, "span_text": {"type": "literal", "value": "We genotyped a Hispanic population (69 women with preeclampsia and 47 controls) for two polymorphisms of the interleukin-1 beta gene (promoter region and exon 5) and one polymorphism of the interleukin-1 receptor antagonist gene in intron 2."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11339912"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX1"}, "span_text": {"type": "literal", "value": "In preeclampsia, placental production of lipid peroxides is abnormally increased, while placental glutathione peroxidase (GSH-Px) and superoxide dismutase (SOD) activities are decreased."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11339508"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX3"}, "span_text": {"type": "literal", "value": "In preeclampsia, placental production of lipid peroxides is abnormally increased, while placental glutathione peroxidase (GSH-Px) and superoxide dismutase (SOD) activities are decreased."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11339508"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX2"}, "span_text": {"type": "literal", "value": "In preeclampsia, placental production of lipid peroxides is abnormally increased, while placental glutathione peroxidase (GSH-Px) and superoxide dismutase (SOD) activities are decreased."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11339508"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD1"}, "span_text": {"type": "literal", "value": "In preeclampsia, placental production of lipid peroxides is abnormally increased, while placental glutathione peroxidase (GSH-Px) and superoxide dismutase (SOD) activities are decreased."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11339508"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD3"}, "span_text": {"type": "literal", "value": "In preeclampsia, placental production of lipid peroxides is abnormally increased, while placental glutathione peroxidase (GSH-Px) and superoxide dismutase (SOD) activities are decreased."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11339508"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ESAM"}, "span_text": {"type": "literal", "value": "It was also reported that in preeclampsia, cytotrophoblasts fail to express PECAM-1 and that failure to express endothelial cell adhesion molecules may account for failed trophoblast invasion."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11337369"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Decreased maternal serum leptin in pregnancies complicated by preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11336879"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Median umbilical venous leptin was not significantly different between groups (preeclampsia 11.8 ng/mL, range 2.0-37.2 ng/mL; normal 7.6 ng/mL, range 1.6-24.3 ng/mL; P = .377)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11336879"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Our data suggest that the correlation between umbilical venous leptin concentration and birth weight is independent of the presence of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11336879"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Maternal and umbilical venous plasma leptin concentrations obtained at delivery were compared in 36 pairs of women with either preeclampsia or normal pregnancy, matched 1:1 for prepregnancy body mass index and fetal gestational age at delivery."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11336879"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Umbilical venous leptin levels correlated positively with birth weight in both groups (preeclampsia rho = 0.501, P = .002; normal rho = 0.517, P = .001), whereas no correlations were found between maternal and fetal hormone concentrations."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11336879"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "To determine whether circulating levels of leptin differed between women with preeclampsia and women who had an uncomplicated pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11336879"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Median leptin concentrations were significantly lower (P <.0001) in women with preeclampsia (8.3 ng/mL, range 3.5-20.0 ng/mL) than in normal pregnant women (20.2 ng/mL, range 6.0-63.7 ng/mL)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11336879"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Given the inconsistency in literature concerning circulating leptin levels in preeclampsia, further studies should investigate the regulatory systems of leptin in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11336879"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "The pre-eclamptics had significantly higher serum leptin levels than those in normal pregnancies (p<0.001) but no difference was noted between normal and gestational hypertensive pregnancies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11311762"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Alterations of maternal and fetal leptin concentrations in hypertensive disorders of pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11311762"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "To investigate whether hypertensive disorders of pregnancy alter the maternal and fetal leptin levels."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11311762"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Pre-eclampsia is associated with an increase in maternal plasma leptin levels and fetal of leptin production increases in gestational hypertension and even more in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11311762"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Pre-eclamptic women had significantly higher umbilical vein leptin levels (4.68+/-1.66ng/ml) compared to normal pregnancies (1.92+/-0.71ng/ml) and those with gestational hypertension (2.47+/-0.81ng/ml)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11311762"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MTHFR"}, "span_text": {"type": "literal", "value": "Therefore, we investigated the role of hyperhomocysteinaemia in preeclampsia by measuring plasma levels of homocysteine and studying the prevalence of the 677(C-->T) polymorphism in the 5,10-methylenetetrahydrofolate reductase (MTHFR) gene, which may lead to reduced MTHFR enzyme activity and subsequently to higher plasma homocysteine levels."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11301178"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LDHD"}, "span_text": {"type": "literal", "value": "Differential expression of lactate dehydrogenase isozymes (LDH) in human placenta with high expression of LDH-A(4) isozyme in the endothelial cells of pre-eclampsia villi."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11286567"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LDHA"}, "span_text": {"type": "literal", "value": "Differential expression of lactate dehydrogenase isozymes (LDH) in human placenta with high expression of LDH-A(4) isozyme in the endothelial cells of pre-eclampsia villi."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11286567"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LDHB"}, "span_text": {"type": "literal", "value": "Differential expression of lactate dehydrogenase isozymes (LDH) in human placenta with high expression of LDH-A(4) isozyme in the endothelial cells of pre-eclampsia villi."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11286567"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EPHX3"}, "span_text": {"type": "literal", "value": "However, polymorphisms in the epoxide hydrolase gene do not seem to influence the risk for concurrent development of the HELLP syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11283205"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EPHX4"}, "span_text": {"type": "literal", "value": "However, polymorphisms in the epoxide hydrolase gene do not seem to influence the risk for concurrent development of the HELLP syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11283205"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EPHX2"}, "span_text": {"type": "literal", "value": "However, polymorphisms in the epoxide hydrolase gene do not seem to influence the risk for concurrent development of the HELLP syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11283205"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EPHX2"}, "span_text": {"type": "literal", "value": "A total of 183 non-pregnant women with a history of pre-eclampsia, 96 of whom had concurrently developed the HELLP syndrome, and 151 healthy female controls were genotyped for the 113Tyr-->His polymorphism in exon 3 and the 139His-->Arg polymorphism in exon 4 of the epoxide hydrolase gene by a polymerase chain reaction-restriction fragment length polymorphism assay."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11283205"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EPHX2"}, "span_text": {"type": "literal", "value": "In women with a history of pre-eclampsia, no difference in epoxide hydrolase genotypes was found between women who either did or did not develop the HELLP syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11283205"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EPHX1"}, "span_text": {"type": "literal", "value": "A total of 183 non-pregnant women with a history of pre-eclampsia, 96 of whom had concurrently developed the HELLP syndrome, and 151 healthy female controls were genotyped for the 113Tyr-->His polymorphism in exon 3 and the 139His-->Arg polymorphism in exon 4 of the epoxide hydrolase gene by a polymerase chain reaction-restriction fragment length polymorphism assay."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11283205"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EPHX4"}, "span_text": {"type": "literal", "value": "A total of 183 non-pregnant women with a history of pre-eclampsia, 96 of whom had concurrently developed the HELLP syndrome, and 151 healthy female controls were genotyped for the 113Tyr-->His polymorphism in exon 3 and the 139His-->Arg polymorphism in exon 4 of the epoxide hydrolase gene by a polymerase chain reaction-restriction fragment length polymorphism assay."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11283205"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EPHX3"}, "span_text": {"type": "literal", "value": "In women with a history of pre-eclampsia, no difference in epoxide hydrolase genotypes was found between women who either did or did not develop the HELLP syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11283205"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EPHX1"}, "span_text": {"type": "literal", "value": "However, polymorphisms in the epoxide hydrolase gene do not seem to influence the risk for concurrent development of the HELLP syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11283205"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EPHX1"}, "span_text": {"type": "literal", "value": "In women with a history of pre-eclampsia, no difference in epoxide hydrolase genotypes was found between women who either did or did not develop the HELLP syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11283205"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EPHX3"}, "span_text": {"type": "literal", "value": "A total of 183 non-pregnant women with a history of pre-eclampsia, 96 of whom had concurrently developed the HELLP syndrome, and 151 healthy female controls were genotyped for the 113Tyr-->His polymorphism in exon 3 and the 139His-->Arg polymorphism in exon 4 of the epoxide hydrolase gene by a polymerase chain reaction-restriction fragment length polymorphism assay."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11283205"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EPHX4"}, "span_text": {"type": "literal", "value": "In women with a history of pre-eclampsia, no difference in epoxide hydrolase genotypes was found between women who either did or did not develop the HELLP syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11283205"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "To determine whether second-trimester serum concentrations of insulin, insulin-like growth factor-I (IGF-I), and insulin-like growth factor binding protein-1 (IGFBP-1) were altered in women before they developed clinical signs of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11275021"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP3"}, "span_text": {"type": "literal", "value": "Serum insulin, insulin-like growth factor-I, and insulin-like growth factor binding protein-1 in women who develop preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11275021"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP3"}, "span_text": {"type": "literal", "value": "To determine whether second-trimester serum concentrations of insulin, insulin-like growth factor-I (IGF-I), and insulin-like growth factor binding protein-1 (IGFBP-1) were altered in women before they developed clinical signs of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11275021"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF2"}, "span_text": {"type": "literal", "value": "Serum insulin, insulin-like growth factor-I, and insulin-like growth factor binding protein-1 in women who develop preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11275021"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP2"}, "span_text": {"type": "literal", "value": "To determine whether second-trimester serum concentrations of insulin, insulin-like growth factor-I (IGF-I), and insulin-like growth factor binding protein-1 (IGFBP-1) were altered in women before they developed clinical signs of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11275021"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP5"}, "span_text": {"type": "literal", "value": "To determine whether second-trimester serum concentrations of insulin, insulin-like growth factor-I (IGF-I), and insulin-like growth factor binding protein-1 (IGFBP-1) were altered in women before they developed clinical signs of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11275021"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Serum insulin, insulin-like growth factor-I, and insulin-like growth factor binding protein-1 in women who develop preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11275021"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP2"}, "span_text": {"type": "literal", "value": "Serum insulin, insulin-like growth factor-I, and insulin-like growth factor binding protein-1 in women who develop preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11275021"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF1"}, "span_text": {"type": "literal", "value": "To determine whether second-trimester serum concentrations of insulin, insulin-like growth factor-I (IGF-I), and insulin-like growth factor binding protein-1 (IGFBP-1) were altered in women before they developed clinical signs of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11275021"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Women who developed preeclampsia had insulin concentrations that were not significantly different from controls, but serum concentrations of IGF-I were significantly higher and IGFBP-1 were significantly lower than those of the controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11275021"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP5"}, "span_text": {"type": "literal", "value": "Serum insulin, insulin-like growth factor-I, and insulin-like growth factor binding protein-1 in women who develop preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11275021"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP4"}, "span_text": {"type": "literal", "value": "Serum insulin, insulin-like growth factor-I, and insulin-like growth factor binding protein-1 in women who develop preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11275021"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP7"}, "span_text": {"type": "literal", "value": "Serum insulin, insulin-like growth factor-I, and insulin-like growth factor binding protein-1 in women who develop preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11275021"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP4"}, "span_text": {"type": "literal", "value": "To determine whether second-trimester serum concentrations of insulin, insulin-like growth factor-I (IGF-I), and insulin-like growth factor binding protein-1 (IGFBP-1) were altered in women before they developed clinical signs of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11275021"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP7"}, "span_text": {"type": "literal", "value": "To determine whether second-trimester serum concentrations of insulin, insulin-like growth factor-I (IGF-I), and insulin-like growth factor binding protein-1 (IGFBP-1) were altered in women before they developed clinical signs of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11275021"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF1"}, "span_text": {"type": "literal", "value": "Serum insulin, insulin-like growth factor-I, and insulin-like growth factor binding protein-1 in women who develop preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11275021"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF2"}, "span_text": {"type": "literal", "value": "To determine whether second-trimester serum concentrations of insulin, insulin-like growth factor-I (IGF-I), and insulin-like growth factor binding protein-1 (IGFBP-1) were altered in women before they developed clinical signs of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11275021"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF2"}, "span_text": {"type": "literal", "value": "Markers of type I and type III collagen turnover, insulin-like growth factors, and their binding proteins in cord plasma of small premature infants: relationships with fetal growth, gestational age, preeclampsia, and antenatal glucocorticoid treatment."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11264430"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF1"}, "span_text": {"type": "literal", "value": "Markers of type I and type III collagen turnover, insulin-like growth factors, and their binding proteins in cord plasma of small premature infants: relationships with fetal growth, gestational age, preeclampsia, and antenatal glucocorticoid treatment."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11264430"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PRL"}, "span_text": {"type": "literal", "value": "Prolactin and pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/1125642"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PRL"}, "span_text": {"type": "literal", "value": "Toxaemia of pregnancy and plasma prolactin."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/1125579"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MPO"}, "span_text": {"type": "literal", "value": "Neutrophil activation in preeclampsia was shown by systemic increases in myeloperoxidase."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11239639"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MPO"}, "span_text": {"type": "literal", "value": "Myeloperoxidase was significantly higher in women with preeclampsia (197 microg/L, 95% confidence interval [CI] 94, 646) than in women with uncomplicated pregnancies (124 microg/L, 95% CI 70, 289; P =.009), whereas lactoferrin did not differ between groups."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11239639"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GAPDH"}, "span_text": {"type": "literal", "value": "When comparing matched pairs, there were 3-fold lower 11beta-HSD2/glyceraldehyde-3-phosphate dehydrogenase (11beta-HSD2/GAPDH) mRNA levels in placentas of patients with preeclampsia than in controls [0.18 +/- 0.04 relative units (RU) and 0.61 +/- 0.10 RU, P = 0.0003]."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11238526"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADM2"}, "span_text": {"type": "literal", "value": "Although fetoplacental adrenomedullin levels are reported to increase in preeclampsia, maternal plasma levels may be elevated or decreased, or they may resemble those in normal pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11230276"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADM"}, "span_text": {"type": "literal", "value": "Although fetoplacental adrenomedullin levels are reported to increase in preeclampsia, maternal plasma levels may be elevated or decreased, or they may resemble those in normal pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11230276"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADM2"}, "span_text": {"type": "literal", "value": "We conclude that the increased placental vascular resistance observed in preeclampsia is due neither to reduced adrenomedullin secretion nor to an attenuated vascular responsiveness."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11230276"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADM"}, "span_text": {"type": "literal", "value": "We conclude that the increased placental vascular resistance observed in preeclampsia is due neither to reduced adrenomedullin secretion nor to an attenuated vascular responsiveness."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11230276"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADM2"}, "span_text": {"type": "literal", "value": "Contrary to our hypothesis, there were no significant differences in maternal plasma adrenomedullin levels among patients with normal pregnancies, gestational hypertension, and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11230276"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADM"}, "span_text": {"type": "literal", "value": "Contrary to our hypothesis, there were no significant differences in maternal plasma adrenomedullin levels among patients with normal pregnancies, gestational hypertension, and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11230276"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADM"}, "span_text": {"type": "literal", "value": "Adrenomedullin concentrations in plasma from women with normotensive pregnancies, gestational hypertension, and preeclampsia were determined by radioimmunoassay."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11230276"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADM2"}, "span_text": {"type": "literal", "value": "Adrenomedullin concentrations in plasma from women with normotensive pregnancies, gestational hypertension, and preeclampsia were determined by radioimmunoassay."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11230276"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MTHFR"}, "span_text": {"type": "literal", "value": "This study was undertaken to assess frequencies of the methylenetetrahydrofolate reductase gene mutations cytosine-to-thymine substitution at base 677 (C677T) and adenine-to-cytosine substitution at base 1298 (A1298C) and their interactions with homocysteine and vitamin levels among Dutch women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11228493"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MTHFR"}, "span_text": {"type": "literal", "value": "Hyperhomocysteinemia in women with preeclampsia was associated with mutations in the gene for methylenetetrahydrofolate reductase, but the high frequency of hyperhomocysteinemia itself cannot be explained by these mutations alone."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11228493"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MTHFR"}, "span_text": {"type": "literal", "value": "Mutations in the gene for methylenetetrahydrofolate reductase, homocysteine levels, and vitamin status in women with a history of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11228493"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "In conclusion, cord leptin concentrations in pregnancies complicated by pre-eclampsia correlate positively with birth weight and gender."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11228066"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Serum leptin concentration in cord blood: relationship to birth weight and gender in pregnancies complicated by pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11228066"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "The aim of the study was to investigate cord blood leptin concentrations and their relationship to birth weight and gender in term pregnancies complicated by pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11228066"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGFB2"}, "span_text": {"type": "literal", "value": "The emerging role of transforming growth factor beta in hypertension, kidney disease, and trophoblast differentiation promoted our interest in evaluating the clinical value of assaying maternal serum TGF-beta2 levels in pregnancies complicated by preeclampsia and eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11223354"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGFB3"}, "span_text": {"type": "literal", "value": "The emerging role of transforming growth factor beta in hypertension, kidney disease, and trophoblast differentiation promoted our interest in evaluating the clinical value of assaying maternal serum TGF-beta2 levels in pregnancies complicated by preeclampsia and eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11223354"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGFB1"}, "span_text": {"type": "literal", "value": "The emerging role of transforming growth factor beta in hypertension, kidney disease, and trophoblast differentiation promoted our interest in evaluating the clinical value of assaying maternal serum TGF-beta2 levels in pregnancies complicated by preeclampsia and eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11223354"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TGFB2"}, "span_text": {"type": "literal", "value": "Maternal serum transforming growth factor beta-2 in preeclampsia and eclampsia, a potential biomarker for the assessment of disease severity and fetal outcome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11223354"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "To investigate the effect of neutrophil activation on pathogenesis of pre-eclampsia, neutrophil activation was examined by using flow cytometry to assess the CD11b expression and the levels of plasma endothelin-1 (ET-1) and serum NO2- were also measured by using non-equilibrium radioimmunoassay and by Griess assay in 29 pregnant women with pre-eclampsia and 31 normal pregnant women at third trimester."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11215062"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX1"}, "span_text": {"type": "literal", "value": "It was observed that in patients with pre-eclampsia the plasma concentrations of nitric oxide and lipid peroxides were elevated with a decrease in those of anti-oxidants such as catalase and superoxide dismutase and a concomitant increase in that of glutathione peroxidase."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11208430"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX2"}, "span_text": {"type": "literal", "value": "It was observed that in patients with pre-eclampsia the plasma concentrations of nitric oxide and lipid peroxides were elevated with a decrease in those of anti-oxidants such as catalase and superoxide dismutase and a concomitant increase in that of glutathione peroxidase."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11208430"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD1"}, "span_text": {"type": "literal", "value": "It was observed that in patients with pre-eclampsia the plasma concentrations of nitric oxide and lipid peroxides were elevated with a decrease in those of anti-oxidants such as catalase and superoxide dismutase and a concomitant increase in that of glutathione peroxidase."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11208430"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD3"}, "span_text": {"type": "literal", "value": "It was observed that in patients with pre-eclampsia the plasma concentrations of nitric oxide and lipid peroxides were elevated with a decrease in those of anti-oxidants such as catalase and superoxide dismutase and a concomitant increase in that of glutathione peroxidase."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11208430"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CAT"}, "span_text": {"type": "literal", "value": "It was observed that in patients with pre-eclampsia the plasma concentrations of nitric oxide and lipid peroxides were elevated with a decrease in those of anti-oxidants such as catalase and superoxide dismutase and a concomitant increase in that of glutathione peroxidase."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11208430"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX3"}, "span_text": {"type": "literal", "value": "It was observed that in patients with pre-eclampsia the plasma concentrations of nitric oxide and lipid peroxides were elevated with a decrease in those of anti-oxidants such as catalase and superoxide dismutase and a concomitant increase in that of glutathione peroxidase."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11208430"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "We speculate that the hyperdynamic circulation that characterizes the latent phase of preeclampsia causes vascular shear stress, which in turn increases the levels of circulating vascular endothelial growth factor."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11174494"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Mean vascular endothelial growth factor concentrations were similar in the control and gestational hypertension groups; in both groups levels remained stable until 34 to 36 weeks' gestation, when levels increased a further 1.3-fold (P <.01)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11174494"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "In comparison, vascular endothelial growth factor concentrations in subjects in the preeclampsia group were greater at 28 to 32 weeks' gestation (P =.002) and at 34 to 36 weeks' gestation (P <.001)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11174494"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Plasma concentrations of total immunoreactive vascular endothelial growth factor and total peripheral resistances were measured serially throughout pregnancy in 20 women with preeclampsia, 24 women with gestational hypertension, and 26 normotensive control women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11174494"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Plasma concentrations of total immunoreactive vascular endothelial growth factor and total peripheral resistances were measured serially throughout pregnancy in 20 women with preeclampsia, 24 women with gestational hypertension, and 26 normotensive control women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11174494"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Vascular endothelial growth factor concentrations were also increased during the 4 weeks that preceded the diagnosis of preeclampsia (P <.05)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11174494"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Maternal plasma vascular endothelial growth factor concentrations increased before the clinical onset of preeclampsia and were further elevated during the vasoconstricted state observed in this disorder."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11174494"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Mean vascular endothelial growth factor concentrations were similar in the control and gestational hypertension groups; in both groups levels remained stable until 34 to 36 weeks' gestation, when levels increased a further 1.3-fold (P <.01)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11174494"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Maternal plasma vascular endothelial growth factor concentrations increased before the clinical onset of preeclampsia and were further elevated during the vasoconstricted state observed in this disorder."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11174494"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "We speculate that the hyperdynamic circulation that characterizes the latent phase of preeclampsia causes vascular shear stress, which in turn increases the levels of circulating vascular endothelial growth factor."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11174494"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Plasma concentrations of total immunoreactive vascular endothelial growth factor and total peripheral resistances were measured serially throughout pregnancy in 20 women with preeclampsia, 24 women with gestational hypertension, and 26 normotensive control women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11174494"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Vascular endothelial growth factor concentrations were also increased during the 4 weeks that preceded the diagnosis of preeclampsia (P <.05)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11174494"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "In comparison, vascular endothelial growth factor concentrations in subjects in the preeclampsia group were greater at 28 to 32 weeks' gestation (P =.002) and at 34 to 36 weeks' gestation (P <.001)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11174494"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Vascular endothelial growth factor concentrations were also increased during the 4 weeks that preceded the diagnosis of preeclampsia (P <.05)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11174494"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Vascular endothelial growth factor concentrations were associated with the elevated total peripheral resistance observed during the clinical disorder in the preeclampsia group but not in the other groups."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11174494"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Mean vascular endothelial growth factor concentrations were similar in the control and gestational hypertension groups; in both groups levels remained stable until 34 to 36 weeks' gestation, when levels increased a further 1.3-fold (P <.01)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11174494"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Vascular endothelial growth factor concentrations were associated with the elevated total peripheral resistance observed during the clinical disorder in the preeclampsia group but not in the other groups."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11174494"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Vascular endothelial growth factor concentrations were associated with the elevated total peripheral resistance observed during the clinical disorder in the preeclampsia group but not in the other groups."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11174494"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "In comparison, vascular endothelial growth factor concentrations in subjects in the preeclampsia group were greater at 28 to 32 weeks' gestation (P =.002) and at 34 to 36 weeks' gestation (P <.001)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11174494"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Maternal plasma vascular endothelial growth factor concentrations increased before the clinical onset of preeclampsia and were further elevated during the vasoconstricted state observed in this disorder."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11174494"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "We speculate that the hyperdynamic circulation that characterizes the latent phase of preeclampsia causes vascular shear stress, which in turn increases the levels of circulating vascular endothelial growth factor."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11174494"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD1"}, "span_text": {"type": "literal", "value": "Increased superoxide generation is associated with decreased superoxide dismutase activity and mRNA expression in placental trophoblast cells in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11170825"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD3"}, "span_text": {"type": "literal", "value": "Increased superoxide generation is associated with decreased superoxide dismutase activity and mRNA expression in placental trophoblast cells in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11170825"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Endothelin-1, being a powerful vasoconstrictor, could cause significant vasoconstriction in the placental vasculature, and alterations in endothelin-1 levels in placental vasculature may therefore have a role in the pathogenesis of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11167202"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Placental hypoperfusion, which precedes the maternal manifestations of pre-eclampsia, could be due to some vasoconstrictor factor/s like endothelin-1."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11167202"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Endothelin-1 concentrations were significantly higher in the amnion, chorion laeve, placental plate chorion and fetal placenta from women with pre-eclampsia when compared to tissues from normotensive pregnant women (p<0.01)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11167202"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Endothelin-1 levels were significantly higher in the placental tissues from women with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11167202"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "The aim of the study therefore was to estimate the levels of endothelin-1 in feto-placental tissue homogenates from normotensive pregnant women and women with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11167202"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "Placental nitric oxide synthase (NOS) activity and nitric oxide (NO) production in normal pregnancy, pre-eclampsia and eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11166745"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TCF4"}, "span_text": {"type": "literal", "value": "Selective overexpression of the hypoxia-inducible transcription factor, HIF-2alpha, in placentas from women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11159352"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AFP"}, "span_text": {"type": "literal", "value": "Data from a nested case-control study were analyzed to examine high mean arterial pressure (MAP), hypertension of pregnancy, and preeclampsia as independent predictors and as surrogate markers for elevated alpha-fetoprotein (AFP) levels in evaluating breast cancer risk."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11142421"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AFP"}, "span_text": {"type": "literal", "value": "Mean arterial pressure, pregnancy-induced hypertension, and preeclampsia: evaluation as independent risk factors and as surrogates for high maternal serum alpha-fetoprotein in estimating breast cancer risk."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11142421"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MAOA"}, "span_text": {"type": "literal", "value": "We have attempted to elucidate the possible participation of 5-HT as an aetiological factor in pre-eclampsia, by estimating the activity and expression of the 5-HT transporter (SERT) and monoamine oxidase A (MAO-A) in human placenta from full term normal (NG) and severe pre-eclamptic (PES) pregnancies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11133008"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Altered gene expression of endothelin-A and endothelin-B receptors, but not endothelin-1, in myometrium and placenta from pregnancies complicated by preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11129514"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "The aim of the present study was to compare the mRNA expression of endothelin-1 (ET-1), ET-1 receptors ET(A) and ET(B) in myometrium and placenta obtained from biopsies collected from women with preeclampsia (n=10) or normal pregnant (n=12)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11129514"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MPO"}, "span_text": {"type": "literal", "value": "Plasma myeloperoxidase levels were lower both in pre-eclampsia (P < 0.05) and in normal pregnancies (P < 0.001)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11122327"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Reductions of vascular endothelial growth factor and placental growth factor concentrations in severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11120527"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Reductions of vascular endothelial growth factor and placental growth factor concentrations in severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11120527"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Reductions of vascular endothelial growth factor and placental growth factor concentrations in severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11120527"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Women with severe preeclampsia demonstrated significantly lower plasma concentrations of both vascular endothelial growth factor (6.36 +/- 3.96 pg/mL vs 18.65 +/- 5.98 pg/mL; P <.0001) and placental growth factor (138 +/- 119 pg/mL vs 531 +/- 340 pg/mL; P <.0001) than did women with normotensive pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11120527"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "We performed a case-control study to compare plasma concentrations of vascular endothelial growth factor and placental growth factor between women with severe preeclampsia and normotensive women admitted for delivery."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11120527"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Women with severe preeclampsia demonstrated significantly lower plasma concentrations of both vascular endothelial growth factor (6.36 +/- 3.96 pg/mL vs 18.65 +/- 5.98 pg/mL; P <.0001) and placental growth factor (138 +/- 119 pg/mL vs 531 +/- 340 pg/mL; P <.0001) than did women with normotensive pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11120527"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "The aim of this study was to determine whether plasma concentrations of vascular endothelial growth factor and placental growth factor are altered in women with severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11120527"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "We performed a case-control study to compare plasma concentrations of vascular endothelial growth factor and placental growth factor between women with severe preeclampsia and normotensive women admitted for delivery."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11120527"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "We performed a case-control study to compare plasma concentrations of vascular endothelial growth factor and placental growth factor between women with severe preeclampsia and normotensive women admitted for delivery."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11120527"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Patients with severe preeclampsia had decreased maternal serum concentrations of both vascular endothelial growth factor and placental growth factor."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11120527"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Women with severe preeclampsia demonstrated significantly lower plasma concentrations of both vascular endothelial growth factor (6.36 +/- 3.96 pg/mL vs 18.65 +/- 5.98 pg/mL; P <.0001) and placental growth factor (138 +/- 119 pg/mL vs 531 +/- 340 pg/mL; P <.0001) than did women with normotensive pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11120527"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Women with severe preeclampsia demonstrated significantly lower plasma concentrations of both vascular endothelial growth factor (6.36 +/- 3.96 pg/mL vs 18.65 +/- 5.98 pg/mL; P <.0001) and placental growth factor (138 +/- 119 pg/mL vs 531 +/- 340 pg/mL; P <.0001) than did women with normotensive pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11120527"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Patients with severe preeclampsia had decreased maternal serum concentrations of both vascular endothelial growth factor and placental growth factor."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11120527"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "The aim of this study was to determine whether plasma concentrations of vascular endothelial growth factor and placental growth factor are altered in women with severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11120527"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Patients with severe preeclampsia had decreased maternal serum concentrations of both vascular endothelial growth factor and placental growth factor."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11120527"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Logistic regression analysis showed an independent association between plasma vascular endothelial growth factor concentration and plasma placental growth factor concentration and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11120527"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Patients with severe preeclampsia had decreased maternal serum concentrations of both vascular endothelial growth factor and placental growth factor."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11120527"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Logistic regression analysis showed an independent association between plasma vascular endothelial growth factor concentration and plasma placental growth factor concentration and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11120527"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Reductions of vascular endothelial growth factor and placental growth factor concentrations in severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11120527"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "The aim of this study was to determine whether plasma concentrations of vascular endothelial growth factor and placental growth factor are altered in women with severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11120527"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "The aim of this study was to determine whether plasma concentrations of vascular endothelial growth factor and placental growth factor are altered in women with severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11120527"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "We performed a case-control study to compare plasma concentrations of vascular endothelial growth factor and placental growth factor between women with severe preeclampsia and normotensive women admitted for delivery."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11120527"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Logistic regression analysis showed an independent association between plasma vascular endothelial growth factor concentration and plasma placental growth factor concentration and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11120527"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PGF"}, "span_text": {"type": "literal", "value": "Logistic regression analysis showed an independent association between plasma vascular endothelial growth factor concentration and plasma placental growth factor concentration and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11120527"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SDC1"}, "span_text": {"type": "literal", "value": "An immunohistochemical analysis of 30 placentas of women with severe preeclampsia and 15 placentas of women without preeclampsia was performed with the monoclonal anti-syndecan 1 antibody B-B4."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11120517"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SDC1"}, "span_text": {"type": "literal", "value": "The objective of this study was to examine whether placental expression of syndecan 1 in preeclampsia differs from that in normal pregnancy and whether gestational age and fetal growth affect syndecan 1 expression."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11120517"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SDC1"}, "span_text": {"type": "literal", "value": "Placental expression of syndecan 1 is diminished in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11120517"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SDC1"}, "span_text": {"type": "literal", "value": "The reduction in placental expression of syndecan 1 in preeclampsia was not associated with gestational age or impaired fetal growth."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11120517"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SDC1"}, "span_text": {"type": "literal", "value": "The expression of syndecan 1 on the chorionic villi is reduced in preeclampsia irrespective of gestational age or fetal growth."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11120517"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOE"}, "span_text": {"type": "literal", "value": "The relationship between the apolipoprotein E allele and genotype frequencies to preeclampsia as well as adverse perinatal outcome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11118404"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOE"}, "span_text": {"type": "literal", "value": "The study suggests that, despite the high incidence of both preeclampsia and the varepsilon2 and varepsilon4 alleles in South African Zulu women, apolipoprotein E genotype does not appear to be a risk factor for preeclampsia in this population."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11118404"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOE"}, "span_text": {"type": "literal", "value": "Apolipoprotein E polymorphism in South African Zulu women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11118404"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOE"}, "span_text": {"type": "literal", "value": "We carried out a study to determine whether the apolipoprotein E genotype plays any role as a risk factor for preeclampsia in a black South African population with a high incidence of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11118404"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOE"}, "span_text": {"type": "literal", "value": "Apolipoprotein E may contribute to the hypertiglyceridemia and consequent endothelial dysfunction of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11118404"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MTHFR"}, "span_text": {"type": "literal", "value": "Methylenetetrahydrofolate reductase polymorphisms in preeclampsia and the HELLP syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11118403"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PRL"}, "span_text": {"type": "literal", "value": "The possible role of prolactin in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/1105099"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "There were no significant differences in serum leptin concentrations between the patients with mild preeclampsia [13.6 +/- 11.2 (95% CI, 7.7-19.4) ng/mL], severe preeclampsia [14.8 +/- 11.5 (95% CI, 8.2-21.3) ng/mL] and normotensive pregnant women [12.5 +/- 7.9 (95% CI, 9.7-15.2) ng/mL]."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11045326"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "In conclusion, serum leptin levels were similar in the patients with different grades of preeclampsia and normotensive pregnant women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11045326"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Serum leptin levels and the severity of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11045326"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "The aim of this study was to evaluate the serum leptin levels in preeclampsia patients and in normotensive pregnant women, as well as, to assess an association with the severity of the disease."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11045326"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EPO"}, "span_text": {"type": "literal", "value": "Pre-eclampsia and eclampsia are associated with higher levels of cord blood erythropoietin."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11044534"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EPO"}, "span_text": {"type": "literal", "value": "Erythropoietin was measured, using ELISA, in the cord blood of infants born to 83 mothers with pre-eclampsia, and 7 with eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11044534"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EPO"}, "span_text": {"type": "literal", "value": "Estimation of cord blood erythropoietin in pre-eclampsia and eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11044534"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EPO"}, "span_text": {"type": "literal", "value": "Cord blood erythropoietin levels were statistically significantly higher (P<0.001) in infants born to mothers with pre-eclampsia and eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11044534"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EPO"}, "span_text": {"type": "literal", "value": "The estimation of cord blood erythropoietin in subjects with pre-eclampsia and eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11044534"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CDH5"}, "span_text": {"type": "literal", "value": "Therefore, we addressed the question of whether pre-eclampsia alters cadherin-5 expression and intracellular distribution."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11044466"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CDH5"}, "span_text": {"type": "literal", "value": "We suggest that intracellular retention of cadherin-5 caused by serum factors in patients with pre-eclampsia may decrease the number of adhesion complexes in the cell membrane, thereby contributing to endothelial dysfunction."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11044466"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CDH5"}, "span_text": {"type": "literal", "value": "Altered subcellular distribution of cadherin-5 in endothelial cells caused by the serum of pre-eclamptic patients."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11044466"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CDH5"}, "span_text": {"type": "literal", "value": "After incubation with sera from patients with pre-eclampsia, immunostaining analyses showed cadherin-5 accumulation in vesicular and tubular structures of the Golgi apparatus."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11044466"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CDH5"}, "span_text": {"type": "literal", "value": "Immunoblot analyses of HUVEC after pre-eclampsia serum incubation showed an increase of the stable form of cadherin-5 while degradation products decreased."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11044466"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF1"}, "span_text": {"type": "literal", "value": "Preeclampsia is associated with alterations in insulin-like growth factor (IGF)-1 and IGF-binding proteins in Wharton's jelly of the umbilical cord."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11028764"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF2"}, "span_text": {"type": "literal", "value": "Preeclampsia is associated with alterations in insulin-like growth factor (IGF)-1 and IGF-binding proteins in Wharton's jelly of the umbilical cord."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11028764"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP3"}, "span_text": {"type": "literal", "value": "A longitudinal study of maternal plasma insulin-like growth factor binding protein-1 concentrations during normal pregnancy and pregnancies complicated by pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11006202"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP5"}, "span_text": {"type": "literal", "value": "A longitudinal study of maternal plasma insulin-like growth factor binding protein-1 concentrations during normal pregnancy and pregnancies complicated by pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11006202"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP7"}, "span_text": {"type": "literal", "value": "A longitudinal study of maternal plasma insulin-like growth factor binding protein-1 concentrations during normal pregnancy and pregnancies complicated by pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11006202"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP2"}, "span_text": {"type": "literal", "value": "A longitudinal study of maternal plasma insulin-like growth factor binding protein-1 concentrations during normal pregnancy and pregnancies complicated by pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11006202"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP4"}, "span_text": {"type": "literal", "value": "A longitudinal study of maternal plasma insulin-like growth factor binding protein-1 concentrations during normal pregnancy and pregnancies complicated by pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11006202"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MAPK11"}, "span_text": {"type": "literal", "value": "Phosphorylation of the transcription factor c-Jun and Rac1 activity also were significantly lower in women with preeclampsia and HELLP than in controls. p38 mitogen-activated protein kinase activity was significantly higher in women with preeclampsia than with HELLP syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11004363"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MAPK11"}, "span_text": {"type": "literal", "value": "Placental activity (measured by immunoprecipitation-kinase assay) and protein expression (measured by western blot) of Jun aminoterminal kinase, extracellular regulated kinase, and p38 mitogen-activated protein kinase were measured in four groups of eight women each with preeclampsia, HELLP syndrome, and normal vaginal or cesarean deliveries."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11004363"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MAPK13"}, "span_text": {"type": "literal", "value": "To investigate whether the activity of the three mitogen-activated protein kinases (Jun aminoterminal kinase, extracellular regulated kinase, and p38) is altered in placental tissue of women with preeclampsia and hemolysis, elevated liver enzymes, low platelets (HELLP) syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11004363"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MAPK12"}, "span_text": {"type": "literal", "value": "Phosphorylation of the transcription factor c-Jun and Rac1 activity also were significantly lower in women with preeclampsia and HELLP than in controls. p38 mitogen-activated protein kinase activity was significantly higher in women with preeclampsia than with HELLP syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11004363"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MAPK15"}, "span_text": {"type": "literal", "value": "Downregulation of a mitogen-activated protein kinase signaling pathway in the placentas of women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11004363"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MAPK1"}, "span_text": {"type": "literal", "value": "Phosphorylation of the transcription factor c-Jun and Rac1 activity also were significantly lower in women with preeclampsia and HELLP than in controls. p38 mitogen-activated protein kinase activity was significantly higher in women with preeclampsia than with HELLP syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11004363"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MAPK9"}, "span_text": {"type": "literal", "value": "Downregulation of a mitogen-activated protein kinase signaling pathway in the placentas of women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11004363"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MAPK10"}, "span_text": {"type": "literal", "value": "Phosphorylation of the transcription factor c-Jun and Rac1 activity also were significantly lower in women with preeclampsia and HELLP than in controls. p38 mitogen-activated protein kinase activity was significantly higher in women with preeclampsia than with HELLP syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11004363"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MAPK11"}, "span_text": {"type": "literal", "value": "Downregulation of a mitogen-activated protein kinase signaling pathway in the placentas of women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11004363"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MAPK9"}, "span_text": {"type": "literal", "value": "To investigate whether the activity of the three mitogen-activated protein kinases (Jun aminoterminal kinase, extracellular regulated kinase, and p38) is altered in placental tissue of women with preeclampsia and hemolysis, elevated liver enzymes, low platelets (HELLP) syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11004363"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MAPK15"}, "span_text": {"type": "literal", "value": "Placental activity (measured by immunoprecipitation-kinase assay) and protein expression (measured by western blot) of Jun aminoterminal kinase, extracellular regulated kinase, and p38 mitogen-activated protein kinase were measured in four groups of eight women each with preeclampsia, HELLP syndrome, and normal vaginal or cesarean deliveries."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11004363"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MAPK13"}, "span_text": {"type": "literal", "value": "Phosphorylation of the transcription factor c-Jun and Rac1 activity also were significantly lower in women with preeclampsia and HELLP than in controls. p38 mitogen-activated protein kinase activity was significantly higher in women with preeclampsia than with HELLP syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11004363"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MAPK8"}, "span_text": {"type": "literal", "value": "Placental activity (measured by immunoprecipitation-kinase assay) and protein expression (measured by western blot) of Jun aminoterminal kinase, extracellular regulated kinase, and p38 mitogen-activated protein kinase were measured in four groups of eight women each with preeclampsia, HELLP syndrome, and normal vaginal or cesarean deliveries."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11004363"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MAPK1"}, "span_text": {"type": "literal", "value": "Placental activity (measured by immunoprecipitation-kinase assay) and protein expression (measured by western blot) of Jun aminoterminal kinase, extracellular regulated kinase, and p38 mitogen-activated protein kinase were measured in four groups of eight women each with preeclampsia, HELLP syndrome, and normal vaginal or cesarean deliveries."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11004363"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MAPK12"}, "span_text": {"type": "literal", "value": "Downregulation of a mitogen-activated protein kinase signaling pathway in the placentas of women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11004363"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MAPK8"}, "span_text": {"type": "literal", "value": "Downregulation of a mitogen-activated protein kinase signaling pathway in the placentas of women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11004363"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MAPK1"}, "span_text": {"type": "literal", "value": "To investigate whether the activity of the three mitogen-activated protein kinases (Jun aminoterminal kinase, extracellular regulated kinase, and p38) is altered in placental tissue of women with preeclampsia and hemolysis, elevated liver enzymes, low platelets (HELLP) syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11004363"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MAPK9"}, "span_text": {"type": "literal", "value": "Placental activity (measured by immunoprecipitation-kinase assay) and protein expression (measured by western blot) of Jun aminoterminal kinase, extracellular regulated kinase, and p38 mitogen-activated protein kinase were measured in four groups of eight women each with preeclampsia, HELLP syndrome, and normal vaginal or cesarean deliveries."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11004363"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MAPK1"}, "span_text": {"type": "literal", "value": "Downregulation of a mitogen-activated protein kinase signaling pathway in the placentas of women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11004363"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MAPK13"}, "span_text": {"type": "literal", "value": "Downregulation of a mitogen-activated protein kinase signaling pathway in the placentas of women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11004363"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MAPK12"}, "span_text": {"type": "literal", "value": "Placental activity (measured by immunoprecipitation-kinase assay) and protein expression (measured by western blot) of Jun aminoterminal kinase, extracellular regulated kinase, and p38 mitogen-activated protein kinase were measured in four groups of eight women each with preeclampsia, HELLP syndrome, and normal vaginal or cesarean deliveries."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11004363"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MAPK6"}, "span_text": {"type": "literal", "value": "Phosphorylation of the transcription factor c-Jun and Rac1 activity also were significantly lower in women with preeclampsia and HELLP than in controls. p38 mitogen-activated protein kinase activity was significantly higher in women with preeclampsia than with HELLP syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11004363"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TCF4"}, "span_text": {"type": "literal", "value": "Phosphorylation of the transcription factor c-Jun and Rac1 activity also were significantly lower in women with preeclampsia and HELLP than in controls. p38 mitogen-activated protein kinase activity was significantly higher in women with preeclampsia than with HELLP syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11004363"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MAPK10"}, "span_text": {"type": "literal", "value": "To investigate whether the activity of the three mitogen-activated protein kinases (Jun aminoterminal kinase, extracellular regulated kinase, and p38) is altered in placental tissue of women with preeclampsia and hemolysis, elevated liver enzymes, low platelets (HELLP) syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11004363"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MAPK14"}, "span_text": {"type": "literal", "value": "Phosphorylation of the transcription factor c-Jun and Rac1 activity also were significantly lower in women with preeclampsia and HELLP than in controls. p38 mitogen-activated protein kinase activity was significantly higher in women with preeclampsia than with HELLP syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11004363"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MAPK14"}, "span_text": {"type": "literal", "value": "Placental activity (measured by immunoprecipitation-kinase assay) and protein expression (measured by western blot) of Jun aminoterminal kinase, extracellular regulated kinase, and p38 mitogen-activated protein kinase were measured in four groups of eight women each with preeclampsia, HELLP syndrome, and normal vaginal or cesarean deliveries."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11004363"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MAPK12"}, "span_text": {"type": "literal", "value": "To investigate whether the activity of the three mitogen-activated protein kinases (Jun aminoterminal kinase, extracellular regulated kinase, and p38) is altered in placental tissue of women with preeclampsia and hemolysis, elevated liver enzymes, low platelets (HELLP) syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11004363"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MAPK14"}, "span_text": {"type": "literal", "value": "Downregulation of a mitogen-activated protein kinase signaling pathway in the placentas of women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11004363"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MAPK6"}, "span_text": {"type": "literal", "value": "Placental activity (measured by immunoprecipitation-kinase assay) and protein expression (measured by western blot) of Jun aminoterminal kinase, extracellular regulated kinase, and p38 mitogen-activated protein kinase were measured in four groups of eight women each with preeclampsia, HELLP syndrome, and normal vaginal or cesarean deliveries."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11004363"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MAPK15"}, "span_text": {"type": "literal", "value": "Phosphorylation of the transcription factor c-Jun and Rac1 activity also were significantly lower in women with preeclampsia and HELLP than in controls. p38 mitogen-activated protein kinase activity was significantly higher in women with preeclampsia than with HELLP syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11004363"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MAPK6"}, "span_text": {"type": "literal", "value": "Downregulation of a mitogen-activated protein kinase signaling pathway in the placentas of women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11004363"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MAPK10"}, "span_text": {"type": "literal", "value": "Placental activity (measured by immunoprecipitation-kinase assay) and protein expression (measured by western blot) of Jun aminoterminal kinase, extracellular regulated kinase, and p38 mitogen-activated protein kinase were measured in four groups of eight women each with preeclampsia, HELLP syndrome, and normal vaginal or cesarean deliveries."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11004363"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MAPK9"}, "span_text": {"type": "literal", "value": "Phosphorylation of the transcription factor c-Jun and Rac1 activity also were significantly lower in women with preeclampsia and HELLP than in controls. p38 mitogen-activated protein kinase activity was significantly higher in women with preeclampsia than with HELLP syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11004363"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MAPK13"}, "span_text": {"type": "literal", "value": "Placental activity (measured by immunoprecipitation-kinase assay) and protein expression (measured by western blot) of Jun aminoterminal kinase, extracellular regulated kinase, and p38 mitogen-activated protein kinase were measured in four groups of eight women each with preeclampsia, HELLP syndrome, and normal vaginal or cesarean deliveries."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11004363"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MAPK8"}, "span_text": {"type": "literal", "value": "To investigate whether the activity of the three mitogen-activated protein kinases (Jun aminoterminal kinase, extracellular regulated kinase, and p38) is altered in placental tissue of women with preeclampsia and hemolysis, elevated liver enzymes, low platelets (HELLP) syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11004363"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MAPK8"}, "span_text": {"type": "literal", "value": "Phosphorylation of the transcription factor c-Jun and Rac1 activity also were significantly lower in women with preeclampsia and HELLP than in controls. p38 mitogen-activated protein kinase activity was significantly higher in women with preeclampsia than with HELLP syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11004363"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MAPK11"}, "span_text": {"type": "literal", "value": "To investigate whether the activity of the three mitogen-activated protein kinases (Jun aminoterminal kinase, extracellular regulated kinase, and p38) is altered in placental tissue of women with preeclampsia and hemolysis, elevated liver enzymes, low platelets (HELLP) syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11004363"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MAPK15"}, "span_text": {"type": "literal", "value": "To investigate whether the activity of the three mitogen-activated protein kinases (Jun aminoterminal kinase, extracellular regulated kinase, and p38) is altered in placental tissue of women with preeclampsia and hemolysis, elevated liver enzymes, low platelets (HELLP) syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11004363"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MAPK14"}, "span_text": {"type": "literal", "value": "To investigate whether the activity of the three mitogen-activated protein kinases (Jun aminoterminal kinase, extracellular regulated kinase, and p38) is altered in placental tissue of women with preeclampsia and hemolysis, elevated liver enzymes, low platelets (HELLP) syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11004363"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MAPK6"}, "span_text": {"type": "literal", "value": "To investigate whether the activity of the three mitogen-activated protein kinases (Jun aminoterminal kinase, extracellular regulated kinase, and p38) is altered in placental tissue of women with preeclampsia and hemolysis, elevated liver enzymes, low platelets (HELLP) syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11004363"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MAPK10"}, "span_text": {"type": "literal", "value": "Downregulation of a mitogen-activated protein kinase signaling pathway in the placentas of women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/11004363"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TXN"}, "span_text": {"type": "literal", "value": "Decreased expression of thioredoxin and glutaredoxin in placentae from pregnancies with pre-eclampsia and intrauterine growth restriction."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10985961"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GLRX"}, "span_text": {"type": "literal", "value": "Decreased expression of thioredoxin and glutaredoxin in placentae from pregnancies with pre-eclampsia and intrauterine growth restriction."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10985961"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GLRX5"}, "span_text": {"type": "literal", "value": "Decreased expression of thioredoxin and glutaredoxin in placentae from pregnancies with pre-eclampsia and intrauterine growth restriction."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10985961"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GLRX2"}, "span_text": {"type": "literal", "value": "Decreased expression of thioredoxin and glutaredoxin in placentae from pregnancies with pre-eclampsia and intrauterine growth restriction."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10985961"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TXN"}, "span_text": {"type": "literal", "value": "This study was performed to test a hypothesis which suggests that pre-eclampsia is associated with inadequate control by the thioredoxin system and other related reducing systems."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10985961"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GLRX2"}, "span_text": {"type": "literal", "value": "We conclude that the thioredoxin and glutaredoxin reducing systems are affected in placenta from pregnancies with pre-eclampsia and/or growth restriction of fetuses, and that the decrease correlates to the severity of the condition."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10985961"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GLRX5"}, "span_text": {"type": "literal", "value": "We conclude that the thioredoxin and glutaredoxin reducing systems are affected in placenta from pregnancies with pre-eclampsia and/or growth restriction of fetuses, and that the decrease correlates to the severity of the condition."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10985961"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:TXN"}, "span_text": {"type": "literal", "value": "We conclude that the thioredoxin and glutaredoxin reducing systems are affected in placenta from pregnancies with pre-eclampsia and/or growth restriction of fetuses, and that the decrease correlates to the severity of the condition."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10985961"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GLRX"}, "span_text": {"type": "literal", "value": "We conclude that the thioredoxin and glutaredoxin reducing systems are affected in placenta from pregnancies with pre-eclampsia and/or growth restriction of fetuses, and that the decrease correlates to the severity of the condition."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10985961"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "The relationship between serum nitrate and endothelin-1 concentrations in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10983841"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "The prevalence of pre-eclampsia was significantly increased in the group of women treated with metformin compared to women treated with sulphonylurea or insulin (32 vs. 7 vs. 10%, P < 0.001)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10972579"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD1"}, "span_text": {"type": "literal", "value": "The serum levels of lipid peroxide were significantly increased (p<0.0001) and antioxidant enzyme activities (superoxide dismutase and glutathione levels) in erythrocytes were significantly decreased (p<0.0001) in women with preeclampsia and eclampsia compared with the controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10968357"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CAT"}, "span_text": {"type": "literal", "value": "The groups of preeclampsia and eclampsia had similar values of catalase activities as the controls (p>0.05)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10968357"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD3"}, "span_text": {"type": "literal", "value": "The serum levels of lipid peroxide were significantly increased (p<0.0001) and antioxidant enzyme activities (superoxide dismutase and glutathione levels) in erythrocytes were significantly decreased (p<0.0001) in women with preeclampsia and eclampsia compared with the controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10968357"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Leptin concentrations have been found to be elevated in cross-sectional studies of established pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10967010"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "This study confirms that plasma leptin concentrations are increased in established pre-eclampsia and reports for the first time that leptin concentrations are elevated before pre-eclampsia is clinically evident."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10967010"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "In the cross-sectional study, plasma leptin concentrations were significantly greater in women with pre-eclampsia than in normal controls (P: = 0.001)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10967010"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Longitudinal analysis of maternal plasma leptin concentrations during normal pregnancy and pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10967010"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Circulating concentrations of leptin were measured in a cross-sectional study to confirm these findings (19 women with pre-eclampsia and 13 normal pregnant controls) and in a longitudinal study to establish the timing of the increase in leptin concentrations (samples obtained at 16, 20, 24, 28, 32, 36 and 38 weeks gestation from eight women who went on to develop pre-eclampsia and seven normal pregnant controls)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10967010"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10964023"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "In conclusion, the free leptin concentration increases in normal pregnancy and is further increased in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10954024"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Free leptin is increased in normal pregnancy and further increased in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10954024"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "This supports the hypothesis that biologically active leptin is elevated in normal pregnancy and is increased more in women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10954024"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "The total maternal serum leptin concentration was significantly higher in normal pregnancy compared with the nonpregnant state and was further increased in preeclampsia (33.8 +/- 4.1 v 15.2 +/- 1.8 ng/mL, P = .002, and 48.1 +/- 5.6 ng/mL, P = .02, respectively)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10954024"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "We measured bound and free leptin levels in preeclamptic and matched normal pregnant and never-pregnant women to determine whether the free component of leptin is increased during pregnancy and further increased in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10954024"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Free leptin was increased in normal pregnant compared with never-pregnant women (25.9 +/- 4.1 v 11.0 +/- 2.0 ng/mL, respectively, P = .01), while the increase of total leptin in preeclampsia was exclusively in the free fraction that was significantly higher versus the normal pregnant group (41.8 +/- 5.6 v25.9 +/- 4.1 ng/mL, respectively, P = .01)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10954024"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "To evaluate the value of 24-h blood pressure monitoring compared to office blood pressure and urinary albumin excretion in predicting pre-eclampsia in Type I (insulin-dependent) diabetes mellitus."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10952467"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "Urinary albumin excretion and systolic blood pressure were higher before and throughout pregnancy in 14 women developing pre-eclampsia compared with women remaining normotensive (p <0.001; p < 0.05, respectively)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10952467"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "Urinary albumin excretion and 24-hour blood pressure as predictors of pre-eclampsia in Type I diabetes."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10952467"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "In arteries from gravid women with preeclampsia, inhibition of nitric oxide synthase enhanced myogenic-induced tone (25% +/- 4% control vs 35% +/- 5% N omega-nitro-L -arginine; P <.05) and norepinephrine-induced tone (36% +/- 4% control vs 46% +/- 6% N omega-nitro-L -arginine; P <.05), as in arteries from healthy gravid women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10920325"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "Relationship of systemic hemodynamics, left ventricular structure and function, and plasma natriuretic peptide concentrations during pregnancy complicated by preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10920322"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "These changes coincided with increases in plasma levels of atrial natriuretic peptide and brain natriuretic peptide that were linearly related to the left ventricular structural and functional changes observed in patients with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10920322"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "The study compared 75 pregnant women (n = 40 with preeclampsia; n = 35 normotensive pregnant women) and 10 nonpregnant normotensive control subjects undergoing an echocardiographic and biohumoral (renin activity and aldosterone, atrial natriuretic peptide, and brain natriuretic peptide concentrations) evaluation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10920322"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "A simple evaluation of plasma natriuretic peptide concentrations could help to discriminate patients with preeclampsia who have a condition of mild left ventricular overload."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10920322"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "Pregnant patients with preeclampsia showed adaptation to the increase in systemic blood pressure, with significant modification of left ventricular structure and function related to the plasma levels of both atrial natriuretic peptide and brain natriuretic peptide."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10920322"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AFP"}, "span_text": {"type": "literal", "value": "Analysis of mid-trimester corticotrophin-releasing hormone and alpha-fetoprotein concentrations for predicting pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10920109"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AFP"}, "span_text": {"type": "literal", "value": "The aims of this study were firstly to examine if corticotrophin-releasing hormone (CRH) concentrations in maternal plasma were significantly elevated in Chinese pregnancies complicated by pre-eclampsia, secondly to assess if this elevation could be detected in the mid-trimester before onset of clinical signs of the disease, and thirdly to evaluate the performance of using maternal CRH and/or alpha-fetoprotein (AFP) concentrations in the mid-trimester for prediction of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10920109"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MTHFR"}, "span_text": {"type": "literal", "value": "A carrier status for the T677 allele of the methylenetetrahydrofolate reductase gene does not predispose to preeclampsia, at least in the Finnish population."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10908777"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MTHFR"}, "span_text": {"type": "literal", "value": "677 C-->T polymorphism of the methylenetetrahydrofolate reductase gene and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10908777"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADM"}, "span_text": {"type": "literal", "value": "The intensity of adrenomedullin expression in the placenta obtained from pregnancies with pre-eclampsia was significantly decreased compared with expression in placentas from uncomplicated normotensive pregnancies (P < 0.005)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10886735"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADM2"}, "span_text": {"type": "literal", "value": "Immunohistochemical adrenomedullin expression is decreased in the placenta from pregnancies with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10886735"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADM"}, "span_text": {"type": "literal", "value": "Immunohistochemical adrenomedullin expression is decreased in the placenta from pregnancies with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10886735"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADM"}, "span_text": {"type": "literal", "value": "The purpose of the present study was to investigate whether placental immunohistochemical adrenomedullin expression in normal normotensive pregnancies is different from that in pregnancies with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10886735"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADM2"}, "span_text": {"type": "literal", "value": "These results suggest that adrenomedullin synthesis in the villous syncytiotrophoblasts is decreased in pregnancies with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10886735"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADM"}, "span_text": {"type": "literal", "value": "These results suggest that adrenomedullin synthesis in the villous syncytiotrophoblasts is decreased in pregnancies with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10886735"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADM2"}, "span_text": {"type": "literal", "value": "The purpose of the present study was to investigate whether placental immunohistochemical adrenomedullin expression in normal normotensive pregnancies is different from that in pregnancies with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10886735"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADM2"}, "span_text": {"type": "literal", "value": "The intensity of adrenomedullin expression in the placenta obtained from pregnancies with pre-eclampsia was significantly decreased compared with expression in placentas from uncomplicated normotensive pregnancies (P < 0.005)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10886735"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ELN"}, "span_text": {"type": "literal", "value": "The insoluble elastin content decreased in the umbilical cord veins of newborns delivered by mothers with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10875100"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Increased fetal leptin in maternal pre-eclampsia may reflect a physiological adaptation to fetal stress such as hypoxia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10873164"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "In multiple regression analysis, leptin was associated with gestational age and maternal pre-eclampsia (both p < 0.05), but not with antenatal corticosteroids."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10873164"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "To study the effect of maternal pre-eclampsia on cord plasma leptin concentrations in preterm infants."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10873164"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MTHFR"}, "span_text": {"type": "literal", "value": "An association between preeclampsia (PE) and a common missense mutation of the methylenetetrahydrofolate reductase gene (MTHFR), a C to T substitution at nucleotide 677 (C677T), which converts an alanine to a valine residue, has been reported in Italian and Japanese populations."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10869114"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MTHFR"}, "span_text": {"type": "literal", "value": "Absence of association between a common mutation in the methylenetetrahydrofolate reductase gene and preeclampsia in Japanese women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10869114"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AFP"}, "span_text": {"type": "literal", "value": "To determine whether second-trimester maternal serum levels of inhibin A, human chorionic gonadotropin (hCG), unconjugated estriol (uE3), and alpha-fetoprotein (AFP) are predictive of the later onset of preeclampsia in pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10865185"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "To investigate the susceptibility to oxidation of low-density lipoprotein (LDL) and high-density lipoprotein (HDL) in women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10862842"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Lipoprotein particles in preeclampsia: susceptibility to oxidative modification."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10862842"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Low-density lipoprotein and HDL particles were more susceptible to oxidative modification, and plasma concentration of LDL particles, but not of HDL particles, was increased in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10862842"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Study of serum lipid and lipoprotein in pre-eclampsia with special reference to parity."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10846634"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF1"}, "span_text": {"type": "literal", "value": "Preeclampsia is associated with low circulating levels of insulin-like growth factor I and 1,25-dihydroxyvitamin D in maternal and umbilical cord compartments."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10843160"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF2"}, "span_text": {"type": "literal", "value": "Preeclampsia is associated with low circulating levels of insulin-like growth factor I and 1,25-dihydroxyvitamin D in maternal and umbilical cord compartments."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10843160"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "To determine whether placental vascular endothelial growth factor (VEGF) is increased in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10826585"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "To determine whether placental vascular endothelial growth factor (VEGF) is increased in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10826585"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "To determine whether placental vascular endothelial growth factor (VEGF) is increased in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10826585"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EPO"}, "span_text": {"type": "literal", "value": "Acute and chronic bleeding, multiple gestations, and preeclampsia are all associated with various serum erythropoietin levels."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10819826"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EPO"}, "span_text": {"type": "literal", "value": "Our purpose was to evaluate and compare erythropoietin levels as related to obstetric conditions, including acute and chronic bleeding, preeclampsia, and multiple gestations."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10819826"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGT"}, "span_text": {"type": "literal", "value": "More recently RT-PCR methods have revealed angiotensinogen transcription in the smooth muscle of spiral anteries of the decidua; a specific allele of this gene may be associated with hypertension in pregnancy as well as in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10818397"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VCAM1"}, "span_text": {"type": "literal", "value": "Maternal serum soluble vascular cell adhesion molecule-1 (sVCAM-1) and soluble intercellular adhesion molecule-1 (sICAM-1) were evaluated in preeclampsia to investigate whether these molecules could be helpful with regard to this pregnancy complication."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10785888"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ICAM1"}, "span_text": {"type": "literal", "value": "Maternal serum soluble vascular cell adhesion molecule-1 (sVCAM-1) and soluble intercellular adhesion molecule-1 (sICAM-1) were evaluated in preeclampsia to investigate whether these molecules could be helpful with regard to this pregnancy complication."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10785888"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ICAM1"}, "span_text": {"type": "literal", "value": "A comparative study of serum soluble vascular cell adhesion molecule-1 and soluble intercellular adhesion molecule-1 in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10785888"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VCAM1"}, "span_text": {"type": "literal", "value": "A comparative study of serum soluble vascular cell adhesion molecule-1 and soluble intercellular adhesion molecule-1 in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10785888"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VCAM1"}, "span_text": {"type": "literal", "value": "Correlation between placental bed biopsy findings, vascular cell adhesion molecule and fibronectin levels in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10759271"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FST"}, "span_text": {"type": "literal", "value": "The finding of apparently normal follistatin and high activin A levels in patients with PIH and pre-eclampsia suggests that unbound, biologically active, activin A is increased in women with these gestational diseases."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10750046"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FST"}, "span_text": {"type": "literal", "value": "The ratio between activin A and follistatin was significantly increased in patients with PIH (1.5 MoM) and was further increased in patients with pre-eclampsia (4.5 MoM) and in the group with pre-eclampsia+IUGR (2.6 MoM)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10750046"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:FST"}, "span_text": {"type": "literal", "value": "Follistatin levels were not different between controls and patients, while activin A levels were significantly increased in patients with PIH (1.8 MoM), pre-eclampsia (4.6 MoM), and pre-eclampsia+IUGR (3.2 MoM, P<0.01, ANOVA)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10750046"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOE"}, "span_text": {"type": "literal", "value": "Apolipoprotein E polymorphism in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10745965"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:B2M"}, "span_text": {"type": "literal", "value": "Our purpose was to determine whether second-trimester maternal serum beta(2)-microglobulin levels could be used to predict subsequent development of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10739513"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:B2M"}, "span_text": {"type": "literal", "value": "No difference was found in early serum beta(2)-microglobulin concentrations between women in whom preeclampsia subsequently developed and those who remained normotensive throughout gestation (1.02 +/- 0.12 vs 0.95 +/- 0.12 mg/L)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10739513"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:B2M"}, "span_text": {"type": "literal", "value": "Serum beta(2)-microglobulin levels do not predict subsequent preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10739513"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:B2M"}, "span_text": {"type": "literal", "value": "Failure of serum beta2-microglobulin levels as an early marker of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10739513"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:B2M"}, "span_text": {"type": "literal", "value": "In the cross-sectional study serum beta(2)-microglobulin levels were significantly higher in women with preeclampsia than in control women (1.87 +/- 0.36 mg/L vs 1.01 +/- 0."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10739513"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:B2M"}, "span_text": {"type": "literal", "value": "We first did a cross-sectional study to compare serum concentrations of beta(2)-microglobulin between women with preeclampsia and normotensive women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10739513"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:B2M"}, "span_text": {"type": "literal", "value": "Serum beta(2)-microglobulin concentrations of 11 consecutive patients hospitalized for preeclampsia were compared with those of 11 normotensive women hospitalized for threatened premature labor."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10739513"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AFP"}, "span_text": {"type": "literal", "value": "After we controlled for confounding variables, case patients and control subjects had similar human chorionic gonadotropin and alpha-fetoprotein levels, and the only variables that remained significantly associated with severe preeclampsia were nulliparity (relative risk, 3.8; 95% confidence interval, 1.7-8.3), history of preeclampsia (relative risk, 5.0; 95% confidence interval, 1.7-17.2), elevated screening mean arterial pressure (relative risk, 3.5; 95% confidence interval, 1.7-7.2), and low unconjugated estriol concentration (relative risk, 1.7; 95% confidence interval, 0.9-3.4)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10739512"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AFP"}, "span_text": {"type": "literal", "value": "The addition of the human chorionic gonadotropin and alpha-fetoprotein biochemical markers did not enhance the model's predictive value for severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10739512"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SELL"}, "span_text": {"type": "literal", "value": "Pre-eclampsia did not change the expression of leukocyte-endothelium adhesion or lymphocyte homing-associated antigens, ICAM-1, ICAM-2, VCAM, P-selectin, E-selectin, L-selectin, CLA-1, CD73, VAP-1 and alphaEbeta7 in the placental bed."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10736235"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SELE"}, "span_text": {"type": "literal", "value": "Pre-eclampsia did not change the expression of leukocyte-endothelium adhesion or lymphocyte homing-associated antigens, ICAM-1, ICAM-2, VCAM, P-selectin, E-selectin, L-selectin, CLA-1, CD73, VAP-1 and alphaEbeta7 in the placental bed."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10736235"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "The number of placental vascular guanylate-coupled receptors. corresponding to bioactive natriuretic peptide receptors is greater in preeclampsia. but there are no clear data about atrial natriuretic peptide (ANP) concentration in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10728627"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPR3"}, "span_text": {"type": "literal", "value": "The number of placental vascular guanylate-coupled receptors. corresponding to bioactive natriuretic peptide receptors is greater in preeclampsia. but there are no clear data about atrial natriuretic peptide (ANP) concentration in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10728627"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPR2"}, "span_text": {"type": "literal", "value": "The number of placental vascular guanylate-coupled receptors. corresponding to bioactive natriuretic peptide receptors is greater in preeclampsia. but there are no clear data about atrial natriuretic peptide (ANP) concentration in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10728627"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Measurements have been made of the urinary content of inositol phosphoglycans IPG P-type and IPG A-type, putative insulin second messengers, in preeclampsia, in type I insulin-treated diabetic pregnant women and their matched control subjects, and nonpregnant women of child-bearing age."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10720442"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "First trimester plasma endothelin-1 levels in pregnant women who subsequently developed mild, severe pre-eclampsia and eclampsia were significantly higher than those of pregnant women who remained normotensive."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10717813"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "The predictive values of plasma endothelin-1 for pre-eclampsia were: sensitivity 96.8%, specificity 51%, positive predictive value 55.5% and negative predictive value 91%, whereas those of MAP were 48.4, 45, 35.7 and 58%, respectively."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10717813"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "To determine whether increased first trimester plasma endothelin-1 and/or increased midtrimester mean arterial blood pressure detected in pregnant women who are free of symptoms can predict the subsequent development of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10717813"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Plasma endothelin-1 and mean arterial pressure in the prediction of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10717813"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EPO"}, "span_text": {"type": "literal", "value": "Preeclampsia is associated with increased levels of soluble VEGFR-1, which are independent of erythropoietin, another hypoxia-inducible factor."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10711543"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ICAM1"}, "span_text": {"type": "literal", "value": "Circulating levels of von Willebrand factor and soluble vascular adhesion molecule 1, soluble intercellular adhesion molecule 1, and E-selectin were assayed in 71 women with eventual preeclampsia and 71 control subjects."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10694331"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ICAM1"}, "span_text": {"type": "literal", "value": "Soluble vascular adhesion molecule 1 concentration was significantly lower in the women with eventual preeclampsia (median, 649.0 ng/mL vs 762.4 ng/mL; P <.001), whereas soluble intercellular adhesion molecule 1 concentration was significantly higher (median, 239.8 ng/mL vs 178.3 ng/mL; P <.001)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10694331"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ICAM1"}, "span_text": {"type": "literal", "value": "However, decreased serum concentration of soluble vascular adhesion molecule 1 and increased serum concentration of soluble intercellular adhesion molecule 1 may reflect the disturbed placentation known to be associated with the development of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10694331"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VWF"}, "span_text": {"type": "literal", "value": "Circulating levels of von Willebrand factor and soluble vascular adhesion molecule 1, soluble intercellular adhesion molecule 1, and E-selectin were assayed in 71 women with eventual preeclampsia and 71 control subjects."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10694331"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGT"}, "span_text": {"type": "literal", "value": "We detected no mutation of codon 10 in angiotensinogen in any of the 32 women studied, indicating that this mutation is not commonly associated with proteinuric pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10694185"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGT"}, "span_text": {"type": "literal", "value": "To determine whether mutation of codon 10 of angiotensinogen is common in pre-eclampsia, and therefore likely to be involved in disease susceptibility."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10694185"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGT"}, "span_text": {"type": "literal", "value": "A mutation in the gene for angiotensinogen, changing the leucine residue at position 10 to a phenylalanine (L10F), has been reported in a patient with proteinuric pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10694185"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGT"}, "span_text": {"type": "literal", "value": "The L10F mutation of angiotensinogen is rare in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10694185"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Leptin was higher in preeclampsia (mean +/- SE, 34.6 +/- 3.9 v 20.0 +/- 3.3 microg/L, P = .002) and correlated directly with the level of proteinuria (r = .47, P = .03) and normal pregnancy (r = .52, P = .04), whereas insulin sensitivity as assessed by an intravenous glucose tolerance test showed no relationship to leptin."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10690955"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Leptin was higher in preeclampsia (mean +/- SE, 34.6 +/- 3.9 v 20.0 +/- 3.3 microg/L, P = .002) and correlated directly with the level of proteinuria (r = .47, P = .03) and normal pregnancy (r = .52, P = .04), whereas insulin sensitivity as assessed by an intravenous glucose tolerance test showed no relationship to leptin."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10690955"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "We studied serum leptin in preeclampsia, which is an insulin-resistant state, and sought associations between leptin and insulin or insulin sensitivity during and after pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10690955"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "In conclusion, (1) serum leptin is elevated in preeclampsia, (2) insulin is an important determinant of serum leptin in preeclamptic and normotensive women both during pregnancy and in the puerperium, and (3) hyperleptinemia may be part of the insulin resistance syndrome also in women with prior preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10690955"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "In conclusion, (1) serum leptin is elevated in preeclampsia, (2) insulin is an important determinant of serum leptin in preeclamptic and normotensive women both during pregnancy and in the puerperium, and (3) hyperleptinemia may be part of the insulin resistance syndrome also in women with prior preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10690955"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "We studied serum leptin in preeclampsia, which is an insulin-resistant state, and sought associations between leptin and insulin or insulin sensitivity during and after pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10690955"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "Our purpose was to evaluate plasma levels of brain natriuretic peptide (pBNP) and cyclic guanosine monophosphate (pcGMP) in preeclamptic patients and controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10680338"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "Brain natriuretic peptide (BNP) and cyclic guanosine monophosphate (cGMP) levels in normal pregnancy and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10680338"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP3"}, "span_text": {"type": "literal", "value": "Serum insulin-like growth factor binding protein-1 at 16 weeks and subsequent preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10674577"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP7"}, "span_text": {"type": "literal", "value": "Serum insulin-like growth factor binding protein-1 at 16 weeks and subsequent preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10674577"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP2"}, "span_text": {"type": "literal", "value": "Serum insulin-like growth factor binding protein-1 at 16 weeks and subsequent preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10674577"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP4"}, "span_text": {"type": "literal", "value": "Serum insulin-like growth factor binding protein-1 at 16 weeks and subsequent preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10674577"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGFBP5"}, "span_text": {"type": "literal", "value": "Serum insulin-like growth factor binding protein-1 at 16 weeks and subsequent preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10674577"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Lipoprotein (a) levels in normal pregnancy and in pregnancy complicated with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10657577"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MTHFR"}, "span_text": {"type": "literal", "value": "We genotyped a total of 171 cases with preeclampsia or eclampsia and 185 normotensive control subjects for the methylenetetrahydrofolate reductase (MTHFR) 677 C --> T genotype."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10655155"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MTHFR"}, "span_text": {"type": "literal", "value": "Methylenetetrahydrofolate reductase 677 C --> T polymorphism, plasma folate, vitamin B(12) concentrations, and risk of preeclampsia among black African women from Zimbabwe."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10655155"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Vascular endothelial growth factor has the ability to alter endothelial cell function in a manner analogous to that of plasma from women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10649176"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "An as yet unidentified circulating factor causes widespread alteration in endothelial function, and levels of vascular endothelial growth factor are elevated in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10649176"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Vascular endothelial growth factor has the ability to alter endothelial cell function in a manner analogous to that of plasma from women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10649176"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "The effects of vascular endothelial growth factor on endothelial cells: a potential role in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10649176"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "An as yet unidentified circulating factor causes widespread alteration in endothelial function, and levels of vascular endothelial growth factor are elevated in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10649176"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "An as yet unidentified circulating factor causes widespread alteration in endothelial function, and levels of vascular endothelial growth factor are elevated in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10649176"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "These cultured cells were then stimulated with vascular endothelial growth factor and with plasma from women with preeclampsia in the presence and absence of anti-vascular endothelial growth factor antibody."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10649176"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "The effects of vascular endothelial growth factor on endothelial cells: a potential role in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10649176"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Vascular endothelial growth factor has the ability to alter endothelial cell function in a manner analogous to that of plasma from women with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10649176"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "These cultured cells were then stimulated with vascular endothelial growth factor and with plasma from women with preeclampsia in the presence and absence of anti-vascular endothelial growth factor antibody."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10649176"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "The effects of vascular endothelial growth factor on endothelial cells: a potential role in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10649176"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "These cultured cells were then stimulated with vascular endothelial growth factor and with plasma from women with preeclampsia in the presence and absence of anti-vascular endothelial growth factor antibody."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10649176"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Vascular endothelial growth factor serum levels in pregnancy and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10646821"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Vascular endothelial growth factor serum levels in pregnancy and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10646821"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Vascular endothelial growth factor serum levels in pregnancy and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10646821"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPL"}, "span_text": {"type": "literal", "value": "Association of pre-eclampsia with common coding sequence variations in the lipoprotein lipase gene."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10636447"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Because TG-rich particles may play an important role in thrombin generation and may induce platelet aggregation, the observed changes in lipoprotein metabolism in preeclampsia and HELLP syndrome may contribute to the coagulopathy seen in these conditions."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10625202"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Therefore, we analyzed the lipoprotein distribution and platelet counts in uncomplicated preeclamptic and HELLP syndrome pregnancies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10625202"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Serum activin A and inhibin A elevated in pre-eclampsia: no relation to insulin sensitivity."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10609725"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Activin A, inhibin A, and pro-alphaC are elevated in pre-eclampsia but do not appear to relate to the insulin sensitivity in pre-eclamptic or normal pregnancies."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10609725"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "These glycoproteins were not associated with insulin sensitivity either in women with pre-eclampsia or controls."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10609725"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "To assess the possible role of serum levels of activin A, inhibin A and pro-alpha inhibin (pro-alphaC) in insulin sensitivity in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10609725"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Patients with a recent history of preeclampsia demonstrate signs of relative insulin resistance, hypertriglyceridemia and hyperuricemia as well as increased blood pressure as compared with women who had a normal pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10592425"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Significantly higher values were found in the preeclampsia than in the control group for fasting insulin, fasting glucose, fasting insulin resistance index (FIRI, fasting glucose x fasting insulin/25), serum triglycerides, uric acid and blood pressure."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10592425"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOE"}, "span_text": {"type": "literal", "value": "Implication of apolipoprotein E and the L-arginine-nitric oxide system in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10586526"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "In order to evaluate whether lipid abnormalities may contribute to endothelial dysfunction in pre-eclampsia, the present study examined the in vitro effects of very-low-density lipoprotein (VLDL), low-density lipoprotein (LDL) and high-density lipoprotein (HDL), isolated from women with pre-eclampsia and matched controls, on the endothelial synthesis of 6-oxo-prostaglandin F(1alpha) (6-oxo-PGF(1alpha); a metabolite of prostacyclin) and endothelin 1, and on the expression of nitric oxide synthase 3 (NOS3) mRNA."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10585897"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "In order to evaluate whether lipid abnormalities may contribute to endothelial dysfunction in pre-eclampsia, the present study examined the in vitro effects of very-low-density lipoprotein (VLDL), low-density lipoprotein (LDL) and high-density lipoprotein (HDL), isolated from women with pre-eclampsia and matched controls, on the endothelial synthesis of 6-oxo-prostaglandin F(1alpha) (6-oxo-PGF(1alpha); a metabolite of prostacyclin) and endothelin 1, and on the expression of nitric oxide synthase 3 (NOS3) mRNA."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10585897"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "VLDL, LDL and HDL from women with pre-eclampsia did not affect endothelial cell synthesis of endothelin 1 or expression of NOS3 mRNA differently from lipoproteins from normal pregnant women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10585897"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "In order to evaluate whether lipid abnormalities may contribute to endothelial dysfunction in pre-eclampsia, the present study examined the in vitro effects of very-low-density lipoprotein (VLDL), low-density lipoprotein (LDL) and high-density lipoprotein (HDL), isolated from women with pre-eclampsia and matched controls, on the endothelial synthesis of 6-oxo-prostaglandin F(1alpha) (6-oxo-PGF(1alpha); a metabolite of prostacyclin) and endothelin 1, and on the expression of nitric oxide synthase 3 (NOS3) mRNA."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10585897"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "VLDL, LDL and HDL from women with pre-eclampsia did not affect endothelial cell synthesis of endothelin 1 or expression of NOS3 mRNA differently from lipoproteins from normal pregnant women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10585897"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "This study set out to examine the potential association between lipoprotein(a) and the development of severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10582861"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOF"}, "span_text": {"type": "literal", "value": "The focus of this study was to investigate the potential utility of apolipoprotein(a) isoforms as possible diagnostic markers for identifying women at risk for developing preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10582861"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOE"}, "span_text": {"type": "literal", "value": "The focus of this study was to investigate the potential utility of apolipoprotein(a) isoforms as possible diagnostic markers for identifying women at risk for developing preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10582861"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOM"}, "span_text": {"type": "literal", "value": "The focus of this study was to investigate the potential utility of apolipoprotein(a) isoforms as possible diagnostic markers for identifying women at risk for developing preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10582861"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Although the exact mechanism of pathogenesis continues to elude investigators, our results suggest that lipoprotein(a) may act as an acute-phase reactant during preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10582861"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:APOO"}, "span_text": {"type": "literal", "value": "The focus of this study was to investigate the potential utility of apolipoprotein(a) isoforms as possible diagnostic markers for identifying women at risk for developing preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10582861"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "In agreement with previous studies, albumin excretion rate appeared to be the best predictive test for pre-eclampsia in hypertensive pregnant women, giving a higher positive predictive value and specificity (87.5 and 98.9%, respectively)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10580670"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:HGF"}, "span_text": {"type": "literal", "value": "Hepatocyte growth factor stimulates trophoblast invasion: a potential mechanism for abnormal placentation in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10566655"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL6"}, "span_text": {"type": "literal", "value": "The induction of cyclooxygenase-2 (COX-2) in cultured endothelial cells treated with serum from preeclampsia is mediated by interleukin-6."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10561943"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MTHFR"}, "span_text": {"type": "literal", "value": "5,10 methylenetetrahydrofolate reductase polymorphism in black South African women with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10549971"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MTHFR"}, "span_text": {"type": "literal", "value": "The polymorphic C677T mutation in the gene encoding 5,10 methylenetetrahydrofolate reductase has been shown to be a risk factor for pre-eclampsia in Japanese and European women when inherited as a homozygous trait."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10549971"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MTHFR"}, "span_text": {"type": "literal", "value": "Only one woman with pre-eclampsia was TT homozygous, suggesting that methylenetetrahydrofolate reductase polymorphism is not an important factor in the pathogenesis of pre-eclampsia in black South African women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10549971"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IGF1"}, "span_text": {"type": "literal", "value": "Preeclampsia is characterized by reduced levels of estrogens and insulin-like growth factor-1, and by elevated levels of progesterone, androgens, human chorionic gonadotropin, IGF-1 binding protein, corticotropin-releasing factor, cortisol, and insulin."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10535787"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Preeclampsia is characterized by reduced levels of estrogens and insulin-like growth factor-1, and by elevated levels of progesterone, androgens, human chorionic gonadotropin, IGF-1 binding protein, corticotropin-releasing factor, cortisol, and insulin."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10535787"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL1B"}, "span_text": {"type": "literal", "value": "We investigated the role of the fetal immune system in pregnancies complicated by preeclampsia by assessing umbilical cord plasma levels of the cytokines tumor necrosis factor-alpha (TNF-alpha) and interleukin-1beta (IL-1beta)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10535611"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL1B"}, "span_text": {"type": "literal", "value": "Expression of the placental cytokines tumor necrosis factor alpha, interleukin 1beta, and interleukin 10 is increased in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10521753"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL1B"}, "span_text": {"type": "literal", "value": "Placentas from preeclamptic patients demonstrated increased expression of interleukin 1beta, interleukin 10, and tumor necrosis factor alpha."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10521753"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL10"}, "span_text": {"type": "literal", "value": "Placentas from preeclamptic patients demonstrated increased expression of interleukin 1beta, interleukin 10, and tumor necrosis factor alpha."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10521753"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL10"}, "span_text": {"type": "literal", "value": "Expression of the placental cytokines tumor necrosis factor alpha, interleukin 1beta, and interleukin 10 is increased in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10521753"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Vascular endothelial growth factor (VEGF) is an angiogenic growth factor that acts via two high-affinity receptors (KDR and Flt-1), and its production is increased in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10496528"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Vascular endothelial growth factor (VEGF) is an angiogenic growth factor that acts via two high-affinity receptors (KDR and Flt-1), and its production is increased in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10496528"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Vascular endothelial growth factor (VEGF) is an angiogenic growth factor that acts via two high-affinity receptors (KDR and Flt-1), and its production is increased in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10496528"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "There were no differences in a number of other biochemical markers of pre-eclampsia, including plasma albumin, uric acid, triacylglycerol, and total, low-density lipoprotein and high-density lipoprotein cholesterol."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10491348"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "There were no differences in a number of other biochemical markers of pre-eclampsia, including plasma albumin, uric acid, triacylglycerol, and total, low-density lipoprotein and high-density lipoprotein cholesterol."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10491348"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "Markers of severity of pre-eclampsia, which normalized by 6 months postpartum, included plasma creatinine, uric acid, albumin, endothelin 1 and urinary protein, 2,3, dinor-6-keto-PGF1alpha, blood platelet and neutrophil counts."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10489109"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "The primary outcome measures were blood pressure, body mass index (BMI), triglycerides, total cholesterol, low density lipoprotein (LDL) and high density lipoprotein cholesterol and markers of severity of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10489109"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "Markers of severity of pre-eclampsia, which normalized by 6 months postpartum, included plasma creatinine, uric acid, albumin, endothelin 1 and urinary protein, 2,3, dinor-6-keto-PGF1alpha, blood platelet and neutrophil counts."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10489109"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CADM1"}, "span_text": {"type": "literal", "value": "To determine the degree of endothelium-dependent relaxation in myometrial and omental resistance arteries from normal pregnancies and pregnancies complicated with preeclampsia or fetal growth restriction (FGR) (compromised pregnancy group), and to correlate the results with the endothelial surface expression of cell adhesion molecules (CAMs) in the same vessels."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10486781"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CADM1"}, "span_text": {"type": "literal", "value": "Relationship of cell adhesion molecule expression to endothelium-dependent relaxation in normal pregnancy and pregnancies complicated with preeclampsia or fetal growth restriction."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10486781"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CADM3"}, "span_text": {"type": "literal", "value": "To determine the degree of endothelium-dependent relaxation in myometrial and omental resistance arteries from normal pregnancies and pregnancies complicated with preeclampsia or fetal growth restriction (FGR) (compromised pregnancy group), and to correlate the results with the endothelial surface expression of cell adhesion molecules (CAMs) in the same vessels."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10486781"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CADM3"}, "span_text": {"type": "literal", "value": "Relationship of cell adhesion molecule expression to endothelium-dependent relaxation in normal pregnancy and pregnancies complicated with preeclampsia or fetal growth restriction."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10486781"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Insulin resistance and preeclampsia: is there a relationship?"}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10486534"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GSTP1"}, "span_text": {"type": "literal", "value": "Plasma glutathione S-transferase Pi 1-1 measurements in the study of hemolysis in hypertensive disorders of pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10476616"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LDHD"}, "span_text": {"type": "literal", "value": "Plasma GSTP1-1 and haptoglobin levels and serum lactate dehydrogenase (LDH) activity were measured in 81 healthy nonpregnant female blood donors between 20 and 40 years of age, 41 women during uncomplicated normotensive pregnancy, 35 women with pregnancy-induced hypertension, 67 women with preeclampsia, and 34 women with the HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10476616"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LDHA"}, "span_text": {"type": "literal", "value": "Plasma GSTP1-1 and haptoglobin levels and serum lactate dehydrogenase (LDH) activity were measured in 81 healthy nonpregnant female blood donors between 20 and 40 years of age, 41 women during uncomplicated normotensive pregnancy, 35 women with pregnancy-induced hypertension, 67 women with preeclampsia, and 34 women with the HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10476616"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LDHB"}, "span_text": {"type": "literal", "value": "Plasma GSTP1-1 and haptoglobin levels and serum lactate dehydrogenase (LDH) activity were measured in 81 healthy nonpregnant female blood donors between 20 and 40 years of age, 41 women during uncomplicated normotensive pregnancy, 35 women with pregnancy-induced hypertension, 67 women with preeclampsia, and 34 women with the HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10476616"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GSTP1"}, "span_text": {"type": "literal", "value": "To investigate the value of plasma glutathione S-transferase Pi1-1(GSTP1-1) measurements in the assessment of hemolysis in hypertensive disorders of pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10476616"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "Nitric oxide synthase activity and Doppler parameters in the fetoplacental and uteroplacental circulation in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10476613"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LDHB"}, "span_text": {"type": "literal", "value": "Laboratory evaluation of patients suspected of having preeclampsia need not include a PT, aPTT, or fibrinogen test when there is no evidence of bleeding or of a condition that could produce coagulopathy and when the platelet count and lactate dehydrogenase level are both normal."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10472861"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LDHA"}, "span_text": {"type": "literal", "value": "Laboratory evaluation of patients suspected of having preeclampsia need not include a PT, aPTT, or fibrinogen test when there is no evidence of bleeding or of a condition that could produce coagulopathy and when the platelet count and lactate dehydrogenase level are both normal."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10472861"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LDHD"}, "span_text": {"type": "literal", "value": "Laboratory evaluation of patients suspected of having preeclampsia need not include a PT, aPTT, or fibrinogen test when there is no evidence of bleeding or of a condition that could produce coagulopathy and when the platelet count and lactate dehydrogenase level are both normal."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10472861"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL1B"}, "span_text": {"type": "literal", "value": "The purpose of the present study was to evaluate the clinical significance of tumour necrosis factor-alpha (TNF-alpha) and interleukin-1beta (IL-1beta) for endothelial cell activation in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10471140"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "In this study, short-term antihypertensive treatment with isradipine or metoprolol in preeclampsia had no detrimental effect on serum lipid and lipoprotein levels or insulin sensitivity."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10466475"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "In this study, short-term antihypertensive treatment with isradipine or metoprolol in preeclampsia had no detrimental effect on serum lipid and lipoprotein levels or insulin sensitivity."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10466475"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL6"}, "span_text": {"type": "literal", "value": "To evaluate the contribution of cytokines (Cks) in the pathophysiology of preeclampsia, we investigated the plasma levels of interferon-gamma (IFN-gamma), interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha), respectively, by an enzyme-linked immunosorbent assay."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10466079"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:IL6"}, "span_text": {"type": "literal", "value": "Evaluation of nonspecific immunity and plasma levels of interferon-gamma, interleukin-6 and tumor necrosis factor-alpha in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10466079"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CSF2"}, "span_text": {"type": "literal", "value": "In order to elucidate the potential role of granulocyte-colony-stimulating factor (G-CSF) during the course of normal pregnancy and preeclampsia, we measured the serum concentrations of G-CSF in both normal pregnant women and preeclamptic patients."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10464003"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CSF2"}, "span_text": {"type": "literal", "value": "Concentrations of serum granulocyte-colony-stimulating factor in normal pregnancy and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10464003"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CSF1"}, "span_text": {"type": "literal", "value": "Concentrations of serum granulocyte-colony-stimulating factor in normal pregnancy and preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10464003"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CSF1"}, "span_text": {"type": "literal", "value": "In order to elucidate the potential role of granulocyte-colony-stimulating factor (G-CSF) during the course of normal pregnancy and preeclampsia, we measured the serum concentrations of G-CSF in both normal pregnant women and preeclamptic patients."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10464003"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "To investigate the endothelial cell nitric oxide synthase (eNOS) gene as a candidate for susceptibility to preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10464002"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "We found that a history of severe preeclampsia and spontaneous abortion was associated with elevated lipoprotein(a) levels as a post-hoc finding."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10456446"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Lipoprotein(a) concentrations in women with a history of severe preeclampsia--a case control study."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10456446"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "There was a statistically significant higher prevalence of abnormal levels of lipoprotein(a) in women with a history of severe preeclampsia (33%) in comparison with women with a history of preeclampsia and (H)ELLP syndrome (9%) and with the control group (10%)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10456446"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "We hypothesized that a high concentration of lipoprotein(a) is associated with the development of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10456446"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Insulin sensitivity in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10453843"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX1"}, "span_text": {"type": "literal", "value": "Enhanced glutathione concentrations and glutathione peroxidase activities were often found in placenta and decidua in pre-eclampsia, probably as a compensatory mechanism to prevent further damage by peroxides, (oxygen) radicals or other toxins in the placenta or in the feto-placental interface."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10452907"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX3"}, "span_text": {"type": "literal", "value": "Enhanced glutathione concentrations and glutathione peroxidase activities were often found in placenta and decidua in pre-eclampsia, probably as a compensatory mechanism to prevent further damage by peroxides, (oxygen) radicals or other toxins in the placenta or in the feto-placental interface."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10452907"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:GPX2"}, "span_text": {"type": "literal", "value": "Enhanced glutathione concentrations and glutathione peroxidase activities were often found in placenta and decidua in pre-eclampsia, probably as a compensatory mechanism to prevent further damage by peroxides, (oxygen) radicals or other toxins in the placenta or in the feto-placental interface."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10452907"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MTHFR"}, "span_text": {"type": "literal", "value": "Similarly, homozygosity for the methylenetetrahydrofolate reductase thermolabile variant was associated with a moderate risk of preeclampsia (odds ratio 2.6, 95 per cent CI 1.4-5.1)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10452905"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MTHFR"}, "span_text": {"type": "literal", "value": "Five case-control studies examined the relationship between pre-eclampsia and abnormal levels of vitamin B12, folate, homocyst(e)ine or methylenetetrahydrofolate reductase."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10452905"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MTHFR"}, "span_text": {"type": "literal", "value": "There is a general agreement among several observational studies that folate deficiency, hyperhomocyst(e)inaemia and homozygosity for the methylenetetrahydrofolate reductase thermolabile variant are probable risk factors for placenta-mediated diseases, such as pre-eclampsia, spontaneous abortion and placental abruption."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10452905"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MTHFR"}, "span_text": {"type": "literal", "value": "Terms relating to the measurement of vitamin B12, folic acid, methylenetetrahydrofolate reductase or homocyst(e)ine were combined with those of pre-eclampsia, placental abruption/infarction or spontaneous and habitual abortion."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10452905"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "In patients with preeclampsia, elevated leptin expression goes along with suppressed NPY expression."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10443674"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "The objective of the present study was to examine the impact of preeclampsia on the relation of leptin and neuropeptide Y (NPY) gene expression in human placenta."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10443674"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGT"}, "span_text": {"type": "literal", "value": "There is no evidence that the angiotensinogen 235 Thr allele is associated with pre-eclampsia in the Nottingham population."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10426644"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGT"}, "span_text": {"type": "literal", "value": "There is preliminary evidence that maternal-fetal transmission of an angiotensinogen allele associated with low plasma angiotensinogen concentrations is associated with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10426644"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGT"}, "span_text": {"type": "literal", "value": "Maternal and fetal angiotensinogen gene allele sharing in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10426644"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:AGT"}, "span_text": {"type": "literal", "value": "In contrast to earlier studies, no association was demonstrated between the angiotensinogen 235 Thr variant and pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10426644"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADM"}, "span_text": {"type": "literal", "value": "Adrenomedullin and atrial natriuretic peptide concentrations in normal pregnancy and pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10421805"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADM2"}, "span_text": {"type": "literal", "value": "Adrenomedullin and atrial natriuretic peptide concentrations in normal pregnancy and pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10421805"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NPPB"}, "span_text": {"type": "literal", "value": "Adrenomedullin and atrial natriuretic peptide concentrations in normal pregnancy and pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10421805"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Evidence of a state of increased insulin resistance in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10421232"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CP"}, "span_text": {"type": "literal", "value": "Defective antioxidant mechanisms via changes in serum ceruloplasmin and total iron binding capacity of serum in women with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10413229"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CP"}, "span_text": {"type": "literal", "value": "The aim of this study was to investigate the role of serum ceruloplasmin, its ferroxidase activity and total iron binding capacity in women with pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10413229"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VCAM1"}, "span_text": {"type": "literal", "value": "The study was conducted to determine whether altered plasma levels of soluble intercellular adhesion molecule (ICAM)-1 and soluble vascular cell adhesion molecule (VCAM)-1 are involved in the pathogenesis of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10392229"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VCAM1"}, "span_text": {"type": "literal", "value": "A selective increase in plasma soluble vascular cell adhesion molecule-1 levels in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10392229"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ICAM2"}, "span_text": {"type": "literal", "value": "The study was conducted to determine whether altered plasma levels of soluble intercellular adhesion molecule (ICAM)-1 and soluble vascular cell adhesion molecule (VCAM)-1 are involved in the pathogenesis of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10392229"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ICAM5"}, "span_text": {"type": "literal", "value": "The study was conducted to determine whether altered plasma levels of soluble intercellular adhesion molecule (ICAM)-1 and soluble vascular cell adhesion molecule (VCAM)-1 are involved in the pathogenesis of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10392229"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ICAM1"}, "span_text": {"type": "literal", "value": "The study was conducted to determine whether altered plasma levels of soluble intercellular adhesion molecule (ICAM)-1 and soluble vascular cell adhesion molecule (VCAM)-1 are involved in the pathogenesis of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10392229"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Gestational hypertension but not pre-eclampsia is associated with insulin resistance syndrome characteristics."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10374124"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MTHFR"}, "span_text": {"type": "literal", "value": "Factor V Leiden and thermolabile methylenetetrahydrofolate reductase gene variants in an East Anglian preeclampsia cohort."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10373212"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MTHFR"}, "span_text": {"type": "literal", "value": "Women in the preeclampsia cohort (n=283) were genotyped for both the Leiden variant (G1691A) of factor V and the thermolabile variant (C677T) of methylenetetrahydrofolate reductase."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10373212"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LDHA"}, "span_text": {"type": "literal", "value": "The presence of nausea and vomiting, epigastric pain, or both in association with admission laboratory values that are in excess of the cutoffs for lactate dehydrogenase, aspartate aminotransferase, and uric acid concentrations or for all 6 tests is predictive of high risk of morbidity for the patient with severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10368478"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LDHD"}, "span_text": {"type": "literal", "value": "The presence of nausea and vomiting, epigastric pain, or both in association with admission laboratory values that are in excess of the cutoffs for lactate dehydrogenase, aspartate aminotransferase, and uric acid concentrations or for all 6 tests is predictive of high risk of morbidity for the patient with severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10368478"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LDHB"}, "span_text": {"type": "literal", "value": "The presence of nausea and vomiting, epigastric pain, or both in association with admission laboratory values that are in excess of the cutoffs for lactate dehydrogenase, aspartate aminotransferase, and uric acid concentrations or for all 6 tests is predictive of high risk of morbidity for the patient with severe preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10368478"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LDHD"}, "span_text": {"type": "literal", "value": "Although a significant trend was apparent in increasing levels of lactate dehydrogenase, aspartate aminotransferase, and uric acid as HELLP syndrome worsened, there was considerable variation within groups."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10368474"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LDHB"}, "span_text": {"type": "literal", "value": "Although a significant trend was apparent in increasing levels of lactate dehydrogenase, aspartate aminotransferase, and uric acid as HELLP syndrome worsened, there was considerable variation within groups."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10368474"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LDHA"}, "span_text": {"type": "literal", "value": "Although a significant trend was apparent in increasing levels of lactate dehydrogenase, aspartate aminotransferase, and uric acid as HELLP syndrome worsened, there was considerable variation within groups."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10368474"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ALB"}, "span_text": {"type": "literal", "value": "Thyroid functions in pre-eclampsia and its correlation with maternal age, parity, severity of blood pressure and serum albumin."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10365311"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADM"}, "span_text": {"type": "literal", "value": "We examined the effect of adrenomedullin on the cardiovascular system of an animal model for preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10357253"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "An inhibitor of nitric oxide synthase, N(G)-nitro-L-arginine methyl ester (L-NAME), was infused subcutaneously into rats at a constant rate from day 14 of pregnancy to make an animal model for preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10357253"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:ADM2"}, "span_text": {"type": "literal", "value": "We examined the effect of adrenomedullin on the cardiovascular system of an animal model for preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10357253"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "A condition similar to preeclampsia was induced by infusing pregnant rats with the nitric oxide synthase inhibitor N G -nitro- L -arginine methyl ester through subcutaneously implanted osmotic minipumps."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10329876"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "This study was designed to determine the effects of cyclooxygenase inhibition and prostacyclin agonists on the hypertension induced by nitric oxide synthase blockade in a previously characterized rat model of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10329876"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Both the fasting plasma insulin and insulin response following glucose injection were lower in patients with severe pre-eclampsia than in those with mild pre-eclampsia or a normal pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/1032812"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "To compare maternal and umbilical venous big endothelin (big ET) and endothelin-1 (ET-1) levels of pregnancies complicated by severe preeclampsia (PE) or HELLP-syndrome to those of a well-matched normotensive pregnant control group."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10326629"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:CP"}, "span_text": {"type": "literal", "value": "Assessment of serum copper level and ceruloplasmin activity in toxaemia of pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/1032372"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "To determine whether perturbations of haemostatic function and lipoprotein metabolism prevail long after preeclampsia and increase the risk of future coronary heart disease (CHD), we conducted a follow-up study in women with (cases, n = 25) or without (controls, n = 24) a history of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10235435"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Compared to control women who had undergone a normal pregnancy, the formerly preeclamptic patients had higher systolic (p <0.01) and diastolic (p <0.05) BPs and increased plasma levels of von Willebrand factor (vWF), fibrinogen, cholesterol, triglycerides and very low density lipoprotein (VLDL) (all p <0.05)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10235435"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LPA"}, "span_text": {"type": "literal", "value": "Haemostatic, endothelial and lipoprotein parameters and blood pressure levels in women with a history of preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10235435"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VWF"}, "span_text": {"type": "literal", "value": "Compared to control women who had undergone a normal pregnancy, the formerly preeclamptic patients had higher systolic (p <0.01) and diastolic (p <0.05) BPs and increased plasma levels of von Willebrand factor (vWF), fibrinogen, cholesterol, triglycerides and very low density lipoprotein (VLDL) (all p <0.05)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10235435"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD1"}, "span_text": {"type": "literal", "value": "A deficiency in superoxide dismutase (SOD) activity in preeclamptic placentas can lead to an excess of superoxide radicals and may be responsible for the development and the severity of preeclampsia (PE)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10224751"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:SOD3"}, "span_text": {"type": "literal", "value": "A deficiency in superoxide dismutase (SOD) activity in preeclamptic placentas can lead to an excess of superoxide radicals and may be responsible for the development and the severity of preeclampsia (PE)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10224751"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "In association with a 3-hour intravenous glucose-tolerance test (glucose 0.3 g/kg at 0 and 0.03 IU insulin 20 minutes later), we measured plasma levels of homocysteine, vitamin B12, and folic acid in 22 women with preeclampsia and 16 controls between 29 and 39 weeks' gestation."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10214820"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "In women with preeclampsia but not in controls, plasma homocysteine was negatively related to insulin sensitivity (r = -.51, P = .02)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10214820"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Plasma homocysteine levels elevated and inversely related to insulin sensitivity in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10214820"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "Women with preeclampsia have high plasma homocysteine levels that are inversely related to insulin sensitivity."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10214820"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "To study the plasma levels of homocysteine in preeclampsia and relate them to insulin sensitivity."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10214820"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "The placenta was also shown recently to be a possible source of leptin in pregnant women, raising the possibility that the normal relationship between leptin and adiposity may be altered in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10214609"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Multiple least-squares regression procedures were used to assess the independent relationship between leptin concentrations and risk of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10214609"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "In contrast, pre-eclampsia cases had lower mean leptin concentrations than controls for those women with a pre-pregnancy body mass index above 25 kg/m2."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10214609"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "We therefore sought to assess the extent to which maternal second trimester serum leptin concentrations differed for women who would subsequently develop pre-eclampsia and those who would remain normotensive."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10214609"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Our results suggest the possibility that leptin, like several other placentally derived substances (e.g. steroid hormones, eicosanoids and cytokines), may be involved in the pathogenesis of pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10214609"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Serum leptin concentrations, measured by radioimmunoassay, were highly correlated with maternal pre-pregnancy and second trimester body mass index (r = 0.71 and r = 0.74 respectively; P < 0.001 for both) among normotensive women, and to a lesser extent among women who developed pre-eclampsia (r = 0.29 and r = 0.42; P = 0.09 and 0.02 respectively)."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10214609"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Pre-eclampsia disrupts the normal relationship between serum leptin concentrations and adiposity in pregnant women."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10214609"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Among women with a pre-pregnancy body mass index of < or = 25 kg/m2, pre-eclampsia cases compared with controls had higher mean second trimester leptin concentrations after adjustment for confounding factors."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10214609"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:MTHFR"}, "span_text": {"type": "literal", "value": "Methylenetetrahydrofolate reductase polymorphism, folate, and susceptibility to preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10205777"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:PDGFD"}, "span_text": {"type": "literal", "value": "Immunochemical localization of platelet-derived growth factor in placenta and its possible role in pre-eclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10198568"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "In comparing hypertensive subgroups, fasting insulin levels were significantly higher among women who subsequently developed preeclampsia, but not among those subsequently developing nonproteinuric gestational hypertension."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10192230"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:INS"}, "span_text": {"type": "literal", "value": "We performed a case-control study comparing cholesterol, insulin, and glucose levels in the early third trimester of pregnancy among 31 women who developed pregnancy-induced hypertension (PIH) (either preeclampsia [n = 6] or nonproteinuric gestational hypertension [n = 25]), with 31 women remaining normotensive through pregnancy."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10192230"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:NOS3"}, "span_text": {"type": "literal", "value": "Chronic nitric oxide synthase inhibition in rats produces a pattern of change that resembles the symptoms of preeclampsia, and the preeclamptic-like response of rats with adriamycin nephropathy and hyperinsulinemia is associated with endothelial dysfunction."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10102166"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Maternal and cord leptin correlated significantly (rho = 0.76, P <.01) only in preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10076155"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "We tested the hypothesis that the maternal leptin concentration would be increased in preeclampsia, independent of maternal obesity."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10076155"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Maternal plasma leptin is increased in preeclampsia and positively correlates with fetal cord concentration."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10076155"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Maternal and cord plasma leptin concentrations were compared in 2 groups of women with either preeclampsia (n = 24) or normal pregnancy (n = 24), matched 1:1 for prepregnancy body mass index and fetal gestational age at sampling."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10076155"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:LEP"}, "span_text": {"type": "literal", "value": "Preeclampsia is associated with an increase in maternal plasma leptin concentrations that strongly correlates with the fetal cord concentration at delivery."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10076155"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:EDN1"}, "span_text": {"type": "literal", "value": "The mean plasma level of endothelin-1 was increased (5.1+/-1.4 versus 3.6+/-1.0 pg/mL, P < .001), and urinary output of the prostacyclin metabolite 2,3-dinor-6-keto-prostaglandin F1alpha was decreased (39.1+/-18.0 versus 61.3+/-35.6 ng/mmol creatinine, P = .019) with preeclampsia."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10074996"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFB"}, "span_text": {"type": "literal", "value": "Preeclampsia: the endothelium, circulating factor(s) and vascular endothelial growth factor."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10065419"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFA"}, "span_text": {"type": "literal", "value": "Preeclampsia: the endothelium, circulating factor(s) and vascular endothelial growth factor."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10065419"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VEGFC"}, "span_text": {"type": "literal", "value": "Preeclampsia: the endothelium, circulating factor(s) and vascular endothelial growth factor."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10065419"}}, {"disease": {"type": "uri", "value": "http://pubannotation.org/projects/Preeclampsia/ORPHA:275555"}, "gene": {"type": "uri", "value": "http://pubannotation.org/projects/preeclampsia_genes/HGNC:VWF"}, "span_text": {"type": "literal", "value": "Also associated with preeclampsia is a loss of endothelial cell integrity, with the consequent increase in vascular permeability, and an increase in the circulating levels of the endothelial cell markers, fibronectin, von Willebrand factor, tissue plasminogen activator, and plasminogen activator inhibitor-1."}, "doc": {"type": "uri", "value": "http://pubannotation.org/docs/sourcedb/PubMed/sourceid/10065419"}}]}}